data_2g9o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2g9o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 122.834 1.302 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -82.46 159.42 22.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.712 0.767 . . . . 0.0 110.915 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -152.82 153.35 32.95 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.954 -1.092 . . . . 0.0 108.284 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.5 39.91 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.094 1.758 . . . . 0.0 110.763 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 m -126.16 141.1 52.07 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.586 1.154 . . . . 0.0 109.842 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -140.28 136.4 33.24 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.66 135.69 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 C-N-CA 125.07 1.348 . . . . 0.0 110.57 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.84 129.34 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.403 1.081 . . . . 0.0 111.07 -172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.43 129.62 46.42 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.662 -0.649 . . . . 0.0 109.547 163.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 -1.67 28.42 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.852 1.215 . . . . 0.0 113.554 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.0 ptm -65.35 149.0 50.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.033 0.917 . . . . 0.0 113.087 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -73.64 33.78 0.08 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.48 1.512 . . . . 0.0 112.999 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t 66.3 -143.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.399 1.48 . . . . 0.0 111.301 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HE3' HD11 ' A' ' 38' ' ' LEU . 46.4 mttp -61.72 -14.68 34.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.652 1.981 . . . . 0.0 115.576 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.0 p -91.74 -41.51 10.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.04 168.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.37 -49.32 70.09 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 121.53 1.968 . . . . 0.0 109.62 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -36.05 -48.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.797 2.039 . . . . 0.0 112.91 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -83.4 -25.36 31.39 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -58.0 -35.54 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 119.91 -1.744 . . . . 0.0 110.138 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -43.15 78.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 CA-C-O 117.531 -1.223 . . . . 0.0 110.424 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -50.4 -51.04 49.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.664 0.786 . . . . 0.0 110.145 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -69.77 -42.14 74.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -70.87 -41.09 71.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 110.714 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -46.1 46.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.554 -1.212 . . . . 0.0 111.668 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -72.62 14.74 0.23 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.465 1.484 . . . . 0.0 113.579 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.97 -2.79 18.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.411 1.484 . . . . 0.0 112.187 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.25 130.58 35.3 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 111.332 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -58.99 -2.84 0.28 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.646 1.578 . . . . 0.0 115.25 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 -3.4 11.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.608 1.963 . . . . 0.0 115.942 172.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -95.16 144.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.197 1.817 . . . . 0.0 110.523 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -99.0 -27.77 13.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.87 1.668 . . . . 0.0 111.789 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m 176.79 176.67 0.31 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.898 2.079 . . . . 0.0 112.802 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -172.27 150.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.967 2.107 . . . . 0.0 110.493 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.73 134.64 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.074 2.15 . . . . 0.0 106.869 166.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.04 141.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.052 0.93 . . . . 0.0 110.468 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 m -76.44 84.37 3.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.659 1.183 . . . . 0.0 110.046 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.4 HD11 ' HE3' ' A' ' 15' ' ' LYS . 1.3 tm? -51.93 -43.35 63.4 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 113.07 -167.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.36 -41.89 94.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.479 0.712 . . . . 0.0 112.319 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -100.72 -170.74 1.9 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.313 3.445 . . . . 0.0 112.98 -169.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.21 32.61 4.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.052 2.141 . . . . 0.0 114.473 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.8 p -137.23 166.02 24.76 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.17 -1.581 . . . . 0.0 114.114 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.07 142.64 40.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.438 1.895 . . . . 0.0 110.649 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -108.74 117.36 54.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 131.83 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.164 1.386 . . . . 0.0 108.336 -167.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.48 110.86 32.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.445 1.498 . . . . 0.0 107.724 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -121.88 -165.28 1.24 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.565 1.546 . . . . 0.0 111.351 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.479 0.992 0 CA-C-N 122.269 2.304 . . . . 0.0 114.119 178.004 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo . . . . . 0 CA--C 1.54 0.779 0 N-CA-C 113.872 0.681 . . . . 0.0 113.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.91 -31.17 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.437 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.4 p -70.37 -38.87 74.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.552 -1.342 . . . . 0.0 112.818 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.99 -43.97 70.33 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.564 175.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -50.52 -50.95 51.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.578 1.151 . . . . 0.0 110.768 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -37.39 74.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.332 1.453 . . . . 0.0 113.801 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.5 73.87 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.582 1.083 . . . . 0.0 111.636 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -68.37 -51.47 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.131 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -49.4 -35.77 20.03 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.618 0.645 . . . . 0.0 111.377 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.03 5.2 8.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -100.03 -26.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.003 1.321 . . . . 0.0 111.577 176.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.97 68.29 8.8 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 167.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.38 144.25 90.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.09 3.193 . . . . 0.0 112.717 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 -25.02 3.98 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.736 1.16 . . . . 0.0 113.392 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.18 -45.09 8.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.283 1.433 . . . . 0.0 111.948 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -75.02 109.65 8.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -169.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -86.55 81.7 8.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.5 t -87.51 124.66 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.758 0.823 . . . . 0.0 112.641 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.76 131.59 43.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.177 0.991 . . . . 0.0 111.862 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.45 83.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.656 -1.278 . . . . 0.0 110.796 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 124.724 1.21 . . . . 0.0 111.472 -179.181 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 CA-C-O 122.062 0.934 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -93.8 174.4 7.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.093 0.949 . . . . 0.0 110.018 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -165.13 148.32 8.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.017 -1.052 . . . . 0.0 110.478 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.08 31.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.569 1.548 . . . . 0.0 110.94 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -134.03 143.2 47.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 109.613 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -143.07 149.35 38.07 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.414 1.486 . . . . 0.0 111.724 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -133.46 136.75 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 125.301 1.44 . . . . 0.0 110.959 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.38 90.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.188 2.195 . . . . 0.0 109.606 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.14 39.01 0.3 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.179 1.392 . . . . 0.0 113.452 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.48 40.11 0.18 Allowed Glycine 0 N--CA 1.469 0.844 0 C-N-CA 125.763 1.649 . . . . 0.0 112.638 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 tmm? -102.72 150.11 23.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.671 1.588 . . . . 0.0 111.743 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -66.59 9.22 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m 81.91 -54.11 0.25 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.276 3.03 . . . . 0.0 114.572 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HE2' HD11 ' A' ' 38' ' ' LEU 0.29 50.8 mttt -125.42 -57.1 1.49 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.667 1.121 . . . . 0.0 112.656 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -65.37 -13.54 58.83 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.333 -2.105 . . . . 0.0 113.903 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.275 1.2 m -71.76 -36.06 70.28 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.668 168.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.8 t -47.11 -48.85 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.308 1.843 . . . . 0.0 111.83 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -63.83 -42.39 97.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.315 1.446 . . . . 0.0 113.091 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.48 -34.77 72.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.122 -1.611 . . . . 0.0 113.014 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -41.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.573 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -52.45 -54.51 31.37 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 167.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.7 t -69.95 -38.24 76.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -75.22 -37.17 61.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 110.594 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 27' ' ' ALA . 6.5 mt -74.01 -51.16 16.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.749 -1.119 . . . . 0.0 112.866 171.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -71.8 11.86 0.46 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.28 1.4 . . . . 0.0 113.866 -169.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -108.87 -1.5 19.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.861 1.664 . . . . 0.0 112.591 172.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -77.39 134.31 38.47 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 120.789 -1.195 . . . . 0.0 111.589 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.22 72.39 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 109.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 159.73 -20.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.804 3.642 . . . . 0.0 113.676 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.8 p -91.12 144.63 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 121.933 2.152 . . . . 0.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 t -114.96 -7.9 12.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m 178.76 172.84 0.75 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.914 2.086 . . . . 0.0 112.971 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -171.4 152.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.173 2.189 . . . . 0.0 110.077 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.4 150.53 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 128.712 2.805 . . . . 0.0 106.614 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.82 151.02 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.952 0.501 . . . . 0.0 110.942 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -82.57 135.78 34.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.166 0.587 . . . . 0.0 111.209 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.422 HD11 ' HE2' ' A' ' 15' ' ' LYS . 1.3 tm? -76.18 -33.99 59.33 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 121.098 -1.001 . . . . 0.0 112.083 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.77 -55.78 3.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.237 1.415 . . . . 0.0 111.917 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -76.99 138.1 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.551 0.74 . . . . 0.0 109.467 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 40.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 p -141.47 152.7 44.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.42 1.488 . . . . 0.0 114.627 -169.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.86 143.01 50.59 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.217 2.207 . . . . 0.0 111.105 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.11 120.16 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 127.199 2.2 . . . . 0.0 105.716 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 t -125.61 134.56 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.124 0.969 . . . . 0.0 109.96 -166.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 110.28 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.132 1.373 . . . . 0.0 108.863 -168.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 44.3 p90 -123.16 168.34 12.54 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.42 1.088 . . . . 0.0 113.853 -170.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 CA--C 1.534 0.34 0 O-C-N 120.551 -1.343 . . . . 0.0 110.406 -172.15 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.539 0.77 0 CA-C-O 119.468 -0.305 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 5.8 tm-20 -61.08 -30.3 70.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -74.25 -39.94 62.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.599 1.16 . . . . 0.0 113.668 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.2 -43.84 85.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.285 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -49.33 -56.39 9.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.123 0.874 . . . . 0.0 110.459 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 55' ' ' GLU . 1.2 mptm? -49.85 -39.5 39.25 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.56 72.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.57 1.077 . . . . 0.0 111.803 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.91 -54.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.274 0.63 . . . . 0.0 109.691 170.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -51.83 -29.35 19.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.785 0.834 . . . . 0.0 111.877 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.01 0.41 40.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -96.57 -29.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.692 1.197 . . . . 0.0 111.386 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.99 65.4 9.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 121.545 -0.722 . . . . 0.0 111.801 168.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.23 144.77 98.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.355 3.37 . . . . 0.0 113.376 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.04 -19.56 6.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.537 1.541 . . . . 0.0 114.08 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -106.16 -45.99 4.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.961 1.704 . . . . 0.0 111.216 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.412 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.0 m-30 -66.74 109.03 2.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.268 1.027 . . . . 0.0 113.703 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -78.5 80.03 4.9 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 110.759 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 t -84.97 127.25 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.1 0.863 . . . . 0.0 111.877 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -138.4 146.81 42.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.59 1.156 . . . . 0.0 111.089 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.69 130.21 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.725 0.774 . . . . 0.0 110.561 172.483 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 122.575 1.179 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -137.53 173.1 12.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.726 2.01 . . . . 0.0 109.084 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -161.75 156.39 22.8 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.734 -1.229 . . . . 0.0 110.336 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.35 160.89 38.94 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.48 1.512 . . . . 0.0 111.055 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -124.19 141.56 51.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.163 1.385 . . . . 0.0 110.194 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -141.75 145.2 34.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.853 1.261 . . . . 0.0 111.629 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.26 127.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 111.933 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.81 102.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.514 1.926 . . . . 0.0 111.497 -167.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -81.81 42.55 0.71 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.235 1.014 . . . . 0.0 113.665 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.02 3.66 0.03 OUTLIER Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.223 1.868 . . . . 0.0 117.438 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -75.73 145.6 40.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.739 2.269 . . . . 0.0 113.781 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -66.04 27.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.693 1.997 . . . . 0.0 114.982 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m 53.5 -129.53 2.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.825 1.65 . . . . 0.0 110.967 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HE2' HD13 ' A' ' 38' ' ' LEU . 1.6 mptm? -52.25 -32.31 36.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -170.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m -84.62 -28.57 26.4 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.555 -1.341 . . . . 0.0 113.143 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.81 -41.04 72.11 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.18 -1.391 . . . . 0.0 111.532 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -40.15 -54.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.7 2.0 . . . . 0.0 111.033 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -61.09 -41.74 97.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.508 1.123 . . . . 0.0 113.768 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.99 -38.38 85.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.297 -1.502 . . . . 0.0 112.934 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -36.44 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.213 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.27 -55.35 32.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.47 1.108 . . . . 0.0 109.687 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -67.61 -53.33 28.95 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.477 ' HG1' HG23 ' A' ' 64' ' ' VAL . 62.5 m -62.02 -38.46 88.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.894 1.278 . . . . 0.0 111.316 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -51.23 12.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.65 -1.167 . . . . 0.0 112.199 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -69.98 6.19 1.32 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.739 1.609 . . . . 0.0 113.928 -171.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.68 -6.81 24.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.817 1.647 . . . . 0.0 111.305 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 mt -75.39 128.02 34.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.15 -15.87 27.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -93.84 -12.17 29.57 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 p -93.57 143.72 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 121.161 1.8 . . . . 0.0 109.965 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.2 t -111.21 -11.63 14.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m 176.91 174.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.763 2.425 . . . . 0.0 113.005 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -172.71 150.48 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.674 2.39 . . . . 0.0 109.561 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.85 130.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 107.029 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.55 149.91 12.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.792 0.806 . . . . 0.0 111.041 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -80.58 113.02 18.47 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.487 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.5 tm? -60.31 -41.62 93.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.911 0.778 . . . . 0.0 111.366 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 1.9 tp10 -97.25 -22.42 16.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.276 1.83 . . . . 0.0 114.638 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -115.91 155.85 27.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.773 1.229 . . . . 0.0 110.835 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.292 0.0 OUTLIER -78.5 38.32 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 p -138.77 157.92 45.18 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.52 139.9 35.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.809 2.044 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.76 121.26 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 106.14 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.9 t -120.26 136.97 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.164 1.386 . . . . 0.0 108.468 -169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.5 t -124.34 105.2 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.714 1.205 . . . . 0.0 109.72 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -122.0 164.91 16.83 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.32 1.448 . . . . 0.0 113.967 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.974 -171.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.176 0.798 . . . . 0.0 114.176 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.16 -32.16 67.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.388 0.995 . . . . 0.0 113.215 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 m -70.22 -36.3 74.45 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.907 -1.121 . . . . 0.0 112.215 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -71.86 -45.76 60.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.674 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -48.86 -47.49 42.78 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.659 0.783 . . . . 0.0 110.463 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -35.39 79.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.36 73.26 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 121.28 1.855 . . . . 0.0 112.127 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.93 -57.97 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.719 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -49.72 -27.89 5.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.488 1.115 . . . . 0.0 112.573 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 0.68 44.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 ' HG1' ' A' ' 24' ' ' THR . 0.8 OUTLIER -93.56 -29.9 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.978 0.911 . . . . 0.0 111.514 177.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.84 64.06 9.87 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 121.424 -0.798 . . . . 0.0 111.5 167.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.28 144.01 99.5 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.095 3.197 . . . . 0.0 112.464 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.31 -29.89 4.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.714 1.149 . . . . 0.0 113.007 -174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.3 tp -92.23 -48.23 6.8 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.046 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.441 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -71.26 99.09 1.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.354 1.062 . . . . 0.0 113.346 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -75.06 119.87 19.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 114.617 -2.611 . . . . 0.0 105.336 162.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 t -123.25 134.96 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 124.274 3.215 . . . . 0.0 112.544 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.16 134.6 45.6 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.042 1.337 . . . . 0.0 110.178 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.9 mt -74.22 123.45 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.185 -1.572 . . . . 0.0 110.38 170.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.522 -0.13 0 C-N-CA 123.456 0.702 . . . . 0.0 109.126 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.796 0.807 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -88.91 172.15 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 163.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -157.33 138.29 13.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.52 -1.362 . . . . 0.0 110.311 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.35 158.74 43.59 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.672 1.589 . . . . 0.0 110.654 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.4 m -120.35 141.86 49.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.724 1.21 . . . . 0.0 109.414 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -137.04 139.89 41.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.106 1.362 . . . . 0.0 109.512 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -121.55 139.67 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 123.924 0.89 . . . . 0.0 110.818 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 147.57 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 O-C-N 125.086 1.492 . . . . 0.0 110.25 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -123.59 141.38 52.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.449 1.1 . . . . 0.0 108.465 162.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.43 -27.24 8.57 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 126.19 1.852 . . . . 0.0 113.369 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.546 ' CB ' ' HG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -67.32 125.1 25.04 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 129.632 3.173 . . . . 0.0 118.104 -166.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.62 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 2.5 m-70 -74.61 55.58 0.66 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.789 2.836 . . . . 0.0 117.871 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.76 -141.46 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 119.94 -1.725 . . . . 0.0 114.781 165.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.84 -31.24 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 118.823 -2.423 . . . . 0.0 111.149 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.03 -54.29 27.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.704 -1.141 . . . . 0.0 112.224 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.546 ' HG ' ' CB ' ' A' ' 12' ' ' MET . 32.0 p -55.02 -55.14 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.475 1.488 . . . . 0.0 110.275 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -44.74 -54.12 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.523 2.329 . . . . 0.0 111.487 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.8 m -70.72 -26.5 63.42 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -60.5 -46.57 89.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.614 1.097 . . . . 0.0 109.309 165.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -40.25 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.437 -0.79 . . . . 0.0 111.846 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -54.19 -46.41 72.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.285 1.434 . . . . 0.0 109.33 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 t -73.03 -64.33 0.99 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -56.41 -36.58 69.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.828 2.451 . . . . 0.0 112.439 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 27' ' ' ALA . 10.4 mt -72.31 -43.92 63.46 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.828 169.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -67.84 13.05 0.09 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.642 1.565 . . . . 0.0 114.636 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -114.57 2.13 14.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.691 1.996 . . . . 0.0 112.262 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.32 137.65 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.81 -1.181 . . . . 0.0 111.863 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 67.27 0.77 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.685 1.594 . . . . 0.0 111.864 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 166.73 -20.77 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 129.956 3.303 . . . . 0.0 113.148 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.7 p -85.92 137.16 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 121.288 1.858 . . . . 0.0 110.895 -171.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -103.82 -19.04 14.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.376 1.47 . . . . 0.0 112.594 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m 178.16 167.19 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.632 2.373 . . . . 0.0 112.423 -171.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.4 tt -171.64 149.22 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.672 1.989 . . . . 0.0 112.479 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.7 t -141.09 144.35 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.494 2.317 . . . . 0.0 106.948 166.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.51 130.14 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 123.382 1.563 . . . . 0.0 110.842 168.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -80.64 91.28 5.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.807 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tp -51.21 -56.95 10.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.311 1.444 . . . . 0.0 111.201 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.85 -56.07 13.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.45 1.1 . . . . 0.0 110.926 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.44 15.42 5.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 51.47 29.47 5.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.452 1.901 . . . . 0.0 114.738 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 p -133.59 149.73 51.62 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -168.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.65 53.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.466 1.506 . . . . 0.0 109.109 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -101.25 109.75 26.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.96 132.61 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 124.781 1.232 . . . . 0.0 108.251 -166.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.03 108.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -169.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 12.6 p90 -130.87 137.59 49.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.774 1.23 . . . . 0.0 113.84 -167.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.616 0 O-C-N 120.223 -1.548 . . . . 0.0 112.378 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 118.813 -0.578 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.95 -20.39 23.35 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.156 0.889 . . . . 0.0 112.13 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -42.17 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.501 -1.374 . . . . 0.0 112.134 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.06 -42.05 73.34 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.693 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -51.44 -49.86 60.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.428 1.091 . . . . 0.0 110.913 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -61.59 -34.28 75.35 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.22 75.17 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 120.277 1.399 . . . . 0.0 112.159 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -70.27 -55.29 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.331 -0.856 . . . . 0.0 110.974 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.54 -16.86 17.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.276 0.943 . . . . 0.0 112.124 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.15 -0.65 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.421 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -91.93 -31.34 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.059 0.845 . . . . 0.0 111.83 175.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -144.35 59.32 6.59 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.9 139.43 84.31 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 125.128 3.885 . . . . 0.0 114.374 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.31 -25.71 3.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.014 1.292 . . . . 0.0 113.571 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -42.28 9.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.032 1.733 . . . . 0.0 109.245 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 4.3 m-30 -76.53 106.93 8.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 115.176 1.546 . . . . 0.0 115.176 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.283 5.5 mtt-85 -73.47 137.24 44.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 158.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.36 135.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 122.375 2.352 . . . . 0.0 110.292 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 p -138.45 151.79 47.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.3 mt -84.04 85.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.465 1.106 . . . . 0.0 108.397 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 122.436 1.113 . . . . 0.0 108.287 169.406 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 122.224 1.011 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 t -125.98 171.72 10.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.888 1.275 . . . . 0.0 110.105 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.418 ' HG1' ' HA ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -152.21 166.53 31.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.196 0.999 . . . . 0.0 110.421 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.98 36.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.648 1.579 . . . . 0.0 110.898 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -123.3 135.09 54.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.276 1.43 . . . . 0.0 110.245 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -138.2 146.63 42.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.816 1.246 . . . . 0.0 111.406 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -132.8 135.81 56.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.905 1.282 . . . . 0.0 112.224 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.48 106.39 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.463 1.505 . . . . 0.0 111.771 -167.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.36 -3.96 36.59 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 119.346 -2.096 . . . . 0.0 115.673 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.54 5.85 44.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.556 1.074 . . . . 0.0 111.736 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 ttp -77.51 131.1 37.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 122.041 -0.682 . . . . 0.0 110.012 -169.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -64.86 6.62 0.22 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.553 1.541 . . . . 0.0 113.572 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.1 m 76.88 -40.13 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.388 2.275 . . . . 0.0 116.607 164.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 -85.2 0.62 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -52.47 -27.93 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.403 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.3 m -51.15 -39.19 55.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.261 1.391 . . . . 0.0 112.964 169.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -57.0 -42.2 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.073 1.349 . . . . 0.0 112.771 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -59.96 -40.41 88.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 0.0 111.434 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -66.3 -44.72 82.69 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 121.989 -0.445 . . . . 0.0 111.594 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -45.75 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 119.229 -0.415 . . . . 0.0 109.962 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.92 -51.4 61.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.525 1.13 . . . . 0.0 110.45 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.6 t -70.71 -37.18 73.52 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -74.28 -41.36 61.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 110.329 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -72.61 -48.17 41.8 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.899 -1.524 . . . . 0.0 110.66 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 t -72.83 14.64 0.25 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.312 1.869 . . . . 0.0 113.588 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -108.45 -6.85 15.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.12 1.768 . . . . 0.0 112.108 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.9 mt -73.29 129.44 38.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.909 -1.119 . . . . 0.0 109.167 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -60.22 -17.59 42.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -170.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.61 -8.56 31.42 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 171.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.3 p -94.54 138.6 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.604 2.002 . . . . 0.0 109.725 -173.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 t -107.77 -12.98 15.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.819 . . . . 0.0 113.165 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m 179.17 174.63 0.72 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.82 2.448 . . . . 0.0 111.769 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -172.73 154.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.694 2.398 . . . . 0.0 109.468 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.28 129.8 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.464 2.305 . . . . 0.0 108.162 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -103.62 136.63 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 122.701 1.238 . . . . 0.0 111.739 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -78.29 93.23 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.577 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.9 -43.41 73.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.714 0.806 . . . . 0.0 112.981 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.95 -44.02 19.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.187 1.395 . . . . 0.0 112.587 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.41 -170.93 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.286 2.634 . . . . 0.0 114.646 -168.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -101.18 19.15 18.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.233 1.813 . . . . 0.0 114.376 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 p -136.55 156.61 48.34 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -167.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.36 136.95 49.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.495 1.918 . . . . 0.0 110.572 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.14 122.03 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -123.42 120.61 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 108.996 -166.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HA ' ' HG1' ' A' ' 4' ' ' THR . 69.7 t -105.49 111.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.515 1.526 . . . . 0.0 109.14 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 38.9 p90 -123.23 157.86 32.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.48 1.112 . . . . 0.0 112.821 -173.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 CA--C 1.538 0.496 0 O-C-N 121.012 -1.055 . . . . 0.0 111.879 -169.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 N-CA-C 113.506 0.541 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -55.96 -48.0 76.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.276 1.43 . . . . 0.0 111.479 -172.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.6 -29.16 68.43 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.275 -0.891 . . . . 0.0 112.373 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.83 -49.22 48.62 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.02 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -52.8 -48.23 67.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.362 1.065 . . . . 0.0 110.648 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -56.86 -40.52 76.3 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.05 85.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.541 1.519 . . . . 0.0 112.128 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -63.37 -54.85 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.051 0.54 . . . . 0.0 109.923 172.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -50.81 -33.68 24.58 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.353 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.62 5.12 13.98 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -101.46 -26.7 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.981 1.312 . . . . 0.0 111.725 176.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.51 65.99 8.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.793 0.837 . . . . 0.0 110.633 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.9 143.86 92.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.113 3.209 . . . . 0.0 112.583 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -33.51 3.01 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.882 1.229 . . . . 0.0 113.183 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 tp -85.72 -46.66 10.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.545 1.538 . . . . 0.0 111.631 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' A' ' 64' ' ' VAL . 4.0 m-30 -73.97 106.19 5.55 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -71.64 39.02 0.06 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.405 1.882 . . . . 0.0 114.893 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.55 125.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.3 m -137.43 156.68 47.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.245 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.7 mt -95.63 127.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.355 1.462 . . . . 0.0 109.152 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 C-N-CA 123.774 0.829 . . . . 0.0 109.703 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 122.526 1.155 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -102.07 -172.69 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.356 1.462 . . . . 0.0 111.869 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.28 149.76 10.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.054 1.342 . . . . 0.0 109.711 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.15 162.46 41.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.948 1.699 . . . . 0.0 110.816 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m -119.83 140.06 51.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 109.576 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -140.71 143.68 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 111.601 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.21 131.07 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.944 0.898 . . . . 0.0 110.957 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.77 128.63 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.497 -168.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.67 116.65 29.15 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.406 -0.809 . . . . 0.0 108.967 164.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.24 -12.55 8.02 Favored Glycine 0 N--CA 1.466 0.692 0 C-N-CA 124.062 0.839 . . . . 0.0 113.236 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 146.35 54.15 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.1 0.95 . . . . 0.0 111.462 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -62.05 2.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.706 2.002 . . . . 0.0 115.737 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.2 m 64.63 26.92 13.25 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 166.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.38 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.638 2.775 . . . . 0.0 106.597 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m -52.76 -26.87 15.49 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.1 2.227 . . . . 0.0 115.456 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.1 -38.57 39.23 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 120.19 1.359 . . . . 0.0 112.288 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 t -53.83 -41.38 48.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 125.107 1.363 . . . . 0.0 113.653 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -62.6 -38.22 89.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.819 0.447 . . . . 0.0 111.572 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -68.21 -45.95 71.91 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.174 0.589 . . . . 0.0 111.947 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -44.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.348 -173.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.25 -49.17 70.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.905 1.282 . . . . 0.0 110.423 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.0 m -68.45 -44.17 75.44 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 m -70.66 -39.52 73.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.764 1.226 . . . . 0.0 111.253 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.78 -51.48 16.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.436 -1.269 . . . . 0.0 110.565 175.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t -74.91 17.96 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.685 1.584 . . . . 0.0 113.394 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -114.86 -0.5 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.491 1.916 . . . . 0.0 112.178 171.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.61 135.43 42.02 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.675 -1.266 . . . . 0.0 111.103 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -47.85 -19.11 0.21 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.464 2.305 . . . . 0.0 116.355 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -7.96 11.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.231 1.813 . . . . 0.0 115.621 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.23 136.13 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 121.739 2.063 . . . . 0.0 111.938 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -89.95 -33.91 16.22 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -173.98 176.06 2.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.771 1.628 . . . . 0.0 112.394 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -172.77 154.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.324 2.25 . . . . 0.0 109.981 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.5 t -147.29 128.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.327 2.251 . . . . 0.0 108.045 166.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -102.31 135.94 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.682 1.23 . . . . 0.0 111.595 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -77.02 94.36 3.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.122 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.02 -38.42 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -51.78 -48.39 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.503 1.121 . . . . 0.0 111.104 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -96.99 -170.56 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 129.791 3.237 . . . . 0.0 113.487 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.11 34.94 3.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.217 1.407 . . . . 0.0 112.639 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 p -142.83 153.22 43.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.87 136.33 50.3 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.881 2.072 . . . . 0.0 110.812 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -106.9 116.87 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -118.81 132.23 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 0.0 107.704 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.98 101.45 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 37.8 p90 -122.02 141.63 51.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -168.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 CA--C 1.541 0.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.796 178.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 CA--C 1.536 0.596 0 CA-C-O 119.278 -0.384 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -47.55 -26.63 1.49 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.731 1.612 . . . . 0.0 112.811 168.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -69.38 -42.45 75.13 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.046 -1.034 . . . . 0.0 112.722 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.92 -43.54 74.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.852 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -50.4 -46.96 56.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.35 0.977 . . . . 0.0 111.094 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.88 64.0 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.94 90.92 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.574 1.988 . . . . 0.0 110.361 168.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.28 -56.48 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.745 -0.597 . . . . 0.0 110.917 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -56.96 -19.8 20.14 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.06 0.4 56.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -89.76 -32.89 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.838 0.855 . . . . 0.0 111.332 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.93 67.13 12.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.064 0.546 . . . . 0.0 111.373 169.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.74 139.02 88.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 124.219 3.279 . . . . 0.0 112.224 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.31 -33.85 3.14 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.973 1.273 . . . . 0.0 113.146 -173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -78.7 -46.94 17.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.896 0.848 . . . . 0.0 110.07 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CE2' HG11 ' A' ' 64' ' ' VAL . 4.2 m-30 -84.54 122.84 29.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.892 1.677 . . . . 0.0 113.844 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.33 105.36 13.98 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.831 1.652 . . . . 0.0 108.408 169.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.86 135.1 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 120.889 1.677 . . . . 0.0 111.402 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.1 p -126.46 156.0 41.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.241 0.543 . . . . 0.0 111.795 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.4 mt -92.9 121.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.171 1.388 . . . . 0.0 109.264 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.154 0 C-N-CA 123.153 0.581 . . . . 0.0 110.088 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 121.753 0.787 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 t -89.95 177.8 6.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.223 1.011 . . . . 0.0 111.832 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -161.19 147.62 14.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.796 1.238 . . . . 0.0 110.363 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.37 44.61 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.317 1.047 . . . . 0.0 111.978 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m -116.28 137.1 52.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 109.98 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -136.35 143.94 44.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.089 1.356 . . . . 0.0 110.311 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 tt -133.44 134.13 57.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 110.986 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.9 111.26 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -169.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.73 92.45 8.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.01 -34.2 0.61 Allowed Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.343 0.973 . . . . 0.0 114.159 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -58.71 126.94 29.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.268 0.627 . . . . 0.0 110.905 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 24.7 m-70 -61.54 41.26 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -169.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.0 m 70.44 -48.25 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 130.538 3.535 . . . . 0.0 114.908 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -128.29 -69.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.909 0.884 . . . . 0.0 110.852 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -57.38 -18.75 19.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 p -50.72 -50.54 55.1 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.652 1.115 . . . . 0.0 111.365 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.65 -43.05 71.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 124.303 1.041 . . . . 0.0 111.775 -168.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -66.83 -34.74 78.48 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -65.62 -45.86 81.49 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.81 -1.181 . . . . 0.0 111.039 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -39.91 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -51.4 -51.58 53.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 109.831 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.0 m -70.37 -48.14 57.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -69.63 -37.74 76.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.371 1.068 . . . . 0.0 111.125 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -74.38 -51.15 15.89 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.144 -1.408 . . . . 0.0 111.186 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.31 16.36 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.355 1.889 . . . . 0.0 113.739 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -111.35 -5.29 14.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.264 1.826 . . . . 0.0 112.227 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.57 133.9 44.95 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 120.549 -1.344 . . . . 0.0 109.967 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -66.3 0.02 2.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.59 -6.68 11.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.59 134.43 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 121.581 1.991 . . . . 0.0 111.258 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 m -91.41 -25.24 19.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.567 0.747 . . . . 0.0 112.942 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.14 175.26 1.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.813 1.645 . . . . 0.0 113.177 -170.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -166.51 152.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.036 2.134 . . . . 0.0 109.632 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.36 148.92 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.147 2.579 . . . . 0.0 105.946 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.7 150.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 112.367 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -91.31 135.55 33.73 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.233 1.413 . . . . 0.0 111.682 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 tp -104.06 -30.02 10.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.559 1.544 . . . . 0.0 112.607 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -32.38 68.61 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.864 2.065 . . . . 0.0 112.786 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -104.89 -174.5 2.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.074 2.15 . . . . 0.0 113.189 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.78 32.95 5.76 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.03 2.532 . . . . 0.0 110.7 -174.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 p -140.17 156.71 46.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.042 -1.661 . . . . 0.0 114.728 -167.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.46 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 110.692 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -115.67 116.87 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.37 130.63 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 108.563 -168.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.2 105.11 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 108.781 -168.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -124.92 150.06 46.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.359 0.664 . . . . 0.0 111.04 -173.812 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 CA-C-O 118.987 -0.505 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -52.95 -25.68 12.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.594 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.8 p -66.76 -44.25 81.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.678 1.191 . . . . 0.0 113.346 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.03 -41.6 70.63 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.594 -0.692 . . . . 0.0 110.73 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.21 -48.65 45.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.405 1.082 . . . . 0.0 111.016 170.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.209 1.403 . . . . 0.0 114.554 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.56 76.25 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.012 1.278 . . . . 0.0 111.551 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.915 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -51.08 -34.45 30.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.667 0.667 . . . . 0.0 110.389 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.9 4.22 14.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.404 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -97.5 -30.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.952 0.901 . . . . 0.0 111.35 177.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.01 64.57 7.59 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 111.493 169.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.35 147.56 95.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.492 3.462 . . . . 0.0 113.211 -172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.53 -24.51 3.65 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.794 1.188 . . . . 0.0 114.185 -173.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.37 -36.01 8.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.161 1.384 . . . . 0.0 111.509 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 64' ' ' VAL . 4.1 m-30 -76.98 106.08 8.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -80.8 71.3 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.085 -1.634 . . . . 0.0 111.654 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.6 128.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.702 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -135.75 146.26 47.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.327 1.451 . . . . 0.0 109.298 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 94.2 mt -90.71 126.78 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.708 -1.245 . . . . 0.0 108.093 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 109.6 168.398 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 122.573 1.178 . . . . 0.0 113.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -80.32 177.29 9.07 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.947 0.879 . . . . 0.0 110.947 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -165.9 145.6 6.33 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.815 1.246 . . . . 0.0 110.23 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.92 166.1 31.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.593 1.557 . . . . 0.0 111.321 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.6 m -127.18 135.54 50.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.449 1.5 . . . . 0.0 110.923 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.81 149.18 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.99 141.93 42.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 111.008 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -124.62 108.21 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 123.833 0.708 . . . . 0.0 110.902 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.95 26.8 0.58 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.98 22.48 1.27 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.5 1.524 . . . . 0.0 113.482 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -84.7 130.39 34.71 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 4.6 m170 -71.45 12.14 0.38 Allowed 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 t 90.82 -145.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.354 2.661 . . . . 0.0 111.46 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HE3' HD11 ' A' ' 38' ' ' LEU . 14.1 mptt -58.75 -30.07 67.23 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.317 -1.49 . . . . 0.0 113.283 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -69.06 -34.42 75.14 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.136 -1.603 . . . . 0.0 112.725 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.417 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.2 m -70.34 -38.78 74.93 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 116.356 -1.783 . . . . 0.0 113.318 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -42.57 -53.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -58.87 -39.96 82.92 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.64 -39.94 88.48 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.722 -0.611 . . . . 0.0 111.986 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -42.58 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.419 0.554 . . . . 0.0 110.118 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.28 -48.49 71.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.384 1.074 . . . . 0.0 110.518 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 m -71.2 -46.71 60.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -71.12 -37.16 72.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 125.472 1.509 . . . . 0.0 111.5 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 27' ' ' ALA . 5.2 mt -74.73 -49.77 19.87 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.162 170.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -72.75 15.38 0.2 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 121.576 1.989 . . . . 0.0 113.427 -170.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.88 -2.38 16.1 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 112.511 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 30' ' ' TYR . 43.0 mt -76.09 137.07 39.91 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.757 -1.214 . . . . 0.0 111.127 -169.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.29 31.08 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.767 2.027 . . . . 0.0 114.234 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -157.16 -3.0 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.12 2.568 . . . . 0.0 113.945 173.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.5 p -99.43 140.84 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.505 1.957 . . . . 0.0 108.852 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -112.74 -8.54 13.76 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -176.35 171.95 2.34 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.379 1.871 . . . . 0.0 113.505 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -175.13 154.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.904 2.482 . . . . 0.0 110.229 -171.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -147.67 126.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 127.596 2.358 . . . . 0.0 107.518 165.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.9 t -91.42 134.26 30.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.43 1.11 . . . . 0.0 109.865 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.9 m -69.83 89.93 0.59 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.483 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 15' ' ' LYS . 1.9 tm? -45.49 -43.59 11.77 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.287 2.235 . . . . 0.0 112.011 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -53.06 57.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.669 1.188 . . . . 0.0 111.347 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.92 -174.73 4.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.395 2.278 . . . . 0.0 113.909 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.21 36.6 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.955 1.702 . . . . 0.0 113.296 169.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.01 154.9 43.75 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.047 -1.658 . . . . 0.0 114.137 -169.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.8 135.08 41.52 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.253 1.821 . . . . 0.0 110.35 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.48 119.23 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -125.81 139.9 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.696 1.198 . . . . 0.0 109.979 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.31 112.51 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.709 1.604 . . . . 0.0 109.063 -168.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 p90 -131.29 148.4 52.68 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -168.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.535 0.368 0 O-C-N 120.701 -1.249 . . . . 0.0 112.483 -167.092 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 CA-C-O 118.806 -0.581 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -51.16 -23.95 3.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.583 1.153 . . . . 0.0 111.789 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -68.2 -44.83 74.95 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.666 -1.271 . . . . 0.0 113.278 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.67 -43.6 68.76 Favored 'General case' 0 C--O 1.226 -0.161 0 O-C-N 121.515 -0.741 . . . . 0.0 110.356 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -48.54 -51.92 25.22 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.503 1.121 . . . . 0.0 110.993 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.26 -30.71 71.61 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.8 -33.36 74.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.236 1.38 . . . . 0.0 112.051 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.28 -55.8 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.752 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.43 -37.34 11.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.861 0.755 . . . . 0.0 111.156 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.29 4.63 8.42 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.415 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -98.09 -33.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.622 1.569 . . . . 0.0 111.919 174.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.12 61.85 18.93 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 169.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.21 139.8 79.89 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.9 3.067 . . . . 0.0 112.835 -171.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.66 -21.41 14.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.193 1.378 . . . . 0.0 114.04 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.06 -45.82 5.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.423 1.889 . . . . 0.0 110.59 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.415 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 1.7 m-30 -64.99 100.98 0.46 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.066 1.346 . . . . 0.0 114.509 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -77.8 73.68 4.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.908 1.283 . . . . 0.0 111.321 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.04 132.92 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.755 0.788 . . . . 0.0 111.976 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.5 m -145.89 166.24 26.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.632 1.573 . . . . 0.0 110.858 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.6 mt -99.09 132.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.913 1.685 . . . . 0.0 108.059 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.304 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 123.968 1.842 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 t -100.69 -176.73 3.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.04 2.536 . . . . 0.0 110.969 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -163.06 148.57 11.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 110.112 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 162.89 40.79 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.243 1.417 . . . . 0.0 110.974 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.0 m -121.43 137.86 54.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.726 1.21 . . . . 0.0 109.622 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -137.51 147.08 44.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.235 1.414 . . . . 0.0 110.202 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 tt -132.52 137.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.696 1.198 . . . . 0.0 110.603 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.97 99.24 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.703 1.601 . . . . 0.0 111.255 -171.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.25 101.23 10.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.265 1.031 . . . . 0.0 110.609 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.98 -7.88 4.14 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.776 1.179 . . . . 0.0 114.855 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -64.71 143.36 57.98 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.892 1.346 . . . . 0.0 112.026 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -67.21 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 126.705 2.002 . . . . 0.0 114.89 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m 54.5 -131.61 1.96 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.962 2.105 . . . . 0.0 112.033 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -48.5 -32.87 8.53 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.565 1.946 . . . . 0.0 114.151 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 m -91.18 -29.27 17.34 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -37.92 89.23 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.971 1.26 . . . . 0.0 111.23 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.1 t -37.73 -58.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.565 1.546 . . . . 0.0 112.277 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -55.28 -43.77 75.06 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 111.929 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -62.95 -42.64 99.88 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.571 -0.705 . . . . 0.0 112.602 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -44.18 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.807 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.71 -51.1 70.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.368 1.067 . . . . 0.0 110.064 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -35.94 79.27 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.9 m -75.81 -37.73 58.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.653 0.781 . . . . 0.0 110.383 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -50.36 17.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.903 175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -74.53 12.84 0.7 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.765 1.166 . . . . 0.0 112.765 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.47 -7.19 18.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.507 1.523 . . . . 0.0 111.942 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 mt -78.29 126.65 31.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.24 -11.81 7.3 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.47 -13.06 24.87 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 169.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.98 140.46 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 121.789 2.086 . . . . 0.0 108.866 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.1 t -96.52 -29.49 13.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.368 1.467 . . . . 0.0 111.666 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -176.07 174.6 2.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.684 1.594 . . . . 0.0 112.336 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -174.59 150.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.631 1.972 . . . . 0.0 110.521 -172.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.82 132.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 127.352 2.261 . . . . 0.0 108.053 167.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -107.12 143.32 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.078 0.951 . . . . 0.0 111.277 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.5 t -74.79 108.31 7.45 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 165.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -47.3 -25.84 1.08 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.753 2.021 . . . . 0.0 114.459 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -109.34 -35.48 6.26 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.913 2.885 . . . . 0.0 114.243 -174.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -83.91 -175.15 5.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.718 0.407 . . . . 0.0 110.539 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER -112.97 39.31 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 175.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -141.44 155.7 45.85 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.461 -1.399 . . . . 0.0 113.046 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.55 50.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.737 2.015 . . . . 0.0 110.041 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -106.18 114.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.08 130.51 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.756 1.222 . . . . 0.0 108.487 -168.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.6 t -117.59 117.55 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.472 1.909 . . . . 0.0 107.434 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -139.21 155.21 47.96 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.613 1.551 . . . . 0.0 113.233 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t30 . . . . . 0 CA--C 1.541 0.618 0 O-C-N 120.122 -1.611 . . . . 0.0 113.688 -167.531 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 CA--C 1.542 0.92 0 N-CA-C 114.82 1.046 . . . . 0.0 114.82 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.97 -35.85 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.206 1.002 . . . . 0.0 113.094 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.7 p -69.39 -41.48 76.39 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.318 -0.864 . . . . 0.0 113.243 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.81 -49.0 72.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.88 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.27 -56.63 6.4 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.861 1.264 . . . . 0.0 110.36 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -51.7 -41.82 61.76 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.75 67.59 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.104 0.865 . . . . 0.0 112.954 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -69.95 -56.37 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.959 0.904 . . . . 0.0 109.65 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -50.66 -31.68 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.707 0.803 . . . . 0.0 111.812 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.16 28.88 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.44 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -97.64 -31.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.37 65.83 9.67 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.463 -0.773 . . . . 0.0 111.085 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.93 141.96 96.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.98 3.12 . . . . 0.0 112.112 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.71 -28.54 4.87 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.756 1.17 . . . . 0.0 113.454 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -92.12 -44.16 8.97 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 111.633 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 2.7 m-30 -72.67 99.73 2.64 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 78.14 0.64 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.332 -1.48 . . . . 0.0 109.326 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.95 135.37 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.464 1.125 . . . . 0.0 111.684 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.2 m -150.9 158.11 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.951 1.7 . . . . 0.0 111.238 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 126.17 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.896 1.679 . . . . 0.0 109.48 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 124.286 1.034 . . . . 0.0 111.559 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.337 1.065 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -95.24 176.61 6.15 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.92 1.688 . . . . 0.0 111.746 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -160.65 140.58 11.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.924 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.51 161.28 38.29 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.017 1.327 . . . . 0.0 109.911 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.4 m -123.32 136.21 54.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.75 0.82 . . . . 0.0 109.036 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.48 147.49 52.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.222 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -135.56 133.6 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.266 1.026 . . . . 0.0 110.847 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.66 116.0 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.969 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -81.12 5.31 17.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.39 22.22 1.07 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.02 1.771 . . . . 0.0 115.395 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.85 146.02 49.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.215 2.008 . . . . 0.0 112.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.433 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 3.0 m170 -74.0 23.3 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.714 1.606 . . . . 0.0 113.3 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t 76.51 -141.63 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.23 2.212 . . . . 0.0 111.182 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 13.6 mptt -55.94 -36.31 67.62 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.423 -1.423 . . . . 0.0 114.182 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -69.98 -34.17 73.02 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.257 -1.527 . . . . 0.0 112.074 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.0 OUTLIER -67.86 -42.38 81.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 116.068 -1.92 . . . . 0.0 112.587 173.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -40.6 -55.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.96 1.255 . . . . 0.0 111.351 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.0 t -62.57 -37.68 87.13 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -62.75 -42.03 99.49 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.159 -0.963 . . . . 0.0 111.963 171.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.74 -42.68 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 118.919 0.781 . . . . 0.0 110.034 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -52.86 -53.29 51.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.997 0.919 . . . . 0.0 110.17 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 m -70.52 -44.79 66.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.8 m -70.07 -36.03 74.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.132 1.773 . . . . 0.0 110.846 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -74.49 -50.45 18.19 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.871 172.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -68.12 12.53 0.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.466 1.485 . . . . 0.0 114.139 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.5 1.85 18.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.649 1.98 . . . . 0.0 111.809 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.08 129.75 34.7 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.854 -1.154 . . . . 0.0 110.127 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.93 -1.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.38 -8.08 11.09 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.22 135.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 121.772 2.078 . . . . 0.0 110.926 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 19.5 m -92.65 -25.02 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.265 1.426 . . . . 0.0 111.889 -173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m 178.89 175.97 0.58 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.545 2.338 . . . . 0.0 112.726 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.8 tt -174.04 152.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 127.136 2.174 . . . . 0.0 109.49 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.07 131.71 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 126.087 1.755 . . . . 0.0 107.448 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.47 135.52 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 123.073 1.416 . . . . 0.0 109.505 168.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 m -67.41 90.62 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.063 167.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.417 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 0.7 OUTLIER -55.68 -31.45 62.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.577 1.151 . . . . 0.0 112.638 -171.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -59.77 4.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.982 0.81 . . . . 0.0 111.116 169.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -72.58 -176.36 1.91 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 125.356 2.503 . . . . 0.0 114.027 -171.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.554 2.342 . . . . 0.0 113.024 170.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.2 p -137.38 160.17 39.84 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.704 -1.872 . . . . 0.0 115.056 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.71 136.79 44.88 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.228 1.811 . . . . 0.0 110.683 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.1 112.68 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.66 130.5 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.474 1.509 . . . . 0.0 108.339 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.69 114.51 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.247 1.419 . . . . 0.0 108.038 -168.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.414 ' HA ' ' H ' ' A' ' 32' ' ' SER . 30.6 p90 -132.86 155.22 49.4 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 120.457 1.481 . . . . 0.0 113.373 -168.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 CA--C 1.543 0.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.362 -175.562 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 CA--C 1.538 0.68 0 N-CA-C 113.127 0.395 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -18.32 3.9 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 m -82.58 -40.34 21.03 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 121.03 1.741 . . . . 0.0 112.702 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.0 mt -67.65 -45.52 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.219 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -48.38 -46.93 37.7 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.278 0.944 . . . . 0.0 110.643 170.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -35.49 79.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.438 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.07 71.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.789 1.631 . . . . 0.0 112.28 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -72.82 -57.77 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.992 0.917 . . . . 0.0 109.699 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -55.59 -16.23 3.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.931 1.293 . . . . 0.0 113.737 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.03 -0.42 57.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.448 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -90.87 -35.59 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.956 0.798 . . . . 0.0 111.457 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -141.22 63.32 17.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 169.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.35 143.52 86.02 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.364 3.376 . . . . 0.0 114.231 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.9 -31.35 2.81 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.28 1.419 . . . . 0.0 113.502 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.28 -40.99 11.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.881 1.673 . . . . 0.0 110.395 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.0 m-30 -75.31 93.91 2.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.164 -0.96 . . . . 0.0 113.421 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -71.97 121.01 18.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 161.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.51 136.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 123.754 2.979 . . . . 0.0 111.832 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -134.91 156.57 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.135 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.38 130.3 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.144 1.378 . . . . 0.0 108.391 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 122.387 1.089 . . . . 0.0 111.456 174.045 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.821 0.819 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -87.84 173.8 8.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.096 0.951 . . . . 0.0 110.592 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -163.95 148.05 10.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.074 1.35 . . . . 0.0 110.051 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.66 159.82 37.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.484 1.513 . . . . 0.0 111.387 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -125.77 136.56 53.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.991 1.316 . . . . 0.0 110.148 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.39 145.77 49.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.925 1.29 . . . . 0.0 111.156 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tt -121.74 145.12 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.273 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.4 168.67 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 124.567 1.147 . . . . 0.0 107.943 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.82 125.44 8.28 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.036 -1.04 . . . . 0.0 109.145 168.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.81 -6.49 44.19 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.613 1.101 . . . . 0.0 113.292 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.35 141.31 47.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.488 1.515 . . . . 0.0 112.267 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -51.68 -46.21 63.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 p 160.81 -65.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.427 1.891 . . . . 0.0 113.848 -171.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 -57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.136 2.175 . . . . 0.0 109.217 -166.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -20.01 21.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.121 0.968 . . . . 0.0 113.448 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 p -56.28 -48.8 75.89 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.256 168.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.33 -49.88 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.0 111.153 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -65.61 -35.73 81.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.429 1.092 . . . . 0.0 112.929 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.26 -39.59 95.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.564 -1.335 . . . . 0.0 111.976 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -30.4 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.54 -175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -59.35 -56.68 18.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.511 0.725 . . . . 0.0 109.752 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t -70.19 -41.47 73.67 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.0 m -73.77 -34.81 64.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.595 1.158 . . . . 0.0 110.946 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -74.88 -52.06 12.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.258 171.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 t -71.08 16.27 0.09 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.988 1.722 . . . . 0.0 113.773 -172.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -109.4 -5.01 15.96 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.744 2.018 . . . . 0.0 112.074 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.7 mt -77.72 130.24 36.52 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 109.508 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.03 -17.35 24.62 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.59 -8.17 29.56 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.78 140.78 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 122.105 2.23 . . . . 0.0 110.091 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -98.06 -24.29 15.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 111.878 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m 178.73 173.26 0.72 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.704 2.001 . . . . 0.0 113.246 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -168.25 153.19 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.917 2.087 . . . . 0.0 110.552 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 151.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.089 2.955 . . . . 0.0 106.131 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.27 151.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 122.035 0.922 . . . . 0.0 111.738 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -74.13 123.83 25.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.615 1.166 . . . . 0.0 109.174 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.49 -42.7 24.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.817 1.189 . . . . 0.0 112.089 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -61.2 -63.96 1.11 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.106 1.321 . . . . 0.0 109.614 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -85.4 168.49 14.56 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 122.878 1.323 . . . . 0.0 113.693 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.19 44.92 1.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -140.91 150.23 42.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 140.61 52.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.161 2.184 . . . . 0.0 111.174 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.06 115.87 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.29 136.48 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.893 1.277 . . . . 0.0 109.214 -166.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.24 113.67 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.233 1.413 . . . . 0.0 108.122 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -130.64 154.1 48.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.698 1.199 . . . . 0.0 113.857 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 CA--C 1.535 0.397 0 O-C-N 121.028 -1.045 . . . . 0.0 110.595 -173.521 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.534 0.511 0 N-CA-C 113.053 0.366 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.04 -8.97 53.6 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.514 1.052 . . . . 0.0 112.802 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -68.26 -49.59 59.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.767 1.167 . . . . 0.0 110.736 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.81 -43.78 87.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 117.445 -1.264 . . . . 0.0 111.04 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -47.39 -50.03 23.41 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.255 1.389 . . . . 0.0 112.788 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.07 87.68 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 174.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -33.97 76.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.359 1.436 . . . . 0.0 112.341 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -69.77 -52.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.605 172.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -50.36 -35.86 29.87 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.264 0.938 . . . . 0.0 110.941 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.88 3.32 12.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.42 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -98.67 -29.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 111.786 177.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.01 66.98 9.86 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.912 0.885 . . . . 0.0 110.347 168.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.64 140.27 80.04 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.098 3.199 . . . . 0.0 111.872 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.62 -22.16 6.79 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.626 1.107 . . . . 0.0 113.666 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 tp -99.46 -29.26 12.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.297 1.439 . . . . 0.0 112.732 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -92.3 105.59 17.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -69.96 47.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.241 2.216 . . . . 0.0 115.046 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.8 121.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 120.325 -1.485 . . . . 0.0 113.588 -168.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -134.9 152.18 51.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.223 1.409 . . . . 0.0 110.747 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.3 mt -90.91 130.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.739 -1.225 . . . . 0.0 108.086 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 109.462 172.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.702 0.763 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -91.76 -179.16 5.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.393 1.477 . . . . 0.0 111.17 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -165.54 155.12 12.53 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 109.861 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.37 161.25 30.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.14 1.776 . . . . 0.0 111.436 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -122.44 141.58 51.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.546 1.539 . . . . 0.0 110.432 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -145.1 141.26 28.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.36 1.464 . . . . 0.0 111.171 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.68 134.39 62.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.957 1.303 . . . . 0.0 111.46 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.32 103.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.585 1.954 . . . . 0.0 111.908 -170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 127.62 32.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.529 -1.357 . . . . 0.0 110.315 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.57 39.38 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 121.69 -0.631 . . . . 0.0 111.952 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.4 ptm -59.38 142.0 53.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 167.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.29 11.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.826 1.65 . . . . 0.0 115.025 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 m 70.76 -23.08 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.437 2.295 . . . . 0.0 116.059 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -87.16 0.34 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.903 1.681 . . . . 0.0 106.692 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -23.38 30.8 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.034 -1.666 . . . . 0.0 114.699 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.55 -37.71 88.35 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 116.824 -1.56 . . . . 0.0 113.034 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.0 t -50.46 -46.44 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.089 1.356 . . . . 0.0 109.985 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -67.92 -37.81 82.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.596 1.558 . . . . 0.0 114.105 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.13 -39.23 94.09 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 120.796 -1.19 . . . . 0.0 110.95 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.67 -40.4 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.519 -176.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -52.37 -55.29 22.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.983 0.913 . . . . 0.0 110.262 168.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 t -70.56 -42.48 71.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -73.14 -36.35 66.65 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.84 1.256 . . . . 0.0 110.731 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -75.4 -49.56 18.58 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.559 172.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 t -71.6 17.23 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.879 1.672 . . . . 0.0 113.722 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.55 -2.48 16.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.895 1.678 . . . . 0.0 112.545 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.5 135.83 38.28 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.779 -1.201 . . . . 0.0 111.309 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -54.71 -9.66 0.36 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -5.58 9.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.855 1.662 . . . . 0.0 115.075 176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.4 p -91.91 138.23 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.65 2.023 . . . . 0.0 110.58 -170.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -94.82 -30.54 14.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.994 1.318 . . . . 0.0 111.345 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -174.57 174.54 2.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 123.36 1.552 . . . . 0.0 113.054 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 tt -165.93 151.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.244 2.217 . . . . 0.0 109.356 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.23 147.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.699 2.4 . . . . 0.0 106.286 167.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.79 152.71 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.086 0.555 . . . . 0.0 109.789 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.3 t -84.78 144.35 28.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.556 0.693 . . . . 0.0 111.743 171.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -20.86 23.73 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -60.39 1.98 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.416 1.087 . . . . 0.0 108.385 168.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -78.79 143.23 36.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.061 0.934 . . . . 0.0 110.967 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.34 42.61 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.086 0.955 . . . . 0.0 112.672 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 p -140.68 150.67 43.78 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.132 -1.605 . . . . 0.0 113.999 -172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.91 146.26 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.096 2.158 . . . . 0.0 110.584 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.26 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.03 133.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.867 1.267 . . . . 0.0 108.418 -167.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.1 t -120.73 109.79 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.786 1.634 . . . . 0.0 108.146 -167.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 33.6 p90 -127.08 146.68 50.28 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.067 -1.021 . . . . 0.0 113.718 -168.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 CA--C 1.54 0.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.535 0.553 0 CA-C-O 118.7 -0.625 . . . . 0.0 113.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -49.28 -40.64 35.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.242 1.017 . . . . 0.0 112.174 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 -38.2 67.59 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.938 -1.101 . . . . 0.0 112.416 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.14 -44.94 67.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.106 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -54.18 11.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.661 1.184 . . . . 0.0 110.372 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -51.95 -43.37 63.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.87 68.05 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.975 1.261 . . . . 0.0 112.824 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.51 -54.79 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.923 0.889 . . . . 0.0 109.958 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -53.16 -28.97 28.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.827 0.851 . . . . 0.0 111.402 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.35 -2.81 43.28 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -87.8 -39.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 110.484 177.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -136.96 77.37 43.76 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 122.681 0.392 . . . . 0.0 110.496 164.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.04 116.31 3.05 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.429 2.753 . . . . 0.0 109.456 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.03 -21.88 41.71 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 117.116 -1.936 . . . . 0.0 115.402 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tp -95.24 -26.51 15.93 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 121.333 2.567 . . . . 0.0 112.673 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 3.6 m-30 -91.66 105.36 17.68 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -166.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 66.68 1.31 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.214 1.406 . . . . 0.0 110.463 168.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.62 137.76 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.284 0.633 . . . . 0.0 111.737 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.17 133.83 13.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.35 1.06 . . . . 0.0 112.009 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.6 mt -73.75 122.79 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 121.113 -0.992 . . . . 0.0 108.39 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 C-N-CA 124.021 0.929 . . . . 0.0 110.228 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 123.021 1.391 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 t -93.24 174.46 7.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -157.41 144.03 18.07 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.157 1.383 . . . . 0.0 110.034 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.96 159.78 43.52 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.624 1.57 . . . . 0.0 111.683 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m -120.61 139.84 52.4 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.551 1.541 . . . . 0.0 110.055 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -140.76 142.54 34.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.945 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -124.13 140.72 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.491 1.116 . . . . 0.0 110.064 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.78 148.42 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.219 1.808 . . . . 0.0 108.295 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.5 142.3 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 162.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.15 -16.01 55.94 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.042 0.83 . . . . 0.0 111.142 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptm -58.81 133.63 56.16 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 122.012 -0.699 . . . . 0.0 109.142 168.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -61.48 15.59 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 115.624 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 m 68.55 -15.43 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.268 2.227 . . . . 0.0 116.463 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -88.6 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 107.408 -169.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 p -55.09 -27.65 46.53 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.998 -1.689 . . . . 0.0 114.544 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HA ' HD21 ' A' ' 20' ' ' ASN . 1.2 m -60.27 -38.2 82.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 120.881 1.673 . . . . 0.0 112.084 172.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.97 -48.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.533 1.533 . . . . 0.0 109.574 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -71.24 -29.9 65.67 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.557 HD21 ' HA ' ' A' ' 17' ' ' CYS . 76.2 m-20 -64.54 -40.38 95.49 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.293 -1.504 . . . . 0.0 110.681 167.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -38.93 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.06 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -52.85 -53.67 45.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 109.894 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 -46.33 63.54 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -170.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.546 ' HG1' HG23 ' A' ' 64' ' ' VAL . 68.0 m -69.27 -35.48 76.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.021 1.328 . . . . 0.0 111.183 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -50.6 14.04 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.399 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.3 t -72.69 11.21 0.68 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.432 1.469 . . . . 0.0 113.892 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.57 -7.92 19.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.477 1.511 . . . . 0.0 111.668 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.5 129.21 36.89 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.028 0.831 . . . . 0.0 109.451 -171.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -58.29 -20.65 44.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 -10.8 37.9 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -90.55 141.5 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 122.271 2.305 . . . . 0.0 109.936 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 t -97.6 -30.83 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.695 1.598 . . . . 0.0 111.33 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -175.51 172.85 2.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.29 1.436 . . . . 0.0 113.254 -169.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -168.57 150.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.564 1.946 . . . . 0.0 111.311 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.97 150.09 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 128.971 2.908 . . . . 0.0 106.345 167.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.29 147.65 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.083 0.468 . . . . 0.0 110.716 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -70.38 141.16 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.101 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.92 -23.77 14.84 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 111.836 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.09 -39.6 10.05 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 130.316 3.447 . . . . 0.0 112.981 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -97.62 -177.29 3.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.797 1.639 . . . . 0.0 110.913 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -112.33 44.39 1.45 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.965 1.306 . . . . 0.0 111.777 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -137.14 153.71 50.43 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.488 -1.383 . . . . 0.0 113.98 -169.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.52 140.08 52.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.111 1.764 . . . . 0.0 111.427 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -110.06 116.1 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.93 132.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.939 1.295 . . . . 0.0 108.327 -167.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.56 112.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.628 1.971 . . . . 0.0 107.53 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -130.84 150.9 51.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.72 1.6 . . . . 0.0 113.478 -171.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 CA--C 1.536 0.425 0 O-C-N 120.818 -1.176 . . . . 0.0 111.696 -171.386 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.536 0.579 0 N-CA-C 113.018 0.353 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 62.1 mm-40 -60.18 -28.94 68.36 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -172.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.1 p -62.09 -40.33 95.47 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.063 -1.648 . . . . 0.0 112.708 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.6 mt -70.13 -46.35 64.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.426 ' HE ' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -49.24 -55.48 12.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.515 1.126 . . . . 0.0 111.753 173.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.76 -30.67 69.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.571 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.62 80.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.243 1.383 . . . . 0.0 111.817 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mt -61.78 -53.77 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.136 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -54.07 -25.71 23.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.38 0.672 . . . . 0.0 112.717 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.79 2.27 49.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.546 HG23 ' HG1' ' A' ' 24' ' ' THR . 0.5 OUTLIER -92.88 -30.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.941 0.896 . . . . 0.0 111.434 175.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.08 68.53 9.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.701 0.8 . . . . 0.0 111.16 169.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.78 136.43 70.23 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.103 3.202 . . . . 0.0 111.807 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.74 -24.17 6.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.678 1.133 . . . . 0.0 113.585 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.01 -35.93 15.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.867 1.267 . . . . 0.0 111.06 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.423 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.6 m-30 -88.27 108.89 19.54 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 32.58 0.09 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 128.634 2.774 . . . . 0.0 115.695 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.34 130.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -166.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.6 m -145.0 148.55 33.86 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.476 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 98.6 mt -83.44 122.85 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.73 1.212 . . . . 0.0 108.499 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.522 -0.108 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.475 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 122.853 1.311 . . . . 0.0 113.512 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -122.29 -174.48 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.331 2.252 . . . . 0.0 110.473 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.32 147.37 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.663 -1.273 . . . . 0.0 109.918 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.97 158.89 44.62 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.993 1.317 . . . . 0.0 111.273 169.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.1 m -120.34 137.29 54.36 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.753 1.221 . . . . 0.0 110.46 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.04 149.13 47.24 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.912 0.885 . . . . 0.0 112.909 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tt -137.56 136.61 46.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 124.343 1.057 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.87 108.34 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.284 1.434 . . . . 0.0 112.288 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 87.86 7.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.822 0.82 . . . . 0.0 108.8 168.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.14 -23.83 0.28 Allowed Glycine 0 N--CA 1.48 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 114.837 -168.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.462 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.9 ptt? -79.82 138.82 37.32 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.175 0.987 . . . . 0.0 113.192 -169.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -65.68 27.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.229 2.212 . . . . 0.0 114.368 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' H ' ' C ' ' A' ' 12' ' ' MET . 98.7 m 52.15 -115.5 0.92 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.046 2.138 . . . . 0.0 111.419 176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 40.3 mttp -67.01 -17.46 64.93 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -165.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.9 p -88.4 -43.41 11.51 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.003 1.274 . . . . 0.0 110.446 166.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.84 -43.1 76.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 116.838 -1.553 . . . . 0.0 112.049 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 t -37.78 -56.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.273 1.829 . . . . 0.0 111.567 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 t -65.65 -39.36 91.32 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.569 0.748 . . . . 0.0 111.661 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -60.52 -40.02 89.96 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -42.79 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 118.74 -0.648 . . . . 0.0 109.743 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -54.81 -51.32 66.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.951 0.9 . . . . 0.0 110.876 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -70.37 -41.41 73.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.412 ' HG1' HG22 ' A' ' 64' ' ' VAL . 31.7 m -70.69 -40.03 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.318 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -45.46 44.2 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.669 -1.158 . . . . 0.0 111.518 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 t -71.01 11.3 0.42 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.836 1.653 . . . . 0.0 113.819 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.87 -6.37 22.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.326 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.7 mt -77.08 125.42 29.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.196 -0.94 . . . . 0.0 108.669 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.78 -15.13 52.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -12.56 33.98 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -87.2 135.93 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.68 2.036 . . . . 0.0 109.975 -170.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 t -103.45 -15.01 16.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m 178.75 173.64 0.7 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.141 2.576 . . . . 0.0 112.333 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -173.19 152.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 127.509 2.323 . . . . 0.0 108.962 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -145.15 129.22 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.129 2.172 . . . . 0.0 107.838 166.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 t -94.5 139.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 123.006 1.384 . . . . 0.0 111.346 169.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -74.32 85.11 1.94 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.748 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.43 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 1.5 tt -49.81 -38.44 34.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.244 2.218 . . . . 0.0 114.36 -168.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -60.25 4.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.473 1.13 . . . . 0.0 110.264 170.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -79.83 -176.92 5.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.389 2.676 . . . . 0.0 116.072 -168.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 33.54 3.65 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.075 -2.33 . . . . 0.0 110.774 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 p -144.4 160.84 40.39 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.94 37.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.776 1.63 . . . . 0.0 111.217 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -106.25 112.54 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 133.31 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.364 1.466 . . . . 0.0 107.625 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.28 95.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.89 1.276 . . . . 0.0 108.506 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 26.7 p90 -114.34 145.63 41.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 CA--C 1.535 0.391 0 O-C-N 121.223 -0.923 . . . . 0.0 111.354 -177.772 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.46 -0.485 0 CA-C-O 119.053 -0.478 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.15 -27.03 63.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.123 0.874 . . . . 0.0 112.789 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m -70.25 -35.06 73.55 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.36 1.891 . . . . 0.0 112.049 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.2 mt -70.12 -44.7 68.41 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.52 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -53.06 -44.3 67.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.672 0.789 . . . . 0.0 111.278 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.59 98.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.169 1.788 . . . . 0.0 113.961 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.21 71.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 120.081 1.31 . . . . 0.0 112.031 173.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.6 -56.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.787 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -46.46 -35.99 6.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.357 1.063 . . . . 0.0 111.605 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 1.23 27.18 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -96.28 -29.3 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.709 1.204 . . . . 0.0 112.229 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -148.39 59.3 4.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 121.202 -0.937 . . . . 0.0 112.277 169.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.43 140.01 92.22 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.662 2.908 . . . . 0.0 111.192 -175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.33 -54.53 0.64 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.794 1.188 . . . . 0.0 110.756 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 mt -75.55 -46.06 34.3 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.386 1.093 . . . . 0.0 112.038 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.451 ' CE2' HG11 ' A' ' 64' ' ' VAL . 3.4 m-30 -67.86 88.18 0.25 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 69.49 2.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.486 1.515 . . . . 0.0 109.105 168.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.17 138.7 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 122.768 1.271 . . . . 0.0 110.951 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 m -143.07 168.73 19.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.356 1.463 . . . . 0.0 110.24 174.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.75 131.47 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.557 1.543 . . . . 0.0 108.524 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 124.357 1.063 . . . . 0.0 112.009 -169.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 122.396 1.093 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 t -129.56 170.73 13.38 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.726 1.61 . . . . 0.0 108.267 167.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.481 ' HG1' ' HA ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -154.86 163.98 39.5 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.959 -1.088 . . . . 0.0 111.699 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.74 160.4 37.84 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.737 1.215 . . . . 0.0 111.859 169.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 m -123.77 136.73 54.59 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.215 1.406 . . . . 0.0 110.737 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.52 145.52 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.012 1.325 . . . . 0.0 111.032 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 tt -134.06 130.85 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.685 1.194 . . . . 0.0 110.64 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.91 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.967 1.307 . . . . 0.0 109.047 -169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 1.04 7.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.25 35.85 1.79 Allowed Glycine 0 C--O 1.222 -0.628 0 C-N-CA 125.976 1.751 . . . . 0.0 111.141 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ttm -90.86 148.34 22.56 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.915 0.886 . . . . 0.0 111.115 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -73.72 3.41 6.48 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.372 0.669 . . . . 0.0 111.599 167.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.2 m 61.54 -112.78 0.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.564 2.346 . . . . 0.0 112.16 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -51.58 27.64 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -166.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 m -80.01 -22.58 42.29 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.838 -1.789 . . . . 0.0 113.936 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.64 -39.79 95.25 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-O 116.497 -1.716 . . . . 0.0 111.516 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -47.9 -51.49 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.638 1.563 . . . . 0.0 112.788 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.5 t -55.07 -43.55 73.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.292 0.637 . . . . 0.0 111.981 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -63.2 -39.38 94.48 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -45.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.133 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.62 -48.44 63.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.41 1.084 . . . . 0.0 109.858 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -70.05 -42.18 73.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -74.64 -38.28 62.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 111.192 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 27' ' ' ALA . 7.0 mt -73.06 -45.66 56.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 116.58 -1.676 . . . . 0.0 112.604 171.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 t -69.42 14.33 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 121.885 2.129 . . . . 0.0 114.543 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.21 -5.33 15.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.892 1.677 . . . . 0.0 112.655 176.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.67 137.95 41.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.202 0.91 . . . . 0.0 111.475 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -73.66 55.39 0.51 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.473 1.909 . . . . 0.0 112.622 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 p90 174.09 -22.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.882 2.873 . . . . 0.0 113.894 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.8 p -86.66 142.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 120.826 1.648 . . . . 0.0 109.256 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -108.05 -19.66 13.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.697 0.799 . . . . 0.0 112.573 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -175.43 174.28 2.34 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.435 1.894 . . . . 0.0 112.277 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 tt -174.86 151.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.938 2.095 . . . . 0.0 110.209 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.08 131.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.345 2.258 . . . . 0.0 107.732 166.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.08 137.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 123.53 1.633 . . . . 0.0 111.638 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m -79.37 81.36 5.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.261 1.424 . . . . 0.0 111.087 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 17.0 tp -50.85 -43.68 59.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -168.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.18 -42.15 60.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.994 0.918 . . . . 0.0 111.978 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -103.42 -170.82 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.138 3.775 . . . . 0.0 111.729 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.61 31.33 6.05 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.894 1.678 . . . . 0.0 114.579 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 p -135.2 157.68 46.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.63 138.6 51.32 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.851 1.661 . . . . 0.0 110.525 -175.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.68 121.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -125.06 125.18 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.081 1.352 . . . . 0.0 109.192 -166.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HG1' ' A' ' 4' ' ' THR . 78.9 t -111.98 109.52 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 109.933 -168.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 50.0 p90 -124.33 166.98 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 113.207 -171.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 CA--C 1.541 0.623 0 O-C-N 121.318 -0.864 . . . . 0.0 112.142 -169.039 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 N-CA-C 114.788 1.034 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.25 -25.09 67.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.182 0.901 . . . . 0.0 112.906 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -69.56 -38.68 77.54 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.026 -1.046 . . . . 0.0 113.161 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.69 -44.53 77.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.27 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.417 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -47.11 -54.89 9.44 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.322 1.049 . . . . 0.0 110.222 169.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -53.8 -41.62 67.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -30.62 69.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.017 0.826 . . . . 0.0 111.81 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.7 mt -68.1 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.752 0.821 . . . . 0.0 109.685 169.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -49.91 -33.43 17.37 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.704 0.683 . . . . 0.0 111.911 175.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.13 -0.4 24.77 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -99.58 -27.12 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.672 1.589 . . . . 0.0 111.689 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.55 64.06 8.29 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.387 -0.821 . . . . 0.0 111.098 168.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.5 144.93 95.39 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.364 3.376 . . . . 0.0 112.973 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.56 -28.8 3.39 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.17 1.367 . . . . 0.0 113.581 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -97.45 -43.76 7.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.158 1.783 . . . . 0.0 111.048 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.43 ' CE2' HG11 ' A' ' 64' ' ' VAL . 2.4 m-30 -68.88 99.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 80.26 4.49 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.823 -1.173 . . . . 0.0 109.142 169.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.25 132.46 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.65 -0.656 . . . . 0.0 111.27 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 134.2 30.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.519 1.128 . . . . 0.0 109.188 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.29 122.01 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.451 -1.406 . . . . 0.0 108.003 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 122.569 1.176 . . . . 0.0 110.383 176.802 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 t -95.73 176.65 6.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 111.684 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.54 149.41 9.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.409 1.484 . . . . 0.0 109.407 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.67 157.28 37.89 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 110.479 169.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 m -119.28 135.93 54.48 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.782 0.833 . . . . 0.0 109.759 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.86 145.44 51.21 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.527 1.531 . . . . 0.0 110.868 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.09 139.26 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 125.13 1.372 . . . . 0.0 111.153 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.1 97.59 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.462 1.905 . . . . 0.0 109.91 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.412 ' CG ' HH21 ' A' ' 41' ' ' ARG . 0.5 OUTLIER -85.9 78.25 9.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 123.355 1.55 . . . . 0.0 111.622 -177.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.05 12.28 0.15 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 113.203 -1.817 . . . . 0.0 116.305 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 151.47 45.61 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.917 2.358 . . . . 0.0 113.123 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -70.58 36.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.225 -1.547 . . . . 0.0 114.118 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.9 m 64.29 -142.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.251 -1.531 . . . . 0.0 111.087 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HE3' HD11 ' A' ' 38' ' ' LEU . 13.8 mptt -56.76 -37.18 70.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.919 0.888 . . . . 0.0 113.158 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -66.08 -45.56 80.83 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.151 -0.968 . . . . 0.0 112.578 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.472 ' HA ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -60.9 -50.42 73.48 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.962 172.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -44.85 -46.82 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.508 1.923 . . . . 0.0 112.154 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -66.56 -42.46 87.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 17' ' ' CYS . 83.4 m-20 -54.94 -35.85 64.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.503 -1.373 . . . . 0.0 113.144 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -39.34 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.482 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -62.38 -49.15 76.68 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -65.53 -42.29 92.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 m -69.54 -40.95 76.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.994 1.318 . . . . 0.0 110.966 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -45.92 48.95 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.813 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -74.09 11.61 0.88 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.961 1.255 . . . . 0.0 113.389 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.51 -5.0 17.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.675 1.59 . . . . 0.0 112.009 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.8 mt -75.69 129.62 37.41 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.01 -1.056 . . . . 0.0 110.097 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -53.21 -22.65 7.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.69 1.196 . . . . 0.0 114.157 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 -8.94 29.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.37 139.86 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 121.862 2.119 . . . . 0.0 109.624 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -109.37 -12.96 14.68 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -178.05 173.13 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.544 2.338 . . . . 0.0 111.322 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -178.59 152.66 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 109.835 -171.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 t -147.33 132.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 128.18 2.592 . . . . 0.0 107.755 167.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -101.64 149.34 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.468 1.128 . . . . 0.0 112.115 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 m -70.73 111.85 6.51 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.463 HD11 ' HE3' ' A' ' 15' ' ' LYS . 1.4 tm? -61.64 -45.43 94.09 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.047 1.294 . . . . 0.0 110.348 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.13 -56.38 11.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.735 0.814 . . . . 0.0 112.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -93.2 -179.98 5.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -166.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.412 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.96 16.36 3.45 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -172.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 p -139.4 155.62 47.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -166.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.4 131.55 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.762 2.425 . . . . 0.0 110.708 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -101.21 110.01 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.19 133.78 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.598 1.559 . . . . 0.0 108.024 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.62 108.18 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.538 1.535 . . . . 0.0 108.128 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -127.27 154.45 44.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.532 0.273 0 O-C-N 121.462 -0.774 . . . . 0.0 110.223 -173.806 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 CA--C 1.537 0.661 0 N-CA-C 113.259 0.446 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.68 -20.74 63.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.306 1.442 . . . . 0.0 113.087 -172.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.6 p -69.14 -44.33 72.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.54 -1.35 . . . . 0.0 112.697 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.89 -46.89 82.86 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.109 0.564 . . . . 0.0 109.869 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -48.94 -52.75 22.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.082 0.953 . . . . 0.0 110.8 170.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -54.93 -38.2 67.39 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.64 80.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.253 0.933 . . . . 0.0 111.15 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.4 mt -66.94 -52.54 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.844 -0.535 . . . . 0.0 109.794 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.94 -22.21 24.96 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.014 -1.054 . . . . 0.0 112.676 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.55 -1.3 57.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.282 1.401 . . . . 0.0 114.76 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -95.37 -27.42 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.584 1.153 . . . . 0.0 111.046 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.72 71.08 7.33 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.556 1.142 . . . . 0.0 111.459 168.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.9 145.95 97.02 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.664 3.576 . . . . 0.0 113.839 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.33 -40.21 2.36 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.937 1.732 . . . . 0.0 113.085 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.89 -55.29 6.84 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.263 1.425 . . . . 0.0 111.156 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.432 ' CE2' HG11 ' A' ' 64' ' ' VAL . 4.4 m-30 -69.01 110.42 4.45 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.985 1.314 . . . . 0.0 114.425 -169.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.21 57.02 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.398 -1.439 . . . . 0.0 113.279 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.0 118.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 122.319 1.057 . . . . 0.0 113.023 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -135.21 147.71 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.093 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.47 120.94 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.607 1.163 . . . . 0.0 109.672 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.9 p . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 125.817 1.647 . . . . 0.0 110.477 -179.234 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 CA--C 1.55 0.957 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -116.52 -178.94 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.168 1.787 . . . . 0.0 111.146 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -157.36 148.46 21.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.27 1.428 . . . . 0.0 110.289 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.18 43.85 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.015 1.326 . . . . 0.0 111.783 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.5 m -121.32 140.18 52.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.991 1.317 . . . . 0.0 109.958 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -139.22 145.9 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.403 1.481 . . . . 0.0 111.068 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.3 tt -131.0 134.43 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.461 1.504 . . . . 0.0 111.072 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 100.15 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.465 1.106 . . . . 0.0 109.813 -169.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.2 41.06 0.36 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.481 1.512 . . . . 0.0 112.709 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.83 23.92 0.08 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.208 1.385 . . . . 0.0 113.764 -171.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.459 ' CE ' ' HG ' ' A' ' 17' ' ' CYS . 4.9 ttt -95.81 135.12 37.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.416 1.886 . . . . 0.0 112.064 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -60.48 21.75 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m 71.1 -62.31 0.46 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.248 2.619 . . . . 0.0 114.086 171.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 13.3 mptt -122.82 -53.94 1.85 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.516 1.126 . . . . 0.0 113.626 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 p -65.74 -22.3 66.59 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.481 -2.012 . . . . 0.0 113.199 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.459 ' HG ' ' CE ' ' A' ' 12' ' ' MET . 1.9 p -45.41 -56.82 4.58 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.596 1.158 . . . . 0.0 110.041 168.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -47.23 -53.65 3.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 127.9 2.48 . . . . 0.0 111.076 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.3 t -64.84 -25.41 67.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.64 -53.27 12.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.2 0.909 . . . . 0.0 110.257 167.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -44.96 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.58 -0.7 . . . . 0.0 110.562 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.3 -21.62 62.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 0.0 112.873 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.7 t -91.77 -58.94 2.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.574 1.15 . . . . 0.0 113.759 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.0 m -54.95 -39.61 69.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.329 2.252 . . . . 0.0 112.491 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -74.53 -49.79 20.64 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.603 172.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -70.69 14.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.252 1.387 . . . . 0.0 113.856 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -105.59 -7.01 18.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.041 1.736 . . . . 0.0 111.766 173.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.64 129.72 36.79 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 -172.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.47 -17.34 59.32 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -171.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 -11.52 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 169.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.9 p -94.11 135.91 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 122.172 2.26 . . . . 0.0 110.395 -170.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -107.49 -12.78 15.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.664 0.786 . . . . 0.0 113.094 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -179.81 174.38 0.93 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.219 2.608 . . . . 0.0 112.552 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 tt -172.42 153.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.038 2.535 . . . . 0.0 109.59 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 t -147.0 131.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.258 2.223 . . . . 0.0 107.99 167.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.29 137.29 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.487 1.613 . . . . 0.0 112.425 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 m -88.33 86.21 7.02 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.582 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mt -47.94 -36.75 12.96 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.89 2.876 . . . . 0.0 115.286 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 12.6 mm-40 -88.23 -4.96 58.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.868 1.318 . . . . 0.0 113.792 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -116.36 -168.02 1.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.185 2.594 . . . . 0.0 108.769 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.46 43.41 2.97 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.91 -1.744 . . . . 0.0 110.056 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -134.47 151.58 51.24 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.083 -1.011 . . . . 0.0 112.959 -172.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.38 140.45 52.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.601 1.96 . . . . 0.0 109.347 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.7 mt -111.2 116.7 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -117.98 129.63 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.773 1.629 . . . . 0.0 107.447 -169.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 102.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 108.962 -168.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 29.3 p90 -120.92 141.0 51.05 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.532 1.133 . . . . 0.0 113.945 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 CA--C 1.535 0.396 0 O-C-N 120.685 -1.259 . . . . 0.0 110.786 -172.571 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 CA--C 1.534 0.484 0 CA-C-O 118.755 -0.602 . . . . 0.0 113.182 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -54.2 -32.53 55.91 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.365 0.984 . . . . 0.0 112.47 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 m -88.77 -23.7 22.82 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.964 -169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.11 -42.24 80.54 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.27 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -47.11 -55.64 7.99 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.611 0.764 . . . . 0.0 109.521 168.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 55' ' ' GLU . 2.4 mptm? -47.57 -48.22 28.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.355 1.062 . . . . 0.0 113.823 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.53 -27.95 69.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.118 0.872 . . . . 0.0 112.959 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.17 -49.7 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.124 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -51.3 -34.3 32.61 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 123.443 0.697 . . . . 0.0 110.284 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.38 5.75 14.08 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.86 -27.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.875 0.87 . . . . 0.0 111.699 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.54 65.5 8.54 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.088 168.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.5 146.27 97.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.341 3.361 . . . . 0.0 113.356 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.21 -29.44 2.81 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.852 1.215 . . . . 0.0 113.383 -174.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -94.79 -45.1 7.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.969 1.708 . . . . 0.0 110.791 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -71.8 106.96 4.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -80.96 78.24 7.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.154 0.982 . . . . 0.0 111.393 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -85.8 125.0 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.876 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 137.3 41.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 108.793 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.87 127.5 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 0.0 108.829 172.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 123.174 1.464 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -140.2 175.28 9.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.627 3.171 . . . . 0.0 107.734 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -159.56 156.8 28.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.658 -1.276 . . . . 0.0 111.146 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.05 163.44 40.28 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 125.486 1.514 . . . . 0.0 111.316 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.3 m -125.54 139.58 53.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.197 1.399 . . . . 0.0 110.109 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -139.21 140.78 37.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.056 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.35 141.43 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.525 1.13 . . . . 0.0 109.347 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.05 165.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 125.179 1.392 . . . . 0.0 107.628 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.39 137.75 23.26 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.327 1.051 . . . . 0.0 108.313 167.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.17 69.96 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.244 0.925 . . . . 0.0 112.681 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 161.47 10.1 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.327 2.251 . . . . 0.0 114.437 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -68.98 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 126.155 1.782 . . . . 0.0 115.275 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 52.89 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 130.573 3.549 . . . . 0.0 119.279 167.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -49.77 1.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.601 1.56 . . . . 0.0 109.428 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -55.95 -27.1 50.9 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.359 -1.463 . . . . 0.0 113.048 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.5 p -49.69 -49.33 48.09 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 119.504 1.047 . . . . 0.0 111.645 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.8 t -52.91 -46.7 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.084 2.154 . . . . 0.0 111.967 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -62.61 -42.79 99.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.134 0.574 . . . . 0.0 111.23 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -63.33 -43.06 98.84 Favored 'General case' 0 C--O 1.222 -0.37 0 O-C-N 121.968 -0.458 . . . . 0.0 111.792 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.21 -45.32 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.428 0.558 . . . . 0.0 109.53 -172.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.41 -50.67 59.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.306 1.442 . . . . 0.0 110.783 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -76.2 -31.58 58.52 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -79.71 -41.25 27.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.34 1.456 . . . . 0.0 110.289 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -74.56 -44.62 50.12 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 116.861 -1.542 . . . . 0.0 111.272 175.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -73.31 17.28 0.14 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 121.148 1.795 . . . . 0.0 113.165 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -111.6 -3.11 15.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.709 1.604 . . . . 0.0 113.007 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 mt -75.27 134.87 41.0 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.82 -1.175 . . . . 0.0 111.964 -169.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.63 63.14 1.53 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.688 1.195 . . . . 0.0 112.059 -176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.0 p90 168.38 -21.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 130.394 3.478 . . . . 0.0 114.531 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.09 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.54 1.518 . . . . 0.0 109.422 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -115.48 -11.39 11.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -169.97 173.16 6.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.941 1.353 . . . . 0.0 112.634 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -155.73 157.39 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 109.972 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -144.7 124.48 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 126.765 2.026 . . . . 0.0 107.124 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.19 134.26 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.732 1.253 . . . . 0.0 110.146 169.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 m -67.59 90.26 0.26 Allowed 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.148 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.04 -38.21 50.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.748 1.158 . . . . 0.0 112.332 -168.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -66.31 0.56 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.451 0.569 . . . . 0.0 110.643 170.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.22 165.18 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.318 1.532 . . . . 0.0 112.19 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 40.4 0.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.319 -1.488 . . . . 0.0 113.174 168.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 p -133.91 158.62 43.0 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 140.42 51.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.123 2.169 . . . . 0.0 110.984 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.73 118.31 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -121.45 131.92 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.537 1.135 . . . . 0.0 108.22 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 t -118.32 120.9 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.331 1.453 . . . . 0.0 108.713 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 48.4 p90 -135.99 160.82 37.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 -170.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 CA--C 1.543 0.682 0 O-C-N 120.927 -1.108 . . . . 0.0 112.417 -169.026 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.537 0.64 0 N-CA-C 115.185 1.187 . . . . 0.0 115.185 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 p -66.58 -40.5 88.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.996 1.725 . . . . 0.0 112.917 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.5 mt -69.2 -43.61 73.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.19 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -52.01 -48.24 64.59 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.768 0.713 . . . . 0.0 109.913 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -60.93 -31.54 71.06 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.58 84.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.966 1.257 . . . . 0.0 111.891 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.86 -53.28 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.743 -0.598 . . . . 0.0 110.209 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -57.02 -21.13 28.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 112.102 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.39 1.99 55.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -93.47 -30.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.732 0.813 . . . . 0.0 111.258 175.44 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 69.49 10.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.536 0.734 . . . . 0.0 111.053 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.47 142.49 98.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.622 3.548 . . . . 0.0 112.574 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.87 -27.61 2.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.07 1.319 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 tp -88.62 -45.04 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.368 1.467 . . . . 0.0 111.514 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -78.67 102.5 8.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.817 1.247 . . . . 0.0 114.203 -168.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -70.3 44.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.62 130.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 122.588 1.185 . . . . 0.0 113.244 -166.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -136.7 148.33 47.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.491 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.88 126.45 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.79 -1.194 . . . . 0.0 108.271 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.089 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.984 0.897 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 t -115.55 -177.99 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 108.486 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -160.69 148.88 16.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.966 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.92 159.51 43.79 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.039 1.336 . . . . 0.0 110.958 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 m -117.85 134.54 54.83 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.46 1.504 . . . . 0.0 109.569 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -130.65 148.19 52.41 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.009 1.324 . . . . 0.0 111.054 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.6 tt -131.28 137.9 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.12 1.368 . . . . 0.0 110.4 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.69 110.9 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.769 1.628 . . . . 0.0 109.592 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.9 119.17 26.83 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 168.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.76 8.25 30.42 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.155 0.883 . . . . 0.0 113.413 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 138.23 58.28 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.491 -1.005 . . . . 0.0 110.76 171.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -55.32 -32.19 62.29 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p 144.71 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 131.642 3.977 . . . . 0.0 108.352 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 10.6 mptt -19.79 -61.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 129.597 3.159 . . . . 0.0 114.439 165.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -57.19 -11.24 1.56 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.48 -45.03 85.32 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.689 1.586 . . . . 0.0 109.693 168.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.5 -47.28 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 125.297 1.439 . . . . 0.0 111.995 -169.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.2 t -58.01 -38.6 76.49 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.156 0.979 . . . . 0.0 111.834 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -72.86 -40.02 66.01 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.166 -0.959 . . . . 0.0 113.035 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.663 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -46.51 -55.49 7.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.287 1.835 . . . . 0.0 109.484 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.4 m -70.32 -44.96 67.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -71.79 -38.55 70.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.451 1.101 . . . . 0.0 110.834 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -75.55 -49.44 18.63 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.161 -1.4 . . . . 0.0 111.393 175.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -72.25 12.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.006 1.73 . . . . 0.0 113.184 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -101.16 -6.16 24.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.615 1.566 . . . . 0.0 111.703 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.6 127.27 32.69 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.31 -19.31 13.78 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -8.97 33.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.4 p -94.23 140.03 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 121.88 2.127 . . . . 0.0 109.554 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 t -111.39 -8.25 14.32 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.96 171.7 3.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.479 1.512 . . . . 0.0 113.237 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.68 150.04 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.402 1.481 . . . . 0.0 112.358 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.62 146.51 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 127.685 2.394 . . . . 0.0 105.867 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.16 149.26 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.973 0.892 . . . . 0.0 111.11 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -101.49 96.11 6.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HG ' ' HE3' ' A' ' 15' ' ' LYS . 9.6 tp -62.38 -30.75 71.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.715 1.606 . . . . 0.0 115.208 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 19.0 mm-40 -86.25 1.84 49.36 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.507 1.146 . . . . 0.0 113.308 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -126.55 -170.55 2.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.669 2.788 . . . . 0.0 109.813 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 34.39 5.22 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.333 1.853 . . . . 0.0 112.205 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -141.29 154.78 45.91 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.89 143.38 51.11 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.614 2.366 . . . . 0.0 111.264 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -112.36 116.19 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.59 129.43 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -168.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 114.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.437 1.495 . . . . 0.0 107.044 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 20.4 p90 -136.45 151.02 49.02 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.374 1.069 . . . . 0.0 111.932 -168.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 CA--C 1.544 0.723 0 O-C-N 120.653 -1.28 . . . . 0.0 111.728 -175.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.542 0.895 0 N-CA-C 114.616 0.968 . . . . 0.0 114.616 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.126 0.875 . . . . 0.0 112.165 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -81.25 -18.1 47.17 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.126 -168.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.19 -46.32 64.82 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.477 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 3.3 ttt85 -49.24 -52.64 25.86 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.537 1.062 . . . . 0.0 109.351 170.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.98 -41.82 71.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.26 69.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.826 1.194 . . . . 0.0 112.592 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.9 mt -72.7 -52.96 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.431 0.692 . . . . 0.0 109.954 170.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.409 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 54.9 mt-10 -54.13 -25.96 25.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.645 0.778 . . . . 0.0 112.518 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -0.89 37.83 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.06 -30.17 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.414 1.086 . . . . 0.0 111.297 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.79 66.48 10.66 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 121.605 -0.684 . . . . 0.0 111.479 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.58 142.21 98.48 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.525 3.483 . . . . 0.0 112.949 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.02 -30.18 2.99 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.286 1.422 . . . . 0.0 113.673 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.93 -39.49 10.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 112.01 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -79.76 107.2 12.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 113.424 -177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -83.9 78.06 9.8 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.707 -1.246 . . . . 0.0 111.217 171.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 135.09 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.843 0.83 . . . . 0.0 111.079 -173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 m -152.1 165.41 34.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.464 1.105 . . . . 0.0 111.312 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.7 mt -93.4 133.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.538 1.135 . . . . 0.0 109.112 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.141 0 C-N-CA 123.777 0.831 . . . . 0.0 109.851 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.626 0 CA-C-O 122.901 1.334 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 t -141.29 -175.76 4.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.439 2.696 . . . . 0.0 109.082 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 m -166.54 141.84 4.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.003 -1.061 . . . . 0.0 110.515 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.58 32.59 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.064 1.346 . . . . 0.0 110.676 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.2 m -130.2 138.63 50.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.863 1.265 . . . . 0.0 109.807 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -139.57 151.73 46.3 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.612 0.765 . . . . 0.0 112.259 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.9 tt -141.89 129.65 21.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 124.048 0.939 . . . . 0.0 112.077 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.75 114.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 126.485 1.914 . . . . 0.0 110.61 -168.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 1.46 17.15 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.69 4.15 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.027 1.775 . . . . 0.0 116.822 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -71.55 141.72 50.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.89 2.345 . . . . 0.0 113.477 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -68.49 32.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 127.483 2.313 . . . . 0.0 114.96 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t 54.71 -131.78 1.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.181 1.393 . . . . 0.0 111.158 171.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 74.6 mttt -54.58 -25.24 25.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -168.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -82.49 -46.17 13.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.975 1.261 . . . . 0.0 111.851 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.1 m -57.99 -40.85 81.7 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 117.123 -1.417 . . . . 0.0 111.387 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -39.82 -56.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.022 1.729 . . . . 0.0 111.287 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -59.04 -43.1 91.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.856 . . . . 0.0 112.24 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -62.84 -40.73 98.34 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.752 -0.593 . . . . 0.0 112.461 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -49.39 76.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.11 -50.54 61.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.679 1.192 . . . . 0.0 110.673 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 t -68.76 -32.64 72.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.0 m -77.34 -48.7 16.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.642 0.734 . . . . 0.0 109.936 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.7 -20.05 57.02 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.168 1.387 . . . . 0.0 114.227 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.2 t -85.5 1.29 49.51 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.606 1.548 . . . . 0.0 112.969 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.36 1.75 11.83 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.606 -1.309 . . . . 0.0 114.187 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.89 152.05 42.89 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.4 -0.812 . . . . 0.0 112.568 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.72 47.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.919 2.087 . . . . 0.0 112.604 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.185 3.394 . . . . 0.0 114.095 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.4 p -94.23 142.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 122.402 2.365 . . . . 0.0 112.135 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 m -107.48 -18.59 13.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.507 1.523 . . . . 0.0 113.928 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 m -178.65 171.07 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.747 2.019 . . . . 0.0 111.854 -171.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -167.2 161.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.211 2.604 . . . . 0.0 109.701 -175.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 t -152.09 128.31 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 127.991 2.516 . . . . 0.0 107.718 165.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.9 t -96.24 142.79 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 123.39 1.566 . . . . 0.0 112.207 170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 m -74.41 86.77 2.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.007 1.323 . . . . 0.0 110.284 170.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.451 HD12 ' HE2' ' A' ' 15' ' ' LYS . 1.1 tm? -44.0 -43.46 6.69 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.301 3.04 . . . . 0.0 113.096 -175.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.528 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -83.94 -9.4 58.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.084 1.354 . . . . 0.0 114.623 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.61 -170.01 2.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.377 2.671 . . . . 0.0 110.243 -167.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.64 33.87 5.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.319 1.848 . . . . 0.0 112.623 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -140.66 159.18 42.76 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.53 142.87 41.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.88 1.672 . . . . 0.0 111.129 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.8 121.19 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -121.46 128.61 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.513 1.525 . . . . 0.0 107.729 -168.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 103.12 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.648 1.579 . . . . 0.0 109.184 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 46.2 p90 -119.31 156.51 29.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.49 1.116 . . . . 0.0 112.977 -170.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 124.429 1.092 . . . . 0.0 110.885 -172.739 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 CA-C-O 119.129 -0.446 . . . . 0.0 113.062 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -32.35 17.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.415 1.086 . . . . 0.0 112.339 170.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 m -72.88 -35.0 67.05 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.849 1.204 . . . . 0.0 111.791 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -70.8 -43.47 68.58 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.925 -0.559 . . . . 0.0 109.736 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -52.71 -42.02 64.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.654 0.782 . . . . 0.0 110.84 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -39.79 95.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 169.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.97 69.53 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 121.104 1.775 . . . . 0.0 112.172 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.86 -58.77 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.587 0.755 . . . . 0.0 111.338 170.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -54.99 -18.59 5.26 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.836 1.254 . . . . 0.0 113.431 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.07 57.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -90.82 -29.71 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.282 1.033 . . . . 0.0 111.28 177.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.04 65.18 7.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 121.594 -0.691 . . . . 0.0 111.683 168.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.82 149.08 62.58 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.068 3.179 . . . . 0.0 112.586 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.14 -44.28 3.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.665 1.126 . . . . 0.0 112.513 -173.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 tp -77.05 -44.79 29.42 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.167 1.387 . . . . 0.0 110.717 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -81.36 94.75 6.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.458 1.123 . . . . 0.0 113.243 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -77.8 110.51 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 164.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.17 146.93 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 124.371 3.259 . . . . 0.0 111.887 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -131.67 158.12 41.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.481 1.512 . . . . 0.0 110.029 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.6 mt -94.73 124.62 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 122.189 0.995 . . . . 0.0 109.593 174.549 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 123.273 1.511 . . . . 0.0 113.515 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -102.49 -177.52 3.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.741 2.017 . . . . 0.0 111.332 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.39 166.93 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.893 -1.129 . . . . 0.0 111.505 172.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.4 152.22 30.81 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.707 1.203 . . . . 0.0 111.223 169.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.0 m -114.7 139.07 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.697 1.599 . . . . 0.0 109.716 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -140.24 143.17 35.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.28 -176.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.8 132.45 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.295 1.038 . . . . 0.0 110.662 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.72 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.443 1.497 . . . . 0.0 110.072 -169.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.12 50.73 0.92 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.058 -1.026 . . . . 0.0 112.922 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 -8.27 0.02 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.008 1.766 . . . . 0.0 117.409 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -72.71 144.24 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.909 2.354 . . . . 0.0 111.723 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -64.52 5.48 0.28 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.24 1.816 . . . . 0.0 115.845 -176.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.55 -35.87 0.28 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.884 2.873 . . . . 0.0 115.52 171.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HE2' HD12 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -103.1 -87.44 0.42 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.303 1.411 . . . . 0.0 110.602 172.515 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p -63.62 -13.04 38.47 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 119.152 -2.218 . . . . 0.0 115.256 -175.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.91 -39.79 94.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 121.213 1.824 . . . . 0.0 110.813 167.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -50.31 -47.28 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.084 2.154 . . . . 0.0 111.381 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.5 t -69.63 -37.58 76.87 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.689 -1.257 . . . . 0.0 111.881 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -49.68 80.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.058 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -51.28 -51.34 55.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.363 170.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -70.15 -31.14 68.5 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -176.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -78.14 -51.31 10.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.876 0.871 . . . . 0.0 109.134 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.12 -19.68 56.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.5 t -87.66 14.82 7.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 121.282 1.856 . . . . 0.0 112.697 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.56 4.13 9.59 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 30' ' ' TYR . 18.1 mt -77.2 154.35 33.18 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.04 -1.038 . . . . 0.0 112.472 -171.212 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -64.58 13.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.535 2.734 . . . . 0.0 114.71 -174.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -167.2 3.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.295 2.238 . . . . 0.0 113.89 -169.667 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 14.3 p -104.64 133.14 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.966 1.712 . . . . 0.0 110.543 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -105.9 -12.41 15.85 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -177.57 174.22 1.56 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.146 1.778 . . . . 0.0 112.78 -176.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -167.33 153.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.249 2.22 . . . . 0.0 110.806 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.21 143.42 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.959 2.503 . . . . 0.0 106.581 166.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.85 148.85 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.8 p -77.97 136.55 38.0 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 176.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.476 HD12 ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -92.35 -15.88 26.72 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 112.873 169.78 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.49 -57.6 3.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.975 1.71 . . . . 0.0 110.63 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.32 -179.11 5.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 113.202 -172.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 37.96 1.98 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.217 1.807 . . . . 0.0 113.965 177.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -141.96 147.19 36.58 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.635 -1.915 . . . . 0.0 115.255 -170.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.56 143.19 50.36 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.484 -174.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -117.64 117.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.9 t -122.88 119.67 58.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.914 1.286 . . . . 0.0 109.625 -165.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.6 t -103.95 108.95 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 109.425 -169.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p90 -122.86 144.68 49.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.896 1.278 . . . . 0.0 113.186 -171.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 120.495 -1.378 . . . . 0.0 111.935 -171.939 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.537 0.664 0 CA-C-O 118.951 -0.52 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -50.29 -40.94 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.04 0.936 . . . . 0.0 112.418 171.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -70.77 -32.78 70.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.384 -1.447 . . . . 0.0 112.731 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.96 -45.44 50.24 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.42 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -48.92 -51.63 29.02 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.386 1.474 . . . . 0.0 109.821 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -55.46 -43.25 75.3 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.932 1.293 . . . . 0.0 113.413 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.34 74.95 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.419 0.554 . . . . 0.0 112.332 173.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -54.54 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.793 -0.567 . . . . 0.0 111.595 172.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.54 -27.85 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.528 1.131 . . . . 0.0 111.425 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.15 1.36 48.3 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -95.3 -29.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.15 0.98 . . . . 0.0 111.477 177.149 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.03 66.73 8.83 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.664 -0.647 . . . . 0.0 111.453 168.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.55 141.15 97.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.014 3.143 . . . . 0.0 112.592 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.38 -40.99 3.05 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.109 1.338 . . . . 0.0 112.815 -174.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.09 -42.98 45.58 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.544 1.137 . . . . 0.0 111.52 172.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.427 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.9 m-30 -78.45 97.71 5.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -78.94 79.61 5.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.273 168.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 t -88.05 121.79 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.181 0.592 . . . . 0.0 111.896 -172.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.73 133.01 52.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.571 1.148 . . . . 0.0 110.931 -174.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mt -86.32 84.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.408 0.623 . . . . 0.0 109.789 -178.775 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p30 . . . . . 0 CA--C 1.545 0.771 0 CA-C-O 121.661 0.743 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -117.0 178.81 4.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.478 1.511 . . . . 0.0 110.872 170.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 m -156.38 146.48 21.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 125.636 1.574 . . . . 0.0 109.112 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.33 159.29 43.49 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.815 171.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.3 m -114.17 132.44 56.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.87 1.268 . . . . 0.0 109.986 174.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.94 146.07 50.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.775 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -131.85 134.78 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.817 1.247 . . . . 0.0 110.621 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.98 100.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.643 1.577 . . . . 0.0 109.015 -169.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.22 3.53 10.56 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.59 10.53 8.55 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 125.887 1.708 . . . . 0.0 113.357 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -70.59 138.19 50.66 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.289 1.036 . . . . 0.0 110.2 -175.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.79 -6.89 1.96 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 174.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 t 81.74 -43.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.586 2.355 . . . . 0.0 110.601 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -122.95 149.4 44.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.764 1.226 . . . . 0.0 109.397 169.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m 69.77 -44.53 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.328 1.851 . . . . 0.0 113.261 -168.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.53 -47.87 63.2 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 121.096 1.771 . . . . 0.0 110.563 174.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -29.9 -58.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 127.257 2.223 . . . . 0.0 113.844 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -70.5 -34.78 72.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 117.839 0.29 . . . . 0.0 111.4 -169.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -58.85 -43.82 90.87 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.545 -0.722 . . . . 0.0 112.104 168.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -41.37 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.43 -172.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.73 -50.62 69.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.815 0.846 . . . . 0.0 110.292 169.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -67.81 -45.71 73.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -175.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.444 ' HG1' HG22 ' A' ' 64' ' ' VAL . 49.9 m -66.85 -40.27 87.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.554 1.542 . . . . 0.0 110.576 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -47.02 42.86 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.838 176.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -68.77 6.32 0.89 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.244 1.384 . . . . 0.0 113.733 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.98 -5.46 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.512 176.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.7 mt -77.24 127.72 33.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.197 -0.939 . . . . 0.0 109.843 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -54.25 -21.93 10.41 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.68 -16.54 24.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 175.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.272 4.1 p -82.83 138.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.658 1.572 . . . . 0.0 110.031 -168.369 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -99.67 -31.25 11.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.951 1.701 . . . . 0.0 110.668 -174.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -166.49 174.76 8.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.596 1.189 . . . . 0.0 112.875 173.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 150.73 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.011 1.324 . . . . 0.0 111.601 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.73 134.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.293 1.837 . . . . 0.0 107.24 166.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.31 134.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.171 0.986 . . . . 0.0 109.776 168.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -68.59 92.26 0.45 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.808 169.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -47.9 -43.05 28.44 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.989 1.715 . . . . 0.0 111.305 -177.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.52 -51.87 67.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.553 1.141 . . . . 0.0 112.031 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.69 -176.19 5.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 124.893 2.282 . . . . 0.0 113.814 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 30.2 4.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.482 2.313 . . . . 0.0 112.133 169.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 150.87 41.93 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.182 -1.574 . . . . 0.0 114.744 -167.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.8 136.45 51.49 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.592 1.957 . . . . 0.0 110.517 -171.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.23 111.37 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 t -117.5 130.79 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.2 1.4 . . . . 0.0 108.792 -169.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.65 112.78 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.195 1.398 . . . . 0.0 107.481 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 2.0 p90 -131.84 134.81 46.17 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.897 1.226 . . . . 0.0 112.303 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 CA--C 1.538 0.498 0 O-C-N 121.471 -0.768 . . . . 0.0 110.547 179.824 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 CA--C 1.535 0.573 0 CA-C-O 119.32 -0.367 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -52.81 -24.79 9.65 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 112.502 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -42.6 79.99 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.704 -1.248 . . . . 0.0 112.233 177.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.47 -45.5 65.59 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.801 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -46.06 -52.25 12.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.984 0.914 . . . . 0.0 110.345 170.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -32.83 74.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 177.4 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.297 1.408 . . . . 0.0 111.537 170.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.53 -52.85 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.876 0.47 . . . . 0.0 110.684 171.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.07 -27.75 14.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.237 0.926 . . . . 0.0 112.0 174.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.57 4.15 33.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.444 HG22 ' HG1' ' A' ' 24' ' ' THR . 0.4 OUTLIER -98.32 -28.04 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.926 0.89 . . . . 0.0 111.544 173.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.36 67.81 9.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.506 -0.746 . . . . 0.0 111.068 168.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.9 139.87 87.31 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.054 3.169 . . . . 0.0 111.868 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.82 -23.06 7.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.571 1.081 . . . . 0.0 114.073 -175.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 -45.16 7.37 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.376 1.471 . . . . 0.0 111.492 173.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -76.95 102.07 6.24 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -168.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.545 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -75.86 75.99 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 110.267 168.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.91 129.65 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 122.227 1.013 . . . . 0.0 111.744 -176.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -138.66 159.72 41.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.613 1.565 . . . . 0.0 109.992 178.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.3 mt -95.69 129.61 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.584 0.707 . . . . 0.0 109.955 -179.195 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 122.994 1.378 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -120.13 168.89 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.297 2.239 . . . . 0.0 107.972 167.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m -152.89 147.89 26.51 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.196 -0.94 . . . . 0.0 110.601 -175.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.52 161.32 42.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.558 1.143 . . . . 0.0 112.162 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.1 m -121.47 137.73 54.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.101 1.36 . . . . 0.0 110.257 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -136.9 143.16 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.779 1.231 . . . . 0.0 110.31 -178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 tt -132.07 131.67 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 111.052 -175.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.63 102.36 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.329 1.852 . . . . 0.0 108.768 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -76.52 33.07 0.13 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.052 -1.655 . . . . 0.0 114.143 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.97 -0.71 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.424 1.488 . . . . 0.0 116.263 -176.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.8 ptm -69.94 141.02 53.12 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.466 2.133 . . . . 0.0 110.786 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -59.19 12.09 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 127.235 2.214 . . . . 0.0 116.17 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' H ' ' C ' ' A' ' 12' ' ' MET . 19.4 m 73.12 -42.64 0.54 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.275 2.63 . . . . 0.0 115.768 167.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.11 -89.64 0.47 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.046 1.338 . . . . 0.0 109.129 174.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 p -55.57 -22.77 23.49 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 121.679 2.036 . . . . 0.0 115.601 -173.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -57.87 -42.75 85.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 112.527 169.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.6 t -46.43 -54.59 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.038 1.735 . . . . 0.0 110.814 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 t -60.01 -37.95 81.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.2 0.6 . . . . 0.0 111.605 -176.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -65.7 -42.76 90.79 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.36 -0.829 . . . . 0.0 112.375 174.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -44.48 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.095 0.861 . . . . 0.0 110.055 -175.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.76 -55.61 21.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.404 1.082 . . . . 0.0 110.37 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.4 t -64.1 -49.36 72.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.5 m -69.95 -36.25 75.14 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.98 1.312 . . . . 0.0 111.16 -172.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.98 -47.97 40.65 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.746 168.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -65.81 7.68 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 121.288 1.858 . . . . 0.0 115.283 -171.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.51 -3.32 18.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.824 2.05 . . . . 0.0 112.199 176.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.5 136.84 46.01 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.99 -1.069 . . . . 0.0 110.996 -171.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -75.63 65.65 1.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.786 1.634 . . . . 0.0 111.274 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 p90 167.25 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 129.961 3.304 . . . . 0.0 113.041 -173.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.2 p -86.03 142.63 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 121.184 1.811 . . . . 0.0 110.186 -175.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.06 -21.79 12.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -170.54 172.01 6.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.073 1.749 . . . . 0.0 112.369 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -176.25 153.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 127.804 2.442 . . . . 0.0 109.593 -169.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -147.11 132.6 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.588 2.355 . . . . 0.0 107.743 166.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.09 142.14 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.458 0.647 . . . . 0.0 110.825 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -73.28 108.79 6.36 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 122.81 1.29 . . . . 0.0 109.126 166.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -20.24 44.68 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.341 -0.849 . . . . 0.0 112.139 168.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -91.9 -45.6 8.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.539 1.063 . . . . 0.0 112.57 175.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -99.6 157.56 16.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.828 1.251 . . . . 0.0 112.178 -171.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.81 35.01 0.23 Allowed 'General case' 0 CA--C 1.548 0.872 0 O-C-N 119.732 -1.855 . . . . 0.0 113.946 -177.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -140.49 154.55 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 119.914 -1.741 . . . . 0.0 115.431 -170.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.56 139.19 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.187 2.195 . . . . 0.0 109.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -110.26 118.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 169.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.9 t -121.65 138.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.899 1.28 . . . . 0.0 110.125 -167.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.14 99.4 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.238 1.415 . . . . 0.0 109.925 -167.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 20.4 p90 -118.13 143.01 46.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.537 1.535 . . . . 0.0 113.539 -168.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 CA--C 1.536 0.413 0 O-C-N 120.565 -1.334 . . . . 0.0 111.583 -169.385 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.533 0.448 0 CA-C-O 119.44 -0.317 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.411 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -60.46 -16.96 41.53 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.155 0.982 . . . . 0.0 112.608 174.528 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -68.06 -47.07 69.34 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.957 -1.089 . . . . 0.0 112.802 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.6 -42.88 86.22 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.608 -0.683 . . . . 0.0 110.435 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.68 -52.5 18.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.207 1.403 . . . . 0.0 111.785 171.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.411 ' HZ1' ' CD ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -65.1 -32.52 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.225 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.14 83.97 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.984 1.265 . . . . 0.0 111.8 172.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.02 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.432 -0.793 . . . . 0.0 110.762 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.19 -20.67 18.96 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.71 1.19 55.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -93.96 -28.79 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.282 0.946 . . . . 0.0 111.252 176.352 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.422 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -151.15 67.79 7.75 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.764 0.826 . . . . 0.0 112.161 169.027 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.45 145.41 88.45 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.269 3.313 . . . . 0.0 113.062 -178.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.96 -40.98 2.93 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.416 1.484 . . . . 0.0 112.929 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -77.01 -45.81 26.01 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.046 1.338 . . . . 0.0 111.698 173.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 3.2 m-30 -72.28 96.97 1.91 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.25 1.5 . . . . 0.0 114.11 -168.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -72.85 65.02 0.7 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.715 2.006 . . . . 0.0 113.594 170.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.97 136.78 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.77 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 p -151.79 156.95 41.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.845 1.258 . . . . 0.0 110.57 174.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.65 129.61 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.166 0.986 . . . . 0.0 109.71 174.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 109.097 -179.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -100.65 -175.88 3.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.821 1.648 . . . . 0.0 110.141 168.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -162.77 150.79 13.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.044 1.338 . . . . 0.0 109.62 -172.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.4 159.93 39.17 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.678 1.591 . . . . 0.0 111.321 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -121.87 139.22 53.9 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 109.947 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -140.5 139.48 35.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.185 -176.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.12 130.75 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.05 1.34 . . . . 0.0 111.122 -175.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.42 103.46 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.978 1.711 . . . . 0.0 109.524 -168.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.404 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -72.08 0.19 10.17 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.357 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 10.47 5.75 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 125.784 1.659 . . . . 0.0 114.36 -173.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 17' ' ' CYS . 4.5 tmm? -66.59 135.92 54.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.304 1.042 . . . . 0.0 111.231 -174.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -62.56 0.25 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m 76.34 -40.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.965 2.506 . . . . 0.0 114.623 167.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HE3' HD12 ' A' ' 38' ' ' LEU . 12.3 mptt -111.55 -75.79 0.61 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.11 0.868 . . . . 0.0 109.507 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -32.32 69.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.552 -1.968 . . . . 0.0 114.045 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 1.6 m -57.25 -41.73 80.17 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.69 176.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -47.13 -49.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.887 2.075 . . . . 0.0 112.242 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -61.62 -40.07 93.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.395 0.678 . . . . 0.0 112.348 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -63.8 -46.95 82.87 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 122.06 -0.4 . . . . 0.0 111.743 171.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.23 -50.98 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -171.12 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.06 -44.47 67.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.33 1.852 . . . . 0.0 109.899 175.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -70.49 -44.59 67.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 m -70.76 -40.3 72.76 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.95 1.3 . . . . 0.0 110.853 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.71 -49.55 25.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 116.845 -1.55 . . . . 0.0 111.199 175.724 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.96 16.74 0.11 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.472 1.942 . . . . 0.0 113.534 -174.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -111.92 -3.45 14.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.224 1.81 . . . . 0.0 112.423 174.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.85 139.86 47.23 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.86 -1.15 . . . . 0.0 111.634 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.88 -15.2 7.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.817 1.647 . . . . 0.0 115.004 -170.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.79 -6.47 11.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.367 1.867 . . . . 0.0 114.95 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.1 p -88.82 137.32 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.923 1.692 . . . . 0.0 111.271 -168.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.23 -26.19 14.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.266 1.027 . . . . 0.0 111.506 -173.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -177.8 173.55 1.57 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.06 2.144 . . . . 0.0 111.636 -171.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -177.32 155.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.622 2.369 . . . . 0.0 108.624 -172.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -149.58 135.38 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 127.48 2.312 . . . . 0.0 108.645 166.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.19 141.44 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.072 0.949 . . . . 0.0 110.75 169.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -79.16 112.76 16.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 123.153 1.454 . . . . 0.0 110.259 168.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.489 HD12 ' HE3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.59 -22.06 31.17 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 120.692 -1.255 . . . . 0.0 112.664 167.886 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 -69.04 0.73 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.519 1.528 . . . . 0.0 111.057 169.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -73.52 137.23 44.28 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.855 1.262 . . . . 0.0 111.278 -171.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -130.86 154.73 47.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.247 2.219 . . . . 0.0 113.691 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.26 143.97 44.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.259 2.223 . . . . 0.0 109.296 172.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.74 118.84 59.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.99 135.52 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.329 1.452 . . . . 0.0 108.881 -168.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.73 96.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.21 1.404 . . . . 0.0 108.52 -168.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 25.6 p90 -118.63 140.07 50.5 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.729 1.212 . . . . 0.0 113.55 -168.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 CA--C 1.539 0.542 0 O-C-N 121.077 -1.014 . . . . 0.0 111.629 -178.385 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 N-CA-C 112.329 0.088 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.83 -13.65 62.12 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -37.32 81.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.301 1.864 . . . . 0.0 111.44 170.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.7 mt -70.03 -46.14 65.68 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.182 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -49.01 -52.42 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 111.072 174.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -56.5 -37.71 70.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.286 1.434 . . . . 0.0 114.749 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.77 95.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.733 1.606 . . . . 0.0 111.474 171.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mt -63.06 -56.18 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.667 174.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -53.18 -24.68 11.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.936 0.894 . . . . 0.0 113.002 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 0.01 55.94 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -95.39 -30.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 177.696 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.01 67.48 9.18 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.39 0.676 . . . . 0.0 111.145 169.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 143.71 99.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.13 3.22 . . . . 0.0 112.081 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.71 -39.18 2.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.863 1.22 . . . . 0.0 113.093 -174.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.2 tp -78.21 -41.95 32.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.81 1.244 . . . . 0.0 111.529 174.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CE2' HG13 ' A' ' 64' ' ' VAL . 4.8 m-30 -83.16 94.51 7.87 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -168.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -73.36 66.14 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.189 1.796 . . . . 0.0 111.146 169.213 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.19 131.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 121.747 0.784 . . . . 0.0 110.756 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -138.0 147.62 44.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 0.0 109.017 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.48 130.33 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 119.894 -1.754 . . . . 0.0 109.916 174.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 123.447 0.699 . . . . 0.0 110.184 178.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 122.834 1.302 . . . . 0.0 113.861 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -103.49 175.11 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.291 1.436 . . . . 0.0 110.794 176.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -163.99 147.53 9.8 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.862 -1.149 . . . . 0.0 110.384 -169.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.28 161.98 41.4 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.198 1.399 . . . . 0.0 111.321 170.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.5 m -123.93 139.77 53.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.837 1.255 . . . . 0.0 110.218 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -140.79 136.99 33.02 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.722 1.209 . . . . 0.0 110.024 -174.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tt -119.44 132.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 120.82 -1.175 . . . . 0.0 110.424 177.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.0 106.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.16 1.384 . . . . 0.0 108.676 -175.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.45 98.91 11.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.764 1.269 . . . . 0.0 109.678 169.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.55 -13.42 1.38 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.672 1.606 . . . . 0.0 114.057 177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.401 ' SD ' ' SG ' ' A' ' 17' ' ' CYS 0.257 0.0 OUTLIER -77.07 132.65 39.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.85 1.325 . . . . 0.0 112.187 -176.779 . . . . . . . . 4 4 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -67.94 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 t 66.61 -53.9 0.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.197 2.599 . . . . 0.0 116.23 169.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -63.34 1.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.67 -1.269 . . . . 0.0 112.931 -178.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -59.07 -32.69 70.01 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 121.424 1.92 . . . . 0.0 114.221 -177.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 12' ' ' MET . 2.3 p -40.6 -58.17 1.67 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.217 1.807 . . . . 0.0 111.376 169.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -46.24 -54.19 2.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 127.541 2.336 . . . . 0.0 111.007 -176.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -64.02 -30.23 71.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -69.93 -46.91 64.32 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.89 0.768 . . . . 0.0 111.353 168.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -46.46 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.255 0.934 . . . . 0.0 110.645 -170.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -51.43 -48.86 62.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.113 1.365 . . . . 0.0 110.786 170.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -68.75 -52.19 33.16 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.9 m -69.32 -35.87 76.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.531 1.532 . . . . 0.0 110.567 -169.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 27' ' ' ALA . 7.4 mt -73.24 -48.94 30.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.057 168.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 t -70.96 13.65 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.739 2.063 . . . . 0.0 114.421 -171.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -109.94 -3.94 16.25 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.886 2.074 . . . . 0.0 111.398 173.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.99 125.86 29.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.11 -15.13 43.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.15 -11.57 35.25 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 169.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.7 p -94.68 137.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 121.586 1.994 . . . . 0.0 109.739 -173.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -105.38 -14.79 15.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.197 0.599 . . . . 0.0 112.491 -176.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -178.61 172.18 1.44 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.805 2.042 . . . . 0.0 112.288 -172.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -176.05 152.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 127.743 2.417 . . . . 0.0 109.29 -170.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.5 133.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 127.503 2.321 . . . . 0.0 107.236 167.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.54 141.77 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 123.247 1.499 . . . . 0.0 112.326 171.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -77.57 84.15 3.95 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.596 1.559 . . . . 0.0 109.384 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.09 -29.34 60.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.756 1.622 . . . . 0.0 114.191 -173.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' C ' HD21 ' A' ' 40' ' ' ASN . 17.8 mt-10 -88.4 -0.31 57.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.712 1.605 . . . . 0.0 114.325 176.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.403 HD21 ' C ' ' A' ' 39' ' ' GLU . 1.8 m-80 -135.67 -171.51 2.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.535 2.734 . . . . 0.0 110.411 -175.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER -111.24 33.72 4.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.022 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 p -132.66 155.74 48.23 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.019 -1.676 . . . . 0.0 115.505 -170.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.27 138.02 54.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.144 2.178 . . . . 0.0 110.107 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -108.79 115.91 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 170.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -118.73 136.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.133 1.373 . . . . 0.0 108.977 -167.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.66 104.29 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.758 1.223 . . . . 0.0 109.191 -169.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 34.5 p90 -120.23 161.82 20.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.016 . . . . 0.0 113.274 -171.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 . . . . . 0 CA--C 1.54 0.596 0 O-C-N 120.982 -1.073 . . . . 0.0 110.921 -176.818 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.538 0.693 0 N-CA-C 113.109 0.388 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -54.95 -32.67 61.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.057 1.343 . . . . 0.0 113.4 -176.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 m -73.65 -35.95 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.371 -1.456 . . . . 0.0 112.666 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.56 -44.58 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -50.7 -51.18 52.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.845 1.258 . . . . 0.0 111.201 172.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -39.55 79.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.643 1.177 . . . . 0.0 114.108 172.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 -36.33 80.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.929 1.24 . . . . 0.0 111.83 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.48 -51.67 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.763 -0.585 . . . . 0.0 109.718 170.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.69 -19.02 14.4 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.145 0.884 . . . . 0.0 112.844 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 1.2 57.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.413 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -92.22 -32.35 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.969 0.804 . . . . 0.0 111.014 175.581 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.46 69.12 11.33 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.355 0.662 . . . . 0.0 111.65 168.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.58 142.0 97.9 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.291 3.327 . . . . 0.0 112.785 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.42 -35.56 3.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.143 1.354 . . . . 0.0 113.066 -176.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.65 -43.78 16.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.718 1.607 . . . . 0.0 112.064 174.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.413 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.8 m-30 -80.66 105.08 11.63 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -167.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.14 75.37 8.12 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.618 -1.926 . . . . 0.0 112.927 169.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.43 126.26 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 121.25 -0.906 . . . . 0.0 112.849 -174.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -140.48 139.48 35.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.198 0.999 . . . . 0.0 111.608 -169.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.1 mt -85.41 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.659 -1.276 . . . . 0.0 109.176 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 121.671 0.748 . . . . 0.0 109.281 173.317 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 122.301 1.048 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 t -94.7 -179.67 4.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.576 1.95 . . . . 0.0 110.987 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -158.88 145.96 17.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.287 1.435 . . . . 0.0 110.244 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.03 153.82 39.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.043 1.737 . . . . 0.0 111.07 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 m -117.69 139.52 50.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.913 177.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.98 144.97 41.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.941 1.296 . . . . 0.0 110.644 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.24 135.0 64.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.514 1.525 . . . . 0.0 110.282 178.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.59 123.51 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.969 1.308 . . . . 0.0 108.775 -171.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.67 146.48 27.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 164.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.61 -4.67 77.67 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.401 0.524 . . . . 0.0 112.559 -168.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.42 127.53 27.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.303 1.441 . . . . 0.0 112.118 174.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -64.98 41.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.664 1.986 . . . . 0.0 113.961 170.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 30.62 -110.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.961 3.305 . . . . 0.0 114.84 175.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -39.38 58.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 113.375 -179.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -83.12 -32.89 26.46 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.009 -1.057 . . . . 0.0 112.196 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 t -55.15 -49.08 72.72 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.972 1.26 . . . . 0.0 110.672 171.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -42.34 -50.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 124.489 1.118 . . . . 0.0 112.5 -179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -69.3 -35.54 76.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -62.81 -45.24 93.54 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.756 -1.215 . . . . 0.0 111.005 169.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mm -67.45 -49.21 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.983 -170.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -43.97 -50.83 8.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.488 1.515 . . . . 0.0 109.539 170.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -71.63 -50.95 25.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -66.26 -42.55 88.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.26 1.424 . . . . 0.0 110.51 -176.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.08 -49.65 23.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.159 177.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 t -74.26 13.75 0.53 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.476 1.943 . . . . 0.0 113.302 -173.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.16 -3.1 18.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.733 1.613 . . . . 0.0 111.858 173.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.06 133.64 41.55 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.046 -1.034 . . . . 0.0 110.435 -172.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -59.5 2.98 0.05 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -174.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 -8.09 4.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.696 1.999 . . . . 0.0 114.717 174.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 8.7 p -88.24 139.21 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 121.369 1.895 . . . . 0.0 110.426 -169.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -99.92 -19.02 16.81 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m 178.75 171.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.094 1.758 . . . . 0.0 113.039 -172.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -168.13 152.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.857 2.063 . . . . 0.0 110.473 -174.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.21 148.76 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 128.383 2.673 . . . . 0.0 106.544 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.41 145.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.96 0.409 . . . . 0.0 110.85 175.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 m -91.59 125.52 36.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.582 0.705 . . . . 0.0 112.307 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -36.47 73.6 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.025 -1.047 . . . . 0.0 112.869 -176.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -104.15 -8.85 19.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.291 1.436 . . . . 0.0 114.732 -177.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -121.76 130.39 53.38 Favored 'General case' 0 C--O 1.221 -0.431 0 O-C-N 120.264 -1.523 . . . . 0.0 107.108 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 35.12 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 p -128.23 152.5 48.01 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -172.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.48 137.53 54.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.956 2.502 . . . . 0.0 110.491 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.3 mt -110.66 117.18 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.42 130.67 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.503 1.121 . . . . 0.0 109.041 -167.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.01 108.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.378 1.471 . . . . 0.0 108.555 -167.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 21.6 p90 -128.3 145.67 50.99 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.29 1.405 . . . . 0.0 113.844 -168.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.304 -1.498 . . . . 0.0 112.11 -172.139 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 120.083 -0.049 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 17.0 mp0 -64.54 -8.96 15.85 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.461 1.504 . . . . 0.0 112.26 173.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 p -79.17 -51.87 8.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.787 1.176 . . . . 0.0 111.906 169.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.79 -41.55 95.73 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.774 -1.107 . . . . 0.0 110.639 176.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -53.4 15.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.498 1.045 . . . . 0.0 111.545 172.064 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -37.69 72.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.36 1.464 . . . . 0.0 113.518 175.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.13 84.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.369 1.44 . . . . 0.0 112.085 175.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.26 -56.74 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.455 0.702 . . . . 0.0 110.758 171.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -53.41 -27.33 23.82 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 123.801 0.84 . . . . 0.0 111.534 176.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.42 1.98 38.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -27.94 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.726 0.81 . . . . 0.0 111.643 175.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.77 69.1 9.23 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.082 0.953 . . . . 0.0 110.644 169.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.34 145.3 98.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.257 3.305 . . . . 0.0 112.489 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.06 -40.83 2.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.961 1.267 . . . . 0.0 113.013 -174.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.82 -55.4 5.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.436 1.494 . . . . 0.0 111.062 177.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -71.5 107.76 4.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -169.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -78.89 47.68 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.226 1.811 . . . . 0.0 113.761 176.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.3 126.95 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.972 0.909 . . . . 0.0 111.076 -168.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 m -139.58 148.52 42.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.649 -175.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.67 124.28 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.692 -1.255 . . . . 0.0 109.758 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.208 0 C-N-CA 123.694 0.798 . . . . 0.0 109.608 -175.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 122.419 1.104 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -102.07 -175.25 2.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.88 1.672 . . . . 0.0 109.751 172.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -158.77 150.76 21.21 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.845 -1.159 . . . . 0.0 109.893 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.06 156.01 40.2 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.996 1.719 . . . . 0.0 109.864 173.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.0 m -127.26 138.58 53.11 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.996 0.919 . . . . 0.0 109.453 -178.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -136.53 144.85 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.413 1.085 . . . . 0.0 111.303 -174.106 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 tt -122.38 140.87 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 125.205 1.402 . . . . 0.0 109.19 175.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.18 153.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.683 1.193 . . . . 0.0 108.639 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.26 144.66 50.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.413 0.285 . . . . 0.0 110.971 164.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.77 -1.67 68.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.22 1.39 . . . . 0.0 112.504 -174.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.49 165.91 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.514 1.525 . . . . 0.0 114.338 -171.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.57 ' CE1' ' HG ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -73.55 37.23 0.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 125.022 1.329 . . . . 0.0 113.76 -179.021 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 t 52.39 -143.09 0.72 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.632 1.573 . . . . 0.0 111.7 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 29.5 mttp -61.23 -13.87 21.65 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.196 -1.565 . . . . 0.0 114.273 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -91.79 -11.83 35.52 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.051 -1.656 . . . . 0.0 112.268 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -48.09 77.8 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.643 1.111 . . . . 0.0 108.179 168.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -40.45 -56.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 130.392 3.477 . . . . 0.0 111.937 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -38.27 90.47 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 120.888 0.375 . . . . 0.0 111.808 -173.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -60.81 -41.49 95.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.831 -1.168 . . . . 0.0 112.412 168.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 -47.38 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.731 -171.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.68 -51.53 15.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.746 1.618 . . . . 0.0 109.307 169.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -70.55 -44.26 67.82 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.6 m -70.55 -40.68 73.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.769 1.228 . . . . 0.0 110.5 -175.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.43 -44.89 57.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.224 178.679 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t -70.38 13.36 0.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 120.416 1.462 . . . . 0.0 113.813 -176.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -105.03 -6.84 19.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.399 1.48 . . . . 0.0 111.95 174.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.26 129.0 34.54 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.063 -1.023 . . . . 0.0 110.327 -169.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.72 -25.07 25.17 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -5.13 48.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 174.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.254 5.0 p -92.55 134.73 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 121.606 2.003 . . . . 0.0 110.314 -173.261 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 t -93.3 -27.39 16.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.383 1.473 . . . . 0.0 111.796 -176.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -178.06 175.91 1.2 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.959 2.104 . . . . 0.0 112.409 -171.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -172.75 151.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.748 2.019 . . . . 0.0 109.724 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.58 141.37 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 126.901 2.08 . . . . 0.0 105.782 166.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.37 137.84 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.681 1.229 . . . . 0.0 110.46 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.0 m -75.92 83.11 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.45 176.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.418 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 2.5 tm? -43.49 -42.91 5.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.509 2.324 . . . . 0.0 112.314 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -47.61 84.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.345 1.069 . . . . 0.0 112.29 178.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -98.43 -171.48 2.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.99 2.516 . . . . 0.0 112.031 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.98 29.56 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.081 2.552 . . . . 0.0 113.309 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 p -144.81 158.64 43.72 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.012 -1.68 . . . . 0.0 115.406 -167.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.41 51.76 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.103 2.161 . . . . 0.0 110.774 -173.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.77 110.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.67 130.46 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.19 1.396 . . . . 0.0 108.141 -168.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.87 106.46 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 107.813 -168.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.1 p90 -127.25 147.15 50.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.588 1.155 . . . . 0.0 113.617 -168.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 CA--C 1.539 0.537 0 O-C-N 120.284 -1.51 . . . . 0.0 112.172 179.047 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 N-CA-C 114.66 0.985 . . . . 0.0 114.66 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' CD ' ' HZ3' ' A' ' 59' ' ' LYS . 3.3 tm-20 -64.16 -32.78 74.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.745 1.157 . . . . 0.0 112.913 -168.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -74.51 -28.43 60.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.065 0.946 . . . . 0.0 112.984 -178.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.81 -47.58 58.69 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.407 170.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -45.34 -53.68 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.142 0.883 . . . . 0.0 110.761 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HZ3' ' CD ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -56.96 -37.54 71.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.65 78.48 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.423 1.465 . . . . 0.0 111.892 172.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.23 -50.74 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.263 0.625 . . . . 0.0 110.029 173.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -58.37 -19.36 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.429 -1.419 . . . . 0.0 112.486 174.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.31 0.43 56.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 174.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.422 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -89.63 -37.39 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 118.997 0.817 . . . . 0.0 110.967 173.186 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.57 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -140.35 70.51 33.11 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.964 0.412 . . . . 0.0 111.718 169.846 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.32 134.82 61.35 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.433 3.422 . . . . 0.0 111.909 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 -17.2 27.47 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.095 1.331 . . . . 0.0 114.167 -174.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 tp -105.25 -23.82 12.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.686 1.594 . . . . 0.0 112.532 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 2.8 m-30 -102.61 111.29 23.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.24 45.71 0.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 119.578 -1.951 . . . . 0.0 114.851 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.75 124.06 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -166.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -141.11 155.65 46.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.827 1.651 . . . . 0.0 109.451 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.89 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.411 -1.43 . . . . 0.0 107.369 176.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.476 0.841 0 C-N-CA 124.38 1.072 . . . . 0.0 112.411 -169.129 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t -124.67 169.58 11.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.682 1.23 . . . . 0.0 111.692 168.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -146.84 146.64 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.754 1.222 . . . . 0.0 109.832 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.98 37.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.105 1.762 . . . . 0.0 110.699 174.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.1 m -133.71 142.91 48.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.156 0.982 . . . . 0.0 110.871 -175.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -145.16 140.1 27.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.321 1.448 . . . . 0.0 111.072 -168.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.53 131.7 60.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 O-C-N 120.744 -1.222 . . . . 0.0 111.899 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.36 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.003 2.121 . . . . 0.0 109.982 -169.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.43 4.14 6.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.08 1.752 . . . . 0.0 114.34 178.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.41 27.04 3.62 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 126.252 1.882 . . . . 0.0 110.577 -178.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.8 138.95 39.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.748 0.819 . . . . 0.0 109.599 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -53.81 -43.13 69.11 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p 172.17 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -140.98 -50.27 0.44 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 127.117 2.167 . . . . 0.0 110.771 -167.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -26.59 61.33 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.132 -2.23 . . . . 0.0 112.8 171.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -57.36 -39.18 75.44 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.718 170.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -47.89 -46.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.702 2.001 . . . . 0.0 111.564 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -67.51 -40.35 85.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.916 1.686 . . . . 0.0 113.605 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -61.33 -36.92 81.47 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.885 -1.134 . . . . 0.0 112.047 172.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -46.34 85.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -49.13 73.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 111.665 170.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -65.67 -41.86 92.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -177.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.0 m -69.3 -47.8 63.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.886 0.874 . . . . 0.0 110.79 177.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -24.87 53.52 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 117.716 -1.135 . . . . 0.0 113.947 -177.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 t -81.64 11.53 4.65 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 121.144 1.793 . . . . 0.0 112.47 177.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.73 7.07 9.4 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -169.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 30' ' ' TYR . 13.6 mt -85.54 151.84 23.62 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.025 -1.047 . . . . 0.0 112.173 -169.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -67.13 22.95 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.467 2.307 . . . . 0.0 114.396 178.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -166.51 19.64 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.625 2.37 . . . . 0.0 112.868 -178.343 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 14.5 p -125.05 136.22 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.827 1.649 . . . . 0.0 112.726 177.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -118.28 -3.26 11.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -177.31 174.02 1.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.315 2.246 . . . . 0.0 111.914 176.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -172.99 154.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.67 2.788 . . . . 0.0 108.421 -172.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -145.98 123.24 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 C-N-CA 126.2 1.8 . . . . 0.0 107.522 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.71 149.67 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.171 172.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -73.54 124.31 25.64 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.46 1.504 . . . . 0.0 108.816 166.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -40.41 30.5 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.03 -51.6 30.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.888 2.475 . . . . 0.0 112.772 -173.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -88.87 -174.81 4.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.588 1.955 . . . . 0.0 112.398 169.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.2 43.56 1.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.31 1.444 . . . . 0.0 111.397 177.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 p -131.99 160.23 36.45 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.344 -2.097 . . . . 0.0 114.774 -168.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.54 136.94 33.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.092 1.357 . . . . 0.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -105.09 115.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.419 2.287 . . . . 0.0 105.425 171.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.9 t -111.55 129.49 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.011 1.724 . . . . 0.0 108.537 -169.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.3 t -109.2 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.063 1.345 . . . . 0.0 108.174 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -101.3 132.57 46.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.043 1.737 . . . . 0.0 111.481 -170.461 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.286 2.8 p30 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 122.485 1.136 . . . . 0.0 110.508 -167.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 CA-C-O 118.754 -0.603 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -54.37 -36.84 64.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.617 1.099 . . . . 0.0 112.118 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -67.6 -33.37 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.09 -1.006 . . . . 0.0 112.907 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.1 mt -76.18 -43.92 40.43 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.577 0.751 . . . . 0.0 111.343 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.06 -47.2 65.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -45.08 74.88 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.094 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -33.18 73.95 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.049 1.295 . . . . 0.0 111.653 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.74 -54.04 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.284 0.633 . . . . 0.0 110.524 172.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -49.42 -33.75 14.79 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.686 0.794 . . . . 0.0 111.39 175.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.34 0.75 27.71 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -96.53 -27.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.151 1.381 . . . . 0.0 111.579 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.62 64.21 7.62 Favored Pre-proline 0 CA--C 1.549 0.912 0 O-C-N 121.689 -0.632 . . . . 0.0 111.498 168.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.21 144.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.29 3.327 . . . . 0.0 112.912 -172.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.67 -18.02 9.73 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.577 1.084 . . . . 0.0 113.975 -175.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.65 -47.36 3.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.979 1.711 . . . . 0.0 110.6 177.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.421 ' CE2' HG13 ' A' ' 64' ' ' VAL . 2.9 m-30 -66.38 107.28 1.97 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -175.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 75.36 4.72 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.419 -1.425 . . . . 0.0 109.887 169.123 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.16 129.79 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.458 -0.777 . . . . 0.0 111.464 -176.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.59 38.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.387 1.075 . . . . 0.0 110.634 -171.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.22 112.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.806 -1.184 . . . . 0.0 108.888 170.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.224 -0.267 0 C-N-CA 124.57 1.148 . . . . 0.0 108.896 168.695 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 t -125.09 -177.74 3.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.454 1.102 . . . . 0.0 110.182 167.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -164.07 151.54 12.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.15 0.98 . . . . 0.0 109.989 -169.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.63 158.86 44.05 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.284 1.434 . . . . 0.0 111.216 171.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.4 m -120.86 140.04 52.33 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.931 1.293 . . . . 0.0 109.672 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.85 151.61 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.608 1.163 . . . . 0.0 111.176 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -134.77 140.03 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.948 1.299 . . . . 0.0 110.717 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.8 140.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.631 1.572 . . . . 0.0 110.907 -173.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . 0.262 0.4 OUTLIER -123.27 145.78 48.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 165.818 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.41 54.91 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.744 1.164 . . . . 0.0 112.708 -171.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.22 153.04 23.86 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.824 1.65 . . . . 0.0 111.378 -171.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -77.99 32.25 0.17 Allowed 'General case' 0 CA--C 1.556 1.203 0 O-C-N 119.711 -1.868 . . . . 0.0 114.519 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t 66.31 -71.6 0.09 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.129 2.172 . . . . 0.0 114.886 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 39' ' ' GLU . 10.5 mptt -108.31 -38.4 5.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 112.944 177.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 p -74.25 -21.47 59.76 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 119.425 -2.047 . . . . 0.0 112.79 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -51.17 -51.63 51.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.487 1.04 . . . . 0.0 110.073 169.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -46.35 -55.54 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 128.042 2.537 . . . . 0.0 112.234 -174.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -40.17 95.63 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 123.441 0.463 . . . . 0.0 111.585 -171.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -57.64 -46.49 84.1 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.699 -0.625 . . . . 0.0 112.401 169.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -44.51 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 118.721 -0.657 . . . . 0.0 109.842 -172.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.22 -49.28 67.1 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.247 0.967 . . . . 0.0 110.286 171.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -70.41 -41.31 73.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.491 ' HG1' HG22 ' A' ' 64' ' ' VAL . 36.8 m -76.92 -36.43 56.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.833 1.253 . . . . 0.0 111.255 -175.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.23 -45.91 53.25 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.75 172.077 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -72.17 16.24 0.14 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 121.483 1.947 . . . . 0.0 114.206 -172.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -109.93 -7.52 14.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.12 1.768 . . . . 0.0 112.311 174.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.32 133.58 45.07 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.922 -1.111 . . . . 0.0 110.448 -169.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.5 -0.04 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -170.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.89 -10.36 11.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.412 1.485 . . . . 0.0 114.855 169.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -89.4 138.97 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 121.088 1.767 . . . . 0.0 110.362 -169.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -99.24 -34.71 10.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 112.242 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -158.76 160.33 36.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.342 1.057 . . . . 0.0 110.644 -165.432 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.75 152.21 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.632 1.573 . . . . 0.0 109.8 174.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.62 129.98 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 C-N-CA 126.449 1.9 . . . . 0.0 107.449 167.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.72 143.71 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 123.399 1.571 . . . . 0.0 111.826 171.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -78.19 87.09 4.29 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.028 174.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.418 HD12 ' HE3' ' A' ' 15' ' ' LYS . 1.1 tm? -44.87 -42.51 8.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.959 2.504 . . . . 0.0 113.417 -177.003 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 15' ' ' LYS . 71.6 mm-40 -81.92 -8.87 59.71 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.406 HD21 ' C ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -131.17 -173.82 3.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.969 2.508 . . . . 0.0 109.347 -169.761 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 30.05 7.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.927 1.291 . . . . 0.0 113.525 -175.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 p -131.82 160.69 34.89 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.08 140.79 48.96 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.473 1.909 . . . . 0.0 110.658 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.17 114.25 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.26 131.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.541 1.536 . . . . 0.0 107.482 -169.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 57.4 t -120.52 107.89 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 -168.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 42.7 p90 -127.54 148.37 50.34 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.061 -1.024 . . . . 0.0 112.981 -168.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 CA--C 1.538 0.495 0 C-N-CA 124.114 0.966 . . . . 0.0 110.795 177.315 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.529 0.243 0 CA-C-O 118.734 -0.611 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -67.95 -10.26 51.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.78 1.173 . . . . 0.0 113.563 178.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 p -61.58 -45.15 95.35 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.789 -1.194 . . . . 0.0 112.1 168.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.12 -42.89 68.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.642 175.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.78 -46.99 51.32 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.431 172.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -62.22 -38.09 87.86 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.96 76.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.699 1.59 . . . . 0.0 111.783 173.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -68.28 -54.7 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.139 0.576 . . . . 0.0 110.905 171.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -55.75 -22.52 24.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.159 0.891 . . . . 0.0 112.615 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.42 5.31 42.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.491 HG22 ' HG1' ' A' ' 24' ' ' THR . 0.3 OUTLIER -97.22 -30.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 173.187 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.405 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -144.2 64.83 12.9 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.732 -0.605 . . . . 0.0 111.666 168.795 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.79 138.39 82.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.232 3.288 . . . . 0.0 112.431 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.12 -22.29 5.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.466 1.031 . . . . 0.0 113.662 -175.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 tp -93.41 -54.07 3.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.477 1.511 . . . . 0.0 110.133 173.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CE2' HG11 ' A' ' 64' ' ' VAL . 4.7 m-30 -70.09 117.0 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.045 1.738 . . . . 0.0 114.048 -177.482 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -111.68 139.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 119.363 0.983 . . . . 0.0 112.672 -173.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -144.63 160.04 41.82 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.824 1.25 . . . . 0.0 112.764 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.41 119.84 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.99 1.716 . . . . 0.0 107.469 173.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -175.081 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 122.767 1.27 . . . . 0.0 112.934 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -112.96 176.73 4.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.127 2.171 . . . . 0.0 110.853 -177.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.408 ' HG1' ' HA ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -154.66 163.33 40.4 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 120.623 -1.298 . . . . 0.0 111.548 178.915 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.03 159.09 44.54 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.132 1.373 . . . . 0.0 110.187 169.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.9 154.59 26.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 110.435 172.025 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -150.61 141.81 23.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.822 -1.536 . . . . 0.0 110.738 -176.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 tt -126.62 140.05 50.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.095 1.358 . . . . 0.0 110.289 177.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.3 98.39 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 126.478 1.911 . . . . 0.0 109.515 -170.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 65.26 7.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 123.534 1.635 . . . . 0.0 113.876 -169.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.99 0.11 Allowed Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 174.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 tmm? 45.08 -149.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.272 1.429 . . . . 0.0 109.56 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -120.53 -33.06 3.92 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.407 -1.433 . . . . 0.0 111.386 167.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 p 161.76 -72.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.927 2.091 . . . . 0.0 113.589 178.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 20.0 tptt -144.31 -57.38 0.37 Allowed 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.241 1.017 . . . . 0.0 109.815 -168.151 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -30.77 28.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.016 -1.678 . . . . 0.0 113.478 171.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.454 ' HA ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -57.61 -41.48 81.37 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.695 172.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -51.07 -42.73 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.834 1.653 . . . . 0.0 112.034 -176.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.6 t -71.09 -37.47 72.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.933 1.293 . . . . 0.0 113.277 178.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 17' ' ' CYS . 85.3 m-20 -60.24 -36.97 78.96 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.024 -1.048 . . . . 0.0 112.291 170.337 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -48.23 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.81 -51.91 64.34 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 124.044 0.84 . . . . 0.0 111.624 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -61.46 -41.28 96.99 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -68.41 -49.15 62.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.761 1.224 . . . . 0.0 110.189 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -15.76 60.23 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.405 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -76.26 -3.07 34.6 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 173.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.49 7.68 11.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -166.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 30' ' ' TYR . 18.6 mt -79.35 152.29 30.52 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.165 -0.96 . . . . 0.0 112.599 -169.392 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -67.79 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.403 2.281 . . . . 0.0 114.501 -177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -166.45 2.02 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.508 2.323 . . . . 0.0 114.341 -175.756 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 14.6 p -105.24 139.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 121.876 2.125 . . . . 0.0 111.307 -174.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 t -111.19 -11.62 14.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.07 175.03 1.98 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.175 1.79 . . . . 0.0 112.08 -175.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -175.55 152.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.041 2.536 . . . . 0.0 109.968 -171.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -147.88 134.57 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.86 2.464 . . . . 0.0 107.5 166.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.14 151.74 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 122.142 0.973 . . . . 0.0 113.174 170.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -90.15 102.75 15.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.58 0.752 . . . . 0.0 111.257 170.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.466 HD23 ' HE3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -57.81 -35.54 70.99 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.255 1.422 . . . . 0.0 113.401 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 20.6 mm-40 -91.99 5.55 49.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.152 1.381 . . . . 0.0 113.874 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -119.34 -173.94 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.951 1.7 . . . . 0.0 109.527 169.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 42.81 2.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.082 -1.011 . . . . 0.0 111.057 168.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -146.22 151.81 38.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -168.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.26 41.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.591 2.356 . . . . 0.0 112.055 -169.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.63 118.71 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.588 1.955 . . . . 0.0 106.544 174.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.77 120.35 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.756 1.622 . . . . 0.0 109.323 -167.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HA ' ' HG1' ' A' ' 4' ' ' THR . 94.2 t -107.06 107.78 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.854 1.662 . . . . 0.0 109.548 -169.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 38.7 p90 -121.0 158.32 28.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.041 1.336 . . . . 0.0 113.515 -171.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 CA--C 1.538 0.516 0 O-C-N 120.397 -1.439 . . . . 0.0 112.902 -168.821 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 CA-C-O 118.503 -0.707 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -61.7 -32.06 72.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.949 1.25 . . . . 0.0 113.001 -174.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.28 64.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.924 -1.735 . . . . 0.0 113.416 -178.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.2 mt -78.76 -46.42 18.9 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.898 -0.501 . . . . 0.0 110.145 173.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -46.87 -49.63 19.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.603 0.761 . . . . 0.0 110.124 169.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -58.32 -41.16 83.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 113.734 176.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.26 73.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.38 0.991 . . . . 0.0 112.18 172.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mt -70.84 -54.41 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.322 0.649 . . . . 0.0 110.557 172.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -55.03 -23.14 18.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.498 1.119 . . . . 0.0 112.52 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.65 4.25 37.29 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -98.83 -39.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.781 0.833 . . . . 0.0 111.582 -179.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -139.84 64.77 29.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.943 -0.473 . . . . 0.0 112.053 166.816 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.77 143.17 81.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 124.297 3.331 . . . . 0.0 114.189 -171.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.97 -43.41 3.24 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 125.438 1.494 . . . . 0.0 112.414 -175.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.47 -39.22 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.686 1.194 . . . . 0.0 110.524 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.2 m-85 -71.76 89.98 1.06 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.162 -0.961 . . . . 0.0 112.895 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -74.96 76.18 2.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.315 1.446 . . . . 0.0 110.098 169.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 t -92.05 133.69 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.952 -1.092 . . . . 0.0 111.785 -169.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -151.28 159.21 44.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.95 1.357 . . . . 0.0 111.289 168.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.66 130.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 166.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.225 -0.226 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.799 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.38 154.96 26.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.882 2.073 . . . . 0.0 112.908 172.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -82.46 159.42 22.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.712 0.767 . . . . 0.0 110.915 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -152.82 153.35 32.95 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.954 -1.092 . . . . 0.0 108.284 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.5 39.91 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.094 1.758 . . . . 0.0 110.763 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 m -126.16 141.1 52.07 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.586 1.154 . . . . 0.0 109.842 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -140.28 136.4 33.24 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.66 135.69 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 C-N-CA 125.07 1.348 . . . . 0.0 110.57 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.84 129.34 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.403 1.081 . . . . 0.0 111.07 -172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.43 129.62 46.42 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.662 -0.649 . . . . 0.0 109.547 163.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 -1.67 28.42 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.852 1.215 . . . . 0.0 113.554 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.0 ptm -65.35 149.0 50.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.033 0.917 . . . . 0.0 113.087 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -73.64 33.78 0.08 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.48 1.512 . . . . 0.0 112.999 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t 66.3 -143.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.399 1.48 . . . . 0.0 111.301 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HE3' HD11 ' A' ' 38' ' ' LEU . 46.4 mttp -61.72 -14.68 34.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.652 1.981 . . . . 0.0 115.576 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.0 p -91.74 -41.51 10.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.04 168.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.37 -49.32 70.09 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 121.53 1.968 . . . . 0.0 109.62 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -36.05 -48.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.797 2.039 . . . . 0.0 112.91 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -83.4 -25.36 31.39 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -58.0 -35.54 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 119.91 -1.744 . . . . 0.0 110.138 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -43.15 78.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 CA-C-O 117.531 -1.223 . . . . 0.0 110.424 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -50.4 -51.04 49.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.664 0.786 . . . . 0.0 110.145 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -69.77 -42.14 74.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -70.87 -41.09 71.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 110.714 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -46.1 46.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.554 -1.212 . . . . 0.0 111.668 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -72.62 14.74 0.23 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.465 1.484 . . . . 0.0 113.579 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.97 -2.79 18.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.411 1.484 . . . . 0.0 112.187 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.25 130.58 35.3 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 111.332 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -58.99 -2.84 0.28 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.646 1.578 . . . . 0.0 115.25 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 -3.4 11.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.608 1.963 . . . . 0.0 115.942 172.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -95.16 144.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.197 1.817 . . . . 0.0 110.523 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -99.0 -27.77 13.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.87 1.668 . . . . 0.0 111.789 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m 176.79 176.67 0.31 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.898 2.079 . . . . 0.0 112.802 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -172.27 150.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.967 2.107 . . . . 0.0 110.493 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.73 134.64 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.074 2.15 . . . . 0.0 106.869 166.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.04 141.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.052 0.93 . . . . 0.0 110.468 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 m -76.44 84.37 3.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.659 1.183 . . . . 0.0 110.046 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.4 HD11 ' HE3' ' A' ' 15' ' ' LYS . 1.3 tm? -51.93 -43.35 63.4 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 113.07 -167.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.36 -41.89 94.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.479 0.712 . . . . 0.0 112.319 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -100.72 -170.74 1.9 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.313 3.445 . . . . 0.0 112.98 -169.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.21 32.61 4.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.052 2.141 . . . . 0.0 114.473 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.8 p -137.23 166.02 24.76 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.17 -1.581 . . . . 0.0 114.114 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.07 142.64 40.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.438 1.895 . . . . 0.0 110.649 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -108.74 117.36 54.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.81 131.83 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.164 1.386 . . . . 0.0 108.336 -167.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.48 110.86 32.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.445 1.498 . . . . 0.0 107.724 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -121.88 -165.28 1.24 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.565 1.546 . . . . 0.0 111.351 -174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -144.84 123.58 12.59 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 122.269 2.304 . . . . 0.0 114.119 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 176.06 137.98 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.357 2.263 . . . . 0.0 110.795 -167.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 p -79.81 -40.38 28.69 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.903 0.859 . . . . 0.0 110.343 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -70.18 76.44 0.52 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.645 1.178 . . . . 0.0 110.828 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.5 t -44.78 108.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.247 1.419 . . . . 0.0 111.029 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -136.55 84.08 28.98 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.653 1.581 . . . . 0.0 109.688 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.27 -16.36 13.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.514 2.81 . . . . 0.0 113.872 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.91 -31.17 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.437 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.4 p -70.37 -38.87 74.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.552 -1.342 . . . . 0.0 112.818 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.1 mt -69.99 -43.97 70.33 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.564 175.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -50.52 -50.95 51.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.578 1.151 . . . . 0.0 110.768 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -37.39 74.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.332 1.453 . . . . 0.0 113.801 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.5 73.87 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.582 1.083 . . . . 0.0 111.636 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -68.37 -51.47 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.131 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -49.4 -35.77 20.03 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.618 0.645 . . . . 0.0 111.377 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.03 5.2 8.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -100.03 -26.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.003 1.321 . . . . 0.0 111.577 176.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.97 68.29 8.8 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 167.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.38 144.25 90.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.09 3.193 . . . . 0.0 112.717 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 -25.02 3.98 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.736 1.16 . . . . 0.0 113.392 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.18 -45.09 8.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.283 1.433 . . . . 0.0 111.948 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -75.02 109.65 8.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -169.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -86.55 81.7 8.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.5 t -87.51 124.66 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.758 0.823 . . . . 0.0 112.641 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.76 131.59 43.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.177 0.991 . . . . 0.0 111.862 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.45 83.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.656 -1.278 . . . . 0.0 110.796 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.3 t -78.91 80.83 5.23 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.724 1.21 . . . . 0.0 111.472 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.5 m -91.74 164.32 13.76 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.144 0.977 . . . . 0.0 112.603 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.33 120.69 19.29 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 C--N 1.325 -0.487 0 C-N-CA 126.982 2.113 . . . . 0.0 108.045 174.784 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.7 156.04 38.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.254 1.822 . . . . 0.0 111.725 -173.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -93.8 174.4 7.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.093 0.949 . . . . 0.0 110.018 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -165.13 148.32 8.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.017 -1.052 . . . . 0.0 110.478 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.08 31.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.569 1.548 . . . . 0.0 110.94 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -134.03 143.2 47.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 109.613 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -143.07 149.35 38.07 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.414 1.486 . . . . 0.0 111.724 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -133.46 136.75 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 125.301 1.44 . . . . 0.0 110.959 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.38 90.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.188 2.195 . . . . 0.0 109.606 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.14 39.01 0.3 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.179 1.392 . . . . 0.0 113.452 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.48 40.11 0.18 Allowed Glycine 0 N--CA 1.469 0.844 0 C-N-CA 125.763 1.649 . . . . 0.0 112.638 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.4 tmm? -102.72 150.11 23.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.671 1.588 . . . . 0.0 111.743 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -66.59 9.22 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m 81.91 -54.11 0.25 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.276 3.03 . . . . 0.0 114.572 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HE2' HD11 ' A' ' 38' ' ' LEU 0.29 50.8 mttt -125.42 -57.1 1.49 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.667 1.121 . . . . 0.0 112.656 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -65.37 -13.54 58.83 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.333 -2.105 . . . . 0.0 113.903 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . 0.275 1.2 m -71.76 -36.06 70.28 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.668 168.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.8 t -47.11 -48.85 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.308 1.843 . . . . 0.0 111.83 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -63.83 -42.39 97.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.315 1.446 . . . . 0.0 113.091 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.48 -34.77 72.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.122 -1.611 . . . . 0.0 113.014 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -41.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.573 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -52.45 -54.51 31.37 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 167.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.7 t -69.95 -38.24 76.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -75.22 -37.17 61.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 110.594 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 27' ' ' ALA . 6.5 mt -74.01 -51.16 16.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.749 -1.119 . . . . 0.0 112.866 171.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -71.8 11.86 0.46 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.28 1.4 . . . . 0.0 113.866 -169.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -108.87 -1.5 19.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.861 1.664 . . . . 0.0 112.591 172.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -77.39 134.31 38.47 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 120.789 -1.195 . . . . 0.0 111.589 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.22 72.39 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 109.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 159.73 -20.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.804 3.642 . . . . 0.0 113.676 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.8 p -91.12 144.63 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 121.933 2.152 . . . . 0.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 t -114.96 -7.9 12.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m 178.76 172.84 0.75 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.914 2.086 . . . . 0.0 112.971 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -171.4 152.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.173 2.189 . . . . 0.0 110.077 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.4 150.53 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 128.712 2.805 . . . . 0.0 106.614 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.82 151.02 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.952 0.501 . . . . 0.0 110.942 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -82.57 135.78 34.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.166 0.587 . . . . 0.0 111.209 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.422 HD11 ' HE2' ' A' ' 15' ' ' LYS . 1.3 tm? -76.18 -33.99 59.33 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 121.098 -1.001 . . . . 0.0 112.083 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.77 -55.78 3.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.237 1.415 . . . . 0.0 111.917 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -76.99 138.1 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.551 0.74 . . . . 0.0 109.467 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 40.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 p -141.47 152.7 44.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.42 1.488 . . . . 0.0 114.627 -169.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.86 143.01 50.59 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.217 2.207 . . . . 0.0 111.105 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.11 120.16 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 127.199 2.2 . . . . 0.0 105.716 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 t -125.61 134.56 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.124 0.969 . . . . 0.0 109.96 -166.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 110.28 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.132 1.373 . . . . 0.0 108.863 -168.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 44.3 p90 -123.16 168.34 12.54 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.42 1.088 . . . . 0.0 113.853 -170.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -110.21 114.94 28.83 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.551 -1.343 . . . . 0.0 110.406 -172.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.51 132.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.864 1.265 . . . . 0.0 111.671 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 m -68.53 -26.44 65.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.448 0.567 . . . . 0.0 111.633 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -170.62 117.16 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.113 1.765 . . . . 0.0 109.362 167.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -148.84 144.34 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.054 2.142 . . . . 0.0 106.875 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -69.53 140.96 90.1 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 112.358 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.6 -8.81 24.28 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.552 2.835 . . . . 0.0 112.883 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' CD ' ' HZ2' ' A' ' 59' ' ' LYS . 5.8 tm-20 -61.08 -30.3 70.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -74.25 -39.94 62.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.599 1.16 . . . . 0.0 113.668 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.7 mt -66.2 -43.84 85.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.285 173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -49.33 -56.39 9.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.123 0.874 . . . . 0.0 110.459 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HZ2' ' CD ' ' A' ' 55' ' ' GLU . 1.2 mptm? -49.85 -39.5 39.25 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.56 72.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.57 1.077 . . . . 0.0 111.803 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.91 -54.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.274 0.63 . . . . 0.0 109.691 170.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -51.83 -29.35 19.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.785 0.834 . . . . 0.0 111.877 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.01 0.41 40.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -96.57 -29.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.692 1.197 . . . . 0.0 111.386 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.99 65.4 9.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 121.545 -0.722 . . . . 0.0 111.801 168.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.23 144.77 98.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.355 3.37 . . . . 0.0 113.376 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.04 -19.56 6.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.537 1.541 . . . . 0.0 114.08 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -106.16 -45.99 4.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.961 1.704 . . . . 0.0 111.216 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.412 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.0 m-30 -66.74 109.03 2.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.268 1.027 . . . . 0.0 113.703 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -78.5 80.03 4.9 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 110.759 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 t -84.97 127.25 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.1 0.863 . . . . 0.0 111.877 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -138.4 146.81 42.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.59 1.156 . . . . 0.0 111.089 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.69 130.21 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.4 t -116.44 105.5 12.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.725 0.774 . . . . 0.0 110.561 172.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 65.9 m -161.32 158.27 26.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.282 2.233 . . . . 0.0 108.321 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.65 131.63 44.91 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 163.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.32 -0.71 0 C-N-CA 126.328 1.851 . . . . 0.0 108.82 178.67 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.614 0.721 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -97.88 160.74 14.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.44 1.896 . . . . 0.0 113.198 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -137.53 173.1 12.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.726 2.01 . . . . 0.0 109.084 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -161.75 156.39 22.8 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.734 -1.229 . . . . 0.0 110.336 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.35 160.89 38.94 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.48 1.512 . . . . 0.0 111.055 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -124.19 141.56 51.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.163 1.385 . . . . 0.0 110.194 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -141.75 145.2 34.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.853 1.261 . . . . 0.0 111.629 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.26 127.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 111.933 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.81 102.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.514 1.926 . . . . 0.0 111.497 -167.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -81.81 42.55 0.71 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.235 1.014 . . . . 0.0 113.665 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.02 3.66 0.03 OUTLIER Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.223 1.868 . . . . 0.0 117.438 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -75.73 145.6 40.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.739 2.269 . . . . 0.0 113.781 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -66.04 27.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.693 1.997 . . . . 0.0 114.982 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m 53.5 -129.53 2.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.825 1.65 . . . . 0.0 110.967 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HE2' HD13 ' A' ' 38' ' ' LEU . 1.6 mptm? -52.25 -32.31 36.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -170.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m -84.62 -28.57 26.4 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.555 -1.341 . . . . 0.0 113.143 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.81 -41.04 72.11 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.18 -1.391 . . . . 0.0 111.532 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -40.15 -54.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.7 2.0 . . . . 0.0 111.033 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -61.09 -41.74 97.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.508 1.123 . . . . 0.0 113.768 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.99 -38.38 85.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.297 -1.502 . . . . 0.0 112.934 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -36.44 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.213 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.27 -55.35 32.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.47 1.108 . . . . 0.0 109.687 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -67.61 -53.33 28.95 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.477 ' HG1' HG23 ' A' ' 64' ' ' VAL . 62.5 m -62.02 -38.46 88.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.894 1.278 . . . . 0.0 111.316 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -51.23 12.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.65 -1.167 . . . . 0.0 112.199 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -69.98 6.19 1.32 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.739 1.609 . . . . 0.0 113.928 -171.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.68 -6.81 24.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.817 1.647 . . . . 0.0 111.305 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 mt -75.39 128.02 34.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.15 -15.87 27.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -93.84 -12.17 29.57 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 p -93.57 143.72 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 121.161 1.8 . . . . 0.0 109.965 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.2 t -111.21 -11.63 14.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m 176.91 174.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.763 2.425 . . . . 0.0 113.005 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -172.71 150.48 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.674 2.39 . . . . 0.0 109.561 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.85 130.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 107.029 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.55 149.91 12.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.792 0.806 . . . . 0.0 111.041 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -80.58 113.02 18.47 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.487 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.5 tm? -60.31 -41.62 93.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.911 0.778 . . . . 0.0 111.366 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 1.9 tp10 -97.25 -22.42 16.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.276 1.83 . . . . 0.0 114.638 -171.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -115.91 155.85 27.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.773 1.229 . . . . 0.0 110.835 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.292 0.0 OUTLIER -78.5 38.32 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 p -138.77 157.92 45.18 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.52 139.9 35.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.809 2.044 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.76 121.26 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 106.14 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.9 t -120.26 136.97 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.164 1.386 . . . . 0.0 108.468 -169.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.5 t -124.34 105.2 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.714 1.205 . . . . 0.0 109.72 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -122.0 164.91 16.83 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.32 1.448 . . . . 0.0 113.967 -169.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.36 112.47 24.43 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.974 -171.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -175.39 152.18 1.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.659 1.584 . . . . 0.0 110.971 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -88.42 23.88 2.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.017 0.927 . . . . 0.0 110.911 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -165.67 -177.91 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.677 -1.264 . . . . 0.0 111.955 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.44 116.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 111.169 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -135.75 60.8 38.47 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.961 1.304 . . . . 0.0 110.241 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.26 -24.43 10.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.045 2.497 . . . . 0.0 114.176 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.16 -32.16 67.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.388 0.995 . . . . 0.0 113.215 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 m -70.22 -36.3 74.45 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.907 -1.121 . . . . 0.0 112.215 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.2 mt -71.86 -45.76 60.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.674 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -48.86 -47.49 42.78 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.659 0.783 . . . . 0.0 110.463 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -35.39 79.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.36 73.26 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 121.28 1.855 . . . . 0.0 112.127 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.93 -57.97 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.719 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -49.72 -27.89 5.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.488 1.115 . . . . 0.0 112.573 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 0.68 44.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.477 HG23 ' HG1' ' A' ' 24' ' ' THR . 0.8 OUTLIER -93.56 -29.9 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.978 0.911 . . . . 0.0 111.514 177.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.84 64.06 9.87 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 121.424 -0.798 . . . . 0.0 111.5 167.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.28 144.01 99.5 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.095 3.197 . . . . 0.0 112.464 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.31 -29.89 4.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.714 1.149 . . . . 0.0 113.007 -174.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.3 tp -92.23 -48.23 6.8 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.046 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.441 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -71.26 99.09 1.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.354 1.062 . . . . 0.0 113.346 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -75.06 119.87 19.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 114.617 -2.611 . . . . 0.0 105.336 162.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 t -123.25 134.96 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 124.274 3.215 . . . . 0.0 112.544 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.16 134.6 45.6 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.042 1.337 . . . . 0.0 110.178 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.9 mt -74.22 123.45 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.185 -1.572 . . . . 0.0 110.38 170.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.15 112.9 23.23 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.456 0.702 . . . . 0.0 109.126 174.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.7 m -163.57 165.44 23.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 109.825 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -66.45 111.07 3.38 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.049 1.74 . . . . 0.0 110.829 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 125.082 1.353 . . . . 0.0 111.121 177.238 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 CA--C 1.544 0.728 0 CA-C-O 122.04 0.924 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.4 168.25 9.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.305 2.642 . . . . 0.0 111.802 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -88.91 172.15 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 163.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -157.33 138.29 13.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.52 -1.362 . . . . 0.0 110.311 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.35 158.74 43.59 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.672 1.589 . . . . 0.0 110.654 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.4 m -120.35 141.86 49.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.724 1.21 . . . . 0.0 109.414 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -137.04 139.89 41.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.106 1.362 . . . . 0.0 109.512 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -121.55 139.67 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 123.924 0.89 . . . . 0.0 110.818 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 147.57 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 O-C-N 125.086 1.492 . . . . 0.0 110.25 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -123.59 141.38 52.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.449 1.1 . . . . 0.0 108.465 162.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.43 -27.24 8.57 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 126.19 1.852 . . . . 0.0 113.369 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.546 ' CB ' ' HG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -67.32 125.1 25.04 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 129.632 3.173 . . . . 0.0 118.104 -166.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.62 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 2.5 m-70 -74.61 55.58 0.66 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.789 2.836 . . . . 0.0 117.871 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.76 -141.46 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 119.94 -1.725 . . . . 0.0 114.781 165.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.84 -31.24 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 118.823 -2.423 . . . . 0.0 111.149 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.03 -54.29 27.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.704 -1.141 . . . . 0.0 112.224 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.546 ' HG ' ' CB ' ' A' ' 12' ' ' MET . 32.0 p -55.02 -55.14 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.475 1.488 . . . . 0.0 110.275 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 t -44.74 -54.12 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.523 2.329 . . . . 0.0 111.487 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.8 m -70.72 -26.5 63.42 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -60.5 -46.57 89.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.614 1.097 . . . . 0.0 109.309 165.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -40.25 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.437 -0.79 . . . . 0.0 111.846 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -54.19 -46.41 72.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.285 1.434 . . . . 0.0 109.33 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 t -73.03 -64.33 0.99 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -56.41 -36.58 69.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.828 2.451 . . . . 0.0 112.439 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 27' ' ' ALA . 10.4 mt -72.31 -43.92 63.46 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.828 169.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -67.84 13.05 0.09 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.642 1.565 . . . . 0.0 114.636 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -114.57 2.13 14.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.691 1.996 . . . . 0.0 112.262 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.32 137.65 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.81 -1.181 . . . . 0.0 111.863 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 67.27 0.77 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.685 1.594 . . . . 0.0 111.864 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 166.73 -20.77 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 129.956 3.303 . . . . 0.0 113.148 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.7 p -85.92 137.16 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 121.288 1.858 . . . . 0.0 110.895 -171.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -103.82 -19.04 14.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.376 1.47 . . . . 0.0 112.594 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m 178.16 167.19 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.632 2.373 . . . . 0.0 112.423 -171.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.4 tt -171.64 149.22 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.672 1.989 . . . . 0.0 112.479 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.7 t -141.09 144.35 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.494 2.317 . . . . 0.0 106.948 166.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.8 t -113.51 130.14 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 123.382 1.563 . . . . 0.0 110.842 168.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -80.64 91.28 5.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.807 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tp -51.21 -56.95 10.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.311 1.444 . . . . 0.0 111.201 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.85 -56.07 13.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.45 1.1 . . . . 0.0 110.926 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.44 15.42 5.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 51.47 29.47 5.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.452 1.901 . . . . 0.0 114.738 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 p -133.59 149.73 51.62 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -168.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.65 53.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.466 1.506 . . . . 0.0 109.109 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -101.25 109.75 26.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.96 132.61 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 124.781 1.232 . . . . 0.0 108.251 -166.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.03 108.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -169.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 12.6 p90 -130.87 137.59 49.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.774 1.23 . . . . 0.0 113.84 -167.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.09 83.07 8.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.223 -1.548 . . . . 0.0 112.378 -172.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.16 105.4 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.729 0.811 . . . . 0.0 112.866 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -85.5 -12.65 51.27 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.745 -1.222 . . . . 0.0 112.916 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.1 p -120.66 31.64 6.35 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.4 160.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.178 0.899 . . . . 0.0 112.08 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -73.98 144.15 81.94 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 111.711 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.11 -16.37 54.8 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.413 2.742 . . . . 0.0 111.924 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.95 -20.39 23.35 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.156 0.889 . . . . 0.0 112.13 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -42.17 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.501 -1.374 . . . . 0.0 112.134 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.06 -42.05 73.34 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.693 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -51.44 -49.86 60.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.428 1.091 . . . . 0.0 110.913 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -61.59 -34.28 75.35 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.22 75.17 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 120.277 1.399 . . . . 0.0 112.159 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -70.27 -55.29 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.331 -0.856 . . . . 0.0 110.974 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.54 -16.86 17.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.276 0.943 . . . . 0.0 112.124 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.15 -0.65 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -91.93 -31.34 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.059 0.845 . . . . 0.0 111.83 175.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -144.35 59.32 6.59 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.9 139.43 84.31 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 125.128 3.885 . . . . 0.0 114.374 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.31 -25.71 3.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.014 1.292 . . . . 0.0 113.571 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -42.28 9.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.032 1.733 . . . . 0.0 109.245 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.443 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 4.3 m-30 -76.53 106.93 8.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 115.176 1.546 . . . . 0.0 115.176 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.283 5.5 mtt-85 -73.47 137.24 44.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 158.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.36 135.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 122.375 2.352 . . . . 0.0 110.292 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 p -138.45 151.79 47.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.3 mt -84.04 85.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.465 1.106 . . . . 0.0 108.397 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -60.01 118.86 6.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 122.436 1.113 . . . . 0.0 108.287 169.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -149.13 143.76 26.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.981 1.712 . . . . 0.0 108.339 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -78.2 68.26 4.19 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.997 0.919 . . . . 0.0 110.254 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.437 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 121.866 0.841 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -109.64 168.35 9.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 131.066 3.746 . . . . 0.0 111.84 -169.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 t -125.98 171.72 10.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.888 1.275 . . . . 0.0 110.105 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.418 ' HG1' ' HA ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -152.21 166.53 31.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.196 0.999 . . . . 0.0 110.421 174.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.98 36.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.648 1.579 . . . . 0.0 110.898 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -123.3 135.09 54.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.276 1.43 . . . . 0.0 110.245 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -138.2 146.63 42.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.816 1.246 . . . . 0.0 111.406 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -132.8 135.81 56.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.905 1.282 . . . . 0.0 112.224 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.48 106.39 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.463 1.505 . . . . 0.0 111.771 -167.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.36 -3.96 36.59 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 119.346 -2.096 . . . . 0.0 115.673 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.54 5.85 44.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.556 1.074 . . . . 0.0 111.736 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 ttp -77.51 131.1 37.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 122.041 -0.682 . . . . 0.0 110.012 -169.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -64.86 6.62 0.22 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.553 1.541 . . . . 0.0 113.572 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.1 m 76.88 -40.13 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.388 2.275 . . . . 0.0 116.607 164.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 -85.2 0.62 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -52.47 -27.93 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.403 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.3 m -51.15 -39.19 55.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.261 1.391 . . . . 0.0 112.964 169.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.1 t -57.0 -42.2 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.073 1.349 . . . . 0.0 112.771 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -59.96 -40.41 88.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 0.0 111.434 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -66.3 -44.72 82.69 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 121.989 -0.445 . . . . 0.0 111.594 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -45.75 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 119.229 -0.415 . . . . 0.0 109.962 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.92 -51.4 61.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.525 1.13 . . . . 0.0 110.45 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.6 t -70.71 -37.18 73.52 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -74.28 -41.36 61.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 110.329 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -72.61 -48.17 41.8 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.899 -1.524 . . . . 0.0 110.66 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 t -72.83 14.64 0.25 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.312 1.869 . . . . 0.0 113.588 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -108.45 -6.85 15.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.12 1.768 . . . . 0.0 112.108 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.9 mt -73.29 129.44 38.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.909 -1.119 . . . . 0.0 109.167 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -60.22 -17.59 42.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -170.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.61 -8.56 31.42 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 171.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.3 p -94.54 138.6 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.604 2.002 . . . . 0.0 109.725 -173.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 t -107.77 -12.98 15.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.819 . . . . 0.0 113.165 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m 179.17 174.63 0.72 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.82 2.448 . . . . 0.0 111.769 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -172.73 154.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.694 2.398 . . . . 0.0 109.468 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.28 129.8 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.464 2.305 . . . . 0.0 108.162 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 78.9 t -103.62 136.63 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 122.701 1.238 . . . . 0.0 111.739 169.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -78.29 93.23 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.577 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.1 tp -54.9 -43.41 73.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.714 0.806 . . . . 0.0 112.981 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.95 -44.02 19.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.187 1.395 . . . . 0.0 112.587 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.41 -170.93 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.286 2.634 . . . . 0.0 114.646 -168.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -101.18 19.15 18.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.233 1.813 . . . . 0.0 114.376 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 p -136.55 156.61 48.34 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -167.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.36 136.95 49.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.495 1.918 . . . . 0.0 110.572 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.14 122.03 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -123.42 120.61 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 108.996 -166.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HA ' ' HG1' ' A' ' 4' ' ' THR . 69.7 t -105.49 111.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.515 1.526 . . . . 0.0 109.14 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 38.9 p90 -123.23 157.86 32.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.48 1.112 . . . . 0.0 112.821 -173.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -98.37 108.09 20.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.012 -1.055 . . . . 0.0 111.879 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.76 147.29 2.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.014 1.325 . . . . 0.0 110.817 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 m -82.26 2.48 31.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.536 -0.727 . . . . 0.0 111.881 168.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.4 m -122.52 152.81 39.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.157 1.383 . . . . 0.0 111.06 -171.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -85.76 112.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -148.23 72.47 11.05 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.224 1.41 . . . . 0.0 108.835 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.64 -12.98 20.26 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.034 3.156 . . . . 0.0 113.506 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -55.96 -48.0 76.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.276 1.43 . . . . 0.0 111.479 -172.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.6 -29.16 68.43 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.275 -0.891 . . . . 0.0 112.373 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 54.2 mt -70.83 -49.22 48.62 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.02 172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -52.8 -48.23 67.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.362 1.065 . . . . 0.0 110.648 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -56.86 -40.52 76.3 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.05 85.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.541 1.519 . . . . 0.0 112.128 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -63.37 -54.85 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.051 0.54 . . . . 0.0 109.923 172.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -50.81 -33.68 24.58 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.353 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.62 5.12 13.98 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -101.46 -26.7 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.981 1.312 . . . . 0.0 111.725 176.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.51 65.99 8.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.793 0.837 . . . . 0.0 110.633 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.9 143.86 92.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.113 3.209 . . . . 0.0 112.583 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -33.51 3.01 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.882 1.229 . . . . 0.0 113.183 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 tp -85.72 -46.66 10.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.545 1.538 . . . . 0.0 111.631 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' A' ' 64' ' ' VAL . 4.0 m-30 -73.97 106.19 5.55 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -71.64 39.02 0.06 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.405 1.882 . . . . 0.0 114.893 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.55 125.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.3 m -137.43 156.68 47.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.245 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.7 mt -95.63 127.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.355 1.462 . . . . 0.0 109.152 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 105.47 17.39 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.774 0.829 . . . . 0.0 109.703 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.3 m -161.23 162.07 31.04 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.8 1.24 . . . . 0.0 110.952 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.87 68.4 7.11 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.339 1.456 . . . . 0.0 111.013 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.342 173.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -125.78 167.08 15.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.221 3.009 . . . . 0.0 113.162 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -102.07 -172.69 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.356 1.462 . . . . 0.0 111.869 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.28 149.76 10.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.054 1.342 . . . . 0.0 109.711 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.15 162.46 41.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.948 1.699 . . . . 0.0 110.816 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m -119.83 140.06 51.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 109.576 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -140.71 143.68 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 111.601 -177.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.21 131.07 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.944 0.898 . . . . 0.0 110.957 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.77 128.63 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.497 -168.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.67 116.65 29.15 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.406 -0.809 . . . . 0.0 108.967 164.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.24 -12.55 8.02 Favored Glycine 0 N--CA 1.466 0.692 0 C-N-CA 124.062 0.839 . . . . 0.0 113.236 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.86 146.35 54.15 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.1 0.95 . . . . 0.0 111.462 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -62.05 2.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.706 2.002 . . . . 0.0 115.737 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 99.2 m 64.63 26.92 13.25 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 166.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.38 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.638 2.775 . . . . 0.0 106.597 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m -52.76 -26.87 15.49 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.1 2.227 . . . . 0.0 115.456 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.1 -38.57 39.23 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 120.19 1.359 . . . . 0.0 112.288 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.5 t -53.83 -41.38 48.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 125.107 1.363 . . . . 0.0 113.653 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -62.6 -38.22 89.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.819 0.447 . . . . 0.0 111.572 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -68.21 -45.95 71.91 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.174 0.589 . . . . 0.0 111.947 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -44.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.348 -173.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.25 -49.17 70.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.905 1.282 . . . . 0.0 110.423 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.0 m -68.45 -44.17 75.44 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 m -70.66 -39.52 73.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.764 1.226 . . . . 0.0 111.253 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.78 -51.48 16.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.436 -1.269 . . . . 0.0 110.565 175.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t -74.91 17.96 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.685 1.584 . . . . 0.0 113.394 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -114.86 -0.5 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.491 1.916 . . . . 0.0 112.178 171.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.61 135.43 42.02 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.675 -1.266 . . . . 0.0 111.103 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -47.85 -19.11 0.21 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.464 2.305 . . . . 0.0 116.355 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -7.96 11.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.231 1.813 . . . . 0.0 115.621 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.23 136.13 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 121.739 2.063 . . . . 0.0 111.938 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -89.95 -33.91 16.22 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -173.98 176.06 2.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.771 1.628 . . . . 0.0 112.394 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -172.77 154.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.324 2.25 . . . . 0.0 109.981 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.5 t -147.29 128.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.327 2.251 . . . . 0.0 108.045 166.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -102.31 135.94 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.682 1.23 . . . . 0.0 111.595 170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -77.02 94.36 3.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.122 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.9 tp -55.02 -38.42 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -51.78 -48.39 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.503 1.121 . . . . 0.0 111.104 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -96.99 -170.56 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 129.791 3.237 . . . . 0.0 113.487 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.11 34.94 3.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.217 1.407 . . . . 0.0 112.639 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 p -142.83 153.22 43.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.87 136.33 50.3 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.881 2.072 . . . . 0.0 110.812 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -106.9 116.87 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.3 t -118.81 132.23 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 0.0 107.704 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.98 101.45 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 37.8 p90 -122.02 141.63 51.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -168.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -86.03 129.9 34.7 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.796 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -174.99 127.82 0.29 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.468 1.107 . . . . 0.0 111.489 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t -81.34 -8.8 59.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.2 m 176.23 106.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.572 2.749 . . . . 0.0 111.226 169.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.44 156.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.667 1.987 . . . . 0.0 107.737 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 55' ' ' GLU . 27.8 m -81.18 135.36 50.97 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.382 1.073 . . . . 0.0 110.246 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.34 -21.93 69.07 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.101 3.201 . . . . 0.0 112.664 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 53' ' ' THR . 15.1 tp10 -47.55 -26.63 1.49 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.731 1.612 . . . . 0.0 112.811 168.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -69.38 -42.45 75.13 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.046 -1.034 . . . . 0.0 112.722 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.92 -43.54 74.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.852 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -50.4 -46.96 56.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.35 0.977 . . . . 0.0 111.094 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.88 64.0 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.94 90.92 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.574 1.988 . . . . 0.0 110.361 168.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.28 -56.48 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.745 -0.597 . . . . 0.0 110.917 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -56.96 -19.8 20.14 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.06 0.4 56.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.418 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -89.76 -32.89 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.838 0.855 . . . . 0.0 111.332 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.93 67.13 12.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.064 0.546 . . . . 0.0 111.373 169.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.74 139.02 88.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 124.219 3.279 . . . . 0.0 112.224 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.31 -33.85 3.14 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.973 1.273 . . . . 0.0 113.146 -173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -78.7 -46.94 17.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.896 0.848 . . . . 0.0 110.07 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.418 ' CE2' HG11 ' A' ' 64' ' ' VAL . 4.2 m-30 -84.54 122.84 29.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.892 1.677 . . . . 0.0 113.844 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.33 105.36 13.98 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.831 1.652 . . . . 0.0 108.408 169.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.86 135.1 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 120.889 1.677 . . . . 0.0 111.402 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.1 p -126.46 156.0 41.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.241 0.543 . . . . 0.0 111.795 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.4 mt -92.9 121.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.171 1.388 . . . . 0.0 109.264 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 102.62 12.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.153 0.581 . . . . 0.0 110.088 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.0 m -164.04 160.34 21.59 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.146 1.779 . . . . 0.0 108.662 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.76 114.63 15.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.437 1.495 . . . . 0.0 109.119 169.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 125.035 1.334 . . . . 0.0 111.897 -174.32 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.2 t30 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.62 155.35 3.13 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.961 1.304 . . . . 0.0 112.017 167.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 t -89.95 177.8 6.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.223 1.011 . . . . 0.0 111.832 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -161.19 147.62 14.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.796 1.238 . . . . 0.0 110.363 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.37 44.61 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.317 1.047 . . . . 0.0 111.978 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m -116.28 137.1 52.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 109.98 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -136.35 143.94 44.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.089 1.356 . . . . 0.0 110.311 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 tt -133.44 134.13 57.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 110.986 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.9 111.26 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -169.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.73 92.45 8.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.01 -34.2 0.61 Allowed Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.343 0.973 . . . . 0.0 114.159 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -58.71 126.94 29.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.268 0.627 . . . . 0.0 110.905 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 24.7 m-70 -61.54 41.26 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -169.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.0 m 70.44 -48.25 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 130.538 3.535 . . . . 0.0 114.908 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -128.29 -69.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.909 0.884 . . . . 0.0 110.852 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -57.38 -18.75 19.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 p -50.72 -50.54 55.1 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.652 1.115 . . . . 0.0 111.365 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.65 -43.05 71.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 124.303 1.041 . . . . 0.0 111.775 -168.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -66.83 -34.74 78.48 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -65.62 -45.86 81.49 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.81 -1.181 . . . . 0.0 111.039 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -39.91 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -51.4 -51.58 53.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 109.831 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.0 m -70.37 -48.14 57.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -69.63 -37.74 76.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.371 1.068 . . . . 0.0 111.125 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -74.38 -51.15 15.89 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.144 -1.408 . . . . 0.0 111.186 175.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.31 16.36 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.355 1.889 . . . . 0.0 113.739 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -111.35 -5.29 14.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.264 1.826 . . . . 0.0 112.227 174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.57 133.9 44.95 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 120.549 -1.344 . . . . 0.0 109.967 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -66.3 0.02 2.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.59 -6.68 11.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.59 134.43 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 121.581 1.991 . . . . 0.0 111.258 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 m -91.41 -25.24 19.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.567 0.747 . . . . 0.0 112.942 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.14 175.26 1.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.813 1.645 . . . . 0.0 113.177 -170.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -166.51 152.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.036 2.134 . . . . 0.0 109.632 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.36 148.92 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.147 2.579 . . . . 0.0 105.946 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.7 150.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 112.367 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -91.31 135.55 33.73 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.233 1.413 . . . . 0.0 111.682 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.0 tp -104.06 -30.02 10.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.559 1.544 . . . . 0.0 112.607 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -32.38 68.61 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.864 2.065 . . . . 0.0 112.786 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -104.89 -174.5 2.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.074 2.15 . . . . 0.0 113.189 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.78 32.95 5.76 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.03 2.532 . . . . 0.0 110.7 -174.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 p -140.17 156.71 46.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.042 -1.661 . . . . 0.0 114.728 -167.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.46 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 110.692 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -115.67 116.87 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.37 130.63 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 108.563 -168.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.2 105.11 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 108.781 -168.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -124.92 150.06 46.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -99.48 122.91 43.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.359 0.664 . . . . 0.0 111.04 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.9 142.08 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.854 1.662 . . . . 0.0 110.489 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m -66.96 -33.38 75.46 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.513 0.597 . . . . 0.0 111.923 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.9 t -178.05 153.71 0.82 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.883 2.473 . . . . 0.0 108.845 167.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.0 m 179.78 169.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 131.684 3.994 . . . . 0.0 106.198 -174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.52 135.6 34.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.67 -0.644 . . . . 0.0 111.621 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.61 -17.49 54.61 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.686 2.924 . . . . 0.0 111.956 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -52.95 -25.68 12.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.594 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.8 p -66.76 -44.25 81.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.678 1.191 . . . . 0.0 113.346 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.4 mt -71.03 -41.6 70.63 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.594 -0.692 . . . . 0.0 110.73 174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.21 -48.65 45.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.405 1.082 . . . . 0.0 111.016 170.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.209 1.403 . . . . 0.0 114.554 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.56 76.25 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.012 1.278 . . . . 0.0 111.551 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.915 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -51.08 -34.45 30.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.667 0.667 . . . . 0.0 110.389 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.9 4.22 14.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.404 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -97.5 -30.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.952 0.901 . . . . 0.0 111.35 177.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.01 64.57 7.59 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 111.493 169.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.35 147.56 95.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.492 3.462 . . . . 0.0 113.211 -172.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.53 -24.51 3.65 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.794 1.188 . . . . 0.0 114.185 -173.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.37 -36.01 8.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.161 1.384 . . . . 0.0 111.509 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 64' ' ' VAL . 4.1 m-30 -76.98 106.08 8.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -80.8 71.3 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.085 -1.634 . . . . 0.0 111.654 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.6 128.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.702 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -135.75 146.26 47.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.327 1.451 . . . . 0.0 109.298 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 94.2 mt -90.71 126.78 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.708 -1.245 . . . . 0.0 108.093 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -108.96 113.18 25.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 109.6 168.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 t -163.05 157.38 20.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.657 1.583 . . . . 0.0 110.54 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -83.79 74.7 10.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.958 1.361 . . . . 0.0 109.656 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.725 2.01 . . . . 0.0 110.146 171.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 CA--C 1.549 0.924 0 CA-C-O 120.619 0.247 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -71.16 159.06 35.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.715 1.606 . . . . 0.0 113.476 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -80.32 177.29 9.07 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.947 0.879 . . . . 0.0 110.947 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -165.9 145.6 6.33 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.815 1.246 . . . . 0.0 110.23 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.92 166.1 31.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.593 1.557 . . . . 0.0 111.321 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.6 m -127.18 135.54 50.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.449 1.5 . . . . 0.0 110.923 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.81 149.18 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.99 141.93 42.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 111.008 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -124.62 108.21 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 123.833 0.708 . . . . 0.0 110.902 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.95 26.8 0.58 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.98 22.48 1.27 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.5 1.524 . . . . 0.0 113.482 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -84.7 130.39 34.71 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 4.6 m170 -71.45 12.14 0.38 Allowed 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 t 90.82 -145.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.354 2.661 . . . . 0.0 111.46 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HE3' HD11 ' A' ' 38' ' ' LEU . 14.1 mptt -58.75 -30.07 67.23 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.317 -1.49 . . . . 0.0 113.283 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -69.06 -34.42 75.14 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.136 -1.603 . . . . 0.0 112.725 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.417 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.2 m -70.34 -38.78 74.93 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 116.356 -1.783 . . . . 0.0 113.318 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -42.57 -53.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -58.87 -39.96 82.92 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.64 -39.94 88.48 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.722 -0.611 . . . . 0.0 111.986 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -42.58 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.419 0.554 . . . . 0.0 110.118 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.28 -48.49 71.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.384 1.074 . . . . 0.0 110.518 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 m -71.2 -46.71 60.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -71.12 -37.16 72.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 125.472 1.509 . . . . 0.0 111.5 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 27' ' ' ALA . 5.2 mt -74.73 -49.77 19.87 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.162 170.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -72.75 15.38 0.2 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 121.576 1.989 . . . . 0.0 113.427 -170.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.88 -2.38 16.1 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 112.511 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 30' ' ' TYR . 43.0 mt -76.09 137.07 39.91 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.757 -1.214 . . . . 0.0 111.127 -169.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.29 31.08 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.767 2.027 . . . . 0.0 114.234 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -157.16 -3.0 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.12 2.568 . . . . 0.0 113.945 173.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.5 p -99.43 140.84 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.505 1.957 . . . . 0.0 108.852 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -112.74 -8.54 13.76 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -176.35 171.95 2.34 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.379 1.871 . . . . 0.0 113.505 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -175.13 154.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.904 2.482 . . . . 0.0 110.229 -171.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -147.67 126.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 127.596 2.358 . . . . 0.0 107.518 165.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.9 t -91.42 134.26 30.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.43 1.11 . . . . 0.0 109.865 168.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.9 m -69.83 89.93 0.59 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.483 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.489 HD11 ' HE3' ' A' ' 15' ' ' LYS . 1.9 tm? -45.49 -43.59 11.77 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.287 2.235 . . . . 0.0 112.011 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -53.06 57.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.669 1.188 . . . . 0.0 111.347 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.92 -174.73 4.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.395 2.278 . . . . 0.0 113.909 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.21 36.6 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.955 1.702 . . . . 0.0 113.296 169.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.01 154.9 43.75 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.047 -1.658 . . . . 0.0 114.137 -169.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.8 135.08 41.52 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.253 1.821 . . . . 0.0 110.35 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.48 119.23 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -125.81 139.9 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.696 1.198 . . . . 0.0 109.979 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.31 112.51 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.709 1.604 . . . . 0.0 109.063 -168.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 p90 -131.29 148.4 52.68 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -168.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.95 74.06 6.44 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.701 -1.249 . . . . 0.0 112.483 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.18 -162.2 0.89 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.189 0.996 . . . . 0.0 111.283 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -177.24 -51.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.538 2.335 . . . . 0.0 108.991 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 p -75.1 55.0 0.71 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.73 -1.231 . . . . 0.0 112.399 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.21 150.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.267 1.827 . . . . 0.0 109.495 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 t -81.3 141.33 49.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.041 0.937 . . . . 0.0 112.128 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.16 -15.03 41.53 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.653 2.902 . . . . 0.0 112.474 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -51.16 -23.95 3.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.583 1.153 . . . . 0.0 111.789 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -68.2 -44.83 74.95 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.666 -1.271 . . . . 0.0 113.278 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.67 -43.6 68.76 Favored 'General case' 0 C--O 1.226 -0.161 0 O-C-N 121.515 -0.741 . . . . 0.0 110.356 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -48.54 -51.92 25.22 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.503 1.121 . . . . 0.0 110.993 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.26 -30.71 71.61 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.8 -33.36 74.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.236 1.38 . . . . 0.0 112.051 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.28 -55.8 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.752 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.43 -37.34 11.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.861 0.755 . . . . 0.0 111.156 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.29 4.63 8.42 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.415 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -98.09 -33.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.622 1.569 . . . . 0.0 111.919 174.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.415 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.12 61.85 18.93 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 169.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.21 139.8 79.89 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.9 3.067 . . . . 0.0 112.835 -171.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.66 -21.41 14.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.193 1.378 . . . . 0.0 114.04 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.06 -45.82 5.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.423 1.889 . . . . 0.0 110.59 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.415 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 1.7 m-30 -64.99 100.98 0.46 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.066 1.346 . . . . 0.0 114.509 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -77.8 73.68 4.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.908 1.283 . . . . 0.0 111.321 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.04 132.92 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.755 0.788 . . . . 0.0 111.976 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.5 m -145.89 166.24 26.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.632 1.573 . . . . 0.0 110.858 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.6 mt -99.09 132.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.913 1.685 . . . . 0.0 108.059 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -114.67 114.02 25.11 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.6 m -164.56 159.9 19.66 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.943 1.297 . . . . 0.0 111.929 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -77.15 45.05 0.43 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.39 2.276 . . . . 0.0 113.145 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 125.672 1.589 . . . . 0.0 113.546 -167.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.75 157.13 33.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 123.968 1.842 . . . . 0.0 113.057 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 t -100.69 -176.73 3.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.04 2.536 . . . . 0.0 110.969 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -163.06 148.57 11.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 110.112 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 162.89 40.79 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.243 1.417 . . . . 0.0 110.974 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.0 m -121.43 137.86 54.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.726 1.21 . . . . 0.0 109.622 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -137.51 147.08 44.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.235 1.414 . . . . 0.0 110.202 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 tt -132.52 137.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.696 1.198 . . . . 0.0 110.603 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.97 99.24 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.703 1.601 . . . . 0.0 111.255 -171.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.25 101.23 10.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.265 1.031 . . . . 0.0 110.609 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.98 -7.88 4.14 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.776 1.179 . . . . 0.0 114.855 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -64.71 143.36 57.98 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.892 1.346 . . . . 0.0 112.026 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -67.21 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 126.705 2.002 . . . . 0.0 114.89 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m 54.5 -131.61 1.96 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.962 2.105 . . . . 0.0 112.033 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -48.5 -32.87 8.53 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.565 1.946 . . . . 0.0 114.151 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 m -91.18 -29.27 17.34 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -37.92 89.23 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.971 1.26 . . . . 0.0 111.23 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 49.1 t -37.73 -58.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.565 1.546 . . . . 0.0 112.277 169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -55.28 -43.77 75.06 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 111.929 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -62.95 -42.64 99.88 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.571 -0.705 . . . . 0.0 112.602 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -44.18 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.807 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.71 -51.1 70.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.368 1.067 . . . . 0.0 110.064 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -35.94 79.27 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.9 m -75.81 -37.73 58.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.653 0.781 . . . . 0.0 110.383 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -50.36 17.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.903 175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -74.53 12.84 0.7 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.765 1.166 . . . . 0.0 112.765 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.47 -7.19 18.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.507 1.523 . . . . 0.0 111.942 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 mt -78.29 126.65 31.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.24 -11.81 7.3 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.47 -13.06 24.87 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 169.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.98 140.46 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 121.789 2.086 . . . . 0.0 108.866 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.1 t -96.52 -29.49 13.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.368 1.467 . . . . 0.0 111.666 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -176.07 174.6 2.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.684 1.594 . . . . 0.0 112.336 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -174.59 150.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.631 1.972 . . . . 0.0 110.521 -172.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.82 132.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 127.352 2.261 . . . . 0.0 108.053 167.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -107.12 143.32 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.078 0.951 . . . . 0.0 111.277 170.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.5 t -74.79 108.31 7.45 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 165.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 mt -47.3 -25.84 1.08 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.753 2.021 . . . . 0.0 114.459 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -109.34 -35.48 6.26 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.913 2.885 . . . . 0.0 114.243 -174.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -83.91 -175.15 5.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.718 0.407 . . . . 0.0 110.539 173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER -112.97 39.31 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 175.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -141.44 155.7 45.85 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.461 -1.399 . . . . 0.0 113.046 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.55 50.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.737 2.015 . . . . 0.0 110.041 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -106.18 114.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.08 130.51 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.756 1.222 . . . . 0.0 108.487 -168.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.6 t -117.59 117.55 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.472 1.909 . . . . 0.0 107.434 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -139.21 155.21 47.96 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.613 1.551 . . . . 0.0 113.233 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -99.24 117.08 32.91 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.122 -1.611 . . . . 0.0 113.688 -167.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.34 151.33 3.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.172 1.389 . . . . 0.0 112.221 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -90.53 52.92 2.31 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -175.43 154.0 1.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -92.19 88.59 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.24 1.016 . . . . 0.0 109.792 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -120.98 68.35 16.49 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.731 1.212 . . . . 0.0 110.905 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.65 -11.17 15.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.915 3.076 . . . . 0.0 114.82 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.97 -35.85 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.206 1.002 . . . . 0.0 113.094 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.7 p -69.39 -41.48 76.39 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.318 -0.864 . . . . 0.0 113.243 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.81 -49.0 72.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.88 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.27 -56.63 6.4 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.861 1.264 . . . . 0.0 110.36 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -51.7 -41.82 61.76 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.75 67.59 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.104 0.865 . . . . 0.0 112.954 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -69.95 -56.37 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.959 0.904 . . . . 0.0 109.65 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -50.66 -31.68 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.707 0.803 . . . . 0.0 111.812 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.16 28.88 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.44 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -97.64 -31.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.37 65.83 9.67 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.463 -0.773 . . . . 0.0 111.085 167.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.93 141.96 96.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.98 3.12 . . . . 0.0 112.112 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.71 -28.54 4.87 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.756 1.17 . . . . 0.0 113.454 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -92.12 -44.16 8.97 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 111.633 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.44 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 2.7 m-30 -72.67 99.73 2.64 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 78.14 0.64 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.332 -1.48 . . . . 0.0 109.326 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.95 135.37 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.464 1.125 . . . . 0.0 111.684 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.2 m -150.9 158.11 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.951 1.7 . . . . 0.0 111.238 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 126.17 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.896 1.679 . . . . 0.0 109.48 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.8 72.32 10.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.286 1.034 . . . . 0.0 111.559 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -122.87 163.25 20.65 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.11 133.33 41.55 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 127.841 2.456 . . . . 0.0 108.563 -175.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.9 m120 . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.957 0.408 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.49 146.75 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.998 1.319 . . . . 0.0 111.758 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -95.24 176.61 6.15 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.92 1.688 . . . . 0.0 111.746 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -160.65 140.58 11.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.924 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.51 161.28 38.29 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.017 1.327 . . . . 0.0 109.911 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.4 m -123.32 136.21 54.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.75 0.82 . . . . 0.0 109.036 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.48 147.49 52.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.222 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -135.56 133.6 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.266 1.026 . . . . 0.0 110.847 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.66 116.0 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.969 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -81.12 5.31 17.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.39 22.22 1.07 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.02 1.771 . . . . 0.0 115.395 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.85 146.02 49.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.215 2.008 . . . . 0.0 112.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.433 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 3.0 m170 -74.0 23.3 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.714 1.606 . . . . 0.0 113.3 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t 76.51 -141.63 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.23 2.212 . . . . 0.0 111.182 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 13.6 mptt -55.94 -36.31 67.62 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.423 -1.423 . . . . 0.0 114.182 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -69.98 -34.17 73.02 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.257 -1.527 . . . . 0.0 112.074 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.0 OUTLIER -67.86 -42.38 81.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 116.068 -1.92 . . . . 0.0 112.587 173.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 t -40.6 -55.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.96 1.255 . . . . 0.0 111.351 174.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.0 t -62.57 -37.68 87.13 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -62.75 -42.03 99.49 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.159 -0.963 . . . . 0.0 111.963 171.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.74 -42.68 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 118.919 0.781 . . . . 0.0 110.034 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -52.86 -53.29 51.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.997 0.919 . . . . 0.0 110.17 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 m -70.52 -44.79 66.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.8 m -70.07 -36.03 74.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.132 1.773 . . . . 0.0 110.846 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -74.49 -50.45 18.19 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.871 172.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -68.12 12.53 0.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.466 1.485 . . . . 0.0 114.139 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.5 1.85 18.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.649 1.98 . . . . 0.0 111.809 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.08 129.75 34.7 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.854 -1.154 . . . . 0.0 110.127 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.93 -1.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.38 -8.08 11.09 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.22 135.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 121.772 2.078 . . . . 0.0 110.926 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 19.5 m -92.65 -25.02 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.265 1.426 . . . . 0.0 111.889 -173.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m 178.89 175.97 0.58 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.545 2.338 . . . . 0.0 112.726 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.8 tt -174.04 152.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 127.136 2.174 . . . . 0.0 109.49 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.07 131.71 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 126.087 1.755 . . . . 0.0 107.448 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 t -94.47 135.52 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 123.073 1.416 . . . . 0.0 109.505 168.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 m -67.41 90.62 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.063 167.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.417 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 0.7 OUTLIER -55.68 -31.45 62.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.577 1.151 . . . . 0.0 112.638 -171.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -59.77 4.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.982 0.81 . . . . 0.0 111.116 169.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -72.58 -176.36 1.91 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 125.356 2.503 . . . . 0.0 114.027 -171.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.554 2.342 . . . . 0.0 113.024 170.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.2 p -137.38 160.17 39.84 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.704 -1.872 . . . . 0.0 115.056 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.71 136.79 44.88 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.228 1.811 . . . . 0.0 110.683 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.1 112.68 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.9 t -116.66 130.5 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.474 1.509 . . . . 0.0 108.339 -168.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.69 114.51 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.247 1.419 . . . . 0.0 108.038 -168.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' HA ' ' H ' ' A' ' 32' ' ' SER . 30.6 p90 -132.86 155.22 49.4 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 120.457 1.481 . . . . 0.0 113.373 -168.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -94.18 122.04 36.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.362 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.31 155.01 3.42 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.968 1.707 . . . . 0.0 111.218 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -89.28 30.29 1.0 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.699 -1.251 . . . . 0.0 111.038 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -168.54 169.26 10.47 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.13 117.79 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.868 2.067 . . . . 0.0 109.784 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -154.46 58.72 2.18 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 125.75 1.62 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.83 -19.59 52.71 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.609 2.873 . . . . 0.0 113.127 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -18.32 3.9 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 m -82.58 -40.34 21.03 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 121.03 1.741 . . . . 0.0 112.702 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.0 mt -67.65 -45.52 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.219 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -48.38 -46.93 37.7 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.278 0.944 . . . . 0.0 110.643 170.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -35.49 79.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.438 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.07 71.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.789 1.631 . . . . 0.0 112.28 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -72.82 -57.77 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.992 0.917 . . . . 0.0 109.699 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -55.59 -16.23 3.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.931 1.293 . . . . 0.0 113.737 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.03 -0.42 57.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.448 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -90.87 -35.59 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.956 0.798 . . . . 0.0 111.457 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -141.22 63.32 17.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 169.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.35 143.52 86.02 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.364 3.376 . . . . 0.0 114.231 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.9 -31.35 2.81 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.28 1.419 . . . . 0.0 113.502 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.28 -40.99 11.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.881 1.673 . . . . 0.0 110.395 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.0 m-30 -75.31 93.91 2.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.164 -0.96 . . . . 0.0 113.421 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -71.97 121.01 18.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 161.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.51 136.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 123.754 2.979 . . . . 0.0 111.832 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -134.91 156.57 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.135 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.38 130.3 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.144 1.378 . . . . 0.0 108.391 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -126.68 107.71 10.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.387 1.089 . . . . 0.0 111.456 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 p -146.33 155.03 42.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.343 1.057 . . . . 0.0 111.578 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.66 66.62 6.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 123.094 1.426 . . . . 0.0 111.398 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 126.41 1.884 . . . . 0.0 110.889 174.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.65 159.21 21.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.212 1.005 . . . . 0.0 110.105 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -87.84 173.8 8.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.096 0.951 . . . . 0.0 110.592 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -163.95 148.05 10.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.074 1.35 . . . . 0.0 110.051 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.66 159.82 37.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.484 1.513 . . . . 0.0 111.387 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -125.77 136.56 53.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.991 1.316 . . . . 0.0 110.148 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.39 145.77 49.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.925 1.29 . . . . 0.0 111.156 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tt -121.74 145.12 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.273 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.4 168.67 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 124.567 1.147 . . . . 0.0 107.943 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.82 125.44 8.28 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.036 -1.04 . . . . 0.0 109.145 168.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.81 -6.49 44.19 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.613 1.101 . . . . 0.0 113.292 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.35 141.31 47.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.488 1.515 . . . . 0.0 112.267 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -51.68 -46.21 63.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 p 160.81 -65.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.427 1.891 . . . . 0.0 113.848 -171.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 -57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.136 2.175 . . . . 0.0 109.217 -166.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -20.01 21.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.121 0.968 . . . . 0.0 113.448 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 p -56.28 -48.8 75.89 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.256 168.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.33 -49.88 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.0 111.153 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -65.61 -35.73 81.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.429 1.092 . . . . 0.0 112.929 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.26 -39.59 95.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.564 -1.335 . . . . 0.0 111.976 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -30.4 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.54 -175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -59.35 -56.68 18.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.511 0.725 . . . . 0.0 109.752 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t -70.19 -41.47 73.67 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.0 m -73.77 -34.81 64.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.595 1.158 . . . . 0.0 110.946 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -74.88 -52.06 12.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.258 171.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 t -71.08 16.27 0.09 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.988 1.722 . . . . 0.0 113.773 -172.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -109.4 -5.01 15.96 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.744 2.018 . . . . 0.0 112.074 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.7 mt -77.72 130.24 36.52 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 109.508 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.03 -17.35 24.62 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.59 -8.17 29.56 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.78 140.78 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 122.105 2.23 . . . . 0.0 110.091 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -98.06 -24.29 15.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 111.878 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m 178.73 173.26 0.72 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.704 2.001 . . . . 0.0 113.246 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -168.25 153.19 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.917 2.087 . . . . 0.0 110.552 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 151.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.089 2.955 . . . . 0.0 106.131 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.27 151.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 122.035 0.922 . . . . 0.0 111.738 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -74.13 123.83 25.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.615 1.166 . . . . 0.0 109.174 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.49 -42.7 24.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.817 1.189 . . . . 0.0 112.089 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -61.2 -63.96 1.11 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.106 1.321 . . . . 0.0 109.614 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -85.4 168.49 14.56 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 122.878 1.323 . . . . 0.0 113.693 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.19 44.92 1.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -140.91 150.23 42.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 140.61 52.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.161 2.184 . . . . 0.0 111.174 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.06 115.87 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.29 136.48 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.893 1.277 . . . . 0.0 109.214 -166.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.24 113.67 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.233 1.413 . . . . 0.0 108.122 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -130.64 154.1 48.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.698 1.199 . . . . 0.0 113.857 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -93.12 113.01 25.14 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.028 -1.045 . . . . 0.0 110.595 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.14 142.22 0.48 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.306 1.442 . . . . 0.0 110.805 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -76.48 -3.07 35.31 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.64 -0.663 . . . . 0.0 111.591 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -111.52 126.16 54.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.08 1.352 . . . . 0.0 111.227 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -72.27 82.59 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.67 0.788 . . . . 0.0 109.878 168.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.6 m -119.37 64.89 7.98 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 125.162 1.385 . . . . 0.0 110.021 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.51 -17.5 53.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.956 3.104 . . . . 0.0 113.053 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.04 -8.97 53.6 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.514 1.052 . . . . 0.0 112.802 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -68.26 -49.59 59.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.767 1.167 . . . . 0.0 110.736 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.6 mt -65.81 -43.78 87.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 117.445 -1.264 . . . . 0.0 111.04 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -47.39 -50.03 23.41 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.255 1.389 . . . . 0.0 112.788 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.07 87.68 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 174.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.83 -33.97 76.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.359 1.436 . . . . 0.0 112.341 173.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -69.77 -52.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.605 172.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -50.36 -35.86 29.87 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.264 0.938 . . . . 0.0 110.941 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.88 3.32 12.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -98.67 -29.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 111.786 177.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.01 66.98 9.86 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.912 0.885 . . . . 0.0 110.347 168.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.64 140.27 80.04 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.098 3.199 . . . . 0.0 111.872 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.62 -22.16 6.79 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.626 1.107 . . . . 0.0 113.666 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 tp -99.46 -29.26 12.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.297 1.439 . . . . 0.0 112.732 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -92.3 105.59 17.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -69.96 47.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.241 2.216 . . . . 0.0 115.046 171.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.8 121.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 120.325 -1.485 . . . . 0.0 113.588 -168.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -134.9 152.18 51.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.223 1.409 . . . . 0.0 110.747 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.3 mt -90.91 130.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.739 -1.225 . . . . 0.0 108.086 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.6 t -110.9 115.33 29.32 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 109.462 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -164.85 174.95 10.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.477 1.511 . . . . 0.0 111.926 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.99 65.61 0.36 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.169 2.188 . . . . 0.0 111.74 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 125.172 1.389 . . . . 0.0 112.768 171.742 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -95.07 158.12 15.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.808 1.243 . . . . 0.0 110.543 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -91.76 -179.16 5.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.393 1.477 . . . . 0.0 111.17 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -165.54 155.12 12.53 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 109.861 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.37 161.25 30.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.14 1.776 . . . . 0.0 111.436 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -122.44 141.58 51.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.546 1.539 . . . . 0.0 110.432 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -145.1 141.26 28.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.36 1.464 . . . . 0.0 111.171 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.68 134.39 62.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.957 1.303 . . . . 0.0 111.46 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.32 103.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.585 1.954 . . . . 0.0 111.908 -170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 127.62 32.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.529 -1.357 . . . . 0.0 110.315 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.57 39.38 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 121.69 -0.631 . . . . 0.0 111.952 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.4 ptm -59.38 142.0 53.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 167.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.29 11.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.826 1.65 . . . . 0.0 115.025 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 m 70.76 -23.08 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.437 2.295 . . . . 0.0 116.059 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -87.16 0.34 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.903 1.681 . . . . 0.0 106.692 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -23.38 30.8 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.034 -1.666 . . . . 0.0 114.699 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.55 -37.71 88.35 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 116.824 -1.56 . . . . 0.0 113.034 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.0 t -50.46 -46.44 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.089 1.356 . . . . 0.0 109.985 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -67.92 -37.81 82.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.596 1.558 . . . . 0.0 114.105 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.13 -39.23 94.09 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 120.796 -1.19 . . . . 0.0 110.95 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.67 -40.4 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.519 -176.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -52.37 -55.29 22.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.983 0.913 . . . . 0.0 110.262 168.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 t -70.56 -42.48 71.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -73.14 -36.35 66.65 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.84 1.256 . . . . 0.0 110.731 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -75.4 -49.56 18.58 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.559 172.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 t -71.6 17.23 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.879 1.672 . . . . 0.0 113.722 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.55 -2.48 16.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.895 1.678 . . . . 0.0 112.545 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.5 135.83 38.28 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.779 -1.201 . . . . 0.0 111.309 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -54.71 -9.66 0.36 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -5.58 9.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.855 1.662 . . . . 0.0 115.075 176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.4 p -91.91 138.23 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.65 2.023 . . . . 0.0 110.58 -170.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -94.82 -30.54 14.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.994 1.318 . . . . 0.0 111.345 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -174.57 174.54 2.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 123.36 1.552 . . . . 0.0 113.054 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 tt -165.93 151.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.244 2.217 . . . . 0.0 109.356 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.23 147.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.699 2.4 . . . . 0.0 106.286 167.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.79 152.71 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.086 0.555 . . . . 0.0 109.789 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.3 t -84.78 144.35 28.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.556 0.693 . . . . 0.0 111.743 171.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -20.86 23.73 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -60.39 1.98 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.416 1.087 . . . . 0.0 108.385 168.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -78.79 143.23 36.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.061 0.934 . . . . 0.0 110.967 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.34 42.61 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.086 0.955 . . . . 0.0 112.672 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 p -140.68 150.67 43.78 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.132 -1.605 . . . . 0.0 113.999 -172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.91 146.26 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.096 2.158 . . . . 0.0 110.584 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.26 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.5 t -119.03 133.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.867 1.267 . . . . 0.0 108.418 -167.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.1 t -120.73 109.79 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.786 1.634 . . . . 0.0 108.146 -167.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 33.6 p90 -127.08 146.68 50.28 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.067 -1.021 . . . . 0.0 113.718 -168.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.95 119.23 26.03 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.17 146.2 2.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.942 2.097 . . . . 0.0 109.102 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -89.08 23.93 2.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.821 1.249 . . . . 0.0 111.429 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -159.32 176.5 12.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.054 1.342 . . . . 0.0 110.404 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 m -94.45 129.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.231 1.012 . . . . 0.0 110.721 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t -146.43 51.54 1.23 Allowed Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -57.69 -25.02 66.0 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.175 3.25 . . . . 0.0 113.211 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -49.28 -40.64 35.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.242 1.017 . . . . 0.0 112.174 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 -38.2 67.59 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.938 -1.101 . . . . 0.0 112.416 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.14 -44.94 67.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.106 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -54.18 11.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.661 1.184 . . . . 0.0 110.372 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -51.95 -43.37 63.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.87 68.05 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.975 1.261 . . . . 0.0 112.824 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.51 -54.79 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.923 0.889 . . . . 0.0 109.958 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -53.16 -28.97 28.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.827 0.851 . . . . 0.0 111.402 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.35 -2.81 43.28 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -87.8 -39.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 110.484 177.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -136.96 77.37 43.76 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 122.681 0.392 . . . . 0.0 110.496 164.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.04 116.31 3.05 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.429 2.753 . . . . 0.0 109.456 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.03 -21.88 41.71 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 117.116 -1.936 . . . . 0.0 115.402 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tp -95.24 -26.51 15.93 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 121.333 2.567 . . . . 0.0 112.673 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.462 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 3.6 m-30 -91.66 105.36 17.68 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -166.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 66.68 1.31 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.214 1.406 . . . . 0.0 110.463 168.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.62 137.76 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.284 0.633 . . . . 0.0 111.737 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.17 133.83 13.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.35 1.06 . . . . 0.0 112.009 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.6 mt -73.75 122.79 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 121.113 -0.992 . . . . 0.0 108.39 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.78 101.45 14.05 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.021 0.929 . . . . 0.0 110.228 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.7 m -132.08 163.29 28.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.148 0.979 . . . . 0.0 110.283 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -71.52 126.29 29.27 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 127.927 2.491 . . . . 0.0 106.669 172.471 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -77.0 158.01 30.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 123.021 1.391 . . . . 0.0 113.273 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 t -93.24 174.46 7.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -157.41 144.03 18.07 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.157 1.383 . . . . 0.0 110.034 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.96 159.78 43.52 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.624 1.57 . . . . 0.0 111.683 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m -120.61 139.84 52.4 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.551 1.541 . . . . 0.0 110.055 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -140.76 142.54 34.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.945 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -124.13 140.72 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.491 1.116 . . . . 0.0 110.064 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.78 148.42 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.219 1.808 . . . . 0.0 108.295 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.5 142.3 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 162.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.15 -16.01 55.94 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.042 0.83 . . . . 0.0 111.142 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptm -58.81 133.63 56.16 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 122.012 -0.699 . . . . 0.0 109.142 168.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -61.48 15.59 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 115.624 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 m 68.55 -15.43 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.268 2.227 . . . . 0.0 116.463 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -88.6 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 107.408 -169.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 p -55.09 -27.65 46.53 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.998 -1.689 . . . . 0.0 114.544 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HA ' HD21 ' A' ' 20' ' ' ASN . 1.2 m -60.27 -38.2 82.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 120.881 1.673 . . . . 0.0 112.084 172.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.97 -48.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.533 1.533 . . . . 0.0 109.574 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -71.24 -29.9 65.67 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.557 HD21 ' HA ' ' A' ' 17' ' ' CYS . 76.2 m-20 -64.54 -40.38 95.49 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.293 -1.504 . . . . 0.0 110.681 167.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -38.93 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.06 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -52.85 -53.67 45.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 109.894 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 -46.33 63.54 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -170.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.546 ' HG1' HG23 ' A' ' 64' ' ' VAL . 68.0 m -69.27 -35.48 76.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.021 1.328 . . . . 0.0 111.183 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -50.6 14.04 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.399 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.3 t -72.69 11.21 0.68 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.432 1.469 . . . . 0.0 113.892 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.57 -7.92 19.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.477 1.511 . . . . 0.0 111.668 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.5 129.21 36.89 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.028 0.831 . . . . 0.0 109.451 -171.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -58.29 -20.65 44.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 -10.8 37.9 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -90.55 141.5 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 122.271 2.305 . . . . 0.0 109.936 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 t -97.6 -30.83 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.695 1.598 . . . . 0.0 111.33 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -175.51 172.85 2.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.29 1.436 . . . . 0.0 113.254 -169.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -168.57 150.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.564 1.946 . . . . 0.0 111.311 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.97 150.09 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 128.971 2.908 . . . . 0.0 106.345 167.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.29 147.65 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.083 0.468 . . . . 0.0 110.716 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -70.38 141.16 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.101 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.92 -23.77 14.84 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 111.836 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.09 -39.6 10.05 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 130.316 3.447 . . . . 0.0 112.981 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -97.62 -177.29 3.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.797 1.639 . . . . 0.0 110.913 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -112.33 44.39 1.45 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.965 1.306 . . . . 0.0 111.777 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -137.14 153.71 50.43 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.488 -1.383 . . . . 0.0 113.98 -169.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.52 140.08 52.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.111 1.764 . . . . 0.0 111.427 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -110.06 116.1 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.93 132.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.939 1.295 . . . . 0.0 108.327 -167.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.56 112.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.628 1.971 . . . . 0.0 107.53 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -130.84 150.9 51.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.72 1.6 . . . . 0.0 113.478 -171.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.74 111.13 22.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.818 -1.176 . . . . 0.0 111.696 -171.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.74 146.34 1.61 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.771 2.028 . . . . 0.0 108.667 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -77.12 7.8 4.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.54 -0.725 . . . . 0.0 112.317 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.9 m -127.57 133.36 49.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.565 1.146 . . . . 0.0 112.0 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.26 95.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 168.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.6 m -135.96 65.89 60.09 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 126.753 2.021 . . . . 0.0 108.432 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.34 -22.58 39.5 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.041 2.494 . . . . 0.0 113.018 -173.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 62.1 mm-40 -60.18 -28.94 68.36 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -172.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.1 p -62.09 -40.33 95.47 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.063 -1.648 . . . . 0.0 112.708 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 49.6 mt -70.13 -46.35 64.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 0.0 111.298 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.426 ' HE ' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -49.24 -55.48 12.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.515 1.126 . . . . 0.0 111.753 173.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.76 -30.67 69.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.571 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.62 80.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.243 1.383 . . . . 0.0 111.817 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mt -61.78 -53.77 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.136 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -54.07 -25.71 23.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.38 0.672 . . . . 0.0 112.717 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.79 2.27 49.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.546 HG23 ' HG1' ' A' ' 24' ' ' THR . 0.5 OUTLIER -92.88 -30.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.941 0.896 . . . . 0.0 111.434 175.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.08 68.53 9.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.701 0.8 . . . . 0.0 111.16 169.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.78 136.43 70.23 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.103 3.202 . . . . 0.0 111.807 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.74 -24.17 6.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.678 1.133 . . . . 0.0 113.585 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.01 -35.93 15.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.867 1.267 . . . . 0.0 111.06 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.423 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.6 m-30 -88.27 108.89 19.54 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 32.58 0.09 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 128.634 2.774 . . . . 0.0 115.695 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.34 130.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -166.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.6 m -145.0 148.55 33.86 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.476 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 98.6 mt -83.44 122.85 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.73 1.212 . . . . 0.0 108.499 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t -95.12 126.97 40.81 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.1 m -140.7 162.8 34.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.098 1.359 . . . . 0.0 110.208 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.47 114.58 15.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 127.79 2.436 . . . . 0.0 108.777 178.212 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 122.998 1.38 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.25 152.89 39.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.219 2.608 . . . . 0.0 113.512 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -122.29 -174.48 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.331 2.252 . . . . 0.0 110.473 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.32 147.37 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.663 -1.273 . . . . 0.0 109.918 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.97 158.89 44.62 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.993 1.317 . . . . 0.0 111.273 169.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.1 m -120.34 137.29 54.36 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.753 1.221 . . . . 0.0 110.46 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.04 149.13 47.24 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.912 0.885 . . . . 0.0 112.909 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tt -137.56 136.61 46.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 124.343 1.057 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.87 108.34 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.284 1.434 . . . . 0.0 112.288 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 87.86 7.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.822 0.82 . . . . 0.0 108.8 168.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.14 -23.83 0.28 Allowed Glycine 0 N--CA 1.48 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 114.837 -168.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.462 ' C ' ' H ' ' A' ' 14' ' ' CYS . 1.9 ptt? -79.82 138.82 37.32 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.175 0.987 . . . . 0.0 113.192 -169.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -65.68 27.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.229 2.212 . . . . 0.0 114.368 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.462 ' H ' ' C ' ' A' ' 12' ' ' MET . 98.7 m 52.15 -115.5 0.92 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.046 2.138 . . . . 0.0 111.419 176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 40.3 mttp -67.01 -17.46 64.93 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -165.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.9 p -88.4 -43.41 11.51 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.003 1.274 . . . . 0.0 110.446 166.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.84 -43.1 76.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 116.838 -1.553 . . . . 0.0 112.049 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 t -37.78 -56.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.273 1.829 . . . . 0.0 111.567 171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 t -65.65 -39.36 91.32 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.569 0.748 . . . . 0.0 111.661 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -60.52 -40.02 89.96 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -42.79 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 118.74 -0.648 . . . . 0.0 109.743 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -54.81 -51.32 66.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.951 0.9 . . . . 0.0 110.876 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -70.37 -41.41 73.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.412 ' HG1' HG22 ' A' ' 64' ' ' VAL . 31.7 m -70.69 -40.03 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.318 -177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -45.46 44.2 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.669 -1.158 . . . . 0.0 111.518 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 t -71.01 11.3 0.42 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.836 1.653 . . . . 0.0 113.819 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.87 -6.37 22.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.326 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.7 mt -77.08 125.42 29.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.196 -0.94 . . . . 0.0 108.669 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.78 -15.13 52.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -12.56 33.98 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -87.2 135.93 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.68 2.036 . . . . 0.0 109.975 -170.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 t -103.45 -15.01 16.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m 178.75 173.64 0.7 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.141 2.576 . . . . 0.0 112.333 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -173.19 152.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 127.509 2.323 . . . . 0.0 108.962 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -145.15 129.22 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.129 2.172 . . . . 0.0 107.838 166.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.4 t -94.5 139.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 123.006 1.384 . . . . 0.0 111.346 169.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -74.32 85.11 1.94 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.748 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.43 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 1.5 tt -49.81 -38.44 34.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.244 2.218 . . . . 0.0 114.36 -168.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -60.25 4.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.473 1.13 . . . . 0.0 110.264 170.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -79.83 -176.92 5.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.389 2.676 . . . . 0.0 116.072 -168.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 33.54 3.65 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.075 -2.33 . . . . 0.0 110.774 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 p -144.4 160.84 40.39 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.94 37.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.776 1.63 . . . . 0.0 111.217 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -106.25 112.54 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.05 133.31 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.364 1.466 . . . . 0.0 107.625 -171.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.28 95.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.89 1.276 . . . . 0.0 108.506 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 26.7 p90 -114.34 145.63 41.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -91.6 121.53 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.223 -0.923 . . . . 0.0 111.354 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -174.98 127.87 0.29 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.046 0.939 . . . . 0.0 112.106 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 t -68.55 -36.51 78.89 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.397 -0.19 . . . . 0.0 111.032 168.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -163.32 97.71 0.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.916 0.886 . . . . 0.0 110.902 172.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -137.61 136.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t -64.54 140.02 97.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.88 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.52 -18.07 57.52 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.426 2.084 . . . . 0.0 111.624 169.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.15 -27.03 63.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.123 0.874 . . . . 0.0 112.789 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m -70.25 -35.06 73.55 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.36 1.891 . . . . 0.0 112.049 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.2 mt -70.12 -44.7 68.41 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.52 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -53.06 -44.3 67.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.672 0.789 . . . . 0.0 111.278 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.59 98.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.169 1.788 . . . . 0.0 113.961 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.21 71.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 120.081 1.31 . . . . 0.0 112.031 173.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.6 -56.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.787 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -46.46 -35.99 6.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.357 1.063 . . . . 0.0 111.605 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 1.23 27.18 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -96.28 -29.3 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.709 1.204 . . . . 0.0 112.229 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.404 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -148.39 59.3 4.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 121.202 -0.937 . . . . 0.0 112.277 169.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.43 140.01 92.22 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.662 2.908 . . . . 0.0 111.192 -175.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.33 -54.53 0.64 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.794 1.188 . . . . 0.0 110.756 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 mt -75.55 -46.06 34.3 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.386 1.093 . . . . 0.0 112.038 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.451 ' CE2' HG11 ' A' ' 64' ' ' VAL . 3.4 m-30 -67.86 88.18 0.25 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 69.49 2.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.486 1.515 . . . . 0.0 109.105 168.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.17 138.7 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 122.768 1.271 . . . . 0.0 110.951 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 m -143.07 168.73 19.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.356 1.463 . . . . 0.0 110.24 174.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.75 131.47 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.557 1.543 . . . . 0.0 108.524 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.41 46.2 1.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.357 1.063 . . . . 0.0 112.009 -169.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.2 p -173.7 75.84 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 111.445 -170.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.16 47.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 128.818 2.847 . . . . 0.0 105.053 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 127.424 2.29 . . . . 0.0 111.71 -169.083 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -81.56 170.63 15.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 129.607 3.163 . . . . 0.0 113.055 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 t -129.56 170.73 13.38 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.726 1.61 . . . . 0.0 108.267 167.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.481 ' HG1' ' HA ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -154.86 163.98 39.5 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.959 -1.088 . . . . 0.0 111.699 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.74 160.4 37.84 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.737 1.215 . . . . 0.0 111.859 169.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 m -123.77 136.73 54.59 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.215 1.406 . . . . 0.0 110.737 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.52 145.52 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.012 1.325 . . . . 0.0 111.032 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 tt -134.06 130.85 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.685 1.194 . . . . 0.0 110.64 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.91 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.967 1.307 . . . . 0.0 109.047 -169.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.86 1.04 7.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.25 35.85 1.79 Allowed Glycine 0 C--O 1.222 -0.628 0 C-N-CA 125.976 1.751 . . . . 0.0 111.141 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ttm -90.86 148.34 22.56 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.915 0.886 . . . . 0.0 111.115 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -73.72 3.41 6.48 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.372 0.669 . . . . 0.0 111.599 167.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.2 m 61.54 -112.78 0.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.564 2.346 . . . . 0.0 112.16 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -51.58 27.64 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -166.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 m -80.01 -22.58 42.29 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.838 -1.789 . . . . 0.0 113.936 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.64 -39.79 95.25 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-O 116.497 -1.716 . . . . 0.0 111.516 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -47.9 -51.49 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.638 1.563 . . . . 0.0 112.788 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.5 t -55.07 -43.55 73.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.292 0.637 . . . . 0.0 111.981 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -63.2 -39.38 94.48 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -45.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.133 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.62 -48.44 63.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.41 1.084 . . . . 0.0 109.858 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -70.05 -42.18 73.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -74.64 -38.28 62.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 111.192 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 27' ' ' ALA . 7.0 mt -73.06 -45.66 56.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 116.58 -1.676 . . . . 0.0 112.604 171.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 t -69.42 14.33 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 121.885 2.129 . . . . 0.0 114.543 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -110.21 -5.33 15.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.892 1.677 . . . . 0.0 112.655 176.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.67 137.95 41.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.202 0.91 . . . . 0.0 111.475 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -73.66 55.39 0.51 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.473 1.909 . . . . 0.0 112.622 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 p90 174.09 -22.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.882 2.873 . . . . 0.0 113.894 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.8 p -86.66 142.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 120.826 1.648 . . . . 0.0 109.256 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -108.05 -19.66 13.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.697 0.799 . . . . 0.0 112.573 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -175.43 174.28 2.34 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.435 1.894 . . . . 0.0 112.277 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 tt -174.86 151.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.938 2.095 . . . . 0.0 110.209 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.08 131.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.345 2.258 . . . . 0.0 107.732 166.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 68.3 t -104.08 137.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 123.53 1.633 . . . . 0.0 111.638 169.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m -79.37 81.36 5.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.261 1.424 . . . . 0.0 111.087 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 17.0 tp -50.85 -43.68 59.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -168.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.18 -42.15 60.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.994 0.918 . . . . 0.0 111.978 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -103.42 -170.82 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.138 3.775 . . . . 0.0 111.729 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.61 31.33 6.05 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.894 1.678 . . . . 0.0 114.579 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 p -135.2 157.68 46.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.63 138.6 51.32 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.851 1.661 . . . . 0.0 110.525 -175.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.68 121.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -125.06 125.18 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.081 1.352 . . . . 0.0 109.192 -166.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' HG1' ' A' ' 4' ' ' THR . 78.9 t -111.98 109.52 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 109.933 -168.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 50.0 p90 -124.33 166.98 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 113.207 -171.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -98.46 106.01 18.23 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.318 -0.864 . . . . 0.0 112.142 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -165.94 148.35 7.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.772 1.629 . . . . 0.0 110.062 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 m -88.15 29.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 171.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.1 t -168.97 -167.54 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.178 1.391 . . . . 0.0 110.054 -170.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.0 m -110.51 132.41 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.915 1.686 . . . . 0.0 111.781 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.3 m -152.42 72.43 7.56 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.781 1.632 . . . . 0.0 109.601 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -87.39 -24.65 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.265 2.643 . . . . 0.0 114.788 -170.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.25 -25.09 67.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.182 0.901 . . . . 0.0 112.906 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -69.56 -38.68 77.54 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.026 -1.046 . . . . 0.0 113.161 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.5 mt -67.69 -44.53 77.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.27 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.417 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -47.11 -54.89 9.44 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.322 1.049 . . . . 0.0 110.222 169.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -53.8 -41.62 67.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -30.62 69.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.017 0.826 . . . . 0.0 111.81 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.7 mt -68.1 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.752 0.821 . . . . 0.0 109.685 169.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -49.91 -33.43 17.37 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.704 0.683 . . . . 0.0 111.911 175.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.13 -0.4 24.77 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -99.58 -27.12 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.672 1.589 . . . . 0.0 111.689 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.55 64.06 8.29 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.387 -0.821 . . . . 0.0 111.098 168.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.5 144.93 95.39 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.364 3.376 . . . . 0.0 112.973 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.56 -28.8 3.39 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.17 1.367 . . . . 0.0 113.581 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -97.45 -43.76 7.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.158 1.783 . . . . 0.0 111.048 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.43 ' CE2' HG11 ' A' ' 64' ' ' VAL . 2.4 m-30 -68.88 99.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.05 80.26 4.49 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.823 -1.173 . . . . 0.0 109.142 169.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.25 132.46 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.65 -0.656 . . . . 0.0 111.27 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 134.2 30.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.519 1.128 . . . . 0.0 109.188 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.29 122.01 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.451 -1.406 . . . . 0.0 108.003 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t -110.84 116.79 31.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 122.569 1.176 . . . . 0.0 110.383 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -151.41 157.52 42.5 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.7 1.6 . . . . 0.0 108.988 168.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -77.63 48.91 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.841 1.656 . . . . 0.0 113.32 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 125.007 1.323 . . . . 0.0 113.225 -175.248 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.38 167.0 5.76 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.723 1.209 . . . . 0.0 113.648 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 t -95.73 176.65 6.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 111.684 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.54 149.41 9.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.409 1.484 . . . . 0.0 109.407 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.67 157.28 37.89 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 110.479 169.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 m -119.28 135.93 54.48 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.782 0.833 . . . . 0.0 109.759 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.86 145.44 51.21 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.527 1.531 . . . . 0.0 110.868 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.09 139.26 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 125.13 1.372 . . . . 0.0 111.153 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.1 97.59 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.462 1.905 . . . . 0.0 109.91 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.412 ' CG ' HH21 ' A' ' 41' ' ' ARG . 0.5 OUTLIER -85.9 78.25 9.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 123.355 1.55 . . . . 0.0 111.622 -177.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.05 12.28 0.15 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 113.203 -1.817 . . . . 0.0 116.305 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 151.47 45.61 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.917 2.358 . . . . 0.0 113.123 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -70.58 36.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.225 -1.547 . . . . 0.0 114.118 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.9 m 64.29 -142.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.251 -1.531 . . . . 0.0 111.087 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HE3' HD11 ' A' ' 38' ' ' LEU . 13.8 mptt -56.76 -37.18 70.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.919 0.888 . . . . 0.0 113.158 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -66.08 -45.56 80.83 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.151 -0.968 . . . . 0.0 112.578 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.472 ' HA ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -60.9 -50.42 73.48 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.962 172.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -44.85 -46.82 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.508 1.923 . . . . 0.0 112.154 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -66.56 -42.46 87.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.472 HD21 ' HA ' ' A' ' 17' ' ' CYS . 83.4 m-20 -54.94 -35.85 64.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.503 -1.373 . . . . 0.0 113.144 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.15 -39.34 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.482 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -62.38 -49.15 76.68 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -65.53 -42.29 92.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 m -69.54 -40.95 76.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.994 1.318 . . . . 0.0 110.966 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -45.92 48.95 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.813 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -74.09 11.61 0.88 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.961 1.255 . . . . 0.0 113.389 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.51 -5.0 17.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.675 1.59 . . . . 0.0 112.009 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.8 mt -75.69 129.62 37.41 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.01 -1.056 . . . . 0.0 110.097 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -53.21 -22.65 7.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.69 1.196 . . . . 0.0 114.157 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 -8.94 29.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.37 139.86 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 121.862 2.119 . . . . 0.0 109.624 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -109.37 -12.96 14.68 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -178.05 173.13 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.544 2.338 . . . . 0.0 111.322 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -178.59 152.66 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 109.835 -171.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 t -147.33 132.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 128.18 2.592 . . . . 0.0 107.755 167.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -101.64 149.34 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.468 1.128 . . . . 0.0 112.115 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 m -70.73 111.85 6.51 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.463 HD11 ' HE3' ' A' ' 15' ' ' LYS . 1.4 tm? -61.64 -45.43 94.09 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.047 1.294 . . . . 0.0 110.348 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.13 -56.38 11.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.735 0.814 . . . . 0.0 112.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -93.2 -179.98 5.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -166.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.412 HH21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -84.96 16.36 3.45 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -172.273 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 p -139.4 155.62 47.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -166.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.4 131.55 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.762 2.425 . . . . 0.0 110.708 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -101.21 110.01 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.19 133.78 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.598 1.559 . . . . 0.0 108.024 -169.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.62 108.18 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.538 1.535 . . . . 0.0 108.128 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -127.27 154.45 44.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -88.86 123.33 33.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.462 -0.774 . . . . 0.0 110.223 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.99 149.79 0.58 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.261 1.425 . . . . 0.0 110.852 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 m -90.03 22.06 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.7 1.2 . . . . 0.0 111.036 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 m -161.23 151.3 17.35 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.477 -1.389 . . . . 0.0 114.559 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.2 m -80.09 74.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.143 1.377 . . . . 0.0 111.675 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -107.88 73.61 0.43 Allowed Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.725 1.61 . . . . 0.0 110.549 171.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -78.15 -23.18 9.24 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.654 2.903 . . . . 0.0 113.259 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.68 -20.74 63.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.306 1.442 . . . . 0.0 113.087 -172.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.6 p -69.14 -44.33 72.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.54 -1.35 . . . . 0.0 112.697 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.0 mt -63.89 -46.89 82.86 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.109 0.564 . . . . 0.0 109.869 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -48.94 -52.75 22.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.082 0.953 . . . . 0.0 110.8 170.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -54.93 -38.2 67.39 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.64 80.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.253 0.933 . . . . 0.0 111.15 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.4 mt -66.94 -52.54 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.844 -0.535 . . . . 0.0 109.794 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.94 -22.21 24.96 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.014 -1.054 . . . . 0.0 112.676 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.55 -1.3 57.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.282 1.401 . . . . 0.0 114.76 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -95.37 -27.42 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.584 1.153 . . . . 0.0 111.046 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.72 71.08 7.33 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.556 1.142 . . . . 0.0 111.459 168.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.9 145.95 97.02 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.664 3.576 . . . . 0.0 113.839 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.33 -40.21 2.36 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.937 1.732 . . . . 0.0 113.085 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.89 -55.29 6.84 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.263 1.425 . . . . 0.0 111.156 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.432 ' CE2' HG11 ' A' ' 64' ' ' VAL . 4.4 m-30 -69.01 110.42 4.45 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.985 1.314 . . . . 0.0 114.425 -169.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.21 57.02 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.398 -1.439 . . . . 0.0 113.279 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.0 118.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 122.319 1.057 . . . . 0.0 113.023 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -135.21 147.71 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.093 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.47 120.94 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.607 1.163 . . . . 0.0 109.672 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.9 p -87.2 87.76 7.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.817 1.647 . . . . 0.0 110.477 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -132.31 161.42 33.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.678 0.791 . . . . 0.0 111.243 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.87 129.25 37.52 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 163.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 127.765 2.426 . . . . 0.0 108.379 -177.067 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 CA--C 1.555 1.16 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.05 174.06 7.61 Favored 'General case' 0 CA--C 1.55 0.957 1 C-N-CA 132.389 4.276 . . . . 0.0 115.222 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -116.52 -178.94 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.168 1.787 . . . . 0.0 111.146 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -157.36 148.46 21.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.27 1.428 . . . . 0.0 110.289 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.18 43.85 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.015 1.326 . . . . 0.0 111.783 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.5 m -121.32 140.18 52.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.991 1.317 . . . . 0.0 109.958 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -139.22 145.9 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.403 1.481 . . . . 0.0 111.068 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.3 tt -131.0 134.43 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.461 1.504 . . . . 0.0 111.072 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 100.15 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.465 1.106 . . . . 0.0 109.813 -169.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.2 41.06 0.36 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.481 1.512 . . . . 0.0 112.709 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.83 23.92 0.08 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.208 1.385 . . . . 0.0 113.764 -171.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.459 ' CE ' ' HG ' ' A' ' 17' ' ' CYS . 4.9 ttt -95.81 135.12 37.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.416 1.886 . . . . 0.0 112.064 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -60.48 21.75 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m 71.1 -62.31 0.46 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.248 2.619 . . . . 0.0 114.086 171.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 13.3 mptt -122.82 -53.94 1.85 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.516 1.126 . . . . 0.0 113.626 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 p -65.74 -22.3 66.59 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.481 -2.012 . . . . 0.0 113.199 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.459 ' HG ' ' CE ' ' A' ' 12' ' ' MET . 1.9 p -45.41 -56.82 4.58 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.596 1.158 . . . . 0.0 110.041 168.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -47.23 -53.65 3.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 127.9 2.48 . . . . 0.0 111.076 -172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.3 t -64.84 -25.41 67.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.64 -53.27 12.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.2 0.909 . . . . 0.0 110.257 167.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -44.96 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.58 -0.7 . . . . 0.0 110.562 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.3 -21.62 62.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 0.0 112.873 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.7 t -91.77 -58.94 2.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.574 1.15 . . . . 0.0 113.759 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.0 m -54.95 -39.61 69.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.329 2.252 . . . . 0.0 112.491 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -74.53 -49.79 20.64 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.603 172.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -70.69 14.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.252 1.387 . . . . 0.0 113.856 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -105.59 -7.01 18.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.041 1.736 . . . . 0.0 111.766 173.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -76.64 129.72 36.79 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 -172.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.47 -17.34 59.32 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -171.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 -11.52 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 169.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.9 p -94.11 135.91 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 122.172 2.26 . . . . 0.0 110.395 -170.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -107.49 -12.78 15.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.664 0.786 . . . . 0.0 113.094 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -179.81 174.38 0.93 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.219 2.608 . . . . 0.0 112.552 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 tt -172.42 153.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.038 2.535 . . . . 0.0 109.59 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 t -147.0 131.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.258 2.223 . . . . 0.0 107.99 167.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.29 137.29 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.487 1.613 . . . . 0.0 112.425 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 m -88.33 86.21 7.02 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.582 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.2 mt -47.94 -36.75 12.96 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.89 2.876 . . . . 0.0 115.286 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 12.6 mm-40 -88.23 -4.96 58.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.868 1.318 . . . . 0.0 113.792 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -116.36 -168.02 1.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.185 2.594 . . . . 0.0 108.769 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.46 43.41 2.97 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.91 -1.744 . . . . 0.0 110.056 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -134.47 151.58 51.24 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.083 -1.011 . . . . 0.0 112.959 -172.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.38 140.45 52.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.601 1.96 . . . . 0.0 109.347 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.7 mt -111.2 116.7 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -117.98 129.63 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.773 1.629 . . . . 0.0 107.447 -169.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 102.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 108.962 -168.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 29.3 p90 -120.92 141.0 51.05 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.532 1.133 . . . . 0.0 113.945 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -90.78 110.54 21.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.685 -1.259 . . . . 0.0 110.786 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 179.46 131.11 0.09 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.256 1.422 . . . . 0.0 112.032 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.8 t -86.19 -9.32 56.81 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.359 -0.838 . . . . 0.0 112.156 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -157.1 58.28 0.52 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.02 -1.05 . . . . 0.0 111.442 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.48 139.82 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 t -83.66 143.56 44.11 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.312 1.445 . . . . 0.0 111.847 -171.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.24 -15.11 46.13 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.277 2.651 . . . . 0.0 113.182 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -54.2 -32.53 55.91 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.365 0.984 . . . . 0.0 112.47 178.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 m -88.77 -23.7 22.82 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.964 -169.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.8 mt -68.11 -42.24 80.54 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.27 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -47.11 -55.64 7.99 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.611 0.764 . . . . 0.0 109.521 168.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 55' ' ' GLU . 2.4 mptm? -47.57 -48.22 28.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.355 1.062 . . . . 0.0 113.823 172.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.53 -27.95 69.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.118 0.872 . . . . 0.0 112.959 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.17 -49.7 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.124 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -51.3 -34.3 32.61 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 123.443 0.697 . . . . 0.0 110.284 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.38 5.75 14.08 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.86 -27.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.875 0.87 . . . . 0.0 111.699 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.54 65.5 8.54 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.088 168.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.5 146.27 97.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.341 3.361 . . . . 0.0 113.356 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.21 -29.44 2.81 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.852 1.215 . . . . 0.0 113.383 -174.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -94.79 -45.1 7.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.969 1.708 . . . . 0.0 110.791 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -71.8 106.96 4.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -80.96 78.24 7.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.154 0.982 . . . . 0.0 111.393 169.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -85.8 125.0 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.876 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 137.3 41.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 108.793 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.87 127.5 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -114.48 108.89 17.47 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 0.0 108.829 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.9 m -147.18 174.97 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.561 1.144 . . . . 0.0 111.317 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -71.87 134.28 45.97 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 163.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.317 -0.847 0 C-N-CA 125.7 1.6 . . . . 0.0 108.931 175.599 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -91.66 171.96 8.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.127 1.771 . . . . 0.0 113.987 170.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -140.2 175.28 9.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.627 3.171 . . . . 0.0 107.734 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -159.56 156.8 28.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.658 -1.276 . . . . 0.0 111.146 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.05 163.44 40.28 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 125.486 1.514 . . . . 0.0 111.316 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.3 m -125.54 139.58 53.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.197 1.399 . . . . 0.0 110.109 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -139.21 140.78 37.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.056 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.35 141.43 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.525 1.13 . . . . 0.0 109.347 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.05 165.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 125.179 1.392 . . . . 0.0 107.628 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.39 137.75 23.26 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.327 1.051 . . . . 0.0 108.313 167.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.17 69.96 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.244 0.925 . . . . 0.0 112.681 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 161.47 10.1 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.327 2.251 . . . . 0.0 114.437 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -68.98 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 126.155 1.782 . . . . 0.0 115.275 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 52.89 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 130.573 3.549 . . . . 0.0 119.279 167.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -49.77 1.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.601 1.56 . . . . 0.0 109.428 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -55.95 -27.1 50.9 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.359 -1.463 . . . . 0.0 113.048 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.5 p -49.69 -49.33 48.09 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 119.504 1.047 . . . . 0.0 111.645 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.8 t -52.91 -46.7 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.084 2.154 . . . . 0.0 111.967 -172.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -62.61 -42.79 99.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.134 0.574 . . . . 0.0 111.23 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -63.33 -43.06 98.84 Favored 'General case' 0 C--O 1.222 -0.37 0 O-C-N 121.968 -0.458 . . . . 0.0 111.792 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.21 -45.32 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.428 0.558 . . . . 0.0 109.53 -172.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.41 -50.67 59.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.306 1.442 . . . . 0.0 110.783 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -76.2 -31.58 58.52 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -79.71 -41.25 27.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.34 1.456 . . . . 0.0 110.289 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -74.56 -44.62 50.12 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 116.861 -1.542 . . . . 0.0 111.272 175.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -73.31 17.28 0.14 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 121.148 1.795 . . . . 0.0 113.165 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -111.6 -3.11 15.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.709 1.604 . . . . 0.0 113.007 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 mt -75.27 134.87 41.0 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.82 -1.175 . . . . 0.0 111.964 -169.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.63 63.14 1.53 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.688 1.195 . . . . 0.0 112.059 -176.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.0 p90 168.38 -21.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 130.394 3.478 . . . . 0.0 114.531 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.09 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.54 1.518 . . . . 0.0 109.422 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -115.48 -11.39 11.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -169.97 173.16 6.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.941 1.353 . . . . 0.0 112.634 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -155.73 157.39 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 109.972 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -144.7 124.48 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 126.765 2.026 . . . . 0.0 107.124 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.19 134.26 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.732 1.253 . . . . 0.0 110.146 169.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 m -67.59 90.26 0.26 Allowed 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.148 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.04 -38.21 50.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.748 1.158 . . . . 0.0 112.332 -168.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -66.31 0.56 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.451 0.569 . . . . 0.0 110.643 170.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.22 165.18 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.318 1.532 . . . . 0.0 112.19 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 40.4 0.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.319 -1.488 . . . . 0.0 113.174 168.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 p -133.91 158.62 43.0 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 140.42 51.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.123 2.169 . . . . 0.0 110.984 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.73 118.31 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.8 t -121.45 131.92 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.537 1.135 . . . . 0.0 108.22 -167.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 t -118.32 120.9 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.331 1.453 . . . . 0.0 108.713 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 48.4 p90 -135.99 160.82 37.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 -170.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -93.98 108.76 20.54 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.927 -1.108 . . . . 0.0 112.417 -169.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -164.24 156.93 17.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.227 1.011 . . . . 0.0 112.585 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.2 p -87.85 19.49 3.5 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.963 -1.086 . . . . 0.0 111.744 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -173.42 -179.43 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.491 1.517 . . . . 0.0 112.101 -168.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.48 122.0 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.913 1.285 . . . . 0.0 111.339 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -143.24 85.2 9.77 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 126.32 1.848 . . . . 0.0 107.853 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -85.68 -24.14 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.887 2.391 . . . . 0.0 115.185 -167.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 p -66.58 -40.5 88.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.996 1.725 . . . . 0.0 112.917 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 76.5 mt -69.2 -43.61 73.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.19 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -52.01 -48.24 64.59 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.768 0.713 . . . . 0.0 109.913 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -60.93 -31.54 71.06 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.58 84.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.966 1.257 . . . . 0.0 111.891 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.86 -53.28 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.743 -0.598 . . . . 0.0 110.209 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -57.02 -21.13 28.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 112.102 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.39 1.99 55.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -93.47 -30.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.732 0.813 . . . . 0.0 111.258 175.44 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.55 69.49 10.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.536 0.734 . . . . 0.0 111.053 168.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.47 142.49 98.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.622 3.548 . . . . 0.0 112.574 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.87 -27.61 2.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.07 1.319 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 tp -88.62 -45.04 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.368 1.467 . . . . 0.0 111.514 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -78.67 102.5 8.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.817 1.247 . . . . 0.0 114.203 -168.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -70.3 44.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.62 130.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 122.588 1.185 . . . . 0.0 113.244 -166.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -136.7 148.33 47.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.491 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.88 126.45 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.79 -1.194 . . . . 0.0 108.271 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.39 106.05 18.23 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 m -161.92 156.42 22.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.202 1.401 . . . . 0.0 110.613 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.69 104.28 2.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.786 0.834 . . . . 0.0 109.823 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 125.136 1.374 . . . . 0.0 113.565 -177.523 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 121.352 0.596 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -157.07 169.91 23.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.884 2.873 . . . . 0.0 110.288 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 t -115.55 -177.99 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 108.486 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -160.69 148.88 16.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.966 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.92 159.51 43.79 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.039 1.336 . . . . 0.0 110.958 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 m -117.85 134.54 54.83 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.46 1.504 . . . . 0.0 109.569 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -130.65 148.19 52.41 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.009 1.324 . . . . 0.0 111.054 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.6 tt -131.28 137.9 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.12 1.368 . . . . 0.0 110.4 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.69 110.9 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.769 1.628 . . . . 0.0 109.592 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.9 119.17 26.83 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 168.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.76 8.25 30.42 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.155 0.883 . . . . 0.0 113.413 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 138.23 58.28 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.491 -1.005 . . . . 0.0 110.76 171.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -55.32 -32.19 62.29 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p 144.71 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 131.642 3.977 . . . . 0.0 108.352 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 10.6 mptt -19.79 -61.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 129.597 3.159 . . . . 0.0 114.439 165.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -57.19 -11.24 1.56 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.48 -45.03 85.32 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.689 1.586 . . . . 0.0 109.693 168.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.0 t -55.5 -47.28 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 125.297 1.439 . . . . 0.0 111.995 -169.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.2 t -58.01 -38.6 76.49 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.156 0.979 . . . . 0.0 111.834 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -72.86 -40.02 66.01 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.166 -0.959 . . . . 0.0 113.035 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.663 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -46.51 -55.49 7.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.287 1.835 . . . . 0.0 109.484 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.4 m -70.32 -44.96 67.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -71.79 -38.55 70.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.451 1.101 . . . . 0.0 110.834 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -75.55 -49.44 18.63 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.161 -1.4 . . . . 0.0 111.393 175.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -72.25 12.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.006 1.73 . . . . 0.0 113.184 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -101.16 -6.16 24.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.615 1.566 . . . . 0.0 111.703 175.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.6 127.27 32.69 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.31 -19.31 13.78 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -8.97 33.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.4 p -94.23 140.03 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 121.88 2.127 . . . . 0.0 109.554 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 t -111.39 -8.25 14.32 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.96 171.7 3.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.479 1.512 . . . . 0.0 113.237 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.68 150.04 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.402 1.481 . . . . 0.0 112.358 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.62 146.51 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 127.685 2.394 . . . . 0.0 105.867 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.16 149.26 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.973 0.892 . . . . 0.0 111.11 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -101.49 96.11 6.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HG ' ' HE3' ' A' ' 15' ' ' LYS . 9.6 tp -62.38 -30.75 71.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.715 1.606 . . . . 0.0 115.208 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 19.0 mm-40 -86.25 1.84 49.36 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.507 1.146 . . . . 0.0 113.308 175.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -126.55 -170.55 2.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.669 2.788 . . . . 0.0 109.813 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 34.39 5.22 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.333 1.853 . . . . 0.0 112.205 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -141.29 154.78 45.91 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.89 143.38 51.11 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.614 2.366 . . . . 0.0 111.264 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -112.36 116.19 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.59 129.43 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -168.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 114.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.437 1.495 . . . . 0.0 107.044 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 20.4 p90 -136.45 151.02 49.02 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.374 1.069 . . . . 0.0 111.932 -168.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.17 136.53 32.99 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.653 -1.28 . . . . 0.0 111.728 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.44 179.16 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.061 2.144 . . . . 0.0 110.893 -171.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -136.66 -46.78 0.6 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.998 1.319 . . . . 0.0 108.211 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 p -76.48 123.78 26.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 165.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -60.65 115.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 120.018 1.281 . . . . 0.0 109.92 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -134.55 64.2 62.87 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.928 0.891 . . . . 0.0 111.555 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.81 -9.84 15.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.193 3.262 . . . . 0.0 114.616 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.126 0.875 . . . . 0.0 112.165 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -81.25 -18.1 47.17 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.126 -168.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.19 -46.32 64.82 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.477 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 3.3 ttt85 -49.24 -52.64 25.86 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.537 1.062 . . . . 0.0 109.351 170.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.98 -41.82 71.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.26 69.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.826 1.194 . . . . 0.0 112.592 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.9 mt -72.7 -52.96 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.431 0.692 . . . . 0.0 109.954 170.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.409 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 54.9 mt-10 -54.13 -25.96 25.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.645 0.778 . . . . 0.0 112.518 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -0.89 37.83 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.06 -30.17 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.414 1.086 . . . . 0.0 111.297 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.79 66.48 10.66 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 121.605 -0.684 . . . . 0.0 111.479 168.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.58 142.21 98.48 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.525 3.483 . . . . 0.0 112.949 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.02 -30.18 2.99 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.286 1.422 . . . . 0.0 113.673 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.93 -39.49 10.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 112.01 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -79.76 107.2 12.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 113.424 -177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -83.9 78.06 9.8 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.707 -1.246 . . . . 0.0 111.217 171.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 135.09 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.843 0.83 . . . . 0.0 111.079 -173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 m -152.1 165.41 34.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.464 1.105 . . . . 0.0 111.312 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.7 mt -93.4 133.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.538 1.135 . . . . 0.0 109.112 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.47 92.26 8.46 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.777 0.831 . . . . 0.0 109.851 -174.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.7 m -163.01 167.54 22.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.421 1.488 . . . . 0.0 110.607 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -80.83 123.83 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 167.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 127.509 2.324 . . . . 0.0 109.688 -177.787 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 122.888 1.328 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.31 158.57 23.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.501 2.72 . . . . 0.0 111.558 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 t -141.29 -175.76 4.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.439 2.696 . . . . 0.0 109.082 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 m -166.54 141.84 4.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.003 -1.061 . . . . 0.0 110.515 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.58 32.59 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.064 1.346 . . . . 0.0 110.676 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.2 m -130.2 138.63 50.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.863 1.265 . . . . 0.0 109.807 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -139.57 151.73 46.3 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.612 0.765 . . . . 0.0 112.259 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.9 tt -141.89 129.65 21.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 124.048 0.939 . . . . 0.0 112.077 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.75 114.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 126.485 1.914 . . . . 0.0 110.61 -168.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 1.46 17.15 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.69 4.15 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.027 1.775 . . . . 0.0 116.822 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -71.55 141.72 50.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.89 2.345 . . . . 0.0 113.477 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -68.49 32.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 127.483 2.313 . . . . 0.0 114.96 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t 54.71 -131.78 1.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.181 1.393 . . . . 0.0 111.158 171.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 74.6 mttt -54.58 -25.24 25.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -168.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -82.49 -46.17 13.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.975 1.261 . . . . 0.0 111.851 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.1 m -57.99 -40.85 81.7 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 117.123 -1.417 . . . . 0.0 111.387 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -39.82 -56.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.022 1.729 . . . . 0.0 111.287 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -59.04 -43.1 91.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.856 . . . . 0.0 112.24 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -62.84 -40.73 98.34 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.752 -0.593 . . . . 0.0 112.461 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -49.39 76.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.11 -50.54 61.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.679 1.192 . . . . 0.0 110.673 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 t -68.76 -32.64 72.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.0 m -77.34 -48.7 16.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.642 0.734 . . . . 0.0 109.936 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.7 -20.05 57.02 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.168 1.387 . . . . 0.0 114.227 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.2 t -85.5 1.29 49.51 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.606 1.548 . . . . 0.0 112.969 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.36 1.75 11.83 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.606 -1.309 . . . . 0.0 114.187 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.89 152.05 42.89 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.4 -0.812 . . . . 0.0 112.568 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.72 47.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.919 2.087 . . . . 0.0 112.604 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.185 3.394 . . . . 0.0 114.095 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.4 p -94.23 142.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 122.402 2.365 . . . . 0.0 112.135 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 m -107.48 -18.59 13.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.507 1.523 . . . . 0.0 113.928 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 m -178.65 171.07 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.747 2.019 . . . . 0.0 111.854 -171.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -167.2 161.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.211 2.604 . . . . 0.0 109.701 -175.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 t -152.09 128.31 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 127.991 2.516 . . . . 0.0 107.718 165.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.9 t -96.24 142.79 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 123.39 1.566 . . . . 0.0 112.207 170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 m -74.41 86.77 2.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.007 1.323 . . . . 0.0 110.284 170.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.451 HD12 ' HE2' ' A' ' 15' ' ' LYS . 1.1 tm? -44.0 -43.46 6.69 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.301 3.04 . . . . 0.0 113.096 -175.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.528 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER -83.94 -9.4 58.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.084 1.354 . . . . 0.0 114.623 -176.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.61 -170.01 2.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.377 2.671 . . . . 0.0 110.243 -167.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.64 33.87 5.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.319 1.848 . . . . 0.0 112.623 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -140.66 159.18 42.76 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.53 142.87 41.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.88 1.672 . . . . 0.0 111.129 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.8 121.19 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -121.46 128.61 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.513 1.525 . . . . 0.0 107.729 -168.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 103.12 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.648 1.579 . . . . 0.0 109.184 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 46.2 p90 -119.31 156.51 29.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.49 1.116 . . . . 0.0 112.977 -170.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -107.85 128.01 54.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.429 1.092 . . . . 0.0 110.885 -172.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.7 142.2 0.22 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -70.03 -30.91 68.31 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.618 -0.676 . . . . 0.0 110.2 166.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.5 t -177.39 168.81 2.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 130.134 3.374 . . . . 0.0 108.219 167.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 p 157.26 149.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 130.913 3.685 . . . . 0.0 108.594 -172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -77.89 130.72 72.2 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.888 1.275 . . . . 0.0 112.187 -169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.3 -20.02 68.85 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.262 2.642 . . . . 0.0 113.062 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -32.35 17.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.415 1.086 . . . . 0.0 112.339 170.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 m -72.88 -35.0 67.05 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.849 1.204 . . . . 0.0 111.791 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.7 mt -70.8 -43.47 68.58 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.925 -0.559 . . . . 0.0 109.736 173.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -52.71 -42.02 64.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.654 0.782 . . . . 0.0 110.84 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -39.79 95.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 169.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.97 69.53 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 121.104 1.775 . . . . 0.0 112.172 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.86 -58.77 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.587 0.755 . . . . 0.0 111.338 170.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -54.99 -18.59 5.26 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.836 1.254 . . . . 0.0 113.431 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.07 57.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -90.82 -29.71 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.282 1.033 . . . . 0.0 111.28 177.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.427 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.04 65.18 7.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 121.594 -0.691 . . . . 0.0 111.683 168.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.82 149.08 62.58 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.068 3.179 . . . . 0.0 112.586 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.14 -44.28 3.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.665 1.126 . . . . 0.0 112.513 -173.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 tp -77.05 -44.79 29.42 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.167 1.387 . . . . 0.0 110.717 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.437 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -81.36 94.75 6.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.458 1.123 . . . . 0.0 113.243 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.255 0.0 OUTLIER -77.8 110.51 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 164.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.17 146.93 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 124.371 3.259 . . . . 0.0 111.887 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -131.67 158.12 41.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.481 1.512 . . . . 0.0 110.029 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.6 mt -94.73 124.62 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -111.74 107.99 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.189 0.995 . . . . 0.0 109.593 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -135.65 161.95 34.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.729 1.612 . . . . 0.0 110.646 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.54 116.46 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.325 -0.491 0 C-N-CA 127.391 2.277 . . . . 0.0 108.969 175.884 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.744 0.307 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.53 153.4 19.07 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.49 2.316 . . . . 0.0 113.515 171.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -102.49 -177.52 3.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.741 2.017 . . . . 0.0 111.332 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.39 166.93 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.893 -1.129 . . . . 0.0 111.505 172.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.4 152.22 30.81 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.707 1.203 . . . . 0.0 111.223 169.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.0 m -114.7 139.07 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.697 1.599 . . . . 0.0 109.716 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -140.24 143.17 35.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.28 -176.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.8 132.45 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.295 1.038 . . . . 0.0 110.662 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.72 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.443 1.497 . . . . 0.0 110.072 -169.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.12 50.73 0.92 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.058 -1.026 . . . . 0.0 112.922 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 -8.27 0.02 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.008 1.766 . . . . 0.0 117.409 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -72.71 144.24 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.909 2.354 . . . . 0.0 111.723 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -64.52 5.48 0.28 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.24 1.816 . . . . 0.0 115.845 -176.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.55 -35.87 0.28 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.884 2.873 . . . . 0.0 115.52 171.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HE2' HD12 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -103.1 -87.44 0.42 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.303 1.411 . . . . 0.0 110.602 172.515 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p -63.62 -13.04 38.47 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 119.152 -2.218 . . . . 0.0 115.256 -175.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.91 -39.79 94.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 121.213 1.824 . . . . 0.0 110.813 167.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -50.31 -47.28 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.084 2.154 . . . . 0.0 111.381 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.5 t -69.63 -37.58 76.87 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.689 -1.257 . . . . 0.0 111.881 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -49.68 80.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.058 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -51.28 -51.34 55.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.363 170.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -70.15 -31.14 68.5 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -176.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -78.14 -51.31 10.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.876 0.871 . . . . 0.0 109.134 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.2 mt -77.12 -19.68 56.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.5 t -87.66 14.82 7.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 121.282 1.856 . . . . 0.0 112.697 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.56 4.13 9.59 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 30' ' ' TYR . 18.1 mt -77.2 154.35 33.18 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.04 -1.038 . . . . 0.0 112.472 -171.212 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -64.58 13.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.535 2.734 . . . . 0.0 114.71 -174.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -167.2 3.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.295 2.238 . . . . 0.0 113.89 -169.667 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 14.3 p -104.64 133.14 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.966 1.712 . . . . 0.0 110.543 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -105.9 -12.41 15.85 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -177.57 174.22 1.56 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.146 1.778 . . . . 0.0 112.78 -176.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -167.33 153.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.249 2.22 . . . . 0.0 110.806 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.21 143.42 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.959 2.503 . . . . 0.0 106.581 166.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.85 148.85 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.8 p -77.97 136.55 38.0 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 176.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.476 HD12 ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -92.35 -15.88 26.72 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 112.873 169.78 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.49 -57.6 3.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.975 1.71 . . . . 0.0 110.63 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -89.32 -179.11 5.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 113.202 -172.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 37.96 1.98 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.217 1.807 . . . . 0.0 113.965 177.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -141.96 147.19 36.58 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.635 -1.915 . . . . 0.0 115.255 -170.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.56 143.19 50.36 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.484 -174.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -117.64 117.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.9 t -122.88 119.67 58.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.914 1.286 . . . . 0.0 109.625 -165.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.6 t -103.95 108.95 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 109.425 -169.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p90 -122.86 144.68 49.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.896 1.278 . . . . 0.0 113.186 -171.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -95.67 117.58 30.75 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.495 -1.378 . . . . 0.0 111.935 -171.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.92 141.46 0.27 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.591 1.956 . . . . 0.0 109.886 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.3 p -83.37 46.93 1.19 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.163 -0.96 . . . . 0.0 108.651 169.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 m -167.32 160.8 13.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.403 1.481 . . . . 0.0 113.666 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.453 1.501 . . . . 0.0 111.072 -175.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -159.7 53.96 0.59 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.245 1.418 . . . . 0.0 112.667 173.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -58.1 -23.97 63.88 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.119 3.213 . . . . 0.0 112.607 177.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -50.29 -40.94 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.04 0.936 . . . . 0.0 112.418 171.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -70.77 -32.78 70.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.384 -1.447 . . . . 0.0 112.731 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.96 -45.44 50.24 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.42 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -48.92 -51.63 29.02 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.386 1.474 . . . . 0.0 109.821 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -55.46 -43.25 75.3 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.932 1.293 . . . . 0.0 113.413 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.34 74.95 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.419 0.554 . . . . 0.0 112.332 173.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.32 -54.54 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.793 -0.567 . . . . 0.0 111.595 172.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.54 -27.85 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.528 1.131 . . . . 0.0 111.425 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.15 1.36 48.3 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.427 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -95.3 -29.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.15 0.98 . . . . 0.0 111.477 177.149 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.03 66.73 8.83 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.664 -0.647 . . . . 0.0 111.453 168.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.55 141.15 97.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.014 3.143 . . . . 0.0 112.592 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.38 -40.99 3.05 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.109 1.338 . . . . 0.0 112.815 -174.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.09 -42.98 45.58 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.544 1.137 . . . . 0.0 111.52 172.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.427 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.9 m-30 -78.45 97.71 5.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -78.94 79.61 5.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.273 168.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 t -88.05 121.79 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.181 0.592 . . . . 0.0 111.896 -172.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.73 133.01 52.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.571 1.148 . . . . 0.0 110.931 -174.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mt -86.32 84.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -77.81 114.29 16.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.408 0.623 . . . . 0.0 109.789 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 t -168.33 175.3 6.48 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.217 1.807 . . . . 0.0 110.109 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -74.57 43.18 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.377 2.271 . . . . 0.0 113.322 -172.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 125.889 1.676 . . . . 0.0 111.319 -171.253 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.34 -168.55 1.41 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.793 2.437 . . . . 0.0 111.916 172.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -117.0 178.81 4.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.478 1.511 . . . . 0.0 110.872 170.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 m -156.38 146.48 21.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 125.636 1.574 . . . . 0.0 109.112 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.33 159.29 43.49 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.815 171.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.3 m -114.17 132.44 56.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.87 1.268 . . . . 0.0 109.986 174.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.94 146.07 50.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.775 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -131.85 134.78 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.817 1.247 . . . . 0.0 110.621 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.98 100.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.643 1.577 . . . . 0.0 109.015 -169.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.22 3.53 10.56 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.59 10.53 8.55 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 125.887 1.708 . . . . 0.0 113.357 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.4 tmm? -70.59 138.19 50.66 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.289 1.036 . . . . 0.0 110.2 -175.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.79 -6.89 1.96 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 174.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 t 81.74 -43.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.586 2.355 . . . . 0.0 110.601 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -122.95 149.4 44.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.764 1.226 . . . . 0.0 109.397 169.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m 69.77 -44.53 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.328 1.851 . . . . 0.0 113.261 -168.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -51.53 -47.87 63.2 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 121.096 1.771 . . . . 0.0 110.563 174.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.2 t -29.9 -58.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 127.257 2.223 . . . . 0.0 113.844 168.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -70.5 -34.78 72.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 117.839 0.29 . . . . 0.0 111.4 -169.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -58.85 -43.82 90.87 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.545 -0.722 . . . . 0.0 112.104 168.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -41.37 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.43 -172.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.73 -50.62 69.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.815 0.846 . . . . 0.0 110.292 169.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -67.81 -45.71 73.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -175.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.444 ' HG1' HG22 ' A' ' 64' ' ' VAL . 49.9 m -66.85 -40.27 87.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.554 1.542 . . . . 0.0 110.576 -178.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -47.02 42.86 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.838 176.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -68.77 6.32 0.89 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.244 1.384 . . . . 0.0 113.733 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.98 -5.46 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.512 176.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.7 mt -77.24 127.72 33.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.197 -0.939 . . . . 0.0 109.843 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -54.25 -21.93 10.41 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.68 -16.54 24.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 175.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.272 4.1 p -82.83 138.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.658 1.572 . . . . 0.0 110.031 -168.369 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -99.67 -31.25 11.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.951 1.701 . . . . 0.0 110.668 -174.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -166.49 174.76 8.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.596 1.189 . . . . 0.0 112.875 173.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 150.73 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.011 1.324 . . . . 0.0 111.601 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.73 134.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.293 1.837 . . . . 0.0 107.24 166.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 t -101.31 134.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.171 0.986 . . . . 0.0 109.776 168.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -68.59 92.26 0.45 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.808 169.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -47.9 -43.05 28.44 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.989 1.715 . . . . 0.0 111.305 -177.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.52 -51.87 67.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.553 1.141 . . . . 0.0 112.031 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.69 -176.19 5.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 124.893 2.282 . . . . 0.0 113.814 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 30.2 4.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.482 2.313 . . . . 0.0 112.133 169.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 150.87 41.93 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.182 -1.574 . . . . 0.0 114.744 -167.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.8 136.45 51.49 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.592 1.957 . . . . 0.0 110.517 -171.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.23 111.37 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 t -117.5 130.79 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.2 1.4 . . . . 0.0 108.792 -169.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.65 112.78 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.195 1.398 . . . . 0.0 107.481 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 2.0 p90 -131.84 134.81 46.17 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.897 1.226 . . . . 0.0 112.303 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -77.66 113.14 15.2 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.471 -0.768 . . . . 0.0 110.547 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.51 167.59 2.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.766 2.426 . . . . 0.0 109.489 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -77.36 31.67 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.894 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.8 m 61.52 -25.4 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 128.917 2.887 . . . . 0.0 117.166 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.84 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.299 1.839 . . . . 0.0 114.052 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.63 34.33 0.23 Allowed Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -173.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.1 -27.32 17.16 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.108 2.538 . . . . 0.0 112.252 -176.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -52.81 -24.79 9.65 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 112.502 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -42.6 79.99 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.704 -1.248 . . . . 0.0 112.233 177.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.47 -45.5 65.59 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.801 178.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -46.06 -52.25 12.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.984 0.914 . . . . 0.0 110.345 170.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -32.83 74.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 177.4 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.297 1.408 . . . . 0.0 111.537 170.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.53 -52.85 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.876 0.47 . . . . 0.0 110.684 171.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.07 -27.75 14.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.237 0.926 . . . . 0.0 112.0 174.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.57 4.15 33.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.444 HG22 ' HG1' ' A' ' 24' ' ' THR . 0.4 OUTLIER -98.32 -28.04 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.926 0.89 . . . . 0.0 111.544 173.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.36 67.81 9.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.506 -0.746 . . . . 0.0 111.068 168.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.9 139.87 87.31 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.054 3.169 . . . . 0.0 111.868 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.82 -23.06 7.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.571 1.081 . . . . 0.0 114.073 -175.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 -45.16 7.37 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.376 1.471 . . . . 0.0 111.492 173.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -76.95 102.07 6.24 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -168.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.545 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -75.86 75.99 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 110.267 168.743 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.91 129.65 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 122.227 1.013 . . . . 0.0 111.744 -176.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -138.66 159.72 41.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.613 1.565 . . . . 0.0 109.992 178.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.3 mt -95.69 129.61 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t -102.37 106.96 17.81 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.584 0.707 . . . . 0.0 109.955 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.6 t -169.55 175.92 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 109.842 173.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.19 30.5 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 129.581 3.153 . . . . 0.0 114.997 -171.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 126.273 1.829 . . . . 0.0 110.538 -172.938 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.173 0.511 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -79.47 166.85 21.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.462 1.505 . . . . 0.0 113.396 174.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -120.13 168.89 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.297 2.239 . . . . 0.0 107.972 167.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m -152.89 147.89 26.51 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.196 -0.94 . . . . 0.0 110.601 -175.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.52 161.32 42.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.558 1.143 . . . . 0.0 112.162 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.1 m -121.47 137.73 54.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.101 1.36 . . . . 0.0 110.257 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -136.9 143.16 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.779 1.231 . . . . 0.0 110.31 -178.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 tt -132.07 131.67 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 111.052 -175.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.63 102.36 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.329 1.852 . . . . 0.0 108.768 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -76.52 33.07 0.13 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.052 -1.655 . . . . 0.0 114.143 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.97 -0.71 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.424 1.488 . . . . 0.0 116.263 -176.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.404 ' C ' ' H ' ' A' ' 14' ' ' CYS . 2.8 ptm -69.94 141.02 53.12 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.466 2.133 . . . . 0.0 110.786 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -59.19 12.09 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 127.235 2.214 . . . . 0.0 116.17 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' H ' ' C ' ' A' ' 12' ' ' MET . 19.4 m 73.12 -42.64 0.54 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.275 2.63 . . . . 0.0 115.768 167.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.11 -89.64 0.47 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.046 1.338 . . . . 0.0 109.129 174.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 p -55.57 -22.77 23.49 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 121.679 2.036 . . . . 0.0 115.601 -173.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -57.87 -42.75 85.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 112.527 169.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.6 t -46.43 -54.59 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.038 1.735 . . . . 0.0 110.814 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 t -60.01 -37.95 81.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.2 0.6 . . . . 0.0 111.605 -176.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -65.7 -42.76 90.79 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.36 -0.829 . . . . 0.0 112.375 174.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -44.48 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.095 0.861 . . . . 0.0 110.055 -175.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.76 -55.61 21.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.404 1.082 . . . . 0.0 110.37 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.4 t -64.1 -49.36 72.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.5 m -69.95 -36.25 75.14 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.98 1.312 . . . . 0.0 111.16 -172.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.98 -47.97 40.65 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.746 168.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -65.81 7.68 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 121.288 1.858 . . . . 0.0 115.283 -171.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.51 -3.32 18.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.824 2.05 . . . . 0.0 112.199 176.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.5 136.84 46.01 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.99 -1.069 . . . . 0.0 110.996 -171.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -75.63 65.65 1.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.786 1.634 . . . . 0.0 111.274 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 p90 167.25 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 129.961 3.304 . . . . 0.0 113.041 -173.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.2 p -86.03 142.63 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 121.184 1.811 . . . . 0.0 110.186 -175.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.06 -21.79 12.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -170.54 172.01 6.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.073 1.749 . . . . 0.0 112.369 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -176.25 153.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 127.804 2.442 . . . . 0.0 109.593 -169.3 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -147.11 132.6 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.588 2.355 . . . . 0.0 107.743 166.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.09 142.14 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.458 0.647 . . . . 0.0 110.825 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -73.28 108.79 6.36 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 122.81 1.29 . . . . 0.0 109.126 166.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -20.24 44.68 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.341 -0.849 . . . . 0.0 112.139 168.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -91.9 -45.6 8.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.539 1.063 . . . . 0.0 112.57 175.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -99.6 157.56 16.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.828 1.251 . . . . 0.0 112.178 -171.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.81 35.01 0.23 Allowed 'General case' 0 CA--C 1.548 0.872 0 O-C-N 119.732 -1.855 . . . . 0.0 113.946 -177.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -140.49 154.55 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 119.914 -1.741 . . . . 0.0 115.431 -170.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.56 139.19 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.187 2.195 . . . . 0.0 109.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -110.26 118.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 169.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.9 t -121.65 138.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.899 1.28 . . . . 0.0 110.125 -167.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.14 99.4 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.238 1.415 . . . . 0.0 109.925 -167.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 20.4 p90 -118.13 143.01 46.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.537 1.535 . . . . 0.0 113.539 -168.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.02 94.28 9.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.565 -1.334 . . . . 0.0 111.583 -169.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.79 129.36 3.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.0 112.394 -175.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -83.52 -11.41 57.46 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.566 -0.708 . . . . 0.0 112.135 174.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 m -168.55 72.34 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 111.768 -177.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.6 t -135.85 138.11 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 168.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -68.94 137.56 89.9 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.198 -174.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.3 -20.64 69.02 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.235 2.623 . . . . 0.0 111.929 170.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -60.46 -16.96 41.53 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.155 0.982 . . . . 0.0 112.608 174.528 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -68.06 -47.07 69.34 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.957 -1.089 . . . . 0.0 112.802 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.6 -42.88 86.22 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.608 -0.683 . . . . 0.0 110.435 176.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.68 -52.5 18.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.207 1.403 . . . . 0.0 111.785 171.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.411 ' HZ1' ' CD ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -65.1 -32.52 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.225 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.14 83.97 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.984 1.265 . . . . 0.0 111.8 172.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.02 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.432 -0.793 . . . . 0.0 110.762 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.19 -20.67 18.96 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.71 1.19 55.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -93.96 -28.79 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.282 0.946 . . . . 0.0 111.252 176.352 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.422 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -151.15 67.79 7.75 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.764 0.826 . . . . 0.0 112.161 169.027 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.45 145.41 88.45 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.269 3.313 . . . . 0.0 113.062 -178.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.96 -40.98 2.93 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.416 1.484 . . . . 0.0 112.929 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -77.01 -45.81 26.01 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.046 1.338 . . . . 0.0 111.698 173.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 3.2 m-30 -72.28 96.97 1.91 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.25 1.5 . . . . 0.0 114.11 -168.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -72.85 65.02 0.7 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.715 2.006 . . . . 0.0 113.594 170.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.97 136.78 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.77 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 p -151.79 156.95 41.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.845 1.258 . . . . 0.0 110.57 174.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.65 129.61 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.166 0.986 . . . . 0.0 109.71 174.643 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.76 107.27 18.87 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 109.097 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.0 t -137.92 163.16 32.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.827 0.851 . . . . 0.0 113.273 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.29 71.45 5.82 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.861 1.315 . . . . 0.0 110.375 175.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 126.105 1.762 . . . . 0.0 109.839 172.084 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 122.435 1.112 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.95 154.42 38.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 113.709 -170.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -100.65 -175.88 3.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.821 1.648 . . . . 0.0 110.141 168.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -162.77 150.79 13.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.044 1.338 . . . . 0.0 109.62 -172.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.4 159.93 39.17 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.678 1.591 . . . . 0.0 111.321 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -121.87 139.22 53.9 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 109.947 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -140.5 139.48 35.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.185 -176.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.12 130.75 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.05 1.34 . . . . 0.0 111.122 -175.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.42 103.46 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.978 1.711 . . . . 0.0 109.524 -168.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.404 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -72.08 0.19 10.17 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.357 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 10.47 5.75 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 125.784 1.659 . . . . 0.0 114.36 -173.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.408 ' SD ' ' HB2' ' A' ' 17' ' ' CYS . 4.5 tmm? -66.59 135.92 54.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.304 1.042 . . . . 0.0 111.231 -174.873 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -62.56 0.25 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m 76.34 -40.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.965 2.506 . . . . 0.0 114.623 167.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HE3' HD12 ' A' ' 38' ' ' LEU . 12.3 mptt -111.55 -75.79 0.61 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.11 0.868 . . . . 0.0 109.507 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -32.32 69.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.552 -1.968 . . . . 0.0 114.045 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' HB2' ' SD ' ' A' ' 12' ' ' MET . 1.6 m -57.25 -41.73 80.17 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.69 176.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -47.13 -49.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.887 2.075 . . . . 0.0 112.242 178.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -61.62 -40.07 93.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.395 0.678 . . . . 0.0 112.348 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -63.8 -46.95 82.87 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 122.06 -0.4 . . . . 0.0 111.743 171.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.23 -50.98 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -171.12 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.06 -44.47 67.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.33 1.852 . . . . 0.0 109.899 175.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -70.49 -44.59 67.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 m -70.76 -40.3 72.76 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.95 1.3 . . . . 0.0 110.853 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.71 -49.55 25.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 116.845 -1.55 . . . . 0.0 111.199 175.724 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.96 16.74 0.11 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.472 1.942 . . . . 0.0 113.534 -174.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -111.92 -3.45 14.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.224 1.81 . . . . 0.0 112.423 174.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.85 139.86 47.23 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.86 -1.15 . . . . 0.0 111.634 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.88 -15.2 7.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.817 1.647 . . . . 0.0 115.004 -170.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.79 -6.47 11.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.367 1.867 . . . . 0.0 114.95 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.1 p -88.82 137.32 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.923 1.692 . . . . 0.0 111.271 -168.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.23 -26.19 14.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.266 1.027 . . . . 0.0 111.506 -173.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -177.8 173.55 1.57 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.06 2.144 . . . . 0.0 111.636 -171.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -177.32 155.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.622 2.369 . . . . 0.0 108.624 -172.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -149.58 135.38 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 127.48 2.312 . . . . 0.0 108.645 166.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -106.19 141.44 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.072 0.949 . . . . 0.0 110.75 169.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -79.16 112.76 16.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 123.153 1.454 . . . . 0.0 110.259 168.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.489 HD12 ' HE3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.59 -22.06 31.17 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 120.692 -1.255 . . . . 0.0 112.664 167.886 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 -69.04 0.73 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.519 1.528 . . . . 0.0 111.057 169.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -73.52 137.23 44.28 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.855 1.262 . . . . 0.0 111.278 -171.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -130.86 154.73 47.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.247 2.219 . . . . 0.0 113.691 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.26 143.97 44.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.259 2.223 . . . . 0.0 109.296 172.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.74 118.84 59.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.11 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 t -119.99 135.52 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.329 1.452 . . . . 0.0 108.881 -168.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.73 96.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.21 1.404 . . . . 0.0 108.52 -168.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 25.6 p90 -118.63 140.07 50.5 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.729 1.212 . . . . 0.0 113.55 -168.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.33 117.31 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.077 -1.014 . . . . 0.0 111.629 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -179.94 132.6 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.095 2.158 . . . . 0.0 108.95 178.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -82.24 -13.44 57.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.095 -1.003 . . . . 0.0 113.002 177.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -167.95 158.55 10.67 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.776 1.63 . . . . 0.0 110.348 167.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p 145.0 153.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 1 C-N-CA 132.515 4.326 . . . . 0.0 106.914 -169.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t -66.16 144.25 98.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.152 171.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -55.38 -19.59 22.83 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.52 2.813 . . . . 0.0 112.329 167.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.83 -13.65 62.12 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -37.32 81.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.301 1.864 . . . . 0.0 111.44 170.294 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 70.7 mt -70.03 -46.14 65.68 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.182 173.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -49.01 -52.42 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 111.072 174.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -56.5 -37.71 70.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.286 1.434 . . . . 0.0 114.749 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.77 95.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.733 1.606 . . . . 0.0 111.474 171.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mt -63.06 -56.18 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.667 174.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -53.18 -24.68 11.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.936 0.894 . . . . 0.0 113.002 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 0.01 55.94 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -95.39 -30.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 177.696 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.01 67.48 9.18 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.39 0.676 . . . . 0.0 111.145 169.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 143.71 99.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.13 3.22 . . . . 0.0 112.081 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.71 -39.18 2.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.863 1.22 . . . . 0.0 113.093 -174.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.2 tp -78.21 -41.95 32.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.81 1.244 . . . . 0.0 111.529 174.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CE2' HG13 ' A' ' 64' ' ' VAL . 4.8 m-30 -83.16 94.51 7.87 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -168.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.404 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -73.36 66.14 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.189 1.796 . . . . 0.0 111.146 169.213 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.19 131.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 121.747 0.784 . . . . 0.0 110.756 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -138.0 147.62 44.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 0.0 109.017 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.48 130.33 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 119.894 -1.754 . . . . 0.0 109.916 174.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.04 93.21 7.24 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.447 0.699 . . . . 0.0 110.184 178.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 m -176.51 165.58 2.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.978 2.511 . . . . 0.0 108.69 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -72.43 111.08 7.3 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 170.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 124.999 1.32 . . . . 0.0 114.322 -171.801 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.58 167.67 20.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.779 2.431 . . . . 0.0 113.861 -175.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -103.49 175.11 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.291 1.436 . . . . 0.0 110.794 176.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -163.99 147.53 9.8 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.862 -1.149 . . . . 0.0 110.384 -169.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.28 161.98 41.4 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.198 1.399 . . . . 0.0 111.321 170.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.5 m -123.93 139.77 53.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.837 1.255 . . . . 0.0 110.218 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -140.79 136.99 33.02 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.722 1.209 . . . . 0.0 110.024 -174.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tt -119.44 132.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 120.82 -1.175 . . . . 0.0 110.424 177.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.0 106.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.16 1.384 . . . . 0.0 108.676 -175.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.45 98.91 11.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.764 1.269 . . . . 0.0 109.678 169.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.55 -13.42 1.38 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.672 1.606 . . . . 0.0 114.057 177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.401 ' SD ' ' SG ' ' A' ' 17' ' ' CYS 0.257 0.0 OUTLIER -77.07 132.65 39.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.85 1.325 . . . . 0.0 112.187 -176.779 . . . . . . . . 4 4 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -67.94 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 t 66.61 -53.9 0.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.197 2.599 . . . . 0.0 116.23 169.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -63.34 1.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.67 -1.269 . . . . 0.0 112.931 -178.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -59.07 -32.69 70.01 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 121.424 1.92 . . . . 0.0 114.221 -177.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 12' ' ' MET . 2.3 p -40.6 -58.17 1.67 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.217 1.807 . . . . 0.0 111.376 169.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -46.24 -54.19 2.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 127.541 2.336 . . . . 0.0 111.007 -176.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -64.02 -30.23 71.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.334 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -69.93 -46.91 64.32 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.89 0.768 . . . . 0.0 111.353 168.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -46.46 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.255 0.934 . . . . 0.0 110.645 -170.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -51.43 -48.86 62.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.113 1.365 . . . . 0.0 110.786 170.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -68.75 -52.19 33.16 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.9 m -69.32 -35.87 76.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.531 1.532 . . . . 0.0 110.567 -169.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 27' ' ' ALA . 7.4 mt -73.24 -48.94 30.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.057 168.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 t -70.96 13.65 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.739 2.063 . . . . 0.0 114.421 -171.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -109.94 -3.94 16.25 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.886 2.074 . . . . 0.0 111.398 173.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.99 125.86 29.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.11 -15.13 43.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.15 -11.57 35.25 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 169.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.7 p -94.68 137.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 121.586 1.994 . . . . 0.0 109.739 -173.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -105.38 -14.79 15.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.197 0.599 . . . . 0.0 112.491 -176.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -178.61 172.18 1.44 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.805 2.042 . . . . 0.0 112.288 -172.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -176.05 152.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 127.743 2.417 . . . . 0.0 109.29 -170.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.5 133.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 127.503 2.321 . . . . 0.0 107.236 167.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.54 141.77 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 123.247 1.499 . . . . 0.0 112.326 171.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -77.57 84.15 3.95 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.596 1.559 . . . . 0.0 109.384 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.09 -29.34 60.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.756 1.622 . . . . 0.0 114.191 -173.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' C ' HD21 ' A' ' 40' ' ' ASN . 17.8 mt-10 -88.4 -0.31 57.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.712 1.605 . . . . 0.0 114.325 176.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.403 HD21 ' C ' ' A' ' 39' ' ' GLU . 1.8 m-80 -135.67 -171.51 2.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.535 2.734 . . . . 0.0 110.411 -175.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER -111.24 33.72 4.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.022 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 p -132.66 155.74 48.23 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.019 -1.676 . . . . 0.0 115.505 -170.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.27 138.02 54.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.144 2.178 . . . . 0.0 110.107 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -108.79 115.91 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 170.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -118.73 136.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.133 1.373 . . . . 0.0 108.977 -167.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.66 104.29 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.758 1.223 . . . . 0.0 109.191 -169.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 34.5 p90 -120.23 161.82 20.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.016 . . . . 0.0 113.274 -171.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -92.5 122.75 35.24 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.982 -1.073 . . . . 0.0 110.921 -176.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.67 156.18 1.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.772 2.029 . . . . 0.0 110.604 174.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -87.43 24.25 1.69 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.151 0.981 . . . . 0.0 111.762 170.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -163.12 -178.82 6.25 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.755 -1.216 . . . . 0.0 113.514 -173.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -111.93 109.33 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.771 2.428 . . . . 0.0 108.927 -176.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.0 m -141.86 69.77 24.34 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 126.193 1.797 . . . . 0.0 109.186 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.93 -20.39 13.2 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.574 2.85 . . . . 0.0 113.109 -171.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -54.95 -32.67 61.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.057 1.343 . . . . 0.0 113.4 -176.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 m -73.65 -35.95 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.371 -1.456 . . . . 0.0 112.666 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.56 -44.58 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -50.7 -51.18 52.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.845 1.258 . . . . 0.0 111.201 172.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -39.55 79.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.643 1.177 . . . . 0.0 114.108 172.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 -36.33 80.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.929 1.24 . . . . 0.0 111.83 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.48 -51.67 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.763 -0.585 . . . . 0.0 109.718 170.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.69 -19.02 14.4 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.145 0.884 . . . . 0.0 112.844 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 1.2 57.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.413 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -92.22 -32.35 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.969 0.804 . . . . 0.0 111.014 175.581 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.46 69.12 11.33 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.355 0.662 . . . . 0.0 111.65 168.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.58 142.0 97.9 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.291 3.327 . . . . 0.0 112.785 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.42 -35.56 3.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.143 1.354 . . . . 0.0 113.066 -176.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.65 -43.78 16.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.718 1.607 . . . . 0.0 112.064 174.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.413 ' CE2' HG13 ' A' ' 64' ' ' VAL . 3.8 m-30 -80.66 105.08 11.63 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -167.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.14 75.37 8.12 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.618 -1.926 . . . . 0.0 112.927 169.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.43 126.26 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 121.25 -0.906 . . . . 0.0 112.849 -174.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -140.48 139.48 35.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.198 0.999 . . . . 0.0 111.608 -169.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.1 mt -85.41 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.659 -1.276 . . . . 0.0 109.176 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t -85.7 121.78 28.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.671 0.748 . . . . 0.0 109.281 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -158.1 166.79 31.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.197 2.199 . . . . 0.0 109.355 170.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -86.41 128.16 34.91 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 167.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 126.858 2.063 . . . . 0.0 110.5 -172.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 123.218 1.485 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.52 27.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.441 1.896 . . . . 0.0 110.491 167.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 t -94.7 -179.67 4.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.576 1.95 . . . . 0.0 110.987 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -158.88 145.96 17.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.287 1.435 . . . . 0.0 110.244 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.03 153.82 39.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.043 1.737 . . . . 0.0 111.07 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 m -117.69 139.52 50.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.913 177.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.98 144.97 41.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.941 1.296 . . . . 0.0 110.644 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.24 135.0 64.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.514 1.525 . . . . 0.0 110.282 178.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.59 123.51 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.969 1.308 . . . . 0.0 108.775 -171.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.67 146.48 27.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 164.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.61 -4.67 77.67 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.401 0.524 . . . . 0.0 112.559 -168.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.42 127.53 27.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.303 1.441 . . . . 0.0 112.118 174.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -64.98 41.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.664 1.986 . . . . 0.0 113.961 170.2 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 30.62 -110.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.961 3.305 . . . . 0.0 114.84 175.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -39.38 58.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 113.375 -179.013 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -83.12 -32.89 26.46 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.009 -1.057 . . . . 0.0 112.196 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 t -55.15 -49.08 72.72 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.972 1.26 . . . . 0.0 110.672 171.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -42.34 -50.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 124.489 1.118 . . . . 0.0 112.5 -179.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -69.3 -35.54 76.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -62.81 -45.24 93.54 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.756 -1.215 . . . . 0.0 111.005 169.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mm -67.45 -49.21 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.983 -170.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -43.97 -50.83 8.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.488 1.515 . . . . 0.0 109.539 170.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -71.63 -50.95 25.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -66.26 -42.55 88.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.26 1.424 . . . . 0.0 110.51 -176.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.08 -49.65 23.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.159 177.624 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 t -74.26 13.75 0.53 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.476 1.943 . . . . 0.0 113.302 -173.044 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.16 -3.1 18.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.733 1.613 . . . . 0.0 111.858 173.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.06 133.64 41.55 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.046 -1.034 . . . . 0.0 110.435 -172.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -59.5 2.98 0.05 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -174.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 -8.09 4.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.696 1.999 . . . . 0.0 114.717 174.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 8.7 p -88.24 139.21 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 121.369 1.895 . . . . 0.0 110.426 -169.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -99.92 -19.02 16.81 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m 178.75 171.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.094 1.758 . . . . 0.0 113.039 -172.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -168.13 152.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.857 2.063 . . . . 0.0 110.473 -174.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.21 148.76 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 128.383 2.673 . . . . 0.0 106.544 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.41 145.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.96 0.409 . . . . 0.0 110.85 175.568 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 m -91.59 125.52 36.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.582 0.705 . . . . 0.0 112.307 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -36.47 73.6 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.025 -1.047 . . . . 0.0 112.869 -176.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -104.15 -8.85 19.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.291 1.436 . . . . 0.0 114.732 -177.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -121.76 130.39 53.38 Favored 'General case' 0 C--O 1.221 -0.431 0 O-C-N 120.264 -1.523 . . . . 0.0 107.108 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 35.12 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 p -128.23 152.5 48.01 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -172.745 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.48 137.53 54.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.956 2.502 . . . . 0.0 110.491 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.3 mt -110.66 117.18 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.42 130.67 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.503 1.121 . . . . 0.0 109.041 -167.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.01 108.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.378 1.471 . . . . 0.0 108.555 -167.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 21.6 p90 -128.3 145.67 50.99 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.29 1.405 . . . . 0.0 113.844 -168.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -97.24 107.92 20.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.304 -1.498 . . . . 0.0 112.11 -172.139 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.46 148.46 0.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.587 1.555 . . . . 0.0 111.411 -170.805 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 m -93.08 17.26 11.15 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.036 -1.04 . . . . 0.0 112.895 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p -124.51 135.22 53.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.783 -1.198 . . . . 0.0 113.347 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.3 t -73.53 98.58 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 166.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 m -144.47 54.16 2.55 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.078 0.951 . . . . 0.0 109.949 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.98 -17.14 58.62 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.945 2.43 . . . . 0.0 111.991 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 55' ' ' GLU . 17.0 mp0 -64.54 -8.96 15.85 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.461 1.504 . . . . 0.0 112.26 173.261 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 p -79.17 -51.87 8.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.787 1.176 . . . . 0.0 111.906 169.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 87.6 mt -64.79 -41.55 95.73 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.774 -1.107 . . . . 0.0 110.639 176.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -53.4 15.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.498 1.045 . . . . 0.0 111.545 172.064 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -37.69 72.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.36 1.464 . . . . 0.0 113.518 175.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.13 84.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.369 1.44 . . . . 0.0 112.085 175.151 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.26 -56.74 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.455 0.702 . . . . 0.0 110.758 171.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -53.41 -27.33 23.82 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 123.801 0.84 . . . . 0.0 111.534 176.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.42 1.98 38.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -27.94 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.726 0.81 . . . . 0.0 111.643 175.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.77 69.1 9.23 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.082 0.953 . . . . 0.0 110.644 169.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.34 145.3 98.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.257 3.305 . . . . 0.0 112.489 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.06 -40.83 2.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.961 1.267 . . . . 0.0 113.013 -174.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.82 -55.4 5.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.436 1.494 . . . . 0.0 111.062 177.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -71.5 107.76 4.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -169.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -78.89 47.68 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.226 1.811 . . . . 0.0 113.761 176.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.3 126.95 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.972 0.909 . . . . 0.0 111.076 -168.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 m -139.58 148.52 42.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.649 -175.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.67 124.28 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.692 -1.255 . . . . 0.0 109.758 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.71 106.99 18.89 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.694 0.798 . . . . 0.0 109.608 -175.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 m 175.67 -25.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 127.934 2.494 . . . . 0.0 114.507 174.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -75.92 85.61 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 122.709 1.242 . . . . 0.0 108.919 176.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.141 170.697 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 124.032 1.873 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -55.76 129.6 39.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.934 2.094 . . . . 0.0 109.732 165.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -102.07 -175.25 2.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.88 1.672 . . . . 0.0 109.751 172.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -158.77 150.76 21.21 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.845 -1.159 . . . . 0.0 109.893 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.06 156.01 40.2 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.996 1.719 . . . . 0.0 109.864 173.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.0 m -127.26 138.58 53.11 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.996 0.919 . . . . 0.0 109.453 -178.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -136.53 144.85 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.413 1.085 . . . . 0.0 111.303 -174.106 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 tt -122.38 140.87 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 125.205 1.402 . . . . 0.0 109.19 175.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.18 153.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.683 1.193 . . . . 0.0 108.639 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.26 144.66 50.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.413 0.285 . . . . 0.0 110.971 164.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.77 -1.67 68.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.22 1.39 . . . . 0.0 112.504 -174.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.49 165.91 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.514 1.525 . . . . 0.0 114.338 -171.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.57 ' CE1' ' HG ' ' A' ' 65' ' ' SER . 0.2 OUTLIER -73.55 37.23 0.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 125.022 1.329 . . . . 0.0 113.76 -179.021 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 t 52.39 -143.09 0.72 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.632 1.573 . . . . 0.0 111.7 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 29.5 mttp -61.23 -13.87 21.65 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.196 -1.565 . . . . 0.0 114.273 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -91.79 -11.83 35.52 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.051 -1.656 . . . . 0.0 112.268 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -48.09 77.8 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.643 1.111 . . . . 0.0 108.179 168.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -40.45 -56.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 130.392 3.477 . . . . 0.0 111.937 -177.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -38.27 90.47 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 120.888 0.375 . . . . 0.0 111.808 -173.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -60.81 -41.49 95.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.831 -1.168 . . . . 0.0 112.412 168.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 -47.38 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.731 -171.699 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.68 -51.53 15.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.746 1.618 . . . . 0.0 109.307 169.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -70.55 -44.26 67.82 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.6 m -70.55 -40.68 73.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.769 1.228 . . . . 0.0 110.5 -175.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.43 -44.89 57.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.224 178.679 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t -70.38 13.36 0.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 120.416 1.462 . . . . 0.0 113.813 -176.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -105.03 -6.84 19.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.399 1.48 . . . . 0.0 111.95 174.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.26 129.0 34.54 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.063 -1.023 . . . . 0.0 110.327 -169.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.72 -25.07 25.17 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -5.13 48.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 174.044 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.254 5.0 p -92.55 134.73 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 121.606 2.003 . . . . 0.0 110.314 -173.261 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 t -93.3 -27.39 16.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.383 1.473 . . . . 0.0 111.796 -176.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -178.06 175.91 1.2 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.959 2.104 . . . . 0.0 112.409 -171.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -172.75 151.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.748 2.019 . . . . 0.0 109.724 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.58 141.37 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 126.901 2.08 . . . . 0.0 105.782 166.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.37 137.84 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.681 1.229 . . . . 0.0 110.46 169.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.0 m -75.92 83.11 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.45 176.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.418 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 2.5 tm? -43.49 -42.91 5.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.509 2.324 . . . . 0.0 112.314 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -47.61 84.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.345 1.069 . . . . 0.0 112.29 178.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -98.43 -171.48 2.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.99 2.516 . . . . 0.0 112.031 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.98 29.56 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.081 2.552 . . . . 0.0 113.309 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 p -144.81 158.64 43.72 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.012 -1.68 . . . . 0.0 115.406 -167.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.41 51.76 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.103 2.161 . . . . 0.0 110.774 -173.299 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.77 110.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.3 t -116.67 130.46 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.19 1.396 . . . . 0.0 108.141 -168.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.87 106.46 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 107.813 -168.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.1 p90 -127.25 147.15 50.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.588 1.155 . . . . 0.0 113.617 -168.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -89.03 141.48 28.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.284 -1.51 . . . . 0.0 112.172 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.26 172.7 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.754 1.622 . . . . 0.0 110.495 -179.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.3 p -98.24 10.04 41.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.229 167.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.1 m -153.24 158.25 41.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.684 1.194 . . . . 0.0 111.373 -168.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.85 110.84 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 167.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -145.85 80.7 10.35 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.007 0.923 . . . . 0.0 109.649 -171.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -89.63 -17.07 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.898 3.065 . . . . 0.0 114.66 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' CD ' ' HZ3' ' A' ' 59' ' ' LYS . 3.3 tm-20 -64.16 -32.78 74.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.745 1.157 . . . . 0.0 112.913 -168.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -74.51 -28.43 60.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.065 0.946 . . . . 0.0 112.984 -178.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.81 -47.58 58.69 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.407 170.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -45.34 -53.68 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.142 0.883 . . . . 0.0 110.761 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' HZ3' ' CD ' ' A' ' 55' ' ' GLU . 0.6 OUTLIER -56.96 -37.54 71.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.65 78.48 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.423 1.465 . . . . 0.0 111.892 172.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.23 -50.74 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.263 0.625 . . . . 0.0 110.029 173.294 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -58.37 -19.36 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.429 -1.419 . . . . 0.0 112.486 174.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.31 0.43 56.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 174.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.422 ' CG1' ' CE2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -89.63 -37.39 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 118.997 0.817 . . . . 0.0 110.967 173.186 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.57 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -140.35 70.51 33.11 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.964 0.412 . . . . 0.0 111.718 169.846 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.32 134.82 61.35 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.433 3.422 . . . . 0.0 111.909 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 -17.2 27.47 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.095 1.331 . . . . 0.0 114.167 -174.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 tp -105.25 -23.82 12.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.686 1.594 . . . . 0.0 112.532 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.422 ' CE2' ' CG1' ' A' ' 64' ' ' VAL . 2.8 m-30 -102.61 111.29 23.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.24 45.71 0.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 119.578 -1.951 . . . . 0.0 114.851 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.75 124.06 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -166.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -141.11 155.65 46.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.827 1.651 . . . . 0.0 109.451 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.89 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.411 -1.43 . . . . 0.0 107.369 176.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 t -110.75 57.56 0.62 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.38 1.072 . . . . 0.0 112.411 -169.129 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -165.22 33.82 0.06 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.976 1.31 . . . . 0.0 113.162 -173.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.22 31.63 5.55 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.663 1.22 . . . . 0.0 109.804 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.477 0.921 0 C-N-CA 126.171 1.789 . . . . 0.0 111.239 -176.965 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -87.11 -172.17 3.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.799 2.44 . . . . 0.0 113.702 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t -124.67 169.58 11.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.682 1.23 . . . . 0.0 111.692 168.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -146.84 146.64 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.754 1.222 . . . . 0.0 109.832 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.98 37.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.105 1.762 . . . . 0.0 110.699 174.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.1 m -133.71 142.91 48.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.156 0.982 . . . . 0.0 110.871 -175.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -145.16 140.1 27.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.321 1.448 . . . . 0.0 111.072 -168.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.53 131.7 60.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 O-C-N 120.744 -1.222 . . . . 0.0 111.899 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.36 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.003 2.121 . . . . 0.0 109.982 -169.35 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.43 4.14 6.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.08 1.752 . . . . 0.0 114.34 178.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.41 27.04 3.62 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 126.252 1.882 . . . . 0.0 110.577 -178.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -77.8 138.95 39.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.748 0.819 . . . . 0.0 109.599 179.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -53.81 -43.13 69.11 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p 172.17 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -140.98 -50.27 0.44 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 127.117 2.167 . . . . 0.0 110.771 -167.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -26.59 61.33 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.132 -2.23 . . . . 0.0 112.8 171.273 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.5 m -57.36 -39.18 75.44 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.718 170.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -47.89 -46.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.702 2.001 . . . . 0.0 111.564 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -67.51 -40.35 85.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.916 1.686 . . . . 0.0 113.605 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -61.33 -36.92 81.47 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.885 -1.134 . . . . 0.0 112.047 172.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -46.34 85.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -49.13 73.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 111.665 170.768 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -65.67 -41.86 92.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -177.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.0 m -69.3 -47.8 63.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.886 0.874 . . . . 0.0 110.79 177.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.58 -24.87 53.52 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 117.716 -1.135 . . . . 0.0 113.947 -177.386 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 t -81.64 11.53 4.65 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 121.144 1.793 . . . . 0.0 112.47 177.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.73 7.07 9.4 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -169.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 30' ' ' TYR . 13.6 mt -85.54 151.84 23.62 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.025 -1.047 . . . . 0.0 112.173 -169.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -67.13 22.95 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.467 2.307 . . . . 0.0 114.396 178.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -166.51 19.64 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.625 2.37 . . . . 0.0 112.868 -178.343 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 14.5 p -125.05 136.22 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.827 1.649 . . . . 0.0 112.726 177.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -118.28 -3.26 11.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -177.31 174.02 1.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.315 2.246 . . . . 0.0 111.914 176.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -172.99 154.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.67 2.788 . . . . 0.0 108.421 -172.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -145.98 123.24 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 C-N-CA 126.2 1.8 . . . . 0.0 107.522 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.71 149.67 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.171 172.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -73.54 124.31 25.64 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.46 1.504 . . . . 0.0 108.816 166.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -40.41 30.5 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.03 -51.6 30.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.888 2.475 . . . . 0.0 112.772 -173.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -88.87 -174.81 4.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.588 1.955 . . . . 0.0 112.398 169.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.2 43.56 1.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.31 1.444 . . . . 0.0 111.397 177.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 p -131.99 160.23 36.45 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.344 -2.097 . . . . 0.0 114.774 -168.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.54 136.94 33.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.092 1.357 . . . . 0.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -105.09 115.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.419 2.287 . . . . 0.0 105.425 171.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.9 t -111.55 129.49 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.011 1.724 . . . . 0.0 108.537 -169.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.3 t -109.2 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.063 1.345 . . . . 0.0 108.174 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -101.3 132.57 46.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.043 1.737 . . . . 0.0 111.481 -170.461 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.286 2.8 p30 -90.02 79.99 6.45 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.485 1.136 . . . . 0.0 110.508 -167.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -165.02 -178.13 5.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.878 -167.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 p -162.9 -61.34 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 45.51 0.2 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.255 1.822 . . . . 0.0 112.837 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 163.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.966 1.307 . . . . 0.0 110.404 -176.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -100.71 148.04 34.47 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.25 -175.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.2 -9.84 26.55 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.459 2.773 . . . . 0.0 112.614 167.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -54.37 -36.84 64.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.617 1.099 . . . . 0.0 112.118 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -67.6 -33.37 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.09 -1.006 . . . . 0.0 112.907 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 68.1 mt -76.18 -43.92 40.43 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.577 0.751 . . . . 0.0 111.343 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.06 -47.2 65.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.411 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -45.08 74.88 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.094 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -33.18 73.95 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.049 1.295 . . . . 0.0 111.653 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.74 -54.04 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.284 0.633 . . . . 0.0 110.524 172.632 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -49.42 -33.75 14.79 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.686 0.794 . . . . 0.0 111.39 175.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.34 0.75 27.71 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -96.53 -27.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.151 1.381 . . . . 0.0 111.579 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.62 64.21 7.62 Favored Pre-proline 0 CA--C 1.549 0.912 0 O-C-N 121.689 -0.632 . . . . 0.0 111.498 168.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.21 144.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.29 3.327 . . . . 0.0 112.912 -172.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.67 -18.02 9.73 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.577 1.084 . . . . 0.0 113.975 -175.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.65 -47.36 3.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.979 1.711 . . . . 0.0 110.6 177.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.421 ' CE2' HG13 ' A' ' 64' ' ' VAL . 2.9 m-30 -66.38 107.28 1.97 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -175.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 75.36 4.72 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.419 -1.425 . . . . 0.0 109.887 169.123 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.16 129.79 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.458 -0.777 . . . . 0.0 111.464 -176.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.59 38.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.387 1.075 . . . . 0.0 110.634 -171.732 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.22 112.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.806 -1.184 . . . . 0.0 108.888 170.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -111.67 128.43 56.06 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.57 1.148 . . . . 0.0 108.896 168.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -132.71 168.0 19.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.537 1.535 . . . . 0.0 112.663 175.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -74.58 83.4 2.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.57 1.176 . . . . 0.0 108.943 169.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.475 0.822 0 C-N-CA 127.242 2.217 . . . . 0.0 109.72 168.914 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.704 0.764 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.82 158.93 32.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.44 3.096 . . . . 0.0 111.406 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 t -125.09 -177.74 3.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.454 1.102 . . . . 0.0 110.182 167.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -164.07 151.54 12.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.15 0.98 . . . . 0.0 109.989 -169.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.63 158.86 44.05 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.284 1.434 . . . . 0.0 111.216 171.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.4 m -120.86 140.04 52.33 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.931 1.293 . . . . 0.0 109.672 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.85 151.61 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.608 1.163 . . . . 0.0 111.176 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -134.77 140.03 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.948 1.299 . . . . 0.0 110.717 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.8 140.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.631 1.572 . . . . 0.0 110.907 -173.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . 0.262 0.4 OUTLIER -123.27 145.78 48.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 165.818 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.41 54.91 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.744 1.164 . . . . 0.0 112.708 -171.245 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.22 153.04 23.86 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.824 1.65 . . . . 0.0 111.378 -171.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -77.99 32.25 0.17 Allowed 'General case' 0 CA--C 1.556 1.203 0 O-C-N 119.711 -1.868 . . . . 0.0 114.519 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t 66.31 -71.6 0.09 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.129 2.172 . . . . 0.0 114.886 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 39' ' ' GLU . 10.5 mptt -108.31 -38.4 5.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 112.944 177.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 p -74.25 -21.47 59.76 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 119.425 -2.047 . . . . 0.0 112.79 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.6 p -51.17 -51.63 51.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.487 1.04 . . . . 0.0 110.073 169.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -46.35 -55.54 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 128.042 2.537 . . . . 0.0 112.234 -174.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -40.17 95.63 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 123.441 0.463 . . . . 0.0 111.585 -171.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -57.64 -46.49 84.1 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.699 -0.625 . . . . 0.0 112.401 169.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -44.51 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 118.721 -0.657 . . . . 0.0 109.842 -172.317 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.22 -49.28 67.1 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.247 0.967 . . . . 0.0 110.286 171.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -70.41 -41.31 73.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.491 ' HG1' HG22 ' A' ' 64' ' ' VAL . 36.8 m -76.92 -36.43 56.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.833 1.253 . . . . 0.0 111.255 -175.008 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -73.23 -45.91 53.25 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.75 172.077 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -72.17 16.24 0.14 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 121.483 1.947 . . . . 0.0 114.206 -172.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 25' ' ' LEU . . . -109.93 -7.52 14.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.12 1.768 . . . . 0.0 112.311 174.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.32 133.58 45.07 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.922 -1.111 . . . . 0.0 110.448 -169.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.5 -0.04 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -170.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.89 -10.36 11.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.412 1.485 . . . . 0.0 114.855 169.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -89.4 138.97 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 121.088 1.767 . . . . 0.0 110.362 -169.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -99.24 -34.71 10.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 112.242 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -158.76 160.33 36.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.342 1.057 . . . . 0.0 110.644 -165.432 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.75 152.21 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.632 1.573 . . . . 0.0 109.8 174.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.62 129.98 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 C-N-CA 126.449 1.9 . . . . 0.0 107.449 167.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.6 t -101.72 143.71 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 123.399 1.571 . . . . 0.0 111.826 171.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -78.19 87.09 4.29 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.028 174.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.418 HD12 ' HE3' ' A' ' 15' ' ' LYS . 1.1 tm? -44.87 -42.51 8.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.959 2.504 . . . . 0.0 113.417 -177.003 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 15' ' ' LYS . 71.6 mm-40 -81.92 -8.87 59.71 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.406 HD21 ' C ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -131.17 -173.82 3.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.969 2.508 . . . . 0.0 109.347 -169.761 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 30.05 7.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.927 1.291 . . . . 0.0 113.525 -175.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 p -131.82 160.69 34.89 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.08 140.79 48.96 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.473 1.909 . . . . 0.0 110.658 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.17 114.25 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 t -116.26 131.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.541 1.536 . . . . 0.0 107.482 -169.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 57.4 t -120.52 107.89 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 -168.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 42.7 p90 -127.54 148.37 50.34 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.061 -1.024 . . . . 0.0 112.981 -168.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.5 136.37 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.114 0.966 . . . . 0.0 110.795 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.74 144.4 0.27 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.97 1.308 . . . . 0.0 111.355 -172.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -74.2 -37.26 63.95 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.432 0.56 . . . . 0.0 109.739 166.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.4 t -178.95 162.25 1.25 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.508 3.123 . . . . 0.0 108.219 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p 172.37 164.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 129.029 2.931 . . . . 0.0 107.524 -169.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.9 t -76.95 133.28 69.68 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.866 173.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -59.95 -21.15 63.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.922 2.414 . . . . 0.0 110.589 168.202 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -67.95 -10.26 51.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.78 1.173 . . . . 0.0 113.563 178.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 p -61.58 -45.15 95.35 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.789 -1.194 . . . . 0.0 112.1 168.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 77.4 mt -71.12 -42.89 68.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.642 175.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.78 -46.99 51.32 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.431 172.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -62.22 -38.09 87.86 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.96 76.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.699 1.59 . . . . 0.0 111.783 173.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -68.28 -54.7 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.139 0.576 . . . . 0.0 110.905 171.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -55.75 -22.52 24.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.159 0.891 . . . . 0.0 112.615 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.42 5.31 42.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.491 HG22 ' HG1' ' A' ' 24' ' ' THR . 0.3 OUTLIER -97.22 -30.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 173.187 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.405 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -144.2 64.83 12.9 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.732 -0.605 . . . . 0.0 111.666 168.795 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.79 138.39 82.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.232 3.288 . . . . 0.0 112.431 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.12 -22.29 5.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.466 1.031 . . . . 0.0 113.662 -175.502 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 tp -93.41 -54.07 3.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.477 1.511 . . . . 0.0 110.133 173.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.411 ' CE2' HG11 ' A' ' 64' ' ' VAL . 4.7 m-30 -70.09 117.0 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.045 1.738 . . . . 0.0 114.048 -177.482 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -111.68 139.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 119.363 0.983 . . . . 0.0 112.672 -173.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -144.63 160.04 41.82 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.824 1.25 . . . . 0.0 112.764 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.41 119.84 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.99 1.716 . . . . 0.0 107.469 173.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 106.56 18.4 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -175.081 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.8 m -159.44 175.29 13.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.702 1.201 . . . . 0.0 112.647 -176.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 121.75 21.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.261 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 127.776 2.43 . . . . 0.0 108.226 169.697 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 CA--C 1.549 0.94 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.37 148.78 31.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.898 1.679 . . . . 0.0 112.934 169.492 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -112.96 176.73 4.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.127 2.171 . . . . 0.0 110.853 -177.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.408 ' HG1' ' HA ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -154.66 163.33 40.4 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 120.623 -1.298 . . . . 0.0 111.548 178.915 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.03 159.09 44.54 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.132 1.373 . . . . 0.0 110.187 169.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.9 154.59 26.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 110.435 172.025 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -150.61 141.81 23.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.822 -1.536 . . . . 0.0 110.738 -176.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 tt -126.62 140.05 50.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.095 1.358 . . . . 0.0 110.289 177.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.3 98.39 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 126.478 1.911 . . . . 0.0 109.515 -170.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 65.26 7.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 123.534 1.635 . . . . 0.0 113.876 -169.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.99 0.11 Allowed Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 174.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 tmm? 45.08 -149.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.272 1.429 . . . . 0.0 109.56 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -120.53 -33.06 3.92 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.407 -1.433 . . . . 0.0 111.386 167.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 p 161.76 -72.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.927 2.091 . . . . 0.0 113.589 178.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HZ3' ' CD ' ' A' ' 39' ' ' GLU . 20.0 tptt -144.31 -57.38 0.37 Allowed 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.241 1.017 . . . . 0.0 109.815 -168.151 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -30.77 28.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.016 -1.678 . . . . 0.0 113.478 171.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.454 ' HA ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -57.61 -41.48 81.37 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.695 172.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -51.07 -42.73 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.834 1.653 . . . . 0.0 112.034 -176.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.6 t -71.09 -37.47 72.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.933 1.293 . . . . 0.0 113.277 178.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 17' ' ' CYS . 85.3 m-20 -60.24 -36.97 78.96 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.024 -1.048 . . . . 0.0 112.291 170.337 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -48.23 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.925 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -54.81 -51.91 64.34 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 124.044 0.84 . . . . 0.0 111.624 170.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -61.46 -41.28 96.99 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -68.41 -49.15 62.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.761 1.224 . . . . 0.0 110.189 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.74 -15.76 60.23 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.405 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -76.26 -3.07 34.6 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 173.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.49 7.68 11.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -166.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' C ' ' H ' ' A' ' 30' ' ' TYR . 18.6 mt -79.35 152.29 30.52 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.165 -0.96 . . . . 0.0 112.599 -169.392 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -67.79 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.403 2.281 . . . . 0.0 114.501 -177.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -166.45 2.02 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.508 2.323 . . . . 0.0 114.341 -175.756 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 14.6 p -105.24 139.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 121.876 2.125 . . . . 0.0 111.307 -174.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 t -111.19 -11.62 14.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.07 175.03 1.98 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.175 1.79 . . . . 0.0 112.08 -175.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -175.55 152.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.041 2.536 . . . . 0.0 109.968 -171.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -147.88 134.57 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.86 2.464 . . . . 0.0 107.5 166.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p -107.14 151.74 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 122.142 0.973 . . . . 0.0 113.174 170.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -90.15 102.75 15.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.58 0.752 . . . . 0.0 111.257 170.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.466 HD23 ' HE3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -57.81 -35.54 70.99 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.255 1.422 . . . . 0.0 113.401 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' CD ' ' HZ3' ' A' ' 15' ' ' LYS . 20.6 mm-40 -91.99 5.55 49.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.152 1.381 . . . . 0.0 113.874 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -119.34 -173.94 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.951 1.7 . . . . 0.0 109.527 169.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 42.81 2.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.082 -1.011 . . . . 0.0 111.057 168.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -146.22 151.81 38.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -168.149 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.26 41.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.591 2.356 . . . . 0.0 112.055 -169.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.63 118.71 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.588 1.955 . . . . 0.0 106.544 174.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.77 120.35 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.756 1.622 . . . . 0.0 109.323 -167.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HA ' ' HG1' ' A' ' 4' ' ' THR . 94.2 t -107.06 107.78 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.854 1.662 . . . . 0.0 109.548 -169.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 38.7 p90 -121.0 158.32 28.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.041 1.336 . . . . 0.0 113.515 -171.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -96.21 101.07 12.66 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.397 -1.439 . . . . 0.0 112.902 -168.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.79 150.87 5.92 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.779 1.632 . . . . 0.0 109.712 173.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 m -83.81 27.64 0.63 Allowed 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.069 -1.019 . . . . 0.0 110.772 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -162.89 -175.37 4.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.895 -1.128 . . . . 0.0 113.12 -170.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.43 137.83 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.433 2.293 . . . . 0.0 111.232 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -171.05 87.38 0.48 Allowed Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 128.6 2.76 . . . . 0.0 106.917 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.04 -18.78 1.35 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.999 2.466 . . . . 0.0 113.871 -171.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -61.7 -32.06 72.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.949 1.25 . . . . 0.0 113.001 -174.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.28 64.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.924 -1.735 . . . . 0.0 113.416 -178.098 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.2 mt -78.76 -46.42 18.9 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.898 -0.501 . . . . 0.0 110.145 173.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -46.87 -49.63 19.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.603 0.761 . . . . 0.0 110.124 169.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -58.32 -41.16 83.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 113.734 176.074 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.26 73.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.38 0.991 . . . . 0.0 112.18 172.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mt -70.84 -54.41 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.322 0.649 . . . . 0.0 110.557 172.708 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -55.03 -23.14 18.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.498 1.119 . . . . 0.0 112.52 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.65 4.25 37.29 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -98.83 -39.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.781 0.833 . . . . 0.0 111.582 -179.009 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -139.84 64.77 29.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.943 -0.473 . . . . 0.0 112.053 166.816 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.77 143.17 81.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 124.297 3.331 . . . . 0.0 114.189 -171.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.97 -43.41 3.24 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 125.438 1.494 . . . . 0.0 112.414 -175.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.47 -39.22 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.686 1.194 . . . . 0.0 110.524 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.2 m-85 -71.76 89.98 1.06 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.162 -0.961 . . . . 0.0 112.895 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -74.96 76.18 2.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.315 1.446 . . . . 0.0 110.098 169.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 t -92.05 133.69 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.952 -1.092 . . . . 0.0 111.785 -169.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -151.28 159.21 44.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.95 1.357 . . . . 0.0 111.289 168.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.66 130.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 166.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t -110.11 121.1 44.48 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.3 t -146.45 -179.28 6.65 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.209 1.404 . . . . 0.0 111.397 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -71.66 61.4 0.37 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.924 2.089 . . . . 0.0 111.556 174.224 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.444 . . . . 0.0 111.344 171.525 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 122.834 1.302 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -82.46 159.42 22.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.712 0.767 . . . . 0.0 110.915 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -152.82 153.35 32.95 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.954 -1.092 . . . . 0.0 108.284 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.5 39.91 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.094 1.758 . . . . 0.0 110.763 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 m -126.16 141.1 52.07 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.586 1.154 . . . . 0.0 109.842 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -140.28 136.4 33.24 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.66 135.69 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 C-N-CA 125.07 1.348 . . . . 0.0 110.57 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.84 129.34 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.403 1.081 . . . . 0.0 111.07 -172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.43 129.62 46.42 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.662 -0.649 . . . . 0.0 109.547 163.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 -1.67 28.42 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.852 1.215 . . . . 0.0 113.554 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.0 ptm -65.35 149.0 50.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.033 0.917 . . . . 0.0 113.087 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -73.64 33.78 0.08 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.48 1.512 . . . . 0.0 112.999 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t 66.3 -143.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.399 1.48 . . . . 0.0 111.301 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HE3' HD13 ' A' ' 38' ' ' LEU . 46.4 mttp -61.72 -14.68 34.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.652 1.981 . . . . 0.0 115.576 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.0 p -91.74 -41.51 10.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.04 168.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.37 -49.32 70.09 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 121.53 1.968 . . . . 0.0 109.62 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -36.05 -48.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.797 2.039 . . . . 0.0 112.91 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -83.4 -25.36 31.39 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -58.0 -35.54 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 119.91 -1.744 . . . . 0.0 110.138 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -43.15 78.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 CA-C-O 117.531 -1.223 . . . . 0.0 110.424 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -50.4 -51.04 49.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.664 0.786 . . . . 0.0 110.145 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -69.77 -42.14 74.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -70.87 -41.09 71.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 110.714 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -46.1 46.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.554 -1.212 . . . . 0.0 111.668 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -72.62 14.74 0.23 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.465 1.484 . . . . 0.0 113.579 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.97 -2.79 18.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.411 1.484 . . . . 0.0 112.187 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.25 130.58 35.3 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 111.332 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -58.99 -2.84 0.28 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.646 1.578 . . . . 0.0 115.25 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 -3.4 11.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.608 1.963 . . . . 0.0 115.942 172.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -95.16 144.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.197 1.817 . . . . 0.0 110.523 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -99.0 -27.77 13.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.87 1.668 . . . . 0.0 111.789 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m 176.79 176.67 0.31 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.898 2.079 . . . . 0.0 112.802 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -172.27 150.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.967 2.107 . . . . 0.0 110.493 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.73 134.64 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.074 2.15 . . . . 0.0 106.869 166.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.04 141.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.052 0.93 . . . . 0.0 110.468 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 m -76.44 84.37 3.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.659 1.183 . . . . 0.0 110.046 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.3 tm? -51.93 -43.35 63.4 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 113.07 -167.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.36 -41.89 94.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.479 0.712 . . . . 0.0 112.319 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -100.72 -170.74 1.9 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.313 3.445 . . . . 0.0 112.98 -169.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.21 32.61 4.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.052 2.141 . . . . 0.0 114.473 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.8 p -137.23 166.02 24.76 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.17 -1.581 . . . . 0.0 114.114 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.07 142.64 40.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.438 1.895 . . . . 0.0 110.649 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -108.74 117.36 54.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.4 t -120.81 131.83 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.164 1.386 . . . . 0.0 108.336 -167.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.48 110.86 32.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.445 1.498 . . . . 0.0 107.724 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.515 ' CD1' HD11 ' A' ' 57' ' ' LEU . 13.9 p90 -121.88 -165.28 1.24 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.565 1.546 . . . . 0.0 111.351 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.479 0.992 0 CA-C-N 122.269 2.304 . . . . 0.0 114.119 178.004 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo . . . . . 0 CA--C 1.54 0.779 0 N-CA-C 113.872 0.681 . . . . 0.0 113.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.91 -31.17 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.437 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.4 p -70.37 -38.87 74.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.552 -1.342 . . . . 0.0 112.818 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.1 mt -69.99 -43.97 70.33 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.564 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -50.52 -50.95 51.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.578 1.151 . . . . 0.0 110.768 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -37.39 74.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.332 1.453 . . . . 0.0 113.801 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.5 73.87 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.582 1.083 . . . . 0.0 111.636 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -68.37 -51.47 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.131 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -49.4 -35.77 20.03 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.618 0.645 . . . . 0.0 111.377 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.03 5.2 8.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -100.03 -26.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.003 1.321 . . . . 0.0 111.577 176.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.97 68.29 8.8 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 167.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.38 144.25 90.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.09 3.193 . . . . 0.0 112.717 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 -25.02 3.98 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.736 1.16 . . . . 0.0 113.392 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.18 -45.09 8.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.283 1.433 . . . . 0.0 111.948 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -75.02 109.65 8.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -169.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -86.55 81.7 8.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.5 t -87.51 124.66 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.758 0.823 . . . . 0.0 112.641 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.76 131.59 43.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.177 0.991 . . . . 0.0 111.862 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.45 83.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.656 -1.278 . . . . 0.0 110.796 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 124.724 1.21 . . . . 0.0 111.472 -179.181 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 CA-C-O 122.062 0.934 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -93.8 174.4 7.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.093 0.949 . . . . 0.0 110.018 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -165.13 148.32 8.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.017 -1.052 . . . . 0.0 110.478 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.08 31.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.569 1.548 . . . . 0.0 110.94 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -134.03 143.2 47.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 109.613 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -143.07 149.35 38.07 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.414 1.486 . . . . 0.0 111.724 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -133.46 136.75 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 125.301 1.44 . . . . 0.0 110.959 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.38 90.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.188 2.195 . . . . 0.0 109.606 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.14 39.01 0.3 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.179 1.392 . . . . 0.0 113.452 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.48 40.11 0.18 Allowed Glycine 0 N--CA 1.469 0.844 0 C-N-CA 125.763 1.649 . . . . 0.0 112.638 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 4.4 tmm? -102.72 150.11 23.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.671 1.588 . . . . 0.0 111.743 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -66.59 9.22 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m 81.91 -54.11 0.25 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.276 3.03 . . . . 0.0 114.572 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.624 ' HE2' HD13 ' A' ' 38' ' ' LEU 0.29 50.8 mttt -125.42 -57.1 1.49 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.667 1.121 . . . . 0.0 112.656 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -65.37 -13.54 58.83 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.333 -2.105 . . . . 0.0 113.903 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' HG2' ' A' ' 12' ' ' MET 0.275 1.2 m -71.76 -36.06 70.28 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.668 168.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.8 t -47.11 -48.85 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.308 1.843 . . . . 0.0 111.83 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -63.83 -42.39 97.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.315 1.446 . . . . 0.0 113.091 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -59.48 -34.77 72.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.122 -1.611 . . . . 0.0 113.014 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -41.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.573 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -52.45 -54.51 31.37 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 167.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.7 t -69.95 -38.24 76.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -75.22 -37.17 61.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 110.594 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.01 -51.16 16.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.749 -1.119 . . . . 0.0 112.866 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -71.8 11.86 0.46 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.28 1.4 . . . . 0.0 113.866 -169.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.87 -1.5 19.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.861 1.664 . . . . 0.0 112.591 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -77.39 134.31 38.47 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 120.789 -1.195 . . . . 0.0 111.589 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.22 72.39 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 109.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 159.73 -20.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.804 3.642 . . . . 0.0 113.676 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -91.12 144.63 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 121.933 2.152 . . . . 0.0 109.749 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 t -114.96 -7.9 12.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m 178.76 172.84 0.75 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.914 2.086 . . . . 0.0 112.971 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -171.4 152.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.173 2.189 . . . . 0.0 110.077 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.4 150.53 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 128.712 2.805 . . . . 0.0 106.614 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.82 151.02 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.952 0.501 . . . . 0.0 110.942 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -82.57 135.78 34.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.166 0.587 . . . . 0.0 111.209 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.624 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.3 tm? -76.18 -33.99 59.33 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 121.098 -1.001 . . . . 0.0 112.083 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.77 -55.78 3.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.237 1.415 . . . . 0.0 111.917 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -76.99 138.1 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.551 0.74 . . . . 0.0 109.467 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 40.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 p -141.47 152.7 44.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.42 1.488 . . . . 0.0 114.627 -169.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.86 143.01 50.59 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.217 2.207 . . . . 0.0 111.105 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.11 120.16 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 127.199 2.2 . . . . 0.0 105.716 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 t -125.61 134.56 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.124 0.969 . . . . 0.0 109.96 -166.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 110.28 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.132 1.373 . . . . 0.0 108.863 -168.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' CD1' HD11 ' A' ' 57' ' ' LEU . 44.3 p90 -123.16 168.34 12.54 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.42 1.088 . . . . 0.0 113.853 -170.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 CA--C 1.534 0.34 0 O-C-N 120.551 -1.343 . . . . 0.0 110.406 -172.15 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.539 0.77 0 CA-C-O 119.468 -0.305 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.08 -30.3 70.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -74.25 -39.94 62.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.599 1.16 . . . . 0.0 113.668 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.7 mt -66.2 -43.84 85.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.285 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -49.33 -56.39 9.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.123 0.874 . . . . 0.0 110.459 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.85 -39.5 39.25 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.56 72.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.57 1.077 . . . . 0.0 111.803 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.91 -54.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.274 0.63 . . . . 0.0 109.691 170.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -51.83 -29.35 19.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.785 0.834 . . . . 0.0 111.877 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.01 0.41 40.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -96.57 -29.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.692 1.197 . . . . 0.0 111.386 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.99 65.4 9.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 121.545 -0.722 . . . . 0.0 111.801 168.036 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.23 144.77 98.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.355 3.37 . . . . 0.0 113.376 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.04 -19.56 6.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.537 1.541 . . . . 0.0 114.08 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -106.16 -45.99 4.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.961 1.704 . . . . 0.0 111.216 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -66.74 109.03 2.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.268 1.027 . . . . 0.0 113.703 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -78.5 80.03 4.9 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 110.759 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 t -84.97 127.25 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.1 0.863 . . . . 0.0 111.877 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -138.4 146.81 42.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.59 1.156 . . . . 0.0 111.089 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.69 130.21 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.725 0.774 . . . . 0.0 110.561 172.483 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 122.575 1.179 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -137.53 173.1 12.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.726 2.01 . . . . 0.0 109.084 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -161.75 156.39 22.8 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.734 -1.229 . . . . 0.0 110.336 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.35 160.89 38.94 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.48 1.512 . . . . 0.0 111.055 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -124.19 141.56 51.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.163 1.385 . . . . 0.0 110.194 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -141.75 145.2 34.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.853 1.261 . . . . 0.0 111.629 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.26 127.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 111.933 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.81 102.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.514 1.926 . . . . 0.0 111.497 -167.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -81.81 42.55 0.71 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.235 1.014 . . . . 0.0 113.665 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.02 3.66 0.03 OUTLIER Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.223 1.868 . . . . 0.0 117.438 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -75.73 145.6 40.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.739 2.269 . . . . 0.0 113.781 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -66.04 27.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.693 1.997 . . . . 0.0 114.982 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m 53.5 -129.53 2.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.825 1.65 . . . . 0.0 110.967 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HE2' HD13 ' A' ' 38' ' ' LEU . 1.6 mptm? -52.25 -32.31 36.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -170.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m -84.62 -28.57 26.4 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.555 -1.341 . . . . 0.0 113.143 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.81 -41.04 72.11 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.18 -1.391 . . . . 0.0 111.532 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -40.15 -54.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.7 2.0 . . . . 0.0 111.033 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -61.09 -41.74 97.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.508 1.123 . . . . 0.0 113.768 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.99 -38.38 85.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.297 -1.502 . . . . 0.0 112.934 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -36.44 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.213 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.27 -55.35 32.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.47 1.108 . . . . 0.0 109.687 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -67.61 -53.33 28.95 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.5 m -62.02 -38.46 88.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.894 1.278 . . . . 0.0 111.316 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -51.23 12.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.65 -1.167 . . . . 0.0 112.199 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -69.98 6.19 1.32 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.739 1.609 . . . . 0.0 113.928 -171.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.68 -6.81 24.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.817 1.647 . . . . 0.0 111.305 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 mt -75.39 128.02 34.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.15 -15.87 27.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -93.84 -12.17 29.57 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 p -93.57 143.72 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 121.161 1.8 . . . . 0.0 109.965 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.2 t -111.21 -11.63 14.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m 176.91 174.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.763 2.425 . . . . 0.0 113.005 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -172.71 150.48 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.674 2.39 . . . . 0.0 109.561 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.85 130.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 107.029 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.55 149.91 12.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.792 0.806 . . . . 0.0 111.041 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -80.58 113.02 18.47 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.547 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.5 tm? -60.31 -41.62 93.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.911 0.778 . . . . 0.0 111.366 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -97.25 -22.42 16.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.276 1.83 . . . . 0.0 114.638 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -115.91 155.85 27.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.773 1.229 . . . . 0.0 110.835 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.292 0.0 OUTLIER -78.5 38.32 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 p -138.77 157.92 45.18 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.52 139.9 35.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.809 2.044 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.76 121.26 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 106.14 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 57' ' ' LEU . 31.9 t -120.26 136.97 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.164 1.386 . . . . 0.0 108.468 -169.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.5 t -124.34 105.2 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.714 1.205 . . . . 0.0 109.72 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CD1' HD11 ' A' ' 57' ' ' LEU . 40.6 p90 -122.0 164.91 16.83 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.32 1.448 . . . . 0.0 113.967 -169.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.974 -171.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.176 0.798 . . . . 0.0 114.176 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.16 -32.16 67.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.388 0.995 . . . . 0.0 113.215 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 m -70.22 -36.3 74.45 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.907 -1.121 . . . . 0.0 112.215 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 47' ' ' TYR . 82.2 mt -71.86 -45.76 60.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.674 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -48.86 -47.49 42.78 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.659 0.783 . . . . 0.0 110.463 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -35.39 79.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.36 73.26 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 121.28 1.855 . . . . 0.0 112.127 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.93 -57.97 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.719 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -49.72 -27.89 5.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.488 1.115 . . . . 0.0 112.573 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 0.68 44.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -93.56 -29.9 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.978 0.911 . . . . 0.0 111.514 177.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.464 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.84 64.06 9.87 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 121.424 -0.798 . . . . 0.0 111.5 167.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.28 144.01 99.5 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.095 3.197 . . . . 0.0 112.464 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.31 -29.89 4.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.714 1.149 . . . . 0.0 113.007 -174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.3 tp -92.23 -48.23 6.8 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.046 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.514 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -71.26 99.09 1.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.354 1.062 . . . . 0.0 113.346 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -75.06 119.87 19.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 114.617 -2.611 . . . . 0.0 105.336 162.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 t -123.25 134.96 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 124.274 3.215 . . . . 0.0 112.544 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.16 134.6 45.6 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.042 1.337 . . . . 0.0 110.178 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.9 mt -74.22 123.45 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.185 -1.572 . . . . 0.0 110.38 170.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.522 -0.13 0 C-N-CA 123.456 0.702 . . . . 0.0 109.126 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.796 0.807 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -88.91 172.15 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 163.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -157.33 138.29 13.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.52 -1.362 . . . . 0.0 110.311 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.35 158.74 43.59 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.672 1.589 . . . . 0.0 110.654 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.4 m -120.35 141.86 49.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.724 1.21 . . . . 0.0 109.414 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -137.04 139.89 41.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.106 1.362 . . . . 0.0 109.512 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -121.55 139.67 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 123.924 0.89 . . . . 0.0 110.818 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 147.57 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 O-C-N 125.086 1.492 . . . . 0.0 110.25 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -123.59 141.38 52.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.449 1.1 . . . . 0.0 108.465 162.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.43 -27.24 8.57 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 126.19 1.852 . . . . 0.0 113.369 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.419 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -67.32 125.1 25.04 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 129.632 3.173 . . . . 0.0 118.104 -166.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.611 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 2.5 m-70 -74.61 55.58 0.66 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.789 2.836 . . . . 0.0 117.871 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.76 -141.46 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 119.94 -1.725 . . . . 0.0 114.781 165.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -54.84 -31.24 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 118.823 -2.423 . . . . 0.0 111.149 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.03 -54.29 27.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.704 -1.141 . . . . 0.0 112.224 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 12' ' ' MET . 32.0 p -55.02 -55.14 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.475 1.488 . . . . 0.0 110.275 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 9.1 t -44.74 -54.12 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.523 2.329 . . . . 0.0 111.487 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.8 m -70.72 -26.5 63.42 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -60.5 -46.57 89.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.614 1.097 . . . . 0.0 109.309 165.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -40.25 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.437 -0.79 . . . . 0.0 111.846 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -54.19 -46.41 72.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.285 1.434 . . . . 0.0 109.33 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 t -73.03 -64.33 0.99 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -56.41 -36.58 69.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.828 2.451 . . . . 0.0 112.439 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.31 -43.92 63.46 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.828 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -67.84 13.05 0.09 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.642 1.565 . . . . 0.0 114.636 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.57 2.13 14.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.691 1.996 . . . . 0.0 112.262 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.32 137.65 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.81 -1.181 . . . . 0.0 111.863 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 67.27 0.77 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.685 1.594 . . . . 0.0 111.864 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 166.73 -20.77 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 129.956 3.303 . . . . 0.0 113.148 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.7 p -85.92 137.16 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 121.288 1.858 . . . . 0.0 110.895 -171.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -103.82 -19.04 14.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.376 1.47 . . . . 0.0 112.594 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m 178.16 167.19 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.632 2.373 . . . . 0.0 112.423 -171.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.4 tt -171.64 149.22 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.672 1.989 . . . . 0.0 112.479 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.7 t -141.09 144.35 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.494 2.317 . . . . 0.0 106.948 166.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 53.8 t -113.51 130.14 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 123.382 1.563 . . . . 0.0 110.842 168.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -80.64 91.28 5.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.807 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 18' ' ' VAL . 7.8 tp -51.21 -56.95 10.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.311 1.444 . . . . 0.0 111.201 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.85 -56.07 13.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.45 1.1 . . . . 0.0 110.926 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.44 15.42 5.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 51.47 29.47 5.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.452 1.901 . . . . 0.0 114.738 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 p -133.59 149.73 51.62 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -168.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.65 53.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.466 1.506 . . . . 0.0 109.109 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -101.25 109.75 26.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.96 132.61 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 124.781 1.232 . . . . 0.0 108.251 -166.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.03 108.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -169.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.451 ' CD1' HD11 ' A' ' 57' ' ' LEU . 12.6 p90 -130.87 137.59 49.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.774 1.23 . . . . 0.0 113.84 -167.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.616 0 O-C-N 120.223 -1.548 . . . . 0.0 112.378 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 118.813 -0.578 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.95 -20.39 23.35 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.156 0.889 . . . . 0.0 112.13 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -42.17 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.501 -1.374 . . . . 0.0 112.134 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 ' CD1' ' A' ' 47' ' ' TYR . 93.5 mt -70.06 -42.05 73.34 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.693 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -51.44 -49.86 60.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.428 1.091 . . . . 0.0 110.913 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -61.59 -34.28 75.35 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.22 75.17 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 120.277 1.399 . . . . 0.0 112.159 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -70.27 -55.29 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.331 -0.856 . . . . 0.0 110.974 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.54 -16.86 17.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.276 0.943 . . . . 0.0 112.124 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.15 -0.65 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.457 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -91.93 -31.34 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.059 0.845 . . . . 0.0 111.83 175.158 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -144.35 59.32 6.59 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.9 139.43 84.31 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 125.128 3.885 . . . . 0.0 114.374 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.31 -25.71 3.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.014 1.292 . . . . 0.0 113.571 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -42.28 9.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.032 1.733 . . . . 0.0 109.245 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 4.3 m-30 -76.53 106.93 8.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 115.176 1.546 . . . . 0.0 115.176 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.283 5.5 mtt-85 -73.47 137.24 44.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 158.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.36 135.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 122.375 2.352 . . . . 0.0 110.292 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 p -138.45 151.79 47.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.3 mt -84.04 85.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.465 1.106 . . . . 0.0 108.397 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 122.436 1.113 . . . . 0.0 108.287 169.406 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 122.224 1.011 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 t -125.98 171.72 10.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.888 1.275 . . . . 0.0 110.105 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.21 166.53 31.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.196 0.999 . . . . 0.0 110.421 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.98 36.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.648 1.579 . . . . 0.0 110.898 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -123.3 135.09 54.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.276 1.43 . . . . 0.0 110.245 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -138.2 146.63 42.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.816 1.246 . . . . 0.0 111.406 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -132.8 135.81 56.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.905 1.282 . . . . 0.0 112.224 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.48 106.39 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.463 1.505 . . . . 0.0 111.771 -167.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.36 -3.96 36.59 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 119.346 -2.096 . . . . 0.0 115.673 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.54 5.85 44.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.556 1.074 . . . . 0.0 111.736 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.53 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 ttp -77.51 131.1 37.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 122.041 -0.682 . . . . 0.0 110.012 -169.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -64.86 6.62 0.22 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.553 1.541 . . . . 0.0 113.572 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.1 m 76.88 -40.13 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.388 2.275 . . . . 0.0 116.607 164.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 -85.2 0.62 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -52.47 -27.93 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.3 m -51.15 -39.19 55.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.261 1.391 . . . . 0.0 112.964 169.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 36' ' ' VAL . 24.1 t -57.0 -42.2 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.073 1.349 . . . . 0.0 112.771 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -59.96 -40.41 88.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 0.0 111.434 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -66.3 -44.72 82.69 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 121.989 -0.445 . . . . 0.0 111.594 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -45.75 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 119.229 -0.415 . . . . 0.0 109.962 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.92 -51.4 61.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.525 1.13 . . . . 0.0 110.45 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.6 t -70.71 -37.18 73.52 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -74.28 -41.36 61.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 110.329 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.61 -48.17 41.8 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.899 -1.524 . . . . 0.0 110.66 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 t -72.83 14.64 0.25 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.312 1.869 . . . . 0.0 113.588 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.45 -6.85 15.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.12 1.768 . . . . 0.0 112.108 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 28.9 mt -73.29 129.44 38.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.909 -1.119 . . . . 0.0 109.167 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -60.22 -17.59 42.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -170.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -96.61 -8.56 31.42 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 171.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.3 p -94.54 138.6 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.604 2.002 . . . . 0.0 109.725 -173.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 t -107.77 -12.98 15.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.819 . . . . 0.0 113.165 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m 179.17 174.63 0.72 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.82 2.448 . . . . 0.0 111.769 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -172.73 154.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.694 2.398 . . . . 0.0 109.468 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.28 129.8 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.464 2.305 . . . . 0.0 108.162 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 18' ' ' VAL . 78.9 t -103.62 136.63 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 122.701 1.238 . . . . 0.0 111.739 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -78.29 93.23 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.577 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 18' ' ' VAL . 21.1 tp -54.9 -43.41 73.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.714 0.806 . . . . 0.0 112.981 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.95 -44.02 19.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.187 1.395 . . . . 0.0 112.587 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.41 -170.93 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.286 2.634 . . . . 0.0 114.646 -168.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -101.18 19.15 18.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.233 1.813 . . . . 0.0 114.376 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 p -136.55 156.61 48.34 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -167.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.36 136.95 49.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.495 1.918 . . . . 0.0 110.572 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.14 122.03 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.479 ' CG1' HD13 ' A' ' 57' ' ' LEU . 39.9 t -123.42 120.61 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 108.996 -166.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.49 111.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.515 1.526 . . . . 0.0 109.14 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' A' ' 57' ' ' LEU . 38.9 p90 -123.23 157.86 32.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.48 1.112 . . . . 0.0 112.821 -173.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 CA--C 1.538 0.496 0 O-C-N 121.012 -1.055 . . . . 0.0 111.879 -169.945 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 N-CA-C 113.506 0.541 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -55.96 -48.0 76.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.276 1.43 . . . . 0.0 111.479 -172.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.6 -29.16 68.43 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.275 -0.891 . . . . 0.0 112.373 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 47' ' ' TYR . 54.2 mt -70.83 -49.22 48.62 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.02 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -52.8 -48.23 67.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.362 1.065 . . . . 0.0 110.648 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -56.86 -40.52 76.3 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.05 85.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.541 1.519 . . . . 0.0 112.128 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -63.37 -54.85 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.051 0.54 . . . . 0.0 109.923 172.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -50.81 -33.68 24.58 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.353 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.62 5.12 13.98 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -101.46 -26.7 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.981 1.312 . . . . 0.0 111.725 176.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.51 65.99 8.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.793 0.837 . . . . 0.0 110.633 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.9 143.86 92.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.113 3.209 . . . . 0.0 112.583 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -33.51 3.01 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.882 1.229 . . . . 0.0 113.183 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 tp -85.72 -46.66 10.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.545 1.538 . . . . 0.0 111.631 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -73.97 106.19 5.55 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -71.64 39.02 0.06 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.405 1.882 . . . . 0.0 114.893 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.55 125.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.3 m -137.43 156.68 47.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.245 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.7 mt -95.63 127.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.355 1.462 . . . . 0.0 109.152 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 C-N-CA 123.774 0.829 . . . . 0.0 109.703 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 122.526 1.155 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -102.07 -172.69 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.356 1.462 . . . . 0.0 111.869 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.28 149.76 10.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.054 1.342 . . . . 0.0 109.711 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.15 162.46 41.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.948 1.699 . . . . 0.0 110.816 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m -119.83 140.06 51.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 109.576 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 7.5 m-85 -140.71 143.68 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 111.601 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.21 131.07 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.944 0.898 . . . . 0.0 110.957 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.77 128.63 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.497 -168.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.67 116.65 29.15 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.406 -0.809 . . . . 0.0 108.967 164.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.24 -12.55 8.02 Favored Glycine 0 N--CA 1.466 0.692 0 C-N-CA 124.062 0.839 . . . . 0.0 113.236 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.468 ' HG3' ' H ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -63.86 146.35 54.15 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.1 0.95 . . . . 0.0 111.462 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -62.05 2.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.706 2.002 . . . . 0.0 115.737 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 12' ' ' MET . 99.2 m 64.63 26.92 13.25 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 166.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.38 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.638 2.775 . . . . 0.0 106.597 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m -52.76 -26.87 15.49 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.1 2.227 . . . . 0.0 115.456 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.1 -38.57 39.23 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 120.19 1.359 . . . . 0.0 112.288 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.636 HG22 HG11 ' A' ' 36' ' ' VAL . 28.5 t -53.83 -41.38 48.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 125.107 1.363 . . . . 0.0 113.653 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -62.6 -38.22 89.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.819 0.447 . . . . 0.0 111.572 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -68.21 -45.95 71.91 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.174 0.589 . . . . 0.0 111.947 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -44.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.348 -173.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.25 -49.17 70.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.905 1.282 . . . . 0.0 110.423 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.0 m -68.45 -44.17 75.44 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 m -70.66 -39.52 73.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.764 1.226 . . . . 0.0 111.253 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -51.48 16.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.436 -1.269 . . . . 0.0 110.565 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t -74.91 17.96 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.685 1.584 . . . . 0.0 113.394 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.86 -0.5 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.491 1.916 . . . . 0.0 112.178 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.61 135.43 42.02 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.675 -1.266 . . . . 0.0 111.103 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -47.85 -19.11 0.21 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.464 2.305 . . . . 0.0 116.355 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -7.96 11.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.231 1.813 . . . . 0.0 115.621 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.23 136.13 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 121.739 2.063 . . . . 0.0 111.938 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -89.95 -33.91 16.22 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -173.98 176.06 2.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.771 1.628 . . . . 0.0 112.394 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -172.77 154.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.324 2.25 . . . . 0.0 109.981 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.5 t -147.29 128.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.327 2.251 . . . . 0.0 108.045 166.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.636 HG11 HG22 ' A' ' 18' ' ' VAL . 77.0 t -102.31 135.94 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.682 1.23 . . . . 0.0 111.595 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -77.02 94.36 3.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.122 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 18' ' ' VAL . 25.9 tp -55.02 -38.42 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -51.78 -48.39 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.503 1.121 . . . . 0.0 111.104 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -96.99 -170.56 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 129.791 3.237 . . . . 0.0 113.487 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.11 34.94 3.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.217 1.407 . . . . 0.0 112.639 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 p -142.83 153.22 43.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.87 136.33 50.3 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.881 2.072 . . . . 0.0 110.812 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -106.9 116.87 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 57' ' ' LEU . 18.3 t -118.81 132.23 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 0.0 107.704 -169.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.98 101.45 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CD1' HD11 ' A' ' 57' ' ' LEU . 37.8 p90 -122.02 141.63 51.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -168.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 CA--C 1.541 0.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.796 178.912 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 CA--C 1.536 0.596 0 CA-C-O 119.278 -0.384 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -47.55 -26.63 1.49 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.731 1.612 . . . . 0.0 112.811 168.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -69.38 -42.45 75.13 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.046 -1.034 . . . . 0.0 112.722 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.6 mt -68.92 -43.54 74.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.852 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -50.4 -46.96 56.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.35 0.977 . . . . 0.0 111.094 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.88 64.0 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.94 90.92 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.574 1.988 . . . . 0.0 110.361 168.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.28 -56.48 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.745 -0.597 . . . . 0.0 110.917 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -56.96 -19.8 20.14 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.06 0.4 56.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -89.76 -32.89 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.838 0.855 . . . . 0.0 111.332 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.93 67.13 12.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.064 0.546 . . . . 0.0 111.373 169.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.74 139.02 88.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 124.219 3.279 . . . . 0.0 112.224 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.31 -33.85 3.14 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.973 1.273 . . . . 0.0 113.146 -173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -78.7 -46.94 17.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.896 0.848 . . . . 0.0 110.07 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.2 m-30 -84.54 122.84 29.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.892 1.677 . . . . 0.0 113.844 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.33 105.36 13.98 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.831 1.652 . . . . 0.0 108.408 169.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.86 135.1 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 120.889 1.677 . . . . 0.0 111.402 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.1 p -126.46 156.0 41.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.241 0.543 . . . . 0.0 111.795 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.4 mt -92.9 121.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.171 1.388 . . . . 0.0 109.264 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.154 0 C-N-CA 123.153 0.581 . . . . 0.0 110.088 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 121.753 0.787 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 t -89.95 177.8 6.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.223 1.011 . . . . 0.0 111.832 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -161.19 147.62 14.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.796 1.238 . . . . 0.0 110.363 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.37 44.61 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.317 1.047 . . . . 0.0 111.978 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m -116.28 137.1 52.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 109.98 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -136.35 143.94 44.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.089 1.356 . . . . 0.0 110.311 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 tt -133.44 134.13 57.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 110.986 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.9 111.26 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -169.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.73 92.45 8.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.01 -34.2 0.61 Allowed Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.343 0.973 . . . . 0.0 114.159 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -58.71 126.94 29.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.268 0.627 . . . . 0.0 110.905 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.429 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 24.7 m-70 -61.54 41.26 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -169.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.0 m 70.44 -48.25 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 130.538 3.535 . . . . 0.0 114.908 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -128.29 -69.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.909 0.884 . . . . 0.0 110.852 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -57.38 -18.75 19.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 p -50.72 -50.54 55.1 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.652 1.115 . . . . 0.0 111.365 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 38' ' ' LEU . 2.1 t -55.65 -43.05 71.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 124.303 1.041 . . . . 0.0 111.775 -168.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -66.83 -34.74 78.48 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -65.62 -45.86 81.49 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.81 -1.181 . . . . 0.0 111.039 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -39.91 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -51.4 -51.58 53.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 109.831 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.0 m -70.37 -48.14 57.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -69.63 -37.74 76.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.371 1.068 . . . . 0.0 111.125 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -51.15 15.89 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.144 -1.408 . . . . 0.0 111.186 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.31 16.36 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.355 1.889 . . . . 0.0 113.739 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.35 -5.29 14.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.264 1.826 . . . . 0.0 112.227 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.57 133.9 44.95 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 120.549 -1.344 . . . . 0.0 109.967 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -66.3 0.02 2.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.59 -6.68 11.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.59 134.43 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 121.581 1.991 . . . . 0.0 111.258 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 m -91.41 -25.24 19.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.567 0.747 . . . . 0.0 112.942 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.14 175.26 1.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.813 1.645 . . . . 0.0 113.177 -170.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -166.51 152.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.036 2.134 . . . . 0.0 109.632 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.36 148.92 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.147 2.579 . . . . 0.0 105.946 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 18' ' ' VAL . 14.6 p -140.7 150.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 112.367 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -91.31 135.55 33.73 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.233 1.413 . . . . 0.0 111.682 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 18' ' ' VAL . 10.0 tp -104.06 -30.02 10.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.559 1.544 . . . . 0.0 112.607 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -32.38 68.61 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.864 2.065 . . . . 0.0 112.786 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -104.89 -174.5 2.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.074 2.15 . . . . 0.0 113.189 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.78 32.95 5.76 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.03 2.532 . . . . 0.0 110.7 -174.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 p -140.17 156.71 46.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.042 -1.661 . . . . 0.0 114.728 -167.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.46 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 110.692 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -115.67 116.87 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.437 ' CG1' HD13 ' A' ' 57' ' ' LEU . 24.1 t -117.37 130.63 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 108.563 -168.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.2 105.11 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 108.781 -168.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.606 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -124.92 150.06 46.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.359 0.664 . . . . 0.0 111.04 -173.812 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 CA-C-O 118.987 -0.505 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -52.95 -25.68 12.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.594 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.8 p -66.76 -44.25 81.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.678 1.191 . . . . 0.0 113.346 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.606 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.4 mt -71.03 -41.6 70.63 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.594 -0.692 . . . . 0.0 110.73 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.21 -48.65 45.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.405 1.082 . . . . 0.0 111.016 170.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.209 1.403 . . . . 0.0 114.554 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.56 76.25 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.012 1.278 . . . . 0.0 111.551 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.915 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -51.08 -34.45 30.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.667 0.667 . . . . 0.0 110.389 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.9 4.22 14.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.432 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -97.5 -30.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.952 0.901 . . . . 0.0 111.35 177.013 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.01 64.57 7.59 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 111.493 169.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.35 147.56 95.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.492 3.462 . . . . 0.0 113.211 -172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.53 -24.51 3.65 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.794 1.188 . . . . 0.0 114.185 -173.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.37 -36.01 8.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.161 1.384 . . . . 0.0 111.509 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.432 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -76.98 106.08 8.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -80.8 71.3 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.085 -1.634 . . . . 0.0 111.654 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.6 128.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.702 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -135.75 146.26 47.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.327 1.451 . . . . 0.0 109.298 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 94.2 mt -90.71 126.78 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.708 -1.245 . . . . 0.0 108.093 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 109.6 168.398 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 122.573 1.178 . . . . 0.0 113.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -80.32 177.29 9.07 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.947 0.879 . . . . 0.0 110.947 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -165.9 145.6 6.33 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.815 1.246 . . . . 0.0 110.23 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.92 166.1 31.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.593 1.557 . . . . 0.0 111.321 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.6 m -127.18 135.54 50.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.449 1.5 . . . . 0.0 110.923 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.81 149.18 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.99 141.93 42.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 111.008 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -124.62 108.21 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 123.833 0.708 . . . . 0.0 110.902 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.95 26.8 0.58 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.98 22.48 1.27 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.5 1.524 . . . . 0.0 113.482 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 1.3 tmt? -84.7 130.39 34.71 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 -169.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 4.6 m170 -71.45 12.14 0.38 Allowed 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 t 90.82 -145.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.354 2.661 . . . . 0.0 111.46 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HE3' HD13 ' A' ' 38' ' ' LEU . 14.1 mptt -58.75 -30.07 67.23 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.317 -1.49 . . . . 0.0 113.283 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -69.06 -34.42 75.14 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.136 -1.603 . . . . 0.0 112.725 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.2 m -70.34 -38.78 74.93 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 116.356 -1.783 . . . . 0.0 113.318 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 35.5 t -42.57 -53.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -58.87 -39.96 82.92 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.64 -39.94 88.48 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.722 -0.611 . . . . 0.0 111.986 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -42.58 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.419 0.554 . . . . 0.0 110.118 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.28 -48.49 71.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.384 1.074 . . . . 0.0 110.518 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 m -71.2 -46.71 60.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -71.12 -37.16 72.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 125.472 1.509 . . . . 0.0 111.5 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -74.73 -49.77 19.87 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.162 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -72.75 15.38 0.2 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 121.576 1.989 . . . . 0.0 113.427 -170.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.88 -2.38 16.1 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 112.511 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -76.09 137.07 39.91 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.757 -1.214 . . . . 0.0 111.127 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.29 31.08 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.767 2.027 . . . . 0.0 114.234 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.16 -3.0 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.12 2.568 . . . . 0.0 113.945 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.5 p -99.43 140.84 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.505 1.957 . . . . 0.0 108.852 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -112.74 -8.54 13.76 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -176.35 171.95 2.34 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.379 1.871 . . . . 0.0 113.505 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -175.13 154.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.904 2.482 . . . . 0.0 110.229 -171.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -147.67 126.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 127.596 2.358 . . . . 0.0 107.518 165.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 50.9 t -91.42 134.26 30.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.43 1.11 . . . . 0.0 109.865 168.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.9 m -69.83 89.93 0.59 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.483 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.563 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.9 tm? -45.49 -43.59 11.77 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.287 2.235 . . . . 0.0 112.011 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -53.06 57.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.669 1.188 . . . . 0.0 111.347 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.92 -174.73 4.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.395 2.278 . . . . 0.0 113.909 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.21 36.6 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.955 1.702 . . . . 0.0 113.296 169.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.01 154.9 43.75 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.047 -1.658 . . . . 0.0 114.137 -169.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.8 135.08 41.52 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.253 1.821 . . . . 0.0 110.35 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.48 119.23 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -125.81 139.9 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.696 1.198 . . . . 0.0 109.979 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.31 112.51 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.709 1.604 . . . . 0.0 109.063 -168.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CD1' HD11 ' A' ' 57' ' ' LEU . 39.5 p90 -131.29 148.4 52.68 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -168.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.535 0.368 0 O-C-N 120.701 -1.249 . . . . 0.0 112.483 -167.092 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 CA-C-O 118.806 -0.581 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -51.16 -23.95 3.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.583 1.153 . . . . 0.0 111.789 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -68.2 -44.83 74.95 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.666 -1.271 . . . . 0.0 113.278 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.8 mt -70.67 -43.6 68.76 Favored 'General case' 0 C--O 1.226 -0.161 0 O-C-N 121.515 -0.741 . . . . 0.0 110.356 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -48.54 -51.92 25.22 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.503 1.121 . . . . 0.0 110.993 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.26 -30.71 71.61 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.8 -33.36 74.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.236 1.38 . . . . 0.0 112.051 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.28 -55.8 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.752 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.43 -37.34 11.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.861 0.755 . . . . 0.0 111.156 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.29 4.63 8.42 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.476 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -98.09 -33.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.622 1.569 . . . . 0.0 111.919 174.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.12 61.85 18.93 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 169.279 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.21 139.8 79.89 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.9 3.067 . . . . 0.0 112.835 -171.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.66 -21.41 14.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.193 1.378 . . . . 0.0 114.04 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.06 -45.82 5.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.423 1.889 . . . . 0.0 110.59 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' HG12 ' A' ' 64' ' ' VAL . 1.7 m-30 -64.99 100.98 0.46 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.066 1.346 . . . . 0.0 114.509 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -77.8 73.68 4.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.908 1.283 . . . . 0.0 111.321 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.04 132.92 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.755 0.788 . . . . 0.0 111.976 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.5 m -145.89 166.24 26.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.632 1.573 . . . . 0.0 110.858 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.6 mt -99.09 132.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.913 1.685 . . . . 0.0 108.059 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.304 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 123.968 1.842 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 t -100.69 -176.73 3.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.04 2.536 . . . . 0.0 110.969 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -163.06 148.57 11.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 110.112 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 162.89 40.79 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.243 1.417 . . . . 0.0 110.974 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.0 m -121.43 137.86 54.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.726 1.21 . . . . 0.0 109.622 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -137.51 147.08 44.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.235 1.414 . . . . 0.0 110.202 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 tt -132.52 137.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.696 1.198 . . . . 0.0 110.603 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.97 99.24 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.703 1.601 . . . . 0.0 111.255 -171.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.25 101.23 10.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.265 1.031 . . . . 0.0 110.609 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.98 -7.88 4.14 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.776 1.179 . . . . 0.0 114.855 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -64.71 143.36 57.98 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.892 1.346 . . . . 0.0 112.026 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -67.21 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 126.705 2.002 . . . . 0.0 114.89 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m 54.5 -131.61 1.96 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.962 2.105 . . . . 0.0 112.033 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.5 tptt -48.5 -32.87 8.53 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.565 1.946 . . . . 0.0 114.151 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 m -91.18 -29.27 17.34 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -37.92 89.23 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.971 1.26 . . . . 0.0 111.23 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 38' ' ' LEU . 49.1 t -37.73 -58.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.565 1.546 . . . . 0.0 112.277 169.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -55.28 -43.77 75.06 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 111.929 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.95 -42.64 99.88 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.571 -0.705 . . . . 0.0 112.602 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -44.18 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.807 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.71 -51.1 70.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.368 1.067 . . . . 0.0 110.064 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -35.94 79.27 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.9 m -75.81 -37.73 58.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.653 0.781 . . . . 0.0 110.383 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -50.36 17.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.903 175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -74.53 12.84 0.7 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.765 1.166 . . . . 0.0 112.765 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.47 -7.19 18.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.507 1.523 . . . . 0.0 111.942 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 mt -78.29 126.65 31.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.24 -11.81 7.3 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.47 -13.06 24.87 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 169.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.98 140.46 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 121.789 2.086 . . . . 0.0 108.866 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.1 t -96.52 -29.49 13.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.368 1.467 . . . . 0.0 111.666 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -176.07 174.6 2.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.684 1.594 . . . . 0.0 112.336 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -174.59 150.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.631 1.972 . . . . 0.0 110.521 -172.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.82 132.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 127.352 2.261 . . . . 0.0 108.053 167.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' CG1' HG13 ' A' ' 18' ' ' VAL . 38.9 t -107.12 143.32 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.078 0.951 . . . . 0.0 111.277 170.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 40' ' ' ASN . 9.5 t -74.79 108.31 7.45 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 165.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 18' ' ' VAL . 3.7 mt -47.3 -25.84 1.08 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.753 2.021 . . . . 0.0 114.459 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.34 -35.48 6.26 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.913 2.885 . . . . 0.0 114.243 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 24.6 m-80 -83.91 -175.15 5.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.718 0.407 . . . . 0.0 110.539 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER -112.97 39.31 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 175.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -141.44 155.7 45.85 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.461 -1.399 . . . . 0.0 113.046 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.55 50.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.737 2.015 . . . . 0.0 110.041 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -106.18 114.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.6 t -121.08 130.51 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.756 1.222 . . . . 0.0 108.487 -168.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.6 t -117.59 117.55 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.472 1.909 . . . . 0.0 107.434 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' A' ' 57' ' ' LEU . 19.8 p90 -139.21 155.21 47.96 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.613 1.551 . . . . 0.0 113.233 -168.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t30 . . . . . 0 CA--C 1.541 0.618 0 O-C-N 120.122 -1.611 . . . . 0.0 113.688 -167.531 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 CA--C 1.542 0.92 0 N-CA-C 114.82 1.046 . . . . 0.0 114.82 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.97 -35.85 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.206 1.002 . . . . 0.0 113.094 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.7 p -69.39 -41.48 76.39 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.318 -0.864 . . . . 0.0 113.243 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.1 mt -64.81 -49.0 72.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.88 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.27 -56.63 6.4 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.861 1.264 . . . . 0.0 110.36 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -51.7 -41.82 61.76 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.75 67.59 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.104 0.865 . . . . 0.0 112.954 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -69.95 -56.37 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.959 0.904 . . . . 0.0 109.65 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -50.66 -31.68 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.707 0.803 . . . . 0.0 111.812 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.16 28.88 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.505 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -97.64 -31.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.37 65.83 9.67 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.463 -0.773 . . . . 0.0 111.085 167.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.93 141.96 96.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.98 3.12 . . . . 0.0 112.112 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.71 -28.54 4.87 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.756 1.17 . . . . 0.0 113.454 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -92.12 -44.16 8.97 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 111.633 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.7 m-30 -72.67 99.73 2.64 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 78.14 0.64 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.332 -1.48 . . . . 0.0 109.326 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.95 135.37 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.464 1.125 . . . . 0.0 111.684 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.2 m -150.9 158.11 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.951 1.7 . . . . 0.0 111.238 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 126.17 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.896 1.679 . . . . 0.0 109.48 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 124.286 1.034 . . . . 0.0 111.559 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.337 1.065 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -95.24 176.61 6.15 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.92 1.688 . . . . 0.0 111.746 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -160.65 140.58 11.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.924 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.51 161.28 38.29 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.017 1.327 . . . . 0.0 109.911 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.4 m -123.32 136.21 54.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.75 0.82 . . . . 0.0 109.036 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.48 147.49 52.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.222 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -135.56 133.6 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.266 1.026 . . . . 0.0 110.847 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.66 116.0 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.969 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -81.12 5.31 17.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.39 22.22 1.07 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.02 1.771 . . . . 0.0 115.395 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.85 146.02 49.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.215 2.008 . . . . 0.0 112.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.433 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 3.0 m170 -74.0 23.3 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.714 1.606 . . . . 0.0 113.3 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t 76.51 -141.63 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.23 2.212 . . . . 0.0 111.182 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -55.94 -36.31 67.62 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.423 -1.423 . . . . 0.0 114.182 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -69.98 -34.17 73.02 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.257 -1.527 . . . . 0.0 112.074 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.0 OUTLIER -67.86 -42.38 81.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 116.068 -1.92 . . . . 0.0 112.587 173.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 36' ' ' VAL . 9.3 t -40.6 -55.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.96 1.255 . . . . 0.0 111.351 174.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.0 t -62.57 -37.68 87.13 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -62.75 -42.03 99.49 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.159 -0.963 . . . . 0.0 111.963 171.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.74 -42.68 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 118.919 0.781 . . . . 0.0 110.034 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -52.86 -53.29 51.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.997 0.919 . . . . 0.0 110.17 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 m -70.52 -44.79 66.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.8 m -70.07 -36.03 74.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.132 1.773 . . . . 0.0 110.846 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -50.45 18.19 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.871 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -68.12 12.53 0.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.466 1.485 . . . . 0.0 114.139 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.85 18.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.649 1.98 . . . . 0.0 111.809 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.08 129.75 34.7 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.854 -1.154 . . . . 0.0 110.127 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.93 -1.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.38 -8.08 11.09 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.22 135.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 121.772 2.078 . . . . 0.0 110.926 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 19.5 m -92.65 -25.02 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.265 1.426 . . . . 0.0 111.889 -173.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m 178.89 175.97 0.58 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.545 2.338 . . . . 0.0 112.726 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.8 tt -174.04 152.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 127.136 2.174 . . . . 0.0 109.49 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.07 131.71 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 126.087 1.755 . . . . 0.0 107.448 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 18' ' ' VAL . 13.7 t -94.47 135.52 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 123.073 1.416 . . . . 0.0 109.505 168.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 m -67.41 90.62 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.063 167.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.436 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -55.68 -31.45 62.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.577 1.151 . . . . 0.0 112.638 -171.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -59.77 4.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.982 0.81 . . . . 0.0 111.116 169.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -72.58 -176.36 1.91 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 125.356 2.503 . . . . 0.0 114.027 -171.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.554 2.342 . . . . 0.0 113.024 170.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.2 p -137.38 160.17 39.84 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.704 -1.872 . . . . 0.0 115.056 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.71 136.79 44.88 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.228 1.811 . . . . 0.0 110.683 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.1 112.68 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' CG1' HD13 ' A' ' 57' ' ' LEU . 20.9 t -116.66 130.5 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.474 1.509 . . . . 0.0 108.339 -168.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.69 114.51 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.247 1.419 . . . . 0.0 108.038 -168.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CD1' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -132.86 155.22 49.4 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 120.457 1.481 . . . . 0.0 113.373 -168.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 CA--C 1.543 0.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.362 -175.562 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 CA--C 1.538 0.68 0 N-CA-C 113.127 0.395 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -18.32 3.9 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 m -82.58 -40.34 21.03 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 121.03 1.741 . . . . 0.0 112.702 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.0 mt -67.65 -45.52 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.219 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -48.38 -46.93 37.7 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.278 0.944 . . . . 0.0 110.643 170.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -35.49 79.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.438 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.07 71.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.789 1.631 . . . . 0.0 112.28 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -72.82 -57.77 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.992 0.917 . . . . 0.0 109.699 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -55.59 -16.23 3.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.931 1.293 . . . . 0.0 113.737 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.03 -0.42 57.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -90.87 -35.59 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.956 0.798 . . . . 0.0 111.457 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -141.22 63.32 17.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 169.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.35 143.52 86.02 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.364 3.376 . . . . 0.0 114.231 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.9 -31.35 2.81 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.28 1.419 . . . . 0.0 113.502 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.28 -40.99 11.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.881 1.673 . . . . 0.0 110.395 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.518 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -75.31 93.91 2.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.164 -0.96 . . . . 0.0 113.421 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -71.97 121.01 18.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 161.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.51 136.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 123.754 2.979 . . . . 0.0 111.832 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -134.91 156.57 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.135 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.38 130.3 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.144 1.378 . . . . 0.0 108.391 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 122.387 1.089 . . . . 0.0 111.456 174.045 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.821 0.819 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -87.84 173.8 8.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.096 0.951 . . . . 0.0 110.592 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -163.95 148.05 10.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.074 1.35 . . . . 0.0 110.051 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.66 159.82 37.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.484 1.513 . . . . 0.0 111.387 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -125.77 136.56 53.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.991 1.316 . . . . 0.0 110.148 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.39 145.77 49.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.925 1.29 . . . . 0.0 111.156 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tt -121.74 145.12 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.273 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.4 168.67 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 124.567 1.147 . . . . 0.0 107.943 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -152.82 125.44 8.28 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.036 -1.04 . . . . 0.0 109.145 168.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.81 -6.49 44.19 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.613 1.101 . . . . 0.0 113.292 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.35 141.31 47.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.488 1.515 . . . . 0.0 112.267 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -51.68 -46.21 63.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 p 160.81 -65.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.427 1.891 . . . . 0.0 113.848 -171.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 -57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.136 2.175 . . . . 0.0 109.217 -166.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -20.01 21.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.121 0.968 . . . . 0.0 113.448 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 p -56.28 -48.8 75.89 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.256 168.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.33 -49.88 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.0 111.153 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -65.61 -35.73 81.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.429 1.092 . . . . 0.0 112.929 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.26 -39.59 95.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.564 -1.335 . . . . 0.0 111.976 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -30.4 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.54 -175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -59.35 -56.68 18.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.511 0.725 . . . . 0.0 109.752 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t -70.19 -41.47 73.67 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.0 m -73.77 -34.81 64.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.595 1.158 . . . . 0.0 110.946 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -52.06 12.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.258 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 t -71.08 16.27 0.09 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.988 1.722 . . . . 0.0 113.773 -172.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.4 -5.01 15.96 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.744 2.018 . . . . 0.0 112.074 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 60' ' ' ALA . 16.7 mt -77.72 130.24 36.52 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 109.508 -172.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.03 -17.35 24.62 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.59 -8.17 29.56 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.78 140.78 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 122.105 2.23 . . . . 0.0 110.091 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -98.06 -24.29 15.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 111.878 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m 178.73 173.26 0.72 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.704 2.001 . . . . 0.0 113.246 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -168.25 153.19 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.917 2.087 . . . . 0.0 110.552 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 151.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.089 2.955 . . . . 0.0 106.131 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.27 151.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 122.035 0.922 . . . . 0.0 111.738 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -74.13 123.83 25.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.615 1.166 . . . . 0.0 109.174 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.49 -42.7 24.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.817 1.189 . . . . 0.0 112.089 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -61.2 -63.96 1.11 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.106 1.321 . . . . 0.0 109.614 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -85.4 168.49 14.56 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 122.878 1.323 . . . . 0.0 113.693 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.19 44.92 1.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -140.91 150.23 42.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 140.61 52.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.161 2.184 . . . . 0.0 111.174 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.06 115.87 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.29 136.48 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.893 1.277 . . . . 0.0 109.214 -166.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.24 113.67 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.233 1.413 . . . . 0.0 108.122 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.3 p90 -130.64 154.1 48.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.698 1.199 . . . . 0.0 113.857 -168.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 CA--C 1.535 0.397 0 O-C-N 121.028 -1.045 . . . . 0.0 110.595 -173.521 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.534 0.511 0 N-CA-C 113.053 0.366 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.04 -8.97 53.6 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.514 1.052 . . . . 0.0 112.802 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -68.26 -49.59 59.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.767 1.167 . . . . 0.0 110.736 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 47' ' ' TYR . 78.6 mt -65.81 -43.78 87.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 117.445 -1.264 . . . . 0.0 111.04 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -47.39 -50.03 23.41 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.255 1.389 . . . . 0.0 112.788 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.07 87.68 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 174.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.457 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.83 -33.97 76.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.359 1.436 . . . . 0.0 112.341 173.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -69.77 -52.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.605 172.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -50.36 -35.86 29.87 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.264 0.938 . . . . 0.0 110.941 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.88 3.32 12.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -98.67 -29.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 111.786 177.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.01 66.98 9.86 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.912 0.885 . . . . 0.0 110.347 168.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.64 140.27 80.04 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.098 3.199 . . . . 0.0 111.872 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.62 -22.16 6.79 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.626 1.107 . . . . 0.0 113.666 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 tp -99.46 -29.26 12.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.297 1.439 . . . . 0.0 112.732 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -92.3 105.59 17.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 6.4 ttt180 -69.96 47.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.241 2.216 . . . . 0.0 115.046 171.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.8 121.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 120.325 -1.485 . . . . 0.0 113.588 -168.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -134.9 152.18 51.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.223 1.409 . . . . 0.0 110.747 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.3 mt -90.91 130.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.739 -1.225 . . . . 0.0 108.086 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 109.462 172.741 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.702 0.763 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -91.76 -179.16 5.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.393 1.477 . . . . 0.0 111.17 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -165.54 155.12 12.53 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 109.861 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.37 161.25 30.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.14 1.776 . . . . 0.0 111.436 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -122.44 141.58 51.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.546 1.539 . . . . 0.0 110.432 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -145.1 141.26 28.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.36 1.464 . . . . 0.0 111.171 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.68 134.39 62.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.957 1.303 . . . . 0.0 111.46 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.32 103.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.585 1.954 . . . . 0.0 111.908 -170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 127.62 32.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.529 -1.357 . . . . 0.0 110.315 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.57 39.38 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 121.69 -0.631 . . . . 0.0 111.952 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.4 ptm -59.38 142.0 53.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 167.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.29 11.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.826 1.65 . . . . 0.0 115.025 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 m 70.76 -23.08 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.437 2.295 . . . . 0.0 116.059 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -87.16 0.34 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.903 1.681 . . . . 0.0 106.692 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -23.38 30.8 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.034 -1.666 . . . . 0.0 114.699 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.55 -37.71 88.35 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 116.824 -1.56 . . . . 0.0 113.034 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.0 t -50.46 -46.44 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.089 1.356 . . . . 0.0 109.985 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -67.92 -37.81 82.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.596 1.558 . . . . 0.0 114.105 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -63.13 -39.23 94.09 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 120.796 -1.19 . . . . 0.0 110.95 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.67 -40.4 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.519 -176.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -52.37 -55.29 22.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.983 0.913 . . . . 0.0 110.262 168.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 t -70.56 -42.48 71.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -73.14 -36.35 66.65 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.84 1.256 . . . . 0.0 110.731 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -49.56 18.58 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.559 172.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 t -71.6 17.23 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.879 1.672 . . . . 0.0 113.722 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 -2.48 16.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.895 1.678 . . . . 0.0 112.545 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.5 135.83 38.28 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.779 -1.201 . . . . 0.0 111.309 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -54.71 -9.66 0.36 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -5.58 9.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.855 1.662 . . . . 0.0 115.075 176.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -91.91 138.23 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.65 2.023 . . . . 0.0 110.58 -170.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -94.82 -30.54 14.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.994 1.318 . . . . 0.0 111.345 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -174.57 174.54 2.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 123.36 1.552 . . . . 0.0 113.054 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 tt -165.93 151.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.244 2.217 . . . . 0.0 109.356 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.23 147.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.699 2.4 . . . . 0.0 106.286 167.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.79 152.71 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.086 0.555 . . . . 0.0 109.789 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.3 t -84.78 144.35 28.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.556 0.693 . . . . 0.0 111.743 171.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -20.86 23.73 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -60.39 1.98 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.416 1.087 . . . . 0.0 108.385 168.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.79 143.23 36.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.061 0.934 . . . . 0.0 110.967 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.34 42.61 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.086 0.955 . . . . 0.0 112.672 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 p -140.68 150.67 43.78 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.132 -1.605 . . . . 0.0 113.999 -172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.91 146.26 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.096 2.158 . . . . 0.0 110.584 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.26 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.5 t -119.03 133.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.867 1.267 . . . . 0.0 108.418 -167.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.1 t -120.73 109.79 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.786 1.634 . . . . 0.0 108.146 -167.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CD1' HD11 ' A' ' 57' ' ' LEU . 33.6 p90 -127.08 146.68 50.28 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.067 -1.021 . . . . 0.0 113.718 -168.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 CA--C 1.54 0.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.535 0.553 0 CA-C-O 118.7 -0.625 . . . . 0.0 113.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -49.28 -40.64 35.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.242 1.017 . . . . 0.0 112.174 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 -38.2 67.59 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.938 -1.101 . . . . 0.0 112.416 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.3 mt -70.14 -44.94 67.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.106 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -54.18 11.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.661 1.184 . . . . 0.0 110.372 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -51.95 -43.37 63.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.87 68.05 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.975 1.261 . . . . 0.0 112.824 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.51 -54.79 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.923 0.889 . . . . 0.0 109.958 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -53.16 -28.97 28.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.827 0.851 . . . . 0.0 111.402 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.35 -2.81 43.28 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -87.8 -39.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 110.484 177.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -136.96 77.37 43.76 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 122.681 0.392 . . . . 0.0 110.496 164.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.04 116.31 3.05 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.429 2.753 . . . . 0.0 109.456 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.03 -21.88 41.71 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 117.116 -1.936 . . . . 0.0 115.402 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tp -95.24 -26.51 15.93 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 121.333 2.567 . . . . 0.0 112.673 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -91.66 105.36 17.68 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -166.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 66.68 1.31 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.214 1.406 . . . . 0.0 110.463 168.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.62 137.76 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.284 0.633 . . . . 0.0 111.737 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.17 133.83 13.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.35 1.06 . . . . 0.0 112.009 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.6 mt -73.75 122.79 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 121.113 -0.992 . . . . 0.0 108.39 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 C-N-CA 124.021 0.929 . . . . 0.0 110.228 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 123.021 1.391 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 t -93.24 174.46 7.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -157.41 144.03 18.07 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.157 1.383 . . . . 0.0 110.034 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.96 159.78 43.52 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.624 1.57 . . . . 0.0 111.683 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m -120.61 139.84 52.4 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.551 1.541 . . . . 0.0 110.055 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -140.76 142.54 34.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.945 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -124.13 140.72 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.491 1.116 . . . . 0.0 110.064 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.78 148.42 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.219 1.808 . . . . 0.0 108.295 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.5 142.3 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 162.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.15 -16.01 55.94 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.042 0.83 . . . . 0.0 111.142 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptm -58.81 133.63 56.16 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 122.012 -0.699 . . . . 0.0 109.142 168.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -61.48 15.59 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 115.624 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 m 68.55 -15.43 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.268 2.227 . . . . 0.0 116.463 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -88.6 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 107.408 -169.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 p -55.09 -27.65 46.53 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.998 -1.689 . . . . 0.0 114.544 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.27 -38.2 82.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 120.881 1.673 . . . . 0.0 112.084 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.97 -48.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.533 1.533 . . . . 0.0 109.574 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -71.24 -29.9 65.67 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -64.54 -40.38 95.49 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.293 -1.504 . . . . 0.0 110.681 167.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -38.93 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.06 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -52.85 -53.67 45.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 109.894 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 -46.33 63.54 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -170.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.0 m -69.27 -35.48 76.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.021 1.328 . . . . 0.0 111.183 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -50.6 14.04 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.399 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.3 t -72.69 11.21 0.68 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.432 1.469 . . . . 0.0 113.892 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.57 -7.92 19.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.477 1.511 . . . . 0.0 111.668 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.5 129.21 36.89 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.028 0.831 . . . . 0.0 109.451 -171.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -58.29 -20.65 44.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 -10.8 37.9 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -90.55 141.5 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 122.271 2.305 . . . . 0.0 109.936 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 t -97.6 -30.83 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.695 1.598 . . . . 0.0 111.33 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -175.51 172.85 2.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.29 1.436 . . . . 0.0 113.254 -169.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -168.57 150.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.564 1.946 . . . . 0.0 111.311 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.97 150.09 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 128.971 2.908 . . . . 0.0 106.345 167.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.29 147.65 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.083 0.468 . . . . 0.0 110.716 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -70.38 141.16 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.101 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.92 -23.77 14.84 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 111.836 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.09 -39.6 10.05 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 130.316 3.447 . . . . 0.0 112.981 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -97.62 -177.29 3.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.797 1.639 . . . . 0.0 110.913 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -112.33 44.39 1.45 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.965 1.306 . . . . 0.0 111.777 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -137.14 153.71 50.43 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.488 -1.383 . . . . 0.0 113.98 -169.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.52 140.08 52.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.111 1.764 . . . . 0.0 111.427 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -110.06 116.1 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 57' ' ' LEU . 16.6 t -122.93 132.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.939 1.295 . . . . 0.0 108.327 -167.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.56 112.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.628 1.971 . . . . 0.0 107.53 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.534 ' CD1' HD11 ' A' ' 57' ' ' LEU . 23.0 p90 -130.84 150.9 51.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.72 1.6 . . . . 0.0 113.478 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 CA--C 1.536 0.425 0 O-C-N 120.818 -1.176 . . . . 0.0 111.696 -171.386 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.536 0.579 0 N-CA-C 113.018 0.353 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 62.1 mm-40 -60.18 -28.94 68.36 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -172.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.1 p -62.09 -40.33 95.47 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.063 -1.648 . . . . 0.0 112.708 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 47' ' ' TYR . 49.6 mt -70.13 -46.35 64.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 0.0 111.298 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -49.24 -55.48 12.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.515 1.126 . . . . 0.0 111.753 173.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.76 -30.67 69.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.571 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.62 80.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.243 1.383 . . . . 0.0 111.817 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mt -61.78 -53.77 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.136 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -54.07 -25.71 23.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.38 0.672 . . . . 0.0 112.717 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.79 2.27 49.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -92.88 -30.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.941 0.896 . . . . 0.0 111.434 175.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.08 68.53 9.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.701 0.8 . . . . 0.0 111.16 169.253 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.78 136.43 70.23 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.103 3.202 . . . . 0.0 111.807 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.74 -24.17 6.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.678 1.133 . . . . 0.0 113.585 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.01 -35.93 15.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.867 1.267 . . . . 0.0 111.06 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -88.27 108.89 19.54 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 32.58 0.09 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 128.634 2.774 . . . . 0.0 115.695 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.34 130.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -166.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.6 m -145.0 148.55 33.86 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.476 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 98.6 mt -83.44 122.85 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.73 1.212 . . . . 0.0 108.499 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.522 -0.108 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.475 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 122.853 1.311 . . . . 0.0 113.512 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -122.29 -174.48 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.331 2.252 . . . . 0.0 110.473 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.32 147.37 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.663 -1.273 . . . . 0.0 109.918 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.97 158.89 44.62 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.993 1.317 . . . . 0.0 111.273 169.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.1 m -120.34 137.29 54.36 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.753 1.221 . . . . 0.0 110.46 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.04 149.13 47.24 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.912 0.885 . . . . 0.0 112.909 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tt -137.56 136.61 46.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 124.343 1.057 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.87 108.34 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.284 1.434 . . . . 0.0 112.288 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 87.86 7.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.822 0.82 . . . . 0.0 108.8 168.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.14 -23.83 0.28 Allowed Glycine 0 N--CA 1.48 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 114.837 -168.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -79.82 138.82 37.32 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.175 0.987 . . . . 0.0 113.192 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -65.68 27.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.229 2.212 . . . . 0.0 114.368 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.7 m 52.15 -115.5 0.92 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.046 2.138 . . . . 0.0 111.419 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 40.3 mttp -67.01 -17.46 64.93 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -165.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.9 p -88.4 -43.41 11.51 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.003 1.274 . . . . 0.0 110.446 166.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.84 -43.1 76.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 116.838 -1.553 . . . . 0.0 112.049 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG13 ' CG1' ' A' ' 36' ' ' VAL . 4.6 t -37.78 -56.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.273 1.829 . . . . 0.0 111.567 171.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 t -65.65 -39.36 91.32 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.569 0.748 . . . . 0.0 111.661 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -60.52 -40.02 89.96 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -42.79 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 118.74 -0.648 . . . . 0.0 109.743 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -54.81 -51.32 66.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.951 0.9 . . . . 0.0 110.876 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -70.37 -41.41 73.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.7 m -70.69 -40.03 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.318 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -45.46 44.2 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.669 -1.158 . . . . 0.0 111.518 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 t -71.01 11.3 0.42 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.836 1.653 . . . . 0.0 113.819 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.87 -6.37 22.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.326 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.7 mt -77.08 125.42 29.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.196 -0.94 . . . . 0.0 108.669 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.78 -15.13 52.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -12.56 33.98 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -87.2 135.93 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.68 2.036 . . . . 0.0 109.975 -170.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 t -103.45 -15.01 16.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m 178.75 173.64 0.7 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.141 2.576 . . . . 0.0 112.333 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -173.19 152.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 127.509 2.323 . . . . 0.0 108.962 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -145.15 129.22 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.129 2.172 . . . . 0.0 107.838 166.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.4 t -94.5 139.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 123.006 1.384 . . . . 0.0 111.346 169.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -74.32 85.11 1.94 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.748 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 1.5 tt -49.81 -38.44 34.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.244 2.218 . . . . 0.0 114.36 -168.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -60.25 4.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.473 1.13 . . . . 0.0 110.264 170.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -79.83 -176.92 5.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.389 2.676 . . . . 0.0 116.072 -168.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 33.54 3.65 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.075 -2.33 . . . . 0.0 110.774 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 p -144.4 160.84 40.39 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.94 37.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.776 1.63 . . . . 0.0 111.217 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -106.25 112.54 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.457 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.0 t -113.05 133.31 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.364 1.466 . . . . 0.0 107.625 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.28 95.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.89 1.276 . . . . 0.0 108.506 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD1' HD11 ' A' ' 57' ' ' LEU . 26.7 p90 -114.34 145.63 41.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 CA--C 1.535 0.391 0 O-C-N 121.223 -0.923 . . . . 0.0 111.354 -177.772 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.46 -0.485 0 CA-C-O 119.053 -0.478 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.15 -27.03 63.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.123 0.874 . . . . 0.0 112.789 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m -70.25 -35.06 73.55 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.36 1.891 . . . . 0.0 112.049 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.2 mt -70.12 -44.7 68.41 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.52 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -53.06 -44.3 67.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.672 0.789 . . . . 0.0 111.278 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.59 98.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.169 1.788 . . . . 0.0 113.961 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.21 71.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 120.081 1.31 . . . . 0.0 112.031 173.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.6 -56.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.787 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -46.46 -35.99 6.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.357 1.063 . . . . 0.0 111.605 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 1.23 27.18 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -96.28 -29.3 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.709 1.204 . . . . 0.0 112.229 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -148.39 59.3 4.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 121.202 -0.937 . . . . 0.0 112.277 169.128 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.43 140.01 92.22 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.662 2.908 . . . . 0.0 111.192 -175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.33 -54.53 0.64 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.794 1.188 . . . . 0.0 110.756 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 mt -75.55 -46.06 34.3 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.386 1.093 . . . . 0.0 112.038 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -67.86 88.18 0.25 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 69.49 2.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.486 1.515 . . . . 0.0 109.105 168.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.17 138.7 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 122.768 1.271 . . . . 0.0 110.951 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 m -143.07 168.73 19.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.356 1.463 . . . . 0.0 110.24 174.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.75 131.47 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.557 1.543 . . . . 0.0 108.524 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 124.357 1.063 . . . . 0.0 112.009 -169.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 122.396 1.093 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 t -129.56 170.73 13.38 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.726 1.61 . . . . 0.0 108.267 167.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.86 163.98 39.5 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.959 -1.088 . . . . 0.0 111.699 -173.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.74 160.4 37.84 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.737 1.215 . . . . 0.0 111.859 169.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 m -123.77 136.73 54.59 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.215 1.406 . . . . 0.0 110.737 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.52 145.52 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.012 1.325 . . . . 0.0 111.032 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 tt -134.06 130.85 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.685 1.194 . . . . 0.0 110.64 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.91 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.967 1.307 . . . . 0.0 109.047 -169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -71.86 1.04 7.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.25 35.85 1.79 Allowed Glycine 0 C--O 1.222 -0.628 0 C-N-CA 125.976 1.751 . . . . 0.0 111.141 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ttm -90.86 148.34 22.56 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.915 0.886 . . . . 0.0 111.115 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.5 m170 -73.72 3.41 6.48 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.372 0.669 . . . . 0.0 111.599 167.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.2 m 61.54 -112.78 0.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.564 2.346 . . . . 0.0 112.16 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -48.66 -51.58 27.64 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -166.094 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 m -80.01 -22.58 42.29 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.838 -1.789 . . . . 0.0 113.936 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 13' ' ' HIS . 1.3 m -63.64 -39.79 95.25 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-O 116.497 -1.716 . . . . 0.0 111.516 171.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 38' ' ' LEU . 23.5 t -47.9 -51.49 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.638 1.563 . . . . 0.0 112.788 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.5 t -55.07 -43.55 73.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.292 0.637 . . . . 0.0 111.981 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -63.2 -39.38 94.48 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -45.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.133 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.62 -48.44 63.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.41 1.084 . . . . 0.0 109.858 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -70.05 -42.18 73.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -74.64 -38.28 62.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 111.192 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.06 -45.66 56.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 116.58 -1.676 . . . . 0.0 112.604 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 t -69.42 14.33 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 121.885 2.129 . . . . 0.0 114.543 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.21 -5.33 15.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.892 1.677 . . . . 0.0 112.655 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.67 137.95 41.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.202 0.91 . . . . 0.0 111.475 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -73.66 55.39 0.51 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.473 1.909 . . . . 0.0 112.622 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 p90 174.09 -22.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.882 2.873 . . . . 0.0 113.894 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.8 p -86.66 142.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 120.826 1.648 . . . . 0.0 109.256 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -108.05 -19.66 13.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.697 0.799 . . . . 0.0 112.573 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -175.43 174.28 2.34 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.435 1.894 . . . . 0.0 112.277 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 tt -174.86 151.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.938 2.095 . . . . 0.0 110.209 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.08 131.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.345 2.258 . . . . 0.0 107.732 166.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 18' ' ' VAL . 68.3 t -104.08 137.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 123.53 1.633 . . . . 0.0 111.638 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m -79.37 81.36 5.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.261 1.424 . . . . 0.0 111.087 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 18' ' ' VAL . 17.0 tp -50.85 -43.68 59.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -168.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.18 -42.15 60.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.994 0.918 . . . . 0.0 111.978 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -103.42 -170.82 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.138 3.775 . . . . 0.0 111.729 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.61 31.33 6.05 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.894 1.678 . . . . 0.0 114.579 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 p -135.2 157.68 46.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.63 138.6 51.32 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.851 1.661 . . . . 0.0 110.525 -175.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.68 121.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -125.06 125.18 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.081 1.352 . . . . 0.0 109.192 -166.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 78.9 t -111.98 109.52 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 109.933 -168.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.462 ' CD1' HD11 ' A' ' 57' ' ' LEU . 50.0 p90 -124.33 166.98 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 113.207 -171.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 CA--C 1.541 0.623 0 O-C-N 121.318 -0.864 . . . . 0.0 112.142 -169.039 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 N-CA-C 114.788 1.034 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.25 -25.09 67.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.182 0.901 . . . . 0.0 112.906 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -69.56 -38.68 77.54 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.026 -1.046 . . . . 0.0 113.161 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.5 mt -67.69 -44.53 77.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.27 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -47.11 -54.89 9.44 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.322 1.049 . . . . 0.0 110.222 169.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -53.8 -41.62 67.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -30.62 69.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.017 0.826 . . . . 0.0 111.81 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.7 mt -68.1 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.752 0.821 . . . . 0.0 109.685 169.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.419 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -49.91 -33.43 17.37 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.704 0.683 . . . . 0.0 111.911 175.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.13 -0.4 24.77 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -99.58 -27.12 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.672 1.589 . . . . 0.0 111.689 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.55 64.06 8.29 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.387 -0.821 . . . . 0.0 111.098 168.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.5 144.93 95.39 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.364 3.376 . . . . 0.0 112.973 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.56 -28.8 3.39 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.17 1.367 . . . . 0.0 113.581 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -97.45 -43.76 7.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.158 1.783 . . . . 0.0 111.048 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.4 m-30 -68.88 99.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.05 80.26 4.49 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.823 -1.173 . . . . 0.0 109.142 169.105 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.25 132.46 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.65 -0.656 . . . . 0.0 111.27 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 134.2 30.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.519 1.128 . . . . 0.0 109.188 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.29 122.01 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.451 -1.406 . . . . 0.0 108.003 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 122.569 1.176 . . . . 0.0 110.383 176.802 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 t -95.73 176.65 6.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 111.684 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.54 149.41 9.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.409 1.484 . . . . 0.0 109.407 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.67 157.28 37.89 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 110.479 169.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 m -119.28 135.93 54.48 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.782 0.833 . . . . 0.0 109.759 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.86 145.44 51.21 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.527 1.531 . . . . 0.0 110.868 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.09 139.26 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 125.13 1.372 . . . . 0.0 111.153 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.1 97.59 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.462 1.905 . . . . 0.0 109.91 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.9 78.25 9.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 123.355 1.55 . . . . 0.0 111.622 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.05 12.28 0.15 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 113.203 -1.817 . . . . 0.0 116.305 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 151.47 45.61 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.917 2.358 . . . . 0.0 113.123 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -70.58 36.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.225 -1.547 . . . . 0.0 114.118 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.9 m 64.29 -142.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.251 -1.531 . . . . 0.0 111.087 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' A' ' 38' ' ' LEU . 13.8 mptt -56.76 -37.18 70.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.919 0.888 . . . . 0.0 113.158 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -66.08 -45.56 80.83 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.151 -0.968 . . . . 0.0 112.578 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.414 ' O ' HG13 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -60.9 -50.42 73.48 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.962 172.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -44.85 -46.82 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.508 1.923 . . . . 0.0 112.154 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -66.56 -42.46 87.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -54.94 -35.85 64.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.503 -1.373 . . . . 0.0 113.144 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -70.15 -39.34 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.482 -174.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -62.38 -49.15 76.68 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -65.53 -42.29 92.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 m -69.54 -40.95 76.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.994 1.318 . . . . 0.0 110.966 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -45.92 48.95 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.813 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -74.09 11.61 0.88 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.961 1.255 . . . . 0.0 113.389 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.51 -5.0 17.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.675 1.59 . . . . 0.0 112.009 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.8 mt -75.69 129.62 37.41 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.01 -1.056 . . . . 0.0 110.097 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -53.21 -22.65 7.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.69 1.196 . . . . 0.0 114.157 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 -8.94 29.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.37 139.86 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 121.862 2.119 . . . . 0.0 109.624 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -109.37 -12.96 14.68 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -178.05 173.13 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.544 2.338 . . . . 0.0 111.322 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -178.59 152.66 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 109.835 -171.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 t -147.33 132.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 128.18 2.592 . . . . 0.0 107.755 167.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -101.64 149.34 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.468 1.128 . . . . 0.0 112.115 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 m -70.73 111.85 6.51 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.518 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.4 tm? -61.64 -45.43 94.09 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.047 1.294 . . . . 0.0 110.348 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.13 -56.38 11.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.735 0.814 . . . . 0.0 112.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -93.2 -179.98 5.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -166.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 16.36 3.45 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 p -139.4 155.62 47.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -166.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.4 131.55 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.762 2.425 . . . . 0.0 110.708 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -101.21 110.01 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.555 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -115.19 133.78 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.598 1.559 . . . . 0.0 108.024 -169.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.62 108.18 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.538 1.535 . . . . 0.0 108.128 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.7 p90 -127.27 154.45 44.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.532 0.273 0 O-C-N 121.462 -0.774 . . . . 0.0 110.223 -173.806 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 CA--C 1.537 0.661 0 N-CA-C 113.259 0.446 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.68 -20.74 63.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.306 1.442 . . . . 0.0 113.087 -172.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.6 p -69.14 -44.33 72.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.54 -1.35 . . . . 0.0 112.697 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 ' CG1' ' A' ' 45' ' ' VAL . 51.0 mt -63.89 -46.89 82.86 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.109 0.564 . . . . 0.0 109.869 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -48.94 -52.75 22.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.082 0.953 . . . . 0.0 110.8 170.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -54.93 -38.2 67.39 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.64 80.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.253 0.933 . . . . 0.0 111.15 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.4 mt -66.94 -52.54 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.844 -0.535 . . . . 0.0 109.794 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.94 -22.21 24.96 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.014 -1.054 . . . . 0.0 112.676 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.55 -1.3 57.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.282 1.401 . . . . 0.0 114.76 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -95.37 -27.42 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.584 1.153 . . . . 0.0 111.046 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.72 71.08 7.33 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.556 1.142 . . . . 0.0 111.459 168.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.9 145.95 97.02 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.664 3.576 . . . . 0.0 113.839 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.33 -40.21 2.36 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.937 1.732 . . . . 0.0 113.085 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.89 -55.29 6.84 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.263 1.425 . . . . 0.0 111.156 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.4 m-30 -69.01 110.42 4.45 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.985 1.314 . . . . 0.0 114.425 -169.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.21 57.02 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.398 -1.439 . . . . 0.0 113.279 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.0 118.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 122.319 1.057 . . . . 0.0 113.023 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -135.21 147.71 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.093 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.47 120.94 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.607 1.163 . . . . 0.0 109.672 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.9 p . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 125.817 1.647 . . . . 0.0 110.477 -179.234 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 CA--C 1.55 0.957 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -116.52 -178.94 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.168 1.787 . . . . 0.0 111.146 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -157.36 148.46 21.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.27 1.428 . . . . 0.0 110.289 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.18 43.85 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.015 1.326 . . . . 0.0 111.783 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.5 m -121.32 140.18 52.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.991 1.317 . . . . 0.0 109.958 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -139.22 145.9 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.403 1.481 . . . . 0.0 111.068 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.3 tt -131.0 134.43 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.461 1.504 . . . . 0.0 111.072 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 100.15 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.465 1.106 . . . . 0.0 109.813 -169.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 23.7 t0 -78.2 41.06 0.36 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.481 1.512 . . . . 0.0 112.709 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.83 23.92 0.08 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.208 1.385 . . . . 0.0 113.764 -171.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.4 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 4.9 ttt -95.81 135.12 37.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.416 1.886 . . . . 0.0 112.064 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -60.48 21.75 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m 71.1 -62.31 0.46 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.248 2.619 . . . . 0.0 114.086 171.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HE3' HD22 ' A' ' 38' ' ' LEU . 13.3 mptt -122.82 -53.94 1.85 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.516 1.126 . . . . 0.0 113.626 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 p -65.74 -22.3 66.59 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.481 -2.012 . . . . 0.0 113.199 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p -45.41 -56.82 4.58 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.596 1.158 . . . . 0.0 110.041 168.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 38' ' ' LEU . 73.6 t -47.23 -53.65 3.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 127.9 2.48 . . . . 0.0 111.076 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.3 t -64.84 -25.41 67.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.64 -53.27 12.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.2 0.909 . . . . 0.0 110.257 167.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -44.96 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.58 -0.7 . . . . 0.0 110.562 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.3 -21.62 62.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 0.0 112.873 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.7 t -91.77 -58.94 2.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.574 1.15 . . . . 0.0 113.759 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.0 m -54.95 -39.61 69.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.329 2.252 . . . . 0.0 112.491 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 -49.79 20.64 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.603 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -70.69 14.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.252 1.387 . . . . 0.0 113.856 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.59 -7.01 18.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.041 1.736 . . . . 0.0 111.766 173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.407 HD11 ' CB ' ' A' ' 60' ' ' ALA . 17.5 mt -76.64 129.72 36.79 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 -172.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.47 -17.34 59.32 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -171.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 -11.52 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 169.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.9 p -94.11 135.91 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 122.172 2.26 . . . . 0.0 110.395 -170.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -107.49 -12.78 15.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.664 0.786 . . . . 0.0 113.094 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -179.81 174.38 0.93 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.219 2.608 . . . . 0.0 112.552 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 tt -172.42 153.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.038 2.535 . . . . 0.0 109.59 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 t -147.0 131.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.258 2.223 . . . . 0.0 107.99 167.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.29 137.29 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.487 1.613 . . . . 0.0 112.425 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 m -88.33 86.21 7.02 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.582 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.479 HD22 ' HE3' ' A' ' 15' ' ' LYS . 7.2 mt -47.94 -36.75 12.96 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.89 2.876 . . . . 0.0 115.286 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.23 -4.96 58.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.868 1.318 . . . . 0.0 113.792 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -116.36 -168.02 1.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.185 2.594 . . . . 0.0 108.769 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.46 43.41 2.97 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.91 -1.744 . . . . 0.0 110.056 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -134.47 151.58 51.24 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.083 -1.011 . . . . 0.0 112.959 -172.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.38 140.45 52.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.601 1.96 . . . . 0.0 109.347 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.7 mt -111.2 116.7 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -117.98 129.63 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.773 1.629 . . . . 0.0 107.447 -169.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 102.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 108.962 -168.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.514 ' CD1' HD11 ' A' ' 57' ' ' LEU . 29.3 p90 -120.92 141.0 51.05 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.532 1.133 . . . . 0.0 113.945 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 CA--C 1.535 0.396 0 O-C-N 120.685 -1.259 . . . . 0.0 110.786 -172.571 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 CA--C 1.534 0.484 0 CA-C-O 118.755 -0.602 . . . . 0.0 113.182 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -32.53 55.91 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.365 0.984 . . . . 0.0 112.47 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 m -88.77 -23.7 22.82 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.964 -169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 47' ' ' TYR . 74.8 mt -68.11 -42.24 80.54 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.27 169.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -47.11 -55.64 7.99 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.611 0.764 . . . . 0.0 109.521 168.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -47.57 -48.22 28.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.355 1.062 . . . . 0.0 113.823 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.53 -27.95 69.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.118 0.872 . . . . 0.0 112.959 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.17 -49.7 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.124 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -51.3 -34.3 32.61 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 123.443 0.697 . . . . 0.0 110.284 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.38 5.75 14.08 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.86 -27.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.875 0.87 . . . . 0.0 111.699 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.54 65.5 8.54 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.088 168.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.5 146.27 97.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.341 3.361 . . . . 0.0 113.356 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.21 -29.44 2.81 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.852 1.215 . . . . 0.0 113.383 -174.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -94.79 -45.1 7.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.969 1.708 . . . . 0.0 110.791 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -71.8 106.96 4.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' CB ' ' HB3' ' A' ' 10' ' ' ASP . 77.9 mtt180 -80.96 78.24 7.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.154 0.982 . . . . 0.0 111.393 169.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -85.8 125.0 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.876 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 137.3 41.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 108.793 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.87 127.5 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 0.0 108.829 172.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 123.174 1.464 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -140.2 175.28 9.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.627 3.171 . . . . 0.0 107.734 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -159.56 156.8 28.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.658 -1.276 . . . . 0.0 111.146 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.05 163.44 40.28 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 125.486 1.514 . . . . 0.0 111.316 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.3 m -125.54 139.58 53.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.197 1.399 . . . . 0.0 110.109 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -139.21 140.78 37.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.056 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.35 141.43 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.525 1.13 . . . . 0.0 109.347 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.05 165.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 125.179 1.392 . . . . 0.0 107.628 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -147.39 137.75 23.26 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.327 1.051 . . . . 0.0 108.313 167.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.17 69.96 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.244 0.925 . . . . 0.0 112.681 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 161.47 10.1 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.327 2.251 . . . . 0.0 114.437 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -68.98 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 126.155 1.782 . . . . 0.0 115.275 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 52.89 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 130.573 3.549 . . . . 0.0 119.279 167.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -49.77 1.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.601 1.56 . . . . 0.0 109.428 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -55.95 -27.1 50.9 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.359 -1.463 . . . . 0.0 113.048 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.5 p -49.69 -49.33 48.09 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 119.504 1.047 . . . . 0.0 111.645 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG11 ' A' ' 36' ' ' VAL . 37.8 t -52.91 -46.7 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.084 2.154 . . . . 0.0 111.967 -172.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -62.61 -42.79 99.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.134 0.574 . . . . 0.0 111.23 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -63.33 -43.06 98.84 Favored 'General case' 0 C--O 1.222 -0.37 0 O-C-N 121.968 -0.458 . . . . 0.0 111.792 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.21 -45.32 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.428 0.558 . . . . 0.0 109.53 -172.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.41 -50.67 59.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.306 1.442 . . . . 0.0 110.783 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -76.2 -31.58 58.52 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -79.71 -41.25 27.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.34 1.456 . . . . 0.0 110.289 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -44.62 50.12 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 116.861 -1.542 . . . . 0.0 111.272 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -73.31 17.28 0.14 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 121.148 1.795 . . . . 0.0 113.165 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.6 -3.11 15.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.709 1.604 . . . . 0.0 113.007 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 mt -75.27 134.87 41.0 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.82 -1.175 . . . . 0.0 111.964 -169.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.63 63.14 1.53 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.688 1.195 . . . . 0.0 112.059 -176.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.0 p90 168.38 -21.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 130.394 3.478 . . . . 0.0 114.531 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.09 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.54 1.518 . . . . 0.0 109.422 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -115.48 -11.39 11.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -169.97 173.16 6.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.941 1.353 . . . . 0.0 112.634 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -155.73 157.39 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 109.972 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -144.7 124.48 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 126.765 2.026 . . . . 0.0 107.124 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.541 HG11 HG13 ' A' ' 18' ' ' VAL . 56.0 t -94.19 134.26 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.732 1.253 . . . . 0.0 110.146 169.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 m -67.59 90.26 0.26 Allowed 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.148 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.04 -38.21 50.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.748 1.158 . . . . 0.0 112.332 -168.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -66.31 0.56 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.451 0.569 . . . . 0.0 110.643 170.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.22 165.18 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.318 1.532 . . . . 0.0 112.19 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 40.4 0.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.319 -1.488 . . . . 0.0 113.174 168.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 p -133.91 158.62 43.0 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 140.42 51.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.123 2.169 . . . . 0.0 110.984 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.73 118.31 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 57' ' ' LEU . 17.8 t -121.45 131.92 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.537 1.135 . . . . 0.0 108.22 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 t -118.32 120.9 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.331 1.453 . . . . 0.0 108.713 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.527 ' CD1' HD11 ' A' ' 57' ' ' LEU . 48.4 p90 -135.99 160.82 37.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 -170.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 CA--C 1.543 0.682 0 O-C-N 120.927 -1.108 . . . . 0.0 112.417 -169.026 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.537 0.64 0 N-CA-C 115.185 1.187 . . . . 0.0 115.185 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 p -66.58 -40.5 88.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.996 1.725 . . . . 0.0 112.917 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.5 mt -69.2 -43.61 73.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.19 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -52.01 -48.24 64.59 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.768 0.713 . . . . 0.0 109.913 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -60.93 -31.54 71.06 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.58 84.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.966 1.257 . . . . 0.0 111.891 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.86 -53.28 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.743 -0.598 . . . . 0.0 110.209 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -57.02 -21.13 28.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 112.102 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.39 1.99 55.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -93.47 -30.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.732 0.813 . . . . 0.0 111.258 175.44 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -148.55 69.49 10.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.536 0.734 . . . . 0.0 111.053 168.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.47 142.49 98.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.622 3.548 . . . . 0.0 112.574 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.87 -27.61 2.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.07 1.319 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 tp -88.62 -45.04 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.368 1.467 . . . . 0.0 111.514 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -78.67 102.5 8.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.817 1.247 . . . . 0.0 114.203 -168.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 9.4 ttt180 -70.3 44.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.62 130.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 122.588 1.185 . . . . 0.0 113.244 -166.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -136.7 148.33 47.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.491 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.88 126.45 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.79 -1.194 . . . . 0.0 108.271 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.089 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.984 0.897 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 t -115.55 -177.99 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 108.486 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -160.69 148.88 16.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.966 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.92 159.51 43.79 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.039 1.336 . . . . 0.0 110.958 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 m -117.85 134.54 54.83 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.46 1.504 . . . . 0.0 109.569 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -130.65 148.19 52.41 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.009 1.324 . . . . 0.0 111.054 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.6 tt -131.28 137.9 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.12 1.368 . . . . 0.0 110.4 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.69 110.9 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.769 1.628 . . . . 0.0 109.592 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.9 119.17 26.83 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 168.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.76 8.25 30.42 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.155 0.883 . . . . 0.0 113.413 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 138.23 58.28 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.491 -1.005 . . . . 0.0 110.76 171.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -55.32 -32.19 62.29 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p 144.71 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 131.642 3.977 . . . . 0.0 108.352 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -19.79 -61.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 129.597 3.159 . . . . 0.0 114.439 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -57.19 -11.24 1.56 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.48 -45.03 85.32 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.689 1.586 . . . . 0.0 109.693 168.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.0 t -55.5 -47.28 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 125.297 1.439 . . . . 0.0 111.995 -169.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.2 t -58.01 -38.6 76.49 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.156 0.979 . . . . 0.0 111.834 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -72.86 -40.02 66.01 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.166 -0.959 . . . . 0.0 113.035 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.663 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -46.51 -55.49 7.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.287 1.835 . . . . 0.0 109.484 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.4 m -70.32 -44.96 67.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -71.79 -38.55 70.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.451 1.101 . . . . 0.0 110.834 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -49.44 18.63 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.161 -1.4 . . . . 0.0 111.393 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -72.25 12.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.006 1.73 . . . . 0.0 113.184 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.16 -6.16 24.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.615 1.566 . . . . 0.0 111.703 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.6 127.27 32.69 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.31 -19.31 13.78 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -8.97 33.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.23 140.03 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 121.88 2.127 . . . . 0.0 109.554 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 t -111.39 -8.25 14.32 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.96 171.7 3.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.479 1.512 . . . . 0.0 113.237 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.68 150.04 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.402 1.481 . . . . 0.0 112.358 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.62 146.51 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 127.685 2.394 . . . . 0.0 105.867 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 18' ' ' VAL . 9.2 p -138.16 149.26 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.973 0.892 . . . . 0.0 111.11 177.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -101.49 96.11 6.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.38 -30.75 71.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.715 1.606 . . . . 0.0 115.208 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.25 1.84 49.36 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.507 1.146 . . . . 0.0 113.308 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -126.55 -170.55 2.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.669 2.788 . . . . 0.0 109.813 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 34.39 5.22 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.333 1.853 . . . . 0.0 112.205 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -141.29 154.78 45.91 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.89 143.38 51.11 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.614 2.366 . . . . 0.0 111.264 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -112.36 116.19 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.59 129.43 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -168.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 114.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.437 1.495 . . . . 0.0 107.044 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.486 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -136.45 151.02 49.02 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.374 1.069 . . . . 0.0 111.932 -168.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 CA--C 1.544 0.723 0 O-C-N 120.653 -1.28 . . . . 0.0 111.728 -175.923 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.542 0.895 0 N-CA-C 114.616 0.968 . . . . 0.0 114.616 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.126 0.875 . . . . 0.0 112.165 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -81.25 -18.1 47.17 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.126 -168.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.486 HD11 ' CD1' ' A' ' 47' ' ' TYR . 53.8 mt -70.19 -46.32 64.82 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.477 169.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -49.24 -52.64 25.86 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.537 1.062 . . . . 0.0 109.351 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.98 -41.82 71.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.26 69.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.826 1.194 . . . . 0.0 112.592 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.9 mt -72.7 -52.96 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.431 0.692 . . . . 0.0 109.954 170.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.13 -25.96 25.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.645 0.778 . . . . 0.0 112.518 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -0.89 37.83 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.06 -30.17 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.414 1.086 . . . . 0.0 111.297 179.355 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.79 66.48 10.66 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 121.605 -0.684 . . . . 0.0 111.479 168.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.58 142.21 98.48 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.525 3.483 . . . . 0.0 112.949 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.02 -30.18 2.99 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.286 1.422 . . . . 0.0 113.673 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.93 -39.49 10.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 112.01 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -79.76 107.2 12.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 113.424 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -83.9 78.06 9.8 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.707 -1.246 . . . . 0.0 111.217 171.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 135.09 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.843 0.83 . . . . 0.0 111.079 -173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 m -152.1 165.41 34.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.464 1.105 . . . . 0.0 111.312 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.7 mt -93.4 133.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.538 1.135 . . . . 0.0 109.112 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.141 0 C-N-CA 123.777 0.831 . . . . 0.0 109.851 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.626 0 CA-C-O 122.901 1.334 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 t -141.29 -175.76 4.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.439 2.696 . . . . 0.0 109.082 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 m -166.54 141.84 4.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.003 -1.061 . . . . 0.0 110.515 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.58 32.59 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.064 1.346 . . . . 0.0 110.676 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.2 m -130.2 138.63 50.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.863 1.265 . . . . 0.0 109.807 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -139.57 151.73 46.3 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.612 0.765 . . . . 0.0 112.259 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.9 tt -141.89 129.65 21.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 124.048 0.939 . . . . 0.0 112.077 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.75 114.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 126.485 1.914 . . . . 0.0 110.61 -168.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 1.46 17.15 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.69 4.15 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.027 1.775 . . . . 0.0 116.822 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -71.55 141.72 50.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.89 2.345 . . . . 0.0 113.477 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -68.49 32.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 127.483 2.313 . . . . 0.0 114.96 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t 54.71 -131.78 1.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.181 1.393 . . . . 0.0 111.158 171.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.565 ' HE2' HD13 ' A' ' 38' ' ' LEU . 74.6 mttt -54.58 -25.24 25.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -168.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -82.49 -46.17 13.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.975 1.261 . . . . 0.0 111.851 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.1 m -57.99 -40.85 81.7 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 117.123 -1.417 . . . . 0.0 111.387 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 36' ' ' VAL . 22.0 t -39.82 -56.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.022 1.729 . . . . 0.0 111.287 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -59.04 -43.1 91.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.856 . . . . 0.0 112.24 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -62.84 -40.73 98.34 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.752 -0.593 . . . . 0.0 112.461 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -49.39 76.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.11 -50.54 61.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.679 1.192 . . . . 0.0 110.673 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 t -68.76 -32.64 72.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.0 m -77.34 -48.7 16.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.642 0.734 . . . . 0.0 109.936 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' HG11 ' A' ' 31' ' ' VAL . 1.1 mm? -76.7 -20.05 57.02 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.168 1.387 . . . . 0.0 114.227 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.2 t -85.5 1.29 49.51 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.606 1.548 . . . . 0.0 112.969 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.36 1.75 11.83 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.606 -1.309 . . . . 0.0 114.187 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.89 152.05 42.89 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.4 -0.812 . . . . 0.0 112.568 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.72 47.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.919 2.087 . . . . 0.0 112.604 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.185 3.394 . . . . 0.0 114.095 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.4 p -94.23 142.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 122.402 2.365 . . . . 0.0 112.135 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 m -107.48 -18.59 13.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.507 1.523 . . . . 0.0 113.928 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 m -178.65 171.07 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.747 2.019 . . . . 0.0 111.854 -171.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -167.2 161.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.211 2.604 . . . . 0.0 109.701 -175.254 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 t -152.09 128.31 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 127.991 2.516 . . . . 0.0 107.718 165.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.438 ' CG1' HG13 ' A' ' 18' ' ' VAL . 37.9 t -96.24 142.79 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 123.39 1.566 . . . . 0.0 112.207 170.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 m -74.41 86.77 2.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.007 1.323 . . . . 0.0 110.284 170.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.565 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.1 tm? -44.0 -43.46 6.69 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.301 3.04 . . . . 0.0 113.096 -175.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.94 -9.4 58.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.084 1.354 . . . . 0.0 114.623 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -129.61 -170.01 2.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.377 2.671 . . . . 0.0 110.243 -167.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.64 33.87 5.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.319 1.848 . . . . 0.0 112.623 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -140.66 159.18 42.76 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.53 142.87 41.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.88 1.672 . . . . 0.0 111.129 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.8 121.19 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 57' ' ' LEU . 19.2 t -121.46 128.61 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.513 1.525 . . . . 0.0 107.729 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 103.12 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.648 1.579 . . . . 0.0 109.184 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CD1' HD11 ' A' ' 57' ' ' LEU . 46.2 p90 -119.31 156.51 29.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.49 1.116 . . . . 0.0 112.977 -170.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 124.429 1.092 . . . . 0.0 110.885 -172.739 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 CA-C-O 119.129 -0.446 . . . . 0.0 113.062 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -32.35 17.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.415 1.086 . . . . 0.0 112.339 170.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 m -72.88 -35.0 67.05 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.849 1.204 . . . . 0.0 111.791 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.54 HD11 ' CD1' ' A' ' 47' ' ' TYR . 73.7 mt -70.8 -43.47 68.58 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.925 -0.559 . . . . 0.0 109.736 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -52.71 -42.02 64.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.654 0.782 . . . . 0.0 110.84 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -39.79 95.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 169.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.97 69.53 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 121.104 1.775 . . . . 0.0 112.172 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.86 -58.77 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.587 0.755 . . . . 0.0 111.338 170.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -54.99 -18.59 5.26 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.836 1.254 . . . . 0.0 113.431 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.07 57.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -90.82 -29.71 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.282 1.033 . . . . 0.0 111.28 177.312 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.471 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.04 65.18 7.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 121.594 -0.691 . . . . 0.0 111.683 168.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.82 149.08 62.58 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.068 3.179 . . . . 0.0 112.586 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.14 -44.28 3.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.665 1.126 . . . . 0.0 112.513 -173.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 tp -77.05 -44.79 29.42 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.167 1.387 . . . . 0.0 110.717 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.482 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -81.36 94.75 6.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.458 1.123 . . . . 0.0 113.243 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' C ' ' HD2' ' A' ' 70' ' ' ARG 0.255 0.0 OUTLIER -77.8 110.51 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 164.274 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.17 146.93 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 124.371 3.259 . . . . 0.0 111.887 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -131.67 158.12 41.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.481 1.512 . . . . 0.0 110.029 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.6 mt -94.73 124.62 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 122.189 0.995 . . . . 0.0 109.593 174.549 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 123.273 1.511 . . . . 0.0 113.515 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -102.49 -177.52 3.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.741 2.017 . . . . 0.0 111.332 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.39 166.93 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.893 -1.129 . . . . 0.0 111.505 172.218 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.4 152.22 30.81 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.707 1.203 . . . . 0.0 111.223 169.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.0 m -114.7 139.07 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.697 1.599 . . . . 0.0 109.716 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -140.24 143.17 35.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.28 -176.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.8 132.45 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.295 1.038 . . . . 0.0 110.662 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.72 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.443 1.497 . . . . 0.0 110.072 -169.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.12 50.73 0.92 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.058 -1.026 . . . . 0.0 112.922 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 -8.27 0.02 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.008 1.766 . . . . 0.0 117.409 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -72.71 144.24 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.909 2.354 . . . . 0.0 111.723 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -64.52 5.48 0.28 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.24 1.816 . . . . 0.0 115.845 -176.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.55 -35.87 0.28 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.884 2.873 . . . . 0.0 115.52 171.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -103.1 -87.44 0.42 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.303 1.411 . . . . 0.0 110.602 172.515 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p -63.62 -13.04 38.47 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 119.152 -2.218 . . . . 0.0 115.256 -175.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.91 -39.79 94.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 121.213 1.824 . . . . 0.0 110.813 167.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -50.31 -47.28 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.084 2.154 . . . . 0.0 111.381 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.5 t -69.63 -37.58 76.87 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.689 -1.257 . . . . 0.0 111.881 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -49.68 80.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.058 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -51.28 -51.34 55.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.363 170.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -70.15 -31.14 68.5 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -176.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -78.14 -51.31 10.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.876 0.871 . . . . 0.0 109.134 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 61' ' ' ILE . 8.2 mt -77.12 -19.68 56.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.5 t -87.66 14.82 7.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 121.282 1.856 . . . . 0.0 112.697 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.56 4.13 9.59 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 18.1 mt -77.2 154.35 33.18 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.04 -1.038 . . . . 0.0 112.472 -171.212 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -64.58 13.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.535 2.734 . . . . 0.0 114.71 -174.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.2 3.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.295 2.238 . . . . 0.0 113.89 -169.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.3 p -104.64 133.14 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.966 1.712 . . . . 0.0 110.543 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -105.9 -12.41 15.85 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -177.57 174.22 1.56 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.146 1.778 . . . . 0.0 112.78 -176.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -167.33 153.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.249 2.22 . . . . 0.0 110.806 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.21 143.42 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.959 2.503 . . . . 0.0 106.581 166.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.85 148.85 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 40' ' ' ASN . 31.8 p -77.97 136.55 38.0 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 176.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.526 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -92.35 -15.88 26.72 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 112.873 169.78 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.49 -57.6 3.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.975 1.71 . . . . 0.0 110.63 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 37' ' ' SER . 39.4 m-80 -89.32 -179.11 5.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 113.202 -172.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 37.96 1.98 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.217 1.807 . . . . 0.0 113.965 177.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -141.96 147.19 36.58 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.635 -1.915 . . . . 0.0 115.255 -170.219 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.56 143.19 50.36 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.484 -174.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -117.64 117.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG1' HD13 ' A' ' 57' ' ' LEU . 36.9 t -122.88 119.67 58.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.914 1.286 . . . . 0.0 109.625 -165.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.6 t -103.95 108.95 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 109.425 -169.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CD1' HD11 ' A' ' 57' ' ' LEU . 31.6 p90 -122.86 144.68 49.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.896 1.278 . . . . 0.0 113.186 -171.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 120.495 -1.378 . . . . 0.0 111.935 -171.939 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.537 0.664 0 CA-C-O 118.951 -0.52 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -50.29 -40.94 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.04 0.936 . . . . 0.0 112.418 171.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -70.77 -32.78 70.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.384 -1.447 . . . . 0.0 112.731 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.3 mt -73.96 -45.44 50.24 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.42 175.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -48.92 -51.63 29.02 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.386 1.474 . . . . 0.0 109.821 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -55.46 -43.25 75.3 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.932 1.293 . . . . 0.0 113.413 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.34 74.95 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.419 0.554 . . . . 0.0 112.332 173.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.559 HG12 HD11 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -70.32 -54.54 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.793 -0.567 . . . . 0.0 111.595 172.549 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.54 -27.85 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.528 1.131 . . . . 0.0 111.425 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.15 1.36 48.3 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -95.3 -29.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.15 0.98 . . . . 0.0 111.477 177.149 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.03 66.73 8.83 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.664 -0.647 . . . . 0.0 111.453 168.51 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.55 141.15 97.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.014 3.143 . . . . 0.0 112.592 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.38 -40.99 3.05 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.109 1.338 . . . . 0.0 112.815 -174.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.09 -42.98 45.58 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.544 1.137 . . . . 0.0 111.52 172.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.458 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.9 m-30 -78.45 97.71 5.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.107 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -78.94 79.61 5.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.273 168.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 t -88.05 121.79 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.181 0.592 . . . . 0.0 111.896 -172.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.73 133.01 52.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.571 1.148 . . . . 0.0 110.931 -174.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mt -86.32 84.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.408 0.623 . . . . 0.0 109.789 -178.775 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p30 . . . . . 0 CA--C 1.545 0.771 0 CA-C-O 121.661 0.743 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -117.0 178.81 4.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.478 1.511 . . . . 0.0 110.872 170.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 m -156.38 146.48 21.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 125.636 1.574 . . . . 0.0 109.112 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.33 159.29 43.49 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.815 171.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.3 m -114.17 132.44 56.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.87 1.268 . . . . 0.0 109.986 174.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.94 146.07 50.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.775 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -131.85 134.78 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.817 1.247 . . . . 0.0 110.621 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.98 100.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.643 1.577 . . . . 0.0 109.015 -169.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.22 3.53 10.56 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.59 10.53 8.55 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 125.887 1.708 . . . . 0.0 113.357 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.4 tmm? -70.59 138.19 50.66 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.289 1.036 . . . . 0.0 110.2 -175.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.79 -6.89 1.96 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 174.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 t 81.74 -43.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.586 2.355 . . . . 0.0 110.601 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -122.95 149.4 44.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.764 1.226 . . . . 0.0 109.397 169.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m 69.77 -44.53 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.328 1.851 . . . . 0.0 113.261 -168.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.6 m -51.53 -47.87 63.2 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 121.096 1.771 . . . . 0.0 110.563 174.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 36' ' ' VAL . 40.2 t -29.9 -58.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 127.257 2.223 . . . . 0.0 113.844 168.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -70.5 -34.78 72.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 117.839 0.29 . . . . 0.0 111.4 -169.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -58.85 -43.82 90.87 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.545 -0.722 . . . . 0.0 112.104 168.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -41.37 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.43 -172.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.73 -50.62 69.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.815 0.846 . . . . 0.0 110.292 169.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -67.81 -45.71 73.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -175.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 m -66.85 -40.27 87.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.554 1.542 . . . . 0.0 110.576 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -47.02 42.86 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.838 176.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -68.77 6.32 0.89 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.244 1.384 . . . . 0.0 113.733 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.98 -5.46 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.512 176.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.7 mt -77.24 127.72 33.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.197 -0.939 . . . . 0.0 109.843 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -54.25 -21.93 10.41 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.68 -16.54 24.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 175.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.272 4.1 p -82.83 138.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.658 1.572 . . . . 0.0 110.031 -168.369 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -99.67 -31.25 11.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.951 1.701 . . . . 0.0 110.668 -174.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -166.49 174.76 8.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.596 1.189 . . . . 0.0 112.875 173.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 150.73 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.011 1.324 . . . . 0.0 111.601 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.73 134.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.293 1.837 . . . . 0.0 107.24 166.633 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 18' ' ' VAL . 28.0 t -101.31 134.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.171 0.986 . . . . 0.0 109.776 168.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -68.59 92.26 0.45 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.808 169.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -47.9 -43.05 28.44 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.989 1.715 . . . . 0.0 111.305 -177.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.52 -51.87 67.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.553 1.141 . . . . 0.0 112.031 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.69 -176.19 5.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 124.893 2.282 . . . . 0.0 113.814 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 30.2 4.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.482 2.313 . . . . 0.0 112.133 169.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 150.87 41.93 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.182 -1.574 . . . . 0.0 114.744 -167.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.8 136.45 51.49 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.592 1.957 . . . . 0.0 110.517 -171.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.23 111.37 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG1' HD13 ' A' ' 57' ' ' LEU . 11.7 t -117.5 130.79 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.2 1.4 . . . . 0.0 108.792 -169.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.65 112.78 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.195 1.398 . . . . 0.0 107.481 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 2.0 p90 -131.84 134.81 46.17 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.897 1.226 . . . . 0.0 112.303 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 CA--C 1.538 0.498 0 O-C-N 121.471 -0.768 . . . . 0.0 110.547 179.824 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 CA--C 1.535 0.573 0 CA-C-O 119.32 -0.367 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -52.81 -24.79 9.65 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 112.502 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -42.6 79.99 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.704 -1.248 . . . . 0.0 112.233 177.165 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD13 ' CG1' ' A' ' 45' ' ' VAL . 94.7 mt -70.47 -45.5 65.59 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.801 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -46.06 -52.25 12.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.984 0.914 . . . . 0.0 110.345 170.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -32.83 74.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 177.4 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.297 1.408 . . . . 0.0 111.537 170.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.53 -52.85 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.876 0.47 . . . . 0.0 110.684 171.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.07 -27.75 14.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.237 0.926 . . . . 0.0 112.0 174.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.57 4.15 33.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.32 -28.04 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.926 0.89 . . . . 0.0 111.544 173.885 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.36 67.81 9.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.506 -0.746 . . . . 0.0 111.068 168.599 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.9 139.87 87.31 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.054 3.169 . . . . 0.0 111.868 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.82 -23.06 7.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.571 1.081 . . . . 0.0 114.073 -175.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 -45.16 7.37 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.376 1.471 . . . . 0.0 111.492 173.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.6 m-30 -76.95 102.07 6.24 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -168.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.622 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -75.86 75.99 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 110.267 168.743 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.91 129.65 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 122.227 1.013 . . . . 0.0 111.744 -176.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -138.66 159.72 41.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.613 1.565 . . . . 0.0 109.992 178.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.3 mt -95.69 129.61 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.584 0.707 . . . . 0.0 109.955 -179.195 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 122.994 1.378 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -120.13 168.89 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.297 2.239 . . . . 0.0 107.972 167.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m -152.89 147.89 26.51 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.196 -0.94 . . . . 0.0 110.601 -175.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.52 161.32 42.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.558 1.143 . . . . 0.0 112.162 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.1 m -121.47 137.73 54.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.101 1.36 . . . . 0.0 110.257 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -136.9 143.16 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.779 1.231 . . . . 0.0 110.31 -178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 tt -132.07 131.67 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 111.052 -175.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.63 102.36 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.329 1.852 . . . . 0.0 108.768 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -76.52 33.07 0.13 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.052 -1.655 . . . . 0.0 114.143 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.97 -0.71 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.424 1.488 . . . . 0.0 116.263 -176.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.8 ptm -69.94 141.02 53.12 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.466 2.133 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -59.19 12.09 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 127.235 2.214 . . . . 0.0 116.17 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.4 m 73.12 -42.64 0.54 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.275 2.63 . . . . 0.0 115.768 167.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.11 -89.64 0.47 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.046 1.338 . . . . 0.0 109.129 174.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 p -55.57 -22.77 23.49 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 121.679 2.036 . . . . 0.0 115.601 -173.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -57.87 -42.75 85.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 112.527 169.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' CG1' ' A' ' 36' ' ' VAL . 37.6 t -46.43 -54.59 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.038 1.735 . . . . 0.0 110.814 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 t -60.01 -37.95 81.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.2 0.6 . . . . 0.0 111.605 -176.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -65.7 -42.76 90.79 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.36 -0.829 . . . . 0.0 112.375 174.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -44.48 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.095 0.861 . . . . 0.0 110.055 -175.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.76 -55.61 21.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.404 1.082 . . . . 0.0 110.37 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.4 t -64.1 -49.36 72.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.5 m -69.95 -36.25 75.14 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.98 1.312 . . . . 0.0 111.16 -172.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.98 -47.97 40.65 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.746 168.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -65.81 7.68 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 121.288 1.858 . . . . 0.0 115.283 -171.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.51 -3.32 18.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.824 2.05 . . . . 0.0 112.199 176.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.5 136.84 46.01 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.99 -1.069 . . . . 0.0 110.996 -171.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -75.63 65.65 1.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.786 1.634 . . . . 0.0 111.274 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 p90 167.25 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 129.961 3.304 . . . . 0.0 113.041 -173.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.2 p -86.03 142.63 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 121.184 1.811 . . . . 0.0 110.186 -175.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.06 -21.79 12.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -170.54 172.01 6.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.073 1.749 . . . . 0.0 112.369 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -176.25 153.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 127.804 2.442 . . . . 0.0 109.593 -169.3 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -147.11 132.6 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.588 2.355 . . . . 0.0 107.743 166.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.2 t -103.09 142.14 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.458 0.647 . . . . 0.0 110.825 169.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -73.28 108.79 6.36 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 122.81 1.29 . . . . 0.0 109.126 166.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -20.24 44.68 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.341 -0.849 . . . . 0.0 112.139 168.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -91.9 -45.6 8.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.539 1.063 . . . . 0.0 112.57 175.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -99.6 157.56 16.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.828 1.251 . . . . 0.0 112.178 -171.021 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.81 35.01 0.23 Allowed 'General case' 0 CA--C 1.548 0.872 0 O-C-N 119.732 -1.855 . . . . 0.0 113.946 -177.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -140.49 154.55 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 119.914 -1.741 . . . . 0.0 115.431 -170.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.56 139.19 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.187 2.195 . . . . 0.0 109.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -110.26 118.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 169.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.411 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -121.65 138.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.899 1.28 . . . . 0.0 110.125 -167.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.14 99.4 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.238 1.415 . . . . 0.0 109.925 -167.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -118.13 143.01 46.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.537 1.535 . . . . 0.0 113.539 -168.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 CA--C 1.536 0.413 0 O-C-N 120.565 -1.334 . . . . 0.0 111.583 -169.385 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.533 0.448 0 CA-C-O 119.44 -0.317 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.46 -16.96 41.53 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.155 0.982 . . . . 0.0 112.608 174.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -68.06 -47.07 69.34 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.957 -1.089 . . . . 0.0 112.802 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.7 mt -66.6 -42.88 86.22 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.608 -0.683 . . . . 0.0 110.435 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.68 -52.5 18.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.207 1.403 . . . . 0.0 111.785 171.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -32.52 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.225 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.14 83.97 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.984 1.265 . . . . 0.0 111.8 172.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.02 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.432 -0.793 . . . . 0.0 110.762 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.19 -20.67 18.96 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.71 1.19 55.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.636 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -93.96 -28.79 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.282 0.946 . . . . 0.0 111.252 176.352 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -151.15 67.79 7.75 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.764 0.826 . . . . 0.0 112.161 169.027 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.45 145.41 88.45 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.269 3.313 . . . . 0.0 113.062 -178.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.96 -40.98 2.93 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.416 1.484 . . . . 0.0 112.929 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -77.01 -45.81 26.01 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.046 1.338 . . . . 0.0 111.698 173.455 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 3.2 m-30 -72.28 96.97 1.91 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.25 1.5 . . . . 0.0 114.11 -168.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -72.85 65.02 0.7 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.715 2.006 . . . . 0.0 113.594 170.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.97 136.78 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.77 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 p -151.79 156.95 41.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.845 1.258 . . . . 0.0 110.57 174.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.65 129.61 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.166 0.986 . . . . 0.0 109.71 174.643 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 109.097 -179.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -100.65 -175.88 3.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.821 1.648 . . . . 0.0 110.141 168.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -162.77 150.79 13.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.044 1.338 . . . . 0.0 109.62 -172.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.4 159.93 39.17 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.678 1.591 . . . . 0.0 111.321 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -121.87 139.22 53.9 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 109.947 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -140.5 139.48 35.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.185 -176.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.12 130.75 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.05 1.34 . . . . 0.0 111.122 -175.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.42 103.46 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.978 1.711 . . . . 0.0 109.524 -168.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.44 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -72.08 0.19 10.17 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.357 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 10.47 5.75 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 125.784 1.659 . . . . 0.0 114.36 -173.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -66.59 135.92 54.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.304 1.042 . . . . 0.0 111.231 -174.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -62.56 0.25 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m 76.34 -40.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.965 2.506 . . . . 0.0 114.623 167.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HE3' HD13 ' A' ' 38' ' ' LEU . 12.3 mptt -111.55 -75.79 0.61 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.11 0.868 . . . . 0.0 109.507 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -32.32 69.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.552 -1.968 . . . . 0.0 114.045 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.25 -41.73 80.17 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.69 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 36' ' ' VAL . 76.7 t -47.13 -49.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.887 2.075 . . . . 0.0 112.242 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -61.62 -40.07 93.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.395 0.678 . . . . 0.0 112.348 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -63.8 -46.95 82.87 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 122.06 -0.4 . . . . 0.0 111.743 171.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.23 -50.98 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -171.12 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.06 -44.47 67.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.33 1.852 . . . . 0.0 109.899 175.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -70.49 -44.59 67.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 m -70.76 -40.3 72.76 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.95 1.3 . . . . 0.0 110.853 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -49.55 25.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 116.845 -1.55 . . . . 0.0 111.199 175.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.96 16.74 0.11 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.472 1.942 . . . . 0.0 113.534 -174.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.92 -3.45 14.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.224 1.81 . . . . 0.0 112.423 174.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.85 139.86 47.23 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.86 -1.15 . . . . 0.0 111.634 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.88 -15.2 7.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.817 1.647 . . . . 0.0 115.004 -170.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.79 -6.47 11.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.367 1.867 . . . . 0.0 114.95 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -88.82 137.32 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.923 1.692 . . . . 0.0 111.271 -168.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.23 -26.19 14.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.266 1.027 . . . . 0.0 111.506 -173.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -177.8 173.55 1.57 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.06 2.144 . . . . 0.0 111.636 -171.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -177.32 155.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.622 2.369 . . . . 0.0 108.624 -172.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -149.58 135.38 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 127.48 2.312 . . . . 0.0 108.645 166.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 18' ' ' VAL . 41.2 t -106.19 141.44 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.072 0.949 . . . . 0.0 110.75 169.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -79.16 112.76 16.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 123.153 1.454 . . . . 0.0 110.259 168.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.549 HD13 ' HE3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.59 -22.06 31.17 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 120.692 -1.255 . . . . 0.0 112.664 167.886 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 -69.04 0.73 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.519 1.528 . . . . 0.0 111.057 169.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -73.52 137.23 44.28 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.855 1.262 . . . . 0.0 111.278 -171.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -130.86 154.73 47.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.247 2.219 . . . . 0.0 113.691 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.26 143.97 44.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.259 2.223 . . . . 0.0 109.296 172.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.74 118.84 59.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.11 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.4 t -119.99 135.52 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.329 1.452 . . . . 0.0 108.881 -168.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.73 96.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.21 1.404 . . . . 0.0 108.52 -168.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.6 p90 -118.63 140.07 50.5 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.729 1.212 . . . . 0.0 113.55 -168.226 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 CA--C 1.539 0.542 0 O-C-N 121.077 -1.014 . . . . 0.0 111.629 -178.385 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 N-CA-C 112.329 0.088 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.83 -13.65 62.12 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -37.32 81.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.301 1.864 . . . . 0.0 111.44 170.294 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 47' ' ' TYR . 70.7 mt -70.03 -46.14 65.68 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.182 173.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -49.01 -52.42 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 111.072 174.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -56.5 -37.71 70.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.286 1.434 . . . . 0.0 114.749 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.77 95.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.733 1.606 . . . . 0.0 111.474 171.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mt -63.06 -56.18 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.667 174.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -53.18 -24.68 11.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.936 0.894 . . . . 0.0 113.002 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 0.01 55.94 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -95.39 -30.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 177.696 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.01 67.48 9.18 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.39 0.676 . . . . 0.0 111.145 169.651 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 143.71 99.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.13 3.22 . . . . 0.0 112.081 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.71 -39.18 2.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.863 1.22 . . . . 0.0 113.093 -174.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.2 tp -78.21 -41.95 32.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.81 1.244 . . . . 0.0 111.529 174.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.45 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.8 m-30 -83.16 94.51 7.87 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -168.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -73.36 66.14 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.189 1.796 . . . . 0.0 111.146 169.213 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.19 131.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 121.747 0.784 . . . . 0.0 110.756 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -138.0 147.62 44.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 0.0 109.017 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.48 130.33 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 119.894 -1.754 . . . . 0.0 109.916 174.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 123.447 0.699 . . . . 0.0 110.184 178.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 122.834 1.302 . . . . 0.0 113.861 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -103.49 175.11 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.291 1.436 . . . . 0.0 110.794 176.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -163.99 147.53 9.8 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.862 -1.149 . . . . 0.0 110.384 -169.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.28 161.98 41.4 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.198 1.399 . . . . 0.0 111.321 170.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.5 m -123.93 139.77 53.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.837 1.255 . . . . 0.0 110.218 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -140.79 136.99 33.02 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.722 1.209 . . . . 0.0 110.024 -174.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tt -119.44 132.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 120.82 -1.175 . . . . 0.0 110.424 177.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.0 106.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.16 1.384 . . . . 0.0 108.676 -175.205 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.45 98.91 11.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.764 1.269 . . . . 0.0 109.678 169.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.55 -13.42 1.38 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.672 1.606 . . . . 0.0 114.057 177.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.401 ' SD ' ' SG ' ' A' ' 17' ' ' CYS 0.257 0.0 OUTLIER -77.07 132.65 39.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.85 1.325 . . . . 0.0 112.187 -176.779 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -67.94 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 t 66.61 -53.9 0.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.197 2.599 . . . . 0.0 116.23 169.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -63.34 1.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.67 -1.269 . . . . 0.0 112.931 -178.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -59.07 -32.69 70.01 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 121.424 1.92 . . . . 0.0 114.221 -177.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 12' ' ' MET . 2.3 p -40.6 -58.17 1.67 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.217 1.807 . . . . 0.0 111.376 169.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -46.24 -54.19 2.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 127.541 2.336 . . . . 0.0 111.007 -176.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -64.02 -30.23 71.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.334 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -69.93 -46.91 64.32 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.89 0.768 . . . . 0.0 111.353 168.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -46.46 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.255 0.934 . . . . 0.0 110.645 -170.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -51.43 -48.86 62.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.113 1.365 . . . . 0.0 110.786 170.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -68.75 -52.19 33.16 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.9 m -69.32 -35.87 76.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.531 1.532 . . . . 0.0 110.567 -169.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -73.24 -48.94 30.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.057 168.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 t -70.96 13.65 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.739 2.063 . . . . 0.0 114.421 -171.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.94 16.25 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.886 2.074 . . . . 0.0 111.398 173.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.99 125.86 29.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.11 -15.13 43.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.15 -11.57 35.25 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 169.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 137.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 121.586 1.994 . . . . 0.0 109.739 -173.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -105.38 -14.79 15.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.197 0.599 . . . . 0.0 112.491 -176.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -178.61 172.18 1.44 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.805 2.042 . . . . 0.0 112.288 -172.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -176.05 152.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 127.743 2.417 . . . . 0.0 109.29 -170.087 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.5 133.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 127.503 2.321 . . . . 0.0 107.236 167.281 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.54 141.77 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 123.247 1.499 . . . . 0.0 112.326 171.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -77.57 84.15 3.95 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.596 1.559 . . . . 0.0 109.384 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.09 -29.34 60.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.756 1.622 . . . . 0.0 114.191 -173.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -88.4 -0.31 57.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.712 1.605 . . . . 0.0 114.325 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -135.67 -171.51 2.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.535 2.734 . . . . 0.0 110.411 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER -111.24 33.72 4.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.022 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 p -132.66 155.74 48.23 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.019 -1.676 . . . . 0.0 115.505 -170.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.27 138.02 54.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.144 2.178 . . . . 0.0 110.107 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -108.79 115.91 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 170.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -118.73 136.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.133 1.373 . . . . 0.0 108.977 -167.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.66 104.29 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.758 1.223 . . . . 0.0 109.191 -169.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 57' ' ' LEU . 34.5 p90 -120.23 161.82 20.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.016 . . . . 0.0 113.274 -171.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 . . . . . 0 CA--C 1.54 0.596 0 O-C-N 120.982 -1.073 . . . . 0.0 110.921 -176.818 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.538 0.693 0 N-CA-C 113.109 0.388 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -54.95 -32.67 61.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.057 1.343 . . . . 0.0 113.4 -176.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 m -73.65 -35.95 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.371 -1.456 . . . . 0.0 112.666 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.6 mt -70.56 -44.58 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -50.7 -51.18 52.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.845 1.258 . . . . 0.0 111.201 172.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -39.55 79.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.643 1.177 . . . . 0.0 114.108 172.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 -36.33 80.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.929 1.24 . . . . 0.0 111.83 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.48 -51.67 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.763 -0.585 . . . . 0.0 109.718 170.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.69 -19.02 14.4 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.145 0.884 . . . . 0.0 112.844 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 1.2 57.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.624 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -92.22 -32.35 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.969 0.804 . . . . 0.0 111.014 175.581 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.46 69.12 11.33 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.355 0.662 . . . . 0.0 111.65 168.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.58 142.0 97.9 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.291 3.327 . . . . 0.0 112.785 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.42 -35.56 3.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.143 1.354 . . . . 0.0 113.066 -176.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.65 -43.78 16.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.718 1.607 . . . . 0.0 112.064 174.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.8 m-30 -80.66 105.08 11.63 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -167.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.14 75.37 8.12 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.618 -1.926 . . . . 0.0 112.927 169.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.43 126.26 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 121.25 -0.906 . . . . 0.0 112.849 -174.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -140.48 139.48 35.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.198 0.999 . . . . 0.0 111.608 -169.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.1 mt -85.41 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.659 -1.276 . . . . 0.0 109.176 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 121.671 0.748 . . . . 0.0 109.281 173.317 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 122.301 1.048 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 t -94.7 -179.67 4.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.576 1.95 . . . . 0.0 110.987 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -158.88 145.96 17.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.287 1.435 . . . . 0.0 110.244 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.03 153.82 39.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.043 1.737 . . . . 0.0 111.07 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 m -117.69 139.52 50.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.913 177.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.98 144.97 41.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.941 1.296 . . . . 0.0 110.644 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.24 135.0 64.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.514 1.525 . . . . 0.0 110.282 178.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.59 123.51 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.969 1.308 . . . . 0.0 108.775 -171.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.67 146.48 27.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 164.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.61 -4.67 77.67 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.401 0.524 . . . . 0.0 112.559 -168.761 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.42 127.53 27.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.303 1.441 . . . . 0.0 112.118 174.155 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -64.98 41.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.664 1.986 . . . . 0.0 113.961 170.2 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 30.62 -110.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.961 3.305 . . . . 0.0 114.84 175.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -51.85 -39.38 58.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 113.375 -179.013 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -83.12 -32.89 26.46 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.009 -1.057 . . . . 0.0 112.196 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 t -55.15 -49.08 72.72 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.972 1.26 . . . . 0.0 110.672 171.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.4 t -42.34 -50.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 124.489 1.118 . . . . 0.0 112.5 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -69.3 -35.54 76.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.036 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -62.81 -45.24 93.54 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.756 -1.215 . . . . 0.0 111.005 169.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mm -67.45 -49.21 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.983 -170.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -43.97 -50.83 8.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.488 1.515 . . . . 0.0 109.539 170.089 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -71.63 -50.95 25.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -66.26 -42.55 88.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.26 1.424 . . . . 0.0 110.51 -176.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.08 -49.65 23.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.159 177.624 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 t -74.26 13.75 0.53 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.476 1.943 . . . . 0.0 113.302 -173.044 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.16 -3.1 18.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.733 1.613 . . . . 0.0 111.858 173.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.06 133.64 41.55 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.046 -1.034 . . . . 0.0 110.435 -172.362 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -59.5 2.98 0.05 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -174.342 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 -8.09 4.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.696 1.999 . . . . 0.0 114.717 174.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 8.7 p -88.24 139.21 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 121.369 1.895 . . . . 0.0 110.426 -169.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -99.92 -19.02 16.81 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m 178.75 171.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.094 1.758 . . . . 0.0 113.039 -172.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -168.13 152.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.857 2.063 . . . . 0.0 110.473 -174.462 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.21 148.76 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 128.383 2.673 . . . . 0.0 106.544 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 18' ' ' VAL . 7.3 p -138.41 145.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.96 0.409 . . . . 0.0 110.85 175.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 m -91.59 125.52 36.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.582 0.705 . . . . 0.0 112.307 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' HE2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -70.58 -36.47 73.6 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.025 -1.047 . . . . 0.0 112.869 -176.206 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -104.15 -8.85 19.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.291 1.436 . . . . 0.0 114.732 -177.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -121.76 130.39 53.38 Favored 'General case' 0 C--O 1.221 -0.431 0 O-C-N 120.264 -1.523 . . . . 0.0 107.108 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 35.12 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.207 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 p -128.23 152.5 48.01 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -172.745 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.48 137.53 54.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.956 2.502 . . . . 0.0 110.491 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.3 mt -110.66 117.18 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.483 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.42 130.67 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.503 1.121 . . . . 0.0 109.041 -167.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.01 108.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.378 1.471 . . . . 0.0 108.555 -167.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.6 p90 -128.3 145.67 50.99 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.29 1.405 . . . . 0.0 113.844 -168.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.304 -1.498 . . . . 0.0 112.11 -172.139 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 120.083 -0.049 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 17.0 mp0 -64.54 -8.96 15.85 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.461 1.504 . . . . 0.0 112.26 173.261 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 p -79.17 -51.87 8.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.787 1.176 . . . . 0.0 111.906 169.361 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.483 HD13 ' CG1' ' A' ' 45' ' ' VAL . 87.6 mt -64.79 -41.55 95.73 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.774 -1.107 . . . . 0.0 110.639 176.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -53.4 15.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.498 1.045 . . . . 0.0 111.545 172.064 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -37.69 72.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.36 1.464 . . . . 0.0 113.518 175.148 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.13 84.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.369 1.44 . . . . 0.0 112.085 175.151 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.26 -56.74 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.455 0.702 . . . . 0.0 110.758 171.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -53.41 -27.33 23.82 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 123.801 0.84 . . . . 0.0 111.534 176.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.42 1.98 38.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -27.94 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.726 0.81 . . . . 0.0 111.643 175.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.77 69.1 9.23 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.082 0.953 . . . . 0.0 110.644 169.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.34 145.3 98.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.257 3.305 . . . . 0.0 112.489 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.06 -40.83 2.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.961 1.267 . . . . 0.0 113.013 -174.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.82 -55.4 5.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.436 1.494 . . . . 0.0 111.062 177.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -71.5 107.76 4.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -169.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -78.89 47.68 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.226 1.811 . . . . 0.0 113.761 176.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.3 126.95 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.972 0.909 . . . . 0.0 111.076 -168.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 m -139.58 148.52 42.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.649 -175.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.67 124.28 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.692 -1.255 . . . . 0.0 109.758 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.208 0 C-N-CA 123.694 0.798 . . . . 0.0 109.608 -175.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 122.419 1.104 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -102.07 -175.25 2.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.88 1.672 . . . . 0.0 109.751 172.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -158.77 150.76 21.21 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.845 -1.159 . . . . 0.0 109.893 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.06 156.01 40.2 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.996 1.719 . . . . 0.0 109.864 173.431 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.0 m -127.26 138.58 53.11 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.996 0.919 . . . . 0.0 109.453 -178.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -136.53 144.85 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.413 1.085 . . . . 0.0 111.303 -174.106 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 tt -122.38 140.87 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 125.205 1.402 . . . . 0.0 109.19 175.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.18 153.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.683 1.193 . . . . 0.0 108.639 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.26 144.66 50.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.413 0.285 . . . . 0.0 110.971 164.148 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.77 -1.67 68.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.22 1.39 . . . . 0.0 112.504 -174.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.49 165.91 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.514 1.525 . . . . 0.0 114.338 -171.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.55 37.23 0.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 125.022 1.329 . . . . 0.0 113.76 -179.021 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 t 52.39 -143.09 0.72 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.632 1.573 . . . . 0.0 111.7 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HE3' HD13 ' A' ' 38' ' ' LEU . 29.5 mttp -61.23 -13.87 21.65 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.196 -1.565 . . . . 0.0 114.273 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -91.79 -11.83 35.52 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.051 -1.656 . . . . 0.0 112.268 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -48.09 77.8 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.643 1.111 . . . . 0.0 108.179 168.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' CG1' ' A' ' 36' ' ' VAL . 54.2 t -40.45 -56.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 130.392 3.477 . . . . 0.0 111.937 -177.554 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -38.27 90.47 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 120.888 0.375 . . . . 0.0 111.808 -173.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -60.81 -41.49 95.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.831 -1.168 . . . . 0.0 112.412 168.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 -47.38 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.731 -171.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.68 -51.53 15.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.746 1.618 . . . . 0.0 109.307 169.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -70.55 -44.26 67.82 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.6 m -70.55 -40.68 73.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.769 1.228 . . . . 0.0 110.5 -175.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -44.89 57.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.224 178.679 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t -70.38 13.36 0.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 120.416 1.462 . . . . 0.0 113.813 -176.205 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.03 -6.84 19.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.399 1.48 . . . . 0.0 111.95 174.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.26 129.0 34.54 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.063 -1.023 . . . . 0.0 110.327 -169.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.72 -25.07 25.17 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -5.13 48.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 174.044 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.254 5.0 p -92.55 134.73 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 121.606 2.003 . . . . 0.0 110.314 -173.261 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 t -93.3 -27.39 16.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.383 1.473 . . . . 0.0 111.796 -176.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -178.06 175.91 1.2 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.959 2.104 . . . . 0.0 112.409 -171.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -172.75 151.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.748 2.019 . . . . 0.0 109.724 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.58 141.37 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 126.901 2.08 . . . . 0.0 105.782 166.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' CG1' HG13 ' A' ' 18' ' ' VAL . 66.2 t -111.37 137.84 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.681 1.229 . . . . 0.0 110.46 169.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.0 m -75.92 83.11 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.45 176.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD13 ' HE3' ' A' ' 15' ' ' LYS . 2.5 tm? -43.49 -42.91 5.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.509 2.324 . . . . 0.0 112.314 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -47.61 84.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.345 1.069 . . . . 0.0 112.29 178.67 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -98.43 -171.48 2.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.99 2.516 . . . . 0.0 112.031 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.98 29.56 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.081 2.552 . . . . 0.0 113.309 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 p -144.81 158.64 43.72 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.012 -1.68 . . . . 0.0 115.406 -167.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.41 51.76 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.103 2.161 . . . . 0.0 110.774 -173.299 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.77 110.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.3 t -116.67 130.46 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.19 1.396 . . . . 0.0 108.141 -168.239 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.87 106.46 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 107.813 -168.589 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CD1' HD11 ' A' ' 57' ' ' LEU . 27.1 p90 -127.25 147.15 50.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.588 1.155 . . . . 0.0 113.617 -168.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 CA--C 1.539 0.537 0 O-C-N 120.284 -1.51 . . . . 0.0 112.172 179.047 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 N-CA-C 114.66 0.985 . . . . 0.0 114.66 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.16 -32.78 74.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.745 1.157 . . . . 0.0 112.913 -168.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -74.51 -28.43 60.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.065 0.946 . . . . 0.0 112.984 -178.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' A' ' 47' ' ' TYR . 69.4 mt -70.81 -47.58 58.69 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.407 170.475 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -45.34 -53.68 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.142 0.883 . . . . 0.0 110.761 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -37.54 71.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.65 78.48 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.423 1.465 . . . . 0.0 111.892 172.069 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.23 -50.74 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.263 0.625 . . . . 0.0 110.029 173.294 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -58.37 -19.36 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.429 -1.419 . . . . 0.0 112.486 174.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.31 0.43 56.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 174.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -89.63 -37.39 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 118.997 0.817 . . . . 0.0 110.967 173.186 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.35 70.51 33.11 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.964 0.412 . . . . 0.0 111.718 169.846 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.32 134.82 61.35 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.433 3.422 . . . . 0.0 111.909 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 -17.2 27.47 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.095 1.331 . . . . 0.0 114.167 -174.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 tp -105.25 -23.82 12.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.686 1.594 . . . . 0.0 112.532 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -102.61 111.29 23.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.24 45.71 0.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 119.578 -1.951 . . . . 0.0 114.851 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.75 124.06 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -166.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -141.11 155.65 46.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.827 1.651 . . . . 0.0 109.451 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.89 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.411 -1.43 . . . . 0.0 107.369 176.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.476 0.841 0 C-N-CA 124.38 1.072 . . . . 0.0 112.411 -169.129 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t -124.67 169.58 11.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.682 1.23 . . . . 0.0 111.692 168.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -146.84 146.64 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.754 1.222 . . . . 0.0 109.832 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.98 37.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.105 1.762 . . . . 0.0 110.699 174.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.1 m -133.71 142.91 48.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.156 0.982 . . . . 0.0 110.871 -175.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 23.4 m-85 -145.16 140.1 27.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.321 1.448 . . . . 0.0 111.072 -168.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.53 131.7 60.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 O-C-N 120.744 -1.222 . . . . 0.0 111.899 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.36 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.003 2.121 . . . . 0.0 109.982 -169.35 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.43 4.14 6.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.08 1.752 . . . . 0.0 114.34 178.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.41 27.04 3.62 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 126.252 1.882 . . . . 0.0 110.577 -178.25 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.438 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -77.8 138.95 39.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.748 0.819 . . . . 0.0 109.599 179.066 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -53.81 -43.13 69.11 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p 172.17 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -140.98 -50.27 0.44 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 127.117 2.167 . . . . 0.0 110.771 -167.439 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -26.59 61.33 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.132 -2.23 . . . . 0.0 112.8 171.273 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.5 m -57.36 -39.18 75.44 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.718 170.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -47.89 -46.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.702 2.001 . . . . 0.0 111.564 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -67.51 -40.35 85.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.916 1.686 . . . . 0.0 113.605 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -61.33 -36.92 81.47 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.885 -1.134 . . . . 0.0 112.047 172.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -46.34 85.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.684 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -49.13 73.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 111.665 170.768 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -65.67 -41.86 92.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -177.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.0 m -69.3 -47.8 63.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.886 0.874 . . . . 0.0 110.79 177.34 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -76.58 -24.87 53.52 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 117.716 -1.135 . . . . 0.0 113.947 -177.386 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 t -81.64 11.53 4.65 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 121.144 1.793 . . . . 0.0 112.47 177.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.73 7.07 9.4 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -169.106 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 31' ' ' VAL . 13.6 mt -85.54 151.84 23.62 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.025 -1.047 . . . . 0.0 112.173 -169.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -67.13 22.95 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.467 2.307 . . . . 0.0 114.396 178.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.51 19.64 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.625 2.37 . . . . 0.0 112.868 -178.343 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.653 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.5 p -125.05 136.22 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.827 1.649 . . . . 0.0 112.726 177.297 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -118.28 -3.26 11.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -177.31 174.02 1.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.315 2.246 . . . . 0.0 111.914 176.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -172.99 154.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.67 2.788 . . . . 0.0 108.421 -172.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -145.98 123.24 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 C-N-CA 126.2 1.8 . . . . 0.0 107.522 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.71 149.67 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.171 172.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -73.54 124.31 25.64 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.46 1.504 . . . . 0.0 108.816 166.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -40.41 30.5 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.03 -51.6 30.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.888 2.475 . . . . 0.0 112.772 -173.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -88.87 -174.81 4.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.588 1.955 . . . . 0.0 112.398 169.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.2 43.56 1.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.31 1.444 . . . . 0.0 111.397 177.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 p -131.99 160.23 36.45 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.344 -2.097 . . . . 0.0 114.774 -168.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.54 136.94 33.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.092 1.357 . . . . 0.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -105.09 115.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.419 2.287 . . . . 0.0 105.425 171.85 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 57' ' ' LEU . 45.9 t -111.55 129.49 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.011 1.724 . . . . 0.0 108.537 -169.206 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.3 t -109.2 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.063 1.345 . . . . 0.0 108.174 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -101.3 132.57 46.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.043 1.737 . . . . 0.0 111.481 -170.461 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.286 8.5 p-10 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 122.485 1.136 . . . . 0.0 110.508 -167.273 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 CA-C-O 118.754 -0.603 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -54.37 -36.84 64.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.617 1.099 . . . . 0.0 112.118 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -67.6 -33.37 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.09 -1.006 . . . . 0.0 112.907 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 45' ' ' VAL . 68.1 mt -76.18 -43.92 40.43 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.577 0.751 . . . . 0.0 111.343 178.31 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.06 -47.2 65.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.411 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -45.08 74.88 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.094 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -33.18 73.95 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.049 1.295 . . . . 0.0 111.653 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.74 -54.04 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.284 0.633 . . . . 0.0 110.524 172.632 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -49.42 -33.75 14.79 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.686 0.794 . . . . 0.0 111.39 175.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.34 0.75 27.71 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -96.53 -27.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.151 1.381 . . . . 0.0 111.579 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.424 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.62 64.21 7.62 Favored Pre-proline 0 CA--C 1.549 0.912 0 O-C-N 121.689 -0.632 . . . . 0.0 111.498 168.473 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.21 144.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.29 3.327 . . . . 0.0 112.912 -172.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.67 -18.02 9.73 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.577 1.084 . . . . 0.0 113.975 -175.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.65 -47.36 3.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.979 1.711 . . . . 0.0 110.6 177.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.9 m-30 -66.38 107.28 1.97 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -175.315 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 75.36 4.72 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.419 -1.425 . . . . 0.0 109.887 169.123 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.16 129.79 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.458 -0.777 . . . . 0.0 111.464 -176.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.59 38.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.387 1.075 . . . . 0.0 110.634 -171.732 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.22 112.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.806 -1.184 . . . . 0.0 108.888 170.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.224 -0.267 0 C-N-CA 124.57 1.148 . . . . 0.0 108.896 168.695 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 t -125.09 -177.74 3.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.454 1.102 . . . . 0.0 110.182 167.628 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -164.07 151.54 12.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.15 0.98 . . . . 0.0 109.989 -169.478 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.63 158.86 44.05 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.284 1.434 . . . . 0.0 111.216 171.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.4 m -120.86 140.04 52.33 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.931 1.293 . . . . 0.0 109.672 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.85 151.61 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.608 1.163 . . . . 0.0 111.176 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -134.77 140.03 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.948 1.299 . . . . 0.0 110.717 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.8 140.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.631 1.572 . . . . 0.0 110.907 -173.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . 0.262 0.4 OUTLIER -123.27 145.78 48.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 165.818 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.41 54.91 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.744 1.164 . . . . 0.0 112.708 -171.245 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.403 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -84.22 153.04 23.86 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.824 1.65 . . . . 0.0 111.378 -171.628 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -77.99 32.25 0.17 Allowed 'General case' 0 CA--C 1.556 1.203 0 O-C-N 119.711 -1.868 . . . . 0.0 114.519 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t 66.31 -71.6 0.09 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.129 2.172 . . . . 0.0 114.886 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 38' ' ' LEU . 10.5 mptt -108.31 -38.4 5.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 112.944 177.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 p -74.25 -21.47 59.76 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 119.425 -2.047 . . . . 0.0 112.79 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 27.6 p -51.17 -51.63 51.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.487 1.04 . . . . 0.0 110.073 169.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.582 HG13 ' CG1' ' A' ' 36' ' ' VAL . 53.9 t -46.35 -55.54 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 128.042 2.537 . . . . 0.0 112.234 -174.374 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -40.17 95.63 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 123.441 0.463 . . . . 0.0 111.585 -171.173 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -57.64 -46.49 84.1 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.699 -0.625 . . . . 0.0 112.401 169.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -44.51 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 118.721 -0.657 . . . . 0.0 109.842 -172.317 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.22 -49.28 67.1 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.247 0.967 . . . . 0.0 110.286 171.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -70.41 -41.31 73.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.8 m -76.92 -36.43 56.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.833 1.253 . . . . 0.0 111.255 -175.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.23 -45.91 53.25 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.75 172.077 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -72.17 16.24 0.14 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 121.483 1.947 . . . . 0.0 114.206 -172.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.93 -7.52 14.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.12 1.768 . . . . 0.0 112.311 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.32 133.58 45.07 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.922 -1.111 . . . . 0.0 110.448 -169.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.5 -0.04 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -170.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.89 -10.36 11.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.412 1.485 . . . . 0.0 114.855 169.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -89.4 138.97 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 121.088 1.767 . . . . 0.0 110.362 -169.695 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -99.24 -34.71 10.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 112.242 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -158.76 160.33 36.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.342 1.057 . . . . 0.0 110.644 -165.432 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.75 152.21 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.632 1.573 . . . . 0.0 109.8 174.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.62 129.98 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 C-N-CA 126.449 1.9 . . . . 0.0 107.449 167.015 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CG1' HG13 ' A' ' 18' ' ' VAL . 51.6 t -101.72 143.71 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 123.399 1.571 . . . . 0.0 111.826 171.168 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -78.19 87.09 4.29 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.028 174.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.487 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.1 tm? -44.87 -42.51 8.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.959 2.504 . . . . 0.0 113.417 -177.003 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 15' ' ' LYS . 71.6 mm-40 -81.92 -8.87 59.71 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -131.17 -173.82 3.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.969 2.508 . . . . 0.0 109.347 -169.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 30.05 7.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.927 1.291 . . . . 0.0 113.525 -175.264 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 p -131.82 160.69 34.89 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.431 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.08 140.79 48.96 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.473 1.909 . . . . 0.0 110.658 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.17 114.25 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.177 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.1 t -116.26 131.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.541 1.536 . . . . 0.0 107.482 -169.511 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 57.4 t -120.52 107.89 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 -168.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -127.54 148.37 50.34 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.061 -1.024 . . . . 0.0 112.981 -168.675 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 CA--C 1.538 0.495 0 C-N-CA 124.114 0.966 . . . . 0.0 110.795 177.315 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.529 0.243 0 CA-C-O 118.734 -0.611 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -67.95 -10.26 51.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.78 1.173 . . . . 0.0 113.563 178.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 p -61.58 -45.15 95.35 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.789 -1.194 . . . . 0.0 112.1 168.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.4 mt -71.12 -42.89 68.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.642 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.78 -46.99 51.32 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.431 172.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -62.22 -38.09 87.86 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.96 76.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.699 1.59 . . . . 0.0 111.783 173.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -68.28 -54.7 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.139 0.576 . . . . 0.0 110.905 171.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -55.75 -22.52 24.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.159 0.891 . . . . 0.0 112.615 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.42 5.31 42.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -97.22 -30.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 173.187 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -144.2 64.83 12.9 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.732 -0.605 . . . . 0.0 111.666 168.795 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.79 138.39 82.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.232 3.288 . . . . 0.0 112.431 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.12 -22.29 5.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.466 1.031 . . . . 0.0 113.662 -175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 tp -93.41 -54.07 3.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.477 1.511 . . . . 0.0 110.133 173.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.7 m-30 -70.09 117.0 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.045 1.738 . . . . 0.0 114.048 -177.482 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -111.68 139.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 119.363 0.983 . . . . 0.0 112.672 -173.174 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -144.63 160.04 41.82 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.824 1.25 . . . . 0.0 112.764 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.41 119.84 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.99 1.716 . . . . 0.0 107.469 173.121 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -175.081 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 122.767 1.27 . . . . 0.0 112.934 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -112.96 176.73 4.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.127 2.171 . . . . 0.0 110.853 -177.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.66 163.33 40.4 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 120.623 -1.298 . . . . 0.0 111.548 178.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.03 159.09 44.54 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.132 1.373 . . . . 0.0 110.187 169.074 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.9 154.59 26.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 110.435 172.025 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 53.2 m-85 -150.61 141.81 23.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.822 -1.536 . . . . 0.0 110.738 -176.627 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 tt -126.62 140.05 50.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.095 1.358 . . . . 0.0 110.289 177.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.3 98.39 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 126.478 1.911 . . . . 0.0 109.515 -170.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 65.26 7.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 123.534 1.635 . . . . 0.0 113.876 -169.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.99 0.11 Allowed Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 174.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 tmm? 45.08 -149.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.272 1.429 . . . . 0.0 109.56 -176.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -120.53 -33.06 3.92 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.407 -1.433 . . . . 0.0 111.386 167.554 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 p 161.76 -72.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.927 2.091 . . . . 0.0 113.589 178.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HE3' HD22 ' A' ' 38' ' ' LEU . 20.0 tptt -144.31 -57.38 0.37 Allowed 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.241 1.017 . . . . 0.0 109.815 -168.151 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -30.77 28.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.016 -1.678 . . . . 0.0 113.478 171.273 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.441 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 0.8 OUTLIER -57.61 -41.48 81.37 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.695 172.51 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.538 HG12 HG11 ' A' ' 36' ' ' VAL . 95.4 t -51.07 -42.73 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.834 1.653 . . . . 0.0 112.034 -176.512 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.6 t -71.09 -37.47 72.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.933 1.293 . . . . 0.0 113.277 178.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -60.24 -36.97 78.96 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.024 -1.048 . . . . 0.0 112.291 170.337 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -68.56 -48.23 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.925 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 36' ' ' VAL . 43.1 mt-10 -54.81 -51.91 64.34 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 124.044 0.84 . . . . 0.0 111.624 170.061 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -61.46 -41.28 96.99 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -68.41 -49.15 62.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.761 1.224 . . . . 0.0 110.189 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -75.74 -15.76 60.23 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.405 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -76.26 -3.07 34.6 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 173.227 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.49 7.68 11.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -166.001 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.35 152.29 30.52 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.165 -0.96 . . . . 0.0 112.599 -169.392 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -67.79 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.403 2.281 . . . . 0.0 114.501 -177.654 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.45 2.02 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.508 2.323 . . . . 0.0 114.341 -175.756 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.6 p -105.24 139.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 121.876 2.125 . . . . 0.0 111.307 -174.601 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 t -111.19 -11.62 14.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.07 175.03 1.98 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.175 1.79 . . . . 0.0 112.08 -175.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -175.55 152.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.041 2.536 . . . . 0.0 109.968 -171.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -147.88 134.57 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.86 2.464 . . . . 0.0 107.5 166.082 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.538 HG11 HG12 ' A' ' 18' ' ' VAL . 2.9 p -107.14 151.74 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 122.142 0.973 . . . . 0.0 113.174 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -90.15 102.75 15.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.58 0.752 . . . . 0.0 111.257 170.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.606 HD22 ' HE3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -57.81 -35.54 70.99 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.255 1.422 . . . . 0.0 113.401 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.99 5.55 49.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.152 1.381 . . . . 0.0 113.874 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -119.34 -173.94 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.951 1.7 . . . . 0.0 109.527 169.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 42.81 2.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.082 -1.011 . . . . 0.0 111.057 168.259 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -146.22 151.81 38.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -168.149 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.26 41.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.591 2.356 . . . . 0.0 112.055 -169.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.63 118.71 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.588 1.955 . . . . 0.0 106.544 174.496 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.2 t -119.77 120.35 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.756 1.622 . . . . 0.0 109.323 -167.783 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -107.06 107.78 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.854 1.662 . . . . 0.0 109.548 -169.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -121.0 158.32 28.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.041 1.336 . . . . 0.0 113.515 -171.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 CA--C 1.538 0.516 0 O-C-N 120.397 -1.439 . . . . 0.0 112.902 -168.821 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 CA-C-O 118.503 -0.707 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -61.7 -32.06 72.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.949 1.25 . . . . 0.0 113.001 -174.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.28 64.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.924 -1.735 . . . . 0.0 113.416 -178.098 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 47' ' ' TYR . 58.2 mt -78.76 -46.42 18.9 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.898 -0.501 . . . . 0.0 110.145 173.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -46.87 -49.63 19.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.603 0.761 . . . . 0.0 110.124 169.376 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -58.32 -41.16 83.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 113.734 176.074 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.26 73.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.38 0.991 . . . . 0.0 112.18 172.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mt -70.84 -54.41 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.322 0.649 . . . . 0.0 110.557 172.708 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -55.03 -23.14 18.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.498 1.119 . . . . 0.0 112.52 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.65 4.25 37.29 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -98.83 -39.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.781 0.833 . . . . 0.0 111.582 -179.009 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -139.84 64.77 29.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.943 -0.473 . . . . 0.0 112.053 166.816 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.77 143.17 81.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 124.297 3.331 . . . . 0.0 114.189 -171.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.97 -43.41 3.24 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 125.438 1.494 . . . . 0.0 112.414 -175.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.47 -39.22 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.686 1.194 . . . . 0.0 110.524 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.2 m-85 -71.76 89.98 1.06 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.162 -0.961 . . . . 0.0 112.895 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -74.96 76.18 2.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.315 1.446 . . . . 0.0 110.098 169.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 t -92.05 133.69 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.952 -1.092 . . . . 0.0 111.785 -169.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -151.28 159.21 44.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.95 1.357 . . . . 0.0 111.289 168.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.66 130.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 166.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.225 -0.226 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.799 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 22.0 p30 . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.38 154.96 26.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.882 2.073 . . . . 0.0 112.908 172.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -82.46 159.42 22.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.712 0.767 . . . . 0.0 110.915 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -152.82 153.35 32.95 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.954 -1.092 . . . . 0.0 108.284 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.5 39.91 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.094 1.758 . . . . 0.0 110.763 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 m -126.16 141.1 52.07 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.586 1.154 . . . . 0.0 109.842 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -140.28 136.4 33.24 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.66 135.69 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 C-N-CA 125.07 1.348 . . . . 0.0 110.57 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.84 129.34 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.403 1.081 . . . . 0.0 111.07 -172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.43 129.62 46.42 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.662 -0.649 . . . . 0.0 109.547 163.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 -1.67 28.42 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.852 1.215 . . . . 0.0 113.554 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.0 ptm -65.35 149.0 50.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.033 0.917 . . . . 0.0 113.087 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -73.64 33.78 0.08 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.48 1.512 . . . . 0.0 112.999 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t 66.3 -143.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.399 1.48 . . . . 0.0 111.301 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HE3' HD13 ' A' ' 38' ' ' LEU . 46.4 mttp -61.72 -14.68 34.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.652 1.981 . . . . 0.0 115.576 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.0 p -91.74 -41.51 10.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.04 168.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.37 -49.32 70.09 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 121.53 1.968 . . . . 0.0 109.62 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -36.05 -48.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.797 2.039 . . . . 0.0 112.91 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -83.4 -25.36 31.39 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -58.0 -35.54 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 119.91 -1.744 . . . . 0.0 110.138 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -43.15 78.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 CA-C-O 117.531 -1.223 . . . . 0.0 110.424 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -50.4 -51.04 49.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.664 0.786 . . . . 0.0 110.145 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -69.77 -42.14 74.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -70.87 -41.09 71.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 110.714 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -46.1 46.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.554 -1.212 . . . . 0.0 111.668 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -72.62 14.74 0.23 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.465 1.484 . . . . 0.0 113.579 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.97 -2.79 18.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.411 1.484 . . . . 0.0 112.187 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.25 130.58 35.3 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 111.332 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -58.99 -2.84 0.28 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.646 1.578 . . . . 0.0 115.25 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 -3.4 11.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.608 1.963 . . . . 0.0 115.942 172.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -95.16 144.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.197 1.817 . . . . 0.0 110.523 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -99.0 -27.77 13.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.87 1.668 . . . . 0.0 111.789 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m 176.79 176.67 0.31 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.898 2.079 . . . . 0.0 112.802 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -172.27 150.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.967 2.107 . . . . 0.0 110.493 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.73 134.64 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.074 2.15 . . . . 0.0 106.869 166.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.04 141.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.052 0.93 . . . . 0.0 110.468 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 m -76.44 84.37 3.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.659 1.183 . . . . 0.0 110.046 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.3 tm? -51.93 -43.35 63.4 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 113.07 -167.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.36 -41.89 94.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.479 0.712 . . . . 0.0 112.319 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -100.72 -170.74 1.9 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.313 3.445 . . . . 0.0 112.98 -169.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.21 32.61 4.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.052 2.141 . . . . 0.0 114.473 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.8 p -137.23 166.02 24.76 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.17 -1.581 . . . . 0.0 114.114 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.07 142.64 40.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.438 1.895 . . . . 0.0 110.649 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -108.74 117.36 54.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.4 t -120.81 131.83 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.164 1.386 . . . . 0.0 108.336 -167.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.48 110.86 32.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.445 1.498 . . . . 0.0 107.724 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.515 ' CD1' HD11 ' A' ' 57' ' ' LEU . 13.9 p90 -121.88 -165.28 1.24 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.565 1.546 . . . . 0.0 111.351 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -144.84 123.58 12.59 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 122.269 2.304 . . . . 0.0 114.119 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 176.06 137.98 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.357 2.263 . . . . 0.0 110.795 -167.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 p -79.81 -40.38 28.69 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.903 0.859 . . . . 0.0 110.343 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -70.18 76.44 0.52 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.645 1.178 . . . . 0.0 110.828 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.5 t -44.78 108.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.247 1.419 . . . . 0.0 111.029 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -136.55 84.08 28.98 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.653 1.581 . . . . 0.0 109.688 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.27 -16.36 13.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.514 2.81 . . . . 0.0 113.872 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.91 -31.17 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.437 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.4 p -70.37 -38.87 74.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.552 -1.342 . . . . 0.0 112.818 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.1 mt -69.99 -43.97 70.33 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.564 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -50.52 -50.95 51.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.578 1.151 . . . . 0.0 110.768 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -37.39 74.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.332 1.453 . . . . 0.0 113.801 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.5 73.87 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.582 1.083 . . . . 0.0 111.636 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -68.37 -51.47 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.131 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -49.4 -35.77 20.03 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.618 0.645 . . . . 0.0 111.377 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.03 5.2 8.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -100.03 -26.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.003 1.321 . . . . 0.0 111.577 176.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.97 68.29 8.8 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 167.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.38 144.25 90.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.09 3.193 . . . . 0.0 112.717 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 -25.02 3.98 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.736 1.16 . . . . 0.0 113.392 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.18 -45.09 8.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.283 1.433 . . . . 0.0 111.948 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -75.02 109.65 8.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -169.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -86.55 81.7 8.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.5 t -87.51 124.66 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.758 0.823 . . . . 0.0 112.641 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.76 131.59 43.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.177 0.991 . . . . 0.0 111.862 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.45 83.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.656 -1.278 . . . . 0.0 110.796 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.3 t -78.91 80.83 5.23 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.724 1.21 . . . . 0.0 111.472 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.5 m -91.74 164.32 13.76 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.144 0.977 . . . . 0.0 112.603 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.33 120.69 19.29 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 C--N 1.325 -0.487 0 C-N-CA 126.982 2.113 . . . . 0.0 108.045 174.784 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.7 156.04 38.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.254 1.822 . . . . 0.0 111.725 -173.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -93.8 174.4 7.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.093 0.949 . . . . 0.0 110.018 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -165.13 148.32 8.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.017 -1.052 . . . . 0.0 110.478 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.08 31.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.569 1.548 . . . . 0.0 110.94 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -134.03 143.2 47.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 109.613 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -143.07 149.35 38.07 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.414 1.486 . . . . 0.0 111.724 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -133.46 136.75 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 125.301 1.44 . . . . 0.0 110.959 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.38 90.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.188 2.195 . . . . 0.0 109.606 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.14 39.01 0.3 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.179 1.392 . . . . 0.0 113.452 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.48 40.11 0.18 Allowed Glycine 0 N--CA 1.469 0.844 0 C-N-CA 125.763 1.649 . . . . 0.0 112.638 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 4.4 tmm? -102.72 150.11 23.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.671 1.588 . . . . 0.0 111.743 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -66.59 9.22 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m 81.91 -54.11 0.25 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.276 3.03 . . . . 0.0 114.572 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' HE2' HD13 ' A' ' 38' ' ' LEU 0.29 50.8 mttt -125.42 -57.1 1.49 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.667 1.121 . . . . 0.0 112.656 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -65.37 -13.54 58.83 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.333 -2.105 . . . . 0.0 113.903 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' HG2' ' A' ' 12' ' ' MET 0.275 1.2 m -71.76 -36.06 70.28 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.668 168.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.8 t -47.11 -48.85 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.308 1.843 . . . . 0.0 111.83 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -63.83 -42.39 97.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.315 1.446 . . . . 0.0 113.091 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -59.48 -34.77 72.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.122 -1.611 . . . . 0.0 113.014 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -41.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.573 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -52.45 -54.51 31.37 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 167.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.7 t -69.95 -38.24 76.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -75.22 -37.17 61.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 110.594 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.01 -51.16 16.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.749 -1.119 . . . . 0.0 112.866 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -71.8 11.86 0.46 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.28 1.4 . . . . 0.0 113.866 -169.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.87 -1.5 19.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.861 1.664 . . . . 0.0 112.591 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -77.39 134.31 38.47 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 120.789 -1.195 . . . . 0.0 111.589 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.22 72.39 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 109.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 159.73 -20.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.804 3.642 . . . . 0.0 113.676 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -91.12 144.63 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 121.933 2.152 . . . . 0.0 109.749 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 t -114.96 -7.9 12.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m 178.76 172.84 0.75 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.914 2.086 . . . . 0.0 112.971 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -171.4 152.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.173 2.189 . . . . 0.0 110.077 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.4 150.53 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 128.712 2.805 . . . . 0.0 106.614 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.82 151.02 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.952 0.501 . . . . 0.0 110.942 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -82.57 135.78 34.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.166 0.587 . . . . 0.0 111.209 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.624 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.3 tm? -76.18 -33.99 59.33 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 121.098 -1.001 . . . . 0.0 112.083 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.77 -55.78 3.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.237 1.415 . . . . 0.0 111.917 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -76.99 138.1 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.551 0.74 . . . . 0.0 109.467 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 40.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 p -141.47 152.7 44.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.42 1.488 . . . . 0.0 114.627 -169.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.86 143.01 50.59 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.217 2.207 . . . . 0.0 111.105 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.11 120.16 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 127.199 2.2 . . . . 0.0 105.716 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 t -125.61 134.56 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.124 0.969 . . . . 0.0 109.96 -166.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 110.28 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.132 1.373 . . . . 0.0 108.863 -168.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' CD1' HD11 ' A' ' 57' ' ' LEU . 44.3 p90 -123.16 168.34 12.54 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.42 1.088 . . . . 0.0 113.853 -170.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -110.21 114.94 28.83 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.551 -1.343 . . . . 0.0 110.406 -172.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.51 132.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.864 1.265 . . . . 0.0 111.671 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 m -68.53 -26.44 65.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.448 0.567 . . . . 0.0 111.633 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -170.62 117.16 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.113 1.765 . . . . 0.0 109.362 167.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -148.84 144.34 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.054 2.142 . . . . 0.0 106.875 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -69.53 140.96 90.1 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 112.358 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.6 -8.81 24.28 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.552 2.835 . . . . 0.0 112.883 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.08 -30.3 70.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -74.25 -39.94 62.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.599 1.16 . . . . 0.0 113.668 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.7 mt -66.2 -43.84 85.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.285 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -49.33 -56.39 9.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.123 0.874 . . . . 0.0 110.459 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.85 -39.5 39.25 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.56 72.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.57 1.077 . . . . 0.0 111.803 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.91 -54.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.274 0.63 . . . . 0.0 109.691 170.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -51.83 -29.35 19.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.785 0.834 . . . . 0.0 111.877 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.01 0.41 40.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -96.57 -29.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.692 1.197 . . . . 0.0 111.386 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.99 65.4 9.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 121.545 -0.722 . . . . 0.0 111.801 168.036 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.23 144.77 98.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.355 3.37 . . . . 0.0 113.376 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.04 -19.56 6.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.537 1.541 . . . . 0.0 114.08 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -106.16 -45.99 4.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.961 1.704 . . . . 0.0 111.216 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -66.74 109.03 2.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.268 1.027 . . . . 0.0 113.703 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -78.5 80.03 4.9 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 110.759 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 t -84.97 127.25 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.1 0.863 . . . . 0.0 111.877 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -138.4 146.81 42.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.59 1.156 . . . . 0.0 111.089 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.69 130.21 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.4 t -116.44 105.5 12.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.725 0.774 . . . . 0.0 110.561 172.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 65.9 m -161.32 158.27 26.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.282 2.233 . . . . 0.0 108.321 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.65 131.63 44.91 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 163.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.32 -0.71 0 C-N-CA 126.328 1.851 . . . . 0.0 108.82 178.67 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.614 0.721 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -97.88 160.74 14.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.44 1.896 . . . . 0.0 113.198 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -137.53 173.1 12.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.726 2.01 . . . . 0.0 109.084 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -161.75 156.39 22.8 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.734 -1.229 . . . . 0.0 110.336 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.35 160.89 38.94 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.48 1.512 . . . . 0.0 111.055 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -124.19 141.56 51.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.163 1.385 . . . . 0.0 110.194 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -141.75 145.2 34.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.853 1.261 . . . . 0.0 111.629 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.26 127.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 111.933 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.81 102.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.514 1.926 . . . . 0.0 111.497 -167.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -81.81 42.55 0.71 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.235 1.014 . . . . 0.0 113.665 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.02 3.66 0.03 OUTLIER Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.223 1.868 . . . . 0.0 117.438 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -75.73 145.6 40.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.739 2.269 . . . . 0.0 113.781 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -66.04 27.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.693 1.997 . . . . 0.0 114.982 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m 53.5 -129.53 2.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.825 1.65 . . . . 0.0 110.967 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HE2' HD13 ' A' ' 38' ' ' LEU . 1.6 mptm? -52.25 -32.31 36.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -170.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m -84.62 -28.57 26.4 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.555 -1.341 . . . . 0.0 113.143 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.81 -41.04 72.11 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.18 -1.391 . . . . 0.0 111.532 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -40.15 -54.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.7 2.0 . . . . 0.0 111.033 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -61.09 -41.74 97.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.508 1.123 . . . . 0.0 113.768 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -60.99 -38.38 85.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.297 -1.502 . . . . 0.0 112.934 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -36.44 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.213 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.27 -55.35 32.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.47 1.108 . . . . 0.0 109.687 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -67.61 -53.33 28.95 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.5 m -62.02 -38.46 88.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.894 1.278 . . . . 0.0 111.316 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -51.23 12.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.65 -1.167 . . . . 0.0 112.199 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -69.98 6.19 1.32 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.739 1.609 . . . . 0.0 113.928 -171.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.68 -6.81 24.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.817 1.647 . . . . 0.0 111.305 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 mt -75.39 128.02 34.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.15 -15.87 27.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -93.84 -12.17 29.57 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 p -93.57 143.72 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 121.161 1.8 . . . . 0.0 109.965 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.2 t -111.21 -11.63 14.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m 176.91 174.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.763 2.425 . . . . 0.0 113.005 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -172.71 150.48 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.674 2.39 . . . . 0.0 109.561 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.85 130.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 107.029 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.55 149.91 12.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.792 0.806 . . . . 0.0 111.041 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -80.58 113.02 18.47 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.547 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.5 tm? -60.31 -41.62 93.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.911 0.778 . . . . 0.0 111.366 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -97.25 -22.42 16.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.276 1.83 . . . . 0.0 114.638 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -115.91 155.85 27.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.773 1.229 . . . . 0.0 110.835 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.292 0.0 OUTLIER -78.5 38.32 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 p -138.77 157.92 45.18 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.52 139.9 35.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.809 2.044 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.76 121.26 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 106.14 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 57' ' ' LEU . 31.9 t -120.26 136.97 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.164 1.386 . . . . 0.0 108.468 -169.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.5 t -124.34 105.2 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.714 1.205 . . . . 0.0 109.72 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CD1' HD11 ' A' ' 57' ' ' LEU . 40.6 p90 -122.0 164.91 16.83 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.32 1.448 . . . . 0.0 113.967 -169.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.36 112.47 24.43 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.974 -171.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -175.39 152.18 1.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.659 1.584 . . . . 0.0 110.971 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -88.42 23.88 2.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.017 0.927 . . . . 0.0 110.911 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -165.67 -177.91 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.677 -1.264 . . . . 0.0 111.955 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.44 116.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 111.169 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -135.75 60.8 38.47 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.961 1.304 . . . . 0.0 110.241 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.26 -24.43 10.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.045 2.497 . . . . 0.0 114.176 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.16 -32.16 67.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.388 0.995 . . . . 0.0 113.215 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 m -70.22 -36.3 74.45 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.907 -1.121 . . . . 0.0 112.215 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 47' ' ' TYR . 82.2 mt -71.86 -45.76 60.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.674 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -48.86 -47.49 42.78 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.659 0.783 . . . . 0.0 110.463 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -35.39 79.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.36 73.26 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 121.28 1.855 . . . . 0.0 112.127 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.93 -57.97 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.719 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -49.72 -27.89 5.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.488 1.115 . . . . 0.0 112.573 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 0.68 44.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -93.56 -29.9 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.978 0.911 . . . . 0.0 111.514 177.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.464 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.84 64.06 9.87 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 121.424 -0.798 . . . . 0.0 111.5 167.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.28 144.01 99.5 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.095 3.197 . . . . 0.0 112.464 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.31 -29.89 4.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.714 1.149 . . . . 0.0 113.007 -174.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.3 tp -92.23 -48.23 6.8 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.046 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.514 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -71.26 99.09 1.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.354 1.062 . . . . 0.0 113.346 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -75.06 119.87 19.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 114.617 -2.611 . . . . 0.0 105.336 162.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 t -123.25 134.96 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 124.274 3.215 . . . . 0.0 112.544 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.16 134.6 45.6 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.042 1.337 . . . . 0.0 110.178 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.9 mt -74.22 123.45 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.185 -1.572 . . . . 0.0 110.38 170.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.15 112.9 23.23 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.456 0.702 . . . . 0.0 109.126 174.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.7 m -163.57 165.44 23.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 109.825 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -66.45 111.07 3.38 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.049 1.74 . . . . 0.0 110.829 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 125.082 1.353 . . . . 0.0 111.121 177.238 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 CA--C 1.544 0.728 0 CA-C-O 122.04 0.924 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.4 168.25 9.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.305 2.642 . . . . 0.0 111.802 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -88.91 172.15 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 163.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -157.33 138.29 13.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.52 -1.362 . . . . 0.0 110.311 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.35 158.74 43.59 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.672 1.589 . . . . 0.0 110.654 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.4 m -120.35 141.86 49.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.724 1.21 . . . . 0.0 109.414 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -137.04 139.89 41.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.106 1.362 . . . . 0.0 109.512 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -121.55 139.67 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 123.924 0.89 . . . . 0.0 110.818 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 147.57 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 O-C-N 125.086 1.492 . . . . 0.0 110.25 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -123.59 141.38 52.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.449 1.1 . . . . 0.0 108.465 162.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.43 -27.24 8.57 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 126.19 1.852 . . . . 0.0 113.369 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.419 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -67.32 125.1 25.04 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 129.632 3.173 . . . . 0.0 118.104 -166.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.611 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 2.5 m-70 -74.61 55.58 0.66 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.789 2.836 . . . . 0.0 117.871 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.76 -141.46 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 119.94 -1.725 . . . . 0.0 114.781 165.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -54.84 -31.24 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 118.823 -2.423 . . . . 0.0 111.149 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.03 -54.29 27.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.704 -1.141 . . . . 0.0 112.224 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 12' ' ' MET . 32.0 p -55.02 -55.14 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.475 1.488 . . . . 0.0 110.275 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 9.1 t -44.74 -54.12 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.523 2.329 . . . . 0.0 111.487 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.8 m -70.72 -26.5 63.42 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -60.5 -46.57 89.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.614 1.097 . . . . 0.0 109.309 165.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -40.25 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.437 -0.79 . . . . 0.0 111.846 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -54.19 -46.41 72.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.285 1.434 . . . . 0.0 109.33 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 t -73.03 -64.33 0.99 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -56.41 -36.58 69.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.828 2.451 . . . . 0.0 112.439 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.31 -43.92 63.46 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.828 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -67.84 13.05 0.09 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.642 1.565 . . . . 0.0 114.636 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.57 2.13 14.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.691 1.996 . . . . 0.0 112.262 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.32 137.65 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.81 -1.181 . . . . 0.0 111.863 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 67.27 0.77 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.685 1.594 . . . . 0.0 111.864 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 166.73 -20.77 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 129.956 3.303 . . . . 0.0 113.148 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.7 p -85.92 137.16 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 121.288 1.858 . . . . 0.0 110.895 -171.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -103.82 -19.04 14.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.376 1.47 . . . . 0.0 112.594 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m 178.16 167.19 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.632 2.373 . . . . 0.0 112.423 -171.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.4 tt -171.64 149.22 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.672 1.989 . . . . 0.0 112.479 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.7 t -141.09 144.35 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.494 2.317 . . . . 0.0 106.948 166.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 53.8 t -113.51 130.14 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 123.382 1.563 . . . . 0.0 110.842 168.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -80.64 91.28 5.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.807 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 18' ' ' VAL . 7.8 tp -51.21 -56.95 10.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.311 1.444 . . . . 0.0 111.201 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.85 -56.07 13.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.45 1.1 . . . . 0.0 110.926 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.44 15.42 5.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 51.47 29.47 5.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.452 1.901 . . . . 0.0 114.738 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 p -133.59 149.73 51.62 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -168.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.65 53.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.466 1.506 . . . . 0.0 109.109 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -101.25 109.75 26.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.96 132.61 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 124.781 1.232 . . . . 0.0 108.251 -166.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.03 108.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -169.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.451 ' CD1' HD11 ' A' ' 57' ' ' LEU . 12.6 p90 -130.87 137.59 49.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.774 1.23 . . . . 0.0 113.84 -167.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.09 83.07 8.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.223 -1.548 . . . . 0.0 112.378 -172.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.16 105.4 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.729 0.811 . . . . 0.0 112.866 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -85.5 -12.65 51.27 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.745 -1.222 . . . . 0.0 112.916 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.1 p -120.66 31.64 6.35 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.4 160.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.178 0.899 . . . . 0.0 112.08 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -73.98 144.15 81.94 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 111.711 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.11 -16.37 54.8 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.413 2.742 . . . . 0.0 111.924 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.95 -20.39 23.35 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.156 0.889 . . . . 0.0 112.13 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -42.17 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.501 -1.374 . . . . 0.0 112.134 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 ' CD1' ' A' ' 47' ' ' TYR . 93.5 mt -70.06 -42.05 73.34 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.693 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -51.44 -49.86 60.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.428 1.091 . . . . 0.0 110.913 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -61.59 -34.28 75.35 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.22 75.17 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 120.277 1.399 . . . . 0.0 112.159 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -70.27 -55.29 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.331 -0.856 . . . . 0.0 110.974 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.54 -16.86 17.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.276 0.943 . . . . 0.0 112.124 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.15 -0.65 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.457 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -91.93 -31.34 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.059 0.845 . . . . 0.0 111.83 175.158 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -144.35 59.32 6.59 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.9 139.43 84.31 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 125.128 3.885 . . . . 0.0 114.374 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.31 -25.71 3.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.014 1.292 . . . . 0.0 113.571 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -42.28 9.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.032 1.733 . . . . 0.0 109.245 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 4.3 m-30 -76.53 106.93 8.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 115.176 1.546 . . . . 0.0 115.176 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.283 5.5 mtt-85 -73.47 137.24 44.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 158.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.36 135.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 122.375 2.352 . . . . 0.0 110.292 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 p -138.45 151.79 47.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.3 mt -84.04 85.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.465 1.106 . . . . 0.0 108.397 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -60.01 118.86 6.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 122.436 1.113 . . . . 0.0 108.287 169.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -149.13 143.76 26.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.981 1.712 . . . . 0.0 108.339 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -78.2 68.26 4.19 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.997 0.919 . . . . 0.0 110.254 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.437 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 121.866 0.841 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -109.64 168.35 9.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 131.066 3.746 . . . . 0.0 111.84 -169.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 t -125.98 171.72 10.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.888 1.275 . . . . 0.0 110.105 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.21 166.53 31.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.196 0.999 . . . . 0.0 110.421 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.98 36.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.648 1.579 . . . . 0.0 110.898 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -123.3 135.09 54.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.276 1.43 . . . . 0.0 110.245 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -138.2 146.63 42.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.816 1.246 . . . . 0.0 111.406 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -132.8 135.81 56.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.905 1.282 . . . . 0.0 112.224 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.48 106.39 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.463 1.505 . . . . 0.0 111.771 -167.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.36 -3.96 36.59 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 119.346 -2.096 . . . . 0.0 115.673 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.54 5.85 44.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.556 1.074 . . . . 0.0 111.736 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.53 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 ttp -77.51 131.1 37.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 122.041 -0.682 . . . . 0.0 110.012 -169.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -64.86 6.62 0.22 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.553 1.541 . . . . 0.0 113.572 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.1 m 76.88 -40.13 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.388 2.275 . . . . 0.0 116.607 164.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 -85.2 0.62 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -52.47 -27.93 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.3 m -51.15 -39.19 55.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.261 1.391 . . . . 0.0 112.964 169.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 36' ' ' VAL . 24.1 t -57.0 -42.2 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.073 1.349 . . . . 0.0 112.771 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -59.96 -40.41 88.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 0.0 111.434 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -66.3 -44.72 82.69 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 121.989 -0.445 . . . . 0.0 111.594 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -45.75 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 119.229 -0.415 . . . . 0.0 109.962 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.92 -51.4 61.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.525 1.13 . . . . 0.0 110.45 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.6 t -70.71 -37.18 73.52 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -74.28 -41.36 61.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 110.329 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.61 -48.17 41.8 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.899 -1.524 . . . . 0.0 110.66 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 t -72.83 14.64 0.25 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.312 1.869 . . . . 0.0 113.588 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.45 -6.85 15.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.12 1.768 . . . . 0.0 112.108 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 28.9 mt -73.29 129.44 38.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.909 -1.119 . . . . 0.0 109.167 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -60.22 -17.59 42.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -170.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -96.61 -8.56 31.42 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 171.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.3 p -94.54 138.6 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.604 2.002 . . . . 0.0 109.725 -173.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 t -107.77 -12.98 15.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.819 . . . . 0.0 113.165 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m 179.17 174.63 0.72 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.82 2.448 . . . . 0.0 111.769 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -172.73 154.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.694 2.398 . . . . 0.0 109.468 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.28 129.8 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.464 2.305 . . . . 0.0 108.162 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 18' ' ' VAL . 78.9 t -103.62 136.63 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 122.701 1.238 . . . . 0.0 111.739 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -78.29 93.23 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.577 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 18' ' ' VAL . 21.1 tp -54.9 -43.41 73.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.714 0.806 . . . . 0.0 112.981 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.95 -44.02 19.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.187 1.395 . . . . 0.0 112.587 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.41 -170.93 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.286 2.634 . . . . 0.0 114.646 -168.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -101.18 19.15 18.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.233 1.813 . . . . 0.0 114.376 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 p -136.55 156.61 48.34 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -167.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.36 136.95 49.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.495 1.918 . . . . 0.0 110.572 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.14 122.03 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.479 ' CG1' HD13 ' A' ' 57' ' ' LEU . 39.9 t -123.42 120.61 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 108.996 -166.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.49 111.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.515 1.526 . . . . 0.0 109.14 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' A' ' 57' ' ' LEU . 38.9 p90 -123.23 157.86 32.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.48 1.112 . . . . 0.0 112.821 -173.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -98.37 108.09 20.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.012 -1.055 . . . . 0.0 111.879 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.76 147.29 2.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.014 1.325 . . . . 0.0 110.817 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 m -82.26 2.48 31.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.536 -0.727 . . . . 0.0 111.881 168.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.4 m -122.52 152.81 39.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.157 1.383 . . . . 0.0 111.06 -171.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -85.76 112.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -148.23 72.47 11.05 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.224 1.41 . . . . 0.0 108.835 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.64 -12.98 20.26 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.034 3.156 . . . . 0.0 113.506 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -55.96 -48.0 76.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.276 1.43 . . . . 0.0 111.479 -172.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.6 -29.16 68.43 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.275 -0.891 . . . . 0.0 112.373 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 47' ' ' TYR . 54.2 mt -70.83 -49.22 48.62 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.02 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -52.8 -48.23 67.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.362 1.065 . . . . 0.0 110.648 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -56.86 -40.52 76.3 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.05 85.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.541 1.519 . . . . 0.0 112.128 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -63.37 -54.85 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.051 0.54 . . . . 0.0 109.923 172.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -50.81 -33.68 24.58 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.353 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.62 5.12 13.98 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -101.46 -26.7 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.981 1.312 . . . . 0.0 111.725 176.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.51 65.99 8.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.793 0.837 . . . . 0.0 110.633 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.9 143.86 92.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.113 3.209 . . . . 0.0 112.583 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -33.51 3.01 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.882 1.229 . . . . 0.0 113.183 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 tp -85.72 -46.66 10.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.545 1.538 . . . . 0.0 111.631 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -73.97 106.19 5.55 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -71.64 39.02 0.06 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.405 1.882 . . . . 0.0 114.893 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.55 125.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.3 m -137.43 156.68 47.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.245 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.7 mt -95.63 127.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.355 1.462 . . . . 0.0 109.152 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 105.47 17.39 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.774 0.829 . . . . 0.0 109.703 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.3 m -161.23 162.07 31.04 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.8 1.24 . . . . 0.0 110.952 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.87 68.4 7.11 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.339 1.456 . . . . 0.0 111.013 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.342 173.882 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -125.78 167.08 15.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.221 3.009 . . . . 0.0 113.162 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -102.07 -172.69 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.356 1.462 . . . . 0.0 111.869 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.28 149.76 10.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.054 1.342 . . . . 0.0 109.711 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.15 162.46 41.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.948 1.699 . . . . 0.0 110.816 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m -119.83 140.06 51.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 109.576 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 7.5 m-85 -140.71 143.68 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 111.601 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.21 131.07 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.944 0.898 . . . . 0.0 110.957 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.77 128.63 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.497 -168.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.67 116.65 29.15 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.406 -0.809 . . . . 0.0 108.967 164.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.24 -12.55 8.02 Favored Glycine 0 N--CA 1.466 0.692 0 C-N-CA 124.062 0.839 . . . . 0.0 113.236 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.468 ' HG3' ' H ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -63.86 146.35 54.15 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.1 0.95 . . . . 0.0 111.462 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -62.05 2.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.706 2.002 . . . . 0.0 115.737 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 12' ' ' MET . 99.2 m 64.63 26.92 13.25 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 166.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.38 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.638 2.775 . . . . 0.0 106.597 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m -52.76 -26.87 15.49 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.1 2.227 . . . . 0.0 115.456 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.1 -38.57 39.23 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 120.19 1.359 . . . . 0.0 112.288 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.636 HG22 HG11 ' A' ' 36' ' ' VAL . 28.5 t -53.83 -41.38 48.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 125.107 1.363 . . . . 0.0 113.653 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -62.6 -38.22 89.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.819 0.447 . . . . 0.0 111.572 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -68.21 -45.95 71.91 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.174 0.589 . . . . 0.0 111.947 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -44.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.348 -173.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.25 -49.17 70.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.905 1.282 . . . . 0.0 110.423 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.0 m -68.45 -44.17 75.44 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 m -70.66 -39.52 73.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.764 1.226 . . . . 0.0 111.253 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -51.48 16.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.436 -1.269 . . . . 0.0 110.565 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t -74.91 17.96 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.685 1.584 . . . . 0.0 113.394 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.86 -0.5 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.491 1.916 . . . . 0.0 112.178 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.61 135.43 42.02 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.675 -1.266 . . . . 0.0 111.103 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -47.85 -19.11 0.21 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.464 2.305 . . . . 0.0 116.355 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -7.96 11.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.231 1.813 . . . . 0.0 115.621 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.23 136.13 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 121.739 2.063 . . . . 0.0 111.938 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -89.95 -33.91 16.22 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -173.98 176.06 2.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.771 1.628 . . . . 0.0 112.394 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -172.77 154.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.324 2.25 . . . . 0.0 109.981 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.5 t -147.29 128.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.327 2.251 . . . . 0.0 108.045 166.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.636 HG11 HG22 ' A' ' 18' ' ' VAL . 77.0 t -102.31 135.94 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.682 1.23 . . . . 0.0 111.595 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -77.02 94.36 3.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.122 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 18' ' ' VAL . 25.9 tp -55.02 -38.42 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -51.78 -48.39 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.503 1.121 . . . . 0.0 111.104 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -96.99 -170.56 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 129.791 3.237 . . . . 0.0 113.487 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.11 34.94 3.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.217 1.407 . . . . 0.0 112.639 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 p -142.83 153.22 43.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.87 136.33 50.3 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.881 2.072 . . . . 0.0 110.812 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -106.9 116.87 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 57' ' ' LEU . 18.3 t -118.81 132.23 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 0.0 107.704 -169.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.98 101.45 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CD1' HD11 ' A' ' 57' ' ' LEU . 37.8 p90 -122.02 141.63 51.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -168.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -86.03 129.9 34.7 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.796 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -174.99 127.82 0.29 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.468 1.107 . . . . 0.0 111.489 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t -81.34 -8.8 59.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.2 m 176.23 106.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.572 2.749 . . . . 0.0 111.226 169.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.44 156.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.667 1.987 . . . . 0.0 107.737 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 55' ' ' GLU . 27.8 m -81.18 135.36 50.97 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.382 1.073 . . . . 0.0 110.246 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.34 -21.93 69.07 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.101 3.201 . . . . 0.0 112.664 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.43 ' H ' HG22 ' A' ' 53' ' ' THR . 15.1 tp10 -47.55 -26.63 1.49 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.731 1.612 . . . . 0.0 112.811 168.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -69.38 -42.45 75.13 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.046 -1.034 . . . . 0.0 112.722 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.6 mt -68.92 -43.54 74.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.852 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -50.4 -46.96 56.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.35 0.977 . . . . 0.0 111.094 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.88 64.0 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.94 90.92 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.574 1.988 . . . . 0.0 110.361 168.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.28 -56.48 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.745 -0.597 . . . . 0.0 110.917 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -56.96 -19.8 20.14 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.06 0.4 56.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -89.76 -32.89 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.838 0.855 . . . . 0.0 111.332 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.93 67.13 12.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.064 0.546 . . . . 0.0 111.373 169.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.74 139.02 88.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 124.219 3.279 . . . . 0.0 112.224 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.31 -33.85 3.14 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.973 1.273 . . . . 0.0 113.146 -173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -78.7 -46.94 17.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.896 0.848 . . . . 0.0 110.07 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.2 m-30 -84.54 122.84 29.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.892 1.677 . . . . 0.0 113.844 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.33 105.36 13.98 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.831 1.652 . . . . 0.0 108.408 169.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.86 135.1 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 120.889 1.677 . . . . 0.0 111.402 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.1 p -126.46 156.0 41.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.241 0.543 . . . . 0.0 111.795 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.4 mt -92.9 121.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.171 1.388 . . . . 0.0 109.264 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 102.62 12.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.153 0.581 . . . . 0.0 110.088 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.0 m -164.04 160.34 21.59 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.146 1.779 . . . . 0.0 108.662 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.76 114.63 15.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.437 1.495 . . . . 0.0 109.119 169.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 125.035 1.334 . . . . 0.0 111.897 -174.32 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.2 t30 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.62 155.35 3.13 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.961 1.304 . . . . 0.0 112.017 167.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 t -89.95 177.8 6.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.223 1.011 . . . . 0.0 111.832 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -161.19 147.62 14.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.796 1.238 . . . . 0.0 110.363 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.37 44.61 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.317 1.047 . . . . 0.0 111.978 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m -116.28 137.1 52.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 109.98 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -136.35 143.94 44.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.089 1.356 . . . . 0.0 110.311 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 tt -133.44 134.13 57.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 110.986 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.9 111.26 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -169.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.73 92.45 8.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.01 -34.2 0.61 Allowed Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.343 0.973 . . . . 0.0 114.159 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -58.71 126.94 29.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.268 0.627 . . . . 0.0 110.905 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.429 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 24.7 m-70 -61.54 41.26 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -169.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.0 m 70.44 -48.25 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 130.538 3.535 . . . . 0.0 114.908 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -128.29 -69.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.909 0.884 . . . . 0.0 110.852 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -57.38 -18.75 19.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 p -50.72 -50.54 55.1 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.652 1.115 . . . . 0.0 111.365 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 38' ' ' LEU . 2.1 t -55.65 -43.05 71.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 124.303 1.041 . . . . 0.0 111.775 -168.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -66.83 -34.74 78.48 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -65.62 -45.86 81.49 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.81 -1.181 . . . . 0.0 111.039 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -39.91 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -51.4 -51.58 53.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 109.831 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.0 m -70.37 -48.14 57.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -69.63 -37.74 76.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.371 1.068 . . . . 0.0 111.125 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -51.15 15.89 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.144 -1.408 . . . . 0.0 111.186 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.31 16.36 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.355 1.889 . . . . 0.0 113.739 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.35 -5.29 14.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.264 1.826 . . . . 0.0 112.227 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.57 133.9 44.95 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 120.549 -1.344 . . . . 0.0 109.967 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -66.3 0.02 2.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.59 -6.68 11.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.59 134.43 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 121.581 1.991 . . . . 0.0 111.258 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 m -91.41 -25.24 19.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.567 0.747 . . . . 0.0 112.942 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.14 175.26 1.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.813 1.645 . . . . 0.0 113.177 -170.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -166.51 152.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.036 2.134 . . . . 0.0 109.632 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.36 148.92 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.147 2.579 . . . . 0.0 105.946 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 18' ' ' VAL . 14.6 p -140.7 150.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 112.367 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -91.31 135.55 33.73 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.233 1.413 . . . . 0.0 111.682 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 18' ' ' VAL . 10.0 tp -104.06 -30.02 10.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.559 1.544 . . . . 0.0 112.607 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -32.38 68.61 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.864 2.065 . . . . 0.0 112.786 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -104.89 -174.5 2.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.074 2.15 . . . . 0.0 113.189 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.78 32.95 5.76 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.03 2.532 . . . . 0.0 110.7 -174.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 p -140.17 156.71 46.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.042 -1.661 . . . . 0.0 114.728 -167.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.46 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 110.692 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -115.67 116.87 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 ' CG1' HD13 ' A' ' 57' ' ' LEU . 24.1 t -117.37 130.63 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 108.563 -168.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.2 105.11 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 108.781 -168.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.606 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -124.92 150.06 46.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -99.48 122.91 43.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.359 0.664 . . . . 0.0 111.04 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.9 142.08 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.854 1.662 . . . . 0.0 110.489 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m -66.96 -33.38 75.46 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.513 0.597 . . . . 0.0 111.923 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 52' ' ' VAL . 16.9 t -178.05 153.71 0.82 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.883 2.473 . . . . 0.0 108.845 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 51' ' ' SER . 9.0 m 179.78 169.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 131.684 3.994 . . . . 0.0 106.198 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.52 135.6 34.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.67 -0.644 . . . . 0.0 111.621 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.61 -17.49 54.61 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.686 2.924 . . . . 0.0 111.956 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -52.95 -25.68 12.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.594 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.8 p -66.76 -44.25 81.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.678 1.191 . . . . 0.0 113.346 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.606 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.4 mt -71.03 -41.6 70.63 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.594 -0.692 . . . . 0.0 110.73 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.21 -48.65 45.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.405 1.082 . . . . 0.0 111.016 170.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.209 1.403 . . . . 0.0 114.554 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.56 76.25 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.012 1.278 . . . . 0.0 111.551 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.915 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -51.08 -34.45 30.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.667 0.667 . . . . 0.0 110.389 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.9 4.22 14.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.432 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -97.5 -30.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.952 0.901 . . . . 0.0 111.35 177.013 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.01 64.57 7.59 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 111.493 169.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.35 147.56 95.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.492 3.462 . . . . 0.0 113.211 -172.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.53 -24.51 3.65 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.794 1.188 . . . . 0.0 114.185 -173.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.37 -36.01 8.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.161 1.384 . . . . 0.0 111.509 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.432 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -76.98 106.08 8.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -80.8 71.3 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.085 -1.634 . . . . 0.0 111.654 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.6 128.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.702 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -135.75 146.26 47.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.327 1.451 . . . . 0.0 109.298 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 94.2 mt -90.71 126.78 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.708 -1.245 . . . . 0.0 108.093 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -108.96 113.18 25.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 109.6 168.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 t -163.05 157.38 20.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.657 1.583 . . . . 0.0 110.54 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -83.79 74.7 10.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.958 1.361 . . . . 0.0 109.656 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.725 2.01 . . . . 0.0 110.146 171.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 CA--C 1.549 0.924 0 CA-C-O 120.619 0.247 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -71.16 159.06 35.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.715 1.606 . . . . 0.0 113.476 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -80.32 177.29 9.07 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.947 0.879 . . . . 0.0 110.947 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -165.9 145.6 6.33 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.815 1.246 . . . . 0.0 110.23 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.92 166.1 31.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.593 1.557 . . . . 0.0 111.321 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.6 m -127.18 135.54 50.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.449 1.5 . . . . 0.0 110.923 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.81 149.18 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.99 141.93 42.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 111.008 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -124.62 108.21 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 123.833 0.708 . . . . 0.0 110.902 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.95 26.8 0.58 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.98 22.48 1.27 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.5 1.524 . . . . 0.0 113.482 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 1.3 tmt? -84.7 130.39 34.71 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 -169.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 4.6 m170 -71.45 12.14 0.38 Allowed 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 t 90.82 -145.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.354 2.661 . . . . 0.0 111.46 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HE3' HD13 ' A' ' 38' ' ' LEU . 14.1 mptt -58.75 -30.07 67.23 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.317 -1.49 . . . . 0.0 113.283 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -69.06 -34.42 75.14 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.136 -1.603 . . . . 0.0 112.725 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.2 m -70.34 -38.78 74.93 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 116.356 -1.783 . . . . 0.0 113.318 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 35.5 t -42.57 -53.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -58.87 -39.96 82.92 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.64 -39.94 88.48 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.722 -0.611 . . . . 0.0 111.986 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -42.58 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.419 0.554 . . . . 0.0 110.118 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.28 -48.49 71.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.384 1.074 . . . . 0.0 110.518 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 m -71.2 -46.71 60.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -71.12 -37.16 72.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 125.472 1.509 . . . . 0.0 111.5 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -74.73 -49.77 19.87 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.162 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -72.75 15.38 0.2 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 121.576 1.989 . . . . 0.0 113.427 -170.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.88 -2.38 16.1 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 112.511 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -76.09 137.07 39.91 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.757 -1.214 . . . . 0.0 111.127 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.29 31.08 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.767 2.027 . . . . 0.0 114.234 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.16 -3.0 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.12 2.568 . . . . 0.0 113.945 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.5 p -99.43 140.84 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.505 1.957 . . . . 0.0 108.852 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -112.74 -8.54 13.76 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -176.35 171.95 2.34 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.379 1.871 . . . . 0.0 113.505 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -175.13 154.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.904 2.482 . . . . 0.0 110.229 -171.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -147.67 126.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 127.596 2.358 . . . . 0.0 107.518 165.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 50.9 t -91.42 134.26 30.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.43 1.11 . . . . 0.0 109.865 168.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.9 m -69.83 89.93 0.59 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.483 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.563 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.9 tm? -45.49 -43.59 11.77 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.287 2.235 . . . . 0.0 112.011 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -53.06 57.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.669 1.188 . . . . 0.0 111.347 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.92 -174.73 4.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.395 2.278 . . . . 0.0 113.909 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.21 36.6 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.955 1.702 . . . . 0.0 113.296 169.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.01 154.9 43.75 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.047 -1.658 . . . . 0.0 114.137 -169.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.8 135.08 41.52 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.253 1.821 . . . . 0.0 110.35 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.48 119.23 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -125.81 139.9 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.696 1.198 . . . . 0.0 109.979 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.31 112.51 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.709 1.604 . . . . 0.0 109.063 -168.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CD1' HD11 ' A' ' 57' ' ' LEU . 39.5 p90 -131.29 148.4 52.68 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -168.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.95 74.06 6.44 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.701 -1.249 . . . . 0.0 112.483 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.18 -162.2 0.89 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.189 0.996 . . . . 0.0 111.283 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -177.24 -51.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.538 2.335 . . . . 0.0 108.991 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 p -75.1 55.0 0.71 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.73 -1.231 . . . . 0.0 112.399 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.21 150.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.267 1.827 . . . . 0.0 109.495 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 t -81.3 141.33 49.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.041 0.937 . . . . 0.0 112.128 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.16 -15.03 41.53 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.653 2.902 . . . . 0.0 112.474 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -51.16 -23.95 3.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.583 1.153 . . . . 0.0 111.789 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -68.2 -44.83 74.95 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.666 -1.271 . . . . 0.0 113.278 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.8 mt -70.67 -43.6 68.76 Favored 'General case' 0 C--O 1.226 -0.161 0 O-C-N 121.515 -0.741 . . . . 0.0 110.356 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -48.54 -51.92 25.22 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.503 1.121 . . . . 0.0 110.993 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.26 -30.71 71.61 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.8 -33.36 74.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.236 1.38 . . . . 0.0 112.051 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.28 -55.8 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.752 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.43 -37.34 11.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.861 0.755 . . . . 0.0 111.156 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.29 4.63 8.42 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.476 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -98.09 -33.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.622 1.569 . . . . 0.0 111.919 174.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.12 61.85 18.93 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 169.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.21 139.8 79.89 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.9 3.067 . . . . 0.0 112.835 -171.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.66 -21.41 14.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.193 1.378 . . . . 0.0 114.04 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.06 -45.82 5.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.423 1.889 . . . . 0.0 110.59 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' HG12 ' A' ' 64' ' ' VAL . 1.7 m-30 -64.99 100.98 0.46 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.066 1.346 . . . . 0.0 114.509 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -77.8 73.68 4.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.908 1.283 . . . . 0.0 111.321 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.04 132.92 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.755 0.788 . . . . 0.0 111.976 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.5 m -145.89 166.24 26.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.632 1.573 . . . . 0.0 110.858 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.6 mt -99.09 132.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.913 1.685 . . . . 0.0 108.059 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -114.67 114.02 25.11 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.6 m -164.56 159.9 19.66 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.943 1.297 . . . . 0.0 111.929 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -77.15 45.05 0.43 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.39 2.276 . . . . 0.0 113.145 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 125.672 1.589 . . . . 0.0 113.546 -167.967 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 36.6 m-20 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.75 157.13 33.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 123.968 1.842 . . . . 0.0 113.057 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 t -100.69 -176.73 3.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.04 2.536 . . . . 0.0 110.969 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -163.06 148.57 11.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 110.112 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 162.89 40.79 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.243 1.417 . . . . 0.0 110.974 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.0 m -121.43 137.86 54.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.726 1.21 . . . . 0.0 109.622 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -137.51 147.08 44.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.235 1.414 . . . . 0.0 110.202 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 tt -132.52 137.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.696 1.198 . . . . 0.0 110.603 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.97 99.24 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.703 1.601 . . . . 0.0 111.255 -171.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.25 101.23 10.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.265 1.031 . . . . 0.0 110.609 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.98 -7.88 4.14 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.776 1.179 . . . . 0.0 114.855 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -64.71 143.36 57.98 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.892 1.346 . . . . 0.0 112.026 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -67.21 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 126.705 2.002 . . . . 0.0 114.89 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m 54.5 -131.61 1.96 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.962 2.105 . . . . 0.0 112.033 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.5 tptt -48.5 -32.87 8.53 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.565 1.946 . . . . 0.0 114.151 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 m -91.18 -29.27 17.34 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -37.92 89.23 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.971 1.26 . . . . 0.0 111.23 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 38' ' ' LEU . 49.1 t -37.73 -58.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.565 1.546 . . . . 0.0 112.277 169.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -55.28 -43.77 75.06 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 111.929 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -62.95 -42.64 99.88 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.571 -0.705 . . . . 0.0 112.602 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -44.18 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.807 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.71 -51.1 70.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.368 1.067 . . . . 0.0 110.064 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -35.94 79.27 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.9 m -75.81 -37.73 58.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.653 0.781 . . . . 0.0 110.383 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -50.36 17.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.903 175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -74.53 12.84 0.7 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.765 1.166 . . . . 0.0 112.765 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.47 -7.19 18.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.507 1.523 . . . . 0.0 111.942 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 mt -78.29 126.65 31.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.24 -11.81 7.3 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.47 -13.06 24.87 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 169.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.98 140.46 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 121.789 2.086 . . . . 0.0 108.866 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.1 t -96.52 -29.49 13.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.368 1.467 . . . . 0.0 111.666 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -176.07 174.6 2.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.684 1.594 . . . . 0.0 112.336 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -174.59 150.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.631 1.972 . . . . 0.0 110.521 -172.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.82 132.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 127.352 2.261 . . . . 0.0 108.053 167.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' CG1' HG13 ' A' ' 18' ' ' VAL . 38.9 t -107.12 143.32 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.078 0.951 . . . . 0.0 111.277 170.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 40' ' ' ASN . 9.5 t -74.79 108.31 7.45 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 165.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 18' ' ' VAL . 3.7 mt -47.3 -25.84 1.08 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.753 2.021 . . . . 0.0 114.459 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.34 -35.48 6.26 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.913 2.885 . . . . 0.0 114.243 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 24.6 m-80 -83.91 -175.15 5.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.718 0.407 . . . . 0.0 110.539 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER -112.97 39.31 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 175.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -141.44 155.7 45.85 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.461 -1.399 . . . . 0.0 113.046 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.55 50.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.737 2.015 . . . . 0.0 110.041 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -106.18 114.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.6 t -121.08 130.51 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.756 1.222 . . . . 0.0 108.487 -168.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.6 t -117.59 117.55 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.472 1.909 . . . . 0.0 107.434 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' A' ' 57' ' ' LEU . 19.8 p90 -139.21 155.21 47.96 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.613 1.551 . . . . 0.0 113.233 -168.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -99.24 117.08 32.91 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.122 -1.611 . . . . 0.0 113.688 -167.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.34 151.33 3.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.172 1.389 . . . . 0.0 112.221 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -90.53 52.92 2.31 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -175.43 154.0 1.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -92.19 88.59 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.24 1.016 . . . . 0.0 109.792 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -120.98 68.35 16.49 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.731 1.212 . . . . 0.0 110.905 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.65 -11.17 15.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.915 3.076 . . . . 0.0 114.82 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.97 -35.85 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.206 1.002 . . . . 0.0 113.094 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.7 p -69.39 -41.48 76.39 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.318 -0.864 . . . . 0.0 113.243 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.1 mt -64.81 -49.0 72.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.88 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.27 -56.63 6.4 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.861 1.264 . . . . 0.0 110.36 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -51.7 -41.82 61.76 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.75 67.59 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.104 0.865 . . . . 0.0 112.954 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -69.95 -56.37 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.959 0.904 . . . . 0.0 109.65 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -50.66 -31.68 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.707 0.803 . . . . 0.0 111.812 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.16 28.88 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.505 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -97.64 -31.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.37 65.83 9.67 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.463 -0.773 . . . . 0.0 111.085 167.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.93 141.96 96.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.98 3.12 . . . . 0.0 112.112 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.71 -28.54 4.87 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.756 1.17 . . . . 0.0 113.454 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -92.12 -44.16 8.97 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 111.633 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.7 m-30 -72.67 99.73 2.64 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 78.14 0.64 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.332 -1.48 . . . . 0.0 109.326 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.95 135.37 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.464 1.125 . . . . 0.0 111.684 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.2 m -150.9 158.11 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.951 1.7 . . . . 0.0 111.238 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 126.17 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.896 1.679 . . . . 0.0 109.48 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.8 72.32 10.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.286 1.034 . . . . 0.0 111.559 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -122.87 163.25 20.65 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.11 133.33 41.55 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 127.841 2.456 . . . . 0.0 108.563 -175.79 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.9 m120 . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.957 0.408 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.49 146.75 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.998 1.319 . . . . 0.0 111.758 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -95.24 176.61 6.15 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.92 1.688 . . . . 0.0 111.746 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -160.65 140.58 11.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.924 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.51 161.28 38.29 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.017 1.327 . . . . 0.0 109.911 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.4 m -123.32 136.21 54.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.75 0.82 . . . . 0.0 109.036 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.48 147.49 52.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.222 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -135.56 133.6 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.266 1.026 . . . . 0.0 110.847 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.66 116.0 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.969 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -81.12 5.31 17.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.39 22.22 1.07 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.02 1.771 . . . . 0.0 115.395 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.85 146.02 49.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.215 2.008 . . . . 0.0 112.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.433 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 3.0 m170 -74.0 23.3 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.714 1.606 . . . . 0.0 113.3 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t 76.51 -141.63 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.23 2.212 . . . . 0.0 111.182 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -55.94 -36.31 67.62 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.423 -1.423 . . . . 0.0 114.182 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -69.98 -34.17 73.02 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.257 -1.527 . . . . 0.0 112.074 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.0 OUTLIER -67.86 -42.38 81.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 116.068 -1.92 . . . . 0.0 112.587 173.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 36' ' ' VAL . 9.3 t -40.6 -55.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.96 1.255 . . . . 0.0 111.351 174.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.0 t -62.57 -37.68 87.13 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -62.75 -42.03 99.49 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.159 -0.963 . . . . 0.0 111.963 171.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.74 -42.68 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 118.919 0.781 . . . . 0.0 110.034 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -52.86 -53.29 51.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.997 0.919 . . . . 0.0 110.17 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 m -70.52 -44.79 66.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.8 m -70.07 -36.03 74.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.132 1.773 . . . . 0.0 110.846 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -50.45 18.19 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.871 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -68.12 12.53 0.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.466 1.485 . . . . 0.0 114.139 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.85 18.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.649 1.98 . . . . 0.0 111.809 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.08 129.75 34.7 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.854 -1.154 . . . . 0.0 110.127 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.93 -1.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.38 -8.08 11.09 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.22 135.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 121.772 2.078 . . . . 0.0 110.926 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 19.5 m -92.65 -25.02 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.265 1.426 . . . . 0.0 111.889 -173.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m 178.89 175.97 0.58 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.545 2.338 . . . . 0.0 112.726 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.8 tt -174.04 152.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 127.136 2.174 . . . . 0.0 109.49 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.07 131.71 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 126.087 1.755 . . . . 0.0 107.448 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 18' ' ' VAL . 13.7 t -94.47 135.52 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 123.073 1.416 . . . . 0.0 109.505 168.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 m -67.41 90.62 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.063 167.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.436 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -55.68 -31.45 62.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.577 1.151 . . . . 0.0 112.638 -171.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -59.77 4.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.982 0.81 . . . . 0.0 111.116 169.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -72.58 -176.36 1.91 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 125.356 2.503 . . . . 0.0 114.027 -171.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.554 2.342 . . . . 0.0 113.024 170.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.2 p -137.38 160.17 39.84 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.704 -1.872 . . . . 0.0 115.056 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.71 136.79 44.88 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.228 1.811 . . . . 0.0 110.683 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.1 112.68 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' CG1' HD13 ' A' ' 57' ' ' LEU . 20.9 t -116.66 130.5 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.474 1.509 . . . . 0.0 108.339 -168.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.69 114.51 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.247 1.419 . . . . 0.0 108.038 -168.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CD1' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -132.86 155.22 49.4 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 120.457 1.481 . . . . 0.0 113.373 -168.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -94.18 122.04 36.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.362 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.31 155.01 3.42 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.968 1.707 . . . . 0.0 111.218 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -89.28 30.29 1.0 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.699 -1.251 . . . . 0.0 111.038 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -168.54 169.26 10.47 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.13 117.79 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.868 2.067 . . . . 0.0 109.784 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -154.46 58.72 2.18 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 125.75 1.62 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.83 -19.59 52.71 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.609 2.873 . . . . 0.0 113.127 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -18.32 3.9 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 m -82.58 -40.34 21.03 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 121.03 1.741 . . . . 0.0 112.702 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.0 mt -67.65 -45.52 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.219 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -48.38 -46.93 37.7 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.278 0.944 . . . . 0.0 110.643 170.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -35.49 79.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.438 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.07 71.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.789 1.631 . . . . 0.0 112.28 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -72.82 -57.77 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.992 0.917 . . . . 0.0 109.699 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -55.59 -16.23 3.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.931 1.293 . . . . 0.0 113.737 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.03 -0.42 57.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -90.87 -35.59 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.956 0.798 . . . . 0.0 111.457 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -141.22 63.32 17.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 169.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.35 143.52 86.02 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.364 3.376 . . . . 0.0 114.231 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.9 -31.35 2.81 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.28 1.419 . . . . 0.0 113.502 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.28 -40.99 11.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.881 1.673 . . . . 0.0 110.395 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.518 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -75.31 93.91 2.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.164 -0.96 . . . . 0.0 113.421 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -71.97 121.01 18.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 161.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.51 136.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 123.754 2.979 . . . . 0.0 111.832 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -134.91 156.57 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.135 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.38 130.3 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.144 1.378 . . . . 0.0 108.391 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -126.68 107.71 10.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.387 1.089 . . . . 0.0 111.456 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 p -146.33 155.03 42.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.343 1.057 . . . . 0.0 111.578 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.66 66.62 6.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 123.094 1.426 . . . . 0.0 111.398 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 126.41 1.884 . . . . 0.0 110.889 174.369 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.65 159.21 21.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.212 1.005 . . . . 0.0 110.105 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -87.84 173.8 8.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.096 0.951 . . . . 0.0 110.592 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -163.95 148.05 10.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.074 1.35 . . . . 0.0 110.051 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.66 159.82 37.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.484 1.513 . . . . 0.0 111.387 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -125.77 136.56 53.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.991 1.316 . . . . 0.0 110.148 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.39 145.77 49.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.925 1.29 . . . . 0.0 111.156 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tt -121.74 145.12 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.273 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.4 168.67 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 124.567 1.147 . . . . 0.0 107.943 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -152.82 125.44 8.28 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.036 -1.04 . . . . 0.0 109.145 168.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.81 -6.49 44.19 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.613 1.101 . . . . 0.0 113.292 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.35 141.31 47.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.488 1.515 . . . . 0.0 112.267 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -51.68 -46.21 63.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 p 160.81 -65.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.427 1.891 . . . . 0.0 113.848 -171.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 -57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.136 2.175 . . . . 0.0 109.217 -166.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -20.01 21.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.121 0.968 . . . . 0.0 113.448 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 p -56.28 -48.8 75.89 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.256 168.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.33 -49.88 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.0 111.153 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -65.61 -35.73 81.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.429 1.092 . . . . 0.0 112.929 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.26 -39.59 95.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.564 -1.335 . . . . 0.0 111.976 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -30.4 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.54 -175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -59.35 -56.68 18.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.511 0.725 . . . . 0.0 109.752 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t -70.19 -41.47 73.67 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.0 m -73.77 -34.81 64.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.595 1.158 . . . . 0.0 110.946 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -52.06 12.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.258 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 t -71.08 16.27 0.09 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.988 1.722 . . . . 0.0 113.773 -172.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.4 -5.01 15.96 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.744 2.018 . . . . 0.0 112.074 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 60' ' ' ALA . 16.7 mt -77.72 130.24 36.52 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 109.508 -172.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.03 -17.35 24.62 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.59 -8.17 29.56 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.78 140.78 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 122.105 2.23 . . . . 0.0 110.091 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -98.06 -24.29 15.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 111.878 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m 178.73 173.26 0.72 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.704 2.001 . . . . 0.0 113.246 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -168.25 153.19 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.917 2.087 . . . . 0.0 110.552 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 151.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.089 2.955 . . . . 0.0 106.131 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.27 151.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 122.035 0.922 . . . . 0.0 111.738 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -74.13 123.83 25.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.615 1.166 . . . . 0.0 109.174 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.49 -42.7 24.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.817 1.189 . . . . 0.0 112.089 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -61.2 -63.96 1.11 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.106 1.321 . . . . 0.0 109.614 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -85.4 168.49 14.56 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 122.878 1.323 . . . . 0.0 113.693 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.19 44.92 1.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -140.91 150.23 42.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 140.61 52.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.161 2.184 . . . . 0.0 111.174 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.06 115.87 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.29 136.48 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.893 1.277 . . . . 0.0 109.214 -166.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.24 113.67 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.233 1.413 . . . . 0.0 108.122 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.3 p90 -130.64 154.1 48.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.698 1.199 . . . . 0.0 113.857 -168.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -93.12 113.01 25.14 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.028 -1.045 . . . . 0.0 110.595 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.14 142.22 0.48 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.306 1.442 . . . . 0.0 110.805 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -76.48 -3.07 35.31 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.64 -0.663 . . . . 0.0 111.591 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -111.52 126.16 54.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.08 1.352 . . . . 0.0 111.227 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -72.27 82.59 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.67 0.788 . . . . 0.0 109.878 168.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.6 m -119.37 64.89 7.98 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 125.162 1.385 . . . . 0.0 110.021 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.51 -17.5 53.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.956 3.104 . . . . 0.0 113.053 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.04 -8.97 53.6 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.514 1.052 . . . . 0.0 112.802 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -68.26 -49.59 59.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.767 1.167 . . . . 0.0 110.736 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 47' ' ' TYR . 78.6 mt -65.81 -43.78 87.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 117.445 -1.264 . . . . 0.0 111.04 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -47.39 -50.03 23.41 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.255 1.389 . . . . 0.0 112.788 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.07 87.68 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 174.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.457 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.83 -33.97 76.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.359 1.436 . . . . 0.0 112.341 173.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -69.77 -52.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.605 172.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -50.36 -35.86 29.87 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.264 0.938 . . . . 0.0 110.941 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.88 3.32 12.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -98.67 -29.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 111.786 177.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.01 66.98 9.86 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.912 0.885 . . . . 0.0 110.347 168.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.64 140.27 80.04 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.098 3.199 . . . . 0.0 111.872 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.62 -22.16 6.79 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.626 1.107 . . . . 0.0 113.666 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 tp -99.46 -29.26 12.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.297 1.439 . . . . 0.0 112.732 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -92.3 105.59 17.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 6.4 ttt180 -69.96 47.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.241 2.216 . . . . 0.0 115.046 171.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.8 121.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 120.325 -1.485 . . . . 0.0 113.588 -168.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -134.9 152.18 51.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.223 1.409 . . . . 0.0 110.747 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.3 mt -90.91 130.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.739 -1.225 . . . . 0.0 108.086 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.6 t -110.9 115.33 29.32 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 109.462 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -164.85 174.95 10.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.477 1.511 . . . . 0.0 111.926 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.99 65.61 0.36 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.169 2.188 . . . . 0.0 111.74 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 125.172 1.389 . . . . 0.0 112.768 171.742 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -95.07 158.12 15.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.808 1.243 . . . . 0.0 110.543 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -91.76 -179.16 5.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.393 1.477 . . . . 0.0 111.17 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -165.54 155.12 12.53 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 109.861 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.37 161.25 30.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.14 1.776 . . . . 0.0 111.436 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -122.44 141.58 51.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.546 1.539 . . . . 0.0 110.432 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -145.1 141.26 28.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.36 1.464 . . . . 0.0 111.171 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.68 134.39 62.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.957 1.303 . . . . 0.0 111.46 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.32 103.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.585 1.954 . . . . 0.0 111.908 -170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 127.62 32.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.529 -1.357 . . . . 0.0 110.315 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.57 39.38 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 121.69 -0.631 . . . . 0.0 111.952 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.4 ptm -59.38 142.0 53.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 167.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.29 11.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.826 1.65 . . . . 0.0 115.025 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 m 70.76 -23.08 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.437 2.295 . . . . 0.0 116.059 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -87.16 0.34 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.903 1.681 . . . . 0.0 106.692 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -23.38 30.8 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.034 -1.666 . . . . 0.0 114.699 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.55 -37.71 88.35 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 116.824 -1.56 . . . . 0.0 113.034 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.0 t -50.46 -46.44 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.089 1.356 . . . . 0.0 109.985 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -67.92 -37.81 82.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.596 1.558 . . . . 0.0 114.105 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -63.13 -39.23 94.09 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 120.796 -1.19 . . . . 0.0 110.95 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.67 -40.4 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.519 -176.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -52.37 -55.29 22.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.983 0.913 . . . . 0.0 110.262 168.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 t -70.56 -42.48 71.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -73.14 -36.35 66.65 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.84 1.256 . . . . 0.0 110.731 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -49.56 18.58 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.559 172.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 t -71.6 17.23 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.879 1.672 . . . . 0.0 113.722 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 -2.48 16.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.895 1.678 . . . . 0.0 112.545 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.5 135.83 38.28 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.779 -1.201 . . . . 0.0 111.309 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -54.71 -9.66 0.36 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -5.58 9.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.855 1.662 . . . . 0.0 115.075 176.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -91.91 138.23 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.65 2.023 . . . . 0.0 110.58 -170.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -94.82 -30.54 14.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.994 1.318 . . . . 0.0 111.345 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -174.57 174.54 2.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 123.36 1.552 . . . . 0.0 113.054 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 tt -165.93 151.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.244 2.217 . . . . 0.0 109.356 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.23 147.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.699 2.4 . . . . 0.0 106.286 167.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.79 152.71 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.086 0.555 . . . . 0.0 109.789 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.3 t -84.78 144.35 28.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.556 0.693 . . . . 0.0 111.743 171.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -20.86 23.73 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -60.39 1.98 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.416 1.087 . . . . 0.0 108.385 168.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -78.79 143.23 36.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.061 0.934 . . . . 0.0 110.967 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.34 42.61 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.086 0.955 . . . . 0.0 112.672 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 p -140.68 150.67 43.78 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.132 -1.605 . . . . 0.0 113.999 -172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.91 146.26 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.096 2.158 . . . . 0.0 110.584 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.26 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.5 t -119.03 133.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.867 1.267 . . . . 0.0 108.418 -167.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.1 t -120.73 109.79 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.786 1.634 . . . . 0.0 108.146 -167.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CD1' HD11 ' A' ' 57' ' ' LEU . 33.6 p90 -127.08 146.68 50.28 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.067 -1.021 . . . . 0.0 113.718 -168.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.95 119.23 26.03 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.17 146.2 2.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.942 2.097 . . . . 0.0 109.102 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -89.08 23.93 2.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.821 1.249 . . . . 0.0 111.429 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -159.32 176.5 12.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.054 1.342 . . . . 0.0 110.404 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 m -94.45 129.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.231 1.012 . . . . 0.0 110.721 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t -146.43 51.54 1.23 Allowed Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -57.69 -25.02 66.0 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.175 3.25 . . . . 0.0 113.211 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -49.28 -40.64 35.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.242 1.017 . . . . 0.0 112.174 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 -38.2 67.59 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.938 -1.101 . . . . 0.0 112.416 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.3 mt -70.14 -44.94 67.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.106 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -54.18 11.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.661 1.184 . . . . 0.0 110.372 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -51.95 -43.37 63.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.87 68.05 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.975 1.261 . . . . 0.0 112.824 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.51 -54.79 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.923 0.889 . . . . 0.0 109.958 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -53.16 -28.97 28.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.827 0.851 . . . . 0.0 111.402 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.35 -2.81 43.28 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -87.8 -39.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 110.484 177.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -136.96 77.37 43.76 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 122.681 0.392 . . . . 0.0 110.496 164.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.04 116.31 3.05 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.429 2.753 . . . . 0.0 109.456 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.03 -21.88 41.71 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 117.116 -1.936 . . . . 0.0 115.402 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tp -95.24 -26.51 15.93 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 121.333 2.567 . . . . 0.0 112.673 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -91.66 105.36 17.68 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -166.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 66.68 1.31 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.214 1.406 . . . . 0.0 110.463 168.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.62 137.76 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.284 0.633 . . . . 0.0 111.737 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.17 133.83 13.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.35 1.06 . . . . 0.0 112.009 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.6 mt -73.75 122.79 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 121.113 -0.992 . . . . 0.0 108.39 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.78 101.45 14.05 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.021 0.929 . . . . 0.0 110.228 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.7 m -132.08 163.29 28.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.148 0.979 . . . . 0.0 110.283 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -71.52 126.29 29.27 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 127.927 2.491 . . . . 0.0 106.669 172.471 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -77.0 158.01 30.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 123.021 1.391 . . . . 0.0 113.273 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 t -93.24 174.46 7.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -157.41 144.03 18.07 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.157 1.383 . . . . 0.0 110.034 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.96 159.78 43.52 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.624 1.57 . . . . 0.0 111.683 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m -120.61 139.84 52.4 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.551 1.541 . . . . 0.0 110.055 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -140.76 142.54 34.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.945 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -124.13 140.72 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.491 1.116 . . . . 0.0 110.064 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.78 148.42 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.219 1.808 . . . . 0.0 108.295 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.5 142.3 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 162.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.15 -16.01 55.94 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.042 0.83 . . . . 0.0 111.142 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptm -58.81 133.63 56.16 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 122.012 -0.699 . . . . 0.0 109.142 168.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -61.48 15.59 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 115.624 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 m 68.55 -15.43 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.268 2.227 . . . . 0.0 116.463 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -88.6 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 107.408 -169.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 p -55.09 -27.65 46.53 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.998 -1.689 . . . . 0.0 114.544 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.27 -38.2 82.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 120.881 1.673 . . . . 0.0 112.084 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.97 -48.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.533 1.533 . . . . 0.0 109.574 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -71.24 -29.9 65.67 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -64.54 -40.38 95.49 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.293 -1.504 . . . . 0.0 110.681 167.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -38.93 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.06 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -52.85 -53.67 45.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 109.894 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 -46.33 63.54 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -170.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.0 m -69.27 -35.48 76.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.021 1.328 . . . . 0.0 111.183 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -50.6 14.04 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.399 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.3 t -72.69 11.21 0.68 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.432 1.469 . . . . 0.0 113.892 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.57 -7.92 19.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.477 1.511 . . . . 0.0 111.668 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.5 129.21 36.89 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.028 0.831 . . . . 0.0 109.451 -171.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -58.29 -20.65 44.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 -10.8 37.9 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -90.55 141.5 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 122.271 2.305 . . . . 0.0 109.936 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 t -97.6 -30.83 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.695 1.598 . . . . 0.0 111.33 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -175.51 172.85 2.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.29 1.436 . . . . 0.0 113.254 -169.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -168.57 150.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.564 1.946 . . . . 0.0 111.311 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.97 150.09 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 128.971 2.908 . . . . 0.0 106.345 167.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.29 147.65 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.083 0.468 . . . . 0.0 110.716 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -70.38 141.16 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.101 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.92 -23.77 14.84 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 111.836 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.09 -39.6 10.05 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 130.316 3.447 . . . . 0.0 112.981 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -97.62 -177.29 3.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.797 1.639 . . . . 0.0 110.913 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -112.33 44.39 1.45 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.965 1.306 . . . . 0.0 111.777 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -137.14 153.71 50.43 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.488 -1.383 . . . . 0.0 113.98 -169.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.52 140.08 52.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.111 1.764 . . . . 0.0 111.427 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -110.06 116.1 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 57' ' ' LEU . 16.6 t -122.93 132.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.939 1.295 . . . . 0.0 108.327 -167.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.56 112.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.628 1.971 . . . . 0.0 107.53 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.534 ' CD1' HD11 ' A' ' 57' ' ' LEU . 23.0 p90 -130.84 150.9 51.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.72 1.6 . . . . 0.0 113.478 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.74 111.13 22.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.818 -1.176 . . . . 0.0 111.696 -171.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.74 146.34 1.61 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.771 2.028 . . . . 0.0 108.667 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -77.12 7.8 4.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.54 -0.725 . . . . 0.0 112.317 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.9 m -127.57 133.36 49.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.565 1.146 . . . . 0.0 112.0 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.26 95.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 168.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.6 m -135.96 65.89 60.09 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 126.753 2.021 . . . . 0.0 108.432 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.34 -22.58 39.5 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.041 2.494 . . . . 0.0 113.018 -173.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 62.1 mm-40 -60.18 -28.94 68.36 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -172.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.1 p -62.09 -40.33 95.47 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.063 -1.648 . . . . 0.0 112.708 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 47' ' ' TYR . 49.6 mt -70.13 -46.35 64.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 0.0 111.298 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -49.24 -55.48 12.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.515 1.126 . . . . 0.0 111.753 173.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.76 -30.67 69.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.571 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.62 80.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.243 1.383 . . . . 0.0 111.817 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mt -61.78 -53.77 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.136 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -54.07 -25.71 23.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.38 0.672 . . . . 0.0 112.717 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.79 2.27 49.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -92.88 -30.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.941 0.896 . . . . 0.0 111.434 175.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.08 68.53 9.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.701 0.8 . . . . 0.0 111.16 169.253 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.78 136.43 70.23 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.103 3.202 . . . . 0.0 111.807 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.74 -24.17 6.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.678 1.133 . . . . 0.0 113.585 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.01 -35.93 15.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.867 1.267 . . . . 0.0 111.06 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -88.27 108.89 19.54 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 32.58 0.09 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 128.634 2.774 . . . . 0.0 115.695 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.34 130.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -166.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.6 m -145.0 148.55 33.86 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.476 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 98.6 mt -83.44 122.85 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.73 1.212 . . . . 0.0 108.499 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t -95.12 126.97 40.81 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.1 m -140.7 162.8 34.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.098 1.359 . . . . 0.0 110.208 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.47 114.58 15.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 127.79 2.436 . . . . 0.0 108.777 178.212 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 122.998 1.38 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.25 152.89 39.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.219 2.608 . . . . 0.0 113.512 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -122.29 -174.48 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.331 2.252 . . . . 0.0 110.473 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.32 147.37 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.663 -1.273 . . . . 0.0 109.918 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.97 158.89 44.62 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.993 1.317 . . . . 0.0 111.273 169.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.1 m -120.34 137.29 54.36 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.753 1.221 . . . . 0.0 110.46 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.04 149.13 47.24 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.912 0.885 . . . . 0.0 112.909 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tt -137.56 136.61 46.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 124.343 1.057 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.87 108.34 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.284 1.434 . . . . 0.0 112.288 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 87.86 7.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.822 0.82 . . . . 0.0 108.8 168.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.14 -23.83 0.28 Allowed Glycine 0 N--CA 1.48 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 114.837 -168.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -79.82 138.82 37.32 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.175 0.987 . . . . 0.0 113.192 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -65.68 27.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.229 2.212 . . . . 0.0 114.368 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.7 m 52.15 -115.5 0.92 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.046 2.138 . . . . 0.0 111.419 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 40.3 mttp -67.01 -17.46 64.93 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -165.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.9 p -88.4 -43.41 11.51 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.003 1.274 . . . . 0.0 110.446 166.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.84 -43.1 76.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 116.838 -1.553 . . . . 0.0 112.049 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG13 ' CG1' ' A' ' 36' ' ' VAL . 4.6 t -37.78 -56.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.273 1.829 . . . . 0.0 111.567 171.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 t -65.65 -39.36 91.32 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.569 0.748 . . . . 0.0 111.661 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -60.52 -40.02 89.96 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -42.79 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 118.74 -0.648 . . . . 0.0 109.743 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -54.81 -51.32 66.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.951 0.9 . . . . 0.0 110.876 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -70.37 -41.41 73.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.7 m -70.69 -40.03 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.318 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -45.46 44.2 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.669 -1.158 . . . . 0.0 111.518 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 t -71.01 11.3 0.42 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.836 1.653 . . . . 0.0 113.819 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.87 -6.37 22.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.326 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.7 mt -77.08 125.42 29.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.196 -0.94 . . . . 0.0 108.669 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.78 -15.13 52.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -12.56 33.98 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -87.2 135.93 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.68 2.036 . . . . 0.0 109.975 -170.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 t -103.45 -15.01 16.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m 178.75 173.64 0.7 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.141 2.576 . . . . 0.0 112.333 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -173.19 152.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 127.509 2.323 . . . . 0.0 108.962 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -145.15 129.22 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.129 2.172 . . . . 0.0 107.838 166.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.4 t -94.5 139.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 123.006 1.384 . . . . 0.0 111.346 169.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -74.32 85.11 1.94 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.748 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 1.5 tt -49.81 -38.44 34.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.244 2.218 . . . . 0.0 114.36 -168.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -60.25 4.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.473 1.13 . . . . 0.0 110.264 170.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -79.83 -176.92 5.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.389 2.676 . . . . 0.0 116.072 -168.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 33.54 3.65 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.075 -2.33 . . . . 0.0 110.774 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 p -144.4 160.84 40.39 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.94 37.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.776 1.63 . . . . 0.0 111.217 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -106.25 112.54 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.457 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.0 t -113.05 133.31 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.364 1.466 . . . . 0.0 107.625 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.28 95.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.89 1.276 . . . . 0.0 108.506 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD1' HD11 ' A' ' 57' ' ' LEU . 26.7 p90 -114.34 145.63 41.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -91.6 121.53 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.223 -0.923 . . . . 0.0 111.354 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -174.98 127.87 0.29 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.046 0.939 . . . . 0.0 112.106 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 t -68.55 -36.51 78.89 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.397 -0.19 . . . . 0.0 111.032 168.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -163.32 97.71 0.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.916 0.886 . . . . 0.0 110.902 172.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -137.61 136.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t -64.54 140.02 97.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.88 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.52 -18.07 57.52 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.426 2.084 . . . . 0.0 111.624 169.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.15 -27.03 63.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.123 0.874 . . . . 0.0 112.789 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m -70.25 -35.06 73.55 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.36 1.891 . . . . 0.0 112.049 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.2 mt -70.12 -44.7 68.41 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.52 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -53.06 -44.3 67.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.672 0.789 . . . . 0.0 111.278 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.59 98.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.169 1.788 . . . . 0.0 113.961 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.21 71.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 120.081 1.31 . . . . 0.0 112.031 173.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.6 -56.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.787 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -46.46 -35.99 6.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.357 1.063 . . . . 0.0 111.605 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 1.23 27.18 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -96.28 -29.3 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.709 1.204 . . . . 0.0 112.229 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -148.39 59.3 4.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 121.202 -0.937 . . . . 0.0 112.277 169.128 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.43 140.01 92.22 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.662 2.908 . . . . 0.0 111.192 -175.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.33 -54.53 0.64 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.794 1.188 . . . . 0.0 110.756 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 mt -75.55 -46.06 34.3 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.386 1.093 . . . . 0.0 112.038 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -67.86 88.18 0.25 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 69.49 2.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.486 1.515 . . . . 0.0 109.105 168.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.17 138.7 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 122.768 1.271 . . . . 0.0 110.951 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 m -143.07 168.73 19.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.356 1.463 . . . . 0.0 110.24 174.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.75 131.47 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.557 1.543 . . . . 0.0 108.524 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.41 46.2 1.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.357 1.063 . . . . 0.0 112.009 -169.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.2 p -173.7 75.84 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 111.445 -170.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.16 47.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 128.818 2.847 . . . . 0.0 105.053 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 127.424 2.29 . . . . 0.0 111.71 -169.083 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -81.56 170.63 15.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 129.607 3.163 . . . . 0.0 113.055 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 t -129.56 170.73 13.38 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.726 1.61 . . . . 0.0 108.267 167.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.86 163.98 39.5 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.959 -1.088 . . . . 0.0 111.699 -173.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.74 160.4 37.84 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.737 1.215 . . . . 0.0 111.859 169.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 m -123.77 136.73 54.59 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.215 1.406 . . . . 0.0 110.737 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.52 145.52 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.012 1.325 . . . . 0.0 111.032 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 tt -134.06 130.85 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.685 1.194 . . . . 0.0 110.64 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.91 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.967 1.307 . . . . 0.0 109.047 -169.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -71.86 1.04 7.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.25 35.85 1.79 Allowed Glycine 0 C--O 1.222 -0.628 0 C-N-CA 125.976 1.751 . . . . 0.0 111.141 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ttm -90.86 148.34 22.56 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.915 0.886 . . . . 0.0 111.115 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.5 m170 -73.72 3.41 6.48 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.372 0.669 . . . . 0.0 111.599 167.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.2 m 61.54 -112.78 0.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.564 2.346 . . . . 0.0 112.16 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -48.66 -51.58 27.64 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -166.094 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 m -80.01 -22.58 42.29 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.838 -1.789 . . . . 0.0 113.936 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 13' ' ' HIS . 1.3 m -63.64 -39.79 95.25 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-O 116.497 -1.716 . . . . 0.0 111.516 171.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 38' ' ' LEU . 23.5 t -47.9 -51.49 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.638 1.563 . . . . 0.0 112.788 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.5 t -55.07 -43.55 73.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.292 0.637 . . . . 0.0 111.981 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -63.2 -39.38 94.48 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -45.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.133 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.62 -48.44 63.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.41 1.084 . . . . 0.0 109.858 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -70.05 -42.18 73.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -74.64 -38.28 62.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 111.192 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.06 -45.66 56.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 116.58 -1.676 . . . . 0.0 112.604 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 t -69.42 14.33 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 121.885 2.129 . . . . 0.0 114.543 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.21 -5.33 15.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.892 1.677 . . . . 0.0 112.655 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.67 137.95 41.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.202 0.91 . . . . 0.0 111.475 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -73.66 55.39 0.51 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.473 1.909 . . . . 0.0 112.622 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 p90 174.09 -22.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.882 2.873 . . . . 0.0 113.894 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.8 p -86.66 142.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 120.826 1.648 . . . . 0.0 109.256 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -108.05 -19.66 13.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.697 0.799 . . . . 0.0 112.573 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -175.43 174.28 2.34 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.435 1.894 . . . . 0.0 112.277 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 tt -174.86 151.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.938 2.095 . . . . 0.0 110.209 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.08 131.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.345 2.258 . . . . 0.0 107.732 166.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 18' ' ' VAL . 68.3 t -104.08 137.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 123.53 1.633 . . . . 0.0 111.638 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m -79.37 81.36 5.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.261 1.424 . . . . 0.0 111.087 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 18' ' ' VAL . 17.0 tp -50.85 -43.68 59.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -168.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.18 -42.15 60.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.994 0.918 . . . . 0.0 111.978 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -103.42 -170.82 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.138 3.775 . . . . 0.0 111.729 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.61 31.33 6.05 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.894 1.678 . . . . 0.0 114.579 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 p -135.2 157.68 46.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.63 138.6 51.32 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.851 1.661 . . . . 0.0 110.525 -175.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.68 121.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -125.06 125.18 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.081 1.352 . . . . 0.0 109.192 -166.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 78.9 t -111.98 109.52 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 109.933 -168.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.462 ' CD1' HD11 ' A' ' 57' ' ' LEU . 50.0 p90 -124.33 166.98 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 113.207 -171.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -98.46 106.01 18.23 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.318 -0.864 . . . . 0.0 112.142 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -165.94 148.35 7.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.772 1.629 . . . . 0.0 110.062 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 m -88.15 29.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 171.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.1 t -168.97 -167.54 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.178 1.391 . . . . 0.0 110.054 -170.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.0 m -110.51 132.41 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.915 1.686 . . . . 0.0 111.781 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.3 m -152.42 72.43 7.56 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.781 1.632 . . . . 0.0 109.601 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -87.39 -24.65 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.265 2.643 . . . . 0.0 114.788 -170.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.25 -25.09 67.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.182 0.901 . . . . 0.0 112.906 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -69.56 -38.68 77.54 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.026 -1.046 . . . . 0.0 113.161 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.5 mt -67.69 -44.53 77.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.27 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -47.11 -54.89 9.44 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.322 1.049 . . . . 0.0 110.222 169.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -53.8 -41.62 67.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -30.62 69.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.017 0.826 . . . . 0.0 111.81 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.7 mt -68.1 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.752 0.821 . . . . 0.0 109.685 169.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -49.91 -33.43 17.37 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.704 0.683 . . . . 0.0 111.911 175.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.13 -0.4 24.77 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -99.58 -27.12 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.672 1.589 . . . . 0.0 111.689 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.55 64.06 8.29 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.387 -0.821 . . . . 0.0 111.098 168.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.5 144.93 95.39 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.364 3.376 . . . . 0.0 112.973 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.56 -28.8 3.39 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.17 1.367 . . . . 0.0 113.581 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -97.45 -43.76 7.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.158 1.783 . . . . 0.0 111.048 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.4 m-30 -68.88 99.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.05 80.26 4.49 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.823 -1.173 . . . . 0.0 109.142 169.105 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.25 132.46 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.65 -0.656 . . . . 0.0 111.27 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 134.2 30.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.519 1.128 . . . . 0.0 109.188 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.29 122.01 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.451 -1.406 . . . . 0.0 108.003 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t -110.84 116.79 31.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 122.569 1.176 . . . . 0.0 110.383 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -151.41 157.52 42.5 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.7 1.6 . . . . 0.0 108.988 168.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -77.63 48.91 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.841 1.656 . . . . 0.0 113.32 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 125.007 1.323 . . . . 0.0 113.225 -175.248 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.38 167.0 5.76 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.723 1.209 . . . . 0.0 113.648 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 t -95.73 176.65 6.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 111.684 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.54 149.41 9.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.409 1.484 . . . . 0.0 109.407 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.67 157.28 37.89 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 110.479 169.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 m -119.28 135.93 54.48 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.782 0.833 . . . . 0.0 109.759 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.86 145.44 51.21 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.527 1.531 . . . . 0.0 110.868 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.09 139.26 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 125.13 1.372 . . . . 0.0 111.153 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.1 97.59 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.462 1.905 . . . . 0.0 109.91 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.9 78.25 9.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 123.355 1.55 . . . . 0.0 111.622 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.05 12.28 0.15 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 113.203 -1.817 . . . . 0.0 116.305 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 151.47 45.61 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.917 2.358 . . . . 0.0 113.123 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -70.58 36.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.225 -1.547 . . . . 0.0 114.118 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.9 m 64.29 -142.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.251 -1.531 . . . . 0.0 111.087 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' A' ' 38' ' ' LEU . 13.8 mptt -56.76 -37.18 70.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.919 0.888 . . . . 0.0 113.158 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -66.08 -45.56 80.83 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.151 -0.968 . . . . 0.0 112.578 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.414 ' O ' HG13 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -60.9 -50.42 73.48 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.962 172.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -44.85 -46.82 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.508 1.923 . . . . 0.0 112.154 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -66.56 -42.46 87.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -54.94 -35.85 64.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.503 -1.373 . . . . 0.0 113.144 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -70.15 -39.34 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.482 -174.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -62.38 -49.15 76.68 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -65.53 -42.29 92.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 m -69.54 -40.95 76.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.994 1.318 . . . . 0.0 110.966 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -45.92 48.95 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.813 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -74.09 11.61 0.88 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.961 1.255 . . . . 0.0 113.389 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.51 -5.0 17.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.675 1.59 . . . . 0.0 112.009 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.8 mt -75.69 129.62 37.41 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.01 -1.056 . . . . 0.0 110.097 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -53.21 -22.65 7.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.69 1.196 . . . . 0.0 114.157 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 -8.94 29.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.37 139.86 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 121.862 2.119 . . . . 0.0 109.624 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -109.37 -12.96 14.68 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -178.05 173.13 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.544 2.338 . . . . 0.0 111.322 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -178.59 152.66 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 109.835 -171.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 t -147.33 132.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 128.18 2.592 . . . . 0.0 107.755 167.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -101.64 149.34 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.468 1.128 . . . . 0.0 112.115 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 m -70.73 111.85 6.51 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.518 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.4 tm? -61.64 -45.43 94.09 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.047 1.294 . . . . 0.0 110.348 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.13 -56.38 11.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.735 0.814 . . . . 0.0 112.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -93.2 -179.98 5.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -166.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 16.36 3.45 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 p -139.4 155.62 47.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -166.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.4 131.55 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.762 2.425 . . . . 0.0 110.708 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -101.21 110.01 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.555 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -115.19 133.78 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.598 1.559 . . . . 0.0 108.024 -169.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.62 108.18 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.538 1.535 . . . . 0.0 108.128 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.7 p90 -127.27 154.45 44.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -88.86 123.33 33.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.462 -0.774 . . . . 0.0 110.223 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.99 149.79 0.58 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.261 1.425 . . . . 0.0 110.852 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 m -90.03 22.06 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.7 1.2 . . . . 0.0 111.036 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 m -161.23 151.3 17.35 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.477 -1.389 . . . . 0.0 114.559 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.2 m -80.09 74.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.143 1.377 . . . . 0.0 111.675 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -107.88 73.61 0.43 Allowed Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.725 1.61 . . . . 0.0 110.549 171.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -78.15 -23.18 9.24 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.654 2.903 . . . . 0.0 113.259 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.68 -20.74 63.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.306 1.442 . . . . 0.0 113.087 -172.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.6 p -69.14 -44.33 72.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.54 -1.35 . . . . 0.0 112.697 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 ' CG1' ' A' ' 45' ' ' VAL . 51.0 mt -63.89 -46.89 82.86 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.109 0.564 . . . . 0.0 109.869 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -48.94 -52.75 22.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.082 0.953 . . . . 0.0 110.8 170.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -54.93 -38.2 67.39 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.64 80.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.253 0.933 . . . . 0.0 111.15 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.4 mt -66.94 -52.54 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.844 -0.535 . . . . 0.0 109.794 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.94 -22.21 24.96 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.014 -1.054 . . . . 0.0 112.676 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.55 -1.3 57.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.282 1.401 . . . . 0.0 114.76 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -95.37 -27.42 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.584 1.153 . . . . 0.0 111.046 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.72 71.08 7.33 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.556 1.142 . . . . 0.0 111.459 168.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.9 145.95 97.02 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.664 3.576 . . . . 0.0 113.839 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.33 -40.21 2.36 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.937 1.732 . . . . 0.0 113.085 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.89 -55.29 6.84 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.263 1.425 . . . . 0.0 111.156 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.4 m-30 -69.01 110.42 4.45 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.985 1.314 . . . . 0.0 114.425 -169.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.21 57.02 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.398 -1.439 . . . . 0.0 113.279 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.0 118.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 122.319 1.057 . . . . 0.0 113.023 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -135.21 147.71 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.093 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.47 120.94 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.607 1.163 . . . . 0.0 109.672 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.9 p -87.2 87.76 7.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.817 1.647 . . . . 0.0 110.477 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -132.31 161.42 33.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.678 0.791 . . . . 0.0 111.243 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.87 129.25 37.52 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 163.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 127.765 2.426 . . . . 0.0 108.379 -177.067 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 CA--C 1.555 1.16 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.05 174.06 7.61 Favored 'General case' 0 CA--C 1.55 0.957 1 C-N-CA 132.389 4.276 . . . . 0.0 115.222 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -116.52 -178.94 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.168 1.787 . . . . 0.0 111.146 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -157.36 148.46 21.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.27 1.428 . . . . 0.0 110.289 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.18 43.85 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.015 1.326 . . . . 0.0 111.783 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.5 m -121.32 140.18 52.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.991 1.317 . . . . 0.0 109.958 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -139.22 145.9 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.403 1.481 . . . . 0.0 111.068 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.3 tt -131.0 134.43 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.461 1.504 . . . . 0.0 111.072 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 100.15 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.465 1.106 . . . . 0.0 109.813 -169.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 23.7 t0 -78.2 41.06 0.36 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.481 1.512 . . . . 0.0 112.709 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.83 23.92 0.08 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.208 1.385 . . . . 0.0 113.764 -171.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.4 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 4.9 ttt -95.81 135.12 37.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.416 1.886 . . . . 0.0 112.064 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -60.48 21.75 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m 71.1 -62.31 0.46 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.248 2.619 . . . . 0.0 114.086 171.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HE3' HD22 ' A' ' 38' ' ' LEU . 13.3 mptt -122.82 -53.94 1.85 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.516 1.126 . . . . 0.0 113.626 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 p -65.74 -22.3 66.59 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.481 -2.012 . . . . 0.0 113.199 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p -45.41 -56.82 4.58 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.596 1.158 . . . . 0.0 110.041 168.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 38' ' ' LEU . 73.6 t -47.23 -53.65 3.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 127.9 2.48 . . . . 0.0 111.076 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.3 t -64.84 -25.41 67.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.64 -53.27 12.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.2 0.909 . . . . 0.0 110.257 167.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -44.96 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.58 -0.7 . . . . 0.0 110.562 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.3 -21.62 62.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 0.0 112.873 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.7 t -91.77 -58.94 2.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.574 1.15 . . . . 0.0 113.759 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.0 m -54.95 -39.61 69.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.329 2.252 . . . . 0.0 112.491 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 -49.79 20.64 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.603 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -70.69 14.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.252 1.387 . . . . 0.0 113.856 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.59 -7.01 18.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.041 1.736 . . . . 0.0 111.766 173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.407 HD11 ' CB ' ' A' ' 60' ' ' ALA . 17.5 mt -76.64 129.72 36.79 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 -172.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.47 -17.34 59.32 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -171.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 -11.52 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 169.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.9 p -94.11 135.91 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 122.172 2.26 . . . . 0.0 110.395 -170.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -107.49 -12.78 15.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.664 0.786 . . . . 0.0 113.094 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -179.81 174.38 0.93 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.219 2.608 . . . . 0.0 112.552 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 tt -172.42 153.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.038 2.535 . . . . 0.0 109.59 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 t -147.0 131.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.258 2.223 . . . . 0.0 107.99 167.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.29 137.29 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.487 1.613 . . . . 0.0 112.425 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 m -88.33 86.21 7.02 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.582 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.479 HD22 ' HE3' ' A' ' 15' ' ' LYS . 7.2 mt -47.94 -36.75 12.96 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.89 2.876 . . . . 0.0 115.286 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.23 -4.96 58.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.868 1.318 . . . . 0.0 113.792 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -116.36 -168.02 1.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.185 2.594 . . . . 0.0 108.769 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.46 43.41 2.97 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.91 -1.744 . . . . 0.0 110.056 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -134.47 151.58 51.24 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.083 -1.011 . . . . 0.0 112.959 -172.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.38 140.45 52.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.601 1.96 . . . . 0.0 109.347 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.7 mt -111.2 116.7 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -117.98 129.63 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.773 1.629 . . . . 0.0 107.447 -169.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 102.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 108.962 -168.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.514 ' CD1' HD11 ' A' ' 57' ' ' LEU . 29.3 p90 -120.92 141.0 51.05 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.532 1.133 . . . . 0.0 113.945 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -90.78 110.54 21.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.685 -1.259 . . . . 0.0 110.786 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 179.46 131.11 0.09 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.256 1.422 . . . . 0.0 112.032 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.8 t -86.19 -9.32 56.81 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.359 -0.838 . . . . 0.0 112.156 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -157.1 58.28 0.52 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.02 -1.05 . . . . 0.0 111.442 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.48 139.82 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 t -83.66 143.56 44.11 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.312 1.445 . . . . 0.0 111.847 -171.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.24 -15.11 46.13 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.277 2.651 . . . . 0.0 113.182 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -32.53 55.91 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.365 0.984 . . . . 0.0 112.47 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 m -88.77 -23.7 22.82 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.964 -169.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 47' ' ' TYR . 74.8 mt -68.11 -42.24 80.54 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.27 169.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -47.11 -55.64 7.99 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.611 0.764 . . . . 0.0 109.521 168.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -47.57 -48.22 28.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.355 1.062 . . . . 0.0 113.823 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.53 -27.95 69.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.118 0.872 . . . . 0.0 112.959 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.17 -49.7 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.124 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -51.3 -34.3 32.61 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 123.443 0.697 . . . . 0.0 110.284 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.38 5.75 14.08 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.86 -27.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.875 0.87 . . . . 0.0 111.699 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.54 65.5 8.54 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.088 168.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.5 146.27 97.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.341 3.361 . . . . 0.0 113.356 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.21 -29.44 2.81 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.852 1.215 . . . . 0.0 113.383 -174.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -94.79 -45.1 7.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.969 1.708 . . . . 0.0 110.791 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -71.8 106.96 4.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' CB ' ' HB3' ' A' ' 10' ' ' ASP . 77.9 mtt180 -80.96 78.24 7.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.154 0.982 . . . . 0.0 111.393 169.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -85.8 125.0 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.876 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 137.3 41.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 108.793 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.87 127.5 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -114.48 108.89 17.47 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 0.0 108.829 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.9 m -147.18 174.97 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.561 1.144 . . . . 0.0 111.317 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -71.87 134.28 45.97 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 163.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.317 -0.847 0 C-N-CA 125.7 1.6 . . . . 0.0 108.931 175.599 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -91.66 171.96 8.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.127 1.771 . . . . 0.0 113.987 170.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -140.2 175.28 9.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.627 3.171 . . . . 0.0 107.734 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -159.56 156.8 28.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.658 -1.276 . . . . 0.0 111.146 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.05 163.44 40.28 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 125.486 1.514 . . . . 0.0 111.316 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.3 m -125.54 139.58 53.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.197 1.399 . . . . 0.0 110.109 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -139.21 140.78 37.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.056 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.35 141.43 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.525 1.13 . . . . 0.0 109.347 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.05 165.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 125.179 1.392 . . . . 0.0 107.628 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -147.39 137.75 23.26 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.327 1.051 . . . . 0.0 108.313 167.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.17 69.96 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.244 0.925 . . . . 0.0 112.681 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 161.47 10.1 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.327 2.251 . . . . 0.0 114.437 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -68.98 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 126.155 1.782 . . . . 0.0 115.275 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 52.89 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 130.573 3.549 . . . . 0.0 119.279 167.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -49.77 1.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.601 1.56 . . . . 0.0 109.428 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -55.95 -27.1 50.9 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.359 -1.463 . . . . 0.0 113.048 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.5 p -49.69 -49.33 48.09 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 119.504 1.047 . . . . 0.0 111.645 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG11 ' A' ' 36' ' ' VAL . 37.8 t -52.91 -46.7 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.084 2.154 . . . . 0.0 111.967 -172.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -62.61 -42.79 99.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.134 0.574 . . . . 0.0 111.23 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -63.33 -43.06 98.84 Favored 'General case' 0 C--O 1.222 -0.37 0 O-C-N 121.968 -0.458 . . . . 0.0 111.792 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.21 -45.32 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.428 0.558 . . . . 0.0 109.53 -172.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.41 -50.67 59.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.306 1.442 . . . . 0.0 110.783 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -76.2 -31.58 58.52 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -79.71 -41.25 27.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.34 1.456 . . . . 0.0 110.289 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -44.62 50.12 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 116.861 -1.542 . . . . 0.0 111.272 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -73.31 17.28 0.14 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 121.148 1.795 . . . . 0.0 113.165 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.6 -3.11 15.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.709 1.604 . . . . 0.0 113.007 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 mt -75.27 134.87 41.0 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.82 -1.175 . . . . 0.0 111.964 -169.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.63 63.14 1.53 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.688 1.195 . . . . 0.0 112.059 -176.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.0 p90 168.38 -21.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 130.394 3.478 . . . . 0.0 114.531 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.09 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.54 1.518 . . . . 0.0 109.422 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -115.48 -11.39 11.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -169.97 173.16 6.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.941 1.353 . . . . 0.0 112.634 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -155.73 157.39 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 109.972 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -144.7 124.48 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 126.765 2.026 . . . . 0.0 107.124 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.541 HG11 HG13 ' A' ' 18' ' ' VAL . 56.0 t -94.19 134.26 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.732 1.253 . . . . 0.0 110.146 169.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 m -67.59 90.26 0.26 Allowed 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.148 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.04 -38.21 50.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.748 1.158 . . . . 0.0 112.332 -168.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -66.31 0.56 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.451 0.569 . . . . 0.0 110.643 170.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.22 165.18 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.318 1.532 . . . . 0.0 112.19 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 40.4 0.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.319 -1.488 . . . . 0.0 113.174 168.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 p -133.91 158.62 43.0 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 140.42 51.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.123 2.169 . . . . 0.0 110.984 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.73 118.31 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 57' ' ' LEU . 17.8 t -121.45 131.92 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.537 1.135 . . . . 0.0 108.22 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 t -118.32 120.9 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.331 1.453 . . . . 0.0 108.713 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.527 ' CD1' HD11 ' A' ' 57' ' ' LEU . 48.4 p90 -135.99 160.82 37.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 -170.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -93.98 108.76 20.54 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.927 -1.108 . . . . 0.0 112.417 -169.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -164.24 156.93 17.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.227 1.011 . . . . 0.0 112.585 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.2 p -87.85 19.49 3.5 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.963 -1.086 . . . . 0.0 111.744 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -173.42 -179.43 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.491 1.517 . . . . 0.0 112.101 -168.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.48 122.0 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.913 1.285 . . . . 0.0 111.339 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -143.24 85.2 9.77 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 126.32 1.848 . . . . 0.0 107.853 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -85.68 -24.14 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.887 2.391 . . . . 0.0 115.185 -167.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 p -66.58 -40.5 88.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.996 1.725 . . . . 0.0 112.917 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.5 mt -69.2 -43.61 73.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.19 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -52.01 -48.24 64.59 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.768 0.713 . . . . 0.0 109.913 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -60.93 -31.54 71.06 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.58 84.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.966 1.257 . . . . 0.0 111.891 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.86 -53.28 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.743 -0.598 . . . . 0.0 110.209 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -57.02 -21.13 28.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 112.102 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.39 1.99 55.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -93.47 -30.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.732 0.813 . . . . 0.0 111.258 175.44 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -148.55 69.49 10.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.536 0.734 . . . . 0.0 111.053 168.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.47 142.49 98.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.622 3.548 . . . . 0.0 112.574 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.87 -27.61 2.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.07 1.319 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 tp -88.62 -45.04 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.368 1.467 . . . . 0.0 111.514 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -78.67 102.5 8.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.817 1.247 . . . . 0.0 114.203 -168.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 9.4 ttt180 -70.3 44.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.62 130.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 122.588 1.185 . . . . 0.0 113.244 -166.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -136.7 148.33 47.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.491 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.88 126.45 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.79 -1.194 . . . . 0.0 108.271 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.39 106.05 18.23 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 m -161.92 156.42 22.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.202 1.401 . . . . 0.0 110.613 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.69 104.28 2.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.786 0.834 . . . . 0.0 109.823 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 125.136 1.374 . . . . 0.0 113.565 -177.523 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 121.352 0.596 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -157.07 169.91 23.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.884 2.873 . . . . 0.0 110.288 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 t -115.55 -177.99 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 108.486 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -160.69 148.88 16.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.966 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.92 159.51 43.79 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.039 1.336 . . . . 0.0 110.958 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 m -117.85 134.54 54.83 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.46 1.504 . . . . 0.0 109.569 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -130.65 148.19 52.41 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.009 1.324 . . . . 0.0 111.054 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.6 tt -131.28 137.9 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.12 1.368 . . . . 0.0 110.4 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.69 110.9 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.769 1.628 . . . . 0.0 109.592 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.9 119.17 26.83 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 168.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.76 8.25 30.42 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.155 0.883 . . . . 0.0 113.413 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 138.23 58.28 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.491 -1.005 . . . . 0.0 110.76 171.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -55.32 -32.19 62.29 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p 144.71 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 131.642 3.977 . . . . 0.0 108.352 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -19.79 -61.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 129.597 3.159 . . . . 0.0 114.439 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -57.19 -11.24 1.56 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.48 -45.03 85.32 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.689 1.586 . . . . 0.0 109.693 168.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.0 t -55.5 -47.28 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 125.297 1.439 . . . . 0.0 111.995 -169.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.2 t -58.01 -38.6 76.49 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.156 0.979 . . . . 0.0 111.834 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -72.86 -40.02 66.01 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.166 -0.959 . . . . 0.0 113.035 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.663 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -46.51 -55.49 7.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.287 1.835 . . . . 0.0 109.484 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.4 m -70.32 -44.96 67.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -71.79 -38.55 70.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.451 1.101 . . . . 0.0 110.834 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -49.44 18.63 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.161 -1.4 . . . . 0.0 111.393 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -72.25 12.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.006 1.73 . . . . 0.0 113.184 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.16 -6.16 24.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.615 1.566 . . . . 0.0 111.703 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.6 127.27 32.69 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.31 -19.31 13.78 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -8.97 33.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.23 140.03 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 121.88 2.127 . . . . 0.0 109.554 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 t -111.39 -8.25 14.32 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.96 171.7 3.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.479 1.512 . . . . 0.0 113.237 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.68 150.04 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.402 1.481 . . . . 0.0 112.358 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.62 146.51 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 127.685 2.394 . . . . 0.0 105.867 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 18' ' ' VAL . 9.2 p -138.16 149.26 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.973 0.892 . . . . 0.0 111.11 177.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -101.49 96.11 6.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.38 -30.75 71.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.715 1.606 . . . . 0.0 115.208 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.25 1.84 49.36 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.507 1.146 . . . . 0.0 113.308 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -126.55 -170.55 2.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.669 2.788 . . . . 0.0 109.813 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 34.39 5.22 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.333 1.853 . . . . 0.0 112.205 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -141.29 154.78 45.91 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.89 143.38 51.11 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.614 2.366 . . . . 0.0 111.264 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -112.36 116.19 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.59 129.43 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -168.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 114.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.437 1.495 . . . . 0.0 107.044 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.486 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -136.45 151.02 49.02 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.374 1.069 . . . . 0.0 111.932 -168.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.17 136.53 32.99 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.653 -1.28 . . . . 0.0 111.728 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.44 179.16 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.061 2.144 . . . . 0.0 110.893 -171.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -136.66 -46.78 0.6 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.998 1.319 . . . . 0.0 108.211 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 p -76.48 123.78 26.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 165.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -60.65 115.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 120.018 1.281 . . . . 0.0 109.92 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -134.55 64.2 62.87 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.928 0.891 . . . . 0.0 111.555 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.81 -9.84 15.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.193 3.262 . . . . 0.0 114.616 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.126 0.875 . . . . 0.0 112.165 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -81.25 -18.1 47.17 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.126 -168.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD11 ' CD1' ' A' ' 47' ' ' TYR . 53.8 mt -70.19 -46.32 64.82 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.477 169.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -49.24 -52.64 25.86 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.537 1.062 . . . . 0.0 109.351 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.98 -41.82 71.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.26 69.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.826 1.194 . . . . 0.0 112.592 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.9 mt -72.7 -52.96 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.431 0.692 . . . . 0.0 109.954 170.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.13 -25.96 25.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.645 0.778 . . . . 0.0 112.518 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -0.89 37.83 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.06 -30.17 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.414 1.086 . . . . 0.0 111.297 179.355 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.79 66.48 10.66 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 121.605 -0.684 . . . . 0.0 111.479 168.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.58 142.21 98.48 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.525 3.483 . . . . 0.0 112.949 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.02 -30.18 2.99 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.286 1.422 . . . . 0.0 113.673 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.93 -39.49 10.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 112.01 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -79.76 107.2 12.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 113.424 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -83.9 78.06 9.8 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.707 -1.246 . . . . 0.0 111.217 171.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 135.09 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.843 0.83 . . . . 0.0 111.079 -173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 m -152.1 165.41 34.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.464 1.105 . . . . 0.0 111.312 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.7 mt -93.4 133.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.538 1.135 . . . . 0.0 109.112 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.47 92.26 8.46 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.777 0.831 . . . . 0.0 109.851 -174.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.7 m -163.01 167.54 22.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.421 1.488 . . . . 0.0 110.607 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -80.83 123.83 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 167.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 127.509 2.324 . . . . 0.0 109.688 -177.787 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 122.888 1.328 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.31 158.57 23.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.501 2.72 . . . . 0.0 111.558 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 t -141.29 -175.76 4.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.439 2.696 . . . . 0.0 109.082 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 m -166.54 141.84 4.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.003 -1.061 . . . . 0.0 110.515 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.58 32.59 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.064 1.346 . . . . 0.0 110.676 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.2 m -130.2 138.63 50.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.863 1.265 . . . . 0.0 109.807 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -139.57 151.73 46.3 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.612 0.765 . . . . 0.0 112.259 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.9 tt -141.89 129.65 21.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 124.048 0.939 . . . . 0.0 112.077 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.75 114.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 126.485 1.914 . . . . 0.0 110.61 -168.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 1.46 17.15 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.69 4.15 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.027 1.775 . . . . 0.0 116.822 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -71.55 141.72 50.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.89 2.345 . . . . 0.0 113.477 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -68.49 32.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 127.483 2.313 . . . . 0.0 114.96 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t 54.71 -131.78 1.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.181 1.393 . . . . 0.0 111.158 171.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.565 ' HE2' HD13 ' A' ' 38' ' ' LEU . 74.6 mttt -54.58 -25.24 25.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -168.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -82.49 -46.17 13.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.975 1.261 . . . . 0.0 111.851 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.1 m -57.99 -40.85 81.7 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 117.123 -1.417 . . . . 0.0 111.387 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 36' ' ' VAL . 22.0 t -39.82 -56.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.022 1.729 . . . . 0.0 111.287 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -59.04 -43.1 91.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.856 . . . . 0.0 112.24 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -62.84 -40.73 98.34 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.752 -0.593 . . . . 0.0 112.461 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -49.39 76.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.11 -50.54 61.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.679 1.192 . . . . 0.0 110.673 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 t -68.76 -32.64 72.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.0 m -77.34 -48.7 16.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.642 0.734 . . . . 0.0 109.936 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' HG11 ' A' ' 31' ' ' VAL . 1.1 mm? -76.7 -20.05 57.02 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.168 1.387 . . . . 0.0 114.227 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.2 t -85.5 1.29 49.51 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.606 1.548 . . . . 0.0 112.969 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.36 1.75 11.83 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.606 -1.309 . . . . 0.0 114.187 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.89 152.05 42.89 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.4 -0.812 . . . . 0.0 112.568 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.72 47.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.919 2.087 . . . . 0.0 112.604 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.185 3.394 . . . . 0.0 114.095 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.4 p -94.23 142.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 122.402 2.365 . . . . 0.0 112.135 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 m -107.48 -18.59 13.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.507 1.523 . . . . 0.0 113.928 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 m -178.65 171.07 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.747 2.019 . . . . 0.0 111.854 -171.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -167.2 161.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.211 2.604 . . . . 0.0 109.701 -175.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 t -152.09 128.31 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 127.991 2.516 . . . . 0.0 107.718 165.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.438 ' CG1' HG13 ' A' ' 18' ' ' VAL . 37.9 t -96.24 142.79 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 123.39 1.566 . . . . 0.0 112.207 170.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 m -74.41 86.77 2.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.007 1.323 . . . . 0.0 110.284 170.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.1 tm? -44.0 -43.46 6.69 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.301 3.04 . . . . 0.0 113.096 -175.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.94 -9.4 58.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.084 1.354 . . . . 0.0 114.623 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -129.61 -170.01 2.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.377 2.671 . . . . 0.0 110.243 -167.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.64 33.87 5.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.319 1.848 . . . . 0.0 112.623 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -140.66 159.18 42.76 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.53 142.87 41.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.88 1.672 . . . . 0.0 111.129 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.8 121.19 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 57' ' ' LEU . 19.2 t -121.46 128.61 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.513 1.525 . . . . 0.0 107.729 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 103.12 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.648 1.579 . . . . 0.0 109.184 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CD1' HD11 ' A' ' 57' ' ' LEU . 46.2 p90 -119.31 156.51 29.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.49 1.116 . . . . 0.0 112.977 -170.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -107.85 128.01 54.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.429 1.092 . . . . 0.0 110.885 -172.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.7 142.2 0.22 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -70.03 -30.91 68.31 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.618 -0.676 . . . . 0.0 110.2 166.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.5 t -177.39 168.81 2.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 130.134 3.374 . . . . 0.0 108.219 167.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 p 157.26 149.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 130.913 3.685 . . . . 0.0 108.594 -172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -77.89 130.72 72.2 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.888 1.275 . . . . 0.0 112.187 -169.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.3 -20.02 68.85 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.262 2.642 . . . . 0.0 113.062 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -32.35 17.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.415 1.086 . . . . 0.0 112.339 170.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 m -72.88 -35.0 67.05 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.849 1.204 . . . . 0.0 111.791 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.54 HD11 ' CD1' ' A' ' 47' ' ' TYR . 73.7 mt -70.8 -43.47 68.58 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.925 -0.559 . . . . 0.0 109.736 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -52.71 -42.02 64.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.654 0.782 . . . . 0.0 110.84 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -39.79 95.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 169.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.97 69.53 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 121.104 1.775 . . . . 0.0 112.172 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.86 -58.77 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.587 0.755 . . . . 0.0 111.338 170.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -54.99 -18.59 5.26 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.836 1.254 . . . . 0.0 113.431 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.07 57.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -90.82 -29.71 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.282 1.033 . . . . 0.0 111.28 177.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.471 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.04 65.18 7.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 121.594 -0.691 . . . . 0.0 111.683 168.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.82 149.08 62.58 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.068 3.179 . . . . 0.0 112.586 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.14 -44.28 3.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.665 1.126 . . . . 0.0 112.513 -173.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 tp -77.05 -44.79 29.42 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.167 1.387 . . . . 0.0 110.717 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.482 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -81.36 94.75 6.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.458 1.123 . . . . 0.0 113.243 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' C ' ' HD2' ' A' ' 70' ' ' ARG 0.255 0.0 OUTLIER -77.8 110.51 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 164.274 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.17 146.93 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 124.371 3.259 . . . . 0.0 111.887 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -131.67 158.12 41.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.481 1.512 . . . . 0.0 110.029 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.6 mt -94.73 124.62 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -111.74 107.99 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.189 0.995 . . . . 0.0 109.593 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -135.65 161.95 34.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.729 1.612 . . . . 0.0 110.646 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.54 116.46 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.325 -0.491 0 C-N-CA 127.391 2.277 . . . . 0.0 108.969 175.884 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.744 0.307 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.53 153.4 19.07 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.49 2.316 . . . . 0.0 113.515 171.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -102.49 -177.52 3.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.741 2.017 . . . . 0.0 111.332 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.39 166.93 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.893 -1.129 . . . . 0.0 111.505 172.218 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.4 152.22 30.81 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.707 1.203 . . . . 0.0 111.223 169.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.0 m -114.7 139.07 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.697 1.599 . . . . 0.0 109.716 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -140.24 143.17 35.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.28 -176.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.8 132.45 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.295 1.038 . . . . 0.0 110.662 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.72 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.443 1.497 . . . . 0.0 110.072 -169.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.12 50.73 0.92 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.058 -1.026 . . . . 0.0 112.922 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 -8.27 0.02 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.008 1.766 . . . . 0.0 117.409 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -72.71 144.24 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.909 2.354 . . . . 0.0 111.723 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -64.52 5.48 0.28 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.24 1.816 . . . . 0.0 115.845 -176.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.55 -35.87 0.28 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.884 2.873 . . . . 0.0 115.52 171.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -103.1 -87.44 0.42 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.303 1.411 . . . . 0.0 110.602 172.515 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p -63.62 -13.04 38.47 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 119.152 -2.218 . . . . 0.0 115.256 -175.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.91 -39.79 94.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 121.213 1.824 . . . . 0.0 110.813 167.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -50.31 -47.28 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.084 2.154 . . . . 0.0 111.381 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.5 t -69.63 -37.58 76.87 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.689 -1.257 . . . . 0.0 111.881 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -49.68 80.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.058 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -51.28 -51.34 55.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.363 170.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -70.15 -31.14 68.5 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -176.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -78.14 -51.31 10.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.876 0.871 . . . . 0.0 109.134 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 61' ' ' ILE . 8.2 mt -77.12 -19.68 56.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.5 t -87.66 14.82 7.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 121.282 1.856 . . . . 0.0 112.697 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.56 4.13 9.59 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 18.1 mt -77.2 154.35 33.18 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.04 -1.038 . . . . 0.0 112.472 -171.212 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -64.58 13.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.535 2.734 . . . . 0.0 114.71 -174.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.2 3.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.295 2.238 . . . . 0.0 113.89 -169.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.3 p -104.64 133.14 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.966 1.712 . . . . 0.0 110.543 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -105.9 -12.41 15.85 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -177.57 174.22 1.56 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.146 1.778 . . . . 0.0 112.78 -176.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -167.33 153.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.249 2.22 . . . . 0.0 110.806 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.21 143.42 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.959 2.503 . . . . 0.0 106.581 166.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.85 148.85 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 40' ' ' ASN . 31.8 p -77.97 136.55 38.0 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 176.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.526 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -92.35 -15.88 26.72 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 112.873 169.78 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.49 -57.6 3.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.975 1.71 . . . . 0.0 110.63 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 37' ' ' SER . 39.4 m-80 -89.32 -179.11 5.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 113.202 -172.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 37.96 1.98 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.217 1.807 . . . . 0.0 113.965 177.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -141.96 147.19 36.58 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.635 -1.915 . . . . 0.0 115.255 -170.219 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.56 143.19 50.36 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.484 -174.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -117.64 117.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG1' HD13 ' A' ' 57' ' ' LEU . 36.9 t -122.88 119.67 58.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.914 1.286 . . . . 0.0 109.625 -165.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.6 t -103.95 108.95 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 109.425 -169.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CD1' HD11 ' A' ' 57' ' ' LEU . 31.6 p90 -122.86 144.68 49.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.896 1.278 . . . . 0.0 113.186 -171.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -95.67 117.58 30.75 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.495 -1.378 . . . . 0.0 111.935 -171.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.92 141.46 0.27 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.591 1.956 . . . . 0.0 109.886 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.3 p -83.37 46.93 1.19 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.163 -0.96 . . . . 0.0 108.651 169.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 m -167.32 160.8 13.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.403 1.481 . . . . 0.0 113.666 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.453 1.501 . . . . 0.0 111.072 -175.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -159.7 53.96 0.59 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.245 1.418 . . . . 0.0 112.667 173.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -58.1 -23.97 63.88 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.119 3.213 . . . . 0.0 112.607 177.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -50.29 -40.94 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.04 0.936 . . . . 0.0 112.418 171.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -70.77 -32.78 70.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.384 -1.447 . . . . 0.0 112.731 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.3 mt -73.96 -45.44 50.24 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.42 175.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -48.92 -51.63 29.02 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.386 1.474 . . . . 0.0 109.821 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -55.46 -43.25 75.3 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.932 1.293 . . . . 0.0 113.413 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.34 74.95 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.419 0.554 . . . . 0.0 112.332 173.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.559 HG12 HD11 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -70.32 -54.54 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.793 -0.567 . . . . 0.0 111.595 172.549 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.54 -27.85 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.528 1.131 . . . . 0.0 111.425 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.15 1.36 48.3 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -95.3 -29.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.15 0.98 . . . . 0.0 111.477 177.149 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.03 66.73 8.83 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.664 -0.647 . . . . 0.0 111.453 168.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.55 141.15 97.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.014 3.143 . . . . 0.0 112.592 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.38 -40.99 3.05 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.109 1.338 . . . . 0.0 112.815 -174.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.09 -42.98 45.58 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.544 1.137 . . . . 0.0 111.52 172.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.458 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.9 m-30 -78.45 97.71 5.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -78.94 79.61 5.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.273 168.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 t -88.05 121.79 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.181 0.592 . . . . 0.0 111.896 -172.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.73 133.01 52.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.571 1.148 . . . . 0.0 110.931 -174.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mt -86.32 84.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -77.81 114.29 16.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.408 0.623 . . . . 0.0 109.789 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 t -168.33 175.3 6.48 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.217 1.807 . . . . 0.0 110.109 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -74.57 43.18 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.377 2.271 . . . . 0.0 113.322 -172.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 125.889 1.676 . . . . 0.0 111.319 -171.253 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.34 -168.55 1.41 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.793 2.437 . . . . 0.0 111.916 172.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -117.0 178.81 4.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.478 1.511 . . . . 0.0 110.872 170.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 m -156.38 146.48 21.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 125.636 1.574 . . . . 0.0 109.112 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.33 159.29 43.49 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.815 171.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.3 m -114.17 132.44 56.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.87 1.268 . . . . 0.0 109.986 174.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.94 146.07 50.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.775 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -131.85 134.78 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.817 1.247 . . . . 0.0 110.621 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.98 100.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.643 1.577 . . . . 0.0 109.015 -169.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.22 3.53 10.56 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.59 10.53 8.55 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 125.887 1.708 . . . . 0.0 113.357 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.4 tmm? -70.59 138.19 50.66 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.289 1.036 . . . . 0.0 110.2 -175.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.79 -6.89 1.96 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 174.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 t 81.74 -43.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.586 2.355 . . . . 0.0 110.601 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -122.95 149.4 44.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.764 1.226 . . . . 0.0 109.397 169.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m 69.77 -44.53 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.328 1.851 . . . . 0.0 113.261 -168.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.6 m -51.53 -47.87 63.2 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 121.096 1.771 . . . . 0.0 110.563 174.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 36' ' ' VAL . 40.2 t -29.9 -58.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 127.257 2.223 . . . . 0.0 113.844 168.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -70.5 -34.78 72.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 117.839 0.29 . . . . 0.0 111.4 -169.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -58.85 -43.82 90.87 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.545 -0.722 . . . . 0.0 112.104 168.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -41.37 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.43 -172.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.73 -50.62 69.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.815 0.846 . . . . 0.0 110.292 169.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -67.81 -45.71 73.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -175.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 m -66.85 -40.27 87.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.554 1.542 . . . . 0.0 110.576 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -47.02 42.86 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.838 176.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -68.77 6.32 0.89 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.244 1.384 . . . . 0.0 113.733 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.98 -5.46 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.512 176.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.7 mt -77.24 127.72 33.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.197 -0.939 . . . . 0.0 109.843 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -54.25 -21.93 10.41 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.68 -16.54 24.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 175.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.272 4.1 p -82.83 138.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.658 1.572 . . . . 0.0 110.031 -168.369 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -99.67 -31.25 11.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.951 1.701 . . . . 0.0 110.668 -174.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -166.49 174.76 8.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.596 1.189 . . . . 0.0 112.875 173.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 150.73 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.011 1.324 . . . . 0.0 111.601 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.73 134.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.293 1.837 . . . . 0.0 107.24 166.633 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 18' ' ' VAL . 28.0 t -101.31 134.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.171 0.986 . . . . 0.0 109.776 168.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -68.59 92.26 0.45 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.808 169.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -47.9 -43.05 28.44 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.989 1.715 . . . . 0.0 111.305 -177.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.52 -51.87 67.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.553 1.141 . . . . 0.0 112.031 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.69 -176.19 5.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 124.893 2.282 . . . . 0.0 113.814 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 30.2 4.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.482 2.313 . . . . 0.0 112.133 169.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 150.87 41.93 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.182 -1.574 . . . . 0.0 114.744 -167.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.8 136.45 51.49 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.592 1.957 . . . . 0.0 110.517 -171.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.23 111.37 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG1' HD13 ' A' ' 57' ' ' LEU . 11.7 t -117.5 130.79 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.2 1.4 . . . . 0.0 108.792 -169.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.65 112.78 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.195 1.398 . . . . 0.0 107.481 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 2.0 p90 -131.84 134.81 46.17 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.897 1.226 . . . . 0.0 112.303 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -77.66 113.14 15.2 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.471 -0.768 . . . . 0.0 110.547 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.51 167.59 2.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.766 2.426 . . . . 0.0 109.489 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -77.36 31.67 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.894 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.8 m 61.52 -25.4 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 128.917 2.887 . . . . 0.0 117.166 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.84 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.299 1.839 . . . . 0.0 114.052 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.63 34.33 0.23 Allowed Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -173.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.1 -27.32 17.16 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.108 2.538 . . . . 0.0 112.252 -176.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -52.81 -24.79 9.65 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 112.502 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -42.6 79.99 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.704 -1.248 . . . . 0.0 112.233 177.165 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD13 ' CG1' ' A' ' 45' ' ' VAL . 94.7 mt -70.47 -45.5 65.59 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.801 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -46.06 -52.25 12.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.984 0.914 . . . . 0.0 110.345 170.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -32.83 74.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 177.4 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.297 1.408 . . . . 0.0 111.537 170.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.53 -52.85 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.876 0.47 . . . . 0.0 110.684 171.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.07 -27.75 14.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.237 0.926 . . . . 0.0 112.0 174.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.57 4.15 33.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.32 -28.04 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.926 0.89 . . . . 0.0 111.544 173.885 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.36 67.81 9.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.506 -0.746 . . . . 0.0 111.068 168.599 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.9 139.87 87.31 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.054 3.169 . . . . 0.0 111.868 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.82 -23.06 7.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.571 1.081 . . . . 0.0 114.073 -175.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 -45.16 7.37 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.376 1.471 . . . . 0.0 111.492 173.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.6 m-30 -76.95 102.07 6.24 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -168.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.622 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -75.86 75.99 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 110.267 168.743 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.91 129.65 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 122.227 1.013 . . . . 0.0 111.744 -176.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -138.66 159.72 41.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.613 1.565 . . . . 0.0 109.992 178.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.3 mt -95.69 129.61 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t -102.37 106.96 17.81 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.584 0.707 . . . . 0.0 109.955 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.6 t -169.55 175.92 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 109.842 173.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.19 30.5 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 129.581 3.153 . . . . 0.0 114.997 -171.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 126.273 1.829 . . . . 0.0 110.538 -172.938 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.173 0.511 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -79.47 166.85 21.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.462 1.505 . . . . 0.0 113.396 174.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -120.13 168.89 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.297 2.239 . . . . 0.0 107.972 167.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m -152.89 147.89 26.51 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.196 -0.94 . . . . 0.0 110.601 -175.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.52 161.32 42.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.558 1.143 . . . . 0.0 112.162 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.1 m -121.47 137.73 54.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.101 1.36 . . . . 0.0 110.257 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -136.9 143.16 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.779 1.231 . . . . 0.0 110.31 -178.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 tt -132.07 131.67 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 111.052 -175.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.63 102.36 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.329 1.852 . . . . 0.0 108.768 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -76.52 33.07 0.13 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.052 -1.655 . . . . 0.0 114.143 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.97 -0.71 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.424 1.488 . . . . 0.0 116.263 -176.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.8 ptm -69.94 141.02 53.12 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.466 2.133 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -59.19 12.09 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 127.235 2.214 . . . . 0.0 116.17 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.4 m 73.12 -42.64 0.54 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.275 2.63 . . . . 0.0 115.768 167.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.11 -89.64 0.47 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.046 1.338 . . . . 0.0 109.129 174.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 p -55.57 -22.77 23.49 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 121.679 2.036 . . . . 0.0 115.601 -173.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -57.87 -42.75 85.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 112.527 169.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' CG1' ' A' ' 36' ' ' VAL . 37.6 t -46.43 -54.59 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.038 1.735 . . . . 0.0 110.814 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 t -60.01 -37.95 81.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.2 0.6 . . . . 0.0 111.605 -176.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -65.7 -42.76 90.79 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.36 -0.829 . . . . 0.0 112.375 174.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -44.48 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.095 0.861 . . . . 0.0 110.055 -175.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.76 -55.61 21.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.404 1.082 . . . . 0.0 110.37 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.4 t -64.1 -49.36 72.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.5 m -69.95 -36.25 75.14 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.98 1.312 . . . . 0.0 111.16 -172.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.98 -47.97 40.65 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.746 168.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -65.81 7.68 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 121.288 1.858 . . . . 0.0 115.283 -171.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.51 -3.32 18.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.824 2.05 . . . . 0.0 112.199 176.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.5 136.84 46.01 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.99 -1.069 . . . . 0.0 110.996 -171.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -75.63 65.65 1.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.786 1.634 . . . . 0.0 111.274 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 p90 167.25 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 129.961 3.304 . . . . 0.0 113.041 -173.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.2 p -86.03 142.63 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 121.184 1.811 . . . . 0.0 110.186 -175.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.06 -21.79 12.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -170.54 172.01 6.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.073 1.749 . . . . 0.0 112.369 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -176.25 153.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 127.804 2.442 . . . . 0.0 109.593 -169.3 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -147.11 132.6 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.588 2.355 . . . . 0.0 107.743 166.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.2 t -103.09 142.14 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.458 0.647 . . . . 0.0 110.825 169.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -73.28 108.79 6.36 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 122.81 1.29 . . . . 0.0 109.126 166.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -20.24 44.68 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.341 -0.849 . . . . 0.0 112.139 168.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -91.9 -45.6 8.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.539 1.063 . . . . 0.0 112.57 175.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -99.6 157.56 16.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.828 1.251 . . . . 0.0 112.178 -171.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.81 35.01 0.23 Allowed 'General case' 0 CA--C 1.548 0.872 0 O-C-N 119.732 -1.855 . . . . 0.0 113.946 -177.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -140.49 154.55 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 119.914 -1.741 . . . . 0.0 115.431 -170.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.56 139.19 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.187 2.195 . . . . 0.0 109.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -110.26 118.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 169.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.411 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -121.65 138.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.899 1.28 . . . . 0.0 110.125 -167.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.14 99.4 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.238 1.415 . . . . 0.0 109.925 -167.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -118.13 143.01 46.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.537 1.535 . . . . 0.0 113.539 -168.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.02 94.28 9.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.565 -1.334 . . . . 0.0 111.583 -169.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.79 129.36 3.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.0 112.394 -175.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -83.52 -11.41 57.46 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.566 -0.708 . . . . 0.0 112.135 174.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 m -168.55 72.34 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 111.768 -177.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.6 t -135.85 138.11 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 168.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -68.94 137.56 89.9 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.198 -174.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.3 -20.64 69.02 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.235 2.623 . . . . 0.0 111.929 170.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.46 -16.96 41.53 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.155 0.982 . . . . 0.0 112.608 174.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -68.06 -47.07 69.34 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.957 -1.089 . . . . 0.0 112.802 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.7 mt -66.6 -42.88 86.22 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.608 -0.683 . . . . 0.0 110.435 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.68 -52.5 18.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.207 1.403 . . . . 0.0 111.785 171.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -32.52 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.225 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.14 83.97 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.984 1.265 . . . . 0.0 111.8 172.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.02 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.432 -0.793 . . . . 0.0 110.762 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.19 -20.67 18.96 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.71 1.19 55.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.636 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -93.96 -28.79 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.282 0.946 . . . . 0.0 111.252 176.352 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -151.15 67.79 7.75 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.764 0.826 . . . . 0.0 112.161 169.027 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.45 145.41 88.45 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.269 3.313 . . . . 0.0 113.062 -178.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.96 -40.98 2.93 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.416 1.484 . . . . 0.0 112.929 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -77.01 -45.81 26.01 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.046 1.338 . . . . 0.0 111.698 173.455 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 3.2 m-30 -72.28 96.97 1.91 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.25 1.5 . . . . 0.0 114.11 -168.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -72.85 65.02 0.7 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.715 2.006 . . . . 0.0 113.594 170.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.97 136.78 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.77 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 p -151.79 156.95 41.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.845 1.258 . . . . 0.0 110.57 174.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.65 129.61 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.166 0.986 . . . . 0.0 109.71 174.643 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.76 107.27 18.87 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 109.097 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.0 t -137.92 163.16 32.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.827 0.851 . . . . 0.0 113.273 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.29 71.45 5.82 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.861 1.315 . . . . 0.0 110.375 175.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 126.105 1.762 . . . . 0.0 109.839 172.084 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 122.435 1.112 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.95 154.42 38.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 113.709 -170.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -100.65 -175.88 3.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.821 1.648 . . . . 0.0 110.141 168.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -162.77 150.79 13.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.044 1.338 . . . . 0.0 109.62 -172.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.4 159.93 39.17 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.678 1.591 . . . . 0.0 111.321 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -121.87 139.22 53.9 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 109.947 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -140.5 139.48 35.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.185 -176.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.12 130.75 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.05 1.34 . . . . 0.0 111.122 -175.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.42 103.46 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.978 1.711 . . . . 0.0 109.524 -168.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.44 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -72.08 0.19 10.17 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.357 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 10.47 5.75 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 125.784 1.659 . . . . 0.0 114.36 -173.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -66.59 135.92 54.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.304 1.042 . . . . 0.0 111.231 -174.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -62.56 0.25 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m 76.34 -40.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.965 2.506 . . . . 0.0 114.623 167.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HE3' HD13 ' A' ' 38' ' ' LEU . 12.3 mptt -111.55 -75.79 0.61 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.11 0.868 . . . . 0.0 109.507 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -32.32 69.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.552 -1.968 . . . . 0.0 114.045 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.25 -41.73 80.17 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.69 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 36' ' ' VAL . 76.7 t -47.13 -49.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.887 2.075 . . . . 0.0 112.242 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -61.62 -40.07 93.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.395 0.678 . . . . 0.0 112.348 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -63.8 -46.95 82.87 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 122.06 -0.4 . . . . 0.0 111.743 171.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.23 -50.98 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -171.12 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.06 -44.47 67.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.33 1.852 . . . . 0.0 109.899 175.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -70.49 -44.59 67.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 m -70.76 -40.3 72.76 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.95 1.3 . . . . 0.0 110.853 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -49.55 25.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 116.845 -1.55 . . . . 0.0 111.199 175.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.96 16.74 0.11 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.472 1.942 . . . . 0.0 113.534 -174.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.92 -3.45 14.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.224 1.81 . . . . 0.0 112.423 174.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.85 139.86 47.23 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.86 -1.15 . . . . 0.0 111.634 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.88 -15.2 7.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.817 1.647 . . . . 0.0 115.004 -170.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.79 -6.47 11.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.367 1.867 . . . . 0.0 114.95 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -88.82 137.32 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.923 1.692 . . . . 0.0 111.271 -168.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.23 -26.19 14.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.266 1.027 . . . . 0.0 111.506 -173.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -177.8 173.55 1.57 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.06 2.144 . . . . 0.0 111.636 -171.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -177.32 155.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.622 2.369 . . . . 0.0 108.624 -172.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -149.58 135.38 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 127.48 2.312 . . . . 0.0 108.645 166.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 18' ' ' VAL . 41.2 t -106.19 141.44 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.072 0.949 . . . . 0.0 110.75 169.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -79.16 112.76 16.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 123.153 1.454 . . . . 0.0 110.259 168.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.549 HD13 ' HE3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.59 -22.06 31.17 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 120.692 -1.255 . . . . 0.0 112.664 167.886 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 -69.04 0.73 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.519 1.528 . . . . 0.0 111.057 169.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -73.52 137.23 44.28 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.855 1.262 . . . . 0.0 111.278 -171.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -130.86 154.73 47.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.247 2.219 . . . . 0.0 113.691 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.26 143.97 44.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.259 2.223 . . . . 0.0 109.296 172.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.74 118.84 59.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.11 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.4 t -119.99 135.52 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.329 1.452 . . . . 0.0 108.881 -168.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.73 96.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.21 1.404 . . . . 0.0 108.52 -168.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.6 p90 -118.63 140.07 50.5 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.729 1.212 . . . . 0.0 113.55 -168.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.33 117.31 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.077 -1.014 . . . . 0.0 111.629 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -179.94 132.6 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.095 2.158 . . . . 0.0 108.95 178.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -82.24 -13.44 57.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.095 -1.003 . . . . 0.0 113.002 177.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -167.95 158.55 10.67 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.776 1.63 . . . . 0.0 110.348 167.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p 145.0 153.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 1 C-N-CA 132.515 4.326 . . . . 0.0 106.914 -169.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t -66.16 144.25 98.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.152 171.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -55.38 -19.59 22.83 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.52 2.813 . . . . 0.0 112.329 167.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.83 -13.65 62.12 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -37.32 81.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.301 1.864 . . . . 0.0 111.44 170.294 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 47' ' ' TYR . 70.7 mt -70.03 -46.14 65.68 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.182 173.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -49.01 -52.42 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 111.072 174.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -56.5 -37.71 70.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.286 1.434 . . . . 0.0 114.749 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.77 95.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.733 1.606 . . . . 0.0 111.474 171.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mt -63.06 -56.18 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.667 174.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -53.18 -24.68 11.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.936 0.894 . . . . 0.0 113.002 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 0.01 55.94 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -95.39 -30.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 177.696 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.01 67.48 9.18 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.39 0.676 . . . . 0.0 111.145 169.651 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 143.71 99.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.13 3.22 . . . . 0.0 112.081 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.71 -39.18 2.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.863 1.22 . . . . 0.0 113.093 -174.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.2 tp -78.21 -41.95 32.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.81 1.244 . . . . 0.0 111.529 174.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.45 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.8 m-30 -83.16 94.51 7.87 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -168.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -73.36 66.14 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.189 1.796 . . . . 0.0 111.146 169.213 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.19 131.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 121.747 0.784 . . . . 0.0 110.756 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -138.0 147.62 44.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 0.0 109.017 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.48 130.33 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 119.894 -1.754 . . . . 0.0 109.916 174.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.04 93.21 7.24 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.447 0.699 . . . . 0.0 110.184 178.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 m -176.51 165.58 2.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.978 2.511 . . . . 0.0 108.69 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -72.43 111.08 7.3 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 170.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 124.999 1.32 . . . . 0.0 114.322 -171.801 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.58 167.67 20.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.779 2.431 . . . . 0.0 113.861 -175.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -103.49 175.11 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.291 1.436 . . . . 0.0 110.794 176.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -163.99 147.53 9.8 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.862 -1.149 . . . . 0.0 110.384 -169.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.28 161.98 41.4 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.198 1.399 . . . . 0.0 111.321 170.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.5 m -123.93 139.77 53.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.837 1.255 . . . . 0.0 110.218 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -140.79 136.99 33.02 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.722 1.209 . . . . 0.0 110.024 -174.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tt -119.44 132.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 120.82 -1.175 . . . . 0.0 110.424 177.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.0 106.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.16 1.384 . . . . 0.0 108.676 -175.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.45 98.91 11.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.764 1.269 . . . . 0.0 109.678 169.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.55 -13.42 1.38 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.672 1.606 . . . . 0.0 114.057 177.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.401 ' SD ' ' SG ' ' A' ' 17' ' ' CYS 0.257 0.0 OUTLIER -77.07 132.65 39.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.85 1.325 . . . . 0.0 112.187 -176.779 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -67.94 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 t 66.61 -53.9 0.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.197 2.599 . . . . 0.0 116.23 169.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -63.34 1.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.67 -1.269 . . . . 0.0 112.931 -178.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -59.07 -32.69 70.01 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 121.424 1.92 . . . . 0.0 114.221 -177.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 12' ' ' MET . 2.3 p -40.6 -58.17 1.67 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.217 1.807 . . . . 0.0 111.376 169.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -46.24 -54.19 2.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 127.541 2.336 . . . . 0.0 111.007 -176.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -64.02 -30.23 71.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.334 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -69.93 -46.91 64.32 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.89 0.768 . . . . 0.0 111.353 168.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -46.46 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.255 0.934 . . . . 0.0 110.645 -170.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -51.43 -48.86 62.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.113 1.365 . . . . 0.0 110.786 170.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -68.75 -52.19 33.16 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.9 m -69.32 -35.87 76.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.531 1.532 . . . . 0.0 110.567 -169.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -73.24 -48.94 30.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.057 168.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 t -70.96 13.65 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.739 2.063 . . . . 0.0 114.421 -171.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.94 16.25 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.886 2.074 . . . . 0.0 111.398 173.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.99 125.86 29.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.11 -15.13 43.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.15 -11.57 35.25 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 169.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 137.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 121.586 1.994 . . . . 0.0 109.739 -173.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -105.38 -14.79 15.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.197 0.599 . . . . 0.0 112.491 -176.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -178.61 172.18 1.44 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.805 2.042 . . . . 0.0 112.288 -172.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -176.05 152.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 127.743 2.417 . . . . 0.0 109.29 -170.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.5 133.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 127.503 2.321 . . . . 0.0 107.236 167.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.54 141.77 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 123.247 1.499 . . . . 0.0 112.326 171.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -77.57 84.15 3.95 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.596 1.559 . . . . 0.0 109.384 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.09 -29.34 60.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.756 1.622 . . . . 0.0 114.191 -173.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -88.4 -0.31 57.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.712 1.605 . . . . 0.0 114.325 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -135.67 -171.51 2.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.535 2.734 . . . . 0.0 110.411 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER -111.24 33.72 4.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.022 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 p -132.66 155.74 48.23 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.019 -1.676 . . . . 0.0 115.505 -170.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.27 138.02 54.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.144 2.178 . . . . 0.0 110.107 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -108.79 115.91 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 170.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -118.73 136.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.133 1.373 . . . . 0.0 108.977 -167.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.66 104.29 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.758 1.223 . . . . 0.0 109.191 -169.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 57' ' ' LEU . 34.5 p90 -120.23 161.82 20.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.016 . . . . 0.0 113.274 -171.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -92.5 122.75 35.24 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.982 -1.073 . . . . 0.0 110.921 -176.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.67 156.18 1.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.772 2.029 . . . . 0.0 110.604 174.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -87.43 24.25 1.69 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.151 0.981 . . . . 0.0 111.762 170.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -163.12 -178.82 6.25 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.755 -1.216 . . . . 0.0 113.514 -173.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -111.93 109.33 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.771 2.428 . . . . 0.0 108.927 -176.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.0 m -141.86 69.77 24.34 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 126.193 1.797 . . . . 0.0 109.186 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.93 -20.39 13.2 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.574 2.85 . . . . 0.0 113.109 -171.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -54.95 -32.67 61.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.057 1.343 . . . . 0.0 113.4 -176.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 m -73.65 -35.95 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.371 -1.456 . . . . 0.0 112.666 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.6 mt -70.56 -44.58 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -50.7 -51.18 52.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.845 1.258 . . . . 0.0 111.201 172.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -39.55 79.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.643 1.177 . . . . 0.0 114.108 172.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 -36.33 80.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.929 1.24 . . . . 0.0 111.83 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.48 -51.67 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.763 -0.585 . . . . 0.0 109.718 170.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.69 -19.02 14.4 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.145 0.884 . . . . 0.0 112.844 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 1.2 57.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -92.22 -32.35 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.969 0.804 . . . . 0.0 111.014 175.581 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.46 69.12 11.33 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.355 0.662 . . . . 0.0 111.65 168.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.58 142.0 97.9 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.291 3.327 . . . . 0.0 112.785 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.42 -35.56 3.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.143 1.354 . . . . 0.0 113.066 -176.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.65 -43.78 16.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.718 1.607 . . . . 0.0 112.064 174.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.8 m-30 -80.66 105.08 11.63 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -167.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.14 75.37 8.12 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.618 -1.926 . . . . 0.0 112.927 169.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.43 126.26 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 121.25 -0.906 . . . . 0.0 112.849 -174.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -140.48 139.48 35.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.198 0.999 . . . . 0.0 111.608 -169.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.1 mt -85.41 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.659 -1.276 . . . . 0.0 109.176 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t -85.7 121.78 28.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.671 0.748 . . . . 0.0 109.281 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -158.1 166.79 31.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.197 2.199 . . . . 0.0 109.355 170.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -86.41 128.16 34.91 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 167.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 126.858 2.063 . . . . 0.0 110.5 -172.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 123.218 1.485 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.52 27.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.441 1.896 . . . . 0.0 110.491 167.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 t -94.7 -179.67 4.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.576 1.95 . . . . 0.0 110.987 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -158.88 145.96 17.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.287 1.435 . . . . 0.0 110.244 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.03 153.82 39.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.043 1.737 . . . . 0.0 111.07 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 m -117.69 139.52 50.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.913 177.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.98 144.97 41.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.941 1.296 . . . . 0.0 110.644 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.24 135.0 64.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.514 1.525 . . . . 0.0 110.282 178.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.59 123.51 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.969 1.308 . . . . 0.0 108.775 -171.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.67 146.48 27.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 164.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.61 -4.67 77.67 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.401 0.524 . . . . 0.0 112.559 -168.761 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.42 127.53 27.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.303 1.441 . . . . 0.0 112.118 174.155 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -64.98 41.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.664 1.986 . . . . 0.0 113.961 170.2 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 30.62 -110.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.961 3.305 . . . . 0.0 114.84 175.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -51.85 -39.38 58.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 113.375 -179.013 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -83.12 -32.89 26.46 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.009 -1.057 . . . . 0.0 112.196 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 t -55.15 -49.08 72.72 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.972 1.26 . . . . 0.0 110.672 171.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.4 t -42.34 -50.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 124.489 1.118 . . . . 0.0 112.5 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -69.3 -35.54 76.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.036 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -62.81 -45.24 93.54 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.756 -1.215 . . . . 0.0 111.005 169.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mm -67.45 -49.21 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.983 -170.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -43.97 -50.83 8.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.488 1.515 . . . . 0.0 109.539 170.089 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -71.63 -50.95 25.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -66.26 -42.55 88.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.26 1.424 . . . . 0.0 110.51 -176.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.08 -49.65 23.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.159 177.624 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 t -74.26 13.75 0.53 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.476 1.943 . . . . 0.0 113.302 -173.044 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.16 -3.1 18.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.733 1.613 . . . . 0.0 111.858 173.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.06 133.64 41.55 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.046 -1.034 . . . . 0.0 110.435 -172.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -59.5 2.98 0.05 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -174.342 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 -8.09 4.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.696 1.999 . . . . 0.0 114.717 174.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 8.7 p -88.24 139.21 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 121.369 1.895 . . . . 0.0 110.426 -169.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -99.92 -19.02 16.81 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m 178.75 171.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.094 1.758 . . . . 0.0 113.039 -172.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -168.13 152.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.857 2.063 . . . . 0.0 110.473 -174.462 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.21 148.76 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 128.383 2.673 . . . . 0.0 106.544 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 18' ' ' VAL . 7.3 p -138.41 145.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.96 0.409 . . . . 0.0 110.85 175.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 m -91.59 125.52 36.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.582 0.705 . . . . 0.0 112.307 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' HE2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -70.58 -36.47 73.6 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.025 -1.047 . . . . 0.0 112.869 -176.206 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -104.15 -8.85 19.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.291 1.436 . . . . 0.0 114.732 -177.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -121.76 130.39 53.38 Favored 'General case' 0 C--O 1.221 -0.431 0 O-C-N 120.264 -1.523 . . . . 0.0 107.108 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 35.12 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.207 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 p -128.23 152.5 48.01 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -172.745 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.48 137.53 54.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.956 2.502 . . . . 0.0 110.491 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.3 mt -110.66 117.18 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.483 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.42 130.67 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.503 1.121 . . . . 0.0 109.041 -167.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.01 108.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.378 1.471 . . . . 0.0 108.555 -167.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.6 p90 -128.3 145.67 50.99 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.29 1.405 . . . . 0.0 113.844 -168.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -97.24 107.92 20.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.304 -1.498 . . . . 0.0 112.11 -172.139 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.46 148.46 0.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.587 1.555 . . . . 0.0 111.411 -170.805 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 m -93.08 17.26 11.15 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.036 -1.04 . . . . 0.0 112.895 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p -124.51 135.22 53.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.783 -1.198 . . . . 0.0 113.347 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.3 t -73.53 98.58 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 166.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 m -144.47 54.16 2.55 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.078 0.951 . . . . 0.0 109.949 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.98 -17.14 58.62 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.945 2.43 . . . . 0.0 111.991 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 17.0 mp0 -64.54 -8.96 15.85 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.461 1.504 . . . . 0.0 112.26 173.261 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 p -79.17 -51.87 8.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.787 1.176 . . . . 0.0 111.906 169.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.483 HD13 ' CG1' ' A' ' 45' ' ' VAL . 87.6 mt -64.79 -41.55 95.73 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.774 -1.107 . . . . 0.0 110.639 176.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -53.4 15.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.498 1.045 . . . . 0.0 111.545 172.064 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -37.69 72.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.36 1.464 . . . . 0.0 113.518 175.148 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.13 84.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.369 1.44 . . . . 0.0 112.085 175.151 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.26 -56.74 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.455 0.702 . . . . 0.0 110.758 171.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -53.41 -27.33 23.82 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 123.801 0.84 . . . . 0.0 111.534 176.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.42 1.98 38.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -27.94 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.726 0.81 . . . . 0.0 111.643 175.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.77 69.1 9.23 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.082 0.953 . . . . 0.0 110.644 169.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.34 145.3 98.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.257 3.305 . . . . 0.0 112.489 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.06 -40.83 2.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.961 1.267 . . . . 0.0 113.013 -174.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.82 -55.4 5.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.436 1.494 . . . . 0.0 111.062 177.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -71.5 107.76 4.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -169.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -78.89 47.68 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.226 1.811 . . . . 0.0 113.761 176.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.3 126.95 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.972 0.909 . . . . 0.0 111.076 -168.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 m -139.58 148.52 42.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.649 -175.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.67 124.28 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.692 -1.255 . . . . 0.0 109.758 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.71 106.99 18.89 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.694 0.798 . . . . 0.0 109.608 -175.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 m 175.67 -25.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 127.934 2.494 . . . . 0.0 114.507 174.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -75.92 85.61 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 122.709 1.242 . . . . 0.0 108.919 176.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.141 170.697 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 124.032 1.873 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -55.76 129.6 39.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.934 2.094 . . . . 0.0 109.732 165.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -102.07 -175.25 2.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.88 1.672 . . . . 0.0 109.751 172.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -158.77 150.76 21.21 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.845 -1.159 . . . . 0.0 109.893 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.06 156.01 40.2 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.996 1.719 . . . . 0.0 109.864 173.431 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.0 m -127.26 138.58 53.11 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.996 0.919 . . . . 0.0 109.453 -178.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -136.53 144.85 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.413 1.085 . . . . 0.0 111.303 -174.106 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 tt -122.38 140.87 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 125.205 1.402 . . . . 0.0 109.19 175.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.18 153.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.683 1.193 . . . . 0.0 108.639 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.26 144.66 50.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.413 0.285 . . . . 0.0 110.971 164.148 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.77 -1.67 68.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.22 1.39 . . . . 0.0 112.504 -174.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.49 165.91 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.514 1.525 . . . . 0.0 114.338 -171.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.55 37.23 0.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 125.022 1.329 . . . . 0.0 113.76 -179.021 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 t 52.39 -143.09 0.72 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.632 1.573 . . . . 0.0 111.7 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HE3' HD13 ' A' ' 38' ' ' LEU . 29.5 mttp -61.23 -13.87 21.65 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.196 -1.565 . . . . 0.0 114.273 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -91.79 -11.83 35.52 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.051 -1.656 . . . . 0.0 112.268 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -48.09 77.8 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.643 1.111 . . . . 0.0 108.179 168.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' CG1' ' A' ' 36' ' ' VAL . 54.2 t -40.45 -56.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 130.392 3.477 . . . . 0.0 111.937 -177.554 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -38.27 90.47 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 120.888 0.375 . . . . 0.0 111.808 -173.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -60.81 -41.49 95.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.831 -1.168 . . . . 0.0 112.412 168.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 -47.38 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.731 -171.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.68 -51.53 15.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.746 1.618 . . . . 0.0 109.307 169.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -70.55 -44.26 67.82 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.6 m -70.55 -40.68 73.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.769 1.228 . . . . 0.0 110.5 -175.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -44.89 57.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.224 178.679 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t -70.38 13.36 0.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 120.416 1.462 . . . . 0.0 113.813 -176.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.03 -6.84 19.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.399 1.48 . . . . 0.0 111.95 174.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.26 129.0 34.54 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.063 -1.023 . . . . 0.0 110.327 -169.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.72 -25.07 25.17 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -5.13 48.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 174.044 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.254 5.0 p -92.55 134.73 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 121.606 2.003 . . . . 0.0 110.314 -173.261 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 t -93.3 -27.39 16.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.383 1.473 . . . . 0.0 111.796 -176.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -178.06 175.91 1.2 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.959 2.104 . . . . 0.0 112.409 -171.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -172.75 151.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.748 2.019 . . . . 0.0 109.724 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.58 141.37 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 126.901 2.08 . . . . 0.0 105.782 166.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' CG1' HG13 ' A' ' 18' ' ' VAL . 66.2 t -111.37 137.84 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.681 1.229 . . . . 0.0 110.46 169.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.0 m -75.92 83.11 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.45 176.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD13 ' HE3' ' A' ' 15' ' ' LYS . 2.5 tm? -43.49 -42.91 5.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.509 2.324 . . . . 0.0 112.314 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -47.61 84.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.345 1.069 . . . . 0.0 112.29 178.67 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -98.43 -171.48 2.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.99 2.516 . . . . 0.0 112.031 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.98 29.56 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.081 2.552 . . . . 0.0 113.309 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 p -144.81 158.64 43.72 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.012 -1.68 . . . . 0.0 115.406 -167.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.41 51.76 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.103 2.161 . . . . 0.0 110.774 -173.299 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.77 110.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.3 t -116.67 130.46 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.19 1.396 . . . . 0.0 108.141 -168.239 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.87 106.46 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 107.813 -168.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CD1' HD11 ' A' ' 57' ' ' LEU . 27.1 p90 -127.25 147.15 50.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.588 1.155 . . . . 0.0 113.617 -168.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -89.03 141.48 28.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.284 -1.51 . . . . 0.0 112.172 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.26 172.7 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.754 1.622 . . . . 0.0 110.495 -179.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.3 p -98.24 10.04 41.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.229 167.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.1 m -153.24 158.25 41.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.684 1.194 . . . . 0.0 111.373 -168.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.85 110.84 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 167.01 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -145.85 80.7 10.35 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.007 0.923 . . . . 0.0 109.649 -171.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -89.63 -17.07 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.898 3.065 . . . . 0.0 114.66 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.16 -32.78 74.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.745 1.157 . . . . 0.0 112.913 -168.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -74.51 -28.43 60.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.065 0.946 . . . . 0.0 112.984 -178.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' A' ' 47' ' ' TYR . 69.4 mt -70.81 -47.58 58.69 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.407 170.475 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -45.34 -53.68 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.142 0.883 . . . . 0.0 110.761 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -37.54 71.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.65 78.48 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.423 1.465 . . . . 0.0 111.892 172.069 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.23 -50.74 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.263 0.625 . . . . 0.0 110.029 173.294 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -58.37 -19.36 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.429 -1.419 . . . . 0.0 112.486 174.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.31 0.43 56.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 174.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -89.63 -37.39 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 118.997 0.817 . . . . 0.0 110.967 173.186 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.35 70.51 33.11 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.964 0.412 . . . . 0.0 111.718 169.846 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.32 134.82 61.35 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.433 3.422 . . . . 0.0 111.909 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 -17.2 27.47 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.095 1.331 . . . . 0.0 114.167 -174.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 tp -105.25 -23.82 12.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.686 1.594 . . . . 0.0 112.532 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -102.61 111.29 23.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.24 45.71 0.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 119.578 -1.951 . . . . 0.0 114.851 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.75 124.06 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -166.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -141.11 155.65 46.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.827 1.651 . . . . 0.0 109.451 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.89 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.411 -1.43 . . . . 0.0 107.369 176.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 t -110.75 57.56 0.62 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.38 1.072 . . . . 0.0 112.411 -169.129 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -165.22 33.82 0.06 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.976 1.31 . . . . 0.0 113.162 -173.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.22 31.63 5.55 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.663 1.22 . . . . 0.0 109.804 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.477 0.921 0 C-N-CA 126.171 1.789 . . . . 0.0 111.239 -176.965 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -87.11 -172.17 3.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.799 2.44 . . . . 0.0 113.702 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t -124.67 169.58 11.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.682 1.23 . . . . 0.0 111.692 168.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -146.84 146.64 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.754 1.222 . . . . 0.0 109.832 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.98 37.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.105 1.762 . . . . 0.0 110.699 174.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.1 m -133.71 142.91 48.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.156 0.982 . . . . 0.0 110.871 -175.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 23.4 m-85 -145.16 140.1 27.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.321 1.448 . . . . 0.0 111.072 -168.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.53 131.7 60.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 O-C-N 120.744 -1.222 . . . . 0.0 111.899 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.36 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.003 2.121 . . . . 0.0 109.982 -169.35 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.43 4.14 6.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.08 1.752 . . . . 0.0 114.34 178.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.41 27.04 3.62 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 126.252 1.882 . . . . 0.0 110.577 -178.25 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.438 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -77.8 138.95 39.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.748 0.819 . . . . 0.0 109.599 179.066 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -53.81 -43.13 69.11 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p 172.17 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -140.98 -50.27 0.44 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 127.117 2.167 . . . . 0.0 110.771 -167.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -26.59 61.33 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.132 -2.23 . . . . 0.0 112.8 171.273 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.5 m -57.36 -39.18 75.44 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.718 170.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -47.89 -46.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.702 2.001 . . . . 0.0 111.564 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -67.51 -40.35 85.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.916 1.686 . . . . 0.0 113.605 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -61.33 -36.92 81.47 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.885 -1.134 . . . . 0.0 112.047 172.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -46.34 85.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.684 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -49.13 73.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 111.665 170.768 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -65.67 -41.86 92.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -177.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.0 m -69.3 -47.8 63.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.886 0.874 . . . . 0.0 110.79 177.34 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -76.58 -24.87 53.52 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 117.716 -1.135 . . . . 0.0 113.947 -177.386 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 t -81.64 11.53 4.65 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 121.144 1.793 . . . . 0.0 112.47 177.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.73 7.07 9.4 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -169.106 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 31' ' ' VAL . 13.6 mt -85.54 151.84 23.62 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.025 -1.047 . . . . 0.0 112.173 -169.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -67.13 22.95 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.467 2.307 . . . . 0.0 114.396 178.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.51 19.64 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.625 2.37 . . . . 0.0 112.868 -178.343 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.653 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.5 p -125.05 136.22 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.827 1.649 . . . . 0.0 112.726 177.297 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -118.28 -3.26 11.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -177.31 174.02 1.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.315 2.246 . . . . 0.0 111.914 176.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -172.99 154.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.67 2.788 . . . . 0.0 108.421 -172.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -145.98 123.24 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 C-N-CA 126.2 1.8 . . . . 0.0 107.522 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.71 149.67 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.171 172.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -73.54 124.31 25.64 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.46 1.504 . . . . 0.0 108.816 166.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -40.41 30.5 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.03 -51.6 30.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.888 2.475 . . . . 0.0 112.772 -173.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -88.87 -174.81 4.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.588 1.955 . . . . 0.0 112.398 169.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.2 43.56 1.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.31 1.444 . . . . 0.0 111.397 177.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 p -131.99 160.23 36.45 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.344 -2.097 . . . . 0.0 114.774 -168.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.54 136.94 33.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.092 1.357 . . . . 0.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -105.09 115.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.419 2.287 . . . . 0.0 105.425 171.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 57' ' ' LEU . 45.9 t -111.55 129.49 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.011 1.724 . . . . 0.0 108.537 -169.206 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.3 t -109.2 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.063 1.345 . . . . 0.0 108.174 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -101.3 132.57 46.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.043 1.737 . . . . 0.0 111.481 -170.461 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.286 8.5 p-10 -90.02 79.99 6.45 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.485 1.136 . . . . 0.0 110.508 -167.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -165.02 -178.13 5.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.878 -167.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 p -162.9 -61.34 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 45.51 0.2 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.255 1.822 . . . . 0.0 112.837 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 163.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.966 1.307 . . . . 0.0 110.404 -176.009 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -100.71 148.04 34.47 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.25 -175.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.2 -9.84 26.55 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.459 2.773 . . . . 0.0 112.614 167.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -54.37 -36.84 64.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.617 1.099 . . . . 0.0 112.118 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -67.6 -33.37 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.09 -1.006 . . . . 0.0 112.907 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 45' ' ' VAL . 68.1 mt -76.18 -43.92 40.43 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.577 0.751 . . . . 0.0 111.343 178.31 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.06 -47.2 65.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.411 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -45.08 74.88 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.094 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -33.18 73.95 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.049 1.295 . . . . 0.0 111.653 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.74 -54.04 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.284 0.633 . . . . 0.0 110.524 172.632 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -49.42 -33.75 14.79 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.686 0.794 . . . . 0.0 111.39 175.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.34 0.75 27.71 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -96.53 -27.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.151 1.381 . . . . 0.0 111.579 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.424 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.62 64.21 7.62 Favored Pre-proline 0 CA--C 1.549 0.912 0 O-C-N 121.689 -0.632 . . . . 0.0 111.498 168.473 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.21 144.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.29 3.327 . . . . 0.0 112.912 -172.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.67 -18.02 9.73 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.577 1.084 . . . . 0.0 113.975 -175.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.65 -47.36 3.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.979 1.711 . . . . 0.0 110.6 177.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.9 m-30 -66.38 107.28 1.97 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -175.315 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 75.36 4.72 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.419 -1.425 . . . . 0.0 109.887 169.123 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.16 129.79 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.458 -0.777 . . . . 0.0 111.464 -176.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.59 38.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.387 1.075 . . . . 0.0 110.634 -171.732 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.22 112.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.806 -1.184 . . . . 0.0 108.888 170.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -111.67 128.43 56.06 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.57 1.148 . . . . 0.0 108.896 168.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -132.71 168.0 19.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.537 1.535 . . . . 0.0 112.663 175.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -74.58 83.4 2.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.57 1.176 . . . . 0.0 108.943 169.268 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.475 0.822 0 C-N-CA 127.242 2.217 . . . . 0.0 109.72 168.914 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.704 0.764 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.82 158.93 32.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.44 3.096 . . . . 0.0 111.406 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 t -125.09 -177.74 3.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.454 1.102 . . . . 0.0 110.182 167.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -164.07 151.54 12.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.15 0.98 . . . . 0.0 109.989 -169.478 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.63 158.86 44.05 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.284 1.434 . . . . 0.0 111.216 171.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.4 m -120.86 140.04 52.33 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.931 1.293 . . . . 0.0 109.672 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.85 151.61 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.608 1.163 . . . . 0.0 111.176 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -134.77 140.03 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.948 1.299 . . . . 0.0 110.717 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.8 140.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.631 1.572 . . . . 0.0 110.907 -173.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . 0.262 0.4 OUTLIER -123.27 145.78 48.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 165.818 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.41 54.91 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.744 1.164 . . . . 0.0 112.708 -171.245 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.403 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -84.22 153.04 23.86 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.824 1.65 . . . . 0.0 111.378 -171.628 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -77.99 32.25 0.17 Allowed 'General case' 0 CA--C 1.556 1.203 0 O-C-N 119.711 -1.868 . . . . 0.0 114.519 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t 66.31 -71.6 0.09 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.129 2.172 . . . . 0.0 114.886 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 38' ' ' LEU . 10.5 mptt -108.31 -38.4 5.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 112.944 177.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 p -74.25 -21.47 59.76 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 119.425 -2.047 . . . . 0.0 112.79 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 27.6 p -51.17 -51.63 51.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.487 1.04 . . . . 0.0 110.073 169.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.582 HG13 ' CG1' ' A' ' 36' ' ' VAL . 53.9 t -46.35 -55.54 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 128.042 2.537 . . . . 0.0 112.234 -174.374 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -40.17 95.63 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 123.441 0.463 . . . . 0.0 111.585 -171.173 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -57.64 -46.49 84.1 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.699 -0.625 . . . . 0.0 112.401 169.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -44.51 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 118.721 -0.657 . . . . 0.0 109.842 -172.317 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.22 -49.28 67.1 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.247 0.967 . . . . 0.0 110.286 171.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -70.41 -41.31 73.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.8 m -76.92 -36.43 56.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.833 1.253 . . . . 0.0 111.255 -175.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.23 -45.91 53.25 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.75 172.077 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -72.17 16.24 0.14 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 121.483 1.947 . . . . 0.0 114.206 -172.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.93 -7.52 14.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.12 1.768 . . . . 0.0 112.311 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.32 133.58 45.07 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.922 -1.111 . . . . 0.0 110.448 -169.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.5 -0.04 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -170.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.89 -10.36 11.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.412 1.485 . . . . 0.0 114.855 169.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -89.4 138.97 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 121.088 1.767 . . . . 0.0 110.362 -169.695 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -99.24 -34.71 10.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 112.242 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -158.76 160.33 36.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.342 1.057 . . . . 0.0 110.644 -165.432 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.75 152.21 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.632 1.573 . . . . 0.0 109.8 174.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.62 129.98 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 C-N-CA 126.449 1.9 . . . . 0.0 107.449 167.015 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CG1' HG13 ' A' ' 18' ' ' VAL . 51.6 t -101.72 143.71 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 123.399 1.571 . . . . 0.0 111.826 171.168 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -78.19 87.09 4.29 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.028 174.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.487 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.1 tm? -44.87 -42.51 8.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.959 2.504 . . . . 0.0 113.417 -177.003 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 15' ' ' LYS . 71.6 mm-40 -81.92 -8.87 59.71 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -131.17 -173.82 3.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.969 2.508 . . . . 0.0 109.347 -169.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 30.05 7.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.927 1.291 . . . . 0.0 113.525 -175.264 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 p -131.82 160.69 34.89 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.431 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.08 140.79 48.96 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.473 1.909 . . . . 0.0 110.658 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.17 114.25 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.177 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.1 t -116.26 131.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.541 1.536 . . . . 0.0 107.482 -169.511 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 57.4 t -120.52 107.89 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 -168.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -127.54 148.37 50.34 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.061 -1.024 . . . . 0.0 112.981 -168.675 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.5 136.37 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.114 0.966 . . . . 0.0 110.795 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.74 144.4 0.27 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.97 1.308 . . . . 0.0 111.355 -172.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -74.2 -37.26 63.95 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.432 0.56 . . . . 0.0 109.739 166.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.4 t -178.95 162.25 1.25 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.508 3.123 . . . . 0.0 108.219 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p 172.37 164.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 129.029 2.931 . . . . 0.0 107.524 -169.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.9 t -76.95 133.28 69.68 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.866 173.45 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -59.95 -21.15 63.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.922 2.414 . . . . 0.0 110.589 168.202 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -67.95 -10.26 51.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.78 1.173 . . . . 0.0 113.563 178.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 p -61.58 -45.15 95.35 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.789 -1.194 . . . . 0.0 112.1 168.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.4 mt -71.12 -42.89 68.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.642 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.78 -46.99 51.32 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.431 172.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -62.22 -38.09 87.86 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.96 76.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.699 1.59 . . . . 0.0 111.783 173.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -68.28 -54.7 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.139 0.576 . . . . 0.0 110.905 171.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -55.75 -22.52 24.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.159 0.891 . . . . 0.0 112.615 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.42 5.31 42.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -97.22 -30.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 173.187 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -144.2 64.83 12.9 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.732 -0.605 . . . . 0.0 111.666 168.795 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.79 138.39 82.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.232 3.288 . . . . 0.0 112.431 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.12 -22.29 5.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.466 1.031 . . . . 0.0 113.662 -175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 tp -93.41 -54.07 3.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.477 1.511 . . . . 0.0 110.133 173.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.7 m-30 -70.09 117.0 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.045 1.738 . . . . 0.0 114.048 -177.482 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -111.68 139.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 119.363 0.983 . . . . 0.0 112.672 -173.174 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -144.63 160.04 41.82 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.824 1.25 . . . . 0.0 112.764 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.41 119.84 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.99 1.716 . . . . 0.0 107.469 173.121 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 106.56 18.4 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -175.081 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.8 m -159.44 175.29 13.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.702 1.201 . . . . 0.0 112.647 -176.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 121.75 21.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.261 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 127.776 2.43 . . . . 0.0 108.226 169.697 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 CA--C 1.549 0.94 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.37 148.78 31.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.898 1.679 . . . . 0.0 112.934 169.492 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -112.96 176.73 4.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.127 2.171 . . . . 0.0 110.853 -177.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.66 163.33 40.4 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 120.623 -1.298 . . . . 0.0 111.548 178.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.03 159.09 44.54 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.132 1.373 . . . . 0.0 110.187 169.074 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.9 154.59 26.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 110.435 172.025 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 53.2 m-85 -150.61 141.81 23.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.822 -1.536 . . . . 0.0 110.738 -176.627 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 tt -126.62 140.05 50.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.095 1.358 . . . . 0.0 110.289 177.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.3 98.39 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 126.478 1.911 . . . . 0.0 109.515 -170.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 65.26 7.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 123.534 1.635 . . . . 0.0 113.876 -169.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.99 0.11 Allowed Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 174.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 tmm? 45.08 -149.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.272 1.429 . . . . 0.0 109.56 -176.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -120.53 -33.06 3.92 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.407 -1.433 . . . . 0.0 111.386 167.554 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 p 161.76 -72.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.927 2.091 . . . . 0.0 113.589 178.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HE3' HD22 ' A' ' 38' ' ' LEU . 20.0 tptt -144.31 -57.38 0.37 Allowed 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.241 1.017 . . . . 0.0 109.815 -168.151 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -30.77 28.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.016 -1.678 . . . . 0.0 113.478 171.273 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.441 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 0.8 OUTLIER -57.61 -41.48 81.37 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.695 172.51 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.538 HG12 HG11 ' A' ' 36' ' ' VAL . 95.4 t -51.07 -42.73 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.834 1.653 . . . . 0.0 112.034 -176.512 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.6 t -71.09 -37.47 72.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.933 1.293 . . . . 0.0 113.277 178.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -60.24 -36.97 78.96 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.024 -1.048 . . . . 0.0 112.291 170.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -68.56 -48.23 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.925 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 36' ' ' VAL . 43.1 mt-10 -54.81 -51.91 64.34 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 124.044 0.84 . . . . 0.0 111.624 170.061 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -61.46 -41.28 96.99 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -68.41 -49.15 62.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.761 1.224 . . . . 0.0 110.189 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -75.74 -15.76 60.23 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.405 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -76.26 -3.07 34.6 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 173.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.49 7.68 11.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -166.001 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.35 152.29 30.52 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.165 -0.96 . . . . 0.0 112.599 -169.392 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -67.79 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.403 2.281 . . . . 0.0 114.501 -177.654 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.45 2.02 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.508 2.323 . . . . 0.0 114.341 -175.756 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.6 p -105.24 139.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 121.876 2.125 . . . . 0.0 111.307 -174.601 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 t -111.19 -11.62 14.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.07 175.03 1.98 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.175 1.79 . . . . 0.0 112.08 -175.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -175.55 152.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.041 2.536 . . . . 0.0 109.968 -171.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -147.88 134.57 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.86 2.464 . . . . 0.0 107.5 166.082 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG11 HG12 ' A' ' 18' ' ' VAL . 2.9 p -107.14 151.74 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 122.142 0.973 . . . . 0.0 113.174 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -90.15 102.75 15.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.58 0.752 . . . . 0.0 111.257 170.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.606 HD22 ' HE3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -57.81 -35.54 70.99 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.255 1.422 . . . . 0.0 113.401 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.99 5.55 49.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.152 1.381 . . . . 0.0 113.874 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -119.34 -173.94 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.951 1.7 . . . . 0.0 109.527 169.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 42.81 2.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.082 -1.011 . . . . 0.0 111.057 168.259 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -146.22 151.81 38.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -168.149 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.26 41.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.591 2.356 . . . . 0.0 112.055 -169.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.63 118.71 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.588 1.955 . . . . 0.0 106.544 174.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.2 t -119.77 120.35 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.756 1.622 . . . . 0.0 109.323 -167.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -107.06 107.78 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.854 1.662 . . . . 0.0 109.548 -169.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -121.0 158.32 28.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.041 1.336 . . . . 0.0 113.515 -171.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -96.21 101.07 12.66 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.397 -1.439 . . . . 0.0 112.902 -168.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.79 150.87 5.92 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.779 1.632 . . . . 0.0 109.712 173.569 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 m -83.81 27.64 0.63 Allowed 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.069 -1.019 . . . . 0.0 110.772 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -162.89 -175.37 4.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.895 -1.128 . . . . 0.0 113.12 -170.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.43 137.83 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.433 2.293 . . . . 0.0 111.232 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -171.05 87.38 0.48 Allowed Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 128.6 2.76 . . . . 0.0 106.917 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.04 -18.78 1.35 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.999 2.466 . . . . 0.0 113.871 -171.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -61.7 -32.06 72.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.949 1.25 . . . . 0.0 113.001 -174.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.28 64.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.924 -1.735 . . . . 0.0 113.416 -178.098 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 47' ' ' TYR . 58.2 mt -78.76 -46.42 18.9 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.898 -0.501 . . . . 0.0 110.145 173.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -46.87 -49.63 19.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.603 0.761 . . . . 0.0 110.124 169.376 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -58.32 -41.16 83.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 113.734 176.074 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.26 73.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.38 0.991 . . . . 0.0 112.18 172.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mt -70.84 -54.41 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.322 0.649 . . . . 0.0 110.557 172.708 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -55.03 -23.14 18.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.498 1.119 . . . . 0.0 112.52 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.65 4.25 37.29 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -98.83 -39.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.781 0.833 . . . . 0.0 111.582 -179.009 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -139.84 64.77 29.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.943 -0.473 . . . . 0.0 112.053 166.816 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.77 143.17 81.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 124.297 3.331 . . . . 0.0 114.189 -171.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.97 -43.41 3.24 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 125.438 1.494 . . . . 0.0 112.414 -175.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.47 -39.22 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.686 1.194 . . . . 0.0 110.524 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.2 m-85 -71.76 89.98 1.06 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.162 -0.961 . . . . 0.0 112.895 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -74.96 76.18 2.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.315 1.446 . . . . 0.0 110.098 169.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 t -92.05 133.69 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.952 -1.092 . . . . 0.0 111.785 -169.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -151.28 159.21 44.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.95 1.357 . . . . 0.0 111.289 168.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.66 130.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 166.575 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t -110.11 121.1 44.48 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.3 t -146.45 -179.28 6.65 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.209 1.404 . . . . 0.0 111.397 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -71.66 61.4 0.37 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.924 2.089 . . . . 0.0 111.556 174.224 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.444 . . . . 0.0 111.344 171.525 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 122.834 1.302 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -82.46 159.42 22.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.712 0.767 . . . . 0.0 110.915 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -152.82 153.35 32.95 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.954 -1.092 . . . . 0.0 108.284 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.5 39.91 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.094 1.758 . . . . 0.0 110.763 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 m -126.16 141.1 52.07 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.586 1.154 . . . . 0.0 109.842 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -140.28 136.4 33.24 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.66 135.69 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 C-N-CA 125.07 1.348 . . . . 0.0 110.57 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.84 129.34 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.403 1.081 . . . . 0.0 111.07 -172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.43 129.62 46.42 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.662 -0.649 . . . . 0.0 109.547 163.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 -1.67 28.42 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.852 1.215 . . . . 0.0 113.554 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.0 ptm -65.35 149.0 50.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.033 0.917 . . . . 0.0 113.087 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -73.64 33.78 0.08 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.48 1.512 . . . . 0.0 112.999 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t 66.3 -143.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.399 1.48 . . . . 0.0 111.301 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HE3' HD13 ' A' ' 38' ' ' LEU . 46.4 mttp -61.72 -14.68 34.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.652 1.981 . . . . 0.0 115.576 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.0 p -91.74 -41.51 10.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.04 168.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.37 -49.32 70.09 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 121.53 1.968 . . . . 0.0 109.62 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -36.05 -48.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.797 2.039 . . . . 0.0 112.91 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -83.4 -25.36 31.39 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -58.0 -35.54 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 119.91 -1.744 . . . . 0.0 110.138 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -43.15 78.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 CA-C-O 117.531 -1.223 . . . . 0.0 110.424 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -50.4 -51.04 49.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.664 0.786 . . . . 0.0 110.145 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -69.77 -42.14 74.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -70.87 -41.09 71.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 110.714 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -46.1 46.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.554 -1.212 . . . . 0.0 111.668 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -72.62 14.74 0.23 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.465 1.484 . . . . 0.0 113.579 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.97 -2.79 18.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.411 1.484 . . . . 0.0 112.187 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.25 130.58 35.3 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 111.332 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -58.99 -2.84 0.28 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.646 1.578 . . . . 0.0 115.25 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 -3.4 11.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.608 1.963 . . . . 0.0 115.942 172.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -95.16 144.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.197 1.817 . . . . 0.0 110.523 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -99.0 -27.77 13.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.87 1.668 . . . . 0.0 111.789 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m 176.79 176.67 0.31 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.898 2.079 . . . . 0.0 112.802 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -172.27 150.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.967 2.107 . . . . 0.0 110.493 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.73 134.64 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.074 2.15 . . . . 0.0 106.869 166.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.04 141.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.052 0.93 . . . . 0.0 110.468 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 m -76.44 84.37 3.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.659 1.183 . . . . 0.0 110.046 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.3 tm? -51.93 -43.35 63.4 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 113.07 -167.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.36 -41.89 94.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.479 0.712 . . . . 0.0 112.319 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -100.72 -170.74 1.9 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.313 3.445 . . . . 0.0 112.98 -169.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.21 32.61 4.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.052 2.141 . . . . 0.0 114.473 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.8 p -137.23 166.02 24.76 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.17 -1.581 . . . . 0.0 114.114 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.07 142.64 40.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.438 1.895 . . . . 0.0 110.649 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -108.74 117.36 54.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.4 t -120.81 131.83 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.164 1.386 . . . . 0.0 108.336 -167.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.48 110.86 32.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.445 1.498 . . . . 0.0 107.724 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.515 ' CD1' HD11 ' A' ' 57' ' ' LEU . 13.9 p90 -121.88 -165.28 1.24 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.565 1.546 . . . . 0.0 111.351 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.479 0.992 0 CA-C-N 122.269 2.304 . . . . 0.0 114.119 178.004 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo . . . . . 0 CA--C 1.54 0.779 0 N-CA-C 113.872 0.681 . . . . 0.0 113.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.91 -31.17 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.437 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.4 p -70.37 -38.87 74.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.552 -1.342 . . . . 0.0 112.818 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.1 mt -69.99 -43.97 70.33 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.564 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -50.52 -50.95 51.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.578 1.151 . . . . 0.0 110.768 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -37.39 74.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.332 1.453 . . . . 0.0 113.801 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.5 73.87 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.582 1.083 . . . . 0.0 111.636 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -68.37 -51.47 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.131 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -49.4 -35.77 20.03 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.618 0.645 . . . . 0.0 111.377 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.03 5.2 8.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -100.03 -26.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.003 1.321 . . . . 0.0 111.577 176.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.97 68.29 8.8 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 167.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.38 144.25 90.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.09 3.193 . . . . 0.0 112.717 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 -25.02 3.98 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.736 1.16 . . . . 0.0 113.392 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.18 -45.09 8.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.283 1.433 . . . . 0.0 111.948 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -75.02 109.65 8.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -169.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -86.55 81.7 8.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.5 t -87.51 124.66 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.758 0.823 . . . . 0.0 112.641 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.76 131.59 43.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.177 0.991 . . . . 0.0 111.862 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.45 83.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.656 -1.278 . . . . 0.0 110.796 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 124.724 1.21 . . . . 0.0 111.472 -179.181 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 CA-C-O 122.062 0.934 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -93.8 174.4 7.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.093 0.949 . . . . 0.0 110.018 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -165.13 148.32 8.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.017 -1.052 . . . . 0.0 110.478 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.08 31.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.569 1.548 . . . . 0.0 110.94 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -134.03 143.2 47.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 109.613 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -143.07 149.35 38.07 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.414 1.486 . . . . 0.0 111.724 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -133.46 136.75 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 125.301 1.44 . . . . 0.0 110.959 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.38 90.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.188 2.195 . . . . 0.0 109.606 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.14 39.01 0.3 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.179 1.392 . . . . 0.0 113.452 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.48 40.11 0.18 Allowed Glycine 0 N--CA 1.469 0.844 0 C-N-CA 125.763 1.649 . . . . 0.0 112.638 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 4.4 tmm? -102.72 150.11 23.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.671 1.588 . . . . 0.0 111.743 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -66.59 9.22 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m 81.91 -54.11 0.25 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.276 3.03 . . . . 0.0 114.572 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.624 ' HE2' HD13 ' A' ' 38' ' ' LEU 0.29 50.8 mttt -125.42 -57.1 1.49 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.667 1.121 . . . . 0.0 112.656 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -65.37 -13.54 58.83 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.333 -2.105 . . . . 0.0 113.903 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' HG2' ' A' ' 12' ' ' MET 0.275 1.2 m -71.76 -36.06 70.28 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.668 168.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.8 t -47.11 -48.85 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.308 1.843 . . . . 0.0 111.83 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -63.83 -42.39 97.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.315 1.446 . . . . 0.0 113.091 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.48 -34.77 72.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.122 -1.611 . . . . 0.0 113.014 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -41.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.573 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -52.45 -54.51 31.37 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 167.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.7 t -69.95 -38.24 76.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -75.22 -37.17 61.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 110.594 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.01 -51.16 16.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.749 -1.119 . . . . 0.0 112.866 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -71.8 11.86 0.46 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.28 1.4 . . . . 0.0 113.866 -169.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.87 -1.5 19.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.861 1.664 . . . . 0.0 112.591 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -77.39 134.31 38.47 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 120.789 -1.195 . . . . 0.0 111.589 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.22 72.39 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 109.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 159.73 -20.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.804 3.642 . . . . 0.0 113.676 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -91.12 144.63 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 121.933 2.152 . . . . 0.0 109.749 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 t -114.96 -7.9 12.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m 178.76 172.84 0.75 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.914 2.086 . . . . 0.0 112.971 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -171.4 152.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.173 2.189 . . . . 0.0 110.077 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.4 150.53 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 128.712 2.805 . . . . 0.0 106.614 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.82 151.02 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.952 0.501 . . . . 0.0 110.942 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -82.57 135.78 34.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.166 0.587 . . . . 0.0 111.209 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.624 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.3 tm? -76.18 -33.99 59.33 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 121.098 -1.001 . . . . 0.0 112.083 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.77 -55.78 3.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.237 1.415 . . . . 0.0 111.917 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -76.99 138.1 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.551 0.74 . . . . 0.0 109.467 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 40.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 p -141.47 152.7 44.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.42 1.488 . . . . 0.0 114.627 -169.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.86 143.01 50.59 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.217 2.207 . . . . 0.0 111.105 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.11 120.16 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 127.199 2.2 . . . . 0.0 105.716 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 t -125.61 134.56 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.124 0.969 . . . . 0.0 109.96 -166.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 110.28 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.132 1.373 . . . . 0.0 108.863 -168.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' CD1' HD11 ' A' ' 57' ' ' LEU . 44.3 p90 -123.16 168.34 12.54 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.42 1.088 . . . . 0.0 113.853 -170.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 CA--C 1.534 0.34 0 O-C-N 120.551 -1.343 . . . . 0.0 110.406 -172.15 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.539 0.77 0 CA-C-O 119.468 -0.305 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.08 -30.3 70.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -74.25 -39.94 62.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.599 1.16 . . . . 0.0 113.668 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.7 mt -66.2 -43.84 85.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.285 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -49.33 -56.39 9.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.123 0.874 . . . . 0.0 110.459 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.85 -39.5 39.25 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.56 72.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.57 1.077 . . . . 0.0 111.803 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.91 -54.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.274 0.63 . . . . 0.0 109.691 170.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -51.83 -29.35 19.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.785 0.834 . . . . 0.0 111.877 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.01 0.41 40.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -96.57 -29.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.692 1.197 . . . . 0.0 111.386 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.99 65.4 9.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 121.545 -0.722 . . . . 0.0 111.801 168.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.23 144.77 98.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.355 3.37 . . . . 0.0 113.376 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.04 -19.56 6.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.537 1.541 . . . . 0.0 114.08 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -106.16 -45.99 4.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.961 1.704 . . . . 0.0 111.216 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -66.74 109.03 2.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.268 1.027 . . . . 0.0 113.703 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -78.5 80.03 4.9 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 110.759 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 t -84.97 127.25 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.1 0.863 . . . . 0.0 111.877 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -138.4 146.81 42.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.59 1.156 . . . . 0.0 111.089 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.69 130.21 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 121.725 0.774 . . . . 0.0 110.561 172.483 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 122.575 1.179 . . . . 0.0 113.198 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -137.53 173.1 12.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.726 2.01 . . . . 0.0 109.084 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -161.75 156.39 22.8 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.734 -1.229 . . . . 0.0 110.336 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.35 160.89 38.94 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.48 1.512 . . . . 0.0 111.055 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -124.19 141.56 51.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.163 1.385 . . . . 0.0 110.194 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -141.75 145.2 34.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.853 1.261 . . . . 0.0 111.629 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.26 127.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 111.933 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.81 102.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.514 1.926 . . . . 0.0 111.497 -167.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -81.81 42.55 0.71 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.235 1.014 . . . . 0.0 113.665 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.02 3.66 0.03 OUTLIER Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.223 1.868 . . . . 0.0 117.438 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -75.73 145.6 40.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.739 2.269 . . . . 0.0 113.781 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -66.04 27.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.693 1.997 . . . . 0.0 114.982 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m 53.5 -129.53 2.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.825 1.65 . . . . 0.0 110.967 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HE2' HD13 ' A' ' 38' ' ' LEU . 1.6 mptm? -52.25 -32.31 36.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -170.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m -84.62 -28.57 26.4 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.555 -1.341 . . . . 0.0 113.143 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.81 -41.04 72.11 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.18 -1.391 . . . . 0.0 111.532 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -40.15 -54.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.7 2.0 . . . . 0.0 111.033 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -61.09 -41.74 97.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.508 1.123 . . . . 0.0 113.768 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.99 -38.38 85.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.297 -1.502 . . . . 0.0 112.934 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -36.44 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.213 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.27 -55.35 32.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.47 1.108 . . . . 0.0 109.687 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -67.61 -53.33 28.95 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.5 m -62.02 -38.46 88.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.894 1.278 . . . . 0.0 111.316 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -51.23 12.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.65 -1.167 . . . . 0.0 112.199 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -69.98 6.19 1.32 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.739 1.609 . . . . 0.0 113.928 -171.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.68 -6.81 24.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.817 1.647 . . . . 0.0 111.305 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 mt -75.39 128.02 34.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.15 -15.87 27.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -93.84 -12.17 29.57 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 p -93.57 143.72 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 121.161 1.8 . . . . 0.0 109.965 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.2 t -111.21 -11.63 14.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m 176.91 174.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.763 2.425 . . . . 0.0 113.005 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -172.71 150.48 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.674 2.39 . . . . 0.0 109.561 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.85 130.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 107.029 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.55 149.91 12.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.792 0.806 . . . . 0.0 111.041 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -80.58 113.02 18.47 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.547 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.5 tm? -60.31 -41.62 93.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.911 0.778 . . . . 0.0 111.366 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -97.25 -22.42 16.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.276 1.83 . . . . 0.0 114.638 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -115.91 155.85 27.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.773 1.229 . . . . 0.0 110.835 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.292 0.0 OUTLIER -78.5 38.32 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 p -138.77 157.92 45.18 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.52 139.9 35.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.809 2.044 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.76 121.26 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 106.14 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 57' ' ' LEU . 31.9 t -120.26 136.97 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.164 1.386 . . . . 0.0 108.468 -169.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.5 t -124.34 105.2 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.714 1.205 . . . . 0.0 109.72 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CD1' HD11 ' A' ' 57' ' ' LEU . 40.6 p90 -122.0 164.91 16.83 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.32 1.448 . . . . 0.0 113.967 -169.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.974 -171.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 CA--C 1.535 0.57 0 N-CA-C 114.176 0.798 . . . . 0.0 114.176 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.16 -32.16 67.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.388 0.995 . . . . 0.0 113.215 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 m -70.22 -36.3 74.45 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.907 -1.121 . . . . 0.0 112.215 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 47' ' ' TYR . 82.2 mt -71.86 -45.76 60.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.674 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -48.86 -47.49 42.78 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.659 0.783 . . . . 0.0 110.463 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -35.39 79.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.36 73.26 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 121.28 1.855 . . . . 0.0 112.127 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.93 -57.97 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.719 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -49.72 -27.89 5.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.488 1.115 . . . . 0.0 112.573 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 0.68 44.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -93.56 -29.9 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.978 0.911 . . . . 0.0 111.514 177.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.464 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.84 64.06 9.87 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 121.424 -0.798 . . . . 0.0 111.5 167.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.28 144.01 99.5 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.095 3.197 . . . . 0.0 112.464 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.31 -29.89 4.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.714 1.149 . . . . 0.0 113.007 -174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.3 tp -92.23 -48.23 6.8 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.046 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.514 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -71.26 99.09 1.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.354 1.062 . . . . 0.0 113.346 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -75.06 119.87 19.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 114.617 -2.611 . . . . 0.0 105.336 162.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 t -123.25 134.96 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 124.274 3.215 . . . . 0.0 112.544 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.16 134.6 45.6 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.042 1.337 . . . . 0.0 110.178 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.9 mt -74.22 123.45 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.185 -1.572 . . . . 0.0 110.38 170.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.522 -0.13 0 C-N-CA 123.456 0.702 . . . . 0.0 109.126 174.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.796 0.807 . . . . 0.0 111.802 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -88.91 172.15 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 163.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -157.33 138.29 13.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.52 -1.362 . . . . 0.0 110.311 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.35 158.74 43.59 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.672 1.589 . . . . 0.0 110.654 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.4 m -120.35 141.86 49.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.724 1.21 . . . . 0.0 109.414 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -137.04 139.89 41.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.106 1.362 . . . . 0.0 109.512 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -121.55 139.67 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 123.924 0.89 . . . . 0.0 110.818 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 147.57 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 O-C-N 125.086 1.492 . . . . 0.0 110.25 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -123.59 141.38 52.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.449 1.1 . . . . 0.0 108.465 162.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.43 -27.24 8.57 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 126.19 1.852 . . . . 0.0 113.369 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.419 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -67.32 125.1 25.04 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 129.632 3.173 . . . . 0.0 118.104 -166.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.611 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 2.5 m-70 -74.61 55.58 0.66 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.789 2.836 . . . . 0.0 117.871 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.76 -141.46 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 119.94 -1.725 . . . . 0.0 114.781 165.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -54.84 -31.24 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 118.823 -2.423 . . . . 0.0 111.149 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.03 -54.29 27.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.704 -1.141 . . . . 0.0 112.224 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 12' ' ' MET . 32.0 p -55.02 -55.14 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.475 1.488 . . . . 0.0 110.275 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 9.1 t -44.74 -54.12 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.523 2.329 . . . . 0.0 111.487 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.8 m -70.72 -26.5 63.42 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -60.5 -46.57 89.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.614 1.097 . . . . 0.0 109.309 165.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -40.25 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.437 -0.79 . . . . 0.0 111.846 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -54.19 -46.41 72.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.285 1.434 . . . . 0.0 109.33 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 t -73.03 -64.33 0.99 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -56.41 -36.58 69.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.828 2.451 . . . . 0.0 112.439 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.31 -43.92 63.46 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.828 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -67.84 13.05 0.09 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.642 1.565 . . . . 0.0 114.636 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.57 2.13 14.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.691 1.996 . . . . 0.0 112.262 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.32 137.65 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.81 -1.181 . . . . 0.0 111.863 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 67.27 0.77 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.685 1.594 . . . . 0.0 111.864 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 166.73 -20.77 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 129.956 3.303 . . . . 0.0 113.148 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.7 p -85.92 137.16 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 121.288 1.858 . . . . 0.0 110.895 -171.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -103.82 -19.04 14.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.376 1.47 . . . . 0.0 112.594 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m 178.16 167.19 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.632 2.373 . . . . 0.0 112.423 -171.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.4 tt -171.64 149.22 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.672 1.989 . . . . 0.0 112.479 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.7 t -141.09 144.35 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.494 2.317 . . . . 0.0 106.948 166.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 53.8 t -113.51 130.14 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 123.382 1.563 . . . . 0.0 110.842 168.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -80.64 91.28 5.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.807 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 18' ' ' VAL . 7.8 tp -51.21 -56.95 10.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.311 1.444 . . . . 0.0 111.201 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.85 -56.07 13.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.45 1.1 . . . . 0.0 110.926 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.44 15.42 5.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 51.47 29.47 5.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.452 1.901 . . . . 0.0 114.738 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 p -133.59 149.73 51.62 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -168.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.65 53.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.466 1.506 . . . . 0.0 109.109 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -101.25 109.75 26.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.96 132.61 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 124.781 1.232 . . . . 0.0 108.251 -166.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.03 108.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -169.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.451 ' CD1' HD11 ' A' ' 57' ' ' LEU . 12.6 p90 -130.87 137.59 49.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.774 1.23 . . . . 0.0 113.84 -167.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.616 0 O-C-N 120.223 -1.548 . . . . 0.0 112.378 -172.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 118.813 -0.578 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.95 -20.39 23.35 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.156 0.889 . . . . 0.0 112.13 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -42.17 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.501 -1.374 . . . . 0.0 112.134 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 ' CD1' ' A' ' 47' ' ' TYR . 93.5 mt -70.06 -42.05 73.34 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.693 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -51.44 -49.86 60.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.428 1.091 . . . . 0.0 110.913 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -61.59 -34.28 75.35 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.22 75.17 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 120.277 1.399 . . . . 0.0 112.159 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -70.27 -55.29 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.331 -0.856 . . . . 0.0 110.974 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.54 -16.86 17.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.276 0.943 . . . . 0.0 112.124 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.15 -0.65 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.457 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -91.93 -31.34 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.059 0.845 . . . . 0.0 111.83 175.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -144.35 59.32 6.59 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.9 139.43 84.31 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 125.128 3.885 . . . . 0.0 114.374 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.31 -25.71 3.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.014 1.292 . . . . 0.0 113.571 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -42.28 9.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.032 1.733 . . . . 0.0 109.245 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 4.3 m-30 -76.53 106.93 8.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 115.176 1.546 . . . . 0.0 115.176 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.283 5.5 mtt-85 -73.47 137.24 44.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 158.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.36 135.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 122.375 2.352 . . . . 0.0 110.292 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 p -138.45 151.79 47.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.3 mt -84.04 85.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.465 1.106 . . . . 0.0 108.397 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.522 -0.117 0 CA-C-O 122.436 1.113 . . . . 0.0 108.287 169.406 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 122.224 1.011 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 t -125.98 171.72 10.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.888 1.275 . . . . 0.0 110.105 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.21 166.53 31.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.196 0.999 . . . . 0.0 110.421 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.98 36.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.648 1.579 . . . . 0.0 110.898 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -123.3 135.09 54.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.276 1.43 . . . . 0.0 110.245 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -138.2 146.63 42.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.816 1.246 . . . . 0.0 111.406 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -132.8 135.81 56.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.905 1.282 . . . . 0.0 112.224 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.48 106.39 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.463 1.505 . . . . 0.0 111.771 -167.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.36 -3.96 36.59 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 119.346 -2.096 . . . . 0.0 115.673 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.54 5.85 44.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.556 1.074 . . . . 0.0 111.736 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.53 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 ttp -77.51 131.1 37.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 122.041 -0.682 . . . . 0.0 110.012 -169.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -64.86 6.62 0.22 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.553 1.541 . . . . 0.0 113.572 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.1 m 76.88 -40.13 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.388 2.275 . . . . 0.0 116.607 164.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 -85.2 0.62 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -52.47 -27.93 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.3 m -51.15 -39.19 55.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.261 1.391 . . . . 0.0 112.964 169.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 36' ' ' VAL . 24.1 t -57.0 -42.2 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.073 1.349 . . . . 0.0 112.771 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -59.96 -40.41 88.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 0.0 111.434 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -66.3 -44.72 82.69 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 121.989 -0.445 . . . . 0.0 111.594 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -45.75 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 119.229 -0.415 . . . . 0.0 109.962 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.92 -51.4 61.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.525 1.13 . . . . 0.0 110.45 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.6 t -70.71 -37.18 73.52 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -74.28 -41.36 61.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 110.329 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.61 -48.17 41.8 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.899 -1.524 . . . . 0.0 110.66 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 t -72.83 14.64 0.25 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.312 1.869 . . . . 0.0 113.588 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.45 -6.85 15.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.12 1.768 . . . . 0.0 112.108 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 28.9 mt -73.29 129.44 38.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.909 -1.119 . . . . 0.0 109.167 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -60.22 -17.59 42.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -170.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -96.61 -8.56 31.42 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 171.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.3 p -94.54 138.6 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.604 2.002 . . . . 0.0 109.725 -173.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 t -107.77 -12.98 15.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.819 . . . . 0.0 113.165 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m 179.17 174.63 0.72 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.82 2.448 . . . . 0.0 111.769 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -172.73 154.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.694 2.398 . . . . 0.0 109.468 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.28 129.8 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.464 2.305 . . . . 0.0 108.162 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 18' ' ' VAL . 78.9 t -103.62 136.63 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 122.701 1.238 . . . . 0.0 111.739 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -78.29 93.23 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.577 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 18' ' ' VAL . 21.1 tp -54.9 -43.41 73.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.714 0.806 . . . . 0.0 112.981 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.95 -44.02 19.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.187 1.395 . . . . 0.0 112.587 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.41 -170.93 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.286 2.634 . . . . 0.0 114.646 -168.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -101.18 19.15 18.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.233 1.813 . . . . 0.0 114.376 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 p -136.55 156.61 48.34 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -167.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.36 136.95 49.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.495 1.918 . . . . 0.0 110.572 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.14 122.03 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.479 ' CG1' HD13 ' A' ' 57' ' ' LEU . 39.9 t -123.42 120.61 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 108.996 -166.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.49 111.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.515 1.526 . . . . 0.0 109.14 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' A' ' 57' ' ' LEU . 38.9 p90 -123.23 157.86 32.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.48 1.112 . . . . 0.0 112.821 -173.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 . . . . . 0 CA--C 1.538 0.496 0 O-C-N 121.012 -1.055 . . . . 0.0 111.879 -169.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 CA--C 1.539 0.729 0 N-CA-C 113.506 0.541 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -55.96 -48.0 76.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.276 1.43 . . . . 0.0 111.479 -172.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.6 -29.16 68.43 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.275 -0.891 . . . . 0.0 112.373 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 47' ' ' TYR . 54.2 mt -70.83 -49.22 48.62 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.02 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -52.8 -48.23 67.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.362 1.065 . . . . 0.0 110.648 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -56.86 -40.52 76.3 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.05 85.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.541 1.519 . . . . 0.0 112.128 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -63.37 -54.85 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.051 0.54 . . . . 0.0 109.923 172.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -50.81 -33.68 24.58 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.353 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.62 5.12 13.98 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -101.46 -26.7 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.981 1.312 . . . . 0.0 111.725 176.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.51 65.99 8.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.793 0.837 . . . . 0.0 110.633 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.9 143.86 92.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.113 3.209 . . . . 0.0 112.583 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -33.51 3.01 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.882 1.229 . . . . 0.0 113.183 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 tp -85.72 -46.66 10.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.545 1.538 . . . . 0.0 111.631 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -73.97 106.19 5.55 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -71.64 39.02 0.06 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.405 1.882 . . . . 0.0 114.893 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.55 125.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.3 m -137.43 156.68 47.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.245 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.7 mt -95.63 127.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.355 1.462 . . . . 0.0 109.152 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 C-N-CA 123.774 0.829 . . . . 0.0 109.703 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 122.526 1.155 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -102.07 -172.69 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.356 1.462 . . . . 0.0 111.869 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.28 149.76 10.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.054 1.342 . . . . 0.0 109.711 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.15 162.46 41.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.948 1.699 . . . . 0.0 110.816 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m -119.83 140.06 51.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 109.576 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 7.5 m-85 -140.71 143.68 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 111.601 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.21 131.07 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.944 0.898 . . . . 0.0 110.957 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.77 128.63 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.497 -168.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.67 116.65 29.15 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.406 -0.809 . . . . 0.0 108.967 164.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.24 -12.55 8.02 Favored Glycine 0 N--CA 1.466 0.692 0 C-N-CA 124.062 0.839 . . . . 0.0 113.236 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.468 ' HG3' ' H ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -63.86 146.35 54.15 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.1 0.95 . . . . 0.0 111.462 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -62.05 2.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.706 2.002 . . . . 0.0 115.737 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 12' ' ' MET . 99.2 m 64.63 26.92 13.25 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 166.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.38 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.638 2.775 . . . . 0.0 106.597 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m -52.76 -26.87 15.49 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.1 2.227 . . . . 0.0 115.456 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.1 -38.57 39.23 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 120.19 1.359 . . . . 0.0 112.288 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.636 HG22 HG11 ' A' ' 36' ' ' VAL . 28.5 t -53.83 -41.38 48.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 125.107 1.363 . . . . 0.0 113.653 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -62.6 -38.22 89.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.819 0.447 . . . . 0.0 111.572 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -68.21 -45.95 71.91 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.174 0.589 . . . . 0.0 111.947 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -44.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.348 -173.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.25 -49.17 70.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.905 1.282 . . . . 0.0 110.423 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.0 m -68.45 -44.17 75.44 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 m -70.66 -39.52 73.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.764 1.226 . . . . 0.0 111.253 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -51.48 16.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.436 -1.269 . . . . 0.0 110.565 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t -74.91 17.96 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.685 1.584 . . . . 0.0 113.394 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.86 -0.5 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.491 1.916 . . . . 0.0 112.178 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.61 135.43 42.02 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.675 -1.266 . . . . 0.0 111.103 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -47.85 -19.11 0.21 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.464 2.305 . . . . 0.0 116.355 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -7.96 11.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.231 1.813 . . . . 0.0 115.621 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.23 136.13 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 121.739 2.063 . . . . 0.0 111.938 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -89.95 -33.91 16.22 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -173.98 176.06 2.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.771 1.628 . . . . 0.0 112.394 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -172.77 154.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.324 2.25 . . . . 0.0 109.981 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.5 t -147.29 128.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.327 2.251 . . . . 0.0 108.045 166.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.636 HG11 HG22 ' A' ' 18' ' ' VAL . 77.0 t -102.31 135.94 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.682 1.23 . . . . 0.0 111.595 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -77.02 94.36 3.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.122 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 18' ' ' VAL . 25.9 tp -55.02 -38.42 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -51.78 -48.39 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.503 1.121 . . . . 0.0 111.104 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -96.99 -170.56 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 129.791 3.237 . . . . 0.0 113.487 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.11 34.94 3.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.217 1.407 . . . . 0.0 112.639 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 p -142.83 153.22 43.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.87 136.33 50.3 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.881 2.072 . . . . 0.0 110.812 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -106.9 116.87 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 57' ' ' LEU . 18.3 t -118.81 132.23 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 0.0 107.704 -169.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.98 101.45 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CD1' HD11 ' A' ' 57' ' ' LEU . 37.8 p90 -122.02 141.63 51.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -168.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 CA--C 1.541 0.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.796 178.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 CA--C 1.536 0.596 0 CA-C-O 119.278 -0.384 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -47.55 -26.63 1.49 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.731 1.612 . . . . 0.0 112.811 168.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -69.38 -42.45 75.13 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.046 -1.034 . . . . 0.0 112.722 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.6 mt -68.92 -43.54 74.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.852 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -50.4 -46.96 56.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.35 0.977 . . . . 0.0 111.094 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.88 64.0 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.94 90.92 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.574 1.988 . . . . 0.0 110.361 168.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.28 -56.48 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.745 -0.597 . . . . 0.0 110.917 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -56.96 -19.8 20.14 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.06 0.4 56.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -89.76 -32.89 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.838 0.855 . . . . 0.0 111.332 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.93 67.13 12.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.064 0.546 . . . . 0.0 111.373 169.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.74 139.02 88.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 124.219 3.279 . . . . 0.0 112.224 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.31 -33.85 3.14 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.973 1.273 . . . . 0.0 113.146 -173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -78.7 -46.94 17.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.896 0.848 . . . . 0.0 110.07 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.2 m-30 -84.54 122.84 29.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.892 1.677 . . . . 0.0 113.844 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.33 105.36 13.98 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.831 1.652 . . . . 0.0 108.408 169.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.86 135.1 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 120.889 1.677 . . . . 0.0 111.402 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.1 p -126.46 156.0 41.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.241 0.543 . . . . 0.0 111.795 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.4 mt -92.9 121.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.171 1.388 . . . . 0.0 109.264 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.154 0 C-N-CA 123.153 0.581 . . . . 0.0 110.088 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 121.753 0.787 . . . . 0.0 112.017 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 t -89.95 177.8 6.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.223 1.011 . . . . 0.0 111.832 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -161.19 147.62 14.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.796 1.238 . . . . 0.0 110.363 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.37 44.61 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.317 1.047 . . . . 0.0 111.978 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m -116.28 137.1 52.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 109.98 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -136.35 143.94 44.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.089 1.356 . . . . 0.0 110.311 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 tt -133.44 134.13 57.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 110.986 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.9 111.26 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -169.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.73 92.45 8.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.01 -34.2 0.61 Allowed Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.343 0.973 . . . . 0.0 114.159 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -58.71 126.94 29.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.268 0.627 . . . . 0.0 110.905 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.429 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 24.7 m-70 -61.54 41.26 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -169.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.0 m 70.44 -48.25 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 130.538 3.535 . . . . 0.0 114.908 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -128.29 -69.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.909 0.884 . . . . 0.0 110.852 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -57.38 -18.75 19.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 p -50.72 -50.54 55.1 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.652 1.115 . . . . 0.0 111.365 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 38' ' ' LEU . 2.1 t -55.65 -43.05 71.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 124.303 1.041 . . . . 0.0 111.775 -168.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -66.83 -34.74 78.48 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -65.62 -45.86 81.49 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.81 -1.181 . . . . 0.0 111.039 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -39.91 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -51.4 -51.58 53.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 109.831 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.0 m -70.37 -48.14 57.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -69.63 -37.74 76.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.371 1.068 . . . . 0.0 111.125 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -51.15 15.89 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.144 -1.408 . . . . 0.0 111.186 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.31 16.36 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.355 1.889 . . . . 0.0 113.739 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.35 -5.29 14.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.264 1.826 . . . . 0.0 112.227 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.57 133.9 44.95 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 120.549 -1.344 . . . . 0.0 109.967 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -66.3 0.02 2.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.59 -6.68 11.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.59 134.43 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 121.581 1.991 . . . . 0.0 111.258 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 m -91.41 -25.24 19.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.567 0.747 . . . . 0.0 112.942 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.14 175.26 1.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.813 1.645 . . . . 0.0 113.177 -170.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -166.51 152.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.036 2.134 . . . . 0.0 109.632 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.36 148.92 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.147 2.579 . . . . 0.0 105.946 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 18' ' ' VAL . 14.6 p -140.7 150.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 112.367 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -91.31 135.55 33.73 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.233 1.413 . . . . 0.0 111.682 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 18' ' ' VAL . 10.0 tp -104.06 -30.02 10.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.559 1.544 . . . . 0.0 112.607 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -32.38 68.61 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.864 2.065 . . . . 0.0 112.786 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -104.89 -174.5 2.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.074 2.15 . . . . 0.0 113.189 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.78 32.95 5.76 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.03 2.532 . . . . 0.0 110.7 -174.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 p -140.17 156.71 46.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.042 -1.661 . . . . 0.0 114.728 -167.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.46 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 110.692 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -115.67 116.87 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.437 ' CG1' HD13 ' A' ' 57' ' ' LEU . 24.1 t -117.37 130.63 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 108.563 -168.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.2 105.11 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 108.781 -168.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.606 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -124.92 150.06 46.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.359 0.664 . . . . 0.0 111.04 -173.812 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 CA-C-O 118.987 -0.505 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -52.95 -25.68 12.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.594 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.8 p -66.76 -44.25 81.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.678 1.191 . . . . 0.0 113.346 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.606 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.4 mt -71.03 -41.6 70.63 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.594 -0.692 . . . . 0.0 110.73 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.21 -48.65 45.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.405 1.082 . . . . 0.0 111.016 170.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.209 1.403 . . . . 0.0 114.554 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.56 76.25 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.012 1.278 . . . . 0.0 111.551 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.915 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -51.08 -34.45 30.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.667 0.667 . . . . 0.0 110.389 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.9 4.22 14.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.432 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -97.5 -30.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.952 0.901 . . . . 0.0 111.35 177.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.01 64.57 7.59 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 111.493 169.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.35 147.56 95.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.492 3.462 . . . . 0.0 113.211 -172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.53 -24.51 3.65 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.794 1.188 . . . . 0.0 114.185 -173.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.37 -36.01 8.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.161 1.384 . . . . 0.0 111.509 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.432 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -76.98 106.08 8.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -80.8 71.3 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.085 -1.634 . . . . 0.0 111.654 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.6 128.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.702 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -135.75 146.26 47.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.327 1.451 . . . . 0.0 109.298 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 94.2 mt -90.71 126.78 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.708 -1.245 . . . . 0.0 108.093 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 109.6 168.398 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 122.573 1.178 . . . . 0.0 113.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -80.32 177.29 9.07 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.947 0.879 . . . . 0.0 110.947 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -165.9 145.6 6.33 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.815 1.246 . . . . 0.0 110.23 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.92 166.1 31.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.593 1.557 . . . . 0.0 111.321 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.6 m -127.18 135.54 50.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.449 1.5 . . . . 0.0 110.923 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.81 149.18 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.99 141.93 42.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 111.008 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -124.62 108.21 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 123.833 0.708 . . . . 0.0 110.902 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.95 26.8 0.58 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.98 22.48 1.27 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.5 1.524 . . . . 0.0 113.482 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 1.3 tmt? -84.7 130.39 34.71 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 -169.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 4.6 m170 -71.45 12.14 0.38 Allowed 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 t 90.82 -145.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.354 2.661 . . . . 0.0 111.46 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HE3' HD13 ' A' ' 38' ' ' LEU . 14.1 mptt -58.75 -30.07 67.23 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.317 -1.49 . . . . 0.0 113.283 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -69.06 -34.42 75.14 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.136 -1.603 . . . . 0.0 112.725 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.2 m -70.34 -38.78 74.93 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 116.356 -1.783 . . . . 0.0 113.318 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 35.5 t -42.57 -53.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -58.87 -39.96 82.92 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.64 -39.94 88.48 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.722 -0.611 . . . . 0.0 111.986 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -42.58 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.419 0.554 . . . . 0.0 110.118 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.28 -48.49 71.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.384 1.074 . . . . 0.0 110.518 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 m -71.2 -46.71 60.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -71.12 -37.16 72.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 125.472 1.509 . . . . 0.0 111.5 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -74.73 -49.77 19.87 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.162 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -72.75 15.38 0.2 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 121.576 1.989 . . . . 0.0 113.427 -170.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.88 -2.38 16.1 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 112.511 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -76.09 137.07 39.91 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.757 -1.214 . . . . 0.0 111.127 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.29 31.08 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.767 2.027 . . . . 0.0 114.234 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.16 -3.0 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.12 2.568 . . . . 0.0 113.945 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.5 p -99.43 140.84 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.505 1.957 . . . . 0.0 108.852 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -112.74 -8.54 13.76 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -176.35 171.95 2.34 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.379 1.871 . . . . 0.0 113.505 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -175.13 154.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.904 2.482 . . . . 0.0 110.229 -171.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -147.67 126.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 127.596 2.358 . . . . 0.0 107.518 165.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 50.9 t -91.42 134.26 30.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.43 1.11 . . . . 0.0 109.865 168.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.9 m -69.83 89.93 0.59 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.483 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.563 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.9 tm? -45.49 -43.59 11.77 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.287 2.235 . . . . 0.0 112.011 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -53.06 57.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.669 1.188 . . . . 0.0 111.347 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.92 -174.73 4.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.395 2.278 . . . . 0.0 113.909 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.21 36.6 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.955 1.702 . . . . 0.0 113.296 169.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.01 154.9 43.75 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.047 -1.658 . . . . 0.0 114.137 -169.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.8 135.08 41.52 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.253 1.821 . . . . 0.0 110.35 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.48 119.23 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -125.81 139.9 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.696 1.198 . . . . 0.0 109.979 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.31 112.51 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.709 1.604 . . . . 0.0 109.063 -168.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CD1' HD11 ' A' ' 57' ' ' LEU . 39.5 p90 -131.29 148.4 52.68 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -168.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 CA--C 1.535 0.368 0 O-C-N 120.701 -1.249 . . . . 0.0 112.483 -167.092 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 CA-C-O 118.806 -0.581 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -51.16 -23.95 3.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.583 1.153 . . . . 0.0 111.789 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -68.2 -44.83 74.95 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.666 -1.271 . . . . 0.0 113.278 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.8 mt -70.67 -43.6 68.76 Favored 'General case' 0 C--O 1.226 -0.161 0 O-C-N 121.515 -0.741 . . . . 0.0 110.356 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -48.54 -51.92 25.22 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.503 1.121 . . . . 0.0 110.993 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.26 -30.71 71.61 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.8 -33.36 74.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.236 1.38 . . . . 0.0 112.051 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.28 -55.8 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.752 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.43 -37.34 11.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.861 0.755 . . . . 0.0 111.156 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.29 4.63 8.42 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.476 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -98.09 -33.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.622 1.569 . . . . 0.0 111.919 174.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.12 61.85 18.93 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 169.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.21 139.8 79.89 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.9 3.067 . . . . 0.0 112.835 -171.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.66 -21.41 14.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.193 1.378 . . . . 0.0 114.04 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.06 -45.82 5.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.423 1.889 . . . . 0.0 110.59 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' HG12 ' A' ' 64' ' ' VAL . 1.7 m-30 -64.99 100.98 0.46 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.066 1.346 . . . . 0.0 114.509 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -77.8 73.68 4.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.908 1.283 . . . . 0.0 111.321 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.04 132.92 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.755 0.788 . . . . 0.0 111.976 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.5 m -145.89 166.24 26.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.632 1.573 . . . . 0.0 110.858 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.6 mt -99.09 132.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.913 1.685 . . . . 0.0 108.059 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.304 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 123.968 1.842 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 t -100.69 -176.73 3.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.04 2.536 . . . . 0.0 110.969 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -163.06 148.57 11.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 110.112 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 162.89 40.79 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.243 1.417 . . . . 0.0 110.974 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.0 m -121.43 137.86 54.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.726 1.21 . . . . 0.0 109.622 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -137.51 147.08 44.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.235 1.414 . . . . 0.0 110.202 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 tt -132.52 137.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.696 1.198 . . . . 0.0 110.603 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.97 99.24 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.703 1.601 . . . . 0.0 111.255 -171.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.25 101.23 10.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.265 1.031 . . . . 0.0 110.609 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.98 -7.88 4.14 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.776 1.179 . . . . 0.0 114.855 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -64.71 143.36 57.98 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.892 1.346 . . . . 0.0 112.026 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -67.21 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 126.705 2.002 . . . . 0.0 114.89 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m 54.5 -131.61 1.96 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.962 2.105 . . . . 0.0 112.033 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.5 tptt -48.5 -32.87 8.53 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.565 1.946 . . . . 0.0 114.151 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 m -91.18 -29.27 17.34 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -37.92 89.23 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.971 1.26 . . . . 0.0 111.23 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 38' ' ' LEU . 49.1 t -37.73 -58.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.565 1.546 . . . . 0.0 112.277 169.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -55.28 -43.77 75.06 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 111.929 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -62.95 -42.64 99.88 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.571 -0.705 . . . . 0.0 112.602 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -44.18 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.807 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.71 -51.1 70.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.368 1.067 . . . . 0.0 110.064 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -35.94 79.27 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.9 m -75.81 -37.73 58.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.653 0.781 . . . . 0.0 110.383 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -50.36 17.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.903 175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -74.53 12.84 0.7 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.765 1.166 . . . . 0.0 112.765 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.47 -7.19 18.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.507 1.523 . . . . 0.0 111.942 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 mt -78.29 126.65 31.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.24 -11.81 7.3 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.47 -13.06 24.87 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 169.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.98 140.46 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 121.789 2.086 . . . . 0.0 108.866 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.1 t -96.52 -29.49 13.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.368 1.467 . . . . 0.0 111.666 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -176.07 174.6 2.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.684 1.594 . . . . 0.0 112.336 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -174.59 150.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.631 1.972 . . . . 0.0 110.521 -172.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.82 132.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 127.352 2.261 . . . . 0.0 108.053 167.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' CG1' HG13 ' A' ' 18' ' ' VAL . 38.9 t -107.12 143.32 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.078 0.951 . . . . 0.0 111.277 170.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 40' ' ' ASN . 9.5 t -74.79 108.31 7.45 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 165.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 18' ' ' VAL . 3.7 mt -47.3 -25.84 1.08 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.753 2.021 . . . . 0.0 114.459 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.34 -35.48 6.26 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.913 2.885 . . . . 0.0 114.243 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 24.6 m-80 -83.91 -175.15 5.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.718 0.407 . . . . 0.0 110.539 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER -112.97 39.31 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 175.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -141.44 155.7 45.85 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.461 -1.399 . . . . 0.0 113.046 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.55 50.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.737 2.015 . . . . 0.0 110.041 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -106.18 114.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.6 t -121.08 130.51 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.756 1.222 . . . . 0.0 108.487 -168.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.6 t -117.59 117.55 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.472 1.909 . . . . 0.0 107.434 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' A' ' 57' ' ' LEU . 19.8 p90 -139.21 155.21 47.96 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.613 1.551 . . . . 0.0 113.233 -168.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t30 . . . . . 0 CA--C 1.541 0.618 0 O-C-N 120.122 -1.611 . . . . 0.0 113.688 -167.531 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo . . . . . 0 CA--C 1.542 0.92 0 N-CA-C 114.82 1.046 . . . . 0.0 114.82 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.97 -35.85 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.206 1.002 . . . . 0.0 113.094 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.7 p -69.39 -41.48 76.39 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.318 -0.864 . . . . 0.0 113.243 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.1 mt -64.81 -49.0 72.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.88 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.27 -56.63 6.4 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.861 1.264 . . . . 0.0 110.36 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -51.7 -41.82 61.76 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.75 67.59 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.104 0.865 . . . . 0.0 112.954 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -69.95 -56.37 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.959 0.904 . . . . 0.0 109.65 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -50.66 -31.68 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.707 0.803 . . . . 0.0 111.812 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.16 28.88 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.505 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -97.64 -31.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.37 65.83 9.67 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.463 -0.773 . . . . 0.0 111.085 167.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.93 141.96 96.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.98 3.12 . . . . 0.0 112.112 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.71 -28.54 4.87 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.756 1.17 . . . . 0.0 113.454 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -92.12 -44.16 8.97 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 111.633 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.7 m-30 -72.67 99.73 2.64 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 78.14 0.64 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.332 -1.48 . . . . 0.0 109.326 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.95 135.37 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.464 1.125 . . . . 0.0 111.684 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.2 m -150.9 158.11 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.951 1.7 . . . . 0.0 111.238 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 126.17 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.896 1.679 . . . . 0.0 109.48 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 124.286 1.034 . . . . 0.0 111.559 -173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 122.337 1.065 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -95.24 176.61 6.15 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.92 1.688 . . . . 0.0 111.746 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -160.65 140.58 11.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.924 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.51 161.28 38.29 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.017 1.327 . . . . 0.0 109.911 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.4 m -123.32 136.21 54.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.75 0.82 . . . . 0.0 109.036 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.48 147.49 52.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.222 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -135.56 133.6 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.266 1.026 . . . . 0.0 110.847 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.66 116.0 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.969 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -81.12 5.31 17.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.39 22.22 1.07 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.02 1.771 . . . . 0.0 115.395 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.85 146.02 49.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.215 2.008 . . . . 0.0 112.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.433 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 3.0 m170 -74.0 23.3 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.714 1.606 . . . . 0.0 113.3 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t 76.51 -141.63 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.23 2.212 . . . . 0.0 111.182 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -55.94 -36.31 67.62 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.423 -1.423 . . . . 0.0 114.182 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -69.98 -34.17 73.02 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.257 -1.527 . . . . 0.0 112.074 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.0 OUTLIER -67.86 -42.38 81.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 116.068 -1.92 . . . . 0.0 112.587 173.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 36' ' ' VAL . 9.3 t -40.6 -55.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.96 1.255 . . . . 0.0 111.351 174.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.0 t -62.57 -37.68 87.13 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -62.75 -42.03 99.49 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.159 -0.963 . . . . 0.0 111.963 171.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.74 -42.68 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 118.919 0.781 . . . . 0.0 110.034 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -52.86 -53.29 51.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.997 0.919 . . . . 0.0 110.17 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 m -70.52 -44.79 66.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.8 m -70.07 -36.03 74.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.132 1.773 . . . . 0.0 110.846 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -50.45 18.19 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.871 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -68.12 12.53 0.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.466 1.485 . . . . 0.0 114.139 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.85 18.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.649 1.98 . . . . 0.0 111.809 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.08 129.75 34.7 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.854 -1.154 . . . . 0.0 110.127 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.93 -1.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.38 -8.08 11.09 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.22 135.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 121.772 2.078 . . . . 0.0 110.926 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 19.5 m -92.65 -25.02 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.265 1.426 . . . . 0.0 111.889 -173.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m 178.89 175.97 0.58 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.545 2.338 . . . . 0.0 112.726 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.8 tt -174.04 152.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 127.136 2.174 . . . . 0.0 109.49 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.07 131.71 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 126.087 1.755 . . . . 0.0 107.448 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 18' ' ' VAL . 13.7 t -94.47 135.52 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 123.073 1.416 . . . . 0.0 109.505 168.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 m -67.41 90.62 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.063 167.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.436 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -55.68 -31.45 62.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.577 1.151 . . . . 0.0 112.638 -171.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -59.77 4.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.982 0.81 . . . . 0.0 111.116 169.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -72.58 -176.36 1.91 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 125.356 2.503 . . . . 0.0 114.027 -171.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.554 2.342 . . . . 0.0 113.024 170.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.2 p -137.38 160.17 39.84 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.704 -1.872 . . . . 0.0 115.056 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.71 136.79 44.88 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.228 1.811 . . . . 0.0 110.683 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.1 112.68 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.47 ' CG1' HD13 ' A' ' 57' ' ' LEU . 20.9 t -116.66 130.5 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.474 1.509 . . . . 0.0 108.339 -168.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.69 114.51 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.247 1.419 . . . . 0.0 108.038 -168.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CD1' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -132.86 155.22 49.4 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 120.457 1.481 . . . . 0.0 113.373 -168.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 CA--C 1.543 0.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.362 -175.562 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 CA--C 1.538 0.68 0 N-CA-C 113.127 0.395 . . . . 0.0 113.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -18.32 3.9 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 m -82.58 -40.34 21.03 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 121.03 1.741 . . . . 0.0 112.702 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.0 mt -67.65 -45.52 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.219 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -48.38 -46.93 37.7 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.278 0.944 . . . . 0.0 110.643 170.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -35.49 79.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.438 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.07 71.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.789 1.631 . . . . 0.0 112.28 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -72.82 -57.77 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.992 0.917 . . . . 0.0 109.699 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -55.59 -16.23 3.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.931 1.293 . . . . 0.0 113.737 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.03 -0.42 57.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -90.87 -35.59 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.956 0.798 . . . . 0.0 111.457 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -141.22 63.32 17.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 169.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.35 143.52 86.02 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.364 3.376 . . . . 0.0 114.231 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.9 -31.35 2.81 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.28 1.419 . . . . 0.0 113.502 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.28 -40.99 11.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.881 1.673 . . . . 0.0 110.395 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.518 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -75.31 93.91 2.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.164 -0.96 . . . . 0.0 113.421 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -71.97 121.01 18.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 161.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.51 136.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 123.754 2.979 . . . . 0.0 111.832 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -134.91 156.57 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.135 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.38 130.3 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.144 1.378 . . . . 0.0 108.391 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 122.387 1.089 . . . . 0.0 111.456 174.045 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.821 0.819 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -87.84 173.8 8.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.096 0.951 . . . . 0.0 110.592 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -163.95 148.05 10.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.074 1.35 . . . . 0.0 110.051 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.66 159.82 37.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.484 1.513 . . . . 0.0 111.387 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -125.77 136.56 53.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.991 1.316 . . . . 0.0 110.148 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.39 145.77 49.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.925 1.29 . . . . 0.0 111.156 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tt -121.74 145.12 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.273 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.4 168.67 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 124.567 1.147 . . . . 0.0 107.943 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -152.82 125.44 8.28 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.036 -1.04 . . . . 0.0 109.145 168.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.81 -6.49 44.19 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.613 1.101 . . . . 0.0 113.292 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.35 141.31 47.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.488 1.515 . . . . 0.0 112.267 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -51.68 -46.21 63.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 p 160.81 -65.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.427 1.891 . . . . 0.0 113.848 -171.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 -57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.136 2.175 . . . . 0.0 109.217 -166.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -20.01 21.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.121 0.968 . . . . 0.0 113.448 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 p -56.28 -48.8 75.89 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.256 168.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.33 -49.88 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.0 111.153 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -65.61 -35.73 81.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.429 1.092 . . . . 0.0 112.929 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.26 -39.59 95.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.564 -1.335 . . . . 0.0 111.976 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -30.4 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.54 -175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -59.35 -56.68 18.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.511 0.725 . . . . 0.0 109.752 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t -70.19 -41.47 73.67 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.0 m -73.77 -34.81 64.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.595 1.158 . . . . 0.0 110.946 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -52.06 12.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.258 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 t -71.08 16.27 0.09 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.988 1.722 . . . . 0.0 113.773 -172.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.4 -5.01 15.96 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.744 2.018 . . . . 0.0 112.074 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 60' ' ' ALA . 16.7 mt -77.72 130.24 36.52 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 109.508 -172.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.03 -17.35 24.62 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.59 -8.17 29.56 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.78 140.78 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 122.105 2.23 . . . . 0.0 110.091 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -98.06 -24.29 15.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 111.878 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m 178.73 173.26 0.72 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.704 2.001 . . . . 0.0 113.246 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -168.25 153.19 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.917 2.087 . . . . 0.0 110.552 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 151.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.089 2.955 . . . . 0.0 106.131 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.27 151.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 122.035 0.922 . . . . 0.0 111.738 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -74.13 123.83 25.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.615 1.166 . . . . 0.0 109.174 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.49 -42.7 24.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.817 1.189 . . . . 0.0 112.089 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -61.2 -63.96 1.11 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.106 1.321 . . . . 0.0 109.614 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -85.4 168.49 14.56 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 122.878 1.323 . . . . 0.0 113.693 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.19 44.92 1.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -140.91 150.23 42.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 140.61 52.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.161 2.184 . . . . 0.0 111.174 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.06 115.87 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.29 136.48 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.893 1.277 . . . . 0.0 109.214 -166.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.24 113.67 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.233 1.413 . . . . 0.0 108.122 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.3 p90 -130.64 154.1 48.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.698 1.199 . . . . 0.0 113.857 -168.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 CA--C 1.535 0.397 0 O-C-N 121.028 -1.045 . . . . 0.0 110.595 -173.521 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 CA--C 1.534 0.511 0 N-CA-C 113.053 0.366 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.04 -8.97 53.6 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.514 1.052 . . . . 0.0 112.802 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -68.26 -49.59 59.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.767 1.167 . . . . 0.0 110.736 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 47' ' ' TYR . 78.6 mt -65.81 -43.78 87.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 117.445 -1.264 . . . . 0.0 111.04 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -47.39 -50.03 23.41 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.255 1.389 . . . . 0.0 112.788 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.07 87.68 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 174.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.457 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.83 -33.97 76.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.359 1.436 . . . . 0.0 112.341 173.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -69.77 -52.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.605 172.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -50.36 -35.86 29.87 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.264 0.938 . . . . 0.0 110.941 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.88 3.32 12.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -98.67 -29.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 111.786 177.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.01 66.98 9.86 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.912 0.885 . . . . 0.0 110.347 168.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.64 140.27 80.04 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.098 3.199 . . . . 0.0 111.872 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.62 -22.16 6.79 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.626 1.107 . . . . 0.0 113.666 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 tp -99.46 -29.26 12.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.297 1.439 . . . . 0.0 112.732 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -92.3 105.59 17.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 6.4 ttt180 -69.96 47.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.241 2.216 . . . . 0.0 115.046 171.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.8 121.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 120.325 -1.485 . . . . 0.0 113.588 -168.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -134.9 152.18 51.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.223 1.409 . . . . 0.0 110.747 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.3 mt -90.91 130.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.739 -1.225 . . . . 0.0 108.086 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.464 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 109.462 172.741 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 CA--C 1.54 0.581 0 CA-C-O 121.702 0.763 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -91.76 -179.16 5.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.393 1.477 . . . . 0.0 111.17 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -165.54 155.12 12.53 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 109.861 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.37 161.25 30.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.14 1.776 . . . . 0.0 111.436 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -122.44 141.58 51.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.546 1.539 . . . . 0.0 110.432 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -145.1 141.26 28.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.36 1.464 . . . . 0.0 111.171 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.68 134.39 62.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.957 1.303 . . . . 0.0 111.46 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.32 103.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.585 1.954 . . . . 0.0 111.908 -170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 127.62 32.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.529 -1.357 . . . . 0.0 110.315 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.57 39.38 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 121.69 -0.631 . . . . 0.0 111.952 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.4 ptm -59.38 142.0 53.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 167.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.29 11.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.826 1.65 . . . . 0.0 115.025 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 m 70.76 -23.08 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.437 2.295 . . . . 0.0 116.059 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -87.16 0.34 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.903 1.681 . . . . 0.0 106.692 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -23.38 30.8 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.034 -1.666 . . . . 0.0 114.699 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.55 -37.71 88.35 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 116.824 -1.56 . . . . 0.0 113.034 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.0 t -50.46 -46.44 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.089 1.356 . . . . 0.0 109.985 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -67.92 -37.81 82.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.596 1.558 . . . . 0.0 114.105 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.13 -39.23 94.09 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 120.796 -1.19 . . . . 0.0 110.95 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.67 -40.4 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.519 -176.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -52.37 -55.29 22.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.983 0.913 . . . . 0.0 110.262 168.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 t -70.56 -42.48 71.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -73.14 -36.35 66.65 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.84 1.256 . . . . 0.0 110.731 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -49.56 18.58 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.559 172.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 t -71.6 17.23 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.879 1.672 . . . . 0.0 113.722 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 -2.48 16.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.895 1.678 . . . . 0.0 112.545 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.5 135.83 38.28 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.779 -1.201 . . . . 0.0 111.309 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -54.71 -9.66 0.36 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -5.58 9.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.855 1.662 . . . . 0.0 115.075 176.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -91.91 138.23 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.65 2.023 . . . . 0.0 110.58 -170.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -94.82 -30.54 14.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.994 1.318 . . . . 0.0 111.345 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -174.57 174.54 2.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 123.36 1.552 . . . . 0.0 113.054 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 tt -165.93 151.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.244 2.217 . . . . 0.0 109.356 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.23 147.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.699 2.4 . . . . 0.0 106.286 167.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.79 152.71 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.086 0.555 . . . . 0.0 109.789 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.3 t -84.78 144.35 28.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.556 0.693 . . . . 0.0 111.743 171.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -20.86 23.73 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -60.39 1.98 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.416 1.087 . . . . 0.0 108.385 168.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -78.79 143.23 36.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.061 0.934 . . . . 0.0 110.967 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.34 42.61 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.086 0.955 . . . . 0.0 112.672 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 p -140.68 150.67 43.78 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.132 -1.605 . . . . 0.0 113.999 -172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.91 146.26 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.096 2.158 . . . . 0.0 110.584 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.26 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.5 t -119.03 133.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.867 1.267 . . . . 0.0 108.418 -167.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.1 t -120.73 109.79 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.786 1.634 . . . . 0.0 108.146 -167.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CD1' HD11 ' A' ' 57' ' ' LEU . 33.6 p90 -127.08 146.68 50.28 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.067 -1.021 . . . . 0.0 113.718 -168.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 CA--C 1.54 0.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.9 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 CA--C 1.535 0.553 0 CA-C-O 118.7 -0.625 . . . . 0.0 113.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -49.28 -40.64 35.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.242 1.017 . . . . 0.0 112.174 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 -38.2 67.59 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.938 -1.101 . . . . 0.0 112.416 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.3 mt -70.14 -44.94 67.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.106 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -54.18 11.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.661 1.184 . . . . 0.0 110.372 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -51.95 -43.37 63.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.87 68.05 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.975 1.261 . . . . 0.0 112.824 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.51 -54.79 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.923 0.889 . . . . 0.0 109.958 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -53.16 -28.97 28.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.827 0.851 . . . . 0.0 111.402 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.35 -2.81 43.28 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -87.8 -39.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 110.484 177.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -136.96 77.37 43.76 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 122.681 0.392 . . . . 0.0 110.496 164.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.04 116.31 3.05 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.429 2.753 . . . . 0.0 109.456 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.03 -21.88 41.71 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 117.116 -1.936 . . . . 0.0 115.402 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tp -95.24 -26.51 15.93 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 121.333 2.567 . . . . 0.0 112.673 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -91.66 105.36 17.68 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -166.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 66.68 1.31 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.214 1.406 . . . . 0.0 110.463 168.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.62 137.76 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.284 0.633 . . . . 0.0 111.737 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.17 133.83 13.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.35 1.06 . . . . 0.0 112.009 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.6 mt -73.75 122.79 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 121.113 -0.992 . . . . 0.0 108.39 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.139 0 C-N-CA 124.021 0.929 . . . . 0.0 110.228 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 123.021 1.391 . . . . 0.0 113.273 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 t -93.24 174.46 7.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -157.41 144.03 18.07 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.157 1.383 . . . . 0.0 110.034 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.96 159.78 43.52 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.624 1.57 . . . . 0.0 111.683 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m -120.61 139.84 52.4 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.551 1.541 . . . . 0.0 110.055 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -140.76 142.54 34.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.945 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -124.13 140.72 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.491 1.116 . . . . 0.0 110.064 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.78 148.42 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.219 1.808 . . . . 0.0 108.295 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.5 142.3 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 162.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.15 -16.01 55.94 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.042 0.83 . . . . 0.0 111.142 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptm -58.81 133.63 56.16 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 122.012 -0.699 . . . . 0.0 109.142 168.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -61.48 15.59 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 115.624 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 m 68.55 -15.43 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.268 2.227 . . . . 0.0 116.463 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -88.6 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 107.408 -169.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 p -55.09 -27.65 46.53 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.998 -1.689 . . . . 0.0 114.544 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' HA ' HD22 ' A' ' 20' ' ' ASN . 1.2 m -60.27 -38.2 82.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 120.881 1.673 . . . . 0.0 112.084 172.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.97 -48.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.533 1.533 . . . . 0.0 109.574 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -71.24 -29.9 65.67 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.532 HD22 ' HA ' ' A' ' 17' ' ' CYS . 76.2 m-20 -64.54 -40.38 95.49 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.293 -1.504 . . . . 0.0 110.681 167.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -38.93 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.06 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -52.85 -53.67 45.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 109.894 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 -46.33 63.54 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -170.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.0 m -69.27 -35.48 76.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.021 1.328 . . . . 0.0 111.183 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -50.6 14.04 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.399 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.3 t -72.69 11.21 0.68 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.432 1.469 . . . . 0.0 113.892 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.57 -7.92 19.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.477 1.511 . . . . 0.0 111.668 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.5 129.21 36.89 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.028 0.831 . . . . 0.0 109.451 -171.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -58.29 -20.65 44.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 -10.8 37.9 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -90.55 141.5 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 122.271 2.305 . . . . 0.0 109.936 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 t -97.6 -30.83 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.695 1.598 . . . . 0.0 111.33 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -175.51 172.85 2.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.29 1.436 . . . . 0.0 113.254 -169.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -168.57 150.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.564 1.946 . . . . 0.0 111.311 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.97 150.09 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 128.971 2.908 . . . . 0.0 106.345 167.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.29 147.65 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.083 0.468 . . . . 0.0 110.716 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -70.38 141.16 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.101 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.92 -23.77 14.84 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 111.836 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.09 -39.6 10.05 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 130.316 3.447 . . . . 0.0 112.981 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -97.62 -177.29 3.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.797 1.639 . . . . 0.0 110.913 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -112.33 44.39 1.45 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.965 1.306 . . . . 0.0 111.777 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -137.14 153.71 50.43 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.488 -1.383 . . . . 0.0 113.98 -169.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.52 140.08 52.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.111 1.764 . . . . 0.0 111.427 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -110.06 116.1 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 57' ' ' LEU . 16.6 t -122.93 132.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.939 1.295 . . . . 0.0 108.327 -167.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.56 112.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.628 1.971 . . . . 0.0 107.53 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.534 ' CD1' HD11 ' A' ' 57' ' ' LEU . 23.0 p90 -130.84 150.9 51.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.72 1.6 . . . . 0.0 113.478 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 . . . . . 0 CA--C 1.536 0.425 0 O-C-N 120.818 -1.176 . . . . 0.0 111.696 -171.386 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.536 0.579 0 N-CA-C 113.018 0.353 . . . . 0.0 113.018 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 62.1 mm-40 -60.18 -28.94 68.36 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -172.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.1 p -62.09 -40.33 95.47 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.063 -1.648 . . . . 0.0 112.708 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 47' ' ' TYR . 49.6 mt -70.13 -46.35 64.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 0.0 111.298 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -49.24 -55.48 12.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.515 1.126 . . . . 0.0 111.753 173.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.76 -30.67 69.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.571 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.62 80.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.243 1.383 . . . . 0.0 111.817 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mt -61.78 -53.77 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.136 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -54.07 -25.71 23.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.38 0.672 . . . . 0.0 112.717 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.79 2.27 49.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -92.88 -30.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.941 0.896 . . . . 0.0 111.434 175.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.08 68.53 9.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.701 0.8 . . . . 0.0 111.16 169.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.78 136.43 70.23 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.103 3.202 . . . . 0.0 111.807 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.74 -24.17 6.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.678 1.133 . . . . 0.0 113.585 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.01 -35.93 15.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.867 1.267 . . . . 0.0 111.06 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -88.27 108.89 19.54 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 32.58 0.09 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 128.634 2.774 . . . . 0.0 115.695 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.34 130.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -166.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.6 m -145.0 148.55 33.86 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.476 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 98.6 mt -83.44 122.85 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.73 1.212 . . . . 0.0 108.499 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.522 -0.108 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.475 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 122.853 1.311 . . . . 0.0 113.512 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -122.29 -174.48 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.331 2.252 . . . . 0.0 110.473 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.32 147.37 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.663 -1.273 . . . . 0.0 109.918 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.97 158.89 44.62 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.993 1.317 . . . . 0.0 111.273 169.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.1 m -120.34 137.29 54.36 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.753 1.221 . . . . 0.0 110.46 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.04 149.13 47.24 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.912 0.885 . . . . 0.0 112.909 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tt -137.56 136.61 46.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 124.343 1.057 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.87 108.34 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.284 1.434 . . . . 0.0 112.288 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 87.86 7.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.822 0.82 . . . . 0.0 108.8 168.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.14 -23.83 0.28 Allowed Glycine 0 N--CA 1.48 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 114.837 -168.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -79.82 138.82 37.32 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.175 0.987 . . . . 0.0 113.192 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -65.68 27.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.229 2.212 . . . . 0.0 114.368 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.7 m 52.15 -115.5 0.92 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.046 2.138 . . . . 0.0 111.419 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 40.3 mttp -67.01 -17.46 64.93 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -165.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.9 p -88.4 -43.41 11.51 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.003 1.274 . . . . 0.0 110.446 166.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.84 -43.1 76.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 116.838 -1.553 . . . . 0.0 112.049 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG13 ' CG1' ' A' ' 36' ' ' VAL . 4.6 t -37.78 -56.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.273 1.829 . . . . 0.0 111.567 171.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 t -65.65 -39.36 91.32 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.569 0.748 . . . . 0.0 111.661 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -60.52 -40.02 89.96 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -42.79 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 118.74 -0.648 . . . . 0.0 109.743 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -54.81 -51.32 66.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.951 0.9 . . . . 0.0 110.876 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -70.37 -41.41 73.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.7 m -70.69 -40.03 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.318 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -45.46 44.2 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.669 -1.158 . . . . 0.0 111.518 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 t -71.01 11.3 0.42 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.836 1.653 . . . . 0.0 113.819 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.87 -6.37 22.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.326 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.7 mt -77.08 125.42 29.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.196 -0.94 . . . . 0.0 108.669 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.78 -15.13 52.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -12.56 33.98 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -87.2 135.93 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.68 2.036 . . . . 0.0 109.975 -170.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 t -103.45 -15.01 16.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m 178.75 173.64 0.7 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.141 2.576 . . . . 0.0 112.333 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -173.19 152.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 127.509 2.323 . . . . 0.0 108.962 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -145.15 129.22 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.129 2.172 . . . . 0.0 107.838 166.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.4 t -94.5 139.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 123.006 1.384 . . . . 0.0 111.346 169.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -74.32 85.11 1.94 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.748 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 1.5 tt -49.81 -38.44 34.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.244 2.218 . . . . 0.0 114.36 -168.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -60.25 4.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.473 1.13 . . . . 0.0 110.264 170.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -79.83 -176.92 5.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.389 2.676 . . . . 0.0 116.072 -168.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 33.54 3.65 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.075 -2.33 . . . . 0.0 110.774 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 p -144.4 160.84 40.39 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.94 37.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.776 1.63 . . . . 0.0 111.217 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -106.25 112.54 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.457 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.0 t -113.05 133.31 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.364 1.466 . . . . 0.0 107.625 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.28 95.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.89 1.276 . . . . 0.0 108.506 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD1' HD11 ' A' ' 57' ' ' LEU . 26.7 p90 -114.34 145.63 41.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 . . . . . 0 CA--C 1.535 0.391 0 O-C-N 121.223 -0.923 . . . . 0.0 111.354 -177.772 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.46 -0.485 0 CA-C-O 119.053 -0.478 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.15 -27.03 63.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.123 0.874 . . . . 0.0 112.789 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m -70.25 -35.06 73.55 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.36 1.891 . . . . 0.0 112.049 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.2 mt -70.12 -44.7 68.41 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.52 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -53.06 -44.3 67.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.672 0.789 . . . . 0.0 111.278 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.59 98.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.169 1.788 . . . . 0.0 113.961 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.21 71.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 120.081 1.31 . . . . 0.0 112.031 173.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.6 -56.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.787 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -46.46 -35.99 6.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.357 1.063 . . . . 0.0 111.605 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 1.23 27.18 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -96.28 -29.3 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.709 1.204 . . . . 0.0 112.229 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -148.39 59.3 4.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 121.202 -0.937 . . . . 0.0 112.277 169.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.43 140.01 92.22 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.662 2.908 . . . . 0.0 111.192 -175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.33 -54.53 0.64 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.794 1.188 . . . . 0.0 110.756 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 mt -75.55 -46.06 34.3 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.386 1.093 . . . . 0.0 112.038 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -67.86 88.18 0.25 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 69.49 2.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.486 1.515 . . . . 0.0 109.105 168.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.17 138.7 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 122.768 1.271 . . . . 0.0 110.951 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 m -143.07 168.73 19.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.356 1.463 . . . . 0.0 110.24 174.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.75 131.47 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.557 1.543 . . . . 0.0 108.524 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 124.357 1.063 . . . . 0.0 112.009 -169.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 122.396 1.093 . . . . 0.0 113.055 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 t -129.56 170.73 13.38 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.726 1.61 . . . . 0.0 108.267 167.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.86 163.98 39.5 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.959 -1.088 . . . . 0.0 111.699 -173.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.74 160.4 37.84 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.737 1.215 . . . . 0.0 111.859 169.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 m -123.77 136.73 54.59 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.215 1.406 . . . . 0.0 110.737 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.52 145.52 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.012 1.325 . . . . 0.0 111.032 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 tt -134.06 130.85 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.685 1.194 . . . . 0.0 110.64 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.91 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.967 1.307 . . . . 0.0 109.047 -169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -71.86 1.04 7.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.25 35.85 1.79 Allowed Glycine 0 C--O 1.222 -0.628 0 C-N-CA 125.976 1.751 . . . . 0.0 111.141 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ttm -90.86 148.34 22.56 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.915 0.886 . . . . 0.0 111.115 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.5 m170 -73.72 3.41 6.48 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.372 0.669 . . . . 0.0 111.599 167.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.2 m 61.54 -112.78 0.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.564 2.346 . . . . 0.0 112.16 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -48.66 -51.58 27.64 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -166.094 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 m -80.01 -22.58 42.29 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.838 -1.789 . . . . 0.0 113.936 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 13' ' ' HIS . 1.3 m -63.64 -39.79 95.25 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-O 116.497 -1.716 . . . . 0.0 111.516 171.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 38' ' ' LEU . 23.5 t -47.9 -51.49 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.638 1.563 . . . . 0.0 112.788 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.5 t -55.07 -43.55 73.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.292 0.637 . . . . 0.0 111.981 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -63.2 -39.38 94.48 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -45.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.133 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.62 -48.44 63.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.41 1.084 . . . . 0.0 109.858 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -70.05 -42.18 73.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -74.64 -38.28 62.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 111.192 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.06 -45.66 56.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 116.58 -1.676 . . . . 0.0 112.604 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 t -69.42 14.33 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 121.885 2.129 . . . . 0.0 114.543 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.21 -5.33 15.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.892 1.677 . . . . 0.0 112.655 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.67 137.95 41.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.202 0.91 . . . . 0.0 111.475 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -73.66 55.39 0.51 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.473 1.909 . . . . 0.0 112.622 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 p90 174.09 -22.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.882 2.873 . . . . 0.0 113.894 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.8 p -86.66 142.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 120.826 1.648 . . . . 0.0 109.256 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -108.05 -19.66 13.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.697 0.799 . . . . 0.0 112.573 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -175.43 174.28 2.34 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.435 1.894 . . . . 0.0 112.277 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 tt -174.86 151.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.938 2.095 . . . . 0.0 110.209 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.08 131.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.345 2.258 . . . . 0.0 107.732 166.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 18' ' ' VAL . 68.3 t -104.08 137.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 123.53 1.633 . . . . 0.0 111.638 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m -79.37 81.36 5.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.261 1.424 . . . . 0.0 111.087 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 18' ' ' VAL . 17.0 tp -50.85 -43.68 59.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -168.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.18 -42.15 60.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.994 0.918 . . . . 0.0 111.978 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -103.42 -170.82 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.138 3.775 . . . . 0.0 111.729 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.61 31.33 6.05 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.894 1.678 . . . . 0.0 114.579 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 p -135.2 157.68 46.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.63 138.6 51.32 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.851 1.661 . . . . 0.0 110.525 -175.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.68 121.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -125.06 125.18 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.081 1.352 . . . . 0.0 109.192 -166.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 78.9 t -111.98 109.52 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 109.933 -168.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.462 ' CD1' HD11 ' A' ' 57' ' ' LEU . 50.0 p90 -124.33 166.98 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 113.207 -171.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 CA--C 1.541 0.623 0 O-C-N 121.318 -0.864 . . . . 0.0 112.142 -169.039 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo . . . . . 0 CA--C 1.54 0.802 0 N-CA-C 114.788 1.034 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.25 -25.09 67.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.182 0.901 . . . . 0.0 112.906 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -69.56 -38.68 77.54 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.026 -1.046 . . . . 0.0 113.161 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.5 mt -67.69 -44.53 77.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.27 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -47.11 -54.89 9.44 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.322 1.049 . . . . 0.0 110.222 169.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -53.8 -41.62 67.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -30.62 69.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.017 0.826 . . . . 0.0 111.81 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.7 mt -68.1 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.752 0.821 . . . . 0.0 109.685 169.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.419 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -49.91 -33.43 17.37 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.704 0.683 . . . . 0.0 111.911 175.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.13 -0.4 24.77 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -99.58 -27.12 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.672 1.589 . . . . 0.0 111.689 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.55 64.06 8.29 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.387 -0.821 . . . . 0.0 111.098 168.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.5 144.93 95.39 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.364 3.376 . . . . 0.0 112.973 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.56 -28.8 3.39 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.17 1.367 . . . . 0.0 113.581 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -97.45 -43.76 7.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.158 1.783 . . . . 0.0 111.048 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.4 m-30 -68.88 99.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.05 80.26 4.49 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.823 -1.173 . . . . 0.0 109.142 169.105 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.25 132.46 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.65 -0.656 . . . . 0.0 111.27 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 134.2 30.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.519 1.128 . . . . 0.0 109.188 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.29 122.01 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.451 -1.406 . . . . 0.0 108.003 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 122.569 1.176 . . . . 0.0 110.383 176.802 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 t -95.73 176.65 6.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 111.684 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.54 149.41 9.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.409 1.484 . . . . 0.0 109.407 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.67 157.28 37.89 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 110.479 169.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 m -119.28 135.93 54.48 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.782 0.833 . . . . 0.0 109.759 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.86 145.44 51.21 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.527 1.531 . . . . 0.0 110.868 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.09 139.26 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 125.13 1.372 . . . . 0.0 111.153 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.1 97.59 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.462 1.905 . . . . 0.0 109.91 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.9 78.25 9.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 123.355 1.55 . . . . 0.0 111.622 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.05 12.28 0.15 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 113.203 -1.817 . . . . 0.0 116.305 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 151.47 45.61 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.917 2.358 . . . . 0.0 113.123 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -70.58 36.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.225 -1.547 . . . . 0.0 114.118 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.9 m 64.29 -142.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.251 -1.531 . . . . 0.0 111.087 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' A' ' 38' ' ' LEU . 13.8 mptt -56.76 -37.18 70.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.919 0.888 . . . . 0.0 113.158 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -66.08 -45.56 80.83 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.151 -0.968 . . . . 0.0 112.578 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.45 ' HA ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -60.9 -50.42 73.48 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.962 172.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -44.85 -46.82 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.508 1.923 . . . . 0.0 112.154 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -66.56 -42.46 87.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 17' ' ' CYS . 83.4 m-20 -54.94 -35.85 64.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.503 -1.373 . . . . 0.0 113.144 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -70.15 -39.34 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.482 -174.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -62.38 -49.15 76.68 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -65.53 -42.29 92.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 m -69.54 -40.95 76.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.994 1.318 . . . . 0.0 110.966 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -45.92 48.95 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.813 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -74.09 11.61 0.88 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.961 1.255 . . . . 0.0 113.389 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.51 -5.0 17.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.675 1.59 . . . . 0.0 112.009 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.8 mt -75.69 129.62 37.41 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.01 -1.056 . . . . 0.0 110.097 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -53.21 -22.65 7.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.69 1.196 . . . . 0.0 114.157 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 -8.94 29.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.37 139.86 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 121.862 2.119 . . . . 0.0 109.624 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -109.37 -12.96 14.68 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -178.05 173.13 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.544 2.338 . . . . 0.0 111.322 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -178.59 152.66 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 109.835 -171.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 t -147.33 132.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 128.18 2.592 . . . . 0.0 107.755 167.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -101.64 149.34 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.468 1.128 . . . . 0.0 112.115 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 m -70.73 111.85 6.51 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.518 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.4 tm? -61.64 -45.43 94.09 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.047 1.294 . . . . 0.0 110.348 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.13 -56.38 11.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.735 0.814 . . . . 0.0 112.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -93.2 -179.98 5.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -166.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 16.36 3.45 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 p -139.4 155.62 47.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -166.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.4 131.55 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.762 2.425 . . . . 0.0 110.708 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -101.21 110.01 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.555 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -115.19 133.78 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.598 1.559 . . . . 0.0 108.024 -169.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.62 108.18 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.538 1.535 . . . . 0.0 108.128 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.7 p90 -127.27 154.45 44.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.532 0.273 0 O-C-N 121.462 -0.774 . . . . 0.0 110.223 -173.806 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 CA--C 1.537 0.661 0 N-CA-C 113.259 0.446 . . . . 0.0 113.259 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.68 -20.74 63.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.306 1.442 . . . . 0.0 113.087 -172.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.6 p -69.14 -44.33 72.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.54 -1.35 . . . . 0.0 112.697 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 ' CG1' ' A' ' 45' ' ' VAL . 51.0 mt -63.89 -46.89 82.86 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.109 0.564 . . . . 0.0 109.869 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -48.94 -52.75 22.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.082 0.953 . . . . 0.0 110.8 170.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -54.93 -38.2 67.39 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.64 80.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.253 0.933 . . . . 0.0 111.15 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.4 mt -66.94 -52.54 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.844 -0.535 . . . . 0.0 109.794 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.94 -22.21 24.96 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.014 -1.054 . . . . 0.0 112.676 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.55 -1.3 57.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.282 1.401 . . . . 0.0 114.76 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -95.37 -27.42 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.584 1.153 . . . . 0.0 111.046 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.72 71.08 7.33 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.556 1.142 . . . . 0.0 111.459 168.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.9 145.95 97.02 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.664 3.576 . . . . 0.0 113.839 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.33 -40.21 2.36 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.937 1.732 . . . . 0.0 113.085 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.89 -55.29 6.84 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.263 1.425 . . . . 0.0 111.156 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.4 m-30 -69.01 110.42 4.45 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.985 1.314 . . . . 0.0 114.425 -169.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.21 57.02 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.398 -1.439 . . . . 0.0 113.279 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.0 118.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 122.319 1.057 . . . . 0.0 113.023 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -135.21 147.71 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.093 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.47 120.94 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.607 1.163 . . . . 0.0 109.672 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.9 p . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 125.817 1.647 . . . . 0.0 110.477 -179.234 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 CA--C 1.55 0.957 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -116.52 -178.94 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.168 1.787 . . . . 0.0 111.146 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -157.36 148.46 21.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.27 1.428 . . . . 0.0 110.289 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.18 43.85 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.015 1.326 . . . . 0.0 111.783 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.5 m -121.32 140.18 52.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.991 1.317 . . . . 0.0 109.958 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -139.22 145.9 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.403 1.481 . . . . 0.0 111.068 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.3 tt -131.0 134.43 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.461 1.504 . . . . 0.0 111.072 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 100.15 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.465 1.106 . . . . 0.0 109.813 -169.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.403 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 23.7 t0 -78.2 41.06 0.36 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.481 1.512 . . . . 0.0 112.709 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.83 23.92 0.08 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.208 1.385 . . . . 0.0 113.764 -171.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.4 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 4.9 ttt -95.81 135.12 37.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.416 1.886 . . . . 0.0 112.064 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -60.48 21.75 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m 71.1 -62.31 0.46 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.248 2.619 . . . . 0.0 114.086 171.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HE3' HD22 ' A' ' 38' ' ' LEU . 13.3 mptt -122.82 -53.94 1.85 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.516 1.126 . . . . 0.0 113.626 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 p -65.74 -22.3 66.59 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.481 -2.012 . . . . 0.0 113.199 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p -45.41 -56.82 4.58 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.596 1.158 . . . . 0.0 110.041 168.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 38' ' ' LEU . 73.6 t -47.23 -53.65 3.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 127.9 2.48 . . . . 0.0 111.076 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.3 t -64.84 -25.41 67.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.64 -53.27 12.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.2 0.909 . . . . 0.0 110.257 167.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -44.96 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.58 -0.7 . . . . 0.0 110.562 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.3 -21.62 62.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 0.0 112.873 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.7 t -91.77 -58.94 2.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.574 1.15 . . . . 0.0 113.759 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.0 m -54.95 -39.61 69.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.329 2.252 . . . . 0.0 112.491 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 -49.79 20.64 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.603 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -70.69 14.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.252 1.387 . . . . 0.0 113.856 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.59 -7.01 18.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.041 1.736 . . . . 0.0 111.766 173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.407 HD11 ' CB ' ' A' ' 60' ' ' ALA . 17.5 mt -76.64 129.72 36.79 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 -172.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.47 -17.34 59.32 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -171.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 -11.52 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 169.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.9 p -94.11 135.91 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 122.172 2.26 . . . . 0.0 110.395 -170.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -107.49 -12.78 15.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.664 0.786 . . . . 0.0 113.094 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -179.81 174.38 0.93 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.219 2.608 . . . . 0.0 112.552 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 tt -172.42 153.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.038 2.535 . . . . 0.0 109.59 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 t -147.0 131.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.258 2.223 . . . . 0.0 107.99 167.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.29 137.29 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.487 1.613 . . . . 0.0 112.425 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 m -88.33 86.21 7.02 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.582 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.479 HD22 ' HE3' ' A' ' 15' ' ' LYS . 7.2 mt -47.94 -36.75 12.96 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.89 2.876 . . . . 0.0 115.286 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.23 -4.96 58.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.868 1.318 . . . . 0.0 113.792 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -116.36 -168.02 1.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.185 2.594 . . . . 0.0 108.769 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.46 43.41 2.97 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.91 -1.744 . . . . 0.0 110.056 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -134.47 151.58 51.24 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.083 -1.011 . . . . 0.0 112.959 -172.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.38 140.45 52.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.601 1.96 . . . . 0.0 109.347 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.7 mt -111.2 116.7 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -117.98 129.63 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.773 1.629 . . . . 0.0 107.447 -169.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 102.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 108.962 -168.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.514 ' CD1' HD11 ' A' ' 57' ' ' LEU . 29.3 p90 -120.92 141.0 51.05 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.532 1.133 . . . . 0.0 113.945 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 CA--C 1.535 0.396 0 O-C-N 120.685 -1.259 . . . . 0.0 110.786 -172.571 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 CA--C 1.534 0.484 0 CA-C-O 118.755 -0.602 . . . . 0.0 113.182 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -32.53 55.91 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.365 0.984 . . . . 0.0 112.47 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 m -88.77 -23.7 22.82 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.964 -169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 47' ' ' TYR . 74.8 mt -68.11 -42.24 80.54 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.27 169.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -47.11 -55.64 7.99 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.611 0.764 . . . . 0.0 109.521 168.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -47.57 -48.22 28.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.355 1.062 . . . . 0.0 113.823 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.53 -27.95 69.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.118 0.872 . . . . 0.0 112.959 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.17 -49.7 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.124 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -51.3 -34.3 32.61 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 123.443 0.697 . . . . 0.0 110.284 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.38 5.75 14.08 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.86 -27.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.875 0.87 . . . . 0.0 111.699 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.54 65.5 8.54 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.088 168.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.5 146.27 97.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.341 3.361 . . . . 0.0 113.356 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.21 -29.44 2.81 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.852 1.215 . . . . 0.0 113.383 -174.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -94.79 -45.1 7.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.969 1.708 . . . . 0.0 110.791 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -71.8 106.96 4.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' CB ' ' HB3' ' A' ' 10' ' ' ASP . 77.9 mtt180 -80.96 78.24 7.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.154 0.982 . . . . 0.0 111.393 169.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -85.8 125.0 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.876 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 137.3 41.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 108.793 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.87 127.5 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 0.0 108.829 172.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 123.174 1.464 . . . . 0.0 113.987 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -140.2 175.28 9.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.627 3.171 . . . . 0.0 107.734 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -159.56 156.8 28.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.658 -1.276 . . . . 0.0 111.146 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.05 163.44 40.28 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 125.486 1.514 . . . . 0.0 111.316 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.3 m -125.54 139.58 53.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.197 1.399 . . . . 0.0 110.109 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -139.21 140.78 37.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.056 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.35 141.43 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.525 1.13 . . . . 0.0 109.347 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.05 165.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 125.179 1.392 . . . . 0.0 107.628 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -147.39 137.75 23.26 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.327 1.051 . . . . 0.0 108.313 167.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.17 69.96 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.244 0.925 . . . . 0.0 112.681 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 161.47 10.1 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.327 2.251 . . . . 0.0 114.437 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -68.98 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 126.155 1.782 . . . . 0.0 115.275 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 52.89 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 130.573 3.549 . . . . 0.0 119.279 167.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -49.77 1.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.601 1.56 . . . . 0.0 109.428 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -55.95 -27.1 50.9 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.359 -1.463 . . . . 0.0 113.048 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.5 p -49.69 -49.33 48.09 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 119.504 1.047 . . . . 0.0 111.645 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG11 ' A' ' 36' ' ' VAL . 37.8 t -52.91 -46.7 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.084 2.154 . . . . 0.0 111.967 -172.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -62.61 -42.79 99.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.134 0.574 . . . . 0.0 111.23 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -63.33 -43.06 98.84 Favored 'General case' 0 C--O 1.222 -0.37 0 O-C-N 121.968 -0.458 . . . . 0.0 111.792 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.21 -45.32 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.428 0.558 . . . . 0.0 109.53 -172.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.41 -50.67 59.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.306 1.442 . . . . 0.0 110.783 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -76.2 -31.58 58.52 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -79.71 -41.25 27.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.34 1.456 . . . . 0.0 110.289 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -44.62 50.12 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 116.861 -1.542 . . . . 0.0 111.272 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -73.31 17.28 0.14 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 121.148 1.795 . . . . 0.0 113.165 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.6 -3.11 15.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.709 1.604 . . . . 0.0 113.007 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 mt -75.27 134.87 41.0 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.82 -1.175 . . . . 0.0 111.964 -169.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.63 63.14 1.53 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.688 1.195 . . . . 0.0 112.059 -176.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.0 p90 168.38 -21.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 130.394 3.478 . . . . 0.0 114.531 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.09 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.54 1.518 . . . . 0.0 109.422 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -115.48 -11.39 11.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -169.97 173.16 6.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.941 1.353 . . . . 0.0 112.634 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -155.73 157.39 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 109.972 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -144.7 124.48 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 126.765 2.026 . . . . 0.0 107.124 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.541 HG11 HG13 ' A' ' 18' ' ' VAL . 56.0 t -94.19 134.26 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.732 1.253 . . . . 0.0 110.146 169.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 m -67.59 90.26 0.26 Allowed 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.148 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.04 -38.21 50.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.748 1.158 . . . . 0.0 112.332 -168.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -66.31 0.56 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.451 0.569 . . . . 0.0 110.643 170.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.22 165.18 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.318 1.532 . . . . 0.0 112.19 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 40.4 0.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.319 -1.488 . . . . 0.0 113.174 168.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 p -133.91 158.62 43.0 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 140.42 51.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.123 2.169 . . . . 0.0 110.984 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.73 118.31 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 57' ' ' LEU . 17.8 t -121.45 131.92 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.537 1.135 . . . . 0.0 108.22 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 t -118.32 120.9 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.331 1.453 . . . . 0.0 108.713 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.527 ' CD1' HD11 ' A' ' 57' ' ' LEU . 48.4 p90 -135.99 160.82 37.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 -170.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 CA--C 1.543 0.682 0 O-C-N 120.927 -1.108 . . . . 0.0 112.417 -169.026 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.537 0.64 0 N-CA-C 115.185 1.187 . . . . 0.0 115.185 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 p -66.58 -40.5 88.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.996 1.725 . . . . 0.0 112.917 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.5 mt -69.2 -43.61 73.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.19 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -52.01 -48.24 64.59 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.768 0.713 . . . . 0.0 109.913 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -60.93 -31.54 71.06 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.58 84.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.966 1.257 . . . . 0.0 111.891 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.86 -53.28 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.743 -0.598 . . . . 0.0 110.209 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -57.02 -21.13 28.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 112.102 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.39 1.99 55.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -93.47 -30.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.732 0.813 . . . . 0.0 111.258 175.44 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -148.55 69.49 10.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.536 0.734 . . . . 0.0 111.053 168.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.47 142.49 98.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.622 3.548 . . . . 0.0 112.574 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.87 -27.61 2.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.07 1.319 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 tp -88.62 -45.04 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.368 1.467 . . . . 0.0 111.514 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -78.67 102.5 8.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.817 1.247 . . . . 0.0 114.203 -168.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 9.4 ttt180 -70.3 44.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.62 130.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 122.588 1.185 . . . . 0.0 113.244 -166.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -136.7 148.33 47.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.491 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.88 126.45 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.79 -1.194 . . . . 0.0 108.271 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.089 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.984 0.897 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 t -115.55 -177.99 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 108.486 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -160.69 148.88 16.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.966 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.92 159.51 43.79 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.039 1.336 . . . . 0.0 110.958 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 m -117.85 134.54 54.83 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.46 1.504 . . . . 0.0 109.569 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -130.65 148.19 52.41 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.009 1.324 . . . . 0.0 111.054 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.6 tt -131.28 137.9 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.12 1.368 . . . . 0.0 110.4 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.69 110.9 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.769 1.628 . . . . 0.0 109.592 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.9 119.17 26.83 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 168.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.76 8.25 30.42 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.155 0.883 . . . . 0.0 113.413 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 138.23 58.28 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.491 -1.005 . . . . 0.0 110.76 171.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -55.32 -32.19 62.29 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p 144.71 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 131.642 3.977 . . . . 0.0 108.352 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -19.79 -61.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 129.597 3.159 . . . . 0.0 114.439 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -57.19 -11.24 1.56 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.48 -45.03 85.32 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.689 1.586 . . . . 0.0 109.693 168.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.0 t -55.5 -47.28 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 125.297 1.439 . . . . 0.0 111.995 -169.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.2 t -58.01 -38.6 76.49 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.156 0.979 . . . . 0.0 111.834 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -72.86 -40.02 66.01 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.166 -0.959 . . . . 0.0 113.035 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.663 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -46.51 -55.49 7.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.287 1.835 . . . . 0.0 109.484 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.4 m -70.32 -44.96 67.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -71.79 -38.55 70.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.451 1.101 . . . . 0.0 110.834 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -49.44 18.63 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.161 -1.4 . . . . 0.0 111.393 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -72.25 12.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.006 1.73 . . . . 0.0 113.184 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.16 -6.16 24.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.615 1.566 . . . . 0.0 111.703 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.6 127.27 32.69 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.31 -19.31 13.78 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -8.97 33.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.23 140.03 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 121.88 2.127 . . . . 0.0 109.554 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 t -111.39 -8.25 14.32 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.96 171.7 3.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.479 1.512 . . . . 0.0 113.237 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.68 150.04 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.402 1.481 . . . . 0.0 112.358 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.62 146.51 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 127.685 2.394 . . . . 0.0 105.867 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 18' ' ' VAL . 9.2 p -138.16 149.26 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.973 0.892 . . . . 0.0 111.11 177.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -101.49 96.11 6.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.38 -30.75 71.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.715 1.606 . . . . 0.0 115.208 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.25 1.84 49.36 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.507 1.146 . . . . 0.0 113.308 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -126.55 -170.55 2.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.669 2.788 . . . . 0.0 109.813 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 34.39 5.22 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.333 1.853 . . . . 0.0 112.205 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -141.29 154.78 45.91 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.89 143.38 51.11 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.614 2.366 . . . . 0.0 111.264 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -112.36 116.19 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.59 129.43 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -168.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 114.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.437 1.495 . . . . 0.0 107.044 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.486 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -136.45 151.02 49.02 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.374 1.069 . . . . 0.0 111.932 -168.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 CA--C 1.544 0.723 0 O-C-N 120.653 -1.28 . . . . 0.0 111.728 -175.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.542 0.895 0 N-CA-C 114.616 0.968 . . . . 0.0 114.616 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.126 0.875 . . . . 0.0 112.165 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -81.25 -18.1 47.17 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.126 -168.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.486 HD11 ' CD1' ' A' ' 47' ' ' TYR . 53.8 mt -70.19 -46.32 64.82 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.477 169.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -49.24 -52.64 25.86 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.537 1.062 . . . . 0.0 109.351 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.98 -41.82 71.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.26 69.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.826 1.194 . . . . 0.0 112.592 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.9 mt -72.7 -52.96 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.431 0.692 . . . . 0.0 109.954 170.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.13 -25.96 25.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.645 0.778 . . . . 0.0 112.518 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -0.89 37.83 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.06 -30.17 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.414 1.086 . . . . 0.0 111.297 179.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.79 66.48 10.66 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 121.605 -0.684 . . . . 0.0 111.479 168.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.58 142.21 98.48 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.525 3.483 . . . . 0.0 112.949 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.02 -30.18 2.99 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.286 1.422 . . . . 0.0 113.673 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.93 -39.49 10.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 112.01 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -79.76 107.2 12.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 113.424 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -83.9 78.06 9.8 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.707 -1.246 . . . . 0.0 111.217 171.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 135.09 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.843 0.83 . . . . 0.0 111.079 -173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 m -152.1 165.41 34.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.464 1.105 . . . . 0.0 111.312 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.7 mt -93.4 133.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.538 1.135 . . . . 0.0 109.112 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.141 0 C-N-CA 123.777 0.831 . . . . 0.0 109.851 -174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 N--CA 1.446 -0.626 0 CA-C-O 122.901 1.334 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 t -141.29 -175.76 4.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.439 2.696 . . . . 0.0 109.082 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 m -166.54 141.84 4.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.003 -1.061 . . . . 0.0 110.515 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.58 32.59 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.064 1.346 . . . . 0.0 110.676 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.2 m -130.2 138.63 50.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.863 1.265 . . . . 0.0 109.807 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -139.57 151.73 46.3 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.612 0.765 . . . . 0.0 112.259 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.9 tt -141.89 129.65 21.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 124.048 0.939 . . . . 0.0 112.077 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.75 114.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 126.485 1.914 . . . . 0.0 110.61 -168.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 1.46 17.15 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.69 4.15 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.027 1.775 . . . . 0.0 116.822 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -71.55 141.72 50.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.89 2.345 . . . . 0.0 113.477 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -68.49 32.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 127.483 2.313 . . . . 0.0 114.96 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t 54.71 -131.78 1.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.181 1.393 . . . . 0.0 111.158 171.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.565 ' HE2' HD13 ' A' ' 38' ' ' LEU . 74.6 mttt -54.58 -25.24 25.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -168.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -82.49 -46.17 13.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.975 1.261 . . . . 0.0 111.851 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.1 m -57.99 -40.85 81.7 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 117.123 -1.417 . . . . 0.0 111.387 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 36' ' ' VAL . 22.0 t -39.82 -56.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.022 1.729 . . . . 0.0 111.287 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -59.04 -43.1 91.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.856 . . . . 0.0 112.24 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -62.84 -40.73 98.34 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.752 -0.593 . . . . 0.0 112.461 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -49.39 76.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.11 -50.54 61.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.679 1.192 . . . . 0.0 110.673 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 t -68.76 -32.64 72.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.0 m -77.34 -48.7 16.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.642 0.734 . . . . 0.0 109.936 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' HG11 ' A' ' 31' ' ' VAL . 1.1 mm? -76.7 -20.05 57.02 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.168 1.387 . . . . 0.0 114.227 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.2 t -85.5 1.29 49.51 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.606 1.548 . . . . 0.0 112.969 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.36 1.75 11.83 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.606 -1.309 . . . . 0.0 114.187 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.89 152.05 42.89 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.4 -0.812 . . . . 0.0 112.568 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.72 47.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.919 2.087 . . . . 0.0 112.604 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.185 3.394 . . . . 0.0 114.095 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.4 p -94.23 142.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 122.402 2.365 . . . . 0.0 112.135 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 m -107.48 -18.59 13.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.507 1.523 . . . . 0.0 113.928 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 m -178.65 171.07 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.747 2.019 . . . . 0.0 111.854 -171.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -167.2 161.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.211 2.604 . . . . 0.0 109.701 -175.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 t -152.09 128.31 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 127.991 2.516 . . . . 0.0 107.718 165.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.438 ' CG1' HG13 ' A' ' 18' ' ' VAL . 37.9 t -96.24 142.79 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 123.39 1.566 . . . . 0.0 112.207 170.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 m -74.41 86.77 2.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.007 1.323 . . . . 0.0 110.284 170.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.565 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.1 tm? -44.0 -43.46 6.69 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.301 3.04 . . . . 0.0 113.096 -175.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.94 -9.4 58.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.084 1.354 . . . . 0.0 114.623 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.61 -170.01 2.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.377 2.671 . . . . 0.0 110.243 -167.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.64 33.87 5.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.319 1.848 . . . . 0.0 112.623 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -140.66 159.18 42.76 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.53 142.87 41.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.88 1.672 . . . . 0.0 111.129 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.8 121.19 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 57' ' ' LEU . 19.2 t -121.46 128.61 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.513 1.525 . . . . 0.0 107.729 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 103.12 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.648 1.579 . . . . 0.0 109.184 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CD1' HD11 ' A' ' 57' ' ' LEU . 46.2 p90 -119.31 156.51 29.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.49 1.116 . . . . 0.0 112.977 -170.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 124.429 1.092 . . . . 0.0 110.885 -172.739 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 CA--C 1.539 0.735 0 CA-C-O 119.129 -0.446 . . . . 0.0 113.062 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -32.35 17.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.415 1.086 . . . . 0.0 112.339 170.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 m -72.88 -35.0 67.05 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.849 1.204 . . . . 0.0 111.791 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.54 HD11 ' CD1' ' A' ' 47' ' ' TYR . 73.7 mt -70.8 -43.47 68.58 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.925 -0.559 . . . . 0.0 109.736 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -52.71 -42.02 64.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.654 0.782 . . . . 0.0 110.84 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -39.79 95.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 169.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.97 69.53 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 121.104 1.775 . . . . 0.0 112.172 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.86 -58.77 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.587 0.755 . . . . 0.0 111.338 170.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -54.99 -18.59 5.26 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.836 1.254 . . . . 0.0 113.431 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.07 57.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -90.82 -29.71 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.282 1.033 . . . . 0.0 111.28 177.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.471 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.04 65.18 7.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 121.594 -0.691 . . . . 0.0 111.683 168.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.82 149.08 62.58 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.068 3.179 . . . . 0.0 112.586 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.14 -44.28 3.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.665 1.126 . . . . 0.0 112.513 -173.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 tp -77.05 -44.79 29.42 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.167 1.387 . . . . 0.0 110.717 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.482 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -81.36 94.75 6.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.458 1.123 . . . . 0.0 113.243 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' C ' ' HD2' ' A' ' 70' ' ' ARG 0.255 0.0 OUTLIER -77.8 110.51 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 164.274 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.17 146.93 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 124.371 3.259 . . . . 0.0 111.887 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -131.67 158.12 41.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.481 1.512 . . . . 0.0 110.029 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.6 mt -94.73 124.62 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 122.189 0.995 . . . . 0.0 109.593 174.549 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 123.273 1.511 . . . . 0.0 113.515 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -102.49 -177.52 3.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.741 2.017 . . . . 0.0 111.332 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.39 166.93 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.893 -1.129 . . . . 0.0 111.505 172.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.4 152.22 30.81 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.707 1.203 . . . . 0.0 111.223 169.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.0 m -114.7 139.07 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.697 1.599 . . . . 0.0 109.716 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -140.24 143.17 35.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.28 -176.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.8 132.45 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.295 1.038 . . . . 0.0 110.662 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.72 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.443 1.497 . . . . 0.0 110.072 -169.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.12 50.73 0.92 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.058 -1.026 . . . . 0.0 112.922 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 -8.27 0.02 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.008 1.766 . . . . 0.0 117.409 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -72.71 144.24 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.909 2.354 . . . . 0.0 111.723 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -64.52 5.48 0.28 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.24 1.816 . . . . 0.0 115.845 -176.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.55 -35.87 0.28 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.884 2.873 . . . . 0.0 115.52 171.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -103.1 -87.44 0.42 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.303 1.411 . . . . 0.0 110.602 172.515 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p -63.62 -13.04 38.47 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 119.152 -2.218 . . . . 0.0 115.256 -175.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.91 -39.79 94.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 121.213 1.824 . . . . 0.0 110.813 167.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -50.31 -47.28 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.084 2.154 . . . . 0.0 111.381 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.5 t -69.63 -37.58 76.87 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.689 -1.257 . . . . 0.0 111.881 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -49.68 80.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.058 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -51.28 -51.34 55.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.363 170.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -70.15 -31.14 68.5 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -176.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -78.14 -51.31 10.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.876 0.871 . . . . 0.0 109.134 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 61' ' ' ILE . 8.2 mt -77.12 -19.68 56.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.5 t -87.66 14.82 7.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 121.282 1.856 . . . . 0.0 112.697 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.56 4.13 9.59 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 18.1 mt -77.2 154.35 33.18 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.04 -1.038 . . . . 0.0 112.472 -171.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -64.58 13.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.535 2.734 . . . . 0.0 114.71 -174.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.2 3.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.295 2.238 . . . . 0.0 113.89 -169.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.3 p -104.64 133.14 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.966 1.712 . . . . 0.0 110.543 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -105.9 -12.41 15.85 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -177.57 174.22 1.56 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.146 1.778 . . . . 0.0 112.78 -176.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -167.33 153.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.249 2.22 . . . . 0.0 110.806 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.21 143.42 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.959 2.503 . . . . 0.0 106.581 166.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.85 148.85 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 40' ' ' ASN . 31.8 p -77.97 136.55 38.0 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 176.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.526 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -92.35 -15.88 26.72 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 112.873 169.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.49 -57.6 3.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.975 1.71 . . . . 0.0 110.63 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 37' ' ' SER . 39.4 m-80 -89.32 -179.11 5.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 113.202 -172.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 37.96 1.98 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.217 1.807 . . . . 0.0 113.965 177.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -141.96 147.19 36.58 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.635 -1.915 . . . . 0.0 115.255 -170.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.56 143.19 50.36 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.484 -174.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -117.64 117.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG1' HD13 ' A' ' 57' ' ' LEU . 36.9 t -122.88 119.67 58.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.914 1.286 . . . . 0.0 109.625 -165.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.6 t -103.95 108.95 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 109.425 -169.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CD1' HD11 ' A' ' 57' ' ' LEU . 31.6 p90 -122.86 144.68 49.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.896 1.278 . . . . 0.0 113.186 -171.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 CA--C 1.537 0.472 0 O-C-N 120.495 -1.378 . . . . 0.0 111.935 -171.939 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.537 0.664 0 CA-C-O 118.951 -0.52 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -50.29 -40.94 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.04 0.936 . . . . 0.0 112.418 171.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -70.77 -32.78 70.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.384 -1.447 . . . . 0.0 112.731 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.3 mt -73.96 -45.44 50.24 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.42 175.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -48.92 -51.63 29.02 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.386 1.474 . . . . 0.0 109.821 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -55.46 -43.25 75.3 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.932 1.293 . . . . 0.0 113.413 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.34 74.95 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.419 0.554 . . . . 0.0 112.332 173.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.559 HG12 HD11 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -70.32 -54.54 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.793 -0.567 . . . . 0.0 111.595 172.549 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.54 -27.85 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.528 1.131 . . . . 0.0 111.425 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.15 1.36 48.3 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -95.3 -29.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.15 0.98 . . . . 0.0 111.477 177.149 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.03 66.73 8.83 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.664 -0.647 . . . . 0.0 111.453 168.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.55 141.15 97.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.014 3.143 . . . . 0.0 112.592 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.38 -40.99 3.05 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.109 1.338 . . . . 0.0 112.815 -174.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.09 -42.98 45.58 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.544 1.137 . . . . 0.0 111.52 172.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.458 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.9 m-30 -78.45 97.71 5.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -78.94 79.61 5.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.273 168.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 t -88.05 121.79 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.181 0.592 . . . . 0.0 111.896 -172.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.73 133.01 52.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.571 1.148 . . . . 0.0 110.931 -174.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mt -86.32 84.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.408 0.623 . . . . 0.0 109.789 -178.775 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p30 . . . . . 0 CA--C 1.545 0.771 0 CA-C-O 121.661 0.743 . . . . 0.0 111.916 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -117.0 178.81 4.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.478 1.511 . . . . 0.0 110.872 170.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 m -156.38 146.48 21.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 125.636 1.574 . . . . 0.0 109.112 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.33 159.29 43.49 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.815 171.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.3 m -114.17 132.44 56.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.87 1.268 . . . . 0.0 109.986 174.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.94 146.07 50.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.775 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -131.85 134.78 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.817 1.247 . . . . 0.0 110.621 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.98 100.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.643 1.577 . . . . 0.0 109.015 -169.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.22 3.53 10.56 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.59 10.53 8.55 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 125.887 1.708 . . . . 0.0 113.357 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.4 tmm? -70.59 138.19 50.66 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.289 1.036 . . . . 0.0 110.2 -175.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.79 -6.89 1.96 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 174.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 t 81.74 -43.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.586 2.355 . . . . 0.0 110.601 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -122.95 149.4 44.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.764 1.226 . . . . 0.0 109.397 169.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m 69.77 -44.53 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.328 1.851 . . . . 0.0 113.261 -168.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.6 m -51.53 -47.87 63.2 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 121.096 1.771 . . . . 0.0 110.563 174.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 36' ' ' VAL . 40.2 t -29.9 -58.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 127.257 2.223 . . . . 0.0 113.844 168.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -70.5 -34.78 72.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 117.839 0.29 . . . . 0.0 111.4 -169.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -58.85 -43.82 90.87 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.545 -0.722 . . . . 0.0 112.104 168.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -41.37 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.43 -172.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.73 -50.62 69.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.815 0.846 . . . . 0.0 110.292 169.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -67.81 -45.71 73.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -175.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 m -66.85 -40.27 87.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.554 1.542 . . . . 0.0 110.576 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -47.02 42.86 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.838 176.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -68.77 6.32 0.89 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.244 1.384 . . . . 0.0 113.733 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.98 -5.46 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.512 176.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.7 mt -77.24 127.72 33.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.197 -0.939 . . . . 0.0 109.843 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -54.25 -21.93 10.41 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.68 -16.54 24.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 175.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.272 4.1 p -82.83 138.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.658 1.572 . . . . 0.0 110.031 -168.369 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -99.67 -31.25 11.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.951 1.701 . . . . 0.0 110.668 -174.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -166.49 174.76 8.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.596 1.189 . . . . 0.0 112.875 173.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 150.73 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.011 1.324 . . . . 0.0 111.601 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.73 134.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.293 1.837 . . . . 0.0 107.24 166.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 18' ' ' VAL . 28.0 t -101.31 134.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.171 0.986 . . . . 0.0 109.776 168.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -68.59 92.26 0.45 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.808 169.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -47.9 -43.05 28.44 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.989 1.715 . . . . 0.0 111.305 -177.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.52 -51.87 67.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.553 1.141 . . . . 0.0 112.031 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.69 -176.19 5.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 124.893 2.282 . . . . 0.0 113.814 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 30.2 4.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.482 2.313 . . . . 0.0 112.133 169.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 150.87 41.93 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.182 -1.574 . . . . 0.0 114.744 -167.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.8 136.45 51.49 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.592 1.957 . . . . 0.0 110.517 -171.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.23 111.37 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG1' HD13 ' A' ' 57' ' ' LEU . 11.7 t -117.5 130.79 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.2 1.4 . . . . 0.0 108.792 -169.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.65 112.78 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.195 1.398 . . . . 0.0 107.481 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 2.0 p90 -131.84 134.81 46.17 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.897 1.226 . . . . 0.0 112.303 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 . . . . . 0 CA--C 1.538 0.498 0 O-C-N 121.471 -0.768 . . . . 0.0 110.547 179.824 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 CA--C 1.535 0.573 0 CA-C-O 119.32 -0.367 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -52.81 -24.79 9.65 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 112.502 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -42.6 79.99 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.704 -1.248 . . . . 0.0 112.233 177.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.507 HD13 ' CG1' ' A' ' 45' ' ' VAL . 94.7 mt -70.47 -45.5 65.59 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.801 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -46.06 -52.25 12.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.984 0.914 . . . . 0.0 110.345 170.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -32.83 74.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 177.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.297 1.408 . . . . 0.0 111.537 170.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.53 -52.85 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.876 0.47 . . . . 0.0 110.684 171.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.07 -27.75 14.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.237 0.926 . . . . 0.0 112.0 174.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.57 4.15 33.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.32 -28.04 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.926 0.89 . . . . 0.0 111.544 173.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.36 67.81 9.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.506 -0.746 . . . . 0.0 111.068 168.599 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.9 139.87 87.31 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.054 3.169 . . . . 0.0 111.868 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.82 -23.06 7.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.571 1.081 . . . . 0.0 114.073 -175.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 -45.16 7.37 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.376 1.471 . . . . 0.0 111.492 173.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.6 m-30 -76.95 102.07 6.24 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -168.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.622 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -75.86 75.99 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 110.267 168.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.91 129.65 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 122.227 1.013 . . . . 0.0 111.744 -176.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -138.66 159.72 41.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.613 1.565 . . . . 0.0 109.992 178.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.3 mt -95.69 129.61 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.584 0.707 . . . . 0.0 109.955 -179.195 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 122.994 1.378 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -120.13 168.89 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.297 2.239 . . . . 0.0 107.972 167.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m -152.89 147.89 26.51 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.196 -0.94 . . . . 0.0 110.601 -175.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.52 161.32 42.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.558 1.143 . . . . 0.0 112.162 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.1 m -121.47 137.73 54.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.101 1.36 . . . . 0.0 110.257 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -136.9 143.16 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.779 1.231 . . . . 0.0 110.31 -178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 tt -132.07 131.67 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 111.052 -175.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.63 102.36 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.329 1.852 . . . . 0.0 108.768 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -76.52 33.07 0.13 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.052 -1.655 . . . . 0.0 114.143 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.97 -0.71 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.424 1.488 . . . . 0.0 116.263 -176.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.8 ptm -69.94 141.02 53.12 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.466 2.133 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -59.19 12.09 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 127.235 2.214 . . . . 0.0 116.17 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.4 m 73.12 -42.64 0.54 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.275 2.63 . . . . 0.0 115.768 167.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.11 -89.64 0.47 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.046 1.338 . . . . 0.0 109.129 174.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 p -55.57 -22.77 23.49 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 121.679 2.036 . . . . 0.0 115.601 -173.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -57.87 -42.75 85.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 112.527 169.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' CG1' ' A' ' 36' ' ' VAL . 37.6 t -46.43 -54.59 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.038 1.735 . . . . 0.0 110.814 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 t -60.01 -37.95 81.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.2 0.6 . . . . 0.0 111.605 -176.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -65.7 -42.76 90.79 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.36 -0.829 . . . . 0.0 112.375 174.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -44.48 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.095 0.861 . . . . 0.0 110.055 -175.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.76 -55.61 21.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.404 1.082 . . . . 0.0 110.37 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.4 t -64.1 -49.36 72.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.5 m -69.95 -36.25 75.14 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.98 1.312 . . . . 0.0 111.16 -172.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.98 -47.97 40.65 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.746 168.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -65.81 7.68 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 121.288 1.858 . . . . 0.0 115.283 -171.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.51 -3.32 18.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.824 2.05 . . . . 0.0 112.199 176.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.5 136.84 46.01 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.99 -1.069 . . . . 0.0 110.996 -171.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -75.63 65.65 1.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.786 1.634 . . . . 0.0 111.274 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 p90 167.25 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 129.961 3.304 . . . . 0.0 113.041 -173.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.2 p -86.03 142.63 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 121.184 1.811 . . . . 0.0 110.186 -175.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.06 -21.79 12.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -170.54 172.01 6.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.073 1.749 . . . . 0.0 112.369 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -176.25 153.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 127.804 2.442 . . . . 0.0 109.593 -169.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -147.11 132.6 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.588 2.355 . . . . 0.0 107.743 166.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.2 t -103.09 142.14 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.458 0.647 . . . . 0.0 110.825 169.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -73.28 108.79 6.36 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 122.81 1.29 . . . . 0.0 109.126 166.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -20.24 44.68 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.341 -0.849 . . . . 0.0 112.139 168.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -91.9 -45.6 8.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.539 1.063 . . . . 0.0 112.57 175.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -99.6 157.56 16.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.828 1.251 . . . . 0.0 112.178 -171.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.81 35.01 0.23 Allowed 'General case' 0 CA--C 1.548 0.872 0 O-C-N 119.732 -1.855 . . . . 0.0 113.946 -177.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -140.49 154.55 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 119.914 -1.741 . . . . 0.0 115.431 -170.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.56 139.19 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.187 2.195 . . . . 0.0 109.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -110.26 118.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 169.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.411 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -121.65 138.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.899 1.28 . . . . 0.0 110.125 -167.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.14 99.4 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.238 1.415 . . . . 0.0 109.925 -167.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -118.13 143.01 46.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.537 1.535 . . . . 0.0 113.539 -168.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 CA--C 1.536 0.413 0 O-C-N 120.565 -1.334 . . . . 0.0 111.583 -169.385 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.533 0.448 0 CA-C-O 119.44 -0.317 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.46 -16.96 41.53 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.155 0.982 . . . . 0.0 112.608 174.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -68.06 -47.07 69.34 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.957 -1.089 . . . . 0.0 112.802 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.7 mt -66.6 -42.88 86.22 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.608 -0.683 . . . . 0.0 110.435 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.68 -52.5 18.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.207 1.403 . . . . 0.0 111.785 171.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -32.52 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.14 83.97 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.984 1.265 . . . . 0.0 111.8 172.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.02 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.432 -0.793 . . . . 0.0 110.762 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.19 -20.67 18.96 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.71 1.19 55.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -93.96 -28.79 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.282 0.946 . . . . 0.0 111.252 176.352 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -151.15 67.79 7.75 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.764 0.826 . . . . 0.0 112.161 169.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.45 145.41 88.45 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.269 3.313 . . . . 0.0 113.062 -178.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.96 -40.98 2.93 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.416 1.484 . . . . 0.0 112.929 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -77.01 -45.81 26.01 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.046 1.338 . . . . 0.0 111.698 173.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 3.2 m-30 -72.28 96.97 1.91 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.25 1.5 . . . . 0.0 114.11 -168.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -72.85 65.02 0.7 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.715 2.006 . . . . 0.0 113.594 170.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.97 136.78 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.77 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 p -151.79 156.95 41.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.845 1.258 . . . . 0.0 110.57 174.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.65 129.61 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.166 0.986 . . . . 0.0 109.71 174.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 109.097 -179.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -100.65 -175.88 3.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.821 1.648 . . . . 0.0 110.141 168.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -162.77 150.79 13.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.044 1.338 . . . . 0.0 109.62 -172.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.4 159.93 39.17 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.678 1.591 . . . . 0.0 111.321 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -121.87 139.22 53.9 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 109.947 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -140.5 139.48 35.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.185 -176.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.12 130.75 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.05 1.34 . . . . 0.0 111.122 -175.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.42 103.46 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.978 1.711 . . . . 0.0 109.524 -168.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.44 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -72.08 0.19 10.17 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.357 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 10.47 5.75 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 125.784 1.659 . . . . 0.0 114.36 -173.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -66.59 135.92 54.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.304 1.042 . . . . 0.0 111.231 -174.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -62.56 0.25 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m 76.34 -40.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.965 2.506 . . . . 0.0 114.623 167.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HE3' HD13 ' A' ' 38' ' ' LEU . 12.3 mptt -111.55 -75.79 0.61 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.11 0.868 . . . . 0.0 109.507 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -32.32 69.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.552 -1.968 . . . . 0.0 114.045 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.25 -41.73 80.17 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.69 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 36' ' ' VAL . 76.7 t -47.13 -49.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.887 2.075 . . . . 0.0 112.242 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -61.62 -40.07 93.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.395 0.678 . . . . 0.0 112.348 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -63.8 -46.95 82.87 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 122.06 -0.4 . . . . 0.0 111.743 171.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.23 -50.98 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -171.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.06 -44.47 67.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.33 1.852 . . . . 0.0 109.899 175.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -70.49 -44.59 67.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 m -70.76 -40.3 72.76 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.95 1.3 . . . . 0.0 110.853 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -49.55 25.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 116.845 -1.55 . . . . 0.0 111.199 175.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.96 16.74 0.11 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.472 1.942 . . . . 0.0 113.534 -174.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.92 -3.45 14.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.224 1.81 . . . . 0.0 112.423 174.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.85 139.86 47.23 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.86 -1.15 . . . . 0.0 111.634 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.88 -15.2 7.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.817 1.647 . . . . 0.0 115.004 -170.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.79 -6.47 11.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.367 1.867 . . . . 0.0 114.95 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -88.82 137.32 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.923 1.692 . . . . 0.0 111.271 -168.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.23 -26.19 14.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.266 1.027 . . . . 0.0 111.506 -173.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -177.8 173.55 1.57 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.06 2.144 . . . . 0.0 111.636 -171.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -177.32 155.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.622 2.369 . . . . 0.0 108.624 -172.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -149.58 135.38 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 127.48 2.312 . . . . 0.0 108.645 166.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 18' ' ' VAL . 41.2 t -106.19 141.44 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.072 0.949 . . . . 0.0 110.75 169.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -79.16 112.76 16.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 123.153 1.454 . . . . 0.0 110.259 168.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.549 HD13 ' HE3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.59 -22.06 31.17 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 120.692 -1.255 . . . . 0.0 112.664 167.886 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 -69.04 0.73 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.519 1.528 . . . . 0.0 111.057 169.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -73.52 137.23 44.28 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.855 1.262 . . . . 0.0 111.278 -171.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -130.86 154.73 47.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.247 2.219 . . . . 0.0 113.691 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.26 143.97 44.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.259 2.223 . . . . 0.0 109.296 172.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.74 118.84 59.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.4 t -119.99 135.52 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.329 1.452 . . . . 0.0 108.881 -168.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.73 96.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.21 1.404 . . . . 0.0 108.52 -168.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.6 p90 -118.63 140.07 50.5 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.729 1.212 . . . . 0.0 113.55 -168.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 CA--C 1.539 0.542 0 O-C-N 121.077 -1.014 . . . . 0.0 111.629 -178.385 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 N-CA-C 112.329 0.088 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.83 -13.65 62.12 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -37.32 81.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.301 1.864 . . . . 0.0 111.44 170.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 47' ' ' TYR . 70.7 mt -70.03 -46.14 65.68 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.182 173.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -49.01 -52.42 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 111.072 174.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -56.5 -37.71 70.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.286 1.434 . . . . 0.0 114.749 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.77 95.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.733 1.606 . . . . 0.0 111.474 171.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mt -63.06 -56.18 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.667 174.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -53.18 -24.68 11.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.936 0.894 . . . . 0.0 113.002 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 0.01 55.94 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -95.39 -30.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 177.696 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.01 67.48 9.18 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.39 0.676 . . . . 0.0 111.145 169.651 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 143.71 99.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.13 3.22 . . . . 0.0 112.081 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.71 -39.18 2.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.863 1.22 . . . . 0.0 113.093 -174.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.2 tp -78.21 -41.95 32.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.81 1.244 . . . . 0.0 111.529 174.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.45 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.8 m-30 -83.16 94.51 7.87 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -168.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -73.36 66.14 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.189 1.796 . . . . 0.0 111.146 169.213 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.19 131.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 121.747 0.784 . . . . 0.0 110.756 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -138.0 147.62 44.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 0.0 109.017 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.48 130.33 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 119.894 -1.754 . . . . 0.0 109.916 174.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 C-N-CA 123.447 0.699 . . . . 0.0 110.184 178.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 122.834 1.302 . . . . 0.0 113.861 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -103.49 175.11 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.291 1.436 . . . . 0.0 110.794 176.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -163.99 147.53 9.8 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.862 -1.149 . . . . 0.0 110.384 -169.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.28 161.98 41.4 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.198 1.399 . . . . 0.0 111.321 170.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.5 m -123.93 139.77 53.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.837 1.255 . . . . 0.0 110.218 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -140.79 136.99 33.02 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.722 1.209 . . . . 0.0 110.024 -174.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tt -119.44 132.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 120.82 -1.175 . . . . 0.0 110.424 177.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.0 106.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.16 1.384 . . . . 0.0 108.676 -175.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.45 98.91 11.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.764 1.269 . . . . 0.0 109.678 169.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.55 -13.42 1.38 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.672 1.606 . . . . 0.0 114.057 177.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.401 ' SD ' ' SG ' ' A' ' 17' ' ' CYS 0.257 0.0 OUTLIER -77.07 132.65 39.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.85 1.325 . . . . 0.0 112.187 -176.779 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -67.94 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 t 66.61 -53.9 0.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.197 2.599 . . . . 0.0 116.23 169.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -63.34 1.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.67 -1.269 . . . . 0.0 112.931 -178.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -59.07 -32.69 70.01 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 121.424 1.92 . . . . 0.0 114.221 -177.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 12' ' ' MET . 2.3 p -40.6 -58.17 1.67 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.217 1.807 . . . . 0.0 111.376 169.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -46.24 -54.19 2.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 127.541 2.336 . . . . 0.0 111.007 -176.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -64.02 -30.23 71.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -69.93 -46.91 64.32 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.89 0.768 . . . . 0.0 111.353 168.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -46.46 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.255 0.934 . . . . 0.0 110.645 -170.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -51.43 -48.86 62.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.113 1.365 . . . . 0.0 110.786 170.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -68.75 -52.19 33.16 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.9 m -69.32 -35.87 76.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.531 1.532 . . . . 0.0 110.567 -169.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -73.24 -48.94 30.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.057 168.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 t -70.96 13.65 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.739 2.063 . . . . 0.0 114.421 -171.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.94 16.25 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.886 2.074 . . . . 0.0 111.398 173.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.99 125.86 29.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.11 -15.13 43.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.15 -11.57 35.25 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 169.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 137.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 121.586 1.994 . . . . 0.0 109.739 -173.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -105.38 -14.79 15.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.197 0.599 . . . . 0.0 112.491 -176.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -178.61 172.18 1.44 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.805 2.042 . . . . 0.0 112.288 -172.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -176.05 152.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 127.743 2.417 . . . . 0.0 109.29 -170.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.5 133.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 127.503 2.321 . . . . 0.0 107.236 167.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.54 141.77 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 123.247 1.499 . . . . 0.0 112.326 171.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -77.57 84.15 3.95 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.596 1.559 . . . . 0.0 109.384 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.09 -29.34 60.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.756 1.622 . . . . 0.0 114.191 -173.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -88.4 -0.31 57.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.712 1.605 . . . . 0.0 114.325 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -135.67 -171.51 2.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.535 2.734 . . . . 0.0 110.411 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER -111.24 33.72 4.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.022 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 p -132.66 155.74 48.23 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.019 -1.676 . . . . 0.0 115.505 -170.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.27 138.02 54.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.144 2.178 . . . . 0.0 110.107 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -108.79 115.91 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 170.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -118.73 136.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.133 1.373 . . . . 0.0 108.977 -167.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.66 104.29 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.758 1.223 . . . . 0.0 109.191 -169.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 57' ' ' LEU . 34.5 p90 -120.23 161.82 20.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.016 . . . . 0.0 113.274 -171.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 . . . . . 0 CA--C 1.54 0.596 0 O-C-N 120.982 -1.073 . . . . 0.0 110.921 -176.818 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 CA--C 1.538 0.693 0 N-CA-C 113.109 0.388 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -54.95 -32.67 61.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.057 1.343 . . . . 0.0 113.4 -176.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 m -73.65 -35.95 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.371 -1.456 . . . . 0.0 112.666 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.6 mt -70.56 -44.58 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -50.7 -51.18 52.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.845 1.258 . . . . 0.0 111.201 172.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -39.55 79.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.643 1.177 . . . . 0.0 114.108 172.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 -36.33 80.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.929 1.24 . . . . 0.0 111.83 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.48 -51.67 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.763 -0.585 . . . . 0.0 109.718 170.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.69 -19.02 14.4 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.145 0.884 . . . . 0.0 112.844 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 1.2 57.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -92.22 -32.35 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.969 0.804 . . . . 0.0 111.014 175.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.46 69.12 11.33 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.355 0.662 . . . . 0.0 111.65 168.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.58 142.0 97.9 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.291 3.327 . . . . 0.0 112.785 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.42 -35.56 3.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.143 1.354 . . . . 0.0 113.066 -176.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.65 -43.78 16.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.718 1.607 . . . . 0.0 112.064 174.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.8 m-30 -80.66 105.08 11.63 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -167.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.14 75.37 8.12 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.618 -1.926 . . . . 0.0 112.927 169.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.43 126.26 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 121.25 -0.906 . . . . 0.0 112.849 -174.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -140.48 139.48 35.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.198 0.999 . . . . 0.0 111.608 -169.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.1 mt -85.41 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.659 -1.276 . . . . 0.0 109.176 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 121.671 0.748 . . . . 0.0 109.281 173.317 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 122.301 1.048 . . . . 0.0 110.491 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 t -94.7 -179.67 4.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.576 1.95 . . . . 0.0 110.987 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -158.88 145.96 17.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.287 1.435 . . . . 0.0 110.244 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.03 153.82 39.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.043 1.737 . . . . 0.0 111.07 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 m -117.69 139.52 50.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.913 177.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.98 144.97 41.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.941 1.296 . . . . 0.0 110.644 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.24 135.0 64.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.514 1.525 . . . . 0.0 110.282 178.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.59 123.51 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.969 1.308 . . . . 0.0 108.775 -171.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.67 146.48 27.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 164.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.61 -4.67 77.67 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.401 0.524 . . . . 0.0 112.559 -168.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.42 127.53 27.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.303 1.441 . . . . 0.0 112.118 174.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -64.98 41.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.664 1.986 . . . . 0.0 113.961 170.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 30.62 -110.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.961 3.305 . . . . 0.0 114.84 175.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -51.85 -39.38 58.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 113.375 -179.013 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -83.12 -32.89 26.46 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.009 -1.057 . . . . 0.0 112.196 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 t -55.15 -49.08 72.72 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.972 1.26 . . . . 0.0 110.672 171.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.4 t -42.34 -50.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 124.489 1.118 . . . . 0.0 112.5 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -69.3 -35.54 76.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -62.81 -45.24 93.54 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.756 -1.215 . . . . 0.0 111.005 169.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mm -67.45 -49.21 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.983 -170.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -43.97 -50.83 8.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.488 1.515 . . . . 0.0 109.539 170.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -71.63 -50.95 25.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -66.26 -42.55 88.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.26 1.424 . . . . 0.0 110.51 -176.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.08 -49.65 23.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.159 177.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 t -74.26 13.75 0.53 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.476 1.943 . . . . 0.0 113.302 -173.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.16 -3.1 18.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.733 1.613 . . . . 0.0 111.858 173.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.06 133.64 41.55 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.046 -1.034 . . . . 0.0 110.435 -172.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -59.5 2.98 0.05 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -174.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 -8.09 4.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.696 1.999 . . . . 0.0 114.717 174.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 8.7 p -88.24 139.21 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 121.369 1.895 . . . . 0.0 110.426 -169.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -99.92 -19.02 16.81 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m 178.75 171.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.094 1.758 . . . . 0.0 113.039 -172.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -168.13 152.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.857 2.063 . . . . 0.0 110.473 -174.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.21 148.76 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 128.383 2.673 . . . . 0.0 106.544 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 18' ' ' VAL . 7.3 p -138.41 145.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.96 0.409 . . . . 0.0 110.85 175.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 m -91.59 125.52 36.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.582 0.705 . . . . 0.0 112.307 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' HE2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -70.58 -36.47 73.6 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.025 -1.047 . . . . 0.0 112.869 -176.206 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -104.15 -8.85 19.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.291 1.436 . . . . 0.0 114.732 -177.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -121.76 130.39 53.38 Favored 'General case' 0 C--O 1.221 -0.431 0 O-C-N 120.264 -1.523 . . . . 0.0 107.108 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 35.12 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 p -128.23 152.5 48.01 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -172.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.48 137.53 54.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.956 2.502 . . . . 0.0 110.491 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.3 mt -110.66 117.18 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.483 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.42 130.67 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.503 1.121 . . . . 0.0 109.041 -167.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.01 108.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.378 1.471 . . . . 0.0 108.555 -167.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.425 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.6 p90 -128.3 145.67 50.99 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.29 1.405 . . . . 0.0 113.844 -168.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.304 -1.498 . . . . 0.0 112.11 -172.139 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.536 0.611 0 CA-C-O 120.083 -0.049 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 17.0 mp0 -64.54 -8.96 15.85 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.461 1.504 . . . . 0.0 112.26 173.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 p -79.17 -51.87 8.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.787 1.176 . . . . 0.0 111.906 169.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.483 HD13 ' CG1' ' A' ' 45' ' ' VAL . 87.6 mt -64.79 -41.55 95.73 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.774 -1.107 . . . . 0.0 110.639 176.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -53.4 15.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.498 1.045 . . . . 0.0 111.545 172.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -37.69 72.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.36 1.464 . . . . 0.0 113.518 175.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.13 84.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.369 1.44 . . . . 0.0 112.085 175.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.26 -56.74 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.455 0.702 . . . . 0.0 110.758 171.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -53.41 -27.33 23.82 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 123.801 0.84 . . . . 0.0 111.534 176.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.42 1.98 38.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -27.94 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.726 0.81 . . . . 0.0 111.643 175.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.77 69.1 9.23 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.082 0.953 . . . . 0.0 110.644 169.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.34 145.3 98.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.257 3.305 . . . . 0.0 112.489 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.06 -40.83 2.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.961 1.267 . . . . 0.0 113.013 -174.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.82 -55.4 5.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.436 1.494 . . . . 0.0 111.062 177.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -71.5 107.76 4.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -169.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -78.89 47.68 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.226 1.811 . . . . 0.0 113.761 176.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.3 126.95 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.972 0.909 . . . . 0.0 111.076 -168.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 m -139.58 148.52 42.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.649 -175.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.67 124.28 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.692 -1.255 . . . . 0.0 109.758 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.225 -0.208 0 C-N-CA 123.694 0.798 . . . . 0.0 109.608 -175.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 122.419 1.104 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -102.07 -175.25 2.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.88 1.672 . . . . 0.0 109.751 172.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -158.77 150.76 21.21 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.845 -1.159 . . . . 0.0 109.893 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.06 156.01 40.2 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.996 1.719 . . . . 0.0 109.864 173.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.0 m -127.26 138.58 53.11 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.996 0.919 . . . . 0.0 109.453 -178.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -136.53 144.85 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.413 1.085 . . . . 0.0 111.303 -174.106 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 tt -122.38 140.87 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 125.205 1.402 . . . . 0.0 109.19 175.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.18 153.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.683 1.193 . . . . 0.0 108.639 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.26 144.66 50.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.413 0.285 . . . . 0.0 110.971 164.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.77 -1.67 68.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.22 1.39 . . . . 0.0 112.504 -174.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.49 165.91 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.514 1.525 . . . . 0.0 114.338 -171.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.55 37.23 0.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 125.022 1.329 . . . . 0.0 113.76 -179.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 t 52.39 -143.09 0.72 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.632 1.573 . . . . 0.0 111.7 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HE3' HD13 ' A' ' 38' ' ' LEU . 29.5 mttp -61.23 -13.87 21.65 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.196 -1.565 . . . . 0.0 114.273 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -91.79 -11.83 35.52 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.051 -1.656 . . . . 0.0 112.268 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -48.09 77.8 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.643 1.111 . . . . 0.0 108.179 168.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' CG1' ' A' ' 36' ' ' VAL . 54.2 t -40.45 -56.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 130.392 3.477 . . . . 0.0 111.937 -177.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -38.27 90.47 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 120.888 0.375 . . . . 0.0 111.808 -173.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -60.81 -41.49 95.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.831 -1.168 . . . . 0.0 112.412 168.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 -47.38 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.731 -171.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.68 -51.53 15.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.746 1.618 . . . . 0.0 109.307 169.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -70.55 -44.26 67.82 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.6 m -70.55 -40.68 73.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.769 1.228 . . . . 0.0 110.5 -175.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -44.89 57.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.224 178.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t -70.38 13.36 0.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 120.416 1.462 . . . . 0.0 113.813 -176.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.03 -6.84 19.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.399 1.48 . . . . 0.0 111.95 174.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.26 129.0 34.54 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.063 -1.023 . . . . 0.0 110.327 -169.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.72 -25.07 25.17 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -5.13 48.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 174.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.254 5.0 p -92.55 134.73 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 121.606 2.003 . . . . 0.0 110.314 -173.261 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 t -93.3 -27.39 16.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.383 1.473 . . . . 0.0 111.796 -176.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -178.06 175.91 1.2 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.959 2.104 . . . . 0.0 112.409 -171.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -172.75 151.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.748 2.019 . . . . 0.0 109.724 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.58 141.37 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 126.901 2.08 . . . . 0.0 105.782 166.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' CG1' HG13 ' A' ' 18' ' ' VAL . 66.2 t -111.37 137.84 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.681 1.229 . . . . 0.0 110.46 169.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.0 m -75.92 83.11 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.45 176.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD13 ' HE3' ' A' ' 15' ' ' LYS . 2.5 tm? -43.49 -42.91 5.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.509 2.324 . . . . 0.0 112.314 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -47.61 84.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.345 1.069 . . . . 0.0 112.29 178.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -98.43 -171.48 2.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.99 2.516 . . . . 0.0 112.031 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.98 29.56 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.081 2.552 . . . . 0.0 113.309 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 p -144.81 158.64 43.72 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.012 -1.68 . . . . 0.0 115.406 -167.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.41 51.76 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.103 2.161 . . . . 0.0 110.774 -173.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.77 110.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.3 t -116.67 130.46 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.19 1.396 . . . . 0.0 108.141 -168.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.87 106.46 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 107.813 -168.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CD1' HD11 ' A' ' 57' ' ' LEU . 27.1 p90 -127.25 147.15 50.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.588 1.155 . . . . 0.0 113.617 -168.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 . . . . . 0 CA--C 1.539 0.537 0 O-C-N 120.284 -1.51 . . . . 0.0 112.172 179.047 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo . . . . . 0 CA--C 1.54 0.786 0 N-CA-C 114.66 0.985 . . . . 0.0 114.66 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.16 -32.78 74.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.745 1.157 . . . . 0.0 112.913 -168.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -74.51 -28.43 60.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.065 0.946 . . . . 0.0 112.984 -178.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' A' ' 47' ' ' TYR . 69.4 mt -70.81 -47.58 58.69 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.407 170.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -45.34 -53.68 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.142 0.883 . . . . 0.0 110.761 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -37.54 71.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.65 78.48 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.423 1.465 . . . . 0.0 111.892 172.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.23 -50.74 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.263 0.625 . . . . 0.0 110.029 173.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -58.37 -19.36 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.429 -1.419 . . . . 0.0 112.486 174.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.31 0.43 56.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 174.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -89.63 -37.39 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 118.997 0.817 . . . . 0.0 110.967 173.186 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.35 70.51 33.11 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.964 0.412 . . . . 0.0 111.718 169.846 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.32 134.82 61.35 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.433 3.422 . . . . 0.0 111.909 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 -17.2 27.47 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.095 1.331 . . . . 0.0 114.167 -174.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 tp -105.25 -23.82 12.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.686 1.594 . . . . 0.0 112.532 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -102.61 111.29 23.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.24 45.71 0.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 119.578 -1.951 . . . . 0.0 114.851 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.75 124.06 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -166.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -141.11 155.65 46.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.827 1.651 . . . . 0.0 109.451 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.89 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.411 -1.43 . . . . 0.0 107.369 176.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 N--CA 1.476 0.841 0 C-N-CA 124.38 1.072 . . . . 0.0 112.411 -169.129 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t -124.67 169.58 11.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.682 1.23 . . . . 0.0 111.692 168.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -146.84 146.64 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.754 1.222 . . . . 0.0 109.832 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.98 37.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.105 1.762 . . . . 0.0 110.699 174.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.1 m -133.71 142.91 48.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.156 0.982 . . . . 0.0 110.871 -175.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 23.4 m-85 -145.16 140.1 27.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.321 1.448 . . . . 0.0 111.072 -168.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.53 131.7 60.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 O-C-N 120.744 -1.222 . . . . 0.0 111.899 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.36 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.003 2.121 . . . . 0.0 109.982 -169.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.43 4.14 6.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.08 1.752 . . . . 0.0 114.34 178.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.41 27.04 3.62 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 126.252 1.882 . . . . 0.0 110.577 -178.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.438 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -77.8 138.95 39.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.748 0.819 . . . . 0.0 109.599 179.066 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -53.81 -43.13 69.11 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p 172.17 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -140.98 -50.27 0.44 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 127.117 2.167 . . . . 0.0 110.771 -167.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -26.59 61.33 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.132 -2.23 . . . . 0.0 112.8 171.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.5 m -57.36 -39.18 75.44 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.718 170.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -47.89 -46.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.702 2.001 . . . . 0.0 111.564 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -67.51 -40.35 85.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.916 1.686 . . . . 0.0 113.605 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -61.33 -36.92 81.47 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.885 -1.134 . . . . 0.0 112.047 172.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -46.34 85.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -49.13 73.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 111.665 170.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -65.67 -41.86 92.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -177.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.0 m -69.3 -47.8 63.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.886 0.874 . . . . 0.0 110.79 177.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -76.58 -24.87 53.52 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 117.716 -1.135 . . . . 0.0 113.947 -177.386 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 t -81.64 11.53 4.65 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 121.144 1.793 . . . . 0.0 112.47 177.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.73 7.07 9.4 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -169.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 31' ' ' VAL . 13.6 mt -85.54 151.84 23.62 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.025 -1.047 . . . . 0.0 112.173 -169.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -67.13 22.95 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.467 2.307 . . . . 0.0 114.396 178.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.51 19.64 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.625 2.37 . . . . 0.0 112.868 -178.343 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.653 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.5 p -125.05 136.22 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.827 1.649 . . . . 0.0 112.726 177.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -118.28 -3.26 11.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -177.31 174.02 1.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.315 2.246 . . . . 0.0 111.914 176.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -172.99 154.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.67 2.788 . . . . 0.0 108.421 -172.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -145.98 123.24 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 C-N-CA 126.2 1.8 . . . . 0.0 107.522 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.71 149.67 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.171 172.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -73.54 124.31 25.64 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.46 1.504 . . . . 0.0 108.816 166.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -40.41 30.5 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.03 -51.6 30.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.888 2.475 . . . . 0.0 112.772 -173.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -88.87 -174.81 4.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.588 1.955 . . . . 0.0 112.398 169.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.2 43.56 1.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.31 1.444 . . . . 0.0 111.397 177.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 p -131.99 160.23 36.45 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.344 -2.097 . . . . 0.0 114.774 -168.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.54 136.94 33.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.092 1.357 . . . . 0.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -105.09 115.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.419 2.287 . . . . 0.0 105.425 171.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 57' ' ' LEU . 45.9 t -111.55 129.49 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.011 1.724 . . . . 0.0 108.537 -169.206 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.3 t -109.2 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.063 1.345 . . . . 0.0 108.174 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -101.3 132.57 46.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.043 1.737 . . . . 0.0 111.481 -170.461 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.286 2.8 p30 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 122.485 1.136 . . . . 0.0 110.508 -167.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 CA-C-O 118.754 -0.603 . . . . 0.0 112.614 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -54.37 -36.84 64.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.617 1.099 . . . . 0.0 112.118 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -67.6 -33.37 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.09 -1.006 . . . . 0.0 112.907 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 45' ' ' VAL . 68.1 mt -76.18 -43.92 40.43 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.577 0.751 . . . . 0.0 111.343 178.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.06 -47.2 65.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -45.08 74.88 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.094 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -33.18 73.95 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.049 1.295 . . . . 0.0 111.653 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.74 -54.04 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.284 0.633 . . . . 0.0 110.524 172.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -49.42 -33.75 14.79 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.686 0.794 . . . . 0.0 111.39 175.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.34 0.75 27.71 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -96.53 -27.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.151 1.381 . . . . 0.0 111.579 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.424 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.62 64.21 7.62 Favored Pre-proline 0 CA--C 1.549 0.912 0 O-C-N 121.689 -0.632 . . . . 0.0 111.498 168.473 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.21 144.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.29 3.327 . . . . 0.0 112.912 -172.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.67 -18.02 9.73 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.577 1.084 . . . . 0.0 113.975 -175.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.65 -47.36 3.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.979 1.711 . . . . 0.0 110.6 177.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.9 m-30 -66.38 107.28 1.97 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -175.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 75.36 4.72 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.419 -1.425 . . . . 0.0 109.887 169.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.16 129.79 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.458 -0.777 . . . . 0.0 111.464 -176.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.59 38.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.387 1.075 . . . . 0.0 110.634 -171.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.22 112.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.806 -1.184 . . . . 0.0 108.888 170.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.224 -0.267 0 C-N-CA 124.57 1.148 . . . . 0.0 108.896 168.695 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 t -125.09 -177.74 3.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.454 1.102 . . . . 0.0 110.182 167.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -164.07 151.54 12.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.15 0.98 . . . . 0.0 109.989 -169.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.63 158.86 44.05 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.284 1.434 . . . . 0.0 111.216 171.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.4 m -120.86 140.04 52.33 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.931 1.293 . . . . 0.0 109.672 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.85 151.61 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.608 1.163 . . . . 0.0 111.176 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -134.77 140.03 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.948 1.299 . . . . 0.0 110.717 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.8 140.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.631 1.572 . . . . 0.0 110.907 -173.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . 0.262 0.4 OUTLIER -123.27 145.78 48.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 165.818 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.41 54.91 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.744 1.164 . . . . 0.0 112.708 -171.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.403 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -84.22 153.04 23.86 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.824 1.65 . . . . 0.0 111.378 -171.628 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -77.99 32.25 0.17 Allowed 'General case' 0 CA--C 1.556 1.203 0 O-C-N 119.711 -1.868 . . . . 0.0 114.519 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t 66.31 -71.6 0.09 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.129 2.172 . . . . 0.0 114.886 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 38' ' ' LEU . 10.5 mptt -108.31 -38.4 5.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 112.944 177.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 p -74.25 -21.47 59.76 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 119.425 -2.047 . . . . 0.0 112.79 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 27.6 p -51.17 -51.63 51.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.487 1.04 . . . . 0.0 110.073 169.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.582 HG13 ' CG1' ' A' ' 36' ' ' VAL . 53.9 t -46.35 -55.54 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 128.042 2.537 . . . . 0.0 112.234 -174.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -40.17 95.63 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 123.441 0.463 . . . . 0.0 111.585 -171.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -57.64 -46.49 84.1 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.699 -0.625 . . . . 0.0 112.401 169.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -44.51 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 118.721 -0.657 . . . . 0.0 109.842 -172.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.22 -49.28 67.1 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.247 0.967 . . . . 0.0 110.286 171.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -70.41 -41.31 73.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.8 m -76.92 -36.43 56.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.833 1.253 . . . . 0.0 111.255 -175.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.23 -45.91 53.25 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.75 172.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -72.17 16.24 0.14 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 121.483 1.947 . . . . 0.0 114.206 -172.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.93 -7.52 14.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.12 1.768 . . . . 0.0 112.311 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.32 133.58 45.07 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.922 -1.111 . . . . 0.0 110.448 -169.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.5 -0.04 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -170.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.89 -10.36 11.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.412 1.485 . . . . 0.0 114.855 169.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -89.4 138.97 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 121.088 1.767 . . . . 0.0 110.362 -169.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -99.24 -34.71 10.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 112.242 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -158.76 160.33 36.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.342 1.057 . . . . 0.0 110.644 -165.432 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.75 152.21 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.632 1.573 . . . . 0.0 109.8 174.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.62 129.98 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 C-N-CA 126.449 1.9 . . . . 0.0 107.449 167.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CG1' HG13 ' A' ' 18' ' ' VAL . 51.6 t -101.72 143.71 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 123.399 1.571 . . . . 0.0 111.826 171.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -78.19 87.09 4.29 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.028 174.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.487 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.1 tm? -44.87 -42.51 8.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.959 2.504 . . . . 0.0 113.417 -177.003 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 15' ' ' LYS . 71.6 mm-40 -81.92 -8.87 59.71 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.433 HD22 ' C ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -131.17 -173.82 3.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.969 2.508 . . . . 0.0 109.347 -169.761 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 30.05 7.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.927 1.291 . . . . 0.0 113.525 -175.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 p -131.82 160.69 34.89 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.08 140.79 48.96 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.473 1.909 . . . . 0.0 110.658 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.17 114.25 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.1 t -116.26 131.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.541 1.536 . . . . 0.0 107.482 -169.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 57.4 t -120.52 107.89 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 -168.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -127.54 148.37 50.34 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.061 -1.024 . . . . 0.0 112.981 -168.675 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 CA--C 1.538 0.495 0 C-N-CA 124.114 0.966 . . . . 0.0 110.795 177.315 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.529 0.243 0 CA-C-O 118.734 -0.611 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -67.95 -10.26 51.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.78 1.173 . . . . 0.0 113.563 178.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 p -61.58 -45.15 95.35 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.789 -1.194 . . . . 0.0 112.1 168.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.4 mt -71.12 -42.89 68.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.642 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.78 -46.99 51.32 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.431 172.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -62.22 -38.09 87.86 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.96 76.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.699 1.59 . . . . 0.0 111.783 173.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -68.28 -54.7 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.139 0.576 . . . . 0.0 110.905 171.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -55.75 -22.52 24.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.159 0.891 . . . . 0.0 112.615 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.42 5.31 42.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -97.22 -30.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 173.187 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -144.2 64.83 12.9 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.732 -0.605 . . . . 0.0 111.666 168.795 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.79 138.39 82.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.232 3.288 . . . . 0.0 112.431 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.12 -22.29 5.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.466 1.031 . . . . 0.0 113.662 -175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 tp -93.41 -54.07 3.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.477 1.511 . . . . 0.0 110.133 173.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.7 m-30 -70.09 117.0 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.045 1.738 . . . . 0.0 114.048 -177.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -111.68 139.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 119.363 0.983 . . . . 0.0 112.672 -173.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -144.63 160.04 41.82 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.824 1.25 . . . . 0.0 112.764 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.41 119.84 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.99 1.716 . . . . 0.0 107.469 173.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -175.081 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 122.767 1.27 . . . . 0.0 112.934 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -112.96 176.73 4.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.127 2.171 . . . . 0.0 110.853 -177.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.66 163.33 40.4 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 120.623 -1.298 . . . . 0.0 111.548 178.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.03 159.09 44.54 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.132 1.373 . . . . 0.0 110.187 169.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.9 154.59 26.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 110.435 172.025 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 53.2 m-85 -150.61 141.81 23.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.822 -1.536 . . . . 0.0 110.738 -176.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 tt -126.62 140.05 50.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.095 1.358 . . . . 0.0 110.289 177.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.3 98.39 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 126.478 1.911 . . . . 0.0 109.515 -170.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 65.26 7.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 123.534 1.635 . . . . 0.0 113.876 -169.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.99 0.11 Allowed Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 174.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 tmm? 45.08 -149.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.272 1.429 . . . . 0.0 109.56 -176.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -120.53 -33.06 3.92 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.407 -1.433 . . . . 0.0 111.386 167.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 p 161.76 -72.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.927 2.091 . . . . 0.0 113.589 178.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HE3' HD22 ' A' ' 38' ' ' LEU . 20.0 tptt -144.31 -57.38 0.37 Allowed 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.241 1.017 . . . . 0.0 109.815 -168.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -30.77 28.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.016 -1.678 . . . . 0.0 113.478 171.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.456 ' HA ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -57.61 -41.48 81.37 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.695 172.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.538 HG12 HG11 ' A' ' 36' ' ' VAL . 95.4 t -51.07 -42.73 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.834 1.653 . . . . 0.0 112.034 -176.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.6 t -71.09 -37.47 72.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.933 1.293 . . . . 0.0 113.277 178.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 17' ' ' CYS . 85.3 m-20 -60.24 -36.97 78.96 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.024 -1.048 . . . . 0.0 112.291 170.337 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -68.56 -48.23 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.925 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 36' ' ' VAL . 43.1 mt-10 -54.81 -51.91 64.34 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 124.044 0.84 . . . . 0.0 111.624 170.061 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -61.46 -41.28 96.99 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -68.41 -49.15 62.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.761 1.224 . . . . 0.0 110.189 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -75.74 -15.76 60.23 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.405 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -76.26 -3.07 34.6 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 173.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.49 7.68 11.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -166.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.35 152.29 30.52 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.165 -0.96 . . . . 0.0 112.599 -169.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -67.79 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.403 2.281 . . . . 0.0 114.501 -177.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.45 2.02 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.508 2.323 . . . . 0.0 114.341 -175.756 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.6 p -105.24 139.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 121.876 2.125 . . . . 0.0 111.307 -174.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 t -111.19 -11.62 14.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.07 175.03 1.98 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.175 1.79 . . . . 0.0 112.08 -175.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -175.55 152.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.041 2.536 . . . . 0.0 109.968 -171.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -147.88 134.57 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.86 2.464 . . . . 0.0 107.5 166.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.538 HG11 HG12 ' A' ' 18' ' ' VAL . 2.9 p -107.14 151.74 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 122.142 0.973 . . . . 0.0 113.174 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -90.15 102.75 15.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.58 0.752 . . . . 0.0 111.257 170.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.606 HD22 ' HE3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -57.81 -35.54 70.99 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.255 1.422 . . . . 0.0 113.401 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.99 5.55 49.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.152 1.381 . . . . 0.0 113.874 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -119.34 -173.94 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.951 1.7 . . . . 0.0 109.527 169.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 42.81 2.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.082 -1.011 . . . . 0.0 111.057 168.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -146.22 151.81 38.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -168.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.26 41.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.591 2.356 . . . . 0.0 112.055 -169.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.63 118.71 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.588 1.955 . . . . 0.0 106.544 174.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.2 t -119.77 120.35 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.756 1.622 . . . . 0.0 109.323 -167.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -107.06 107.78 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.854 1.662 . . . . 0.0 109.548 -169.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -121.0 158.32 28.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.041 1.336 . . . . 0.0 113.515 -171.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 CA--C 1.538 0.516 0 O-C-N 120.397 -1.439 . . . . 0.0 112.902 -168.821 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 CA-C-O 118.503 -0.707 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -61.7 -32.06 72.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.949 1.25 . . . . 0.0 113.001 -174.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.28 64.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.924 -1.735 . . . . 0.0 113.416 -178.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 47' ' ' TYR . 58.2 mt -78.76 -46.42 18.9 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.898 -0.501 . . . . 0.0 110.145 173.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -46.87 -49.63 19.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.603 0.761 . . . . 0.0 110.124 169.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -58.32 -41.16 83.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 113.734 176.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.26 73.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.38 0.991 . . . . 0.0 112.18 172.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mt -70.84 -54.41 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.322 0.649 . . . . 0.0 110.557 172.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -55.03 -23.14 18.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.498 1.119 . . . . 0.0 112.52 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.65 4.25 37.29 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -98.83 -39.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.781 0.833 . . . . 0.0 111.582 -179.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -139.84 64.77 29.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.943 -0.473 . . . . 0.0 112.053 166.816 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.77 143.17 81.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 124.297 3.331 . . . . 0.0 114.189 -171.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.97 -43.41 3.24 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 125.438 1.494 . . . . 0.0 112.414 -175.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.47 -39.22 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.686 1.194 . . . . 0.0 110.524 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.2 m-85 -71.76 89.98 1.06 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.162 -0.961 . . . . 0.0 112.895 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -74.96 76.18 2.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.315 1.446 . . . . 0.0 110.098 169.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 t -92.05 133.69 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.952 -1.092 . . . . 0.0 111.785 -169.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -151.28 159.21 44.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.95 1.357 . . . . 0.0 111.289 168.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.66 130.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 166.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.225 -0.226 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.799 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.748 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -62.38 154.96 26.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.882 2.073 . . . . 0.0 112.908 172.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -82.46 159.42 22.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.712 0.767 . . . . 0.0 110.915 171.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -152.82 153.35 32.95 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.954 -1.092 . . . . 0.0 108.284 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.5 39.91 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.094 1.758 . . . . 0.0 110.763 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 43.0 m -126.16 141.1 52.07 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.586 1.154 . . . . 0.0 109.842 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -140.28 136.4 33.24 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.408 1.483 . . . . 0.0 110.298 -174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.9 tt -126.66 135.69 62.98 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 C-N-CA 125.07 1.348 . . . . 0.0 110.57 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.84 129.34 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.403 1.081 . . . . 0.0 111.07 -172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -100.43 129.62 46.42 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.662 -0.649 . . . . 0.0 109.547 163.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 -1.67 28.42 Favored Glycine 0 N--CA 1.468 0.784 0 C-N-CA 124.852 1.215 . . . . 0.0 113.554 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 7.0 ptm -65.35 149.0 50.74 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.033 0.917 . . . . 0.0 113.087 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -73.64 33.78 0.08 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.48 1.512 . . . . 0.0 112.999 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 t 66.3 -143.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.399 1.48 . . . . 0.0 111.301 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HE3' HD13 ' A' ' 38' ' ' LEU . 46.4 mttp -61.72 -14.68 34.14 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.652 1.981 . . . . 0.0 115.576 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.0 p -91.74 -41.51 10.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 117.239 -1.362 . . . . 0.0 112.04 168.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -54.37 -49.32 70.09 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 121.53 1.968 . . . . 0.0 109.62 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.1 t -36.05 -48.95 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.797 2.039 . . . . 0.0 112.91 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 t -83.4 -25.36 31.39 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -58.0 -35.54 71.39 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 119.91 -1.744 . . . . 0.0 110.138 166.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.39 -43.15 78.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 CA-C-O 117.531 -1.223 . . . . 0.0 110.424 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -50.4 -51.04 49.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.664 0.786 . . . . 0.0 110.145 169.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -69.77 -42.14 74.23 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.0 m -70.87 -41.09 71.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.628 1.171 . . . . 0.0 110.714 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.91 -46.1 46.52 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 117.554 -1.212 . . . . 0.0 111.668 176.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -72.62 14.74 0.23 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 120.465 1.484 . . . . 0.0 113.579 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.97 -2.79 18.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.411 1.484 . . . . 0.0 112.187 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.5 mt -80.25 130.58 35.3 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.055 -1.028 . . . . 0.0 111.332 -169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -58.99 -2.84 0.28 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.646 1.578 . . . . 0.0 115.25 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.24 -3.4 11.03 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.608 1.963 . . . . 0.0 115.942 172.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -95.16 144.35 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.197 1.817 . . . . 0.0 110.523 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -99.0 -27.77 13.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.87 1.668 . . . . 0.0 111.789 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 m 176.79 176.67 0.31 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.898 2.079 . . . . 0.0 112.802 -169.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -172.27 150.23 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.967 2.107 . . . . 0.0 110.493 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -141.73 134.64 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.074 2.15 . . . . 0.0 106.869 166.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.3 p -103.04 141.6 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 122.052 0.93 . . . . 0.0 110.468 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.2 m -76.44 84.37 3.16 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.659 1.183 . . . . 0.0 110.046 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.553 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.3 tm? -51.93 -43.35 63.4 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 113.07 -167.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -60.36 -41.89 94.61 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.479 0.712 . . . . 0.0 112.319 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -100.72 -170.74 1.9 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 130.313 3.445 . . . . 0.0 112.98 -169.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.21 32.61 4.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.052 2.141 . . . . 0.0 114.473 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.8 p -137.23 166.02 24.76 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.17 -1.581 . . . . 0.0 114.114 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.07 142.64 40.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.438 1.895 . . . . 0.0 110.649 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -108.74 117.36 54.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.484 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.4 t -120.81 131.83 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.164 1.386 . . . . 0.0 108.336 -167.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.9 t -117.48 110.86 32.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 C-N-CA 125.445 1.498 . . . . 0.0 107.724 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.515 ' CD1' HD11 ' A' ' 57' ' ' LEU . 13.9 p90 -121.88 -165.28 1.24 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.565 1.546 . . . . 0.0 111.351 -174.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -144.84 123.58 12.59 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 122.269 2.304 . . . . 0.0 114.119 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 176.06 137.98 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.357 2.263 . . . . 0.0 110.795 -167.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.4 p -79.81 -40.38 28.69 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.903 0.859 . . . . 0.0 110.343 167.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -70.18 76.44 0.52 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.645 1.178 . . . . 0.0 110.828 171.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.5 t -44.78 108.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.247 1.419 . . . . 0.0 111.029 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -136.55 84.08 28.98 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 125.653 1.581 . . . . 0.0 109.688 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.27 -16.36 13.83 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.514 2.81 . . . . 0.0 113.872 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -56.91 -31.17 64.63 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.437 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.4 p -70.37 -38.87 74.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.552 -1.342 . . . . 0.0 112.818 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.515 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.1 mt -69.99 -43.97 70.33 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.564 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -50.52 -50.95 51.69 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.578 1.151 . . . . 0.0 110.768 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -37.39 74.92 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.332 1.453 . . . . 0.0 113.801 174.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.89 -33.5 73.87 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.582 1.083 . . . . 0.0 111.636 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -68.37 -51.47 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 118.941 -0.552 . . . . 0.0 110.131 173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -49.4 -35.77 20.03 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 118.618 0.645 . . . . 0.0 111.377 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.03 5.2 8.5 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.493 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -100.03 -26.83 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.003 1.321 . . . . 0.0 111.577 176.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.97 68.29 8.8 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.646 0.778 . . . . 0.0 110.082 167.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.38 144.25 90.55 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.09 3.193 . . . . 0.0 112.717 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 -25.02 3.98 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.736 1.16 . . . . 0.0 113.392 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.18 -45.09 8.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.283 1.433 . . . . 0.0 111.948 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -75.02 109.65 8.65 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 -169.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -86.55 81.7 8.18 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.283 1.033 . . . . 0.0 110.996 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.5 t -87.51 124.66 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.758 0.823 . . . . 0.0 112.641 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.76 131.59 43.09 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.177 0.991 . . . . 0.0 111.862 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.45 83.2 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 120.656 -1.278 . . . . 0.0 110.796 -174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.3 t -78.91 80.83 5.23 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.724 1.21 . . . . 0.0 111.472 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.5 m -91.74 164.32 13.76 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.144 0.977 . . . . 0.0 112.603 173.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.33 120.69 19.29 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 165.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 C--N 1.325 -0.487 0 C-N-CA 126.982 2.113 . . . . 0.0 108.045 174.784 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.7 156.04 38.34 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.254 1.822 . . . . 0.0 111.725 -173.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -93.8 174.4 7.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.093 0.949 . . . . 0.0 110.018 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -165.13 148.32 8.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.017 -1.052 . . . . 0.0 110.478 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.07 166.08 31.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.569 1.548 . . . . 0.0 110.94 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.7 m -134.03 143.2 47.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 109.613 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -143.07 149.35 38.07 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.414 1.486 . . . . 0.0 111.724 -169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 tt -133.46 136.75 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 125.301 1.44 . . . . 0.0 110.959 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 mp -115.38 90.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.188 2.195 . . . . 0.0 109.606 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -78.14 39.01 0.3 Allowed 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 125.179 1.392 . . . . 0.0 113.452 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.48 40.11 0.18 Allowed Glycine 0 N--CA 1.469 0.844 0 C-N-CA 125.763 1.649 . . . . 0.0 112.638 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 4.4 tmm? -102.72 150.11 23.78 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.671 1.588 . . . . 0.0 111.743 -172.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -66.59 9.22 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m 81.91 -54.11 0.25 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.276 3.03 . . . . 0.0 114.572 164.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.624 ' HE2' HD13 ' A' ' 38' ' ' LEU 0.29 50.8 mttt -125.42 -57.1 1.49 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.667 1.121 . . . . 0.0 112.656 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.7 m -65.37 -13.54 58.83 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 119.333 -2.105 . . . . 0.0 113.903 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HB3' ' HG2' ' A' ' 12' ' ' MET 0.275 1.2 m -71.76 -36.06 70.28 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.668 168.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.8 t -47.11 -48.85 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.308 1.843 . . . . 0.0 111.83 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.9 t -63.83 -42.39 97.63 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.315 1.446 . . . . 0.0 113.091 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -59.48 -34.77 72.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.122 -1.611 . . . . 0.0 113.014 170.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.19 -41.56 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 118.36 -0.828 . . . . 0.0 109.573 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -52.45 -54.51 31.37 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.587 0.755 . . . . 0.0 109.878 167.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.7 t -69.95 -38.24 76.09 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -75.22 -37.17 61.22 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 123.557 0.743 . . . . 0.0 110.594 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -74.01 -51.16 16.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 117.749 -1.119 . . . . 0.0 112.866 171.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -71.8 11.86 0.46 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.28 1.4 . . . . 0.0 113.866 -169.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.87 -1.5 19.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.861 1.664 . . . . 0.0 112.591 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -77.39 134.31 38.47 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 120.789 -1.195 . . . . 0.0 111.589 -169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.22 72.39 2.29 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.501 1.521 . . . . 0.0 109.956 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 159.73 -20.63 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 130.804 3.642 . . . . 0.0 113.676 -174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 p -91.12 144.63 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 121.933 2.152 . . . . 0.0 109.749 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 t -114.96 -7.9 12.53 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.6 m 178.76 172.84 0.75 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.914 2.086 . . . . 0.0 112.971 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -171.4 152.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.173 2.189 . . . . 0.0 110.077 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.4 150.53 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 128.712 2.805 . . . . 0.0 106.614 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.82 151.02 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 122.952 0.501 . . . . 0.0 110.942 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 m -82.57 135.78 34.99 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.166 0.587 . . . . 0.0 111.209 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.624 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.3 tm? -76.18 -33.99 59.33 Favored 'General case' 0 C--O 1.222 -0.38 0 O-C-N 121.098 -1.001 . . . . 0.0 112.083 174.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.77 -55.78 3.56 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.237 1.415 . . . . 0.0 111.917 176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -76.99 138.1 39.41 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.551 0.74 . . . . 0.0 109.467 -173.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.35 40.99 0.23 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.4 p -141.47 152.7 44.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.42 1.488 . . . . 0.0 114.627 -169.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.86 143.01 50.59 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.217 2.207 . . . . 0.0 111.105 -175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.6 mt -113.11 120.16 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 127.199 2.2 . . . . 0.0 105.716 173.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 t -125.61 134.56 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.124 0.969 . . . . 0.0 109.96 -166.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.1 t -122.73 110.28 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.132 1.373 . . . . 0.0 108.863 -168.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' CD1' HD11 ' A' ' 57' ' ' LEU . 44.3 p90 -123.16 168.34 12.54 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.42 1.088 . . . . 0.0 113.853 -170.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -110.21 114.94 28.83 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 120.551 -1.343 . . . . 0.0 110.406 -172.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.51 132.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.864 1.265 . . . . 0.0 111.671 -173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 m -68.53 -26.44 65.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.448 0.567 . . . . 0.0 111.633 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.8 t -170.62 117.16 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.113 1.765 . . . . 0.0 109.362 167.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -148.84 144.34 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 127.054 2.142 . . . . 0.0 106.875 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.5 t -69.53 140.96 90.1 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.149 1.38 . . . . 0.0 112.358 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.6 -8.81 24.28 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.552 2.835 . . . . 0.0 112.883 169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -61.08 -30.3 70.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.602 0.761 . . . . 0.0 112.183 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -74.25 -39.94 62.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.599 1.16 . . . . 0.0 113.668 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.7 mt -66.2 -43.84 85.61 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.285 173.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -49.33 -56.39 9.66 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.123 0.874 . . . . 0.0 110.459 169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -49.85 -39.5 39.25 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.42 -34.56 72.65 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.57 1.077 . . . . 0.0 111.803 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.5 mt -65.91 -54.96 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.274 0.63 . . . . 0.0 109.691 170.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -51.83 -29.35 19.07 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.785 0.834 . . . . 0.0 111.877 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.01 0.41 40.37 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -96.57 -29.11 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.692 1.197 . . . . 0.0 111.386 177.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.99 65.4 9.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 121.545 -0.722 . . . . 0.0 111.801 168.036 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.23 144.77 98.97 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.355 3.37 . . . . 0.0 113.376 -174.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.04 -19.56 6.45 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.537 1.541 . . . . 0.0 114.08 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 12.3 tp -106.16 -45.99 4.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.961 1.704 . . . . 0.0 111.216 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.481 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -66.74 109.03 2.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.268 1.027 . . . . 0.0 113.703 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -78.5 80.03 4.9 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 110.759 169.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.5 t -84.97 127.25 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.1 0.863 . . . . 0.0 111.877 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.6 p -138.4 146.81 42.67 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.59 1.156 . . . . 0.0 111.089 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.69 130.21 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.4 t -116.44 105.5 12.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.725 0.774 . . . . 0.0 110.561 172.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 65.9 m -161.32 158.27 26.77 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.282 2.233 . . . . 0.0 108.321 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -69.65 131.63 44.91 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 163.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--N 1.32 -0.71 0 C-N-CA 126.328 1.851 . . . . 0.0 108.82 178.67 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.614 0.721 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -97.88 160.74 14.12 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.44 1.896 . . . . 0.0 113.198 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -137.53 173.1 12.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.726 2.01 . . . . 0.0 109.084 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -161.75 156.39 22.8 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.734 -1.229 . . . . 0.0 110.336 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.35 160.89 38.94 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.48 1.512 . . . . 0.0 111.055 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.5 m -124.19 141.56 51.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.163 1.385 . . . . 0.0 110.194 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -141.75 145.2 34.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.853 1.261 . . . . 0.0 111.629 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.3 tt -134.26 127.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 124.479 1.112 . . . . 0.0 111.933 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -104.81 102.18 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.514 1.926 . . . . 0.0 111.497 -167.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -81.81 42.55 0.71 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.235 1.014 . . . . 0.0 113.665 -174.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.02 3.66 0.03 OUTLIER Glycine 0 CA--C 1.541 1.665 0 C-N-CA 126.223 1.868 . . . . 0.0 117.438 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -75.73 145.6 40.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 120.739 2.269 . . . . 0.0 113.781 -171.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -66.04 27.39 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 126.693 1.997 . . . . 0.0 114.982 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m 53.5 -129.53 2.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.825 1.65 . . . . 0.0 110.967 174.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HE2' HD13 ' A' ' 38' ' ' LEU . 1.6 mptm? -52.25 -32.31 36.45 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -170.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.4 m -84.62 -28.57 26.4 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.555 -1.341 . . . . 0.0 113.143 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -70.81 -41.04 72.11 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 117.18 -1.391 . . . . 0.0 111.532 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 t -40.15 -54.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.7 2.0 . . . . 0.0 111.033 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -61.09 -41.74 97.22 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.508 1.123 . . . . 0.0 113.768 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -60.99 -38.38 85.82 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.297 -1.502 . . . . 0.0 112.934 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -36.44 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.213 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -55.27 -55.35 32.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.47 1.108 . . . . 0.0 109.687 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -67.61 -53.33 28.95 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.5 m -62.02 -38.46 88.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.894 1.278 . . . . 0.0 111.316 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -51.23 12.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.65 -1.167 . . . . 0.0 112.199 174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -69.98 6.19 1.32 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 120.739 1.609 . . . . 0.0 113.928 -171.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.68 -6.81 24.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.817 1.647 . . . . 0.0 111.305 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.9 mt -75.39 128.02 34.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -60.15 -15.87 27.57 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -171.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -93.84 -12.17 29.57 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.7 p -93.57 143.72 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 121.161 1.8 . . . . 0.0 109.965 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.2 t -111.21 -11.63 14.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m 176.91 174.12 0.41 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.763 2.425 . . . . 0.0 113.005 -173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -172.71 150.48 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 127.674 2.39 . . . . 0.0 109.561 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.5 t -141.85 130.73 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 126.683 1.993 . . . . 0.0 107.029 167.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.55 149.91 12.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.792 0.806 . . . . 0.0 111.041 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -80.58 113.02 18.47 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.547 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.5 tm? -60.31 -41.62 93.86 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.911 0.778 . . . . 0.0 111.366 -176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -97.25 -22.42 16.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.276 1.83 . . . . 0.0 114.638 -171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -115.91 155.85 27.24 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.773 1.229 . . . . 0.0 110.835 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.292 0.0 OUTLIER -78.5 38.32 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 -169.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.9 p -138.77 157.92 45.18 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.52 139.9 35.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.809 2.044 . . . . 0.0 111.68 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.0 mt -107.76 121.26 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 127.153 2.181 . . . . 0.0 106.14 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 57' ' ' LEU . 31.9 t -120.26 136.97 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.164 1.386 . . . . 0.0 108.468 -169.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.5 t -124.34 105.2 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.714 1.205 . . . . 0.0 109.72 -169.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CD1' HD11 ' A' ' 57' ' ' LEU . 40.6 p90 -122.0 164.91 16.83 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.32 1.448 . . . . 0.0 113.967 -169.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.36 112.47 24.43 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.023 -1.048 . . . . 0.0 110.974 -171.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -175.39 152.18 1.34 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.659 1.584 . . . . 0.0 110.971 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -88.42 23.88 2.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.017 0.927 . . . . 0.0 110.911 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.2 t -165.67 -177.91 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 120.677 -1.264 . . . . 0.0 111.955 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 m -105.44 116.77 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.417 1.887 . . . . 0.0 111.169 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -135.75 60.8 38.47 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 124.961 1.304 . . . . 0.0 110.241 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.26 -24.43 10.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.045 2.497 . . . . 0.0 114.176 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.16 -32.16 67.94 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 119.388 0.995 . . . . 0.0 113.215 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 m -70.22 -36.3 74.45 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 120.907 -1.121 . . . . 0.0 112.215 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.535 HD11 ' CD1' ' A' ' 47' ' ' TYR . 82.2 mt -71.86 -45.76 60.24 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 118.705 -0.664 . . . . 0.0 109.674 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -48.86 -47.49 42.78 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.659 0.783 . . . . 0.0 110.463 171.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -35.39 79.89 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.33 -32.36 73.26 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 121.28 1.855 . . . . 0.0 112.127 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.93 -57.97 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.719 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -49.72 -27.89 5.4 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.488 1.115 . . . . 0.0 112.573 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.13 0.68 44.08 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -93.56 -29.9 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.978 0.911 . . . . 0.0 111.514 177.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.464 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.84 64.06 9.87 Favored Pre-proline 0 CA--C 1.543 0.673 0 O-C-N 121.424 -0.798 . . . . 0.0 111.5 167.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.28 144.01 99.5 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.095 3.197 . . . . 0.0 112.464 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.31 -29.89 4.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.714 1.149 . . . . 0.0 113.007 -174.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.3 tp -92.23 -48.23 6.8 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.427 1.491 . . . . 0.0 111.046 172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.514 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -71.26 99.09 1.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.354 1.062 . . . . 0.0 113.346 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -75.06 119.87 19.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 114.617 -2.611 . . . . 0.0 105.336 162.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.7 t -123.25 134.96 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-N 124.274 3.215 . . . . 0.0 112.544 176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.16 134.6 45.6 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.042 1.337 . . . . 0.0 110.178 -169.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.9 mt -74.22 123.45 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.185 -1.572 . . . . 0.0 110.38 170.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.15 112.9 23.23 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.456 0.702 . . . . 0.0 109.126 174.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.7 m -163.57 165.44 23.53 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.398 1.879 . . . . 0.0 109.825 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -66.45 111.07 3.38 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.049 1.74 . . . . 0.0 110.829 170.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.3 t . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 125.082 1.353 . . . . 0.0 111.121 177.238 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 CA--C 1.544 0.728 0 CA-C-O 122.04 0.924 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -112.4 168.25 9.79 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.305 2.642 . . . . 0.0 111.802 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -88.91 172.15 9.38 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 163.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.6 m -157.33 138.29 13.39 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.52 -1.362 . . . . 0.0 110.311 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.35 158.74 43.59 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.672 1.589 . . . . 0.0 110.654 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.4 m -120.35 141.86 49.67 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.724 1.21 . . . . 0.0 109.414 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -137.04 139.89 41.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.106 1.362 . . . . 0.0 109.512 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -121.55 139.67 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 C-N-CA 123.924 0.89 . . . . 0.0 110.818 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 147.57 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 O-C-N 125.086 1.492 . . . . 0.0 110.25 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -123.59 141.38 52.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.449 1.1 . . . . 0.0 108.465 162.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.43 -27.24 8.57 Favored Glycine 0 N--CA 1.484 1.898 0 C-N-CA 126.19 1.852 . . . . 0.0 113.369 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.419 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -67.32 125.1 25.04 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 129.632 3.173 . . . . 0.0 118.104 -166.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.611 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 2.5 m-70 -74.61 55.58 0.66 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 128.789 2.836 . . . . 0.0 117.871 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t 64.76 -141.46 0.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 119.94 -1.725 . . . . 0.0 114.781 165.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -54.84 -31.24 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 118.823 -2.423 . . . . 0.0 111.149 178.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.0 m -66.03 -54.29 27.75 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 117.704 -1.141 . . . . 0.0 112.224 177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 12' ' ' MET . 32.0 p -55.02 -55.14 34.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.475 1.488 . . . . 0.0 110.275 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 9.1 t -44.74 -54.12 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 127.523 2.329 . . . . 0.0 111.487 178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.8 m -70.72 -26.5 63.42 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -60.5 -46.57 89.62 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 119.614 1.097 . . . . 0.0 109.309 165.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.77 -40.25 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.437 -0.79 . . . . 0.0 111.846 -174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -54.19 -46.41 72.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.285 1.434 . . . . 0.0 109.33 170.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.7 t -73.03 -64.33 0.99 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -56.41 -36.58 69.09 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.828 2.451 . . . . 0.0 112.439 -174.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -72.31 -43.92 63.46 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.433 -1.27 . . . . 0.0 112.828 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -67.84 13.05 0.09 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 120.642 1.565 . . . . 0.0 114.636 -175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.57 2.13 14.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.691 1.996 . . . . 0.0 112.262 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.3 mt -78.32 137.65 38.17 Favored 'General case' 0 CA--C 1.534 0.356 0 O-C-N 120.81 -1.181 . . . . 0.0 111.863 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.67 67.27 0.77 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.685 1.594 . . . . 0.0 111.864 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 166.73 -20.77 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 129.956 3.303 . . . . 0.0 113.148 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.7 p -85.92 137.16 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 121.288 1.858 . . . . 0.0 110.895 -171.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 m -103.82 -19.04 14.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.376 1.47 . . . . 0.0 112.594 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m 178.16 167.19 0.78 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.632 2.373 . . . . 0.0 112.423 -171.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.4 tt -171.64 149.22 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.672 1.989 . . . . 0.0 112.479 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.7 t -141.09 144.35 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.494 2.317 . . . . 0.0 106.948 166.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 53.8 t -113.51 130.14 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 123.382 1.563 . . . . 0.0 110.842 168.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.0 m -80.64 91.28 5.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.807 169.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HA ' HG21 ' A' ' 18' ' ' VAL . 7.8 tp -51.21 -56.95 10.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.311 1.444 . . . . 0.0 111.201 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -50.85 -56.07 13.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.45 1.1 . . . . 0.0 110.926 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.44 15.42 5.46 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 51.47 29.47 5.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.452 1.901 . . . . 0.0 114.738 174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 p -133.59 149.73 51.62 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -168.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.84 126.65 53.27 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.466 1.506 . . . . 0.0 109.109 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 86.3 mt -101.25 109.75 26.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.96 132.61 69.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 124.781 1.232 . . . . 0.0 108.251 -166.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -122.03 108.45 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -169.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.451 ' CD1' HD11 ' A' ' 57' ' ' LEU . 12.6 p90 -130.87 137.59 49.43 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.774 1.23 . . . . 0.0 113.84 -167.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.09 83.07 8.16 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.223 -1.548 . . . . 0.0 112.378 -172.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.16 105.4 0.56 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.729 0.811 . . . . 0.0 112.866 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -85.5 -12.65 51.27 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.745 -1.222 . . . . 0.0 112.916 -176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.1 p -120.66 31.64 6.35 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.8 m -142.4 160.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.178 0.899 . . . . 0.0 112.08 -175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -73.98 144.15 81.94 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 124.552 1.141 . . . . 0.0 111.711 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -65.11 -16.37 54.8 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.413 2.742 . . . . 0.0 111.924 168.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -56.95 -20.39 23.35 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.156 0.889 . . . . 0.0 112.13 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -42.17 65.73 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.501 -1.374 . . . . 0.0 112.134 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.451 HD11 ' CD1' ' A' ' 47' ' ' TYR . 93.5 mt -70.06 -42.05 73.34 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.693 176.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -51.44 -49.86 60.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.428 1.091 . . . . 0.0 110.913 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -61.59 -34.28 75.35 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.78 -33.22 75.17 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 120.277 1.399 . . . . 0.0 112.159 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -70.27 -55.29 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.331 -0.856 . . . . 0.0 110.974 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.54 -16.86 17.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.276 0.943 . . . . 0.0 112.124 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.15 -0.65 57.71 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.457 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -91.93 -31.34 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.059 0.845 . . . . 0.0 111.83 175.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.477 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -144.35 59.32 6.59 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 170.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -55.9 139.43 84.31 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 125.128 3.885 . . . . 0.0 114.374 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.31 -25.71 3.66 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.014 1.292 . . . . 0.0 113.571 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -42.28 9.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.032 1.733 . . . . 0.0 109.245 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 4.3 m-30 -76.53 106.93 8.46 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 115.176 1.546 . . . . 0.0 115.176 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.283 5.5 mtt-85 -73.47 137.24 44.38 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 158.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.36 135.04 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 122.375 2.352 . . . . 0.0 110.292 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.1 p -138.45 151.79 47.74 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 172.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.3 mt -84.04 85.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.465 1.106 . . . . 0.0 108.397 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -60.01 118.86 6.78 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-O 122.436 1.113 . . . . 0.0 108.287 169.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -149.13 143.76 26.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.981 1.712 . . . . 0.0 108.339 -175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -78.2 68.26 4.19 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.997 0.919 . . . . 0.0 110.254 -175.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -175.437 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 121.866 0.841 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -109.64 168.35 9.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 131.066 3.746 . . . . 0.0 111.84 -169.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 t -125.98 171.72 10.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.888 1.275 . . . . 0.0 110.105 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -152.21 166.53 31.45 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 124.196 0.999 . . . . 0.0 110.421 174.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.98 36.49 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.648 1.579 . . . . 0.0 110.898 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -123.3 135.09 54.05 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.276 1.43 . . . . 0.0 110.245 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -138.2 146.63 42.88 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.816 1.246 . . . . 0.0 111.406 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -132.8 135.81 56.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.905 1.282 . . . . 0.0 112.224 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.48 106.39 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 125.463 1.505 . . . . 0.0 111.771 -167.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.36 -3.96 36.59 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 119.346 -2.096 . . . . 0.0 115.673 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.54 5.85 44.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.556 1.074 . . . . 0.0 111.736 -176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.53 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 ttp -77.51 131.1 37.75 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 122.041 -0.682 . . . . 0.0 110.012 -169.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -64.86 6.62 0.22 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.553 1.541 . . . . 0.0 113.572 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.1 m 76.88 -40.13 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.388 2.275 . . . . 0.0 116.607 164.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 -85.2 0.62 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -52.47 -27.93 18.21 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.3 m -51.15 -39.19 55.78 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.261 1.391 . . . . 0.0 112.964 169.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 36' ' ' VAL . 24.1 t -57.0 -42.2 78.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.073 1.349 . . . . 0.0 112.771 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -59.96 -40.41 88.93 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 0.0 111.434 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -66.3 -44.72 82.69 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 121.989 -0.445 . . . . 0.0 111.594 175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -45.75 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 119.229 -0.415 . . . . 0.0 109.962 -174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -52.92 -51.4 61.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.525 1.13 . . . . 0.0 110.45 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.6 t -70.71 -37.18 73.52 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.6 m -74.28 -41.36 61.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.57 1.148 . . . . 0.0 110.329 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.61 -48.17 41.8 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 116.899 -1.524 . . . . 0.0 110.66 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.6 t -72.83 14.64 0.25 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 121.312 1.869 . . . . 0.0 113.588 -172.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.45 -6.85 15.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.12 1.768 . . . . 0.0 112.108 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 30' ' ' TYR . 28.9 mt -73.29 129.44 38.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 120.909 -1.119 . . . . 0.0 109.167 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -60.22 -17.59 42.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -170.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -96.61 -8.56 31.42 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 171.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.3 p -94.54 138.6 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 121.604 2.002 . . . . 0.0 109.725 -173.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.2 t -107.77 -12.98 15.11 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.819 . . . . 0.0 113.165 -174.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m 179.17 174.63 0.72 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.82 2.448 . . . . 0.0 111.769 -177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -172.73 154.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.694 2.398 . . . . 0.0 109.468 -172.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.9 t -148.28 129.8 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.464 2.305 . . . . 0.0 108.162 165.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 18' ' ' VAL . 78.9 t -103.62 136.63 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 122.701 1.238 . . . . 0.0 111.739 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 m -78.29 93.23 4.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.577 169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.527 HD12 HG21 ' A' ' 18' ' ' VAL . 21.1 tp -54.9 -43.41 73.23 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.714 0.806 . . . . 0.0 112.981 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.95 -44.02 19.65 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 125.187 1.395 . . . . 0.0 112.587 172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -111.41 -170.93 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.286 2.634 . . . . 0.0 114.646 -168.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.2 mmm-85 -101.18 19.15 18.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.233 1.813 . . . . 0.0 114.376 -176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.5 p -136.55 156.61 48.34 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 -167.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.36 136.95 49.63 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.495 1.918 . . . . 0.0 110.572 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.14 122.03 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 168.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.479 ' CG1' HD13 ' A' ' 57' ' ' LEU . 39.9 t -123.42 120.61 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 125.192 1.397 . . . . 0.0 108.996 -166.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.49 111.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 125.515 1.526 . . . . 0.0 109.14 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CD1' HD11 ' A' ' 57' ' ' LEU . 38.9 p90 -123.23 157.86 32.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.48 1.112 . . . . 0.0 112.821 -173.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -98.37 108.09 20.7 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.012 -1.055 . . . . 0.0 111.879 -169.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.76 147.29 2.22 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.014 1.325 . . . . 0.0 110.817 -175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 m -82.26 2.48 31.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.536 -0.727 . . . . 0.0 111.881 168.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.4 m -122.52 152.81 39.98 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.157 1.383 . . . . 0.0 111.06 -171.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 p -85.76 112.27 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -148.23 72.47 11.05 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 125.224 1.41 . . . . 0.0 108.835 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.64 -12.98 20.26 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.034 3.156 . . . . 0.0 113.506 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -55.96 -48.0 76.59 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.276 1.43 . . . . 0.0 111.479 -172.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -67.6 -29.16 68.43 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.275 -0.891 . . . . 0.0 112.373 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 47' ' ' TYR . 54.2 mt -70.83 -49.22 48.62 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.02 172.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -52.8 -48.23 67.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.362 1.065 . . . . 0.0 110.648 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -56.86 -40.52 76.3 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 169.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.66 -37.05 85.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 120.541 1.519 . . . . 0.0 112.128 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.5 mt -63.37 -54.85 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.051 0.54 . . . . 0.0 109.923 172.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -50.81 -33.68 24.58 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.353 175.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.62 5.12 13.98 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -101.46 -26.7 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.981 1.312 . . . . 0.0 111.725 176.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.51 65.99 8.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.793 0.837 . . . . 0.0 110.633 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.9 143.86 92.21 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.113 3.209 . . . . 0.0 112.583 -175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.58 -33.51 3.01 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.882 1.229 . . . . 0.0 113.183 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 tp -85.72 -46.66 10.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.545 1.538 . . . . 0.0 111.631 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -73.97 106.19 5.55 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -71.64 39.02 0.06 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.405 1.882 . . . . 0.0 114.893 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.55 125.44 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -166.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 74.3 m -137.43 156.68 47.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.245 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.7 mt -95.63 127.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.355 1.462 . . . . 0.0 109.152 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.93 105.47 17.39 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.774 0.829 . . . . 0.0 109.703 -177.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.3 m -161.23 162.07 31.04 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.8 1.24 . . . . 0.0 110.952 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -80.87 68.4 7.11 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.339 1.456 . . . . 0.0 111.013 -172.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.342 173.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.3 t30 . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -125.78 167.08 15.67 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.221 3.009 . . . . 0.0 113.162 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 t -102.07 -172.69 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.356 1.462 . . . . 0.0 111.869 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.28 149.76 10.46 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.054 1.342 . . . . 0.0 109.711 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.15 162.46 41.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.948 1.699 . . . . 0.0 110.816 169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 m -119.83 140.06 51.38 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 109.576 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 7.5 m-85 -140.71 143.68 35.17 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.819 0.848 . . . . 0.0 111.601 -177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.21 131.07 48.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 123.944 0.898 . . . . 0.0 110.957 -174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.77 128.63 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.497 -168.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.67 116.65 29.15 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.406 -0.809 . . . . 0.0 108.967 164.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.24 -12.55 8.02 Favored Glycine 0 N--CA 1.466 0.692 0 C-N-CA 124.062 0.839 . . . . 0.0 113.236 170.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.468 ' HG3' ' H ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -63.86 146.35 54.15 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 118.1 0.95 . . . . 0.0 111.462 175.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -62.05 2.21 0.24 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.706 2.002 . . . . 0.0 115.737 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 12' ' ' MET . 99.2 m 64.63 26.92 13.25 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 166.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.38 -99.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 128.638 2.775 . . . . 0.0 106.597 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 m -52.76 -26.87 15.49 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 122.1 2.227 . . . . 0.0 115.456 -175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.1 -38.57 39.23 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-N 120.19 1.359 . . . . 0.0 112.288 170.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.636 HG22 HG11 ' A' ' 36' ' ' VAL . 28.5 t -53.83 -41.38 48.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 C-N-CA 125.107 1.363 . . . . 0.0 113.653 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.9 t -62.6 -38.22 89.29 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.819 0.447 . . . . 0.0 111.572 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -68.21 -45.95 71.91 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.174 0.589 . . . . 0.0 111.947 173.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.71 -44.03 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 119.284 -0.388 . . . . 0.0 110.348 -173.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -54.25 -49.17 70.13 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.905 1.282 . . . . 0.0 110.423 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.0 m -68.45 -44.17 75.44 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 m -70.66 -39.52 73.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.764 1.226 . . . . 0.0 111.253 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.78 -51.48 16.29 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.436 -1.269 . . . . 0.0 110.565 175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 t -74.91 17.96 0.2 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 120.685 1.584 . . . . 0.0 113.394 -171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.86 -0.5 13.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.491 1.916 . . . . 0.0 112.178 171.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.1 mt -74.61 135.43 42.02 Favored 'General case' 0 C--N 1.343 0.301 0 O-C-N 120.675 -1.266 . . . . 0.0 111.103 -173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -47.85 -19.11 0.21 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.464 2.305 . . . . 0.0 116.355 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -7.96 11.62 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.231 1.813 . . . . 0.0 115.621 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.23 136.13 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 121.739 2.063 . . . . 0.0 111.938 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 t -89.95 -33.91 16.22 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.45 1.5 . . . . 0.0 111.847 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -173.98 176.06 2.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.771 1.628 . . . . 0.0 112.394 -168.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -172.77 154.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 127.324 2.25 . . . . 0.0 109.981 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.5 t -147.29 128.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.327 2.251 . . . . 0.0 108.045 166.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.636 HG11 HG22 ' A' ' 18' ' ' VAL . 77.0 t -102.31 135.94 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.682 1.23 . . . . 0.0 111.595 170.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -77.02 94.36 3.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.122 169.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HA ' HG21 ' A' ' 18' ' ' VAL . 25.9 tp -55.02 -38.42 67.9 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -51.78 -48.39 63.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.503 1.121 . . . . 0.0 111.104 175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -96.99 -170.56 2.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 129.791 3.237 . . . . 0.0 113.487 -169.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.11 34.94 3.33 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.217 1.407 . . . . 0.0 112.639 172.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.0 p -142.83 153.22 43.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 -169.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.87 136.33 50.3 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.881 2.072 . . . . 0.0 110.812 -173.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.2 mt -106.9 116.87 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 169.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.401 ' CG1' HD13 ' A' ' 57' ' ' LEU . 18.3 t -118.81 132.23 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.11 1.364 . . . . 0.0 107.704 -169.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.8 t -118.98 101.45 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 -169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CD1' HD11 ' A' ' 57' ' ' LEU . 37.8 p90 -122.02 141.63 51.15 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -168.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -86.03 129.9 34.7 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.796 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -174.99 127.82 0.29 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.468 1.107 . . . . 0.0 111.489 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.0 t -81.34 -8.8 59.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 171.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.2 m 176.23 106.41 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.572 2.749 . . . . 0.0 111.226 169.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.44 156.63 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.667 1.987 . . . . 0.0 107.737 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 55' ' ' GLU . 27.8 m -81.18 135.36 50.97 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.382 1.073 . . . . 0.0 110.246 -177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -60.34 -21.93 69.07 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.101 3.201 . . . . 0.0 112.664 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.43 ' H ' HG22 ' A' ' 53' ' ' THR . 15.1 tp10 -47.55 -26.63 1.49 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.731 1.612 . . . . 0.0 112.811 168.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -69.38 -42.45 75.13 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.046 -1.034 . . . . 0.0 112.722 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.545 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.6 mt -68.92 -43.54 74.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.518 -0.753 . . . . 0.0 110.852 170.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -50.4 -46.96 56.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.35 0.977 . . . . 0.0 111.094 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.29 -26.88 64.0 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.94 90.92 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 121.574 1.988 . . . . 0.0 110.361 168.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -65.28 -56.48 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.745 -0.597 . . . . 0.0 110.917 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -56.96 -19.8 20.14 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.06 0.4 56.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -89.76 -32.89 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.838 0.855 . . . . 0.0 111.332 176.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -145.93 67.13 12.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 123.064 0.546 . . . . 0.0 111.373 169.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.74 139.02 88.98 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 124.219 3.279 . . . . 0.0 112.224 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.31 -33.85 3.14 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.973 1.273 . . . . 0.0 113.146 -173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.4 tp -78.7 -46.94 17.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.896 0.848 . . . . 0.0 110.07 170.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.2 m-30 -84.54 122.84 29.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.892 1.677 . . . . 0.0 113.844 -171.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -111.33 105.36 13.98 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.831 1.652 . . . . 0.0 108.408 169.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.9 t -110.86 135.1 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-N 120.889 1.677 . . . . 0.0 111.402 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 81.1 p -126.46 156.0 41.37 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.241 0.543 . . . . 0.0 111.795 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 91.4 mt -92.9 121.95 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.171 1.388 . . . . 0.0 109.264 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.27 102.62 12.8 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.153 0.581 . . . . 0.0 110.088 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.0 m -164.04 160.34 21.59 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.146 1.779 . . . . 0.0 108.662 177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -76.76 114.63 15.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.437 1.495 . . . . 0.0 109.119 169.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 125.035 1.334 . . . . 0.0 111.897 -174.32 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.2 t30 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.62 155.35 3.13 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.961 1.304 . . . . 0.0 112.017 167.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.1 t -89.95 177.8 6.38 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 122.223 1.011 . . . . 0.0 111.832 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -161.19 147.62 14.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.796 1.238 . . . . 0.0 110.363 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.0 159.37 44.61 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.317 1.047 . . . . 0.0 111.978 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 26.3 m -116.28 137.1 52.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.598 1.559 . . . . 0.0 109.98 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -136.35 143.94 44.35 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.089 1.356 . . . . 0.0 110.311 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.2 tt -133.44 134.13 57.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 110.986 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.9 111.26 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.522 1.129 . . . . 0.0 110.877 -169.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.73 92.45 8.6 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.01 -34.2 0.61 Allowed Glycine 0 N--CA 1.475 1.236 0 C-N-CA 124.343 0.973 . . . . 0.0 114.159 -177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 5.2 ptm -58.71 126.94 29.75 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.268 0.627 . . . . 0.0 110.905 -173.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.429 ' CD2' ' H ' ' A' ' 13' ' ' HIS . 24.7 m-70 -61.54 41.26 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -169.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.0 m 70.44 -48.25 0.64 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 130.538 3.535 . . . . 0.0 114.908 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -128.29 -69.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.909 0.884 . . . . 0.0 110.852 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -57.38 -18.75 19.16 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 p -50.72 -50.54 55.1 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 119.652 1.115 . . . . 0.0 111.365 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 HG21 HD12 ' A' ' 38' ' ' LEU . 2.1 t -55.65 -43.05 71.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.104 0 C-N-CA 124.303 1.041 . . . . 0.0 111.775 -168.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -66.83 -34.74 78.48 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -65.62 -45.86 81.49 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.81 -1.181 . . . . 0.0 111.039 169.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.59 -39.91 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 -171.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -51.4 -51.58 53.49 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.677 1.191 . . . . 0.0 109.831 168.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.0 m -70.37 -48.14 57.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 m -69.63 -37.74 76.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.371 1.068 . . . . 0.0 111.125 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.38 -51.15 15.89 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.144 -1.408 . . . . 0.0 111.186 175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.31 16.36 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 121.355 1.889 . . . . 0.0 113.739 -174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.35 -5.29 14.66 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.264 1.826 . . . . 0.0 112.227 174.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.57 133.9 44.95 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 120.549 -1.344 . . . . 0.0 109.967 -172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -66.3 0.02 2.33 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -170.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.59 -6.68 11.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 170.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.59 134.43 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 121.581 1.991 . . . . 0.0 111.258 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.7 m -91.41 -25.24 19.45 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.567 0.747 . . . . 0.0 112.942 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.14 175.26 1.91 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.813 1.645 . . . . 0.0 113.177 -170.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -166.51 152.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.036 2.134 . . . . 0.0 109.632 -175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.8 t -140.36 148.92 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 128.147 2.579 . . . . 0.0 105.946 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 18' ' ' VAL . 14.6 p -140.7 150.59 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 112.367 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -91.31 135.55 33.73 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 125.233 1.413 . . . . 0.0 111.682 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 18' ' ' VAL . 10.0 tp -104.06 -30.02 10.52 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.559 1.544 . . . . 0.0 112.607 172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -32.38 68.61 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 126.864 2.065 . . . . 0.0 112.786 169.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -104.89 -174.5 2.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.074 2.15 . . . . 0.0 113.189 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.78 32.95 5.76 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.03 2.532 . . . . 0.0 110.7 -174.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 p -140.17 156.71 46.41 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.042 -1.661 . . . . 0.0 114.728 -167.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.46 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.244 2.218 . . . . 0.0 110.692 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -115.67 116.87 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 ' CG1' HD13 ' A' ' 57' ' ' LEU . 24.1 t -117.37 130.63 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.23 1.412 . . . . 0.0 108.563 -168.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -116.2 105.11 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.085 1.754 . . . . 0.0 108.781 -168.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.606 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -124.92 150.06 46.96 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -168.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -99.48 122.91 43.24 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.359 0.664 . . . . 0.0 111.04 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.9 142.08 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.854 1.662 . . . . 0.0 110.489 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.6 m -66.96 -33.38 75.46 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.513 0.597 . . . . 0.0 111.923 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 52' ' ' VAL . 16.9 t -178.05 153.71 0.82 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.883 2.473 . . . . 0.0 108.845 167.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 51' ' ' SER . 9.0 m 179.78 169.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 131.684 3.994 . . . . 0.0 106.198 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -87.52 135.6 34.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 O-C-N 121.67 -0.644 . . . . 0.0 111.621 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.61 -17.49 54.61 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.686 2.924 . . . . 0.0 111.956 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -52.95 -25.68 12.7 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.594 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 71.8 p -66.76 -44.25 81.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.678 1.191 . . . . 0.0 113.346 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.606 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.4 mt -71.03 -41.6 70.63 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.594 -0.692 . . . . 0.0 110.73 174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -49.21 -48.65 45.19 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.405 1.082 . . . . 0.0 111.016 170.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -60.6 -38.55 85.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.209 1.403 . . . . 0.0 114.554 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.34 -33.56 76.25 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 120.012 1.278 . . . . 0.0 111.551 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.0 mt -70.0 -51.93 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 118.799 -0.619 . . . . 0.0 110.915 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -51.08 -34.45 30.33 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.667 0.667 . . . . 0.0 110.389 176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.9 4.22 14.79 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.432 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -97.5 -30.01 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.952 0.901 . . . . 0.0 111.35 177.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.01 64.57 7.59 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.535 -0.728 . . . . 0.0 111.493 169.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.35 147.56 95.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 124.492 3.462 . . . . 0.0 113.211 -172.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.53 -24.51 3.65 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.794 1.188 . . . . 0.0 114.185 -173.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.37 -36.01 8.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.161 1.384 . . . . 0.0 111.509 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.432 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -76.98 106.08 8.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.7 ttp85 -80.8 71.3 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.085 -1.634 . . . . 0.0 111.654 168.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.6 128.46 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.702 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 m -135.75 146.26 47.46 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.327 1.451 . . . . 0.0 109.298 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 94.2 mt -90.71 126.78 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 120.708 -1.245 . . . . 0.0 108.093 171.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -108.96 113.18 25.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 109.6 168.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.4 t -163.05 157.38 20.72 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.657 1.583 . . . . 0.0 110.54 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -83.79 74.7 10.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 122.958 1.361 . . . . 0.0 109.656 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.725 2.01 . . . . 0.0 110.146 171.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 CA--C 1.549 0.924 0 CA-C-O 120.619 0.247 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -71.16 159.06 35.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.715 1.606 . . . . 0.0 113.476 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -80.32 177.29 9.07 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.947 0.879 . . . . 0.0 110.947 168.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -165.9 145.6 6.33 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.815 1.246 . . . . 0.0 110.23 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.92 166.1 31.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.593 1.557 . . . . 0.0 111.321 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.6 m -127.18 135.54 50.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.449 1.5 . . . . 0.0 110.923 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -131.81 149.18 52.54 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.525 1.53 . . . . 0.0 111.296 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.1 tt -133.99 141.93 42.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 125.376 1.47 . . . . 0.0 111.008 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.2 mp -124.62 108.21 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 123.833 0.708 . . . . 0.0 110.902 -171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -82.95 26.8 0.58 Allowed 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.98 22.48 1.27 Allowed Glycine 0 N--CA 1.475 1.255 0 C-N-CA 125.5 1.524 . . . . 0.0 113.482 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.502 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 1.3 tmt? -84.7 130.39 34.71 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.34 1.056 . . . . 0.0 112.791 -169.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 4.6 m170 -71.45 12.14 0.38 Allowed 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -170.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 t 90.82 -145.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.354 2.661 . . . . 0.0 111.46 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.563 ' HE3' HD13 ' A' ' 38' ' ' LEU . 14.1 mptt -58.75 -30.07 67.23 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.317 -1.49 . . . . 0.0 113.283 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -69.06 -34.42 75.14 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.136 -1.603 . . . . 0.0 112.725 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.2 m -70.34 -38.78 74.93 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-O 116.356 -1.783 . . . . 0.0 113.318 173.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 36' ' ' VAL . 35.5 t -42.57 -53.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-N 120.414 1.461 . . . . 0.0 111.884 172.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -58.87 -39.96 82.92 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -66.64 -39.94 88.48 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 121.722 -0.611 . . . . 0.0 111.986 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.46 -42.58 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.419 0.554 . . . . 0.0 110.118 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.28 -48.49 71.17 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.384 1.074 . . . . 0.0 110.518 169.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.0 m -71.2 -46.71 60.66 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -71.12 -37.16 72.33 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 125.472 1.509 . . . . 0.0 111.5 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -74.73 -49.77 19.87 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.162 170.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.8 t -72.75 15.38 0.2 Allowed 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 121.576 1.989 . . . . 0.0 113.427 -170.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.88 -2.38 16.1 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 112.511 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.0 mt -76.09 137.07 39.91 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.757 -1.214 . . . . 0.0 111.127 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -70.29 31.08 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.767 2.027 . . . . 0.0 114.234 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.16 -3.0 0.1 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.12 2.568 . . . . 0.0 113.945 173.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 7.5 p -99.43 140.84 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 121.505 1.957 . . . . 0.0 108.852 -176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.9 t -112.74 -8.54 13.76 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -176.35 171.95 2.34 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.379 1.871 . . . . 0.0 113.505 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -175.13 154.68 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 127.904 2.482 . . . . 0.0 110.229 -171.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 t -147.67 126.71 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 127.596 2.358 . . . . 0.0 107.518 165.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 18' ' ' VAL . 50.9 t -91.42 134.26 30.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 122.43 1.11 . . . . 0.0 109.865 168.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.9 m -69.83 89.93 0.59 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.483 169.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.563 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.9 tm? -45.49 -43.59 11.77 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.287 2.235 . . . . 0.0 112.011 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -53.06 57.76 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.669 1.188 . . . . 0.0 111.347 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -78.92 -174.73 4.15 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.395 2.278 . . . . 0.0 113.909 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.21 36.6 2.32 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.955 1.702 . . . . 0.0 113.296 169.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.01 154.9 43.75 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.047 -1.658 . . . . 0.0 114.137 -169.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.8 135.08 41.52 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.253 1.821 . . . . 0.0 110.35 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -104.48 119.23 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.8 t -125.81 139.9 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.696 1.198 . . . . 0.0 109.979 -167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.31 112.51 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.709 1.604 . . . . 0.0 109.063 -168.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CD1' HD11 ' A' ' 57' ' ' LEU . 39.5 p90 -131.29 148.4 52.68 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -168.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -90.95 74.06 6.44 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.701 -1.249 . . . . 0.0 112.483 -167.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.18 -162.2 0.89 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.189 0.996 . . . . 0.0 111.283 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -177.24 -51.14 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.538 2.335 . . . . 0.0 108.991 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 p -75.1 55.0 0.71 Allowed 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.73 -1.231 . . . . 0.0 112.399 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.21 150.29 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.267 1.827 . . . . 0.0 109.495 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.6 t -81.3 141.33 49.47 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.041 0.937 . . . . 0.0 112.128 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.16 -15.03 41.53 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.653 2.902 . . . . 0.0 112.474 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -51.16 -23.95 3.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.583 1.153 . . . . 0.0 111.789 169.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.5 p -68.2 -44.83 74.95 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.666 -1.271 . . . . 0.0 113.278 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.8 mt -70.67 -43.6 68.76 Favored 'General case' 0 C--O 1.226 -0.161 0 O-C-N 121.515 -0.741 . . . . 0.0 110.356 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -48.54 -51.92 25.22 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.503 1.121 . . . . 0.0 110.993 172.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -65.26 -30.71 71.61 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.8 -33.36 74.65 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.236 1.38 . . . . 0.0 112.051 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.28 -55.8 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.752 170.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -47.43 -37.34 11.38 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.861 0.755 . . . . 0.0 111.156 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.29 4.63 8.42 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.476 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -98.09 -33.8 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.622 1.569 . . . . 0.0 111.919 174.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.12 61.85 18.93 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 169.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.21 139.8 79.89 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.9 3.067 . . . . 0.0 112.835 -171.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.66 -21.41 14.47 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.193 1.378 . . . . 0.0 114.04 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 tp -102.06 -45.82 5.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.423 1.889 . . . . 0.0 110.59 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' HG12 ' A' ' 64' ' ' VAL . 1.7 m-30 -64.99 100.98 0.46 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.066 1.346 . . . . 0.0 114.509 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -77.8 73.68 4.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.908 1.283 . . . . 0.0 111.321 172.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.04 132.92 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-O 121.755 0.788 . . . . 0.0 111.976 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.5 m -145.89 166.24 26.56 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.632 1.573 . . . . 0.0 110.858 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.6 mt -99.09 132.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.913 1.685 . . . . 0.0 108.059 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -114.67 114.02 25.11 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.6 m -164.56 159.9 19.66 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.943 1.297 . . . . 0.0 111.929 -174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -77.15 45.05 0.43 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.39 2.276 . . . . 0.0 113.145 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.483 1.19 0 C-N-CA 125.672 1.589 . . . . 0.0 113.546 -167.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.75 157.13 33.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 123.968 1.842 . . . . 0.0 113.057 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.7 t -100.69 -176.73 3.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.04 2.536 . . . . 0.0 110.969 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -163.06 148.57 11.78 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.849 1.26 . . . . 0.0 110.112 -175.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.12 162.89 40.79 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 125.243 1.417 . . . . 0.0 110.974 173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.0 m -121.43 137.86 54.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.726 1.21 . . . . 0.0 109.622 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -137.51 147.08 44.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.235 1.414 . . . . 0.0 110.202 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 tt -132.52 137.48 54.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 124.696 1.198 . . . . 0.0 110.603 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.97 99.24 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.703 1.601 . . . . 0.0 111.255 -171.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.25 101.23 10.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.265 1.031 . . . . 0.0 110.609 170.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.98 -7.88 4.14 Favored Glycine 0 N--CA 1.471 1.015 0 C-N-CA 124.776 1.179 . . . . 0.0 114.855 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -64.71 143.36 57.98 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.892 1.346 . . . . 0.0 112.026 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -67.21 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 126.705 2.002 . . . . 0.0 114.89 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.9 m 54.5 -131.61 1.96 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.962 2.105 . . . . 0.0 112.033 173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HE3' HD22 ' A' ' 38' ' ' LEU . 3.5 tptt -48.5 -32.87 8.53 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.565 1.946 . . . . 0.0 114.151 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.1 m -91.18 -29.27 17.34 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -37.92 89.23 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.971 1.26 . . . . 0.0 111.23 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 38' ' ' LEU . 49.1 t -37.73 -58.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.565 1.546 . . . . 0.0 112.277 169.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -55.28 -43.77 75.06 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 124.025 0.93 . . . . 0.0 111.929 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -62.95 -42.64 99.88 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.571 -0.705 . . . . 0.0 112.602 176.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.02 -44.18 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.807 -176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -56.71 -51.1 70.12 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.368 1.067 . . . . 0.0 110.064 172.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -35.94 79.27 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.9 m -75.81 -37.73 58.85 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.653 0.781 . . . . 0.0 110.383 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -50.36 17.91 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.903 175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 t -74.53 12.84 0.7 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.765 1.166 . . . . 0.0 112.765 -170.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.47 -7.19 18.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.507 1.523 . . . . 0.0 111.942 174.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 27.0 mt -78.29 126.65 31.09 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.24 -11.81 7.3 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.47 -13.06 24.87 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 169.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.98 140.46 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 121.789 2.086 . . . . 0.0 108.866 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.1 t -96.52 -29.49 13.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.368 1.467 . . . . 0.0 111.666 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -176.07 174.6 2.05 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.684 1.594 . . . . 0.0 112.336 -172.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -174.59 150.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.631 1.972 . . . . 0.0 110.521 -172.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.4 t -143.82 132.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 127.352 2.261 . . . . 0.0 108.053 167.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' CG1' HG13 ' A' ' 18' ' ' VAL . 38.9 t -107.12 143.32 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.078 0.951 . . . . 0.0 111.277 170.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 40' ' ' ASN . 9.5 t -74.79 108.31 7.45 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 165.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 18' ' ' VAL . 3.7 mt -47.3 -25.84 1.08 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.753 2.021 . . . . 0.0 114.459 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.34 -35.48 6.26 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 128.913 2.885 . . . . 0.0 114.243 -174.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 24.6 m-80 -83.91 -175.15 5.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.718 0.407 . . . . 0.0 110.539 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER -112.97 39.31 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 175.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -141.44 155.7 45.85 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.461 -1.399 . . . . 0.0 113.046 -171.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.56 137.55 50.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 126.737 2.015 . . . . 0.0 110.041 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.4 mt -106.18 114.62 45.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.539 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.6 t -121.08 130.51 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.756 1.222 . . . . 0.0 108.487 -168.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.6 t -117.59 117.55 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.472 1.909 . . . . 0.0 107.434 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.555 ' CD1' HD11 ' A' ' 57' ' ' LEU . 19.8 p90 -139.21 155.21 47.96 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 120.613 1.551 . . . . 0.0 113.233 -168.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -99.24 117.08 32.91 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 120.122 -1.611 . . . . 0.0 113.688 -167.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.34 151.33 3.76 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.172 1.389 . . . . 0.0 112.221 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -90.53 52.92 2.31 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 168.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.4 m -175.43 154.0 1.59 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -175.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -92.19 88.59 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.24 1.016 . . . . 0.0 109.792 170.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -120.98 68.35 16.49 Favored Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 124.731 1.212 . . . . 0.0 110.905 -175.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.65 -11.17 15.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.915 3.076 . . . . 0.0 114.82 -173.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -55.97 -35.85 67.19 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.206 1.002 . . . . 0.0 113.094 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 76.7 p -69.39 -41.48 76.39 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.318 -0.864 . . . . 0.0 113.243 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.1 mt -64.81 -49.0 72.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.549 -0.739 . . . . 0.0 110.88 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.27 -56.63 6.4 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.861 1.264 . . . . 0.0 110.36 173.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -51.7 -41.82 61.76 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.75 67.59 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 119.104 0.865 . . . . 0.0 112.954 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.4 mt -69.95 -56.37 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.959 0.904 . . . . 0.0 109.65 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -50.66 -31.68 16.97 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.707 0.803 . . . . 0.0 111.812 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.43 4.16 28.88 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.505 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -97.64 -31.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.43 1.092 . . . . 0.0 111.239 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.37 65.83 9.67 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.463 -0.773 . . . . 0.0 111.085 167.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.93 141.96 96.14 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.98 3.12 . . . . 0.0 112.112 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.71 -28.54 4.87 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.756 1.17 . . . . 0.0 113.454 -174.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.6 tp -92.12 -44.16 8.97 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.185 1.394 . . . . 0.0 111.633 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.7 m-30 -72.67 99.73 2.64 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -170.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 78.14 0.64 Allowed 'General case' 0 N--CA 1.475 0.782 0 O-C-N 120.332 -1.48 . . . . 0.0 109.326 167.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -79.95 135.37 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.464 1.125 . . . . 0.0 111.684 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.2 m -150.9 158.11 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.951 1.7 . . . . 0.0 111.238 172.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.8 mt -98.93 126.17 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.896 1.679 . . . . 0.0 109.48 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.8 72.32 10.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.286 1.034 . . . . 0.0 111.559 -173.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -122.87 163.25 20.65 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.11 133.33 41.55 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 CA--C 1.543 0.711 0 C-N-CA 127.841 2.456 . . . . 0.0 108.563 -175.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.9 m120 . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 120.957 0.408 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -65.49 146.75 54.47 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.998 1.319 . . . . 0.0 111.758 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.3 t -95.24 176.61 6.15 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.92 1.688 . . . . 0.0 111.746 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -160.65 140.58 11.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.924 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.51 161.28 38.29 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 125.017 1.327 . . . . 0.0 109.911 169.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.4 m -123.32 136.21 54.56 Favored 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 123.75 0.82 . . . . 0.0 109.036 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.48 147.49 52.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.222 -173.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -135.56 133.6 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 124.266 1.026 . . . . 0.0 110.847 -176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.66 116.0 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.969 -169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -81.12 5.31 17.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.39 22.22 1.07 Allowed Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.02 1.771 . . . . 0.0 115.395 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.85 146.02 49.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.215 2.008 . . . . 0.0 112.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.433 ' CG ' ' SG ' ' A' ' 17' ' ' CYS . 3.0 m170 -74.0 23.3 0.08 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.714 1.606 . . . . 0.0 113.3 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.1 t 76.51 -141.63 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.23 2.212 . . . . 0.0 111.182 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -55.94 -36.31 67.62 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.423 -1.423 . . . . 0.0 114.182 -173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.8 m -69.98 -34.17 73.02 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.257 -1.527 . . . . 0.0 112.074 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' CG ' ' A' ' 13' ' ' HIS . 1.0 OUTLIER -67.86 -42.38 81.42 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 116.068 -1.92 . . . . 0.0 112.587 173.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.599 HG13 HG11 ' A' ' 36' ' ' VAL . 9.3 t -40.6 -55.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.96 1.255 . . . . 0.0 111.351 174.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.0 t -62.57 -37.68 87.13 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -62.75 -42.03 99.49 Favored 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.159 -0.963 . . . . 0.0 111.963 171.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.74 -42.68 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 118.919 0.781 . . . . 0.0 110.034 -174.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -52.86 -53.29 51.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.997 0.919 . . . . 0.0 110.17 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.1 m -70.52 -44.79 66.83 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.8 m -70.07 -36.03 74.65 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.132 1.773 . . . . 0.0 110.846 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.49 -50.45 18.19 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 117.665 -1.16 . . . . 0.0 111.871 172.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.8 t -68.12 12.53 0.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 120.466 1.485 . . . . 0.0 114.139 -174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.5 1.85 18.48 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.649 1.98 . . . . 0.0 111.809 175.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.6 mt -81.08 129.75 34.7 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 120.854 -1.154 . . . . 0.0 110.127 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -58.93 -1.46 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.38 -8.08 11.09 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 116.258 1.948 . . . . 0.0 116.258 170.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.3 p -92.22 135.7 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 121.772 2.078 . . . . 0.0 110.926 -169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 47' ' ' TYR . 19.5 m -92.65 -25.02 18.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.265 1.426 . . . . 0.0 111.889 -173.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m 178.89 175.97 0.58 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.545 2.338 . . . . 0.0 112.726 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.8 tt -174.04 152.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 127.136 2.174 . . . . 0.0 109.49 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.4 t -144.07 131.71 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 126.087 1.755 . . . . 0.0 107.448 166.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.599 HG11 HG13 ' A' ' 18' ' ' VAL . 13.7 t -94.47 135.52 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 123.073 1.416 . . . . 0.0 109.505 168.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.0 m -67.41 90.62 0.24 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.063 167.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.436 ' HG ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -55.68 -31.45 62.41 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.577 1.151 . . . . 0.0 112.638 -171.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.14 -59.77 4.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.982 0.81 . . . . 0.0 111.116 169.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -72.58 -176.36 1.91 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 125.356 2.503 . . . . 0.0 114.027 -171.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 31.85 3.19 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.554 2.342 . . . . 0.0 113.024 170.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.2 p -137.38 160.17 39.84 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.704 -1.872 . . . . 0.0 115.056 -169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.71 136.79 44.88 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.228 1.811 . . . . 0.0 110.683 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.6 mt -104.1 112.68 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 104.573 -2.38 . . . . 0.0 104.573 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 ' CG1' HD13 ' A' ' 57' ' ' LEU . 20.9 t -116.66 130.5 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.474 1.509 . . . . 0.0 108.339 -168.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.69 114.51 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.247 1.419 . . . . 0.0 108.038 -168.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CD1' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -132.86 155.22 49.4 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 120.457 1.481 . . . . 0.0 113.373 -168.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -94.18 122.04 36.3 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.362 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.31 155.01 3.42 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.968 1.707 . . . . 0.0 111.218 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.5 p -89.28 30.29 1.0 Allowed 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.699 -1.251 . . . . 0.0 111.038 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.6 t -168.54 169.26 10.47 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -171.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -102.13 117.79 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.868 2.067 . . . . 0.0 109.784 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -154.46 58.72 2.18 Favored Pre-proline 0 N--CA 1.481 1.078 0 C-N-CA 125.75 1.62 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.83 -19.59 52.71 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.609 2.873 . . . . 0.0 113.127 -172.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.31 -18.32 3.9 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.5 m -82.58 -40.34 21.03 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 121.03 1.741 . . . . 0.0 112.702 169.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.0 mt -67.65 -45.52 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.219 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -48.38 -46.93 37.7 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 119.278 0.944 . . . . 0.0 110.643 170.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.34 -35.49 79.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 117.373 -1.299 . . . . 0.0 113.438 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.15 -31.07 71.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.789 1.631 . . . . 0.0 112.28 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -72.82 -57.77 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.992 0.917 . . . . 0.0 109.699 172.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -55.59 -16.23 3.79 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.931 1.293 . . . . 0.0 113.737 176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.03 -0.42 57.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 174.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.518 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -90.87 -35.59 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 118.956 0.798 . . . . 0.0 111.457 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -141.22 63.32 17.74 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 169.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -56.35 143.52 86.02 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 124.364 3.376 . . . . 0.0 114.231 -172.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.9 -31.35 2.81 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.28 1.419 . . . . 0.0 113.502 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.28 -40.99 11.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.881 1.673 . . . . 0.0 110.395 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.518 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.0 m-30 -75.31 93.91 2.95 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.164 -0.96 . . . . 0.0 113.421 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -71.97 121.01 18.38 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 161.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.7 t -129.51 136.33 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 123.754 2.979 . . . . 0.0 111.832 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.6 m -134.91 156.57 48.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.135 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 60.1 mt -89.38 130.3 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.144 1.378 . . . . 0.0 108.391 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.2 t -126.68 107.71 10.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.387 1.089 . . . . 0.0 111.456 174.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 p -146.33 155.03 42.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.343 1.057 . . . . 0.0 111.578 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -80.66 66.62 6.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 123.094 1.426 . . . . 0.0 111.398 -175.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 126.41 1.884 . . . . 0.0 110.889 174.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m120 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -83.65 159.21 21.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.212 1.005 . . . . 0.0 110.105 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 t -87.84 173.8 8.73 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.096 0.951 . . . . 0.0 110.592 168.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -163.95 148.05 10.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.074 1.35 . . . . 0.0 110.051 -170.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.66 159.82 37.37 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.484 1.513 . . . . 0.0 111.387 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -125.77 136.56 53.29 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.991 1.316 . . . . 0.0 110.148 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -134.39 145.77 49.25 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.925 1.29 . . . . 0.0 111.156 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.6 tt -121.74 145.12 28.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 125.244 1.417 . . . . 0.0 109.273 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.4 168.67 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 124.567 1.147 . . . . 0.0 107.943 177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -152.82 125.44 8.28 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.036 -1.04 . . . . 0.0 109.145 168.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.81 -6.49 44.19 Favored Glycine 0 N--CA 1.479 1.543 0 C-N-CA 124.613 1.101 . . . . 0.0 113.292 -169.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.35 141.31 47.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.488 1.515 . . . . 0.0 112.267 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -51.68 -46.21 63.72 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 116.576 2.065 . . . . 0.0 116.576 -167.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 p 160.81 -65.61 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.427 1.891 . . . . 0.0 113.848 -171.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 -57.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 127.136 2.175 . . . . 0.0 109.217 -166.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -20.01 21.03 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.121 0.968 . . . . 0.0 113.448 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.7 p -56.28 -48.8 75.89 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.113 -0.946 . . . . 0.0 111.256 168.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.33 -49.88 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.825 2.05 . . . . 0.0 111.153 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 t -65.61 -35.73 81.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.429 1.092 . . . . 0.0 112.929 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -63.26 -39.59 95.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.564 -1.335 . . . . 0.0 111.976 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -30.4 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.54 -175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -59.35 -56.68 18.97 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.511 0.725 . . . . 0.0 109.752 167.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 t -70.19 -41.47 73.67 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 115.772 1.767 . . . . 0.0 115.772 -171.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.0 m -73.77 -34.81 64.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.595 1.158 . . . . 0.0 110.946 -176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -52.06 12.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.258 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.5 t -71.08 16.27 0.09 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.988 1.722 . . . . 0.0 113.773 -172.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.4 -5.01 15.96 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.744 2.018 . . . . 0.0 112.074 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 60' ' ' ALA . 16.7 mt -77.72 130.24 36.52 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 120.858 -1.151 . . . . 0.0 109.508 -172.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -59.03 -17.35 24.62 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -97.59 -8.17 29.56 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -92.78 140.78 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 122.105 2.23 . . . . 0.0 110.091 -173.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.4 m -98.06 -24.29 15.4 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.0 1.32 . . . . 0.0 111.878 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m 178.73 173.26 0.72 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.704 2.001 . . . . 0.0 113.246 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -168.25 153.19 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.917 2.087 . . . . 0.0 110.552 -174.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.19 151.18 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 129.089 2.955 . . . . 0.0 106.131 168.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.27 151.56 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 122.035 0.922 . . . . 0.0 111.738 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -74.13 123.83 25.18 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.615 1.166 . . . . 0.0 109.174 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.49 -42.7 24.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.817 1.189 . . . . 0.0 112.089 172.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -61.2 -63.96 1.11 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.106 1.321 . . . . 0.0 109.614 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -85.4 168.49 14.56 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 122.878 1.323 . . . . 0.0 113.693 -169.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.19 44.92 1.15 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -140.91 150.23 42.92 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 140.61 52.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.161 2.184 . . . . 0.0 111.174 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.2 mt -111.06 115.87 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.29 136.48 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.893 1.277 . . . . 0.0 109.214 -166.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 69.9 t -124.24 113.67 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.233 1.413 . . . . 0.0 108.122 -168.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.3 p90 -130.64 154.1 48.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.698 1.199 . . . . 0.0 113.857 -168.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -93.12 113.01 25.14 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.028 -1.045 . . . . 0.0 110.595 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.14 142.22 0.48 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.306 1.442 . . . . 0.0 110.805 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -76.48 -3.07 35.31 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.64 -0.663 . . . . 0.0 111.591 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.0 m -111.52 126.16 54.68 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.08 1.352 . . . . 0.0 111.227 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 m -72.27 82.59 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.67 0.788 . . . . 0.0 109.878 168.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.6 m -119.37 64.89 7.98 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 125.162 1.385 . . . . 0.0 110.021 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.51 -17.5 53.35 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.956 3.104 . . . . 0.0 113.053 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.04 -8.97 53.6 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.514 1.052 . . . . 0.0 112.802 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.3 p -68.26 -49.59 59.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 119.767 1.167 . . . . 0.0 110.736 169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 47' ' ' TYR . 78.6 mt -65.81 -43.78 87.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 117.445 -1.264 . . . . 0.0 111.04 176.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -47.39 -50.03 23.41 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 120.255 1.389 . . . . 0.0 112.788 174.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -38.07 87.68 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 174.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.457 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.83 -33.97 76.36 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.359 1.436 . . . . 0.0 112.341 173.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.1 mt -69.77 -52.51 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.605 172.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -50.36 -35.86 29.87 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.264 0.938 . . . . 0.0 110.941 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.88 3.32 12.29 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -98.67 -29.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.282 1.033 . . . . 0.0 111.786 177.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.01 66.98 9.86 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.912 0.885 . . . . 0.0 110.347 168.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.64 140.27 80.04 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.098 3.199 . . . . 0.0 111.872 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.62 -22.16 6.79 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.626 1.107 . . . . 0.0 113.666 -173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 tp -99.46 -29.26 12.84 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.297 1.439 . . . . 0.0 112.732 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.0 m-30 -92.3 105.59 17.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -171.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 6.4 ttt180 -69.96 47.49 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 127.241 2.216 . . . . 0.0 115.046 171.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -60.8 121.33 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 120.325 -1.485 . . . . 0.0 113.588 -168.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -134.9 152.18 51.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.223 1.409 . . . . 0.0 110.747 -177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.3 mt -90.91 130.32 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 120.739 -1.225 . . . . 0.0 108.086 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.6 t -110.9 115.33 29.32 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 109.462 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.3 t -164.85 174.95 10.05 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.477 1.511 . . . . 0.0 111.926 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -70.99 65.61 0.36 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.169 2.188 . . . . 0.0 111.74 175.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 125.172 1.389 . . . . 0.0 112.768 171.742 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -95.07 158.12 15.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.808 1.243 . . . . 0.0 110.543 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.6 t -91.76 -179.16 5.25 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.393 1.477 . . . . 0.0 111.17 172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -165.54 155.12 12.53 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.548 1.539 . . . . 0.0 109.861 -170.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -161.37 161.25 30.34 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.14 1.776 . . . . 0.0 111.436 173.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.5 m -122.44 141.58 51.46 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.546 1.539 . . . . 0.0 110.432 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -145.1 141.26 28.66 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.36 1.464 . . . . 0.0 111.171 -172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -130.68 134.39 62.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 124.957 1.303 . . . . 0.0 111.46 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -120.32 103.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.585 1.954 . . . . 0.0 111.908 -170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.27 127.62 32.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.529 -1.357 . . . . 0.0 110.315 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.57 39.38 Favored Glycine 0 N--CA 1.47 0.934 0 O-C-N 121.69 -0.631 . . . . 0.0 111.952 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.4 ptm -59.38 142.0 53.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.012 -1.106 . . . . 0.0 108.012 167.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -61.29 11.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.826 1.65 . . . . 0.0 115.025 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 m 70.76 -23.08 0.17 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.437 2.295 . . . . 0.0 116.059 168.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.07 -87.16 0.34 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.903 1.681 . . . . 0.0 106.692 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -55.88 -23.38 30.8 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.034 -1.666 . . . . 0.0 114.699 177.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.55 -37.71 88.35 Favored 'General case' 0 C--N 1.348 0.507 0 CA-C-O 116.824 -1.56 . . . . 0.0 113.034 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 82.0 t -50.46 -46.44 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.089 1.356 . . . . 0.0 109.985 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 t -67.92 -37.81 82.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.596 1.558 . . . . 0.0 114.105 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -63.13 -39.23 94.09 Favored 'General case' 0 C--O 1.224 -0.258 0 O-C-N 120.796 -1.19 . . . . 0.0 110.95 169.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.67 -40.4 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 117.857 -1.068 . . . . 0.0 109.519 -176.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -52.37 -55.29 22.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.983 0.913 . . . . 0.0 110.262 168.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 t -70.56 -42.48 71.08 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -73.14 -36.35 66.65 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.84 1.256 . . . . 0.0 110.731 -175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -49.56 18.58 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 117.522 -1.228 . . . . 0.0 111.559 172.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.3 t -71.6 17.23 0.09 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 120.879 1.672 . . . . 0.0 113.722 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 -2.48 16.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.895 1.678 . . . . 0.0 112.545 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 mt -77.5 135.83 38.28 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 120.779 -1.201 . . . . 0.0 111.309 -169.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -54.71 -9.66 0.36 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.87 -5.58 9.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.855 1.662 . . . . 0.0 115.075 176.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -91.91 138.23 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 121.65 2.023 . . . . 0.0 110.58 -170.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 t -94.82 -30.54 14.16 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.994 1.318 . . . . 0.0 111.345 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -174.57 174.54 2.68 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 123.36 1.552 . . . . 0.0 113.054 -170.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 tt -165.93 151.06 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.244 2.217 . . . . 0.0 109.356 -176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.23 147.01 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 127.699 2.4 . . . . 0.0 106.286 167.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 p -137.79 152.71 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.086 0.555 . . . . 0.0 109.789 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.3 t -84.78 144.35 28.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.556 0.693 . . . . 0.0 111.743 171.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.14 -20.86 23.73 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 173.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.69 -60.39 1.98 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.416 1.087 . . . . 0.0 108.385 168.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -78.79 143.23 36.28 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 122.061 0.934 . . . . 0.0 110.967 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -80.34 42.61 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.086 0.955 . . . . 0.0 112.672 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 p -140.68 150.67 43.78 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.132 -1.605 . . . . 0.0 113.999 -172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.91 146.26 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.096 2.158 . . . . 0.0 110.584 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.26 116.45 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 170.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.442 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.5 t -119.03 133.76 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.867 1.267 . . . . 0.0 108.418 -167.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.1 t -120.73 109.79 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.786 1.634 . . . . 0.0 108.146 -167.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.567 ' CD1' HD11 ' A' ' 57' ' ' LEU . 33.6 p90 -127.08 146.68 50.28 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.067 -1.021 . . . . 0.0 113.718 -168.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.95 119.23 26.03 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.372 -0.83 . . . . 0.0 110.543 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.17 146.2 2.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.942 2.097 . . . . 0.0 109.102 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -89.08 23.93 2.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.821 1.249 . . . . 0.0 111.429 171.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.8 t -159.32 176.5 12.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.054 1.342 . . . . 0.0 110.404 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.8 m -94.45 129.32 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.231 1.012 . . . . 0.0 110.721 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.0 t -146.43 51.54 1.23 Allowed Pre-proline 0 N--CA 1.482 1.161 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -57.69 -25.02 66.0 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.175 3.25 . . . . 0.0 113.211 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -49.28 -40.64 35.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.242 1.017 . . . . 0.0 112.174 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 -38.2 67.59 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 120.938 -1.101 . . . . 0.0 112.416 -176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 47' ' ' TYR . 79.3 mt -70.14 -44.94 67.86 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.106 176.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -54.18 11.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.661 1.184 . . . . 0.0 110.372 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -51.95 -43.37 63.47 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 171.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.6 -27.87 68.05 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.975 1.261 . . . . 0.0 112.824 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.6 mt -72.51 -54.79 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 123.923 0.889 . . . . 0.0 109.958 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -53.16 -28.97 28.79 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.827 0.851 . . . . 0.0 111.402 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.35 -2.81 43.28 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -87.8 -39.17 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.669 0.788 . . . . 0.0 110.484 177.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.7 t -136.96 77.37 43.76 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 122.681 0.392 . . . . 0.0 110.496 164.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.04 116.31 3.05 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.429 2.753 . . . . 0.0 109.456 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.03 -21.88 41.71 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 117.116 -1.936 . . . . 0.0 115.402 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tp -95.24 -26.51 15.93 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 121.333 2.567 . . . . 0.0 112.673 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -91.66 105.36 17.68 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 116.029 1.863 . . . . 0.0 116.029 -166.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.25 66.68 1.31 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.214 1.406 . . . . 0.0 110.463 168.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.3 t -72.62 137.76 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.284 0.633 . . . . 0.0 111.737 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.17 133.83 13.78 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.35 1.06 . . . . 0.0 112.009 -175.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.6 mt -73.75 122.79 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 121.113 -0.992 . . . . 0.0 108.39 169.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.78 101.45 14.05 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.021 0.929 . . . . 0.0 110.228 -176.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.7 m -132.08 163.29 28.8 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.148 0.979 . . . . 0.0 110.283 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -71.52 126.29 29.27 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 166.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 CA--C 1.542 0.64 0 C-N-CA 127.927 2.491 . . . . 0.0 106.669 172.471 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -77.0 158.01 30.86 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 123.021 1.391 . . . . 0.0 113.273 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.5 t -93.24 174.46 7.2 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.806 1.242 . . . . 0.0 111.027 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 m -157.41 144.03 18.07 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.157 1.383 . . . . 0.0 110.034 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.96 159.78 43.52 Favored 'General case' 0 C--O 1.243 0.732 0 C-N-CA 125.624 1.57 . . . . 0.0 111.683 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.3 m -120.61 139.84 52.4 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.551 1.541 . . . . 0.0 110.055 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -140.76 142.54 34.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.945 -178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.9 tt -124.13 140.72 46.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.491 1.116 . . . . 0.0 110.064 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.78 148.42 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 126.219 1.808 . . . . 0.0 108.295 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -128.5 142.3 51.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 162.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.15 -16.01 55.94 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 124.042 0.83 . . . . 0.0 111.142 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.8 ptm -58.81 133.63 56.16 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 122.012 -0.699 . . . . 0.0 109.142 168.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -61.48 15.59 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 126.743 2.017 . . . . 0.0 115.624 -177.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 m 68.55 -15.43 0.23 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.268 2.227 . . . . 0.0 116.463 166.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -88.6 0.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.249 1.42 . . . . 0.0 107.408 -169.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 p -55.09 -27.65 46.53 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.998 -1.689 . . . . 0.0 114.544 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' HA ' HD22 ' A' ' 20' ' ' ASN . 1.2 m -60.27 -38.2 82.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 120.881 1.673 . . . . 0.0 112.084 172.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 88.6 t -52.97 -48.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.533 1.533 . . . . 0.0 109.574 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.3 t -71.24 -29.9 65.67 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.532 HD22 ' HA ' ' A' ' 17' ' ' CYS . 76.2 m-20 -64.54 -40.38 95.49 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 120.293 -1.504 . . . . 0.0 110.681 167.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 -38.93 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.06 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -52.85 -53.67 45.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.639 0.776 . . . . 0.0 109.894 167.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 45.9 m -70.62 -46.33 63.54 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -170.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.0 m -69.27 -35.48 76.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.021 1.328 . . . . 0.0 111.183 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.22 -50.6 14.04 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-O 117.933 -1.032 . . . . 0.0 112.399 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.3 t -72.69 11.21 0.68 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 120.432 1.469 . . . . 0.0 113.892 -172.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.57 -7.92 19.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.477 1.511 . . . . 0.0 111.668 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.5 129.21 36.89 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 119.028 0.831 . . . . 0.0 109.451 -171.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 21.0 mp0 -58.29 -20.65 44.43 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 -10.8 37.9 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 173.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -90.55 141.5 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 122.271 2.305 . . . . 0.0 109.936 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.7 t -97.6 -30.83 12.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.695 1.598 . . . . 0.0 111.33 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -175.51 172.85 2.55 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.29 1.436 . . . . 0.0 113.254 -169.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -168.57 150.52 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.564 1.946 . . . . 0.0 111.311 -172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.1 t -140.97 150.09 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 128.971 2.908 . . . . 0.0 106.345 167.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.6 p -139.29 147.65 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.083 0.468 . . . . 0.0 110.716 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -70.38 141.16 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.811 1.244 . . . . 0.0 112.101 174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.92 -23.77 14.84 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 111.836 169.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.09 -39.6 10.05 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 130.316 3.447 . . . . 0.0 112.981 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -97.62 -177.29 3.75 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.797 1.639 . . . . 0.0 110.913 168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -112.33 44.39 1.45 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.965 1.306 . . . . 0.0 111.777 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.3 p -137.14 153.71 50.43 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 120.488 -1.383 . . . . 0.0 113.98 -169.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.52 140.08 52.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.111 1.764 . . . . 0.0 111.427 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.4 mt -110.06 116.1 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' CG1' HD13 ' A' ' 57' ' ' LEU . 16.6 t -122.93 132.84 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.939 1.295 . . . . 0.0 108.327 -167.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.1 t -118.56 112.91 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.628 1.971 . . . . 0.0 107.53 -169.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.534 ' CD1' HD11 ' A' ' 57' ' ' LEU . 23.0 p90 -130.84 150.9 51.79 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.72 1.6 . . . . 0.0 113.478 -171.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.74 111.13 22.92 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.818 -1.176 . . . . 0.0 111.696 -171.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -172.74 146.34 1.61 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.771 2.028 . . . . 0.0 108.667 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -77.12 7.8 4.64 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.54 -0.725 . . . . 0.0 112.317 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.9 m -127.57 133.36 49.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.565 1.146 . . . . 0.0 112.0 -169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.2 t -71.26 95.6 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 168.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.6 m -135.96 65.89 60.09 Favored Pre-proline 0 N--CA 1.471 0.592 0 C-N-CA 126.753 2.021 . . . . 0.0 108.432 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.34 -22.58 39.5 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.041 2.494 . . . . 0.0 113.018 -173.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 62.1 mm-40 -60.18 -28.94 68.36 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -172.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.1 p -62.09 -40.33 95.47 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.063 -1.648 . . . . 0.0 112.708 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 47' ' ' TYR . 49.6 mt -70.13 -46.35 64.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 0.0 111.298 177.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HE ' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -49.24 -55.48 12.48 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.515 1.126 . . . . 0.0 111.753 173.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -59.76 -30.67 69.02 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 118.025 -0.988 . . . . 0.0 113.571 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.62 80.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.243 1.383 . . . . 0.0 111.817 171.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.9 mt -61.78 -53.77 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.563 -0.711 . . . . 0.0 110.136 173.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -54.07 -25.71 23.09 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.38 0.672 . . . . 0.0 112.717 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.79 2.27 49.44 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.491 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -92.88 -30.76 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.941 0.896 . . . . 0.0 111.434 175.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.08 68.53 9.54 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.701 0.8 . . . . 0.0 111.16 169.253 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.78 136.43 70.23 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.103 3.202 . . . . 0.0 111.807 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.74 -24.17 6.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.678 1.133 . . . . 0.0 113.585 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.0 tp -90.01 -35.93 15.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.867 1.267 . . . . 0.0 111.06 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -88.27 108.89 19.54 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -168.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.4 32.58 0.09 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 128.634 2.774 . . . . 0.0 115.695 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -55.34 130.39 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -166.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.6 m -145.0 148.55 33.86 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 113.641 -1.618 . . . . 0.0 111.476 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 98.6 mt -83.44 122.85 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.73 1.212 . . . . 0.0 108.499 170.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t -95.12 126.97 40.81 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.1 m -140.7 162.8 34.54 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 125.098 1.359 . . . . 0.0 110.208 169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -76.47 114.58 15.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 173.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 127.79 2.436 . . . . 0.0 108.777 178.212 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 122.998 1.38 . . . . 0.0 112.08 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.25 152.89 39.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 128.219 2.608 . . . . 0.0 113.512 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -122.29 -174.48 2.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.331 2.252 . . . . 0.0 110.473 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -163.32 147.37 10.8 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.663 -1.273 . . . . 0.0 109.918 -176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.97 158.89 44.62 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.993 1.317 . . . . 0.0 111.273 169.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.1 m -120.34 137.29 54.36 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.753 1.221 . . . . 0.0 110.46 -179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -137.04 149.13 47.24 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.912 0.885 . . . . 0.0 112.909 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tt -137.56 136.61 46.13 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 124.343 1.057 . . . . 0.0 112.181 -175.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.2 mp -120.87 108.34 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.284 1.434 . . . . 0.0 112.288 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -86.27 87.86 7.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.822 0.82 . . . . 0.0 108.8 168.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.14 -23.83 0.28 Allowed Glycine 0 N--CA 1.48 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 114.837 -168.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -79.82 138.82 37.32 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.175 0.987 . . . . 0.0 113.192 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 65.9 m-70 -65.68 27.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 127.229 2.212 . . . . 0.0 114.368 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.7 m 52.15 -115.5 0.92 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.046 2.138 . . . . 0.0 111.419 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HE3' ' O ' ' A' ' 38' ' ' LEU . 40.3 mttp -67.01 -17.46 64.93 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -165.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.9 p -88.4 -43.41 11.51 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 120.003 1.274 . . . . 0.0 110.446 166.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -55.84 -43.1 76.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 116.838 -1.553 . . . . 0.0 112.049 175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG13 ' CG1' ' A' ' 36' ' ' VAL . 4.6 t -37.78 -56.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.273 1.829 . . . . 0.0 111.567 171.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 t -65.65 -39.36 91.32 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.569 0.748 . . . . 0.0 111.661 -173.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -60.52 -40.02 89.96 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -42.79 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 118.74 -0.648 . . . . 0.0 109.743 -176.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -54.81 -51.32 66.19 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.951 0.9 . . . . 0.0 110.876 169.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -70.37 -41.41 73.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.7 m -70.69 -40.03 73.15 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.76 1.224 . . . . 0.0 110.318 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.7 -45.46 44.2 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.669 -1.158 . . . . 0.0 111.518 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.9 t -71.01 11.3 0.42 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 120.836 1.653 . . . . 0.0 113.819 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.87 -6.37 22.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.493 1.517 . . . . 0.0 111.326 174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.7 mt -77.08 125.42 29.29 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 121.196 -0.94 . . . . 0.0 108.669 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.78 -15.13 52.38 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -170.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -12.56 33.98 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -87.2 135.93 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-N 121.68 2.036 . . . . 0.0 109.975 -170.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.1 t -103.45 -15.01 16.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m 178.75 173.64 0.7 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.141 2.576 . . . . 0.0 112.333 -176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.6 tt -173.19 152.39 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 127.509 2.323 . . . . 0.0 108.962 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -145.15 129.22 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.129 2.172 . . . . 0.0 107.838 166.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.4 t -94.5 139.34 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 123.006 1.384 . . . . 0.0 111.346 169.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.8 m -74.32 85.11 1.94 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.748 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 1.5 tt -49.81 -38.44 34.57 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.244 2.218 . . . . 0.0 114.36 -168.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -60.25 4.13 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 122.473 1.13 . . . . 0.0 110.264 170.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -79.83 -176.92 5.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 128.389 2.676 . . . . 0.0 116.072 -168.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 33.54 3.65 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 112.075 -2.33 . . . . 0.0 110.774 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.0 p -144.4 160.84 40.39 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -171.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.7 137.94 37.27 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.776 1.63 . . . . 0.0 111.217 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.9 mt -106.25 112.54 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.457 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.0 t -113.05 133.31 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.364 1.466 . . . . 0.0 107.625 -171.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.28 95.09 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.89 1.276 . . . . 0.0 108.506 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD1' HD11 ' A' ' 57' ' ' LEU . 26.7 p90 -114.34 145.63 41.55 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -168.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -91.6 121.53 33.35 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.223 -0.923 . . . . 0.0 111.354 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -174.98 127.87 0.29 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.046 0.939 . . . . 0.0 112.106 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 t -68.55 -36.51 78.89 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.397 -0.19 . . . . 0.0 111.032 168.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.8 t -163.32 97.71 0.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.916 0.886 . . . . 0.0 110.902 172.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.7 t -137.61 136.94 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t -64.54 140.02 97.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.875 -0.583 . . . . 0.0 110.88 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -61.52 -18.07 57.52 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.426 2.084 . . . . 0.0 111.624 169.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.15 -27.03 63.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.123 0.874 . . . . 0.0 112.789 174.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 m -70.25 -35.06 73.55 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 121.36 1.891 . . . . 0.0 112.049 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.2 mt -70.12 -44.7 68.41 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-O 118.866 -0.588 . . . . 0.0 109.52 170.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -53.06 -44.3 67.38 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.672 0.789 . . . . 0.0 111.278 176.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.59 98.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.169 1.788 . . . . 0.0 113.961 169.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.21 71.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 120.081 1.31 . . . . 0.0 112.031 173.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.4 mt -67.6 -56.84 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.787 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -46.46 -35.99 6.17 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.357 1.063 . . . . 0.0 111.605 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.68 1.23 27.18 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -96.28 -29.3 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.709 1.204 . . . . 0.0 112.229 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.44 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -148.39 59.3 4.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 121.202 -0.937 . . . . 0.0 112.277 169.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -59.43 140.01 92.22 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.662 2.908 . . . . 0.0 111.192 -175.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.33 -54.53 0.64 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.794 1.188 . . . . 0.0 110.756 -169.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 19.6 mt -75.55 -46.06 34.3 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 118.386 1.093 . . . . 0.0 112.038 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -67.86 88.18 0.25 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.13 69.49 2.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.486 1.515 . . . . 0.0 109.105 168.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.17 138.7 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 122.768 1.271 . . . . 0.0 110.951 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.0 m -143.07 168.73 19.03 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.356 1.463 . . . . 0.0 110.24 174.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.6 mt -97.75 131.47 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.557 1.543 . . . . 0.0 108.524 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.41 46.2 1.35 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.357 1.063 . . . . 0.0 112.009 -169.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.2 p -173.7 75.84 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 111.445 -170.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -155.16 47.43 0.53 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 128.818 2.847 . . . . 0.0 105.053 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 127.424 2.29 . . . . 0.0 111.71 -169.083 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -81.56 170.63 15.64 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 129.607 3.163 . . . . 0.0 113.055 168.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 t -129.56 170.73 13.38 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.726 1.61 . . . . 0.0 108.267 167.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.86 163.98 39.5 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.959 -1.088 . . . . 0.0 111.699 -173.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.74 160.4 37.84 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.737 1.215 . . . . 0.0 111.859 169.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 m -123.77 136.73 54.59 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.215 1.406 . . . . 0.0 110.737 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -137.52 145.52 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.012 1.325 . . . . 0.0 111.032 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.0 tt -134.06 130.85 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.685 1.194 . . . . 0.0 110.64 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mp -107.91 100.84 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.967 1.307 . . . . 0.0 109.047 -169.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -71.86 1.04 7.66 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -178.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.25 35.85 1.79 Allowed Glycine 0 C--O 1.222 -0.628 0 C-N-CA 125.976 1.751 . . . . 0.0 111.141 -174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ttm -90.86 148.34 22.56 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.915 0.886 . . . . 0.0 111.115 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 6.5 m170 -73.72 3.41 6.48 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.372 0.669 . . . . 0.0 111.599 167.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.2 m 61.54 -112.78 0.49 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.564 2.346 . . . . 0.0 112.16 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -48.66 -51.58 27.64 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -166.094 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.9 m -80.01 -22.58 42.29 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 119.838 -1.789 . . . . 0.0 113.936 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 13' ' ' HIS . 1.3 m -63.64 -39.79 95.25 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-O 116.497 -1.716 . . . . 0.0 111.516 171.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 38' ' ' LEU . 23.5 t -47.9 -51.49 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 120.638 1.563 . . . . 0.0 112.788 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.5 t -55.07 -43.55 73.97 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.292 0.637 . . . . 0.0 111.981 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -63.2 -39.38 94.48 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.65 -45.78 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.133 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -51.62 -48.44 63.27 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.41 1.084 . . . . 0.0 109.858 169.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.4 m -70.05 -42.18 73.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -74.64 -38.28 62.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.69 1.196 . . . . 0.0 111.192 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.06 -45.66 56.12 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 116.58 -1.676 . . . . 0.0 112.604 171.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.5 t -69.42 14.33 0.1 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 121.885 2.129 . . . . 0.0 114.543 -174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.21 -5.33 15.34 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.892 1.677 . . . . 0.0 112.655 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.67 137.95 41.02 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.202 0.91 . . . . 0.0 111.475 -169.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -73.66 55.39 0.51 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.473 1.909 . . . . 0.0 112.622 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.7 p90 174.09 -22.45 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 128.882 2.873 . . . . 0.0 113.894 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.8 p -86.66 142.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 120.826 1.648 . . . . 0.0 109.256 -178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 t -108.05 -19.66 13.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.697 0.799 . . . . 0.0 112.573 -177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -175.43 174.28 2.34 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.435 1.894 . . . . 0.0 112.277 -173.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.1 tt -174.86 151.97 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.938 2.095 . . . . 0.0 110.209 -170.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -146.08 131.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 127.345 2.258 . . . . 0.0 107.732 166.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 18' ' ' VAL . 68.3 t -104.08 137.37 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 123.53 1.633 . . . . 0.0 111.638 169.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 74.6 m -79.37 81.36 5.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.261 1.424 . . . . 0.0 111.087 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 18' ' ' VAL . 17.0 tp -50.85 -43.68 59.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -168.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -51.18 -42.15 60.67 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.994 0.918 . . . . 0.0 111.978 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -103.42 -170.82 1.84 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.138 3.775 . . . . 0.0 111.729 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.61 31.33 6.05 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.894 1.678 . . . . 0.0 114.579 -178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.9 p -135.2 157.68 46.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.63 138.6 51.32 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.851 1.661 . . . . 0.0 110.525 -175.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.6 mt -111.68 121.41 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 167.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -125.06 125.18 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 125.081 1.352 . . . . 0.0 109.192 -166.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 78.9 t -111.98 109.52 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.766 1.626 . . . . 0.0 109.933 -168.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.462 ' CD1' HD11 ' A' ' 57' ' ' LEU . 50.0 p90 -124.33 166.98 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.889 1.276 . . . . 0.0 113.207 -171.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -98.46 106.01 18.23 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.318 -0.864 . . . . 0.0 112.142 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -165.94 148.35 7.26 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.772 1.629 . . . . 0.0 110.062 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.5 m -88.15 29.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.181 -0.949 . . . . 0.0 110.463 171.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.1 t -168.97 -167.54 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.178 1.391 . . . . 0.0 110.054 -170.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.0 m -110.51 132.41 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.915 1.686 . . . . 0.0 111.781 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.3 m -152.42 72.43 7.56 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.781 1.632 . . . . 0.0 109.601 174.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -87.39 -24.65 1.17 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.265 2.643 . . . . 0.0 114.788 -170.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -65.25 -25.09 67.51 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.182 0.901 . . . . 0.0 112.906 -169.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.6 p -69.56 -38.68 77.54 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.026 -1.046 . . . . 0.0 113.161 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.462 HD11 ' CD1' ' A' ' 47' ' ' TYR . 84.5 mt -67.69 -44.53 77.53 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.27 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.419 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -47.11 -54.89 9.44 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.322 1.049 . . . . 0.0 110.222 169.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -53.8 -41.62 67.48 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 175.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.62 -30.62 69.38 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.017 0.826 . . . . 0.0 111.81 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.7 mt -68.1 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 C-N-CA 123.752 0.821 . . . . 0.0 109.685 169.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.419 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 56.8 mt-10 -49.91 -33.43 17.37 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.704 0.683 . . . . 0.0 111.911 175.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.13 -0.4 24.77 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.884 1.439 . . . . 0.0 114.884 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -99.58 -27.12 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.672 1.589 . . . . 0.0 111.689 179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -147.55 64.06 8.29 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.387 -0.821 . . . . 0.0 111.098 168.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.5 144.93 95.39 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 124.364 3.376 . . . . 0.0 112.973 -173.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.56 -28.8 3.39 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.17 1.367 . . . . 0.0 113.581 -174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.8 tp -97.45 -43.76 7.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.158 1.783 . . . . 0.0 111.048 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.4 m-30 -68.88 99.68 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -78.05 80.26 4.49 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.823 -1.173 . . . . 0.0 109.142 169.105 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -83.25 132.46 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.65 -0.656 . . . . 0.0 111.27 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.53 134.2 30.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.519 1.128 . . . . 0.0 109.188 -169.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.29 122.01 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 120.451 -1.406 . . . . 0.0 108.003 171.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t -110.84 116.79 31.87 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 122.569 1.176 . . . . 0.0 110.383 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -151.41 157.52 42.5 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.7 1.6 . . . . 0.0 108.988 168.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -77.63 48.91 0.7 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.841 1.656 . . . . 0.0 113.32 -169.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 125.007 1.323 . . . . 0.0 113.225 -175.248 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.38 167.0 5.76 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.723 1.209 . . . . 0.0 113.648 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 t -95.73 176.65 6.06 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.461 1.104 . . . . 0.0 111.684 174.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.0 m -164.54 149.41 9.79 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.409 1.484 . . . . 0.0 109.407 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -154.67 157.28 37.89 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.037 1.335 . . . . 0.0 110.479 169.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 m -119.28 135.93 54.48 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.782 0.833 . . . . 0.0 109.759 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -128.86 145.44 51.21 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.527 1.531 . . . . 0.0 110.868 -174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.7 tt -127.09 139.26 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 125.13 1.372 . . . . 0.0 111.153 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.1 97.59 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 126.462 1.905 . . . . 0.0 109.91 -173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.9 78.25 9.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 123.355 1.55 . . . . 0.0 111.622 -177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.05 12.28 0.15 Allowed Glycine 0 CA--C 1.533 1.203 0 CA-C-N 113.203 -1.817 . . . . 0.0 116.305 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 151.47 45.61 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.917 2.358 . . . . 0.0 113.123 -177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -70.58 36.27 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 120.225 -1.547 . . . . 0.0 114.118 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.9 m 64.29 -142.29 0.28 Allowed 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.251 -1.531 . . . . 0.0 111.087 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HE3' HD13 ' A' ' 38' ' ' LEU . 13.8 mptt -56.76 -37.18 70.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.919 0.888 . . . . 0.0 113.158 -169.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.6 m -66.08 -45.56 80.83 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.151 -0.968 . . . . 0.0 112.578 173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.45 ' HA ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -60.9 -50.42 73.48 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 117.592 -1.194 . . . . 0.0 110.962 172.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 t -44.85 -46.82 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 126.508 1.923 . . . . 0.0 112.154 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -66.56 -42.46 87.04 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.45 HD22 ' HA ' ' A' ' 17' ' ' CYS . 83.4 m-20 -54.94 -35.85 64.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 120.503 -1.373 . . . . 0.0 113.144 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -70.15 -39.34 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.652 -0.689 . . . . 0.0 109.482 -174.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -62.38 -49.15 76.68 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 169.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -65.53 -42.29 92.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 m -69.54 -40.95 76.56 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.994 1.318 . . . . 0.0 110.966 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.75 -45.92 48.95 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.813 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 t -74.09 11.61 0.88 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.961 1.255 . . . . 0.0 113.389 -170.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.51 -5.0 17.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.675 1.59 . . . . 0.0 112.009 175.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.8 mt -75.69 129.62 37.41 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.01 -1.056 . . . . 0.0 110.097 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -53.21 -22.65 7.0 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.69 1.196 . . . . 0.0 114.157 -175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.81 -8.94 29.8 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 173.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.37 139.86 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 121.862 2.119 . . . . 0.0 109.624 -175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t -109.37 -12.96 14.68 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -178.05 173.13 1.53 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.544 2.338 . . . . 0.0 111.322 -177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -178.59 152.66 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 109.835 -171.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 t -147.33 132.36 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 128.18 2.592 . . . . 0.0 107.755 167.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.7 p -101.64 149.34 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 122.468 1.128 . . . . 0.0 112.115 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 m -70.73 111.85 6.51 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.518 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.4 tm? -61.64 -45.43 94.09 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 120.047 1.294 . . . . 0.0 110.348 178.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.13 -56.38 11.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.735 0.814 . . . . 0.0 112.275 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -93.2 -179.98 5.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -166.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 16.36 3.45 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -172.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 p -139.4 155.62 47.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -166.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.4 131.55 43.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.762 2.425 . . . . 0.0 110.708 -172.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -101.21 110.01 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.555 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -115.19 133.78 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.598 1.559 . . . . 0.0 108.024 -169.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.62 108.18 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.538 1.535 . . . . 0.0 108.128 -169.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.7 p90 -127.27 154.45 44.87 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -168.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -88.86 123.33 33.13 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.462 -0.774 . . . . 0.0 110.223 -173.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.99 149.79 0.58 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.261 1.425 . . . . 0.0 110.852 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 m -90.03 22.06 3.4 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.7 1.2 . . . . 0.0 111.036 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.4 m -161.23 151.3 17.35 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.477 -1.389 . . . . 0.0 114.559 -175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.2 m -80.09 74.3 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.143 1.377 . . . . 0.0 111.675 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.8 m -107.88 73.61 0.43 Allowed Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 125.725 1.61 . . . . 0.0 110.549 171.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -78.15 -23.18 9.24 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.654 2.903 . . . . 0.0 113.259 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.68 -20.74 63.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.306 1.442 . . . . 0.0 113.087 -172.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.6 p -69.14 -44.33 72.55 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.54 -1.35 . . . . 0.0 112.697 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD13 ' CG1' ' A' ' 45' ' ' VAL . 51.0 mt -63.89 -46.89 82.86 Favored 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.109 0.564 . . . . 0.0 109.869 176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -48.94 -52.75 22.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.082 0.953 . . . . 0.0 110.8 170.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -54.93 -38.2 67.39 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 174.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.64 80.73 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.253 0.933 . . . . 0.0 111.15 174.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.4 mt -66.94 -52.54 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 O-C-N 121.844 -0.535 . . . . 0.0 109.794 172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -55.94 -22.21 24.96 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.014 -1.054 . . . . 0.0 112.676 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.55 -1.3 57.98 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.282 1.401 . . . . 0.0 114.76 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -95.37 -27.42 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.584 1.153 . . . . 0.0 111.046 179.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.72 71.08 7.33 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.556 1.142 . . . . 0.0 111.459 168.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.9 145.95 97.02 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.664 3.576 . . . . 0.0 113.839 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.33 -40.21 2.36 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.937 1.732 . . . . 0.0 113.085 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.89 -55.29 6.84 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.263 1.425 . . . . 0.0 111.156 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.4 m-30 -69.01 110.42 4.45 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.985 1.314 . . . . 0.0 114.425 -169.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.21 57.02 4.0 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.398 -1.439 . . . . 0.0 113.279 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.0 118.06 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 122.319 1.057 . . . . 0.0 113.023 -167.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.1 m -135.21 147.71 49.42 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.289 -1.778 . . . . 0.0 111.093 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.47 120.94 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.607 1.163 . . . . 0.0 109.672 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.9 p -87.2 87.76 7.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.817 1.647 . . . . 0.0 110.477 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.8 m -132.31 161.42 33.58 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.678 0.791 . . . . 0.0 111.243 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.87 129.25 37.52 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 163.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 127.765 2.426 . . . . 0.0 108.379 -177.067 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 CA--C 1.555 1.16 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -72.05 174.06 7.61 Favored 'General case' 0 CA--C 1.55 0.957 1 C-N-CA 132.389 4.276 . . . . 0.0 115.222 169.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -116.52 -178.94 3.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.168 1.787 . . . . 0.0 111.146 169.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.9 m -157.36 148.46 21.66 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.27 1.428 . . . . 0.0 110.289 -176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.86 158.18 43.85 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.015 1.326 . . . . 0.0 111.783 172.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.5 m -121.32 140.18 52.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.991 1.317 . . . . 0.0 109.958 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -139.22 145.9 39.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.403 1.481 . . . . 0.0 111.068 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.3 tt -131.0 134.43 61.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 125.461 1.504 . . . . 0.0 111.072 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.27 100.15 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.465 1.106 . . . . 0.0 109.813 -169.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.403 ' HB3' ' CB ' ' A' ' 70' ' ' ARG . 23.7 t0 -78.2 41.06 0.36 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.481 1.512 . . . . 0.0 112.709 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -172.83 23.92 0.08 OUTLIER Glycine 0 N--CA 1.477 1.384 0 C-N-CA 125.208 1.385 . . . . 0.0 113.764 -171.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.4 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 4.9 ttt -95.81 135.12 37.94 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.416 1.886 . . . . 0.0 112.064 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -60.48 21.75 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m 71.1 -62.31 0.46 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 128.248 2.619 . . . . 0.0 114.086 171.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.479 ' HE3' HD22 ' A' ' 38' ' ' LEU . 13.3 mptt -122.82 -53.94 1.85 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.516 1.126 . . . . 0.0 113.626 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 p -65.74 -22.3 66.59 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.481 -2.012 . . . . 0.0 113.199 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.4 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 1.9 p -45.41 -56.82 4.58 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.596 1.158 . . . . 0.0 110.041 168.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 HG21 HD23 ' A' ' 38' ' ' LEU . 73.6 t -47.23 -53.65 3.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 127.9 2.48 . . . . 0.0 111.076 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.3 t -64.84 -25.41 67.89 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -72.64 -53.27 12.28 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.2 0.909 . . . . 0.0 110.257 167.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -44.96 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.58 -0.7 . . . . 0.0 110.562 -170.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.3 -21.62 62.19 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.068 1.747 . . . . 0.0 112.873 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.7 t -91.77 -58.94 2.25 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.574 1.15 . . . . 0.0 113.759 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.0 m -54.95 -39.61 69.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.329 2.252 . . . . 0.0 112.491 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 -49.79 20.64 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 118.209 -0.901 . . . . 0.0 111.603 172.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.1 t -70.69 14.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.252 1.387 . . . . 0.0 113.856 -174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.59 -7.01 18.82 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.041 1.736 . . . . 0.0 111.766 173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.407 HD11 ' CB ' ' A' ' 60' ' ' ALA . 17.5 mt -76.64 129.72 36.79 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 121.034 -1.041 . . . . 0.0 108.757 -172.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.47 -17.34 59.32 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -171.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -90.4 -11.52 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 169.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 3.9 p -94.11 135.91 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 122.172 2.26 . . . . 0.0 110.395 -170.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 t -107.49 -12.78 15.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.664 0.786 . . . . 0.0 113.094 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -179.81 174.38 0.93 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.219 2.608 . . . . 0.0 112.552 -178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.1 tt -172.42 153.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.038 2.535 . . . . 0.0 109.59 -173.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.9 t -147.0 131.55 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.258 2.223 . . . . 0.0 107.99 167.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -105.29 137.29 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 123.487 1.613 . . . . 0.0 112.425 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.6 m -88.33 86.21 7.02 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.582 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.479 HD22 ' HE3' ' A' ' 15' ' ' LYS . 7.2 mt -47.94 -36.75 12.96 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 128.89 2.876 . . . . 0.0 115.286 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.23 -4.96 58.64 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.868 1.318 . . . . 0.0 113.792 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -116.36 -168.02 1.37 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.185 2.594 . . . . 0.0 108.769 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -123.46 43.41 2.97 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.91 -1.744 . . . . 0.0 110.056 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.7 p -134.47 151.58 51.24 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.083 -1.011 . . . . 0.0 112.959 -172.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.38 140.45 52.99 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 126.601 1.96 . . . . 0.0 109.347 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.7 mt -111.2 116.7 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 32.3 t -117.98 129.63 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.773 1.629 . . . . 0.0 107.447 -169.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 102.53 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.985 1.314 . . . . 0.0 108.962 -168.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.514 ' CD1' HD11 ' A' ' 57' ' ' LEU . 29.3 p90 -120.92 141.0 51.05 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.532 1.133 . . . . 0.0 113.945 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -90.78 110.54 21.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.685 -1.259 . . . . 0.0 110.786 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . 179.46 131.11 0.09 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.256 1.422 . . . . 0.0 112.032 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.8 t -86.19 -9.32 56.81 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.359 -0.838 . . . . 0.0 112.156 169.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 t -157.1 58.28 0.52 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.02 -1.05 . . . . 0.0 111.442 -173.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 73.3 t -134.48 139.82 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 t -83.66 143.56 44.11 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.312 1.445 . . . . 0.0 111.847 -171.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -63.24 -15.11 46.13 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.277 2.651 . . . . 0.0 113.182 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.2 -32.53 55.91 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.365 0.984 . . . . 0.0 112.47 178.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.9 m -88.77 -23.7 22.82 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.964 -169.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 47' ' ' TYR . 74.8 mt -68.11 -42.24 80.54 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.27 169.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -47.11 -55.64 7.99 Favored 'General case' 0 C--N 1.347 0.485 0 C-N-CA 123.611 0.764 . . . . 0.0 109.521 168.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -47.57 -48.22 28.01 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.355 1.062 . . . . 0.0 113.823 172.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 28' ' ' LEU . . . -62.53 -27.95 69.51 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.118 0.872 . . . . 0.0 112.959 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -77.17 -49.7 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.124 170.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -51.3 -34.3 32.61 Favored 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 123.443 0.697 . . . . 0.0 110.284 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.38 5.75 14.08 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.86 -27.82 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.875 0.87 . . . . 0.0 111.699 174.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.54 65.5 8.54 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.088 168.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.5 146.27 97.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.341 3.361 . . . . 0.0 113.356 -173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.21 -29.44 2.81 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.852 1.215 . . . . 0.0 113.383 -174.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.5 tp -94.79 -45.1 7.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.969 1.708 . . . . 0.0 110.791 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -71.8 106.96 4.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -176.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' CB ' ' HB3' ' A' ' 10' ' ' ASP . 77.9 mtt180 -80.96 78.24 7.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.154 0.982 . . . . 0.0 111.393 169.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -85.8 125.0 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.876 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 137.3 41.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.07 0.948 . . . . 0.0 108.793 -170.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.87 127.5 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.8 t -114.48 108.89 17.47 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.84 0.856 . . . . 0.0 108.829 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.9 m -147.18 174.97 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.561 1.144 . . . . 0.0 111.317 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -71.87 134.28 45.97 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 163.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 C--N 1.317 -0.847 0 C-N-CA 125.7 1.6 . . . . 0.0 108.931 175.599 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -91.66 171.96 8.81 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.127 1.771 . . . . 0.0 113.987 170.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 t -140.2 175.28 9.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.627 3.171 . . . . 0.0 107.734 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -159.56 156.8 28.7 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.658 -1.276 . . . . 0.0 111.146 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -155.05 163.44 40.28 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 125.486 1.514 . . . . 0.0 111.316 169.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.3 m -125.54 139.58 53.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.197 1.399 . . . . 0.0 110.109 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -139.21 140.78 37.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.056 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.35 141.43 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 C-N-CA 124.525 1.13 . . . . 0.0 109.347 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.05 165.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 125.179 1.392 . . . . 0.0 107.628 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -147.39 137.75 23.26 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.327 1.051 . . . . 0.0 108.313 167.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.17 69.96 Favored Glycine 0 N--CA 1.476 1.334 0 C-N-CA 124.244 0.925 . . . . 0.0 112.681 -176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.75 161.47 10.1 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.327 2.251 . . . . 0.0 114.437 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -68.98 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 126.155 1.782 . . . . 0.0 115.275 174.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.3 m 52.89 -61.14 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 130.573 3.549 . . . . 0.0 119.279 167.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -49.77 1.59 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.601 1.56 . . . . 0.0 109.428 177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -55.95 -27.1 50.9 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.359 -1.463 . . . . 0.0 113.048 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.5 p -49.69 -49.33 48.09 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 119.504 1.047 . . . . 0.0 111.645 171.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG13 HG11 ' A' ' 36' ' ' VAL . 37.8 t -52.91 -46.7 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.084 2.154 . . . . 0.0 111.967 -172.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.9 t -62.61 -42.79 99.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.134 0.574 . . . . 0.0 111.23 -176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -63.33 -43.06 98.84 Favored 'General case' 0 C--O 1.222 -0.37 0 O-C-N 121.968 -0.458 . . . . 0.0 111.792 173.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -66.21 -45.32 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 118.428 0.558 . . . . 0.0 109.53 -172.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.41 -50.67 59.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.306 1.442 . . . . 0.0 110.783 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -76.2 -31.58 58.52 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 116.838 2.162 . . . . 0.0 116.838 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -79.71 -41.25 27.13 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 125.34 1.456 . . . . 0.0 110.289 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.56 -44.62 50.12 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 116.861 -1.542 . . . . 0.0 111.272 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 t -73.31 17.28 0.14 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 121.148 1.795 . . . . 0.0 113.165 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.6 -3.11 15.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.709 1.604 . . . . 0.0 113.007 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.6 mt -75.27 134.87 41.0 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.82 -1.175 . . . . 0.0 111.964 -169.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.63 63.14 1.53 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.688 1.195 . . . . 0.0 112.059 -176.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.0 p90 168.38 -21.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 130.394 3.478 . . . . 0.0 114.531 -173.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 9.9 p -87.09 144.0 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 120.54 1.518 . . . . 0.0 109.422 -176.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -115.48 -11.39 11.81 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -169.97 173.16 6.17 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.941 1.353 . . . . 0.0 112.634 169.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 tt -155.73 157.39 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 126.385 1.874 . . . . 0.0 109.972 169.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -144.7 124.48 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 C-N-CA 126.765 2.026 . . . . 0.0 107.124 165.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.541 HG11 HG13 ' A' ' 18' ' ' VAL . 56.0 t -94.19 134.26 32.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.732 1.253 . . . . 0.0 110.146 169.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.9 m -67.59 90.26 0.26 Allowed 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.148 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.04 -38.21 50.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.748 1.158 . . . . 0.0 112.332 -168.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -66.31 0.56 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.451 0.569 . . . . 0.0 110.643 170.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.22 165.18 16.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 123.318 1.532 . . . . 0.0 112.19 -169.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.81 40.4 0.9 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.319 -1.488 . . . . 0.0 113.174 168.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 p -133.91 158.62 43.0 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 115.523 1.675 . . . . 0.0 115.523 178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 140.42 51.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.123 2.169 . . . . 0.0 110.984 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.5 mt -110.73 118.31 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 105.126 -2.176 . . . . 0.0 105.126 170.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CG1' HD13 ' A' ' 57' ' ' LEU . 17.8 t -121.45 131.92 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.537 1.135 . . . . 0.0 108.22 -167.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 32.6 t -118.32 120.9 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.331 1.453 . . . . 0.0 108.713 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.527 ' CD1' HD11 ' A' ' 57' ' ' LEU . 48.4 p90 -135.99 160.82 37.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.848 -1.158 . . . . 0.0 112.478 -170.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -93.98 108.76 20.54 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.927 -1.108 . . . . 0.0 112.417 -169.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -164.24 156.93 17.29 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.227 1.011 . . . . 0.0 112.585 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.2 p -87.85 19.49 3.5 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.963 -1.086 . . . . 0.0 111.744 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.8 m -173.42 -179.43 1.88 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.491 1.517 . . . . 0.0 112.101 -168.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -112.48 122.0 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.913 1.285 . . . . 0.0 111.339 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.6 m -143.24 85.2 9.77 Favored Pre-proline 0 N--CA 1.48 1.052 0 C-N-CA 126.32 1.848 . . . . 0.0 107.853 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -85.68 -24.14 1.95 Allowed 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.887 2.391 . . . . 0.0 115.185 -167.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -62.71 -24.84 67.87 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.229 1.377 . . . . 0.0 113.461 -173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.9 p -66.58 -40.5 88.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.996 1.725 . . . . 0.0 112.917 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD11 ' CD1' ' A' ' 47' ' ' TYR . 76.5 mt -69.2 -43.61 73.79 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.19 174.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -52.01 -48.24 64.59 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.768 0.713 . . . . 0.0 109.913 173.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -60.93 -31.54 71.06 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.95 -37.58 84.55 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.966 1.257 . . . . 0.0 111.891 170.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.86 -53.28 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 O-C-N 121.743 -0.598 . . . . 0.0 110.209 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -57.02 -21.13 28.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.174 0.99 . . . . 0.0 112.102 174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.39 1.99 55.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -93.47 -30.24 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.732 0.813 . . . . 0.0 111.258 175.44 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -148.55 69.49 10.34 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.536 0.734 . . . . 0.0 111.053 168.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.47 142.49 98.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 124.622 3.548 . . . . 0.0 112.574 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.87 -27.61 2.98 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.07 1.319 . . . . 0.0 113.583 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 30.7 tp -88.62 -45.04 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.368 1.467 . . . . 0.0 111.514 176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.454 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.1 m-30 -78.67 102.5 8.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.817 1.247 . . . . 0.0 114.203 -168.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 9.4 ttt180 -70.3 44.51 0.07 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.617 2.367 . . . . 0.0 114.938 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.62 130.08 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 122.588 1.185 . . . . 0.0 113.244 -166.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -136.7 148.33 47.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 113.538 -1.665 . . . . 0.0 110.491 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 89.6 mt -83.88 126.45 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 120.79 -1.194 . . . . 0.0 108.271 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.39 106.05 18.23 Favored 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 59.8 m -161.92 156.42 22.42 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.202 1.401 . . . . 0.0 110.613 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.69 104.28 2.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.786 0.834 . . . . 0.0 109.823 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.483 1.205 0 C-N-CA 125.136 1.374 . . . . 0.0 113.565 -177.523 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 121.352 0.596 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -157.07 169.91 23.72 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.884 2.873 . . . . 0.0 110.288 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 t -115.55 -177.99 3.28 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.046 1.738 . . . . 0.0 108.486 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -160.69 148.88 16.22 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.084 -1.01 . . . . 0.0 109.966 -175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.92 159.51 43.79 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.039 1.336 . . . . 0.0 110.958 169.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 m -117.85 134.54 54.83 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.46 1.504 . . . . 0.0 109.569 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -130.65 148.19 52.41 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.009 1.324 . . . . 0.0 111.054 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.6 tt -131.28 137.9 54.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.12 1.368 . . . . 0.0 110.4 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.69 110.9 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.769 1.628 . . . . 0.0 109.592 -172.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.9 119.17 26.83 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 168.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.76 8.25 30.42 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 124.155 0.883 . . . . 0.0 113.413 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 138.23 58.28 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 121.491 -1.005 . . . . 0.0 110.76 171.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.9 m170 -55.32 -32.19 62.29 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 -167.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.3 p 144.71 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 131.642 3.977 . . . . 0.0 108.352 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -19.79 -61.21 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 129.597 3.159 . . . . 0.0 114.439 165.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -57.19 -11.24 1.56 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.0 p -57.48 -45.03 85.32 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-N 120.689 1.586 . . . . 0.0 109.693 168.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.0 t -55.5 -47.28 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 125.297 1.439 . . . . 0.0 111.995 -169.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.2 t -58.01 -38.6 76.49 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 122.156 0.979 . . . . 0.0 111.834 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -72.86 -40.02 66.01 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.166 -0.959 . . . . 0.0 113.035 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -45.05 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.663 -175.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -46.51 -55.49 7.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.287 1.835 . . . . 0.0 109.484 168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.4 m -70.32 -44.96 67.16 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -71.79 -38.55 70.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.451 1.101 . . . . 0.0 110.834 -174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.55 -49.44 18.63 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.161 -1.4 . . . . 0.0 111.393 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -72.25 12.85 0.38 Allowed 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 121.006 1.73 . . . . 0.0 113.184 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.16 -6.16 24.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.615 1.566 . . . . 0.0 111.703 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.6 127.27 32.69 Favored 'General case' 0 C--N 1.343 0.288 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -56.31 -19.31 13.78 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -8.97 33.27 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 p -94.23 140.03 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 121.88 2.127 . . . . 0.0 109.554 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 t -111.39 -8.25 14.32 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.96 171.7 3.01 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.479 1.512 . . . . 0.0 113.237 169.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.6 tt -156.68 150.04 10.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.402 1.481 . . . . 0.0 112.358 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.9 t -137.62 146.51 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 127.685 2.394 . . . . 0.0 105.867 167.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 18' ' ' VAL . 9.2 p -138.16 149.26 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.973 0.892 . . . . 0.0 111.11 177.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.5 m -101.49 96.11 6.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.238 1.415 . . . . 0.0 112.085 -169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.6 tp -62.38 -30.75 71.42 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.715 1.606 . . . . 0.0 115.208 -177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.25 1.84 49.36 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 122.507 1.146 . . . . 0.0 113.308 175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -126.55 -170.55 2.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 128.669 2.788 . . . . 0.0 109.813 175.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.67 34.39 5.22 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.333 1.853 . . . . 0.0 112.205 174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -141.29 154.78 45.91 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 -169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.89 143.38 51.11 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.614 2.366 . . . . 0.0 111.264 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -112.36 116.19 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.59 129.43 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -168.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -114.97 114.99 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.437 1.495 . . . . 0.0 107.044 -172.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.486 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -136.45 151.02 49.02 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.374 1.069 . . . . 0.0 111.932 -168.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -90.17 136.53 32.99 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.653 -1.28 . . . . 0.0 111.728 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -173.44 179.16 2.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.061 2.144 . . . . 0.0 110.893 -171.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.8 t -136.66 -46.78 0.6 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.998 1.319 . . . . 0.0 108.211 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.0 p -76.48 123.78 26.55 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 165.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.2 m -60.65 115.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 120.018 1.281 . . . . 0.0 109.92 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -134.55 64.2 62.87 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.928 0.891 . . . . 0.0 111.555 -169.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -78.81 -9.84 15.64 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.193 3.262 . . . . 0.0 114.616 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -44.01 76.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 119.126 0.875 . . . . 0.0 112.165 -174.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.0 m -81.25 -18.1 47.17 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.132 -1.027 . . . . 0.0 112.126 -168.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.486 HD11 ' CD1' ' A' ' 47' ' ' TYR . 53.8 mt -70.19 -46.32 64.82 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.477 169.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -49.24 -52.64 25.86 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.537 1.062 . . . . 0.0 109.351 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -54.98 -41.82 71.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.26 69.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.826 1.194 . . . . 0.0 112.592 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.9 mt -72.7 -52.96 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.431 0.692 . . . . 0.0 109.954 170.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.13 -25.96 25.04 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.645 0.778 . . . . 0.0 112.518 175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.12 -0.89 37.83 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.06 -30.17 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.414 1.086 . . . . 0.0 111.297 179.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -146.79 66.48 10.66 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 121.605 -0.684 . . . . 0.0 111.479 168.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.58 142.21 98.48 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 124.525 3.483 . . . . 0.0 112.949 -176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.02 -30.18 2.99 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.286 1.422 . . . . 0.0 113.673 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.3 tp -93.93 -39.49 10.65 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 112.01 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.4 m-30 -79.76 107.2 12.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.405 1.082 . . . . 0.0 113.424 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -83.9 78.06 9.8 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 120.707 -1.246 . . . . 0.0 111.217 171.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -87.05 135.09 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-O 121.843 0.83 . . . . 0.0 111.079 -173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 8.8 m -152.1 165.41 34.83 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.464 1.105 . . . . 0.0 111.312 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.7 mt -93.4 133.51 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.538 1.135 . . . . 0.0 109.112 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.47 92.26 8.46 Favored 'General case' 0 C--O 1.226 -0.141 0 C-N-CA 123.777 0.831 . . . . 0.0 109.851 -174.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 62.7 m -163.01 167.54 22.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.421 1.488 . . . . 0.0 110.607 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -80.83 123.83 28.58 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 167.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 127.509 2.324 . . . . 0.0 109.688 -177.787 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 122.888 1.328 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -82.31 158.57 23.38 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.501 2.72 . . . . 0.0 111.558 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 t -141.29 -175.76 4.46 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.439 2.696 . . . . 0.0 109.082 173.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.7 m -166.54 141.84 4.44 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.003 -1.061 . . . . 0.0 110.515 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.93 163.58 32.59 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 125.064 1.346 . . . . 0.0 110.676 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 37.2 m -130.2 138.63 50.68 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.863 1.265 . . . . 0.0 109.807 -175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -139.57 151.73 46.3 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.612 0.765 . . . . 0.0 112.259 -170.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.9 tt -141.89 129.65 21.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 124.048 0.939 . . . . 0.0 112.077 -176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.75 114.4 46.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 C-N-CA 126.485 1.914 . . . . 0.0 110.61 -168.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.75 1.46 17.15 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -170.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.69 4.15 2.42 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.027 1.775 . . . . 0.0 116.822 -176.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -71.55 141.72 50.08 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 120.89 2.345 . . . . 0.0 113.477 -173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -68.49 32.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 127.483 2.313 . . . . 0.0 114.96 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.0 t 54.71 -131.78 1.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.181 1.393 . . . . 0.0 111.158 171.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.565 ' HE2' HD13 ' A' ' 38' ' ' LEU . 74.6 mttt -54.58 -25.24 25.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -168.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -82.49 -46.17 13.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.975 1.261 . . . . 0.0 111.851 169.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.1 m -57.99 -40.85 81.7 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-O 117.123 -1.417 . . . . 0.0 111.387 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.438 HG13 ' CG1' ' A' ' 36' ' ' VAL . 22.0 t -39.82 -56.22 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.022 1.729 . . . . 0.0 111.287 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -59.04 -43.1 91.62 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.841 0.856 . . . . 0.0 112.24 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -62.84 -40.73 98.34 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.752 -0.593 . . . . 0.0 112.461 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.16 -49.39 76.54 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -52.11 -50.54 61.45 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.679 1.192 . . . . 0.0 110.673 173.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.2 t -68.76 -32.64 72.53 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.0 m -77.34 -48.7 16.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.642 0.734 . . . . 0.0 109.936 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' HG11 ' A' ' 31' ' ' VAL . 1.1 mm? -76.7 -20.05 57.02 Favored 'General case' 0 C--O 1.221 -0.413 0 C-N-CA 125.168 1.387 . . . . 0.0 114.227 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.2 t -85.5 1.29 49.51 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.606 1.548 . . . . 0.0 112.969 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.36 1.75 11.83 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.606 -1.309 . . . . 0.0 114.187 -169.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.89 152.05 42.89 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.4 -0.812 . . . . 0.0 112.568 -170.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -76.72 47.73 0.52 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.919 2.087 . . . . 0.0 112.604 -173.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 173.68 -12.48 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 130.185 3.394 . . . . 0.0 114.095 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.4 p -94.23 142.37 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 122.402 2.365 . . . . 0.0 112.135 -174.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 m -107.48 -18.59 13.81 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.507 1.523 . . . . 0.0 113.928 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.9 m -178.65 171.07 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.747 2.019 . . . . 0.0 111.854 -171.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -167.2 161.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 128.211 2.604 . . . . 0.0 109.701 -175.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.9 t -152.09 128.31 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 127.991 2.516 . . . . 0.0 107.718 165.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.438 ' CG1' HG13 ' A' ' 18' ' ' VAL . 37.9 t -96.24 142.79 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 123.39 1.566 . . . . 0.0 112.207 170.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 m -74.41 86.77 2.02 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.007 1.323 . . . . 0.0 110.284 170.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.565 HD13 ' HE2' ' A' ' 15' ' ' LYS . 1.1 tm? -44.0 -43.46 6.69 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.301 3.04 . . . . 0.0 113.096 -175.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.94 -9.4 58.72 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.084 1.354 . . . . 0.0 114.623 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.61 -170.01 2.22 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 128.377 2.671 . . . . 0.0 110.243 -167.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.64 33.87 5.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.319 1.848 . . . . 0.0 112.623 -173.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.4 p -140.66 159.18 42.76 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -170.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.53 142.87 41.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.88 1.672 . . . . 0.0 111.129 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.1 mt -110.8 121.19 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 168.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 57' ' ' LEU . 19.2 t -121.46 128.61 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.513 1.525 . . . . 0.0 107.729 -168.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 103.12 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.648 1.579 . . . . 0.0 109.184 -168.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' CD1' HD11 ' A' ' 57' ' ' LEU . 46.2 p90 -119.31 156.51 29.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.49 1.116 . . . . 0.0 112.977 -170.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -107.85 128.01 54.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.429 1.092 . . . . 0.0 110.885 -172.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.7 142.2 0.22 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -168.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.1 m -70.03 -30.91 68.31 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.618 -0.676 . . . . 0.0 110.2 166.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.5 t -177.39 168.81 2.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 130.134 3.374 . . . . 0.0 108.219 167.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.4 p 157.26 149.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 130.913 3.685 . . . . 0.0 108.594 -172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -77.89 130.72 72.2 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.888 1.275 . . . . 0.0 112.187 -169.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.3 -20.02 68.85 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.262 2.642 . . . . 0.0 113.062 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.5 -32.35 17.98 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.415 1.086 . . . . 0.0 112.339 170.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.0 m -72.88 -35.0 67.05 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.849 1.204 . . . . 0.0 111.791 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.54 HD11 ' CD1' ' A' ' 47' ' ' TYR . 73.7 mt -70.8 -43.47 68.58 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 118.925 -0.559 . . . . 0.0 109.736 173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -52.71 -42.02 64.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.654 0.782 . . . . 0.0 110.84 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -39.79 95.15 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 169.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.04 -30.97 69.53 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 121.104 1.775 . . . . 0.0 112.172 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.86 -58.77 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.587 0.755 . . . . 0.0 111.338 170.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -54.99 -18.59 5.26 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.836 1.254 . . . . 0.0 113.431 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.69 -1.07 57.15 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 174.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -90.82 -29.71 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.282 1.033 . . . . 0.0 111.28 177.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.471 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.04 65.18 7.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 O-C-N 121.594 -0.691 . . . . 0.0 111.683 168.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.82 149.08 62.58 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.068 3.179 . . . . 0.0 112.586 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.14 -44.28 3.26 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.665 1.126 . . . . 0.0 112.513 -173.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.8 tp -77.05 -44.79 29.42 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.167 1.387 . . . . 0.0 110.717 172.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.482 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.6 m-30 -81.36 94.75 6.84 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 122.458 1.123 . . . . 0.0 113.243 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' C ' ' HD2' ' A' ' 70' ' ' ARG 0.255 0.0 OUTLIER -77.8 110.51 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 164.274 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.6 t -116.17 146.93 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 124.371 3.259 . . . . 0.0 111.887 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -131.67 158.12 41.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.481 1.512 . . . . 0.0 110.029 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.6 mt -94.73 124.62 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 168.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.8 t -111.74 107.99 17.27 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.189 0.995 . . . . 0.0 109.593 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.4 m -135.65 161.95 34.11 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.729 1.612 . . . . 0.0 110.646 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.54 116.46 10.89 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.325 -0.491 0 C-N-CA 127.391 2.277 . . . . 0.0 108.969 175.884 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 120.744 0.307 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -99.53 153.4 19.07 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.49 2.316 . . . . 0.0 113.515 171.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -102.49 -177.52 3.42 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.741 2.017 . . . . 0.0 111.332 176.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.39 166.93 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.893 -1.129 . . . . 0.0 111.505 172.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.4 152.22 30.81 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.707 1.203 . . . . 0.0 111.223 169.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.0 m -114.7 139.07 49.97 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.697 1.599 . . . . 0.0 109.716 -179.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -140.24 143.17 35.85 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.521 1.528 . . . . 0.0 110.28 -176.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.8 132.45 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.295 1.038 . . . . 0.0 110.662 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.72 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.443 1.497 . . . . 0.0 110.072 -169.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.12 50.73 0.92 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.058 -1.026 . . . . 0.0 112.922 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.53 -8.27 0.02 OUTLIER Glycine 0 CA--C 1.539 1.538 0 C-N-CA 126.008 1.766 . . . . 0.0 117.409 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -72.71 144.24 47.75 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 120.909 2.354 . . . . 0.0 111.723 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -64.52 5.48 0.28 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.24 1.816 . . . . 0.0 115.845 -176.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 67.55 -35.87 0.28 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 128.884 2.873 . . . . 0.0 115.52 171.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HE2' HD13 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -103.1 -87.44 0.42 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.303 1.411 . . . . 0.0 110.602 172.515 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.8 p -63.62 -13.04 38.47 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 119.152 -2.218 . . . . 0.0 115.256 -175.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -64.91 -39.79 94.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 121.213 1.824 . . . . 0.0 110.813 167.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 64.1 t -50.31 -47.28 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 127.084 2.154 . . . . 0.0 111.381 -175.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.5 t -69.63 -37.58 76.87 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -62.01 -39.1 91.13 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.689 -1.257 . . . . 0.0 111.881 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -49.68 80.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 118.217 -0.896 . . . . 0.0 109.058 -179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -51.28 -51.34 55.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.013 0.824 . . . . 0.0 111.363 170.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -70.15 -31.14 68.5 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -176.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.1 m -78.14 -51.31 10.45 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.876 0.871 . . . . 0.0 109.134 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.559 HD11 HG12 ' A' ' 61' ' ' ILE . 8.2 mt -77.12 -19.68 56.63 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -178.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.5 t -87.66 14.82 7.72 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 121.282 1.856 . . . . 0.0 112.697 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.56 4.13 9.59 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HB2' HG12 ' A' ' 31' ' ' VAL . 18.1 mt -77.2 154.35 33.18 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.04 -1.038 . . . . 0.0 112.472 -171.212 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -64.58 13.83 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 128.535 2.734 . . . . 0.0 114.71 -174.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -167.2 3.79 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.295 2.238 . . . . 0.0 113.89 -169.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.3 p -104.64 133.14 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 120.966 1.712 . . . . 0.0 110.543 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.7 t -105.9 -12.41 15.85 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -177.57 174.22 1.56 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.146 1.778 . . . . 0.0 112.78 -176.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.9 tt -167.33 153.85 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.249 2.22 . . . . 0.0 110.806 -175.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -140.21 143.42 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.959 2.503 . . . . 0.0 106.581 166.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.85 148.85 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.276 0.56 . . . . 0.0 110.425 178.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.447 ' HB2' ' H ' ' A' ' 40' ' ' ASN . 31.8 p -77.97 136.55 38.0 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.325 -0.859 . . . . 0.0 112.947 176.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.526 HD13 ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -92.35 -15.88 26.72 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.135 0.974 . . . . 0.0 112.873 169.78 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.49 -57.6 3.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.975 1.71 . . . . 0.0 110.63 169.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.447 ' H ' ' HB2' ' A' ' 37' ' ' SER . 39.4 m-80 -89.32 -179.11 5.78 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.518 1.527 . . . . 0.0 113.202 -172.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 37.96 1.98 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.217 1.807 . . . . 0.0 113.965 177.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 p -141.96 147.19 36.58 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 119.635 -1.915 . . . . 0.0 115.255 -170.219 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.56 143.19 50.36 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.512 1.925 . . . . 0.0 110.484 -174.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.2 mt -117.64 117.77 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 169.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG1' HD13 ' A' ' 57' ' ' LEU . 36.9 t -122.88 119.67 58.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 124.914 1.286 . . . . 0.0 109.625 -165.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.6 t -103.95 108.95 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.797 1.639 . . . . 0.0 109.425 -169.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CD1' HD11 ' A' ' 57' ' ' LEU . 31.6 p90 -122.86 144.68 49.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.896 1.278 . . . . 0.0 113.186 -171.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -95.67 117.58 30.75 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.495 -1.378 . . . . 0.0 111.935 -171.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -177.92 141.46 0.27 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.591 1.956 . . . . 0.0 109.886 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.3 p -83.37 46.93 1.19 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.163 -0.96 . . . . 0.0 108.651 169.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 m -167.32 160.8 13.8 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.403 1.481 . . . . 0.0 113.666 -168.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.453 1.501 . . . . 0.0 111.072 -175.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.1 t -159.7 53.96 0.59 Allowed Pre-proline 0 N--CA 1.483 1.208 0 C-N-CA 125.245 1.418 . . . . 0.0 112.667 173.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -58.1 -23.97 63.88 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 124.119 3.213 . . . . 0.0 112.607 177.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -50.29 -40.94 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.04 0.936 . . . . 0.0 112.418 171.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -70.77 -32.78 70.02 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.384 -1.447 . . . . 0.0 112.731 -177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 ' CD1' ' A' ' 47' ' ' TYR . 46.3 mt -73.96 -45.44 50.24 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.42 175.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -48.92 -51.63 29.02 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 125.386 1.474 . . . . 0.0 109.821 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -55.46 -43.25 75.3 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.932 1.293 . . . . 0.0 113.413 174.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.34 74.95 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.419 0.554 . . . . 0.0 112.332 173.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.559 HG12 HD11 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -70.32 -54.54 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 O-C-N 121.793 -0.567 . . . . 0.0 111.595 172.549 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -52.54 -27.85 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.528 1.131 . . . . 0.0 111.425 177.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.15 1.36 48.3 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 115.497 1.665 . . . . 0.0 115.497 179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.5 OUTLIER -95.3 -29.81 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.15 0.98 . . . . 0.0 111.477 177.149 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -149.03 66.73 8.83 Favored Pre-proline 0 CA--C 1.546 0.798 0 O-C-N 121.664 -0.647 . . . . 0.0 111.453 168.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -58.55 141.15 97.14 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 124.014 3.143 . . . . 0.0 112.592 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.38 -40.99 3.05 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.109 1.338 . . . . 0.0 112.815 -174.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 tp -76.09 -42.98 45.58 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.544 1.137 . . . . 0.0 111.52 172.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.458 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.9 m-30 -78.45 97.71 5.78 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -168.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -78.94 79.61 5.32 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.791 1.236 . . . . 0.0 112.273 168.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.3 t -88.05 121.79 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 123.181 0.592 . . . . 0.0 111.896 -172.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.73 133.01 52.24 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.571 1.148 . . . . 0.0 110.931 -174.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.8 mt -86.32 84.84 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 109.569 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -77.81 114.29 16.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.408 0.623 . . . . 0.0 109.789 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 t -168.33 175.3 6.48 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.217 1.807 . . . . 0.0 110.109 177.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -74.57 43.18 0.18 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.377 2.271 . . . . 0.0 113.322 -172.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 125.889 1.676 . . . . 0.0 111.319 -171.253 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -107.34 -168.55 1.41 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.793 2.437 . . . . 0.0 111.916 172.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.7 t -117.0 178.81 4.22 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.478 1.511 . . . . 0.0 110.872 170.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 m -156.38 146.48 21.28 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 125.636 1.574 . . . . 0.0 109.112 -177.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.33 159.29 43.49 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.82 1.248 . . . . 0.0 110.815 171.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.3 m -114.17 132.44 56.09 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.87 1.268 . . . . 0.0 109.986 174.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.94 146.07 50.01 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.775 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.7 tt -131.85 134.78 59.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.817 1.247 . . . . 0.0 110.621 -176.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -117.98 100.9 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 125.643 1.577 . . . . 0.0 109.015 -169.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.22 3.53 10.56 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -174.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -123.59 10.53 8.55 Favored Glycine 0 N--CA 1.473 1.15 0 C-N-CA 125.887 1.708 . . . . 0.0 113.357 -179.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.4 tmm? -70.59 138.19 50.66 Favored 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 124.289 1.036 . . . . 0.0 110.2 -175.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.79 -6.89 1.96 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 174.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.3 t 81.74 -43.18 0.16 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.586 2.355 . . . . 0.0 110.601 170.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -122.95 149.4 44.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.764 1.226 . . . . 0.0 109.397 169.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m 69.77 -44.53 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.328 1.851 . . . . 0.0 113.261 -168.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.486 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.6 m -51.53 -47.87 63.2 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-N 121.096 1.771 . . . . 0.0 110.563 174.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 36' ' ' VAL . 40.2 t -29.9 -58.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 127.257 2.223 . . . . 0.0 113.844 168.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.2 t -70.5 -34.78 72.73 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 117.839 0.29 . . . . 0.0 111.4 -169.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -58.85 -43.82 90.87 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 121.545 -0.722 . . . . 0.0 112.104 168.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -41.37 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-O 119.191 -0.433 . . . . 0.0 110.43 -172.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -55.73 -50.62 69.88 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.815 0.846 . . . . 0.0 110.292 169.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.1 m -67.81 -45.71 73.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -175.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 m -66.85 -40.27 87.84 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.554 1.542 . . . . 0.0 110.576 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -47.02 42.86 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.838 176.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.9 t -68.77 6.32 0.89 Allowed 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 120.244 1.384 . . . . 0.0 113.733 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -101.98 -5.46 24.61 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.728 1.611 . . . . 0.0 111.512 176.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.7 mt -77.24 127.72 33.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.197 -0.939 . . . . 0.0 109.843 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -54.25 -21.93 10.41 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -172.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.68 -16.54 24.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 175.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.272 4.1 p -82.83 138.4 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 120.658 1.572 . . . . 0.0 110.031 -168.369 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 t -99.67 -31.25 11.66 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.951 1.701 . . . . 0.0 110.668 -174.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -166.49 174.76 8.62 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 122.596 1.189 . . . . 0.0 112.875 173.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.4 tt -162.47 150.73 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 125.011 1.324 . . . . 0.0 111.601 172.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 t -140.73 134.01 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 126.293 1.837 . . . . 0.0 107.24 166.633 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' A' ' 18' ' ' VAL . 28.0 t -101.31 134.98 39.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 122.171 0.986 . . . . 0.0 109.776 168.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -68.59 92.26 0.45 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.808 169.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -47.9 -43.05 28.44 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.989 1.715 . . . . 0.0 111.305 -177.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.52 -51.87 67.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.553 1.141 . . . . 0.0 112.031 176.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -79.69 -176.19 5.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 124.893 2.282 . . . . 0.0 113.814 -173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.3 30.2 4.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.482 2.313 . . . . 0.0 112.133 169.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.98 150.87 41.93 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.182 -1.574 . . . . 0.0 114.744 -167.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.8 136.45 51.49 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.592 1.957 . . . . 0.0 110.517 -171.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -106.23 111.37 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 172.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.507 ' CG1' HD13 ' A' ' 57' ' ' LEU . 11.7 t -117.5 130.79 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.2 1.4 . . . . 0.0 108.792 -169.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.8 t -113.65 112.78 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.195 1.398 . . . . 0.0 107.481 -177.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 2.0 p90 -131.84 134.81 46.17 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.897 1.226 . . . . 0.0 112.303 -171.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -77.66 113.14 15.2 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.471 -0.768 . . . . 0.0 110.547 179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.51 167.59 2.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.766 2.426 . . . . 0.0 109.489 -178.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 m -77.36 31.67 0.15 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.894 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.8 m 61.52 -25.4 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 128.917 2.887 . . . . 0.0 117.166 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.9 m -72.84 21.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.299 1.839 . . . . 0.0 114.052 178.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.63 34.33 0.23 Allowed Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -173.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.1 -27.32 17.16 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.108 2.538 . . . . 0.0 112.252 -176.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -52.81 -24.79 9.65 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.68 1.592 . . . . 0.0 112.502 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -42.6 79.99 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.704 -1.248 . . . . 0.0 112.233 177.165 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.507 HD13 ' CG1' ' A' ' 45' ' ' VAL . 94.7 mt -70.47 -45.5 65.59 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.801 178.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -46.06 -52.25 12.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.984 0.914 . . . . 0.0 110.345 170.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.19 -32.83 74.56 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 177.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.84 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.297 1.408 . . . . 0.0 111.537 170.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -68.53 -52.85 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 122.876 0.47 . . . . 0.0 110.684 171.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -52.07 -27.75 14.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.237 0.926 . . . . 0.0 112.0 174.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.57 4.15 33.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 178.362 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -98.32 -28.04 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.926 0.89 . . . . 0.0 111.544 173.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.418 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.36 67.81 9.91 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.506 -0.746 . . . . 0.0 111.068 168.599 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.9 139.87 87.31 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.054 3.169 . . . . 0.0 111.868 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.82 -23.06 7.04 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.571 1.081 . . . . 0.0 114.073 -175.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 tp -94.98 -45.16 7.37 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.376 1.471 . . . . 0.0 111.492 173.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.428 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.6 m-30 -76.95 102.07 6.24 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -168.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.622 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.4 OUTLIER -75.86 75.99 2.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.118 1.367 . . . . 0.0 110.267 168.743 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.91 129.65 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 122.227 1.013 . . . . 0.0 111.744 -176.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.3 m -138.66 159.72 41.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.613 1.565 . . . . 0.0 109.992 178.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.3 mt -95.69 129.61 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 171.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t -102.37 106.96 17.81 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.584 0.707 . . . . 0.0 109.955 -179.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.6 t -169.55 175.92 5.21 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.145 1.778 . . . . 0.0 109.842 173.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -68.19 30.5 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 129.581 3.153 . . . . 0.0 114.997 -171.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 126.273 1.829 . . . . 0.0 110.538 -172.938 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.173 0.511 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -79.47 166.85 21.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.462 1.505 . . . . 0.0 113.396 174.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 t -120.13 168.89 10.74 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 127.297 2.239 . . . . 0.0 107.972 167.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m -152.89 147.89 26.51 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.196 -0.94 . . . . 0.0 110.601 -175.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.52 161.32 42.75 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.558 1.143 . . . . 0.0 112.162 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.1 m -121.47 137.73 54.59 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.101 1.36 . . . . 0.0 110.257 178.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -136.9 143.16 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.779 1.231 . . . . 0.0 110.31 -178.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.4 tt -132.07 131.67 61.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.668 1.187 . . . . 0.0 111.052 -175.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.63 102.36 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 126.329 1.852 . . . . 0.0 108.768 -170.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -76.52 33.07 0.13 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.052 -1.655 . . . . 0.0 114.143 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.97 -0.71 0.07 OUTLIER Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.424 1.488 . . . . 0.0 116.263 -176.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.8 ptm -69.94 141.02 53.12 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.466 2.133 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -59.19 12.09 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 127.235 2.214 . . . . 0.0 116.17 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.4 m 73.12 -42.64 0.54 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 128.275 2.63 . . . . 0.0 115.768 167.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.11 -89.64 0.47 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.046 1.338 . . . . 0.0 109.129 174.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 p -55.57 -22.77 23.49 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 121.679 2.036 . . . . 0.0 115.601 -173.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.2 m -57.87 -42.75 85.22 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 120.106 1.321 . . . . 0.0 112.527 169.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' CG1' ' A' ' 36' ' ' VAL . 37.6 t -46.43 -54.59 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 126.038 1.735 . . . . 0.0 110.814 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.2 t -60.01 -37.95 81.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.2 0.6 . . . . 0.0 111.605 -176.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -65.7 -42.76 90.79 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-O 118.36 -0.829 . . . . 0.0 112.375 174.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.58 -44.48 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 119.095 0.861 . . . . 0.0 110.055 -175.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.76 -55.61 21.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.404 1.082 . . . . 0.0 110.37 169.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.4 t -64.1 -49.36 72.53 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -179.359 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.5 m -69.95 -36.25 75.14 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.98 1.312 . . . . 0.0 111.16 -172.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.5 mt -72.98 -47.97 40.65 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.746 168.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -65.81 7.68 0.24 Allowed 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 121.288 1.858 . . . . 0.0 115.283 -171.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.51 -3.32 18.2 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.824 2.05 . . . . 0.0 112.199 176.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 mt -72.5 136.84 46.01 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 120.99 -1.069 . . . . 0.0 110.996 -171.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -75.63 65.65 1.85 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.786 1.634 . . . . 0.0 111.274 -174.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.8 p90 167.25 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 129.961 3.304 . . . . 0.0 113.041 -173.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.2 p -86.03 142.63 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 121.184 1.811 . . . . 0.0 110.186 -175.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.06 -21.79 12.12 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -170.54 172.01 6.14 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.073 1.749 . . . . 0.0 112.369 -173.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.7 tt -176.25 153.82 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 127.804 2.442 . . . . 0.0 109.593 -169.3 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.2 t -147.11 132.6 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 127.588 2.355 . . . . 0.0 107.743 166.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.488 ' CG1' HG13 ' A' ' 18' ' ' VAL . 25.2 t -103.09 142.14 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 121.458 0.647 . . . . 0.0 110.825 169.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.5 t -73.28 108.79 6.36 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 122.81 1.29 . . . . 0.0 109.126 166.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -20.24 44.68 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.341 -0.849 . . . . 0.0 112.139 168.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -91.9 -45.6 8.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.539 1.063 . . . . 0.0 112.57 175.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -99.6 157.56 16.38 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.828 1.251 . . . . 0.0 112.178 -171.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.81 35.01 0.23 Allowed 'General case' 0 CA--C 1.548 0.872 0 O-C-N 119.732 -1.855 . . . . 0.0 113.946 -177.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -140.49 154.55 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 119.914 -1.741 . . . . 0.0 115.431 -170.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -122.56 139.19 54.18 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 127.187 2.195 . . . . 0.0 109.923 -178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.8 mt -110.26 118.28 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 169.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.411 ' CG1' HD13 ' A' ' 57' ' ' LEU . 15.9 t -121.65 138.35 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.899 1.28 . . . . 0.0 110.125 -167.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.2 t -125.14 99.4 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.238 1.415 . . . . 0.0 109.925 -167.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.498 ' CD1' HD11 ' A' ' 57' ' ' LEU . 20.4 p90 -118.13 143.01 46.83 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.537 1.535 . . . . 0.0 113.539 -168.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -92.02 94.28 9.18 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.565 -1.334 . . . . 0.0 111.583 -169.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.79 129.36 3.48 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.415 0.686 . . . . 0.0 112.394 -175.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.0 t -83.52 -11.41 57.46 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.566 -0.708 . . . . 0.0 112.135 174.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 m -168.55 72.34 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.42 1.488 . . . . 0.0 111.768 -177.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.6 t -135.85 138.11 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 168.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.0 t -68.94 137.56 89.9 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-O 118.45 -0.786 . . . . 0.0 111.198 -174.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.3 -20.64 69.02 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.235 2.623 . . . . 0.0 111.929 170.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.46 -16.96 41.53 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.155 0.982 . . . . 0.0 112.608 174.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 80.2 p -68.06 -47.07 69.34 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.957 -1.089 . . . . 0.0 112.802 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.498 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.7 mt -66.6 -42.88 86.22 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.608 -0.683 . . . . 0.0 110.435 176.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.68 -52.5 18.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.207 1.403 . . . . 0.0 111.785 171.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -32.52 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 176.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.8 -37.14 83.97 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.984 1.265 . . . . 0.0 111.8 172.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.1 mt -62.02 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 121.432 -0.793 . . . . 0.0 110.762 171.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.19 -20.67 18.96 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.71 1.19 55.56 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.636 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -93.96 -28.79 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 119.282 0.946 . . . . 0.0 111.252 176.352 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.465 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -151.15 67.79 7.75 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.764 0.826 . . . . 0.0 112.161 169.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -57.45 145.41 88.45 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 124.269 3.313 . . . . 0.0 113.062 -178.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.96 -40.98 2.93 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.416 1.484 . . . . 0.0 112.929 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.9 tp -77.01 -45.81 26.01 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.046 1.338 . . . . 0.0 111.698 173.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 65' ' ' SER . 3.2 m-30 -72.28 96.97 1.91 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.25 1.5 . . . . 0.0 114.11 -168.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -72.85 65.02 0.7 Allowed 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.715 2.006 . . . . 0.0 113.594 170.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -82.97 136.78 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.77 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 p -151.79 156.95 41.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.845 1.258 . . . . 0.0 110.57 174.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 93.4 mt -83.65 129.61 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.166 0.986 . . . . 0.0 109.71 174.643 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.76 107.27 18.87 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.097 0.959 . . . . 0.0 109.097 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.0 t -137.92 163.16 32.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.827 0.851 . . . . 0.0 113.273 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -79.29 71.45 5.82 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.861 1.315 . . . . 0.0 110.375 175.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 126.105 1.762 . . . . 0.0 109.839 172.084 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 122.435 1.112 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.95 154.42 38.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.02 1.328 . . . . 0.0 113.709 -170.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 t -100.65 -175.88 3.03 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.821 1.648 . . . . 0.0 110.141 168.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -162.77 150.79 13.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.044 1.338 . . . . 0.0 109.62 -172.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.4 159.93 39.17 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.678 1.591 . . . . 0.0 111.321 175.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 m -121.87 139.22 53.9 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.388 1.475 . . . . 0.0 109.947 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -140.5 139.48 35.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.185 -176.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.7 tt -127.12 130.75 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 125.05 1.34 . . . . 0.0 111.122 -175.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.42 103.46 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 125.978 1.711 . . . . 0.0 109.524 -168.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.44 ' CB ' ' HB3' ' A' ' 70' ' ' ARG . 0.6 OUTLIER -72.08 0.19 10.17 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 -171.357 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.72 10.47 5.75 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 125.784 1.659 . . . . 0.0 114.36 -173.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -66.59 135.92 54.85 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.304 1.042 . . . . 0.0 111.231 -174.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -62.56 0.25 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 172.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.9 m 76.34 -40.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 127.965 2.506 . . . . 0.0 114.623 167.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HE3' HD13 ' A' ' 38' ' ' LEU . 12.3 mptt -111.55 -75.79 0.61 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.11 0.868 . . . . 0.0 109.507 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -58.73 -32.32 69.1 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 119.552 -1.968 . . . . 0.0 114.045 -179.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.25 -41.73 80.17 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.815 -1.088 . . . . 0.0 111.69 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.527 HG13 ' CG1' ' A' ' 36' ' ' VAL . 76.7 t -47.13 -49.21 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.887 2.075 . . . . 0.0 112.242 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.6 t -61.62 -40.07 93.55 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.395 0.678 . . . . 0.0 112.348 -178.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -63.8 -46.95 82.87 Favored 'General case' 0 C--O 1.224 -0.289 0 O-C-N 122.06 -0.4 . . . . 0.0 111.743 171.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.23 -50.98 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -171.12 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.06 -44.47 67.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.33 1.852 . . . . 0.0 109.899 175.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 42.6 m -70.49 -44.59 67.35 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 m -70.76 -40.3 72.76 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.95 1.3 . . . . 0.0 110.853 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.71 -49.55 25.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 116.845 -1.55 . . . . 0.0 111.199 175.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.0 t -71.96 16.74 0.11 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.472 1.942 . . . . 0.0 113.534 -174.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.92 -3.45 14.84 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.224 1.81 . . . . 0.0 112.423 174.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 mt -72.85 139.86 47.23 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.86 -1.15 . . . . 0.0 111.634 -171.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -57.88 -15.2 7.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.817 1.647 . . . . 0.0 115.004 -170.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.79 -6.47 11.53 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.367 1.867 . . . . 0.0 114.95 178.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.1 p -88.82 137.32 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.923 1.692 . . . . 0.0 111.271 -168.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.23 -26.19 14.26 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.266 1.027 . . . . 0.0 111.506 -173.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 m -177.8 173.55 1.57 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.06 2.144 . . . . 0.0 111.636 -171.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -177.32 155.34 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 127.622 2.369 . . . . 0.0 108.624 -172.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.6 t -149.58 135.38 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 127.48 2.312 . . . . 0.0 108.645 166.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' CG1' HG13 ' A' ' 18' ' ' VAL . 41.2 t -106.19 141.44 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 124.072 0.949 . . . . 0.0 110.75 169.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -79.16 112.76 16.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 123.153 1.454 . . . . 0.0 110.259 168.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.549 HD13 ' HE3' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -56.59 -22.06 31.17 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 120.692 -1.255 . . . . 0.0 112.664 167.886 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.61 -69.04 0.73 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.519 1.528 . . . . 0.0 111.057 169.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -73.52 137.23 44.28 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.855 1.262 . . . . 0.0 111.278 -171.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.01 31.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.3 p -130.86 154.73 47.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 127.247 2.219 . . . . 0.0 113.691 -178.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.26 143.97 44.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.259 2.223 . . . . 0.0 109.296 172.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 93.5 mt -114.74 118.84 59.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 169.11 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG1' HD13 ' A' ' 57' ' ' LEU . 14.4 t -119.99 135.52 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.329 1.452 . . . . 0.0 108.881 -168.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 63.4 t -123.73 96.81 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 125.21 1.404 . . . . 0.0 108.52 -168.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.574 ' CD1' HD11 ' A' ' 57' ' ' LEU . 25.6 p90 -118.63 140.07 50.5 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.729 1.212 . . . . 0.0 113.55 -168.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -85.33 117.31 24.18 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.077 -1.014 . . . . 0.0 111.629 -178.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -179.94 132.6 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.095 2.158 . . . . 0.0 108.95 178.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 m -82.24 -13.44 57.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.095 -1.003 . . . . 0.0 113.002 177.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -167.95 158.55 10.67 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.776 1.63 . . . . 0.0 110.348 167.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 p 145.0 153.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 1 C-N-CA 132.515 4.326 . . . . 0.0 106.914 -169.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t -66.16 144.25 98.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.152 171.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -55.38 -19.59 22.83 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.52 2.813 . . . . 0.0 112.329 167.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.83 -13.65 62.12 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -169.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.96 -37.32 81.99 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.301 1.864 . . . . 0.0 111.44 170.294 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 47' ' ' TYR . 70.7 mt -70.03 -46.14 65.68 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.182 173.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -49.01 -52.42 25.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 111.072 174.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -56.5 -37.71 70.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.286 1.434 . . . . 0.0 114.749 171.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.77 95.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.733 1.606 . . . . 0.0 111.474 171.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.2 mt -63.06 -56.18 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.398 -0.814 . . . . 0.0 110.667 174.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -53.18 -24.68 11.37 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.936 0.894 . . . . 0.0 113.002 175.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.08 0.01 55.94 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -95.39 -30.6 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.378 1.071 . . . . 0.0 111.412 177.696 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -149.01 67.48 9.18 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.39 0.676 . . . . 0.0 111.145 169.651 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.25 143.71 99.65 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.13 3.22 . . . . 0.0 112.081 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.71 -39.18 2.82 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 124.863 1.22 . . . . 0.0 113.093 -174.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.2 tp -78.21 -41.95 32.85 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.81 1.244 . . . . 0.0 111.529 174.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.45 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.8 m-30 -83.16 94.51 7.87 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -168.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' HB3' ' CB ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -73.36 66.14 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.189 1.796 . . . . 0.0 111.146 169.213 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.19 131.0 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-O 121.747 0.784 . . . . 0.0 110.756 -175.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -138.0 147.62 44.38 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 0.0 109.017 -176.236 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 86.0 mt -91.48 130.33 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 O-C-N 119.894 -1.754 . . . . 0.0 109.916 174.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.04 93.21 7.24 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.447 0.699 . . . . 0.0 110.184 178.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.5 m -176.51 165.58 2.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.978 2.511 . . . . 0.0 108.69 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -72.43 111.08 7.3 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 170.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 124.999 1.32 . . . . 0.0 114.322 -171.801 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.58 167.67 20.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.779 2.431 . . . . 0.0 113.861 -175.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 t -103.49 175.11 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.291 1.436 . . . . 0.0 110.794 176.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.1 m -163.99 147.53 9.8 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.862 -1.149 . . . . 0.0 110.384 -169.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.28 161.98 41.4 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 125.198 1.399 . . . . 0.0 111.321 170.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.5 m -123.93 139.77 53.63 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.837 1.255 . . . . 0.0 110.218 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -140.79 136.99 33.02 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.722 1.209 . . . . 0.0 110.024 -174.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tt -119.44 132.99 67.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 120.82 -1.175 . . . . 0.0 110.424 177.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.0 106.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 125.16 1.384 . . . . 0.0 108.676 -175.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.45 98.91 11.29 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.764 1.269 . . . . 0.0 109.678 169.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 147.55 -13.42 1.38 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.672 1.606 . . . . 0.0 114.057 177.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.401 ' SD ' ' SG ' ' A' ' 17' ' ' CYS 0.257 0.0 OUTLIER -77.07 132.65 39.01 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 118.85 1.325 . . . . 0.0 112.187 -176.779 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -67.94 43.81 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 t 66.61 -53.9 0.43 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.197 2.599 . . . . 0.0 116.23 169.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -63.34 1.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.67 -1.269 . . . . 0.0 112.931 -178.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.2 p -59.07 -32.69 70.01 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 121.424 1.92 . . . . 0.0 114.221 -177.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.401 ' SG ' ' SD ' ' A' ' 12' ' ' MET . 2.3 p -40.6 -58.17 1.67 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.217 1.807 . . . . 0.0 111.376 169.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -46.24 -54.19 2.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 127.541 2.336 . . . . 0.0 111.007 -176.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -64.02 -30.23 71.32 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.334 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -69.93 -46.91 64.32 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 118.89 0.768 . . . . 0.0 111.353 168.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.98 -46.46 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-N 119.255 0.934 . . . . 0.0 110.645 -170.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -51.43 -48.86 62.57 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.113 1.365 . . . . 0.0 110.786 170.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.2 m -68.75 -52.19 33.16 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.9 m -69.32 -35.87 76.38 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.531 1.532 . . . . 0.0 110.567 -169.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -73.24 -48.94 30.7 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-O 116.853 -1.546 . . . . 0.0 112.057 168.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 17.8 t -70.96 13.65 0.19 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.739 2.063 . . . . 0.0 114.421 -171.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.94 16.25 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.886 2.074 . . . . 0.0 111.398 173.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.99 125.86 29.8 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.11 -15.13 43.21 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -169.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.15 -11.57 35.25 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 169.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -94.68 137.1 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 121.586 1.994 . . . . 0.0 109.739 -173.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 t -105.38 -14.79 15.22 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.197 0.599 . . . . 0.0 112.491 -176.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -178.61 172.18 1.44 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.805 2.042 . . . . 0.0 112.288 -172.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.6 tt -176.05 152.9 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 127.743 2.417 . . . . 0.0 109.29 -170.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.5 133.34 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 127.503 2.321 . . . . 0.0 107.236 167.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.2 t -100.54 141.77 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 123.247 1.499 . . . . 0.0 112.326 171.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -77.57 84.15 3.95 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.596 1.559 . . . . 0.0 109.384 179.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 mt -56.09 -29.34 60.44 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.756 1.622 . . . . 0.0 114.191 -173.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -88.4 -0.31 57.04 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.712 1.605 . . . . 0.0 114.325 176.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -135.67 -171.51 2.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.535 2.734 . . . . 0.0 110.411 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER -111.24 33.72 4.49 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 175.022 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 p -132.66 155.74 48.23 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.019 -1.676 . . . . 0.0 115.505 -170.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.27 138.02 54.44 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.144 2.178 . . . . 0.0 110.107 -178.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 85.2 mt -108.79 115.91 50.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 170.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 t -118.73 136.19 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.133 1.373 . . . . 0.0 108.977 -167.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.8 t -124.66 104.29 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.758 1.223 . . . . 0.0 109.191 -169.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 57' ' ' LEU . 34.5 p90 -120.23 161.82 20.44 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.239 1.016 . . . . 0.0 113.274 -171.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -92.5 122.75 35.24 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.982 -1.073 . . . . 0.0 110.921 -176.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.67 156.18 1.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.772 2.029 . . . . 0.0 110.604 174.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -87.43 24.25 1.69 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.151 0.981 . . . . 0.0 111.762 170.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.8 t -163.12 -178.82 6.25 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.755 -1.216 . . . . 0.0 113.514 -173.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.1 t -111.93 109.33 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 127.771 2.428 . . . . 0.0 108.927 -176.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.0 m -141.86 69.77 24.34 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 126.193 1.797 . . . . 0.0 109.186 177.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.93 -20.39 13.2 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.574 2.85 . . . . 0.0 113.109 -171.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -54.95 -32.67 61.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.057 1.343 . . . . 0.0 113.4 -176.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.4 m -73.65 -35.95 65.33 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 120.371 -1.456 . . . . 0.0 112.666 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.42 HD11 ' CD1' ' A' ' 47' ' ' TYR . 83.6 mt -70.56 -44.58 67.14 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -50.7 -51.18 52.03 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.845 1.258 . . . . 0.0 111.201 172.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -39.55 79.34 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.643 1.177 . . . . 0.0 114.108 172.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.73 -36.33 80.37 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.929 1.24 . . . . 0.0 111.83 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.48 -51.67 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 O-C-N 121.763 -0.585 . . . . 0.0 109.718 170.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -56.69 -19.02 14.4 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.145 0.884 . . . . 0.0 112.844 176.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 1.2 57.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 175.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -92.22 -32.35 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 118.969 0.804 . . . . 0.0 111.014 175.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.46 69.12 11.33 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.355 0.662 . . . . 0.0 111.65 168.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -58.58 142.0 97.9 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 124.291 3.327 . . . . 0.0 112.785 -178.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.42 -35.56 3.45 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.143 1.354 . . . . 0.0 113.066 -176.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.9 tp -82.65 -43.78 16.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.718 1.607 . . . . 0.0 112.064 174.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.448 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.8 m-30 -80.66 105.08 11.63 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -167.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.14 75.37 8.12 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 119.618 -1.926 . . . . 0.0 112.927 169.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 t -80.43 126.26 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 O-C-N 121.25 -0.906 . . . . 0.0 112.849 -174.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -140.48 139.48 35.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.198 0.999 . . . . 0.0 111.608 -169.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 81.1 mt -85.41 110.62 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 120.659 -1.276 . . . . 0.0 109.176 178.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t -85.7 121.78 28.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.671 0.748 . . . . 0.0 109.281 173.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 74.6 m -158.1 166.79 31.61 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.197 2.199 . . . . 0.0 109.355 170.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -86.41 128.16 34.91 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 167.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 126.858 2.063 . . . . 0.0 110.5 -172.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.8 m120 . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 123.218 1.485 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.52 27.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.441 1.896 . . . . 0.0 110.491 167.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.8 t -94.7 -179.67 4.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.576 1.95 . . . . 0.0 110.987 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.8 m -158.88 145.96 17.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.287 1.435 . . . . 0.0 110.244 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.03 153.82 39.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.043 1.737 . . . . 0.0 111.07 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 m -117.69 139.52 50.91 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.074 1.35 . . . . 0.0 109.913 177.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -137.98 144.97 41.39 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.941 1.296 . . . . 0.0 110.644 178.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.1 tt -127.24 135.0 64.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 125.514 1.525 . . . . 0.0 110.282 178.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.59 123.51 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.969 1.308 . . . . 0.0 108.775 -171.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.67 146.48 27.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 164.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.61 -4.67 77.67 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.401 0.524 . . . . 0.0 112.559 -168.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.42 127.53 27.86 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.303 1.441 . . . . 0.0 112.118 174.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -64.98 41.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.664 1.986 . . . . 0.0 113.961 170.2 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 t 30.62 -110.83 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.961 3.305 . . . . 0.0 114.84 175.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HE2' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -51.85 -39.38 58.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.21 1.004 . . . . 0.0 113.375 -179.013 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.8 m -83.12 -32.89 26.46 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.009 -1.057 . . . . 0.0 112.196 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 t -55.15 -49.08 72.72 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.972 1.26 . . . . 0.0 110.672 171.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' CG1' ' A' ' 36' ' ' VAL . 2.4 t -42.34 -50.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 124.489 1.118 . . . . 0.0 112.5 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -69.3 -35.54 76.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -62.81 -45.24 93.54 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.756 -1.215 . . . . 0.0 111.005 169.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mm -67.45 -49.21 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.983 -170.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -43.97 -50.83 8.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.488 1.515 . . . . 0.0 109.539 170.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.3 m -71.63 -50.95 25.91 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -175.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.4 m -66.26 -42.55 88.36 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.26 1.424 . . . . 0.0 110.51 -176.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.08 -49.65 23.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 117.015 -1.469 . . . . 0.0 111.159 177.624 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.6 t -74.26 13.75 0.53 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 121.476 1.943 . . . . 0.0 113.302 -173.044 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.16 -3.1 18.87 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.733 1.613 . . . . 0.0 111.858 173.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.8 mt -75.06 133.64 41.55 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.046 -1.034 . . . . 0.0 110.435 -172.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -59.5 2.98 0.05 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -174.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.23 -8.09 4.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.696 1.999 . . . . 0.0 114.717 174.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 8.7 p -88.24 139.21 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 121.369 1.895 . . . . 0.0 110.426 -169.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -99.92 -19.02 16.81 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m 178.75 171.42 0.81 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.094 1.758 . . . . 0.0 113.039 -172.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.3 tt -168.13 152.1 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 126.857 2.063 . . . . 0.0 110.473 -174.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.6 t -142.21 148.76 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 128.383 2.673 . . . . 0.0 106.544 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 18' ' ' VAL . 7.3 p -138.41 145.93 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.96 0.409 . . . . 0.0 110.85 175.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 m -91.59 125.52 36.36 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.582 0.705 . . . . 0.0 112.307 -176.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.449 HD22 ' HE2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -70.58 -36.47 73.6 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.025 -1.047 . . . . 0.0 112.869 -176.206 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -104.15 -8.85 19.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.291 1.436 . . . . 0.0 114.732 -177.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -121.76 130.39 53.38 Favored 'General case' 0 C--O 1.221 -0.431 0 O-C-N 120.264 -1.523 . . . . 0.0 107.108 172.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 35.12 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -167.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.3 p -128.23 152.5 48.01 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -172.745 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.48 137.53 54.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.956 2.502 . . . . 0.0 110.491 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 98.3 mt -110.66 117.18 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 172.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.483 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.2 t -123.42 130.67 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.503 1.121 . . . . 0.0 109.041 -167.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -118.01 108.87 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.378 1.471 . . . . 0.0 108.555 -167.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.425 ' CD1' HD11 ' A' ' 57' ' ' LEU . 21.6 p90 -128.3 145.67 50.99 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.29 1.405 . . . . 0.0 113.844 -168.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -97.24 107.92 20.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.304 -1.498 . . . . 0.0 112.11 -172.139 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -176.46 148.46 0.74 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.587 1.555 . . . . 0.0 111.411 -170.805 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.1 m -93.08 17.26 11.15 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.036 -1.04 . . . . 0.0 112.895 -178.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.6 p -124.51 135.22 53.02 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.783 -1.198 . . . . 0.0 113.347 -178.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 90.3 t -73.53 98.58 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 166.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 m -144.47 54.16 2.55 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 124.078 0.951 . . . . 0.0 109.949 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.98 -17.14 58.62 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.945 2.43 . . . . 0.0 111.991 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 55' ' ' GLU . 17.0 mp0 -64.54 -8.96 15.85 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.461 1.504 . . . . 0.0 112.26 173.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.0 p -79.17 -51.87 8.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.787 1.176 . . . . 0.0 111.906 169.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.483 HD13 ' CG1' ' A' ' 45' ' ' VAL . 87.6 mt -64.79 -41.55 95.73 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.774 -1.107 . . . . 0.0 110.639 176.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.7 -53.4 15.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.498 1.045 . . . . 0.0 111.545 172.064 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -37.69 72.48 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.36 1.464 . . . . 0.0 113.518 175.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.59 -37.13 84.26 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.369 1.44 . . . . 0.0 112.085 175.151 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.26 -56.74 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 123.455 0.702 . . . . 0.0 110.758 171.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -53.41 -27.33 23.82 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 123.801 0.84 . . . . 0.0 111.534 176.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.42 1.98 38.82 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.23 -27.94 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.726 0.81 . . . . 0.0 111.643 175.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.77 69.1 9.23 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 124.082 0.953 . . . . 0.0 110.644 169.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.34 145.3 98.92 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.257 3.305 . . . . 0.0 112.489 -178.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.06 -40.83 2.56 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.961 1.267 . . . . 0.0 113.013 -174.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 53.7 tp -74.82 -55.4 5.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.436 1.494 . . . . 0.0 111.062 177.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -71.5 107.76 4.56 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -169.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -78.89 47.68 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.226 1.811 . . . . 0.0 113.761 176.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.4 t -59.3 126.95 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.972 0.909 . . . . 0.0 111.076 -168.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 m -139.58 148.52 42.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.649 -175.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.6 mt -89.67 124.28 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 120.692 -1.255 . . . . 0.0 109.758 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.71 106.99 18.89 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 123.694 0.798 . . . . 0.0 109.608 -175.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.8 m 175.67 -25.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 127.934 2.494 . . . . 0.0 114.507 174.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -75.92 85.61 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 122.709 1.242 . . . . 0.0 108.919 176.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 CA--C 1.542 0.642 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.141 170.697 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 124.032 1.873 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -55.76 129.6 39.98 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.934 2.094 . . . . 0.0 109.732 165.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t -102.07 -175.25 2.78 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.88 1.672 . . . . 0.0 109.751 172.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -158.77 150.76 21.21 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.845 -1.159 . . . . 0.0 109.893 -177.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.06 156.01 40.2 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.996 1.719 . . . . 0.0 109.864 173.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.0 m -127.26 138.58 53.11 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 123.996 0.919 . . . . 0.0 109.453 -178.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -136.53 144.85 44.46 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.413 1.085 . . . . 0.0 111.303 -174.106 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.3 tt -122.38 140.87 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 C-N-CA 125.205 1.402 . . . . 0.0 109.19 175.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.18 153.42 12.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 124.683 1.193 . . . . 0.0 108.639 -179.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.26 144.66 50.76 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.413 0.285 . . . . 0.0 110.971 164.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.77 -1.67 68.81 Favored Glycine 0 N--CA 1.476 1.348 0 C-N-CA 125.22 1.39 . . . . 0.0 112.504 -174.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.49 165.91 18.01 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.514 1.525 . . . . 0.0 114.338 -171.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -73.55 37.23 0.09 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 125.022 1.329 . . . . 0.0 113.76 -179.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.1 t 52.39 -143.09 0.72 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.632 1.573 . . . . 0.0 111.7 -178.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HE3' HD13 ' A' ' 38' ' ' LEU . 29.5 mttp -61.23 -13.87 21.65 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.196 -1.565 . . . . 0.0 114.273 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -91.79 -11.83 35.52 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.051 -1.656 . . . . 0.0 112.268 174.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -48.09 77.8 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.643 1.111 . . . . 0.0 108.179 168.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.559 HG13 ' CG1' ' A' ' 36' ' ' VAL . 54.2 t -40.45 -56.36 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 130.392 3.477 . . . . 0.0 111.937 -177.554 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -63.78 -38.27 90.47 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 120.888 0.375 . . . . 0.0 111.808 -173.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -60.81 -41.49 95.81 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.831 -1.168 . . . . 0.0 112.412 168.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.55 -47.38 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.731 -171.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -46.68 -51.53 15.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.746 1.618 . . . . 0.0 109.307 169.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 m -70.55 -44.26 67.82 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.6 m -70.55 -40.68 73.24 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.769 1.228 . . . . 0.0 110.5 -175.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.43 -44.89 57.26 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 117.369 -1.3 . . . . 0.0 111.224 178.679 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t -70.38 13.36 0.17 Allowed 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 120.416 1.462 . . . . 0.0 113.813 -176.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.03 -6.84 19.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.399 1.48 . . . . 0.0 111.95 174.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.26 129.0 34.54 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.063 -1.023 . . . . 0.0 110.327 -169.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -54.72 -25.07 25.17 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -173.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 -5.13 48.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 174.044 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' TYR 0.254 5.0 p -92.55 134.73 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 121.606 2.003 . . . . 0.0 110.314 -173.261 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.0 t -93.3 -27.39 16.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.383 1.473 . . . . 0.0 111.796 -176.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -178.06 175.91 1.2 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.959 2.104 . . . . 0.0 112.409 -171.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.3 tt -172.75 151.18 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.748 2.019 . . . . 0.0 109.724 -175.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.2 t -140.58 141.37 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.559 0 C-N-CA 126.901 2.08 . . . . 0.0 105.782 166.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' CG1' HG13 ' A' ' 18' ' ' VAL . 66.2 t -111.37 137.84 42.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.681 1.229 . . . . 0.0 110.46 169.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.0 m -75.92 83.11 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.45 176.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD13 ' HE3' ' A' ' 15' ' ' LYS . 2.5 tm? -43.49 -42.91 5.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.509 2.324 . . . . 0.0 112.314 -178.231 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.06 -47.61 84.62 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.345 1.069 . . . . 0.0 112.29 178.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -98.43 -171.48 2.14 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.99 2.516 . . . . 0.0 112.031 -171.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.98 29.56 4.96 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.081 2.552 . . . . 0.0 113.309 -179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 p -144.81 158.64 43.72 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.012 -1.68 . . . . 0.0 115.406 -167.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.32 139.41 51.76 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 127.103 2.161 . . . . 0.0 110.774 -173.299 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.9 mt -112.77 110.68 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 174.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.3 t -116.67 130.46 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.19 1.396 . . . . 0.0 108.141 -168.239 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.87 106.46 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.14 1.376 . . . . 0.0 107.813 -168.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.603 ' CD1' HD11 ' A' ' 57' ' ' LEU . 27.1 p90 -127.25 147.15 50.23 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.588 1.155 . . . . 0.0 113.617 -168.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -89.03 141.48 28.45 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 120.284 -1.51 . . . . 0.0 112.172 179.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -171.26 172.7 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.754 1.622 . . . . 0.0 110.495 -179.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 96.3 p -98.24 10.04 41.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.467 1.107 . . . . 0.0 111.229 167.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.1 m -153.24 158.25 41.4 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.684 1.194 . . . . 0.0 111.373 -168.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.2 t -79.85 110.84 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 167.01 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.6 m -145.85 80.7 10.35 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 124.007 0.923 . . . . 0.0 109.649 -171.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -89.63 -17.07 1.85 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.898 3.065 . . . . 0.0 114.66 -173.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -64.16 -32.78 74.48 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.745 1.157 . . . . 0.0 112.913 -168.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 m -74.51 -28.43 60.98 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.065 0.946 . . . . 0.0 112.984 -178.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' CD1' ' A' ' 47' ' ' TYR . 69.4 mt -70.81 -47.58 58.69 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.407 170.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 -45.34 -53.68 8.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.142 0.883 . . . . 0.0 110.761 169.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -37.54 71.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 175.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.65 78.48 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 120.423 1.465 . . . . 0.0 111.892 172.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.4 mt -70.23 -50.74 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.263 0.625 . . . . 0.0 110.029 173.294 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -58.37 -19.36 34.93 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.429 -1.419 . . . . 0.0 112.486 174.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.31 0.43 56.81 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 174.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -89.63 -37.39 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 118.997 0.817 . . . . 0.0 110.967 173.186 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.42 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -140.35 70.51 33.11 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.964 0.412 . . . . 0.0 111.718 169.846 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -59.32 134.82 61.35 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.433 3.422 . . . . 0.0 111.909 178.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 -17.2 27.47 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 125.095 1.331 . . . . 0.0 114.167 -174.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.9 tp -105.25 -23.82 12.82 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.686 1.594 . . . . 0.0 112.532 -179.405 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.429 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.8 m-30 -102.61 111.29 23.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -169.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.24 45.71 0.97 Allowed 'General case' 0 N--CA 1.479 0.982 0 O-C-N 119.578 -1.951 . . . . 0.0 114.851 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -62.75 124.06 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -166.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 m -141.11 155.65 46.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.827 1.651 . . . . 0.0 109.451 -170.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.89 131.39 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.411 -1.43 . . . . 0.0 107.369 176.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.4 t -110.75 57.56 0.62 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.38 1.072 . . . . 0.0 112.411 -169.129 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.7 m -165.22 33.82 0.06 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.976 1.31 . . . . 0.0 113.162 -173.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.22 31.63 5.55 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.663 1.22 . . . . 0.0 109.804 169.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.477 0.921 0 C-N-CA 126.171 1.789 . . . . 0.0 111.239 -176.965 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -87.11 -172.17 3.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.799 2.44 . . . . 0.0 113.702 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.2 t -124.67 169.58 11.82 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.682 1.23 . . . . 0.0 111.692 168.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -146.84 146.64 30.28 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.754 1.222 . . . . 0.0 109.832 179.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.16 161.98 37.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.105 1.762 . . . . 0.0 110.699 174.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 99.1 m -133.71 142.91 48.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.156 0.982 . . . . 0.0 110.871 -175.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 23.4 m-85 -145.16 140.1 27.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.321 1.448 . . . . 0.0 111.072 -168.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 14.2 tt -132.53 131.7 60.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 O-C-N 120.744 -1.222 . . . . 0.0 111.899 -177.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.36 94.2 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 127.003 2.121 . . . . 0.0 109.982 -169.35 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.43 4.14 6.42 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.08 1.752 . . . . 0.0 114.34 178.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.41 27.04 3.62 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 126.252 1.882 . . . . 0.0 110.577 -178.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.438 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 0.2 OUTLIER -77.8 138.95 39.26 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.748 0.819 . . . . 0.0 109.599 179.066 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -53.81 -43.13 69.11 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -178.404 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p 172.17 -88.39 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -169.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -140.98 -50.27 0.44 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 127.117 2.167 . . . . 0.0 110.771 -167.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -57.4 -26.59 61.33 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 119.132 -2.23 . . . . 0.0 112.8 171.273 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HB3' ' HG2' ' A' ' 12' ' ' MET . 1.5 m -57.36 -39.18 75.44 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 117.519 -1.229 . . . . 0.0 112.718 170.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -47.89 -46.86 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.702 2.001 . . . . 0.0 111.564 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -67.51 -40.35 85.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.916 1.686 . . . . 0.0 113.605 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -61.33 -36.92 81.47 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.885 -1.134 . . . . 0.0 112.047 172.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.83 -46.34 85.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -176.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.68 -49.13 73.78 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 111.665 170.768 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.2 t -65.67 -41.86 92.01 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -177.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 84.0 m -69.3 -47.8 63.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.886 0.874 . . . . 0.0 110.79 177.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.653 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -76.58 -24.87 53.52 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 117.716 -1.135 . . . . 0.0 113.947 -177.386 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.0 t -81.64 11.53 4.65 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 121.144 1.793 . . . . 0.0 112.47 177.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.73 7.07 9.4 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -169.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HB2' HG12 ' A' ' 31' ' ' VAL . 13.6 mt -85.54 151.84 23.62 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.025 -1.047 . . . . 0.0 112.173 -169.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -67.13 22.95 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.467 2.307 . . . . 0.0 114.396 178.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.51 19.64 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.625 2.37 . . . . 0.0 112.868 -178.343 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.653 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.5 p -125.05 136.22 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 120.827 1.649 . . . . 0.0 112.726 177.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -118.28 -3.26 11.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -175.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -177.31 174.02 1.67 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.315 2.246 . . . . 0.0 111.914 176.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.7 tt -172.99 154.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.67 2.788 . . . . 0.0 108.421 -172.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.2 t -145.98 123.24 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 C-N-CA 126.2 1.8 . . . . 0.0 107.522 164.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.71 149.67 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.171 172.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -73.54 124.31 25.64 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.46 1.504 . . . . 0.0 108.816 166.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.3 -40.41 30.5 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 167.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.03 -51.6 30.9 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.888 2.475 . . . . 0.0 112.772 -173.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -88.87 -174.81 4.64 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.588 1.955 . . . . 0.0 112.398 169.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.2 43.56 1.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.31 1.444 . . . . 0.0 111.397 177.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.0 p -131.99 160.23 36.45 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 119.344 -2.097 . . . . 0.0 114.774 -168.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.54 136.94 33.37 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.092 1.357 . . . . 0.0 110.662 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.2 mt -105.09 115.88 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.419 2.287 . . . . 0.0 105.425 171.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG11 HD13 ' A' ' 57' ' ' LEU . 45.9 t -111.55 129.49 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.011 1.724 . . . . 0.0 108.537 -169.206 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.3 t -109.2 89.95 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.063 1.345 . . . . 0.0 108.174 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -101.3 132.57 46.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.043 1.737 . . . . 0.0 111.481 -170.461 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.286 2.8 p30 -90.02 79.99 6.45 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.485 1.136 . . . . 0.0 110.508 -167.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -165.02 -178.13 5.0 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.878 -167.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.1 p -162.9 -61.34 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 -176.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 m -73.91 45.51 0.2 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.255 1.822 . . . . 0.0 112.837 179.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -156.05 163.84 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.966 1.307 . . . . 0.0 110.404 -176.009 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -100.71 148.04 34.47 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.689 1.196 . . . . 0.0 112.25 -175.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.2 -9.84 26.55 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.459 2.773 . . . . 0.0 112.614 167.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -54.37 -36.84 64.3 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.617 1.099 . . . . 0.0 112.118 176.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.5 m -67.6 -33.37 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.09 -1.006 . . . . 0.0 112.907 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 HG11 ' A' ' 45' ' ' VAL . 68.1 mt -76.18 -43.92 40.43 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.577 0.751 . . . . 0.0 111.343 178.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -52.06 -47.2 65.24 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.411 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -45.08 74.88 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.094 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.09 -33.18 73.95 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.049 1.295 . . . . 0.0 111.653 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.1 mt -70.74 -54.04 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 123.284 0.633 . . . . 0.0 110.524 172.632 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -49.42 -33.75 14.79 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 123.686 0.794 . . . . 0.0 111.39 175.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.34 0.75 27.71 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.4 OUTLIER -96.53 -27.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.151 1.381 . . . . 0.0 111.579 177.333 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.424 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -148.62 64.21 7.62 Favored Pre-proline 0 CA--C 1.549 0.912 0 O-C-N 121.689 -0.632 . . . . 0.0 111.498 168.473 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.21 144.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 124.29 3.327 . . . . 0.0 112.912 -172.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.67 -18.02 9.73 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.577 1.084 . . . . 0.0 113.975 -175.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -105.65 -47.36 3.92 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.979 1.711 . . . . 0.0 110.6 177.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.459 ' CE2' HG12 ' A' ' 64' ' ' VAL . 2.9 m-30 -66.38 107.28 1.97 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -175.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.19 75.36 4.72 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.419 -1.425 . . . . 0.0 109.887 169.123 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 t -84.16 129.79 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 O-C-N 121.458 -0.777 . . . . 0.0 111.464 -176.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.3 134.59 38.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.387 1.075 . . . . 0.0 110.634 -171.732 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.22 112.54 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 120.806 -1.184 . . . . 0.0 108.888 170.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 t -111.67 128.43 56.06 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.57 1.148 . . . . 0.0 108.896 168.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 t -132.71 168.0 19.1 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.537 1.535 . . . . 0.0 112.663 175.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -74.58 83.4 2.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.57 1.176 . . . . 0.0 108.943 169.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 N--CA 1.475 0.822 0 C-N-CA 127.242 2.217 . . . . 0.0 109.72 168.914 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 121.704 0.764 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -124.82 158.93 32.2 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.44 3.096 . . . . 0.0 111.406 -174.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 t -125.09 -177.74 3.96 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.454 1.102 . . . . 0.0 110.182 167.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -164.07 151.54 12.22 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.15 0.98 . . . . 0.0 109.989 -169.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -151.63 158.86 44.05 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 125.284 1.434 . . . . 0.0 111.216 171.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.4 m -120.86 140.04 52.33 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.931 1.293 . . . . 0.0 109.672 178.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.85 151.61 47.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.608 1.163 . . . . 0.0 111.176 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.2 tt -134.77 140.03 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 124.948 1.299 . . . . 0.0 110.717 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.3 mp -118.8 140.9 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 125.631 1.572 . . . . 0.0 110.907 -173.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . 0.262 0.4 OUTLIER -123.27 145.78 48.41 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 165.818 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.93 11.41 54.91 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.744 1.164 . . . . 0.0 112.708 -171.245 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.403 ' HG2' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -84.22 153.04 23.86 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.824 1.65 . . . . 0.0 111.378 -171.628 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.4 m-70 -77.99 32.25 0.17 Allowed 'General case' 0 CA--C 1.556 1.203 0 O-C-N 119.711 -1.868 . . . . 0.0 114.519 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.7 t 66.31 -71.6 0.09 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 127.129 2.172 . . . . 0.0 114.886 169.681 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HE3' HD13 ' A' ' 38' ' ' LEU . 10.5 mptt -108.31 -38.4 5.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.093 0.957 . . . . 0.0 112.944 177.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 p -74.25 -21.47 59.76 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 119.425 -2.047 . . . . 0.0 112.79 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' ' HG2' ' A' ' 12' ' ' MET . 27.6 p -51.17 -51.63 51.88 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.487 1.04 . . . . 0.0 110.073 169.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.582 HG13 ' CG1' ' A' ' 36' ' ' VAL . 53.9 t -46.35 -55.54 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 128.042 2.537 . . . . 0.0 112.234 -174.374 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.4 t -64.11 -40.17 95.63 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 123.441 0.463 . . . . 0.0 111.585 -171.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -57.64 -46.49 84.1 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.699 -0.625 . . . . 0.0 112.401 169.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -44.51 84.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 118.721 -0.657 . . . . 0.0 109.842 -172.317 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -53.22 -49.28 67.1 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.247 0.967 . . . . 0.0 110.286 171.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 t -70.41 -41.31 73.14 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.732 2.123 . . . . 0.0 116.732 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.8 m -76.92 -36.43 56.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.833 1.253 . . . . 0.0 111.255 -175.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.23 -45.91 53.25 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.75 172.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.7 t -72.17 16.24 0.14 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 121.483 1.947 . . . . 0.0 114.206 -172.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.93 -7.52 14.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.12 1.768 . . . . 0.0 112.311 174.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.32 133.58 45.07 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.922 -1.111 . . . . 0.0 110.448 -169.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -64.5 -0.04 1.22 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -170.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.89 -10.36 11.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.412 1.485 . . . . 0.0 114.855 169.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 5.9 p -89.4 138.97 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-N 121.088 1.767 . . . . 0.0 110.362 -169.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.0 t -99.24 -34.71 10.23 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 112.242 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -158.76 160.33 36.19 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.342 1.057 . . . . 0.0 110.644 -165.432 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.75 152.21 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.632 1.573 . . . . 0.0 109.8 174.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.5 t -143.62 129.98 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.464 0 C-N-CA 126.449 1.9 . . . . 0.0 107.449 167.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' CG1' HG13 ' A' ' 18' ' ' VAL . 51.6 t -101.72 143.71 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 123.399 1.571 . . . . 0.0 111.826 171.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m -78.19 87.09 4.29 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.028 174.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.487 HD13 ' HE3' ' A' ' 15' ' ' LYS . 1.1 tm? -44.87 -42.51 8.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.959 2.504 . . . . 0.0 113.417 -177.003 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 15' ' ' LYS . 71.6 mm-40 -81.92 -8.87 59.71 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.433 HD22 ' C ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -131.17 -173.82 3.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.969 2.508 . . . . 0.0 109.347 -169.761 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.94 30.05 7.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.927 1.291 . . . . 0.0 113.525 -175.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 p -131.82 160.69 34.89 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -174.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.08 140.79 48.96 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.473 1.909 . . . . 0.0 110.658 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -111.17 114.25 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 169.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' CG1' HD13 ' A' ' 57' ' ' LEU . 21.1 t -116.26 131.78 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.541 1.536 . . . . 0.0 107.482 -169.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 33' ' ' SER . 57.4 t -120.52 107.89 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 -168.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CD1' HD11 ' A' ' 57' ' ' LEU . 42.7 p90 -127.54 148.37 50.34 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.061 -1.024 . . . . 0.0 112.981 -168.675 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.5 136.37 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.114 0.966 . . . . 0.0 110.795 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -178.74 144.4 0.27 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.97 1.308 . . . . 0.0 111.355 -172.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -74.2 -37.26 63.95 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.432 0.56 . . . . 0.0 109.739 166.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.4 t -178.95 162.25 1.25 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.508 3.123 . . . . 0.0 108.219 168.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p 172.37 164.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 129.029 2.931 . . . . 0.0 107.524 -169.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.9 t -76.95 133.28 69.68 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.866 173.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -59.95 -21.15 63.45 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.922 2.414 . . . . 0.0 110.589 168.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -67.95 -10.26 51.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.78 1.173 . . . . 0.0 113.563 178.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.3 p -61.58 -45.15 95.35 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.789 -1.194 . . . . 0.0 112.1 168.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 47' ' ' TYR . 77.4 mt -71.12 -42.89 68.64 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.625 -0.702 . . . . 0.0 110.642 175.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.78 -46.99 51.32 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.278 1.031 . . . . 0.0 111.431 172.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -62.22 -38.09 87.86 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.28 -33.96 76.64 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.699 1.59 . . . . 0.0 111.783 173.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -68.28 -54.7 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.139 0.576 . . . . 0.0 110.905 171.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -55.75 -22.52 24.47 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.159 0.891 . . . . 0.0 112.615 175.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.42 5.31 42.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.452 HG12 ' CE2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -97.22 -30.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.058 0.943 . . . . 0.0 111.696 173.187 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.9 OUTLIER -144.2 64.83 12.9 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.732 -0.605 . . . . 0.0 111.666 168.795 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.79 138.39 82.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.232 3.288 . . . . 0.0 112.431 -177.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.12 -22.29 5.25 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.466 1.031 . . . . 0.0 113.662 -175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.7 tp -93.41 -54.07 3.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.477 1.511 . . . . 0.0 110.133 173.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' CE2' HG12 ' A' ' 64' ' ' VAL . 4.7 m-30 -70.09 117.0 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 126.045 1.738 . . . . 0.0 114.048 -177.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? -96.29 100.65 12.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 167.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -111.68 139.25 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 119.363 0.983 . . . . 0.0 112.672 -173.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.5 m -144.63 160.04 41.82 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.824 1.25 . . . . 0.0 112.764 -176.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 74.1 mt -102.41 119.84 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.99 1.716 . . . . 0.0 107.469 173.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 106.56 18.4 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -175.081 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.8 m -159.44 175.29 13.49 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.702 1.201 . . . . 0.0 112.647 -176.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.49 121.75 21.98 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 105.956 -1.868 . . . . 0.0 105.956 166.261 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.1 m . . . . . 0 CA--C 1.54 0.561 0 C-N-CA 127.776 2.43 . . . . 0.0 108.226 169.697 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 CA--C 1.549 0.94 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.37 148.78 31.22 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.898 1.679 . . . . 0.0 112.934 169.492 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -112.96 176.73 4.89 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.127 2.171 . . . . 0.0 110.853 -177.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.66 163.33 40.4 Favored 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 120.623 -1.298 . . . . 0.0 111.548 178.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -149.03 159.09 44.54 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 125.132 1.373 . . . . 0.0 110.187 169.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.9 154.59 26.12 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 124.626 1.17 . . . . 0.0 110.435 172.025 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 57' ' ' LEU . 53.2 m-85 -150.61 141.81 23.18 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.822 -1.536 . . . . 0.0 110.738 -176.627 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.1 tt -126.62 140.05 50.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.095 1.358 . . . . 0.0 110.289 177.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -117.3 98.39 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 126.478 1.911 . . . . 0.0 109.515 -170.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.69 65.26 7.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 123.534 1.635 . . . . 0.0 113.876 -169.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 175.61 -57.99 0.11 Allowed Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 174.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.441 ' HG2' ' HB3' ' A' ' 17' ' ' CYS . 2.6 tmm? 45.08 -149.4 0.07 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.272 1.429 . . . . 0.0 109.56 -176.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -120.53 -33.06 3.92 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.407 -1.433 . . . . 0.0 111.386 167.554 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 p 161.76 -72.94 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.927 2.091 . . . . 0.0 113.589 178.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HE3' HD22 ' A' ' 38' ' ' LEU . 20.0 tptt -144.31 -57.38 0.37 Allowed 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.241 1.017 . . . . 0.0 109.815 -168.151 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 -30.77 28.19 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.016 -1.678 . . . . 0.0 113.478 171.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.456 ' HA ' HD22 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -57.61 -41.48 81.37 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.695 172.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.538 HG12 HG11 ' A' ' 36' ' ' VAL . 95.4 t -51.07 -42.73 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.834 1.653 . . . . 0.0 112.034 -176.512 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.6 t -71.09 -37.47 72.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.933 1.293 . . . . 0.0 113.277 178.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 17' ' ' CYS . 85.3 m-20 -60.24 -36.97 78.96 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.024 -1.048 . . . . 0.0 112.291 170.337 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -68.56 -48.23 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -175.925 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' HG12 ' A' ' 36' ' ' VAL . 43.1 mt-10 -54.81 -51.91 64.34 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 124.044 0.84 . . . . 0.0 111.624 170.061 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.9 m -61.46 -41.28 96.99 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -176.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -68.41 -49.15 62.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.761 1.224 . . . . 0.0 110.189 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -75.74 -15.76 60.23 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -178.405 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -76.26 -3.07 34.6 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 173.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.49 7.68 11.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -166.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.6 mt -79.35 152.29 30.52 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.165 -0.96 . . . . 0.0 112.599 -169.392 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -67.79 23.21 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.403 2.281 . . . . 0.0 114.501 -177.654 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -166.45 2.02 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.508 2.323 . . . . 0.0 114.341 -175.756 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 25' ' ' LEU . 14.6 p -105.24 139.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-N 121.876 2.125 . . . . 0.0 111.307 -174.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.1 t -111.19 -11.62 14.21 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.5 m -176.07 175.03 1.98 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.175 1.79 . . . . 0.0 112.08 -175.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.5 tt -175.55 152.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.041 2.536 . . . . 0.0 109.968 -171.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -147.88 134.57 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 127.86 2.464 . . . . 0.0 107.5 166.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG11 HG12 ' A' ' 18' ' ' VAL . 2.9 p -107.14 151.74 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 122.142 0.973 . . . . 0.0 113.174 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -90.15 102.75 15.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.58 0.752 . . . . 0.0 111.257 170.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.606 HD22 ' HE3' ' A' ' 15' ' ' LYS . 0.3 OUTLIER -57.81 -35.54 70.99 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.255 1.422 . . . . 0.0 113.401 -179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.99 5.55 49.71 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.152 1.381 . . . . 0.0 113.874 -179.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -119.34 -173.94 2.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.951 1.7 . . . . 0.0 109.527 169.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.66 42.81 2.05 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.082 -1.011 . . . . 0.0 111.057 168.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 p -146.22 151.81 38.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -168.149 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.77 137.26 41.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.591 2.356 . . . . 0.0 112.055 -169.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.63 118.71 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 126.588 1.955 . . . . 0.0 106.544 174.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.502 ' CG1' HD13 ' A' ' 57' ' ' LEU . 25.2 t -119.77 120.35 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.756 1.622 . . . . 0.0 109.323 -167.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -107.06 107.78 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.854 1.662 . . . . 0.0 109.548 -169.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.537 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.7 p90 -121.0 158.32 28.01 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.041 1.336 . . . . 0.0 113.515 -171.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -96.21 101.07 12.66 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.397 -1.439 . . . . 0.0 112.902 -168.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.79 150.87 5.92 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 125.779 1.632 . . . . 0.0 109.712 173.569 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.3 m -83.81 27.64 0.63 Allowed 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.069 -1.019 . . . . 0.0 110.772 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.2 t -162.89 -175.37 4.35 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 120.895 -1.128 . . . . 0.0 113.12 -170.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.43 137.83 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 127.433 2.293 . . . . 0.0 111.232 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 m -171.05 87.38 0.48 Allowed Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 128.6 2.76 . . . . 0.0 106.917 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.04 -18.78 1.35 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.999 2.466 . . . . 0.0 113.871 -171.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -61.7 -32.06 72.24 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.949 1.25 . . . . 0.0 113.001 -174.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.28 64.35 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 119.924 -1.735 . . . . 0.0 113.416 -178.098 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 47' ' ' TYR . 58.2 mt -78.76 -46.42 18.9 Favored 'General case' 0 C--N 1.339 0.117 0 O-C-N 121.898 -0.501 . . . . 0.0 110.145 173.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -46.87 -49.63 19.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.603 0.761 . . . . 0.0 110.124 169.376 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -58.32 -41.16 83.93 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.674 1.19 . . . . 0.0 113.734 176.074 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.26 73.75 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.38 0.991 . . . . 0.0 112.18 172.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.2 mt -70.84 -54.41 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.322 0.649 . . . . 0.0 110.557 172.708 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -55.03 -23.14 18.27 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.498 1.119 . . . . 0.0 112.52 179.755 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.65 4.25 37.29 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' A' ' 69' ' ' TYR . 1.4 p -98.83 -39.42 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.781 0.833 . . . . 0.0 111.582 -179.009 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -139.84 64.77 29.34 Favored Pre-proline 0 CA--C 1.547 0.834 0 O-C-N 121.943 -0.473 . . . . 0.0 112.053 166.816 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.77 143.17 81.79 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 124.297 3.331 . . . . 0.0 114.189 -171.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.97 -43.41 3.24 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 125.438 1.494 . . . . 0.0 112.414 -175.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.8 tp -77.47 -39.22 47.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.686 1.194 . . . . 0.0 110.524 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 64' ' ' VAL . 3.2 m-85 -71.76 89.98 1.06 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.162 -0.961 . . . . 0.0 112.895 176.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -74.96 76.18 2.18 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.315 1.446 . . . . 0.0 110.098 169.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.8 t -92.05 133.69 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.952 -1.092 . . . . 0.0 111.785 -169.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 33.2 t -151.28 159.21 44.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 122.95 1.357 . . . . 0.0 111.289 168.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.66 130.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 166.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t -110.11 121.1 44.48 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 169.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.3 t -146.45 -179.28 6.65 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 125.209 1.404 . . . . 0.0 111.397 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -71.66 61.4 0.37 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.924 2.089 . . . . 0.0 111.556 174.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 125.309 1.444 . . . . 0.0 111.344 171.525 . . . . . . . . 0 0 . 1 stop_ save_